var graphJson = {"directed": false, "multigraph": false, "graph": {"node_default": {}, "edge_default": {}}, "nodes": [{"entity_type": "DISEASE", "description": "A condition characterized by excessive body fat accumulation, influenced by genetic factors such as the FTO gene variant.<SEP>Obesity is a condition characterized by excessive body fat accumulation and increased health risks.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "OBESITY"}, {"entity_type": "DISEASE", "description": "Metabolic syndrome includes conditions such as obesity and type 2 diabetes that are linked to variants in the PPAR\u03b3 gene.<SEP>Metabolic syndrome is a cluster of conditions that increase the risk for heart disease, stroke, and diabetes.", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f<SEP>chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "METABOLIC SYNDROME"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "A measurement of abdominal obesity that is higher in groups with abnormal blood glucose levels, indicating a risk factor for T2DM.<SEP>Waist circumference measures abdominal fat and is used as an indicator of metabolic health risks.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "WAIST CIRCUMFERENCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fat mass refers to the total amount of body fat, which can affect metabolic and cardiovascular health.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "FAT MASS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Skeletal muscle mass is the quantity of skeletal muscle tissue in the body, important for overall physical function.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "SKELETAL MUSCLE MASS"}, {"entity_type": "METABOLIC PATHWAY", "description": "Total cholesterol levels reflect the amount of cholesterol carried by lipoproteins in blood and are indicative of cardiovascular health risks.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "SERUM TOTAL CHOLESTEROL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "LDL concentration measures low-density lipoprotein, a form of cholesterol associated with increased risk for heart disease.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "LDL CONCENTRATION"}, {"entity_type": "METABOLIC PATHWAY", "description": "Serum triglycerides are fats in the blood and their high levels can indicate poor metabolic health.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "SERUM TRIGLYCERIDE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "High-density lipoprotein (HDL) concentration is a measure of good cholesterol, which helps remove bad cholesterol from arteries.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 25}]", "id": "SERUM HDL CONCENTRATION"}, {"entity_type": "METABOLIC PATHWAY", "description": "C-reactive protein (CRP) is an acute-phase reactant produced by the liver and its high levels indicate systemic inflammation.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "HS-CRP CONCENTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Blood pressure measures the force of blood against artery walls; hypertension increases risks for heart disease, stroke, etc.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "BLOOD PRESSURE (SBP/DBP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Estimated Glomerular Filtration Rate (eGFR) is a measure used to assess kidney function.<SEP>Estimated glomerular filtration rate is a measure of kidney function and its decrease can indicate kidney damage.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "EGFR"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Alanine transaminase concentration is an enzyme used to detect liver injury or damage.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "ALT CONCENTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Aspartate aminotransferase concentration measures liver health and can indicate muscle diseases or alcohol abuse as well.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "AST CONCENTRATION"}, {"entity_type": "NUTRIENT", "description": "Dietary Inflammatory Index assesses the inflammatory potential of diet based on nutrient intake patterns.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "DII (DIETARY INFLAMMATORY INDEX)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Frequent consumption of fried foods can increase risks for obesity and other chronic diseases due to high fat and calorie content.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "FRIED FOOD INTAKE"}, {"entity_type": "NUTRIENT", "description": "Intake of sugar-containing foods can contribute significantly to energy intake and play a role in weight gain or obesity risk.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "SUGAR-CONTAINING FOODS INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern that includes balanced components typical in Korean cuisine, affecting health outcomes such as obesity risk.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "KOREAN BALANCED DIET INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern characterized by high intake of processed and red meats, refined grains, and sweets associated with higher risks for chronic diseases.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "WESTERN-STYLE DIET INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "A diet rich in vegetables, fruits, whole grains, nuts, seeds, and legumes, which can reduce obesity risk.<SEP>Intake of plant-based diet interacts with PRS for the obesity risk; high intake can protect against obesity even in individuals with high PRS.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 25}]", "id": "PLANT-BASED DIET INTAKE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Alcohol consumption has been linked to various health outcomes including increased risk of obesity.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "ALCOHOL INTAKE"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Being a current smoker is considered a lifestyle factor that can affect overall health status and disease risks.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "CURRENT SMOKER STATUS"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Engaging in regular physical activity as part of a healthy lifestyle, which can reduce obesity risk.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 25}]", "id": "REGULAR EXERCISE"}, {"entity_type": "DEMOGRAPHIC VARIABLE", "description": "Age is a demographic characteristic that can influence health outcomes and risk factors for various diseases.<SEP>The process of aging impacts the prevalence and risk factors associated with snoring.<SEP>Participant age is an environmental factor significantly associated with higher levels of social disinhibition.<SEP>The age of participants was considered as a risk factor for severity of acute and delayed CINV.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "AGE"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Gender is a biological factor affecting health risks, including obesity and metabolic syndrome.<SEP>Gender, as a lifestyle factor, did not show significant association with increased risk of social disinhibition in the multivariable analysis.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 13}]", "id": "GENDER"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of body fat based on an individual\'s weight in relation to their height.<SEP>A measure of body fat based on height and weight, BMI is a risk factor for various diseases including snoring when adjusted in genetic studies.<SEP>A measure of body fat based on height and weight; found to differ by genotype at baseline.<SEP>A measure used to assess obesity levels, studied in association with genetic variants.<SEP>BMI calculation reflects the interaction between genetic factors like FTO SNP and environmental influences such as education level to determine health risks.<SEP>BMI measures body fat based on height and weight and is used to classify overweight or obese individuals.<SEP>BMI is positively correlated with snoring prevalence, especially in both sexes when considering whole-body fat mass.<SEP>A measure of body fat based on an individual\'s weight-to-height ratio; significantly higher in women with PCOS compared to control subjects.<SEP>A measure used to assess body fat based on height and weight; increases with abnormal blood glucose levels (IFG and IGT) leading to T2DM.<SEP>An indicator of body fatness that influences the association between certain SNPs and habitual coffee intake.<SEP>Men show significant differences in BMI according to the rs671 polymorphism; this may be linked to variations in alcohol consumption and cortisol levels.<SEP>An index calculated from a person\'s weight and height, used to assess the risk of obesity-related diseases.<SEP>BMI is a measure of body fat based on height and weight that differed significantly between cases and controls.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5<SEP>chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-7ca64f92964b051cfb1c43f967f243a5<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-6f7ce1c71bd46f223756da44b0d0bb2c<SEP>chunk-a34b927ed42ff0917960122b4d203f83<SEP>chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 13}]", "id": "BMI (BODY MASS INDEX)"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Engagement in physical activities can influence obesity risk, metabolic health, and cardiovascular fitness.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "id": "PHYSICAL ACTIVITY LEVEL"}, {"entity_type": "GENETIC TRAIT", "description": "Having a family history of obesity increases genetic predisposition to weight gain and related conditions.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 13}]", "id": "FAMILY HISTORY OF OBESITY"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs543874) in SEC16B, an endoplasmic reticulum export factor gene, is associated with obesity risk.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "SEC16B_RS543874"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs713586) in DNAJC27, a heat shock protein family member C27, influences the obesity risk.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "DNAJC27_RS713586"}, {"entity_type": "GENOMIC VARIANT", "description": "The CDKAL1 rs9356744 variant is linked to obesity risk and affects energy intake or expenditure via modulation of transcription factors.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "CDKAL1_RS9356744"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant (rs2206277) in the TFAP2B gene, a transcription factor AP-2 Beta, affects obesity risk.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 18}]", "id": "TFAP2B_RS2206277"}, {"entity_type": "GENOMIC VARIANT", "description": "The BDNF rs6265 variant impacts energy intake or expenditure through its influence on transcription factors and is associated with obesity risk.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "BDNF_RS6265"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant (rs3782889) in myosin light chain-2 (MYL2) affects the obesity risk but does not meet statistical criteria.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 18}]", "id": "MYL2_RS3782889"}, {"entity_type": "GENOMIC VARIANT", "description": "The OLFM4 rs9568856 variant is involved in regulating energy intake or expenditure and contributes to obesity risk.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "OLFM4_RS9568856"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs1421085) in the FTO gene acts as a hub gene influencing the obesity risk by modulating energy intake or expenditure.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "FTO_RS1421085"}, {"entity_type": "GENOMIC VARIANT", "description": "The MC4R rs6567160 variant functions as a hub gene that affects obesity risk through its regulation of energy intake or expenditure.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "MC4R_RS6567160"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant (rs1444988703) in the GIPR gene influences obesity risk by modulating transcription factors involved in energy intake or expenditure.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "GIPR_RS1444988703"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Regulation of energy intake and expenditure through modulation of transcription factors is a key physiological process linked to obesity risk.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "ENERGY INTAKE AND EXPENDITURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Adherence to the Mediterranean diet is associated with lower BMI levels among individuals.<SEP>BMI is a measure used to assess the impact of genetic variants on obesity risk, showing an increasing trend with PRS scores.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 36}]", "id": "BODY MASS INDEX (BMI)"}, {"entity_type": "DISEASE", "description": "Increased BMI and waist circumference indicate higher obesity risk, a condition closely linked with the FTO gene variant and educational level.<SEP>Obesity risk is influenced by interactions between genetic factors (PRS) and environmental factors such as dietary patterns.<SEP>The identified SNPs and their interactions contribute significantly to the risk of developing obesity.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 18}]", "id": "OBESITY RISK"}, {"entity_type": "GENOMIC VARIANT", "description": "Polygenic risk score (PRS) for obesity interacts with age at menarche and dietary factors to influence BMI.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 18}]", "id": "PRS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of early onset of menstruation in women, which interacts with PRS to influence the obesity risk.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "id": "EARLY MENARCHE AGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Body Mass Index (BMI) is a measure used for adjusting analyses and assessing its influence on T2D risk associated with genetic variants.<SEP>Body Mass Index (BMI) is a measure used to assess obesity risk and shows interaction with both genetic factors and dietary patterns.<SEP>Body Mass Index (BMI) is a measure used to determine if an individual\'s weight is healthy relative to their height. It plays a role in assessing obesity and related health risks.<SEP>Body Mass Index, a factor mediating pleiotropic effects of certain SNPs on cardiometabolic traits.<SEP>Body Mass Index (BMI) is a measure used to assess obesity or underweight conditions; in this study, cases had slightly higher BMI compared to controls.<SEP>Body Mass Index, a measure used in clinical settings to assess obesity and related health risks.<SEP>Body Mass Index (BMI) is positively correlated with sUA levels and HUA risk, particularly in individuals carrying the ABCG2 rs2231142 T allele.<SEP>Body Mass Index (BMI) is a measure used to assess body fat based on height and weight.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6<SEP>chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-44a871da300abc9be525b468f502f5cb<SEP>chunk-bb507a90a1f5d5ddd01a93200ff2d45e<SEP>chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-372184452f1f9156514992455057f843<SEP>chunk-3ad8ef794841d749e48b3223741e91d3<SEP>chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 22}]", "id": "BMI"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Individuals who consume a high amount of plant-based foods have lower genetic impact on BMI when compared to those with low intake and low PRS.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "id": "HIGH PLANT-BASED DIET INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "Intake of fried food interacts with PRS, where high intake is associated with higher BMI but the genetic impact (PRS) is offset in this group.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 18}]", "id": "FRIED-FOOD INTAKE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Individuals who consume a lot of fried foods have their genetic impact on BMI mitigated, indicating that dietary choices can modify obesity risk irrespective of PRS.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "id": "HIGH FRIED-FOOD INTAKE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Individuals with low intake of plant-based diet show higher BMI when combined with high PRS, compared to those with high plant-based intake and high PRS.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "id": "LOW PLANT-BASED DIET INTAKE"}, {"entity_type": "GENOMIC VARIANT", "description": "A high polygenic risk score (PRS) indicates a higher genetic predisposition towards obesity risk.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "id": "HIGH PRS"}, {"entity_type": "GENOMIC VARIANT", "description": "The FTO rs1558902 genotype is a genetic variant that influences weight loss and body composition changes, particularly in response to high-protein diets.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "FTO RS1558902 GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Weight loss refers to the physiological process of reducing overall body mass, which can be influenced by dietary interventions and genetic factors such as the FTO rs1558902 genotype.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "WEIGHT LOSS"}, {"entity_type": "DIETARY PATTERN", "description": "A high-protein diet is a dietary pattern characterized by higher protein intake relative to other macronutrients, which can influence fat distribution depending on genotype.<SEP>A high-protein diet is a dietary pattern characterized by increased protein intake relative to carbohydrate and fat, which can influence weight loss in individuals with certain genotypes like the FTO rs1558902 risk allele carriers.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "HIGH-PROTEIN DIET"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Changes in fat distribution are a result of interactions between genotype and environmental factors like diet over time.<SEP>Changes in fat distribution refer to physiological processes involving alterations in body composition such as total adipose tissue, visceral and subcutaneous fat levels.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "FAT DISTRIBUTION CHANGES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The linear mixed models analysis is a statistical method used to assess genotype-time interactions on changes in body composition and fat distribution over time, particularly in response to dietary interventions such as protein diets.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "LINEAR MIXED MODELS ANALYSIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Total fat loss involves the physiological process of reducing overall adipose tissue mass within the body.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "TOTAL FAT LOSS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Loss in fat-free mass refers to a decrease in muscle and other non-fat tissues, which can be influenced by dietary protein intake and genetic factors like FTO rs1558902 genotype.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "FAT-FREE MASS (FFM) LOSS"}, {"entity_type": "GENE", "description": "Associated with obesity risk, also tied to alcohol consumption, coffee consumption, and insomnia.<SEP>The FTO gene encodes a protein that is associated with the regulation of energy balance and obesity risk.<SEP>The FTO gene harbors a single nucleotide polymorphism (SNP) that is associated with obesity risk.<SEP>The FTO gene is a critical genetic locus associated with obesity risk and anthropometric measurements.<SEP>The FTO gene is associated with obesity predisposition.<SEP>The FTO gene where one of the novel SNPs (rs1558902) is located and influences CRP levels in association studies.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 14}]", "id": "FTO GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "MAF is a measure used to describe genetic variation within a population, indicating the proportion of a specific allele in the gene pool.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "MINOR ALLELE FREQUENCY (MAF)"}, {"entity_type": "GENOMIC VARIANT", "description": "The A allele at the rs1558902 locus is considered a risk allele for obesity and weight gain due to its influence on energy balance.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "A ALLELE (RISK ALLELE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Baseline Body Mass Index (BMI) represents an individual\'s initial body mass index before intervention, used as a reference point in clinical trials.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 14}]", "id": "BASELINE BMI"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FM%, or fat mass percentage, indicates the proportion of body mass that is fat tissue, which can change in response to diet and genetic influences.<SEP>The percentage of body fat relative to total weight, affected by dietary interventions and genetic predispositions such as the FTO gene variant.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "FM% (FAT MASS PERCENTAGE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Loss of trunk fat is a reduction in adipose tissue localized around the torso area, influenced by diet and genetics.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "TRUNK FAT LOSS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Changes in visceral adipose tissue refer to alterations in intra-abdominal fat deposits that affect health outcomes such as metabolic syndrome.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "VISCERAL ADIPOSE TISSUE (VAT) CHANGES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Alterations in subcutaneous adipose tissue involve changes in superficial body fat deposits which are influenced by dietary and genetic factors.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "SUBCUTANEOUS ADIPOSE TISSUE (SAT) CHANGES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An analysis method used to study the interaction between genetic variants (such as FTO rs1558902) and environmental factors (dietary protein intake), impacting physiological processes like weight loss and body composition changes.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "id": "GENE-DIET INTERACTION ANALYSIS"}, {"entity_type": "GENOMIC VARIANT", "description": "Individuals carrying the AA genotype for the GCKR rs780094 SNP have significantly higher TAG, TC, and apoB concentrations as well as a greater risk of hypertriacylglycerolaemia compared to GG individuals.<SEP>The AA genotype is a genetic variant that influences changes in fat distribution and body composition in response to dietary interventions.<SEP>The AA genotype of rs1695 polymorphism is a genetic variant with no significant association to breast cancer risk according to our study.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e<SEP>chunk-c6fdc5ed25c4e17b8c421a952bb05450<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "AA GENOTYPE"}, {"entity_type": "DIETARY PATTERN", "description": "A low-protein diet is a dietary pattern with lower protein content compared to high-protein diets, affecting changes in fat distribution based on genotypes such as AA genotype.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "LOW-PROTEIN DIET"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fat distribution refers to the physiological process of how body fat is distributed across different regions, influenced by genetic factors and dietary patterns.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "FAT DISTRIBUTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TAT represents total abdominal adipose tissue, a measure of fat distribution that can change in response to diet and genotype interactions.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "TAT (TOTAL ABDOMINAL ADIPOSE TISSUE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "SAT refers to subcutaneous abdominal adipose tissue, which is part of the physiological process of fat distribution affected by dietary patterns and genotypes.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "SAT (SUBCUTANEOUS ABDOMINAL ADIPOSE TISSUE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Total fat measures the overall amount of body fat, influenced by dietary intake and genetic factors like genotype-time interactions.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "TOTAL FAT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Trunk fat refers to fat distribution around the trunk area of the body, influenced by dietary patterns and genotype-time interactions.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "TRUNK FAT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Genotype-time interaction refers to how genetic variants influence physiological processes in response to time-dependent factors such as dietary interventions.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "GENOTYPE-TIME INTERACTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The change in total body fat is influenced by both genetic variants and dietary patterns such as low-fat diets.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "TOTAL FAT CHANGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Alterations in the percentage of body mass that is fat tissue, affected by genotype-time interactions under different dietary conditions.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "FM% (FAT MASS PERCENTAGE) CHANGES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Changes in trunk fat distribution are influenced by genetic and environmental factors such as diet over time.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "TRUNK FAT CHANGE"}, {"source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "description": "Changes in total fat are often accompanied by corresponding losses or gains in fat-free mass, indicating an overall shift in body composition.", "entity_type": "UNKNOWN", "id": "FAT-FREE MASS LOSS"}, {"source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "description": "The initial FM% provides context for how genetic factors and dietary interventions can influence the percentage of body fat over time.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 14}]", "id": "FM%"}, {"source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "description": "Genotype-time interactions on changes in fat distribution are observed under low-fat dietary conditions.", "entity_type": "UNKNOWN", "id": "LOW-FAT DIET"}, {"entity_type": "GENOMIC VARIANT", "description": "The FTO rs9939609 polymorphism is a genomic variant associated with anthropometric variables such as weight, BMI and waist circumference.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "FTO RS9939609 POLYMORPHISM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Anthropometric measurements like body mass index (BMI), weight, and waist circumference are physiological processes used to assess obesity risk and overall health.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "ANTHROPOMETRIC VARIABLES"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Educational background is an environmental factor influencing health outcomes such as obesity risk when interacting with genetic factors like the FTO SNP.<SEP>The education level of participants was noted as lower for cases than controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6<SEP>chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 16}]", "id": "EDUCATION LEVEL"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism in the FTO gene that is associated with obesity risk.<SEP>The FTO single nucleotide polymorphism (SNP) is a genomic variant associated with increased BMI and higher obesity prevalence in certain educational groups.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 16}]", "id": "FTO SNP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "These include weight, BMI, and waist circumference which are used to assess health status and obesity risk.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 14}]", "id": "ANTHROPOMETRIC MEASUREMENTS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Individuals with primary education level show higher obesity risk when carrying the FTO rs9939609 polymorphism compared to those with university education.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "PRIMARY STUDIES EDUCATION LEVEL"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Similar to primary studies, individuals with secondary education also exhibit higher obesity risk associated with the FTO variant.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "SECONDARY STUDIES EDUCATION LEVEL"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Individuals with university-level education show a lower association between the FTO rs9939609 polymorphism and anthropometric variables.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 16}]", "id": "UNIVERSITY STUDIES EDUCATION LEVEL"}, {"entity_type": "LIFESTYLE FACTOR", "description": "A physiological process involving bodily movement that affects metabolism and energy expenditure, which may modify genetic effects on obesity risk when considering environmental factors like education level.<SEP>The level of physical activity in an individual\'s lifestyle, which interacts with genetic factors like the FTO SNP to influence BMI.<SEP>Physical activity is a lifestyle factor that interacts with genetic factors to modify the risk of type 2 diabetes, especially when combined with dietary interventions.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 17}]", "id": "PHYSICAL ACTIVITY (PA)"}, {"entity_type": "DISEASE", "description": "High prevalence of obesity is observed particularly among groups with lower education levels and specific genotypes.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "PREVALENCE OF OBESITY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Level of education can influence lifestyle choices and health outcomes, including obesity risk in relation to genetic variants like those in the FTO gene.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 16}]", "id": "EDUCATION"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Engaging in university studies represents an environmental factor influencing lifestyle and health outcomes, particularly in relation to genetic variants such as the FTO SNP.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 16}]", "id": "UNIVERSITY STUDIES"}, {"entity_type": "GENE", "description": "The TCF7L2 gene has SNPs that are significantly associated with BMI at baseline.<SEP>The TCF7L2 gene is associated with Type 2 diabetes risk and has a specific variant rs7903146 that influences the association with disease.<SEP>The TCF7L2 gene is associated with an increased risk of Type 2 Diabetes (T2D) and End Stage Renal Disease (ESRD), as indicated by the presence of a specific variant rs7903146.<SEP>The TCF7L2 gene is frequently investigated for its interaction with dietary factors in the context of type 2 diabetes risk.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 12}]", "id": "TCF7L2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "The genetic variant includes specific alleles such as CC genotype and T allele, which are associated with colorectal cancer risk.<SEP>Various genetic variants are associated with increased or decreased susceptibility to type 2 diabetes when interacting with environmental and lifestyle factors such as diet and physical activity.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "GENETIC VARIANT"}, {"entity_type": "DIETARY PATTERN", "description": "Although not directly mentioned, dietary patterns may influence CYP24A1 activity and its variants\' expression levels.<SEP>Dietary patterns influence physiological processes and can interact with genotypes.<SEP>Investigations into dietary patterns, including whole grain intake and fiber consumption, reveal interactions with genetic variants that influence the risk of developing type 1 or type 2 diabetes.<SEP>Investigations into dietary patterns, including whole grain intake and fiber consumption, reveal interactions with genetic variants that influence the risk of developing type 2 diabetes.<SEP>Patterns of dietary intake that influence metabolic processes like insulin sensitivity and secretion.<SEP>There is no direct reference to dietary patterns affecting the algorithms or patient outcomes in this context.<SEP>Consumption patterns of dairy products influence the expression and regulation of the LCT gene over time.<SEP>Dietary patterns rich in omega-3 fatty acids can influence the metabolic pathways and inflammatory responses mediated by PPAR\u03b3.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323<SEP>chunk-41c7131af28e2a745ef6b88b8601860f<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6<SEP>chunk-1327975b50e4a0aac1792cb595041ee5", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 29}]", "id": "DIETARY PATTERN"}, {"entity_type": "THERAPY", "description": "An intervention group in RCTs focused on reducing weight through diet modification and increased physical activity to lower type 2 diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 17}]", "id": "INTENSIVE LIFESTYLE INTERVENTION GROUP"}, {"entity_type": "CONTROL GROUP THERAPY", "description": "A control group receiving standard care without specific lifestyle or dietary interventions, used for comparison in RCT studies.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "USUAL CARE CONTROL GROUP"}, {"entity_type": "DIETARY PATTERN", "description": "Participants randomized into two groups consuming extra-virgin olive oil or mixed nuts as part of a Mediterranean diet to assess health outcomes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "MEDITERRANEAN DIET GROUPS"}, {"entity_type": "DIETARY PATTERN", "description": "A control group in RCTs receiving dietary advice aimed at reducing fat intake, used for comparison with intervention groups.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "LOW-FAT DIET GROUP"}, {"entity_type": "NUTRIENT", "description": "Specific dietary factors such as whole grain consumption and fiber intake interact with genetic variants to influence type 2 diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "WHOLE GRAIN INTAKE AND FIBER CONSUMPTION"}, {"entity_type": "DISEASE", "description": "A chronic condition characterized by high blood sugar levels over a prolonged period. The disease was assessed in relation to genetic variants associated with increased risk.<SEP>A condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production, influenced by genetic and environmental factors.<SEP>A metabolic disorder characterized by high blood sugar levels, insulin resistance, and relative lack of insulin.<SEP>A metabolic disease characterized by high blood sugar levels over an extended period due to insulin resistance or insulin deficiency, investigated for its genetic associations with CHI3LI variants.<SEP>A metabolic disorder characterized by high blood sugar levels over a prolonged period due to insulin resistance or insufficient insulin production.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e<SEP>chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-44a871da300abc9be525b468f502f5cb<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "TYPE 2 DIABETES (T2D)"}, {"entity_type": "STUDY COHORT", "description": "A longitudinal cohort study that follows nurses from the United States over time to understand health outcomes, including diet and physical activity effects on diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 29}]", "id": "NURSES\' HEALTH STUDY (NHS)"}, {"entity_type": "RCT STUDY", "description": "An RCT evaluating lifestyle interventions against standard care for reducing type 2 diabetes risk in high-risk individuals.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "clusters": "[{level: 0, cluster: 4}, {level: 1, cluster: 17}]", "id": "FINISH DIABETES PREVENTION STUDY (DPS)"}, {"entity_type": "RCT STUDY", "description": "A large-scale RCT assessing the impact of intensive lifestyle intervention on reducing the incidence of type 2 diabetes compared to usual care or metformin treatment.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "AMERICAN DIABETES PREVENTION PROJECT (DPP)"}, {"entity_type": "RCT STUDY", "description": "An RCT investigating the effects of a Mediterranean diet enriched with olive oil or nuts versus a control low-fat diet on cardiovascular disease risk factors.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "PREVENCI\u00d3N CON DIETA MEDITERR\u00c1NEA (PREDIMED)"}, {"entity_type": "NUTRIENT", "description": "These dietary measures reflect how quickly food is converted into glucose in the bloodstream, influencing diabetes risk when combined with genetic variants.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "GLYCEMIC INDEX AND GLYCEMIC LOAD"}, {"entity_type": "GENE", "description": "The TCF7L2 gene is associated with type 2 diabetes (T2D) risk and modifies the effect of incretins on insulin secretion.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "TCF7L2"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genotype of the rs7903146 variant in TCF7L2 is associated with lower T2D incidence when combined with higher cereal fiber or whole-grain intake.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "RS7903146 CC-GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific allele of the rs7903146 variant in TCF7L2 is associated with increased T2D incidence when combined with higher cereal fiber or whole-grain intake.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "RS7903146 RISK T-ALLELE"}, {"entity_type": "NUTRIENT", "description": "Intake of fiber, particularly cereal fiber, interacts with genetic variants to modify the risk of type 2 diabetes (T2D).", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "FIBER INTAKE"}, {"entity_type": "NUTRIENT", "description": "Consumption of whole grains in conjunction with certain TCF7L2 genotypes can reduce T2D incidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "WHOLE-GRAIN INTAKE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant, rs4506565, within the TCF7L2 gene interacts with cereal fiber and whole-grain intake to modify T2D incidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "TCF7L2 VARIANT RS4506565"}, {"entity_type": "GENOMIC VARIANT", "description": "This genetic variant in TCF7L2 shows interaction with dietary fiber intake but not carbohydrates, affecting T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "TCF7L2 VARIANT RS12255372"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the NOTCH2 gene interacts with fiber intake to influence type 2 diabetes (T2D) incidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "RS10923931 NOTCH2 GENE"}, {"entity_type": "GENE", "description": "The ZBED3 gene, involved in WNT signaling pathway, shows interaction with dietary fiber intake and a genetic variant within this gene modifies T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "ZBED3 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the IRS1 gene associated with increased insulin sensitivity interacts with carbohydrate intake to modify type 2 diabetes (T2D) incidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "IRS1 RS2943641"}, {"entity_type": "GENOMIC VARIANT", "description": "The GIPR rs10423928 variant decreases insulin secretion and shows interaction with carbohydrate intake, influencing T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "GIPR RS10423928"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants in the PPAR\u03b3 gene show a trend for interaction with fat intake to modify type 2 diabetes (T2D) risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "PPAR\u0393 VARIANTS (RS1801282, RS3856806)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant of FFAR4, involved in G\u03b1q signaling, interacts with low-fat diet to increase T2D incidence among certain allele carriers.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "FFAR4 VARIANT RS116454156"}, {"entity_type": "GENOMIC VARIANT", "description": "This genetic variation in the CAV2 gene shows interaction with total fat and saturated fatty acids to modify type 2 diabetes (T2D) risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "CAV2 VARIANT RS2270188"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genotype of ADH1C modifies the association between alcohol intake and T2D risk among women but not men.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "ADH1C *1/*2 VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants in the HECTD4 gene show interaction with alcohol intake to modify type 2 diabetes (T2D) risk, observed in some studies.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "HECTD4 VARIANTS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant of the HFE gene interacts with heme iron intake to increase T2D risk among women and men under different study conditions.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "HFE RS1799945 (H63D)"}, {"entity_type": "GENE", "description": "The SLC40A1 gene, an iron-regulated transporter, shows interaction with dietary factors like heme iron to modify type 2 diabetes (T2D) risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "SLC40A1 GENE"}, {"entity_type": "GENE", "description": "Genetic variants in the TMPRSS6 gene interact with dietary intake of heme iron to influence T2D incidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "TMPRSS6 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Individuals carrying the A allele of TCF7L2 variant rs11196208 show interaction with fiber and whole-grain intake to modify T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "TCF7L2 RS11196208 A-ALLELE CARRIERS"}, {"entity_type": "GENOMIC VARIANT", "description": "Individuals carrying the AA genotype of TCF7L2 variant rs7903146 show interaction with fiber and whole-grain intake to modify T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "TCF7L2 RS7903146 AA-GENOTYPE CARRIERS"}, {"entity_type": "GENOMIC VARIANT", "description": "Individuals carrying the AC genotype of TCF7L2 variant rs7903146 show interaction with fiber and whole-grain intake to modify T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "TCF7L2 RS7903146 AC-GENOTYPE CARRIERS"}, {"entity_type": "GENOMIC VARIANT", "description": "Individuals carrying the rs12255372 variant of TCF7L2 show interaction with dietary fiber but not carbohydrates to modify T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "TCF7L2 RS12255372 CARRIERS"}, {"entity_type": "GENOMIC VARIANT", "description": "Individuals carrying the rs4506565 variant of TCF7L2 show interaction with dietary fiber and whole-grain intake to modify T2D risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "TCF7L2 RS4506565 CARRIERS"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphisms in the TCF7L2 gene interact with diet, modifying type 2 diabetes (T2D) incidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "TCF7L2 POLYMORPHISMS "}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the HFE gene, specifically rs1799945 (H63D), is associated with increased T2D risk among women.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "HFE VARIANTS RS1799945 (H63D)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the HFE gene, specifically rs1800562 (C282Y), is associated with increased T2D risk among women.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "HFE VARIANTS RS1800562 (C282Y)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the SLC40A1 gene, specifically rs744653, interacts with heme iron intake in men.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "SLC40A1 VARIANTS RS744653 "}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the TMPRSS6 gene, specifically rs855791, shows borderline significant interaction with heme iron intake in a total sample.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "TMPRSS6 VARIANTS RS855791 "}, {"entity_type": "GENE", "description": "Genetic variants in SLC30A8 are associated with zinc intake and T2D incidence.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "SLC30A8 VARIANTS (ZINC TRANSPORTER)"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific variants in the SLC30A8 gene are associated with zinc intake but without a clear trend for an association with T2D incidence.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "RS16889462, 8_118252314, AND 8_118252435 "}, {"entity_type": "NUTRIENT", "description": "Intake of magnesium showed no interaction with genetic variants regarding T2D incidence.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "MAGNESIUM INTAKE "}, {"entity_type": "NUTRIENT", "description": "Intake of vitamin A showed no interaction with genetic variants regarding T2D incidence.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "VITAMIN A INTAKE "}, {"entity_type": "FOOD", "description": "High intake of red meat increases the risk to develop T2D among men with a high GRS, but not among those with a low GRS.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "RED MEAT "}, {"entity_type": "FOOD", "description": "High intake of processed meat increases the risk to develop T2D among men with a high GRS, but not among those with a low GRS.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "PROCESSED MEAT "}, {"entity_type": "FOOD", "description": "Consumption of olive oil shows a marginally nonsignificant interaction with genetic variants such as rs10423928 in EPIC-InterAct.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "OLIVE OIL "}, {"entity_type": "FOOD", "description": "Association of dairy products with T2D incidence may be modified by the lactase persistence LCT gene variant, rs4988235.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "DAIRY PRODUCTS "}, {"entity_type": "FOOD", "description": "Consumption of coffee can modify T2D risk depending on genetic variants such as TCF7L2 and IGF2BP2.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "COFFEE "}, {"entity_type": "DIETARY PATTERN", "description": "A Western dietary pattern is associated with higher T2D risk among persons with a high T2D-GRS, but not among those with a low GRS.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "WESTERN DIETARY PATTERN "}, {"entity_type": "DIETARY PATTERN", "description": "Following a Mediterranean diet lowers the incidence of T2D depending on genetic variants such as rs4580796 (CLOCK).", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "MEDITERRANEAN DIET "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Levels of physical activity can modify T2D risk based on genetic variants like HNF1B and IRS1.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "PHYSICAL ACTIVITY "}, {"entity_type": "GENOMIC VARIANT", "description": "Variants in the PPAR\u03b3 gene, such as rs1801282, are associated with changes in leisure-time physical activity (LTPA) and T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "PPAR\u0393 VARIANTS RS1801282 "}, {"entity_type": "GENOMIC VARIANT", "description": "The ADRA2B Glu12-allele shows an increase in leisure-time physical activity (LTPA) resulting in lower T2D incidence compared to others.<SEP>This variant shows an increase in LTPA resulting in lower T2D incidence compared to others.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "ADRA2B GLU12-ALLELE "}, {"entity_type": "GENOMIC VARIANT", "description": "This variant is associated with a reduced combined prediabetes and T2D risk among coffee consumers.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "KCNJ11 VARIANTS RS5215 CC-GENOTYPE "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A polygenic risk score for type 2 diabetes can modify the effect of dietary patterns and physical activity on T2D incidence.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "T2D-GRS "}, {"entity_type": "GENOMIC VARIANT", "description": "Variants in the SLC39A4 gene, specifically rs1790250, are associated with zinc intake and may influence T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "SLC39A4 VARIANTS RS1790250 "}, {"entity_type": "GENE", "description": "Common variants in the TCF7L2 gene are strongly associated with an increased risk of developing type 2 diabetes.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "TCF7L2 VARIANTS "}, {"entity_type": "GENE", "description": "Variants in IGF2BP2 contribute to the development of type 2 diabetes and obesity, depending on genetic predisposition.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "IGF2BP2 VARIANTS "}, {"entity_type": "GENE", "description": "Variants in the FABP2 gene are linked to altered lipid metabolism and can modify T2D risk based on dietary fat intake.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "FABP2 VARIANTS "}, {"entity_type": "GENOMIC VARIANT", "description": "This variant is associated with changes in dietary fat consumption and may influence T2D incidence, particularly among individuals consuming a high-fat diet.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "MYO1D VARIANTS RS6795034 "}, {"entity_type": "GENE", "description": "Variants in the IRS1 gene are associated with altered insulin sensitivity and can modify the risk of developing type 2 diabetes based on lifestyle factors like diet and physical activity.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "IRS1 VARIANTS "}, {"entity_type": "GENOMIC VARIANT", "description": "The APOE \u03b54-allele is linked to increased cholesterol levels and may interact with dietary fats, affecting T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "APOE \u03954-ALLELE "}, {"entity_type": "GENE", "description": "Variants in the CLOCK gene are associated with circadian rhythm regulation and can modify T2D risk based on dietary patterns such as adherence to a Mediterranean diet.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "CLOCK GENE VARIANTS "}, {"entity_type": "GENE", "description": "Mutations in the HNF1A gene cause maturity-onset diabetes of the young (MODY) type 3, which is distinct from type 2 diabetes but shares genetic risk factors.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "HNF1A VARIANTS "}, {"entity_type": "GENOMIC VARIANT", "description": "Variants in KCNQ1 are associated with an increased risk for T2D and can interact with environmental factors like physical activity to modify disease risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "KCNQ1 VARIANTS "}, {"entity_type": "GENE", "description": "Variants in the MTNR1B gene, which encodes a melatonin receptor, increase T2D risk through altered pancreatic beta-cell function.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "MTNR1B VARIANTS "}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphisms in PTPN11 may influence insulin resistance and T2D risk depending on dietary habits and physical activity levels.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "PTPN11 VARIANTS "}, {"entity_type": "GENE", "description": "Variants in the PPARA gene are associated with altered lipid metabolism and can interact with dietary fat intake to modify T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "PPARA VARIANTS "}, {"entity_type": "GENOMIC VARIANT", "description": "The WFS1 gene is implicated in both type 1 diabetes (T1D) and type 2 diabetes (T2D), particularly its variants that affect beta-cell function and glucose homeostasis.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "WFS1 VARIANTS "}, {"entity_type": "GENE", "description": "The SLC2A2 gene contains multiple variants including rs5393, rs5394, rs5400, and rs5404.<SEP>The SLC2A2 gene, also known as the GLUT2 transporter gene, showed associations with ketone body levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "SLC2A2"}, {"entity_type": "GENOMIC VARIANT", "description": "These are specific genomic variants within the SLC2A2 gene that have been investigated for their interaction with lifestyle factors like LTPA.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS5393, RS5394, RS5400, AND RS5404"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "LTPA refers to long-term physical activity, which may influence genetic expression and disease risk.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "LTPA"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a specific variant of the TCF7L2 gene associated with type 2 diabetes (T2D) risk.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 32}]", "id": "TCF7L2 RS12255372"}, {"entity_type": "GENOMIC VARIANT", "description": "This allele of rs7903146 is also linked to an increased risk for T2D, but showed lower incidence in intervention groups.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 32}]", "id": "RS7903146 RISK T\u2010ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant within the ENPP1 gene that is associated with a higher risk of developing type 2 diabetes.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 32}]", "id": "ENPP1 RS1044498 DIABETOGENIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "This genetic variant in MC4R shows a trend for interaction with weight loss interventions but no significant interaction tests were found.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "MC4R RS17066829"}, {"entity_type": "GENOMIC VARIANT", "description": "The PPAR\u03b3 gene variant rs1152003, specifically the CC genotype, shows a lower T2D incidence in intervention groups compared to controls.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 32}]", "id": "PPAR\u0393 RS1152003 CC\u2010GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "This genetic variant of TNF\u03b1 is associated with reduced T2D risk in intervention groups.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 32}]", "id": "TNF\u0391 RS1800629 GG\u2010GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "The ADRA2B gene\'s Glu9 allele was found to have a lower incidence of type 2 diabetes upon weight loss interventions.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "ADRA2B GLU9-ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant in the LIPC gene is linked with reduced risk of T2D under intervention conditions.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 32}]", "id": "LIPC RS2070895 A\u2010ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "Genetic variants have a limited impact on microbial taxa variability, requiring caution when performing and interpreting causality estimation using MR analysis.<SEP>Various genetic variants have been studied for their interaction with weight loss interventions in reducing type 2 diabetes risk.", "source_id": "chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "GENETIC VARIANTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Interventions aimed at promoting weight loss to reduce the risk of developing type 2 diabetes.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "WEIGHT LOSS INTERVENTIONS"}, {"entity_type": "STUDY TYPE", "description": "Randomized controlled trial study populations where genetic interactions with lifestyle factors are investigated.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RCT STUDY POPULATIONS"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The rs4506565 variant within the TCF7L2 gene interacts with dietary fiber and whole-grain intake to modify type 2 diabetes risk.", "entity_type": "UNKNOWN", "id": "RS4506565"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The rs12255372 variant within the TCF7L2 gene shows interaction with dietary fiber but not carbohydrates, affecting type 2 diabetes risk.", "entity_type": "UNKNOWN", "id": "RS12255372"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "A genetic variant in the NOTCH2 gene interacts with fiber intake, influencing type 2 diabetes risk among individuals carrying a specific allele of this gene.", "entity_type": "UNKNOWN", "id": "NOTCH2 GENE"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "Variants in PPAR\u03b3 show a trend for interaction with fat intake and FFAR4 variant interacts with low-fat diet to influence T2D risk, indicating similar dietary impact on genetic interactions.", "entity_type": "UNKNOWN", "id": "FFAR4 VARIANT"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "Variants in PPAR\u03b3 show a trend for interaction with fat intake and FFAR4 variant interacts with low-fat diet to influence T2D risk, indicating similar dietary impact on genetic interactions.", "entity_type": "UNKNOWN", "id": "PPAR\u0393 VARIANTS"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "Polymorphisms in TCF7L2 interact with various dietary factors, including fiber and whole grains, to influence type 2 diabetes incidence.", "entity_type": "UNKNOWN", "id": "DIETARY FACTORS"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18<SEP>chunk-372184452f1f9156514992455057f843<SEP>chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "description": "This genetic variant of TCF7L2 is significantly associated with a reduced incidence of type 2 diabetes in intervention studies compared to control groups.<SEP>Type 2 Diabetes (T2D) is a disease characterized by high blood sugar levels over a prolonged period. It can be associated with obesity and is influenced by genetic factors.<SEP>Type 2 diabetes (T2D) risk influenced by genetic loci and CRP levels.", "entity_type": "DISEASE", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 32}]", "id": "T2D"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "While there\'s a trend towards interaction, the MC4R variant does not show significant interactions with weight loss interventions for reducing T2D incidence.", "entity_type": "UNKNOWN", "id": "WEIGHT LOSS INTERVENTION"}, {"source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "description": "Certain genetic variations increase susceptibility to developing type 2 diabetes, and their interaction with lifestyle factors can modify disease risk.", "entity_type": "UNKNOWN", "id": "TYPE 1 DIABETES (T2D)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in TCF7L2, specifically rs7903146, is significantly associated with an increased risk of Type 2 Diabetes and End Stage Renal Disease.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "RS7903146 GENOMIC VARIANT"}, {"entity_type": "GENE", "description": "The WFS1 gene has a variant, rs10010131, that shows an association with T2D in the study sample.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "WFS1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant in WFS1 (rs10010131) is associated with Type 2 Diabetes risk, according to the results of the individual SNP analysis.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "RS10010131 GENOMIC VARIANT"}, {"entity_type": "GENE", "description": "The CDKAL1 gene includes a genetic variant rs10946398 that shows an association with T2D in both sets of case subjects and controls.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "CDKAL1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs10946398) within the CDKAL1 gene is significantly associated with Type 2 Diabetes, as indicated by odds ratios and confidence intervals.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "RS10946398 GENOMIC VARIANT"}, {"entity_type": "GENE", "description": "The JAZF1 gene harbors a genomic variant rs864745 which demonstrates association with T2D risk in both sets of cases and controls.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "JAZF1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant, rs864745 within JAZF1, is associated with an increased risk of Type 2 Diabetes according to the individual SNP analysis results.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "RS864745 GENOMIC VARIANT"}, {"entity_type": "GENE", "description": "The ADAMTS9 gene has a genomic variant rs4607103 that demonstrates an association with T2D in set 1 and meta-analysis, but with a different direction compared to European samples.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "ADAMTS9 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genetic variant (rs4607103) within ADAMTS9 shows an association with T2D risk in set 1 of the study, but it\'s direction is opposite to previous reports.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "RS4607103 GENOMIC VARIANT"}, {"entity_type": "DISEASE", "description": "The final stage of chronic kidney disease, often requiring dialysis or transplantation. It was observed more frequently among cases with certain genetic markers for T2D.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "END STAGE RENAL DISEASE (ESRD)"}, {"entity_type": "METRIC", "description": "A cumulative risk score based on genetic variants was used to assess the combined effect of multiple risk alleles in predicting Type 2 Diabetes (T2D) risk.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "CUMULATIVE RISK SCORE"}, {"entity_type": "MODEL/FRAMEWORK", "description": "A statistical model used to evaluate the association between cumulative risk allele load and disease status in T2D patients and controls.<SEP>A statistical model used to evaluate the relationship between cumulative risk allele load and disease status in T2D patients and controls.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "LOGISTIC REGRESSION MODEL"}, {"entity_type": "GENOMIC VARIANT", "description": "Rs7903146 is a genomic variant within the TCF7L2 gene linked to Type 2 diabetes risk when adjusted for in genetic analyses.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 12}]", "id": "RS7903146"}, {"entity_type": "DISEASE", "description": "A chronic condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production, influenced by genetic factors such as variants within the TCF7L2 gene.<SEP>A chronic disease characterized by high blood sugar due to insulin resistance or reduced insulin production; shown to have associations with specific SNPs related to ketone body metabolism.<SEP>Type 2 diabetes is a metabolic disease characterized by high blood sugar levels over time.<SEP>A disease outcome that was significantly associated with black and sugared coffee consumption in the study.<SEP>Type 2 diabetes is a chronic condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production.<SEP>Type 2 diabetes is a disease characterized by high blood sugar levels over a prolonged period, typically resulting from insulin resistance and relative insulin deficiency.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b<SEP>chunk-b803830d07bff8ae14550f6458048707", "id": "TYPE 2 DIABETES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Analyzing genetic variants such as rs7903146 in the context of Type 2 diabetes risk involves examining their impact on disease susceptibility.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "id": "TYPE 2 DIABETES RISK ANALYSIS"}, {"source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "description": "Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk.", "entity_type": "UNKNOWN", "id": "TCF7L2 RISK VARIANT"}, {"source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "description": "Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk.", "entity_type": "UNKNOWN", "id": "TCF7LL2 RISK VARIANT"}, {"source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "description": "Genetic analysis shows that adjusting for the genomic variant rs7903146 in TCF7L2 gene removes significant associations with Type 2 diabetes, suggesting its importance.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 12}]", "id": "TYPE 7 DIABETES RISK ANALYSIS"}, {"source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "description": "The count of risk alleles is a factor influencing the association with Type 2 diabetes, particularly when considering variants like rs7903146 in TCF7L2.", "entity_type": "UNKNOWN", "id": "RISK ALLELES COUNT"}, {"source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "description": "There was no evidence for interaction between age and Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant.", "entity_type": "UNKNOWN", "id": "AGE FACTOR"}, {"source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "description": "No significant interaction with sex was found in the analysis of Type 2 diabetes risk associated with the TCF7L2 gene variant.", "entity_type": "UNKNOWN", "id": "SEX FACTOR"}, {"source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "description": "Body Mass Index (BMI) did not significantly interact with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant.", "entity_type": "UNKNOWN", "id": "BMI FACTOR"}, {"source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "description": "The degree of African ancestry had no significant interaction with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant.", "entity_type": "UNKNOWN", "id": "DEGREE OF AFRICAN ANCESTRY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Impaired Fasting Glucose/Impaired Glucose Tolerance (IFG/IGT) refers to the physiological processes where individuals have higher than normal blood glucose levels but not high enough to be classified as diabetes. These conditions are linked to an increased risk of developing Type 2 Diabetes.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 31}]", "id": "IFG/IGT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FPG measures the concentration of glucose in the blood after an overnight fast, used to diagnose prediabetes and type 2 diabetes.<SEP>FPG measures the concentration of glucose in the blood after fasting, used as one indicator for diagnosing diabetes or prediabetes conditions like IFG/IGT.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "FASTING PLASMA GLUCOSE (FPG)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "2hPG is a test taken two hours after consuming a standard glucose drink and measures blood sugar levels, used in assessing risk for Type 2 Diabetes.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "TWO-HOUR PLASMA GLUCOSE (2HPG)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Normal Glucose Tolerance (NGT) refers to the physiological state where an individual\'s blood glucose level remains within the normal range after consuming a standard glucose drink.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 31}]", "id": "NGT"}, {"entity_type": "GENOMIC VARIANT", "description": "Obesity predisposing SNPs are genetic variants that influence an individual\u2019s susceptibility to obesity and associated conditions like T2D.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 31}]", "id": "GENOMIC VARIANT (SNPS)"}, {"entity_type": "ETHNIC FACTOR", "description": "Individuals of East Asian ancestry in the EpiDREAM cohort study showed a lower prevalence of IFG/IGT and T2D compared to other ethnic groups, indicating potential genetic or environmental factors unique to this group.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 0}]", "id": "EAST ASIAN"}, {"entity_type": "ETHNIC FACTOR", "description": "Individuals with African ancestry had higher rates of IFG/IGT and T2D than those with East Asian ancestry, suggesting differences in disease risk across populations.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 0}]", "id": "AFRICAN"}, {"entity_type": "ETHNIC FACTOR", "description": "The prevalence of IFG/IGT and T2D among individuals of European descent was lower compared to African but higher than East Asian groups, indicating varied genetic predispositions or environmental exposures.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "EUROPEAN"}, {"entity_type": "ETHNIC FACTOR", "description": "Subjects with Native North American ancestry had the lowest rate of IFG/IGT and a relatively low prevalence of T2D among all ethnic categories in the study.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 31}]", "id": "NATIVE NORTH AMERICAN"}, {"entity_type": "ETHNIC FACTOR", "description": "The Latino American population exhibited higher rates of both IFG/IGT and T2D compared to East Asian individuals, indicating significant disparities in disease risk across different populations.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "LATINO AMERICAN"}, {"entity_type": "ETHNIC FACTOR", "description": "Individuals with South Asian ancestry had high incidences of IFG/IGT (43.5%) and T2D (16.1%), highlighting the importance of genetic and environmental factors in this group.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "SOUTH ASIAN"}, {"entity_type": "GENE", "description": "The TAL1 gene is associated with obesity predisposition according to the text.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 12}]", "id": "TAL1 GENE"}, {"entity_type": "GENE", "description": "The LEPR gene contains a SNP (rs1011527) that interacts with fasting plasma glucose (FPG) on baseline body mass index (BMI).", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 20}]", "id": "LEPR GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphisms (SNPs) are genetic variants associated with obesity.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 12}]", "id": "SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "Genotype risk score (GRS), a measure of cumulative genetic risk, is significantly associated with increased BMI at baseline.<SEP>The Genetic Risk Score (GRS) is derived from polymorphisms and is associated with cognitive performance metrics in patients.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 19}]", "id": "GRS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Body mass index (BMI) at baseline and change are key physiological processes studied for their association with obesity SNPs and GRS.<SEP>Body mass index at baseline and changes in BMI over time are studied for their association with obesity SNPs and GRS.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 19}]", "id": "BMI BASELINE AND CHANGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "A glycemic status trait that interacts with the rs1011527 SNP in LEPR on baseline BMI, indicating its role in modulating genetic effects on obesity.<SEP>FPG is a glycemic status trait that interacts with the rs1011527 SNP in LEPR on baseline BMI.<SEP>A measure of blood sugar after an overnight fast; elevated in individuals with IFG, IGT, and T2DM compared to those without abnormal glucose levels.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 20}]", "id": "FPG (FASTING PLASMA GLUCOSE)"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific SNPs within the FTO, TAL1, and TCF7L2 genes are associated with BMI at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 12}]", "id": "SNPS IN FTO, TAL1, AND TCF7L2 GENES"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in the FTO gene is significantly associated with BMI at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "RS9939609 SNP IN FTO"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in the TAL1 gene is significantly associated with BMI at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "RS2984618 SNP IN TAL1"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in the TCF7L2 gene is significantly associated with BMI at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "RS7903146 SNP IN TCF7L2"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A cumulative genetic risk measure that is significantly associated with increased BMI at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "GRS (GENOTYPE RISK SCORE)"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in the LEPR gene interacts with fasting plasma glucose (FPG) on baseline BMI, but shows no significant main effect on BMI alone.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 20}]", "id": "RS1011527 SNP IN LEPR"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs associated with increased risk of obesity.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "OBESITY PREDISPOSING SNPS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The associations between obesity predisposing SNPs, GRS, and BMI level as well as changes in BMI over time are significant areas of study.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "id": "BMI LEVEL AND CHANGE ASSOCIATIONS AND INTERACTIONS"}, {"source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "description": "Both Fasting Plasma Glucose and Two-hour Plasma Glucose are physiological processes that, when elevated, contribute to increased risk for T2D and are positively associated with baseline BMI.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 0}]", "id": "2HPG"}, {"source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "description": "Both Fasting Plasma Glucose and Two-hour Plasma Glucose are physiological processes that, when elevated, contribute to increased risk for T2D and are positively associated with baseline BMI.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 0}]", "id": "FPG"}, {"source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "description": "The GRS is significantly associated with increased BMI at baseline, indicating cumulative genetic risk in the context of obesity.", "entity_type": "UNKNOWN", "id": "BMI BASELINE AND CHANGE ASSOCIATIONS AND INTERACTIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism in the MTHFR gene at position 1298, associated with an increased risk of neurocognitive impairment.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTHFR 1298A>C"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism in the MS gene at position 2756, linked to a higher likelihood of neurocognitive deficits.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MS 2756A>G"}, {"entity_type": "GENOMIC VARIANT", "description": "Another polymorphism identified in the MTHFR gene which did not show significant associations with impaired performance on neurocognitive tests.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTHFR 677C>T"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism within the SHMT gene that was not significantly associated with neurocognitive impairment or performance measures.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "SHMT 1520C>T"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism in the MTRR gene, showing no significant association with the assessed cognitive measures but impacting some fine motor skills tests.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTRR 66A>G"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphisms within the TSER region affecting performance on attention and processing speed tests (TMTA/TMTB).", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "TSER POLYMORPHISMS"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Paired Associate Learning Digit Span High Load (PEGDH), a test measuring aspects of attention and memory.<SEP>Test assessing fine motor skills, showing some association with genetic polymorphism effects.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-4b6e8f78911cafc70959cfdfed786c29", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 19}]", "id": "PEGDH"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Neurocognitive test for fine motor skills and executive function, revealing correlations with MTRR 66A>G genotypes.<SEP>Paired Associate Learning Number Digit High Load (PEGNDH) measures cognitive function under high load conditions.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-4b6e8f78911cafc70959cfdfed786c29", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 19}]", "id": "PEGNDH"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Digit Span Test (DIG), assessing working memory and attention.<SEP>Working memory test that did not show associations with genetic polymorphisms or other covariates.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-4b6e8f78911cafc70959cfdfed786c29", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 19}]", "id": "DIG"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Coding Figure Learning (CFL), a test for visual learning and immediate recall.<SEP>Test for executive function, indicating a significant association with MTRR 66A>G genotypes.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-4b6e8f78911cafc70959cfdfed786c29", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 19}]", "id": "CFL"}, {"entity_type": "ENVIRONMENTAL FACTOR/DISEASE", "description": "Early exposure to MTX leading to neurotoxic symptoms and later increased risk of long-term cognitive impairments.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTX-RELATED NEUROTOXICITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Test assessing focused attention and processing speed.<SEP>Trail Making Test Part A (TMTA) measures visual search speed and processing speed, indicating executive function.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-4b6e8f78911cafc70959cfdfed786c29", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 19}]", "id": "TMTA"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Test measuring shifting attention and processing speed.<SEP>Trail Making Test Part B (TMTB) assesses cognitive flexibility, executive control, and working memory.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-4b6e8f78911cafc70959cfdfed786c29", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 21}]", "id": "TMTB"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "A comprehensive cognitive assessment tool used to evaluate various aspects of cognitive function in patients.<SEP>Battery of neurocognitive tests used to assess impairment in the study population.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7<SEP>chunk-4b6e8f78911cafc70959cfdfed786c29", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 19}]", "id": "DIVERGT BATTERY"}, {"entity_type": "DRUG", "description": "Methotrexate (MTX) is used in the treatment of certain diseases, particularly as an intrathecal exposure in cancer therapy.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "MTX"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variation at the DNA sequence level that contributes to the Genetic Risk Score (GRS).", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 19}]", "id": "POLYMORPHISM"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The administration of methotrexate directly into the cerebrospinal fluid for treatment, affecting cognitive performance.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 21}]", "id": "INTRATHECAL MTX EXPOSURE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Total amount of intravenous methotrexate administered over time, impacting patient outcomes and genetic risk scores.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "clusters": "[{level: 0, cluster: 5}, {level: 1, cluster: 19}]", "id": "CUMULATIVE IV MTX EXPOSURE"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Carriers of the MTHFR 1298AC/CC genotypes are at a higher risk for neurocognitive deficits compared to those with AA genotype.", "entity_type": "UNKNOWN", "id": "NEUROCOGNITIVE IMPAIRMENT"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with MS 2756AA genotype scored lower on the PEGNDH test compared to those with AG/GG genotypes.", "entity_type": "UNKNOWN", "id": "PEGNDH SCORE DIFFERENCE"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Individuals carrying MTRR 66AA genotype showed significantly worse performance in executive function tests (CFL).", "entity_type": "UNKNOWN", "id": "CFL PERFORMANCE"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Early MTX-induced neurotoxic symptoms were predictive of long-term cognitive deficits, despite no significant effect on all test measures.", "entity_type": "UNKNOWN", "id": "LONG-TERM NEUROCOGNITIVE IMPAIRMENT"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with MTHFR 1298AC/CC genotypes scored significantly lower on TMTB compared to those with AA genotype.", "entity_type": "UNKNOWN", "id": "TMTB PERFORMANCE"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors carrying MS 2756AA genotype performed worse on TMTA than survivors with AG/GG genotypes.", "entity_type": "UNKNOWN", "id": "TMTA PERFORMANCE"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "The PEGDH test is used to assess fine motor skills, showing some association with genetic polymorphisms but not all covariates.", "entity_type": "UNKNOWN", "id": "FINE MOTOR SKILLS"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "The PEGDH test is used to assess fine motor skills, showing some association with genetic polymorphisms but not all covariates.", "entity_type": "UNKNOWN", "id": "PEGDH TEST"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with MTRR 66AA genotype scored lower on PEGNDH compared to those with AG/GG genotypes, indicating an impact on fine motor skills.", "entity_type": "UNKNOWN", "id": "MTRR 66A>G GENOTYPES"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with MTRR 66AA genotype scored lower on PEGNDH compared to those with AG/GG genotypes, indicating an impact on fine motor skills.", "entity_type": "UNKNOWN", "id": "PEGNDH TEST"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "The DIG test assesses working memory and did not show significant associations with genetic polymorphisms or other covariates.", "entity_type": "UNKNOWN", "id": "DIG TEST"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "The DIG test assesses working memory and did not show significant associations with genetic polymorphisms or other covariates.", "entity_type": "UNKNOWN", "id": "WORKING MEMORY"}, {"entity_type": "GENOMIC VARIANT", "description": "The genomic variant SLC30A8 rs13266634 is associated with higher fasting proinsulin levels at baseline.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "SLC30A8 RS13266634"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fasting proinsulin levels are significantly affected by the genetic risk allele of SLC30A8 and interventions such as lifestyle changes, metformin, or troglitazone.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "FASTING PROINSULIN LEVELS"}, {"entity_type": "DIETARY PATTERN", "description": "The lifestyle intervention group showed a significant decrease in fasting proinsulin levels compared to the placebo and medication groups after one year of DPP intervention.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "LIFESTYLE INTERVENTION GROUP"}, {"entity_type": "DRUG", "description": "Metformin is used as an intervention in the DPP study for reducing proinsulin levels, but its efficacy was less pronounced than lifestyle changes.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "METFORMIN"}, {"entity_type": "DRUG", "description": "Troglitazone was another drug used in the DPP study to reduce fasting proinsulin levels; however, it showed similar effectiveness as metformin compared to lifestyle interventions.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "TROGLITAZONE"}, {"entity_type": "GENE", "description": "The C risk allele at the genomic variant SLC30A8 rs13266634 is associated with higher fasting proinsulin levels and does not modify treatment effectiveness in a gene-treatment interaction.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "C RISK ALLELE AT SLC30A8 RS13266634"}, {"entity_type": "DIETARY PATTERN", "description": "The DPP cohort represents participants involved in a diabetes prevention program intervention study.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "DPP COHORT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fasting insulin levels are measured and used as an adjustment factor in the analysis of proinsulin levels related to SLC30A8 risk allele and treatment effects.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "FASTING INSULIN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Demographic factors such as age, sex, and ethnicity were considered covariates for adjusting proinsulin level associations.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "AGE, SEX, ETHNICITY"}, {"entity_type": "GENE", "description": "PNPLA3 is a gene that plays a role in lipid metabolism regulation, particularly in the liver.<SEP>The PNPLA3 gene is involved in lipid metabolism and its expression can be influenced by glucose levels, fatty acids, and other metabolic factors.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "PNPLA3"}, {"entity_type": "PROTEIN", "description": "SREBP1c is a transcriptional factor important for regulating genes involved in lipid metabolism.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "SREBP1C"}, {"entity_type": "GENE", "description": "ACC-1 gene encodes acetyl-CoA carboxylase, which catalyzes the formation of malonyl-CoA for fatty acid synthesis.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "ACC-1"}, {"entity_type": "DIETARY PATTERN", "description": "High carbohydrate diet is a dietary pattern characterized by high intake of carbohydrates.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HIGH CARBOHYDRATE DIET (HC)"}, {"entity_type": "NUTRIENT", "description": "Lipid emulsion is a nutritional supplement that contains lipids, providing an alternative energy source to glucose.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "LIPID EMULSION (LE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "SREBP1c regulates the expression of genes involved in lipid biosynthesis and transport as a physiological process.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "STEROL REGULATORY ELEMENT BINDING PROTEIN 1C (SREBP1C)"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern high in fat, contributing to fatty liver development when consumed chronically.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HIGH-FAT DIET (HF)"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Voluntary exercise is a lifestyle factor that can modulate gene expression and physiological processes in the body.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "EXERCISE"}, {"entity_type": "NUTRIENT", "description": "Glucose is a critical nutrient for cellular metabolism, particularly affecting glycolysis and lipid synthesis pathways.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "GLUCOSE"}, {"entity_type": "PROTEIN", "description": "Carbohydrate response element binding protein (ChREBP) regulates the expression of genes involved in glucose metabolism and storage.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "CHREBP"}, {"entity_type": "GENE", "description": "FAS is a gene encoding an enzyme responsible for synthesizing fatty acids from acetyl-CoA.<SEP>Fatty acid synthase, a key enzyme in lipid synthesis, shows increased mRNA expression upon PNPLA3 knockdown.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "FATTY ACID SYNTHASE (FAS)"}, {"entity_type": "NUTRIENT", "description": "2-deoxy-D-glucose is a nutrient that suppresses PNPLA3 levels and reduces lipid accumulation in cells.<SEP>Non-metabolizable glucose analog used to study the effects of glycolytic inhibition on cellular processes.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "2-DEOXY-D-GLUCOSE"}, {"entity_type": "METABOLIC PATHWAY INTERMEDIATE", "description": "Citrate, an intermediate of the Krebs cycle, increases PNPLA3 protein levels.<SEP>Krebs cycle intermediate that can influence metabolic pathways, including lipid synthesis.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "CITRATE"}, {"entity_type": "NUTRIENT", "description": "Pyruvate does not influence PNPLA3 levels, unlike citrate and acetate.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "PYRUVATE"}, {"entity_type": "NUTRIENT", "description": "Acetate does not impact PNPLA3 expression levels in cells.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "ACETATE"}, {"entity_type": "PROTEIN", "description": "Fatty acid synthase, a key lipogenic enzyme, shows similar expression patterns to PNPLA3 under different metabolic conditions.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "FAS (FATTY ACID SYNTHASE)"}, {"entity_type": "GENE/PROTEIN", "description": "The gene and protein ACC-1 show expression patterns similar to PNPLA3 in response to various metabolic stimuli.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "ACC-1 (ACETYL-COA CARBOXYLASE 1)"}, {"entity_type": "NUTRIENT", "description": "A hormone produced by beta cells in the pancreas, crucial for regulating blood glucose levels and metabolism.<SEP>A hormone that regulates blood glucose levels; administration can delay but not prevent type 1 diabetes progression when used prophylactically.<SEP>Insulin is a hormone that does not regulate hepatic PNPLA3 expression in HepG2 cells, unlike its effects on other genes and proteins.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-8382a49b61215482f9fc75e3a86cb987", "id": "INSULIN"}, {"entity_type": "HORMONE/NUTRIENT", "description": "Glucagon stimulation has no effect on the expression of PNPLA3 in HepG2 cells under low glucose conditions.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "GLUCAGON"}, {"entity_type": "NUTRIENT", "description": "Oleic acid suppresses PNPLA3 gene expression and does not affect lipid accumulation when PNPLA3 is knocked down.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "OLEIC ACID (OA)"}, {"entity_type": "NUTRIENT", "description": "Linoleic acid decreases PNPLA3 mRNA levels under both low and high glucose conditions in HepG2 cells.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "LINOLEIC ACID (LA)"}, {"entity_type": "NUTRIENT", "description": "Alpha-linolenic acid does not influence PNPLA3 expression levels compared to oleic or linoleic acids.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "\u0391-LINOLENIC ACID (ALA)"}, {"entity_type": "NUTRIENT", "description": "EPA reduces the gene expression of PNPLA3 and other lipogenic factors like SREBP1c and FAS.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "EICOSAPENTAENOIC ACID (EPA)"}, {"entity_type": "NUTRIENT", "description": "DHA suppresses PNPLA3 mRNA levels under both glucose conditions, similar to EPA\'s effects.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "DOCOSAHEXAENOIC ACID (DHA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METHOD", "description": "The technique used to measure lipid accumulation in cells treated with various metabolic stimuli.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "OIL RED O STAINING"}, {"entity_type": "ENVIRONMENTAL FACTOR/METABOLIC STATE", "description": "A high glucose environment can induce PNPLA3 expression and lipid accumulation, which is suppressed by specific fatty acids or metabolic intermediates like citrate.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "HIGH GLUCOSE CONDITION"}, {"entity_type": "ENVIRONMENTAL FACTOR/METABOLIC STATE", "description": "A state of lower glucose availability compared to high glucose conditions, impacting metabolic pathways including PNPLA3 regulation.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "LOW GLUCOSE CONDITION"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "Treatment with 2-deoxy-D-glucose inhibits the induction of SREBP1c and PNPLA3 by high glucose levels, indicating it disrupts metabolic pathways dependent on glucose metabolism.", "entity_type": "UNKNOWN", "id": "HIGH GLUCOSE LEVELS"}, {"source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "Expression patterns of FAS and PNPLA3 are similar under various metabolic conditions, including high glucose levels.<SEP>Fetal Alcohol Syndrome (FAS) is the most severe form of Fetal Alcohol Spectrum Disorders, characterized by pre- and postnatal growth retardation, central nervous system abnormalities, and craniofacial malformations.", "entity_type": "DISEASE", "id": "FAS"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "Treatment with glucagon stimulates PC expression while having no effect on PNPLA3 mRNA levels, indicating specificity of hormonal effects.", "entity_type": "UNKNOWN", "id": "PYRUVATE CARBOXYLASE (PC)"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "La and oleic acid reduce the mRNA levels of SREBP1c, FAS, and PNPLA3 under both low and high glucose conditions.", "entity_type": "UNKNOWN", "id": "SREBP1C, FAS, PNPLA3"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "The combination of OA:LA:ALA suppresses the gene expressions of SREBP1c, FAS, and PNPLA3 to a greater extent than individual fatty acids.", "entity_type": "UNKNOWN", "id": "FATTY ACIDS RATIO MIX"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "Used for assessing lipid accumulation in HepG2 cells following metabolic perturbations like varying glucose conditions or exogenous fatty acid treatments.", "entity_type": "UNKNOWN", "id": "LIPID ACCUMULATION"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "Under low glucose conditions, glucagon stimulation increases the expression of PC but does not affect PNPLA3 mRNA levels.", "entity_type": "UNKNOWN", "id": "GLUCAGON, PYRUVATE CARBOXYLASE (PC)"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "PNPLA3 knockdown results in increased mRNA levels of FAS, a key lipogenic enzyme.", "entity_type": "UNKNOWN", "id": "PNPLA3 KNOCKDOWN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Exposure to prenatal stress (PNS) causes changes in gene expression and miRNA levels in the hippocampus of adult male rats.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "PNS EXPOSURE"}, {"entity_type": "TRANSCRIPTOMIC VARIANT", "description": "Significant modulation of 916 genes in the transcriptome of the hippocampus following PNS exposure.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "HIPPOCAMPAL TRANSCRIPTOME CHANGES"}, {"entity_type": "BIOLOGICAL PROCESS", "description": "Pathways involved in neurodevelopment such as Axonal Guidance Signaling, Protein Kinase A Signaling, Glutamate Receptor Signaling were affected by PNS exposure.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "NEURODEVELOPMENT PATHWAYS"}, {"entity_type": "BIOLOGICAL PROCESS", "description": "Pathways related to inflammation like IL-8 Signaling and STAT3 Pathway were altered in response to PNS exposure.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "INFLAMMATION PATHWAYS"}, {"entity_type": "TRANSCRIPTOMIC VARIANT", "description": "Significant changes in miRNA levels including 68 differentially regulated miRNAs following PNS exposure.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "MIRNOME CHANGES"}, {"entity_type": "TRANSCRIPTOMIC VARIANT", "description": "Differentially modulated genes (250) identified in blood samples of humans exposed to early life trauma, involved in neurodevelopment and inflammation pathways.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "BLOOD MRNA TRANSCRIPTOMICS CHANGES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Top-hit genes were both modulated by PNS exposure and targeted by miRNAs that were also altered due to stress; these interactions involve key processes such as Axonal Guidance and Glucocorticoid Receptor Signaling.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "GENE-PATHWAY INTERACTION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Exposure to early life trauma leads to significant changes in blood mRNA transcriptomics, mirroring findings from PNS model studies.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "EARLY LIFE TRAUMA EXPOSURE"}, {"entity_type": "GENE INTERACTION", "description": "22 common genes were found between the hippocampal transcriptome of PNS-exposed rats and blood transcriptomes of humans with early life trauma exposure.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "COMMON GENE OVERLAP"}, {"entity_type": "EXPERIMENTAL METHOD", "description": "All 22 overlapping genes were validated by Real-Time PCR in both rat hippocampus and human blood samples, confirming their expression patterns.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "REAL-TIME PCR VALIDATION"}, {"entity_type": "TRANSCRIPTOMIC VARIANT", "description": "A total of 916 genes were significantly modulated in the hippocampus following PNS exposure, with a fold change >1.4 and q-value <0.05.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "916 SIGNIFICANTLY MODULATED GENES"}, {"entity_type": "GENE", "description": "Isochorismatase Domain Containing 1 (ISOC1) is a gene involved in certain metabolic processes.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "ISOC1"}, {"entity_type": "GENE", "description": "Low Density Lipoprotein Receptor Adapter Protein 1 (LDLRAP1) is a gene associated with lipid metabolism and transport.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LDLRAP1"}, {"entity_type": "GENE", "description": "Leucine-rich repeat neuronal protein 3 (LRRN3) is a gene involved in neuronal functions.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LRRN3"}, {"entity_type": "GENE", "description": "Myosin ID (MYO1D) is a gene that encodes for myosin, an important motor protein involved in various cellular processes.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "MYO1D"}, {"entity_type": "GENE", "description": "Phosphatidylinositol-4-Phosphate 3-Kinase Catalytic Subunit Type 2 Beta (PIK3C2B) is a gene associated with phospholipid metabolism and signal transduction.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "PIK3C2B"}, {"entity_type": "GENE", "description": "Phosphatidic Acid Phosphatase Type 2A (PPAP2A) is a gene involved in lipid phosphate metabolism.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "PPAP2A"}, {"entity_type": "GENE", "description": "Sterile Alpha Motif Domain Containing 12 (SAMD12) is a gene with functions yet to be fully elucidated but possibly related to cellular signaling and development.<SEP>Sterile Alpha Motif Domain Containing 12 (SAMD12), further noted to be involved in various biological processes, including immune responses. Changing this based on context: Sterile Alpha Motif Domain Containing 12 (SAMD12) is a gene that may play roles in cellular signaling and development, but its specific functions remain under investigation.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "SAMD12"}, {"entity_type": "GENE", "description": "Serine Incorporator 5 (SERINC5) is a gene involved in protein modification processes, particularly in the addition of serine residues to proteins.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "SERINC5"}, {"entity_type": "GENE", "description": "Transforming Growth Factor Beta 1 (TGF-\u03b21) is a gene encoding for a cytokine that regulates cell growth and differentiation, as well as immune response and tissue repair.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "TGF-\u03921"}, {"entity_type": "GENE", "description": "Alpha-2-Macroglobulin (A2M) is a gene involved in the regulation of proteolytic processes and innate immunity.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "A2M"}, {"entity_type": "GENE", "description": "AT-rich Interaction Domain Containing Protein 5B (ARID5B) is a gene associated with DNA binding and transcriptional regulation.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "ARID5B"}, {"entity_type": "GENE", "description": "Adaptor Related Gene with RhoGTPase Domain C4 (ARRDC4) is a gene involved in intracellular signaling pathways.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "ARRDC4"}, {"entity_type": "GENE", "description": "Ephrin Type-A Receptor 4 (EPHA4) is a gene that encodes for receptors involved in cell adhesion and communication processes.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "EPHA4"}, {"entity_type": "GENE", "description": "F-box Protein 32 (FBXO32) is a gene involved in ubiquitination, a post-translational modification process crucial for protein degradation.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "FBXO32"}, {"entity_type": "GENE", "description": "Forkhead Box O1 (FoxO1) is a gene encoding for transcription factors that regulate metabolism and stress response pathways.<SEP>FoxO1 is a gene activated in hippocampal progenitor stem cells following cortisol exposure and mediates the negative effect of stress on neurogenesis.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182<SEP>chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "FOXO1"}, {"entity_type": "GENE", "description": "Heat Shock Factor Protein 2 (HSF2) is a gene involved in the regulation of cellular responses to heat shock and other forms of stress.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "HSF2"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Gene-Environment Interaction (GxE) describes the interaction between genetic factors and environmental conditions that can influence phenotypic outcomes such as depression severity.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "GXE INTERACTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A complex disorder influenced by multiple genes interacting through common or overlapping signaling systems.<SEP>Maternal depression is a mental health condition that can have adverse effects on pregnancy outcomes.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182<SEP>chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "DEPRESSION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "An environmental factor that interacts with genetic factors to predict depressive symptoms in adulthood.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "EMOTIONAL STRESS IN CHILDHOOD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of the severity of depressive symptoms used for assessing individual differences in response to stress and trauma.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "BDI SCORES"}, {"entity_type": "GENE", "description": "B-Cell CLL/Lymphoma 2 (BCL2) is a gene involved in regulating apoptosis and cell survival.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "BCL2"}, {"entity_type": "GENE", "description": "B-Cell CLL/Lymphoma 9 (BCL9) is a gene associated with the Wnt signaling pathway and cellular proliferation.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "BCL9"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Mutations within genes such as BCL2 and BCL9 can influence their interaction with environmental factors like stress.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "SOMATIC MUTATIONS IN GENES"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific genomic variants or SNPs were used in the MR Egger and IVW analyses to detect causal effects of nutrients on physiological outcomes.<SEP>Specific variations in DNA sequences studied, including those in the FADS gene cluster.<SEP>Specific variations in the DNA sequence that occur at a single nucleotide position, affecting gene expression or function.<SEP>Three minor alleles for SNPs (rs1998220, rs9534511, and rs4938056) were associated with increased risk of social disinhibition while three others (rs16116, rs16870286, and rs1003921) showed protective effects.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-22216738ccbae0a6276bb4499018c434<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "An environmental factor contributing to GxE interactions with genes such as TGF-\u03b21 and A2M.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "CHILDHOOD SEXUAL ABUSE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A type of environmental stress influencing gene expression, particularly for genes like FoxO1.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "PHYSICAL ABUSE IN CHILDHOOD"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Another form of childhood trauma interacting with multiple genes to predict adult depression severity.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "EMOTIONAL ABUSE IN CHILDHOOD"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cortisol is a human stress hormone that induces FoxO1 upregulation and reduces neuronal proliferation in vitro.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "CORTISOL"}, {"entity_type": "DRUG", "description": "AS1842856 is an inhibitor of FoxO1 used to test the functional relevance of FoxO1 in cortisol-induced reduction of neuronal proliferation.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "AS1842856"}, {"entity_type": "GENE", "description": "SGK-1 is a stress-responsive gene elevated in both hippocampus and blood under conditions of stress, mediating some glucocorticoid effects on brain function.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "SERUM GLUCOCORTICOID KINASE 1 (SGK-1)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Neurogenesis refers to the process by which new neurons are generated, negatively affected by cortisol through FoxO1 signaling pathway.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "NEUROGENESIS"}, {"entity_type": "METABOLIC PATHWAY", "description": "This pathway includes processes like SGK-1 upregulation in response to stress and glucocorticoids, affecting brain function such as neurogenesis.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "GLUCOCORTICOID EFFECTS ON BRAIN FUNCTION"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant associated with emotional abuse has been identified.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "GENOMIC VARIANT (SNP)"}, {"entity_type": "ANATOMICAL LOCATION", "description": "The hippocampus is a brain region where FoxO1 expression is altered following stress exposure.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "HIPPOCAMPUS"}, {"entity_type": "CELL LINE", "description": "This cell line, established from human fetal tissue, serves as an in vitro model for studying the effects of cortisol on neurogenesis.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "HUMAN FETAL HIPPOCAMPAL PROGENITOR CELL LINE (HPC0A07/03C)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Childhood trauma is associated with upregulation of FoxO1 expression in blood samples.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "CHILDHOOD TRAUMA"}, {"entity_type": "CELL TYPE", "description": "These cells are found in the hippocampus and show altered FoxO1 activity following cortisol exposure.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "PROGENITOR STEM CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of neuronal proliferation is reduced by cortisol, mediated through FoxO1 signaling pathway.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "NEURONAL PROLIFERATION"}, {"entity_type": "ANIMAL MODEL", "description": "Rats exposed to stress show elevated levels of SGK-1 in the hippocampus.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "STRESSED RATS"}, {"entity_type": "PATIENT GROUP", "description": "Blood samples from depressed patients exhibit elevated levels of SGK-1, indicating a link with brain function alterations.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "DEPRESSED PATIENTS"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "The interaction between FoxO1 gene variants and early emotional stress predicts depressive symptoms in adulthood, as observed in two independent clinical cohorts.", "entity_type": "UNKNOWN", "id": "ENVIRONMENTAL FACTOR (EMOTIONAL STRESS IN CHILDHOOD)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs4771122) associated with long-term weight loss after bariatric surgery.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "RS4771122"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Pre-surgical body mass index, a measure of obesity before bariatric surgery that influences post-operative outcomes.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "PRE-SURGICAL BMI"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of weight loss over an extended period after bariatric surgery, influenced by genetic factors like rs4771122.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "LONG-TERM WEIGHT LOSS"}, {"entity_type": "PROCEDURE", "description": "A surgical procedure performed to treat obesity and associated health conditions, impacting long-term weight loss and physiological processes post-surgery.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "BARIATRIC SURGERY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measurements of body weight taken at various times after bariatric surgery to assess the effectiveness of weight loss over time.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "WEIGHT OBSERVATIONS"}, {"entity_type": "DISEASE RISK FACTOR", "description": "Classification based on patterns of weight change post-surgery, indicating different trajectories in weight management outcomes.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "TRAJECTORY GROUP MEMBERSHIP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The maximum percentage of initial body weight lost after bariatric surgery, an important marker for long-term success and health benefits.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "NADIR WEIGHT LOSS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Weight loss measured at two years post-surgery, used to assess the immediate efficacy of bariatric surgery on weight reduction.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "id": "TWO YEAR PERCENT WEIGHT LOSS"}, {"entity_type": "GENE", "description": "The GCK gene is associated with maturity-onset diabetes of the young (MODY), a monogenic form of diabetes caused by mutations in specific genes involved in glucose metabolism.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "GCK GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "These are methods used for identifying genetic variations, particularly pathogenic variants, within the GCK gene that lead to GCK-MODY.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "SANGER SEQUENCING AND MODY GENE PANEL TESTING METHODS"}, {"entity_type": "GENOMIC VARIANT", "description": "The specific mutations in the GCK gene identified through sequencing which are associated with causing or potentially causing GCK-MODY according to ACMG guidelines.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "GCK VARIANTS (PATHOGENIC OR LIKELY PATHOGENIC)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A set of criteria used by geneticists and clinicians to determine the clinical significance of genomic variants, especially in the context of diagnosing genetic disorders like GCK-MODY.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "ACMG GUIDELINES FOR GENOMIC VARIANT INTERPRETATION"}, {"entity_type": "DISEASE", "description": "A type of monogenic diabetes resulting from mutations in the glucokinase gene leading to altered glucose sensing and regulation.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "GCK-MODY (DISEASE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which genetic variations are detected and analyzed for their potential impact on health, particularly in relation to GCK-MODY and other monogenic diabetes conditions.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "SEQUENCING ANALYSIS OF GENETIC VARIANTS "}, {"entity_type": "MOLECULAR INTERACTION", "description": "A method used to confirm the relationship between a specific genetic variant (like those found in the GCK gene) and the manifestation of type 2 diabetes in family members, providing evidence for causation.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "CO-SEGREGATION WITH DIABETES PHENOTYPE TESTING "}, {"entity_type": "GENOMIC VARIANT", "description": "These are genetic variants identified in the GCK gene that have an uncertain clinical significance according to ACMG guidelines.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "GCK GENE VARIANTS (VUS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A process where family members of probands with suspected GCK-MODY undergo testing for specific genetic variations to confirm co-segregation patterns and assess disease risk.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "PARENTAL/EXTENDED FAMILY DNA TESTING "}, {"entity_type": "MOLECULAR INTERACTION", "description": "Tools used computationally to predict the impact of genetic variants on protein function, aiding in their classification as pathogenic or benign.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "IN-SILICO PREDICTION TOOLS "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure indicating elevated blood glucose levels after fasting, which is used to assess metabolic health and disease risk.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "FASTING HYPERGLYCEMIA LEVELS "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A test measuring the average blood sugar level over a period of 2-3 months, providing insight into long-term diabetes management.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "HBA1C TESTING "}, {"source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "description": "Testing family members for VUS helps confirm co-segregation with disease phenotype, aiding in variant classification.", "entity_type": "UNKNOWN", "id": "GCK VARIANTS (VUS)"}, {"entity_type": "DIETARY PATTERN", "description": "Adherence to the Mediterranean diet was observed among individuals with various characteristics such as lower BMI, higher education levels, and physical activity.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 36}]", "id": "MEDITERRANEAN DIET ADHERENCE (MD)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Triglyceride (TAG) concentration is a metabolic marker that shows significant differences in adherence categories of the Mediterranean Diet.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 38}]", "id": "TAG CONCENTRATION"}, {"entity_type": "METABOLIC PATHWAY", "description": "High-density lipoprotein cholesterol (HDL-C) concentration is another lipid metabolic pathway indicator that is affected by the Mediterranean diet adherence level.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 36}]", "id": "HDL-C CONCENTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The apolipoprotein B to apolipoprotein A-I ratio, a measure of cardiovascular risk, is influenced by adherence to the Mediterranean diet.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 36}]", "id": "APOB:APOA-1 RATIO"}, {"entity_type": "METABOLIC PATHWAY", "description": "Haemoglobin A1c (HbA1c) concentration reflects long-term blood sugar control and is affected by dietary patterns such as the Mediterranean diet.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "id": "HBA1C CONCENTRATION"}, {"entity_type": "GENOMIC VARIANT", "description": "The GCKR rs780094 single nucleotide polymorphism affects TAG, total cholesterol (TC), and apolipoprotein B concentrations.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "id": "GLUCOKINASE REGULATORY PROTEIN SNP (GCKR RS780094)"}, {"entity_type": "DISEASE", "description": "A condition characterized by high levels of triglycerides in the blood, associated with both genetic factors like the GCKR rs780094 SNP and dietary patterns.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 38}]", "id": "HYPERTRIACYLGLYCEROLAEMIA"}, {"entity_type": "GENOMIC VARIANT", "description": "Homozygous GG genotype of rs1695 is associated with an increased risk of developing breast cancer compared to other genotypes.<SEP>Individuals carrying the GG genotype for the GCKR rs780094 SNP have lower TAG concentrations compared to those with AA genotypes.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e<SEP>chunk-c6fdc5ed25c4e17b8c421a952bb05450", "id": "GG GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "The GA genotype is associated with increased risk of hypertriacylglycerolaemia compared to the GG genotype.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "id": "GA GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism in high linkage disequilibrium with the GCKR rs780094 SNP, affecting TAG levels similarly.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 38}]", "id": "RS1260326 SNP"}, {"entity_type": "METABOLIC PATHWAY", "description": "Low-density lipoprotein cholesterol (LDL-C) concentration is another lipid metabolic pathway indicator influenced by adherence to the Mediterranean diet.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 38}]", "id": "LDL-C CONCENTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Systolic blood pressure levels are affected by dietary patterns such as the Mediterranean diet, indicating its influence on cardiovascular health.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 36}]", "id": "SYSTOLIC BLOOD PRESSURE (SBP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Diastolic blood pressure is another physiological process indicator influenced by adherence to the Mediterranean diet.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 36}]", "id": "DIASTOLIC BLOOD PRESSURE (DBP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The degree of insulin resistance can be influenced by adherence to dietary patterns like the Mediterranean diet.<SEP>The reduced sensitivity of cells to insulin, exacerbated by HFD leading to more pronounced phenotypes in SENP1-aP2KO mice compared to control.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450<SEP>chunk-174831b97ed170039b374ba254d4f506", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 37}]", "id": "INSULIN RESISTANCE"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Smoking status is a lifestyle factor considered in the multivariate linear regression models to understand its impact on the association between alcohol consumption and cortisol levels.<SEP>Smoking status is an environmental factor that includes smoker and non-smoker categories.<SEP>The smoking status of individuals can influence their behavior in alcohol consumption and response to medications like naltrexone.", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6<SEP>chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 28}]", "id": "SMOKING STATUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TAG levels refer to the measurement of triglycerides in blood, indicative of lipid metabolism status.<SEP>TAG levels refer to the physiological process or measurement related to triglyceride concentrations in blood.", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "id": "TAG LEVELS"}, {"entity_type": "GENOMIC VARIANT", "description": "An individual\'s genetic makeup (genotype) influences various physiological processes and traits such as TAG levels.<SEP>Genotype refers to a specific variant of genes within an individual\'s genetic makeup that can influence traits like TAG levels.", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "id": "GENOTYPE"}, {"source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "description": "Higher adherence to the Mediterranean diet is associated with lower HbA1c concentrations.", "entity_type": "UNKNOWN", "id": "MEDITERRADIAN DIET ADHERENCE (MD)"}, {"source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "description": "The GCKR rs780094 single nucleotide polymorphism is positively associated with TAG levels in individuals carrying the AA genotype compared to GG genotypes.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 38}]", "id": "GCKR RS780094 SNP"}, {"source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450<SEP>chunk-d311ac0182b37003c75c0005b4337fa6<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "A lifestyle factor that influences blood cortisol levels, its effect is adjusted for during multivariate linear regression analysis.<SEP>Individuals who are physically active tend to have higher adherence to the Mediterranean diet.<SEP>Participants with less physical activity had a higher risk for colorectal cancer, according to the study\'s findings.", "entity_type": "LIFESTYLE FACTOR", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 29}]", "id": "PHYSICAL ACTIVITY"}, {"source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6<SEP>chunk-af413a33fae8d27bdb15cd18447dfad4", "description": "Dietary patterns interact with genotypes to modify physiological processes such as lipid metabolism.)<SEP>Interactions between dietary patterns (such as milk product consumption) and specific genotypes modulate microbial abundances in the gut.", "entity_type": "MOLECULAR INTERACTION", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 26}]", "id": "GENE-DIET INTERACTION"}, {"entity_type": "GENOMIC VARIANT", "description": "Mutations identified in the ABCC8 gene among patients with congenital hyperinsulinism (CHI).", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "ABCC8 MUTATIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "Three different heterozygous mutations were identified in the GLUD1 gene in five patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "GLUD1 MUTATIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "No mutations found in KCNJ11 among CHI patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "KCNJ11 MUTATIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "No variants identified in GCK gene for any patient.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "GCK GENE VARIANTS"}, {"entity_type": "DISEASE", "description": "A disease characterized by excessive insulin secretion leading to hypoglycemia. Patients are categorized based on diazoxide responsiveness and treatment methods such as dietary management.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "CONGENITAL HYPERINSULINISM (CHI)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition characterized by abnormally low blood glucose levels, managed through various treatments including diet and medications such as diazoxide.<SEP>Condition where blood glucose levels drop below normal, a common symptom in CHI patients.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd<SEP>chunk-f921f48a406901d82ec2e32af99485bf", "id": "HYPOGLYCEMIA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A hormone that regulates blood sugar levels; its plasma level is measured in diagnosing hypoglycemia and HI.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "INSULIN HORMONE"}, {"entity_type": "THERAPY", "description": "Treatment for CHI patients, especially those who are diazoxide-responsive.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "DIAZOXIDE THERAPY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Imaging technique used to detect focal lesions in the pancreas of CHI patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "18F-DOPA PET/CT SCAN"}, {"entity_type": "GENOMIC VARIANT", "description": "Mutations identified in KATP channel genes, including ABCC8 and KCNJ11.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "KATP CHANNEL GENE MUTATIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "Mutations found in the GLUD1 gene among patients with CHI.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "GLUD1 GENE MUTATIONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A group of CHI patients who do not respond to diazoxide treatment.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "DIAZOXIDE-UNRESPONSIVE GROUP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A group of CHI patients who respond positively to diazoxide treatment.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "DIAZOXIDE-RESPONSIVE GROUP"}, {"entity_type": "PATIENT CONDITION", "description": "Patients with significantly higher birth weight than average, often linked to genetic factors or environmental influences such as maternal diabetes.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "MACROSOMIC PATIENTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The initial period shortly after birth when symptoms of CHI may first appear in some patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "NEONATAL PERIOD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Period during the first year of life where CHI symptoms can manifest, especially for diazoxide-responsive patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "INFANCY PERIOD (1-12 MONTHS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Later period when CHI symptoms may appear in a subset of patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "CHILDHOOD (>12 MONTHS)"}, {"entity_type": "DISEASE", "description": "A neurological condition observed more frequently in diazoxide-responsive Group 2 compared to the diazoxide-unresponsive group.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "EPILEPSY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Brain damage resulting from prolonged periods of hypoglycemia, often associated with CHI patients who do not receive timely treatment.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "HYPOGLYCEMIC BRAIN INJURY"}, {"entity_type": "THERAPY", "description": "A dietary approach to manage blood glucose levels in CHI patients by frequent feeding and nutritional intake.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "FREQUENT FEEDINGS AND DIETARY MANAGEMENT"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Imaging technique used to diagnose focal pancreatic lesions, aiding in surgical decision-making.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "18F-DOPA PET/CT SCAN FOR FOCAL LESIONS"}, {"entity_type": "GENE", "description": "The GLUD1 gene is associated with hypoglycaemia, hyperinsulinism (HI), and mild hyperammonemia (HA) syndromes.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "GLUD1"}, {"entity_type": "GENOMIC VARIANT", "description": "This mutation in the GLUD1 gene has been identified in three patients and is inherited autosomally dominantly from their father, who was an asymptomatic carrier.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "P.ARG322HIS MUTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "Found in one patient with HI/HA due to a GLUD1 genetic defect.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "P.SER498LEU MUTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "Identified in another patient with HI/HA syndrome linked to a GLUD1 gene mutation.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "P.ASN463ASP MUTATION"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern prescribed for patients diagnosed with HI/HA syndrome due to GLUD1 genetic defects.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "LOW-PROTEIN DIET (1.5 G/KG/DAY)"}, {"entity_type": "THERAPY/MOLECULAR INTERACTION", "description": "Used to manage hypoglycemia in patients with HI/HA syndrome; however, it has side effects like gastrointestinal disturbances and hypertrichosis.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "DIAZOXIDE TREATMENT"}, {"entity_type": "THERAPY/MOLECULAR INTERACTION", "description": "A treatment used for hypoglycaemic patients unresponsive to diazoxide, but only one patient was responsive while two had severe diarrhoea as a side effect.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "OCTREOTIDE TREATMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS/SURGICAL PROCEDURE", "description": "A surgical procedure performed on 10 patients who were not responsive to drug treatments, involving partial removal of the pancreas due to diffuse disease or atypical form conditions.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "PANCREATECTOMY"}, {"entity_type": "PHYSIOLOGICAL PROCESS/DISEASE", "description": "A side effect experienced by a significant number (55%) of patients during diazoxide treatment, characterized by abnormal hair growth.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "HYPERTRICHOSIS"}, {"entity_type": "DISEASE", "description": "A metabolic disorder characterized by high blood sugar levels over a prolonged period. It may influence serum uric acid levels indirectly through its impact on kidney function or medications.<SEP>Developed in some cases following surgical intervention for hypoglycaemia management; insulin therapy was required in these cases.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "id": "DIABETES MELLITUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS/DISEASE", "description": "Observed in two patients after surgery, one of whom needed regular feedings to manage mild hypoglycemia post-surgery.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "MALABSORPTION SYMPTOMS"}, {"entity_type": "TRANSCRIPT", "description": "The GLUD1 gene transcript is affected by mutations leading to hypoglycaemia, hyperinsulinism (HI), and mild hyperammonemia (HA) syndromes.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "GLUD1 TRANSCRIPT"}, {"entity_type": "PHYSIOLOGICAL PROCESS/DISEASE MARKER", "description": "A biochemical marker indicating the presence of GLUD1 gene-related hypoglycaemic conditions due to high ammonia levels.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "SERUM AMMONIA CONCENTRATION (85-184 \u039cMOL/L)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/SIDE EFFECT", "description": "Gastrointestinal side effects common among patients treated with diazoxide for managing hypoglycaemia.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "NAUSEA AND VOMITING"}, {"entity_type": "PHYSIOLOGICAL PROCESS/SIDE EFFECT", "description": "A serious adverse reaction to diazoxide treatment, leading to the need for nasogastric feeding in some cases.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "SEVERE GASTROINTESTINAL UPSET"}, {"entity_type": "PHYSIOLOGICAL PROCESS/SIDE EFFECT", "description": "Another common side effect experienced by patients receiving diazoxide therapy.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "POOR APPETITE"}, {"entity_type": "DISEASE/SIDE EFFECT", "description": "A serious condition requiring the cessation of diazoxide treatment in one patient due to its severity.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "THROMBOCYTOPENIC PURPURA"}, {"entity_type": "SURGICAL PROCEDURE", "description": "The most common surgical intervention for managing hypoglycemia unresponsive to drug treatments, involving partial removal of the pancreas.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "SUBTOTAL PANCREATECTOMY"}, {"entity_type": "THERAPY/MOLECULAR INTERACTION", "description": "Used in cases where patients develop diabetes mellitus after pancreatectomy due to surgery-induced insulin deficiency.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "INSULIN TREATMENT"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Patients who do not respond to diazoxide treatment often show diffuse rather than focal pancreatic lesions upon surgical examination.", "entity_type": "UNKNOWN", "id": "DIFFUSE PANCREATIC DISEASE"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Frequent feeding is often initiated early after birth or during infancy to manage blood glucose levels in CHI patients, especially for those with hypoglycemia detected shortly after birth.", "entity_type": "UNKNOWN", "id": "NEONATAL PERIOD AND INFANCY PERIOD (1-12 MONTHS)"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Effective treatment strategy for many CHI patients, reducing the frequency of hypoglycemic episodes and improving overall health outcomes.", "entity_type": "UNKNOWN", "id": "HYPOGLYCEMIA MANAGEMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Levels of AcAc and BHB are physiological processes that significantly change in individuals with different glucose tolerance states.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "ACAC AND BHB LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "2hPG is measured two hours after a meal and is used to assess glucose tolerance in individuals with normal FPG levels.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "TWO-HOUR POST-PRANDIAL GLUCOSE (2HPG)"}, {"entity_type": "DISEASE CONDITION", "description": "A condition where fasting blood sugar levels are higher than normal but not high enough for a diagnosis of diabetes.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "IMPAIRED FASTING GLYCAEMIA (IFG)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition characterized by impaired response to ingested glucose; linked to higher risk of developing T2DM and specific genetic factors like rs10886471.)<SEP>An intermediate stage between normal glucose tolerance and type 2 diabetes, characterized by elevated postprandial blood glucose levels.<SEP>A condition where blood sugar levels are higher than normal but not high enough to be classified as diabetes after a glucose tolerance test.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-44a871da300abc9be525b468f502f5cb", "id": "IMPAIRED GLUCOSE TOLERANCE (IGT)"}, {"entity_type": "STUDY", "description": "The METSIM study is a prospective research project focusing on metabolic syndrome and its risk factors.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "METSIM STUDY"}, {"entity_type": "DISEASE", "description": "A condition characterized by high blood glucose levels, observed to onset earlier (at age 8 weeks) under HFD conditions compared to normal diet in SENP1-aP2KO mice.<SEP>An elevated level of glucose in the bloodstream, often a symptom or indicator of type 2 diabetes and other metabolic disorders.<SEP>An increase in blood sugar above the normal range, often seen as an early indicator of diabetes or prediabetes.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-174831b97ed170039b374ba254d4f506", "id": "HYPERGLYCEMIA"}, {"entity_type": "BIOLOGICAL PATHWAY", "description": "A measure indicating how effectively insulin lowers blood glucose levels; decreased sensitivity can lead to type 1 or type 2 diabetes.<SEP>A measure indicating how effectively insulin lowers blood glucose levels; decreased sensitivity can lead to type 2 diabetes.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "INSULIN SENSITIVITY (ISI)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which the pancreas releases insulin into the bloodstream, crucial for regulating blood sugar levels.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "INSULIN SECRETION"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphisms that are associated with an increased risk of type 2 diabetes or hyperglycemia.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "RISK SNPS FOR TYPE 2 DIABETES OR HYPERGLYCEMIA"}, {"entity_type": "METABOLIC PATHWAY", "description": "Folate metabolism is crucial for DNA synthesis and repair, affecting cardiovascular health through its interaction with MTHFR variants.)<SEP>Not directly mentioned but relevant to nutrient metabolism.<SEP>The metabolic process involving the synthesis, conversion and utilization of folate in various biochemical pathways.<SEP>The process by which folic acid is converted into its active forms for use in various physiological processes such as DNA synthesis.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-7c25217961fba65d15f20beda8a58f1c<SEP>chunk-d0476488384aadcae4630e94d982d2e0", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 34}]", "id": "FOLATE METABOLISM"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Factors such as diet, physical activity, smoking, and BMI which influence glucose tolerance and diabetes risk.<SEP>Genetic background and ancestral admixture (measured by AIMs) are environmental factors influencing pharmacogenomics algorithms.<SEP>Unspecified environmental factors may influence CYP24A1 expression and contribute to disease susceptibility.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-b2730f3087aee6d9cff6e4939b229323", "id": "ENVIRONMENTAL FACTOR"}, {"entity_type": "GENE", "description": "Gene associated with CRP levels and cardiometabolic phenotypes.<SEP>The GCKR gene is involved in glucose metabolism and has risk SNPs associated with elevated BHB levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-372184452f1f9156514992455057f843", "id": "GCKR"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP (rs780094) of the GCKR gene is linked to higher BHB levels, indicating a genetic influence on ketone body metabolism.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "RS780094"}, {"entity_type": "GENE", "description": "The FADS1 gene influences fatty acid desaturation and has been found to have significant associations with AcAc or BHB levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "FADS1"}, {"entity_type": "GENE", "description": "ANK1 is a gene involved in blood clotting and was associated with the levels of AcAc or BHB.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "ANK1"}, {"entity_type": "GENE", "description": "The GIPR gene, which encodes the glucagon-like peptide-1 receptor, showed significant associations with ketone body levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "GIPR"}, {"entity_type": "GENE", "description": "HMGA2 is a high-mobility group AT-hook 2 protein gene and was found to have an association with BHB or AcAc levels.<SEP>High Mobility Group AT-Hook 2, a gene associated with height variation and number of teeth.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "HMGA2"}, {"entity_type": "NUTRIENT", "description": "Free fatty acids are a nutrient involved in energy metabolism and correlate positively with AcAc and BHB levels during fasting conditions.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "FFAS (FREE FATTY ACIDS)"}, {"entity_type": "GENE", "description": "The CPT1A gene encodes an enzyme that plays a crucial role in fatty acid oxidation by transporting long-chain acyl-CoAs into mitochondria for beta-oxidation.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "CPT1A (CARNITINE PALMITOYLTRANSFERASE 1A)"}, {"entity_type": "GENE", "description": "The HMGCS1 gene is involved in ketogenesis and the synthesis of ketone bodies from acetyl-CoA.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "HMGCS1 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 1, SOLUBLE)"}, {"entity_type": "GENE", "description": "HMGCS2 encodes an enzyme that catalyzes a rate-limiting step in ketogenesis and is localized to the mitochondria.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "HMGCS2 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2, MITOCHONDRIAL)"}, {"entity_type": "GENE", "description": "The ACAT1 gene encodes an enzyme crucial for the final step of ketone body breakdown, producing two molecules of acetyl-CoA from acetoacetyl-CoA.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "ACAT1 (ACETYL-COA ACETYLTRANSFERASE 1)"}, {"entity_type": "GENE", "description": "BDH1 is involved in BHB metabolism and was found to have inverse correlations with glucose AUC and insulin secretion while positively correlating with Matsuda ISI.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "BDH1 (BHB DEHYDROGENASE, TYPE 1)"}, {"entity_type": "GENE", "description": "The OXCT1 gene regulates the ketolysis process, converting acetoacetyl-CoA to acetyl-CoA and is correlated with insulin sensitivity and glucose metabolism.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "OXCT1 (3-OXOACID COA TRANSFERASE 1)"}, {"entity_type": "GENE", "description": "The ACSS2 gene encodes an enzyme involved in the activation of fatty acids for subsequent beta-oxidation and has been found to correlate with insulin sensitivity.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "ACSS2 (ACYL-COA SYNTHETASE SHORT-CHAIN FAMILY MEMBER 2)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Ketone bodies, such as BHB and AcAc, are produced during fasting or low carbohydrate intake and their levels are associated with genetic variations and metabolic conditions like type 2 diabetes.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "KBS (KETONE BODIES)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of breaking down fatty acids to produce energy; correlated with ketone body levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "FATTY ACIDS OXIDATION (FFA OXIDATION)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Pathway responsible for the synthesis of ketone bodies from acetyl-CoA during periods of fasting or low carbohydrate intake.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "KETOGENESIS"}, {"entity_type": "METABOLIC PATHWAY", "description": "The metabolic pathway involved in breaking down ketone bodies back into acetyl-CoA and other metabolites.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "KETOLYSIS"}, {"source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "description": "The METSIM study tracks participants over time to identify factors that increase the risk of hyperglycemia and incident diabetes.)", "entity_type": "UNKNOWN", "id": "HYPERGLYCEMIA AND INCIDENT DIABETES"}, {"source_id": "chunk-b2730f3087aee6d9cff6e4939b229323<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "description": "Folate metabolism is part of broader nutrient-related physiological processes.)<SEP>The text does not mention nutrients directly but suggests that genetic background influences therapeutic dose prediction.", "entity_type": "NUTRIENT", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 34}]", "id": "NUTRIENT"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs associated with cardiometabolic phenotypes and serum CRP levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CARDIOMETABOLIC SNP"}, {"entity_type": "DISEASE", "description": "GWAS for C-Reactive Protein (CRP) levels in the context of cardiometabolic traits.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CRP GWAS"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the APOC1 locus associated with CRP and inversely related to cholesterol, LDL-cholesterol, and triglyceride levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "APOC1 GENE VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the HNF1A locus linked to CRP but inversely correlated with cholesterol and LDL-cholesterol levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "HNF1A GENE VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "One of the SNPs located near or within the GCKR gene associated with cardiometabolic traits including CRP.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "GCKR GENE VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP in the IL6R locus, showing significant association with CRP but differing lead SNP compared to other cardiometabolic GWAS for this locus.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "IL6R GENE VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Metabolism regulated by PPAR which may interact with genetic variants affecting CRP and lipid levels.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "PPAR REGULATED LIPID METABOLISM"}, {"entity_type": "CLINICAL PARAMETER", "description": "C-reactive protein levels are elevated in individuals who develop diabetes, particularly those with type 1 diabetes mellitus (T1DM).<SEP>Levels of C-Reactive Protein, a biomarker for systemic inflammation associated with cardiometabolic diseases.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "id": "CRP LEVELS"}, {"entity_type": "METABOLIC PATHWAY", "description": "Pathway involved in cholesterol synthesis and regulation, affected by SNPs identified in the GWAS.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CHOLESTEROL METABOLISM"}, {"entity_type": "DISEASE", "description": "A metabolic disease characterized by hyperglycemia; GWAS for CRP show significant deviations in p-values indicating potential genetic overlap with this condition.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "TYPE 2 DIABETES MELLITUS"}, {"entity_type": "DISEASE", "description": "Cardiovascular disease where atherosclerotic plaques narrow coronary arteries; GWAS of CRP SNPs indicate associations with CAD.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CORONARY ARTERY DISEASE (CAD)"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific single nucleotide polymorphisms (SNPs) associated with CRP levels in various cardiometabolic conditions.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "CRP SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located within the FTO gene, showing a significant association with CRP levels and representing one of the novel associations identified in the GWAS for CRP.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 14}]", "id": "RS1558902 SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "Another SNP near TMEM18 on chromosome 2, also significantly associated with CRP levels as part of the GWAS findings.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "RS2867125 SNP"}, {"entity_type": "GENE", "description": "A gene near which a significant SNP (rs2867125) was found, contributing to the understanding of CRP associations with cardiometabolic traits.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "TMEM18 GENE"}, {"entity_type": "GENE", "description": "The PLTP locus has associated SNPs impacting CRP levels as part of GWAS studies for cardiovascular and metabolic conditions.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "PLTP GENE"}, {"entity_type": "GENE", "description": "A gene upstream where a SNP (rs571312) is significantly linked to higher CRP, contributing insights into cardiometabolic phenotypes.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "MC4R GENE"}, {"entity_type": "METABOLIC PATHWAY", "description": "Pathways involved in the synthesis and regulation of LDL-cholesterol, affected by genetic variants identified in GWAS for CRP.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "LDL-CHOLESTEROL METABOLISM"}, {"entity_type": "METABOLIC PATHWAY", "description": "The metabolic processes regulating HDL cholesterol levels are influenced by genomic loci related to CRP levels as seen in the GWAS.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "HDL-CHOLESTEROL METABOLISM"}, {"entity_type": "METABOLIC PATHWAY", "description": "Genetic factors influencing triglyceride metabolism, demonstrated through associations with CRP SNPs identified in cardiometabolic studies.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "TRIGLYCERIDE REGULATION"}, {"entity_type": "GENE", "description": "Gene identified in association studies for CRP and cardiometabolic traits, not previously reported in GWAS.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "IL1F10"}, {"entity_type": "GENE", "description": "Gene showing pleiotropic effects on CRP and cardiometabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "PPP1R3B"}, {"entity_type": "GENE", "description": "Gene influencing CRP levels and cardiometabolic phenotypes, notably T2D risk.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "HNF4A"}, {"entity_type": "GENE", "description": "Gene involved in pleiotropy with effects on CRP and metabolic parameters.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "PABPC4"}, {"entity_type": "GENE", "description": "Gene associated with changes in HDL cholesterol after adjustment for CRP.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "BCL7B"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP rs1183910 is located within the HNF1A gene, influencing coronary artery disease (CAD) risk and CRP levels.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "HNF1A"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP rs4420638 near APOC1 affects T2D risk and serum CRP levels.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "APOC1"}, {"entity_type": "GENE", "description": "Gene showing pleiotropic effects on CRP without significant effect size diminishment after adjustment for BMI, cholesterol, or HbA1C.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "IL6R"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs near MC4R showed no significant association with CRP levels in the WGHS.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "MC4R"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs near PLTP showed no significant association with CRP after correction for multiple testing.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "PLTP"}, {"entity_type": "GENE", "description": "C-reactive protein (CRP) levels influenced by genetic loci and cardiometabolic phenotypes.<SEP>The CRP gene encodes a protein that serves as an acute-phase reactant during inflammatory processes.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-372184452f1f9156514992455057f843", "id": "CRP"}, {"entity_type": "DISEASE", "description": "Coronary Artery Disease is a condition associated with heart disease due to blockages in the arteries supplying blood to the heart.<SEP>Coronary artery disease, risk associated with SNP rs1183910 in HNF1A.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea<SEP>chunk-372184452f1f9156514992455057f843", "id": "CAD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum cholesterol levels influence genetic associations with CRP and metabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "CHOLESTEROL LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Haemoglobin A1c, a marker of average blood glucose level over time, influences CRP associations in cardiometabolic studies.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "HBA1C"}, {"entity_type": "METABOLIC PATHWAY", "description": "Pathway significantly enriched by pleiotropic genes influencing CRP and cardiometabolic traits.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "FXR/RXR ACTIVATION PATHWAY"}, {"entity_type": "METABOLIC PATHWAY", "description": "Significantly enriched metabolic pathway related to the effects of pleiotropic loci on CRP and cardiometabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "LXR/RXR ACTIVATION PATHWAY"}, {"entity_type": "BIOLOGICAL PATHWAY", "description": "Pathway significantly enriched by genes involved in pleiotropy affecting CRP levels and metabolic traits.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "MATURITY ONSET DIABETES OF THE YOUNG (MODY)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Significantly enriched pathway linked to genetic loci influencing CRP and cardiometabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "HEPATIC CHOLESTASIS"}, {"entity_type": "BIOLOGICAL PATHWAY", "description": "Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "ACUTE PHASE RESPONSE SIGNALING"}, {"source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "description": "SNPs in the HNF1A gene affect fasting glucose levels, illustrating genetic influence on metabolic conditions such as diabetes.)", "entity_type": "UNKNOWN", "id": "GLYCEMIC PHENOTYPES"}, {"source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "description": "Variants near IL6R are linked to inflammatory responses measured by CRP and may modulate cardiovascular risks.)", "entity_type": "UNKNOWN", "id": "INFLAMMATION REGULATION"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "IL1F10 was not previously reported in GWAS for the specific phenotype, indicating novel associations.)", "entity_type": "UNKNOWN", "id": "GWAS NOT REPORTED"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "PPP1R3B gene shows pleiotropic effects on CRP levels and multiple cardiometabolic traits.)", "entity_type": "UNKNOWN", "id": "CRP AND METABOLIC PHENOTYPES"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "HNF4A influences risk of T2D and CRP levels, showing biological pleiotropy.)", "entity_type": "UNKNOWN", "id": "T2D RISK"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Association between BCL7B and HDL cholesterol decreases considerably after adjustment for CRP.)", "entity_type": "UNKNOWN", "id": "HDL CHOLESTEROL"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "SNPs in HNF1A are associated with an increased risk of coronary artery disease (CAD).)", "entity_type": "UNKNOWN", "id": "CAD RISK"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Body Mass Index is a key mediator in the pleiotropy observed between certain SNPs and metabolic phenotypes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 22}]", "id": "MEDIATOR OF PLEIOTROPIC EFFECTS"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Levels of cholesterol influence genetic associations with CRP and cardiometabolic phenotypes.)", "entity_type": "UNKNOWN", "id": "CRP ASSOCIATIONS"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Pathway enriched by genes showing pleiotropic effects on CRP levels and metabolic phenotypes.)", "entity_type": "UNKNOWN", "id": "GENETIC PLEIOTROPY"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes.)", "entity_type": "UNKNOWN", "id": "GENETIC EFFECTS"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes.)", "entity_type": "UNKNOWN", "id": "MODY SIGNALING"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Pathway significantly enriched by genetic loci influencing CRP and cardiometabolic traits.)", "entity_type": "UNKNOWN", "id": "HEPATIC CHOLESTASIS PATHWAY"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Pathway involved in the effects of pleiotropic genes on CRP levels and metabolic phenotypes.)", "entity_type": "UNKNOWN", "id": "ACUTE PHASE RESPONSE SIGNALING PATHWAY"}, {"source_id": "chunk-372184452f1f9156514992455057f843", "description": "Pathway involved in the effects of pleiotropic genes on CRP levels and metabolic phenotypes.)", "entity_type": "UNKNOWN", "id": "GENETIC INFLUENCES"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located in miR-34b/c region that has been genotyped for IA patients and controls.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "MIR-34B/C RS4938723"}, {"entity_type": "GENOMIC VARIANT", "description": "An Arginine to Proline substitution at position 72 of the TP53 gene, which was also genotyped in the study.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "TP53 ARG72PRO"}, {"entity_type": "DISEASE", "description": "A condition characterized by a bulge or balloon-like dilation of an artery wall within the skull that can potentially lead to hemorrhage if it ruptures.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "IA (INTRACRANIAL ANEURYSM)"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide variation at a specific location in the genome that can influence genetic traits.<SEP>A type of genetic variation that involves a change in a single nucleotide at a specific position within the genome.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb<SEP>chunk-055177812e320344d131432b292111b0", "id": "SNP (SINGLE NUCLEOTIDE POLYMORPHISM)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A principle used to check for random mating and non-evolving populations in genetic studies.<SEP>A principle used to test if genotype frequencies in a population are inherited randomly without natural selection, mutation, or other disruptive mechanisms.<SEP>Refers to the state where genotype frequencies in a population remain constant from generation to generation due to random mating and no other evolutionary influences.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d<SEP>chunk-055177812e320344d131432b292111b0", "id": "HARDY-WEINBERG EQUILIBRIUM"}, {"entity_type": "STATISTICAL MEASURE", "description": "OR is a measure indicating the strength of association or correlation between an exposure and a result. In this context, it\'s being used to determine how strongly T2DM is associated with specific alleles.<SEP>The odds ratio is a measure of association between an exposure and health outcome.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9<SEP>chunk-055177812e320344d131432b292111b0", "id": "OR (ODDS RATIO)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A range estimate for the measure of effect, in this case, the Odds Ratio, providing the reliability of the observed effect.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "95% CI (CONFIDENCE INTERVAL)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The proportion or frequency of different genotypes within a population.", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "GENOTYPE FREQUENCY DISTRIBUTION"}, {"entity_type": "GENE", "description": "A gene where a nonsynonymous SNP (rs1056513; G1178S) was found to be near genome-wide significant for weight, BMI, FFM, FM, trunk FM, and hip circumference.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "INADL"}, {"entity_type": "GENE", "description": "A gene on chromosome 13 where an intronic variant (rsID not provided) showed association with weight z-score change.<SEP>An intronic variant in this gene on chromosome 13 showed association with weight z-score change.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "COL4A1"}, {"entity_type": "GENE", "description": "A gene on chromosome 19 where a variant in the 5\u2032UTR region was associated with linear growth (height change).<SEP>A variant in the 5\u2032UTR region of TSEN34 on chromosome 19 is associated with linear growth (height change).", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "TSEN34"}, {"entity_type": "GENE", "description": "An intronic variant within MTNR1B on chromosome 11 was strongly associated with fasting glucose.<SEP>An intronic variant within this gene on chromosome 11 is strongly associated with fasting glucose.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "MTNR1B"}, {"entity_type": "GENOMIC VARIANT, GENE", "description": "This genomic area harboring APOA5 and ZNF259 genes includes variants linked to triglycerides.<SEP>This genomic region encompasses the APOA5 and ZNF259 genes on chromosome 11, harboring intronic and 3\u2032UTR variants linked to triglycerides.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "APOA5-ZNF259 REGION"}, {"entity_type": "GENE", "description": "An intronic variant in PCSK2 on chromosome 20 is associated with total antioxidants in the body.<SEP>An intronic variant within this gene on chromosome 20 is associated with total antioxidants in the body.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "PCSK2"}, {"entity_type": "GENE", "description": "A gene on chromosome 14 where a 3\u2032UTR region variant is linked to urinary nitrogen excretion.<SEP>A gene on chromosome 14 where a flanking 3\u2032UTR region harbors a variant linked to urinary nitrogen excretion.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RNASE1"}, {"entity_type": "GENE", "description": "A gene on chromosome 7 with its flanking 3\u2032UTR containing a variant associated with creatinine excretion.<SEP>A gene on chromosome 7 with its flanking 3\u2032UTR harboring a variant associated with creatinine excretion.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "ASS1P11"}, {"entity_type": "GENE", "description": "An intronic SNP in GCH1 on chromosome 14 was identified for urinary dopamine:creatinine ratio.<SEP>An intronic SNP in this gene on chromosome 14 was identified for urinary dopamine:creatinine ratio.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "GCH1"}, {"entity_type": "GENE", "description": "A gene on chromosome 4 with a nonsynonymous SNP (rs3733402; S143T) linked to serum free IGF-1.<SEP>A nonsynonymous SNP (rs3733402; S143T) within KLKB1 on chromosome 4 is associated with serum free IGF-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "KLKB1"}, {"entity_type": "GENE", "description": "An intronic SNP in MPRIP on chromosome 17 is linked to serum IGFBP-3 levels.<SEP>An intronic SNP within this gene on chromosome 17 is associated with serum IGFBP-3 levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "MPRIP"}, {"entity_type": "GENOMIC VARIANT, GENE", "description": "A block of twenty-three SNPs in the flanking 5\u2032UTR region of XPA/FOXE1 on chromosome 9 is highly associated with serum TSH.<SEP>A block of twenty-three SNPs in the flanking 5\u2032UTR region of this gene on chromosome 9 are highly associated with serum TSH and found to be in strong linkage disequilibrium.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "XPA/FOXE1 (TTF-2)"}, {"entity_type": "GENE", "description": "Contains coding variants linked to MCP-1, including a nonsynonymous SNP (rs12075; G42D) and an intronic SNP.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "DARC"}, {"entity_type": "GENE", "description": "A gene on chromosome 2 with a variant identified for MCP-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "GREB1"}, {"entity_type": "GENE", "description": "A gene on chromosome 9 where coding variants are associated with MCP-1 levels.<SEP>A gene on chromosome 9 where coding variants were found to be associated with MCP-1 levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "DFNB31"}, {"entity_type": "GENE", "description": "A 3\u2032UTR variant in this gene was highly associated with MCP-1 and IL-6.<SEP>Variants in the 3\u2032UTR region of CCR3 and an intronic SNP are highly associated with MCP-1 and IL-6.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "CCR3"}, {"entity_type": "GENE", "description": "An intronic SNP within RASGEF1A is significantly associated with MCP-1 levels.<SEP>An intronic SNP within this gene is significantly associated with MCP-1 levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RASGEF1A"}, {"entity_type": "GENE", "description": "Contains a variant in the intronic region strongly linked to IL-6.<SEP>Variants in the intronic region of ABO are strongly linked to IL-6.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "ABO"}, {"entity_type": "GENE", "description": "A gene on chromosome 14 where an intronic variant is associated with ad libitum energy intake at dinner.<SEP>An intronic variant within TMEM229B on chromosome 14 is associated with ad libitum energy intake at dinner.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "TMEM229B"}, {"entity_type": "GENE", "description": "An intronic SNP in ARHGAP11A on chromosome 15 showed significant association with sleep duration.<SEP>An intronic variant within this gene on chromosome 15 showed significant association with sleep duration.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "ARHGAP11A"}, {"entity_type": "GENE", "description": "Contains an SNP in the intronic region linked to respiratory quotient (RQ) during sleep.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "C21ORF34"}, {"entity_type": "ENDOMETABOLIC TRAITS, INFLAMMATION MARKERS, DIET, ENERGY EXPENDITURE, SUBSTRATE UTILIZATION AND PHYSICAL ACTIVITY", "description": "Various endometabolic traits, inflammation markers, dietary habits, energy expenditure, substrate utilization, and physical activity levels are associated with specific genetic variants identified in the study.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "SERUM FREE IGF-1, SERUM IGFBP-3, SERUM TSH, FASTING GLUCOSE, TRIGLYCERIDES, TOTAL ANTIOXIDANTS, 24-H URINARY NITROGEN EXCRETION, CREATININE EXCRETION, 24-H URINARY DOPAMINE:CREATININE RATIO, MCP-1, IL-6, AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION"}, {"entity_type": "TRAIT", "description": "A trait measured as linear growth (height change) that is associated with a variant in TSEN34 on chromosome 19.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "LINEAR GROWTH (HEIGHT CHANGE)"}, {"entity_type": "ENDOMETABOLIC TRAITS AND INFLAMMATION MARKERS", "description": "These traits are significantly associated with genetic variants identified in the endometabolic and inflammation marker sections.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "FASTING GLUCOSE, TRIGLYCERIDES, TOTAL ANTIOXIDANTS, 24-H URINARY NITROGEN EXCRETION, CREATININE EXCRETION, 24-H URINARY DOPAMINE:CREATININE RATIO, MCP-1, IL-6"}, {"entity_type": "DIETARY HABITS, ENERGY EXPENDITURE, SUBSTRATE UTILIZATION, PHYSICAL ACTIVITY", "description": "These dietary habits and activity measures are associated with genetic variants identified in the respective sections.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION, RESPIRATORY QUOTIENT (RQ) DURING SLEEP, ACCELEROMETER-MEASURED LIGHT ACTIVITY"}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic variant in ARHGAP11A was associated with sleep duration.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "ARHGAP11A INTRONIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "C21ORF34 SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant was identified for accelerometer-measured light activity in the 5\u2032UTR region of RPL7P3.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "RPL7P3 VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant was identified for sedentary-light activity in the 3\u2032UTR region of CTCFL.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "CTCFL VARIANT"}, {"entity_type": "GENE", "description": "Highly significant variants were identified for total energy expenditure associated with MATK gene.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "MATK GENE "}, {"entity_type": "GENE", "description": "Significant genetic associations detected for sleeping energy expenditure linked to CHRNA3 gene.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "CHRNA3 GENE "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A factor that correlates with the occurrence of snoring, although not extensively covered in this text.<SEP>Sleep duration is a physiological process that has been shown to be influenced by genomic variants such as those in ARHGAP11A.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-46227b557f62c59155b1b9cef71d0d17", "id": "SLEEP DURATION "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The respiratory quotient during sleep measures metabolic efficiency and energy use, influenced by genetic factors such as C21orf34.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "RESPIRATORY QUOTIENT (RQ)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Accelerometer-measured light activity is a measure of physical behavior patterns linked to genomic variants in RPL7P3.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "LIGHT ACTIVITY "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Sedentary-light activity during sleep measures low-intensity movements influenced by genetic factors such as CTCFL.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "SEDENTARY-LIGHT ACTIVITY "}, {"entity_type": "METABOLIC PATHWAY", "description": "The total energy expenditure is a key metabolic pathway linked to genomic variants in MATK, indicating its role in overall metabolism.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "TOTAL ENERGY EXPENDITURE "}, {"entity_type": "METABOLIC PATHWAY", "description": "Sleeping energy expenditure is part of the basal metabolic rate during sleep, influenced by genetic factors such as CHRNA3.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "SLEEPING ENERGY EXPENDITURE "}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "An intronic variant in COL4A1 on chromosome 13 is associated with changes in weight z-score.", "entity_type": "UNKNOWN", "id": "WEIGHT Z-SCORE CHANGE"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "An intronic SNP in MTNR1B on chromosome 11 is strongly linked to fasting glucose levels.", "entity_type": "UNKNOWN", "id": "FASTING GLUCOSE"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "Variants within this genomic area significantly affect triglyceride levels.", "entity_type": "UNKNOWN", "id": "TRIGLYCERIDES"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "An intronic SNP in PCSK2 on chromosome 20 is associated with total antioxidants in the body.", "entity_type": "UNKNOWN", "id": "TOTAL ANTIOXIDANTS"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "Variants near RNASE1 and ASS1P11 genes are linked to urinary nitrogen excretion and creatinine excretion, respectively.", "entity_type": "UNKNOWN", "id": "RNASE1, ASS1P11"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "Variants near RNASE1 and ASS1P11 genes are linked to urinary nitrogen excretion and creatinine excretion, respectively.", "entity_type": "UNKNOWN", "id": "URINARY NITROGEN EXCRETION, CREATININE EXCRETION"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "An intronic SNP in GCH1 on chromosome 14 influences the ratio of 24-hour urinary dopamine to creatinine.", "entity_type": "UNKNOWN", "id": "24-H URINARY DOPAMINE:CREATININE RATIO"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "Variants within KLKB1 and MPRIP genes are associated with serum free IGF-1 and IGFBP-3 levels, respectively.", "entity_type": "UNKNOWN", "id": "KLKB1, MPRIP"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "Variants within KLKB1 and MPRIP genes are associated with serum free IGF-1 and IGFBP-3 levels, respectively.", "entity_type": "UNKNOWN", "id": "SERUM FREE IGF-1, SERUM IGFBP-3"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "A group of SNPs in the flanking region of XPA/FOXE1 on chromosome 9 are highly associated with serum thyroid-stimulating hormone levels.", "entity_type": "UNKNOWN", "id": "SERUM TSH"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "Coding variants in DARC, GREB1, and DFNB31; as well as an intronic SNP in CCR3 and RASGEF1A are associated with MCP-1 levels. Additionally, a variant within the ABO gene is strongly linked to IL-6.", "entity_type": "UNKNOWN", "id": "DARC, GREB1, DFNB31, CCR3, RASGEF1A, ABO"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "Coding variants in DARC, GREB1, and DFNB31; as well as an intronic SNP in CCR3 and RASGEF1A are associated with MCP-1 levels. Additionally, a variant within the ABO gene is strongly linked to IL-6.", "entity_type": "UNKNOWN", "id": "MCP-1, IL-6"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "An intronic SNP in TMEM229B is associated with energy intake at dinner. An intronic SNP in ARHGAP11A affects sleep duration and an SNP near C21orf34 influences respiratory quotient during sleep.", "entity_type": "UNKNOWN", "id": "AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION, RESPIRATORY QUOTIENT (RQ) DURING SLEEP"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "An intronic SNP in TMEM229B is associated with energy intake at dinner. An intronic SNP in ARHGAP11A affects sleep duration and an SNP near C21orf34 influences respiratory quotient during sleep.", "entity_type": "UNKNOWN", "id": "TMEM229B, ARHGAP11A, C21ORF34"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "This variant is associated with sleep duration, indicating a genetic influence on this physiological process.", "entity_type": "UNKNOWN", "id": "SLEEP DURATION"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "This variant is associated with accelerometer-measured light activity, implying a genetic effect on physical behavior patterns.", "entity_type": "UNKNOWN", "id": "LIGHT ACTIVITY"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "The variant in the 3\u2032UTR of CTCFL is linked to sedentary-light activity during sleep, indicating an influence on daily movement patterns through genetic variation.", "entity_type": "UNKNOWN", "id": "SEDENTARY-LIGHT ACTIVITY"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "Highly significant variants for total energy expenditure were identified in the MATK gene, suggesting a strong genetic association with overall metabolic rate.", "entity_type": "UNKNOWN", "id": "TOTAL ENERGY EXPENDITURE"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "Genetic associations detected for CHRNA3 linked to sleeping energy expenditure, indicating this gene\'s role in basal metabolism during sleep.", "entity_type": "UNKNOWN", "id": "SLEEPING ENERGY EXPENDITURE"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "The intronic variant in ARHGAP11A is associated with sleep duration, indicating a direct genetic influence on this physiological process.", "entity_type": "UNKNOWN", "id": "ARHGAP11A INTRONIC VARIANT "}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "The SNP in C21orf34 influences the respiratory quotient during sleep, suggesting a significant impact of genetic variation on metabolic efficiency.", "entity_type": "UNKNOWN", "id": "C21ORF34 SNP "}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "Genetic variation in RPL7P3 is associated with accelerometer-measured light activity, indicating its role in physical behavior patterns.", "entity_type": "UNKNOWN", "id": "RPL7P3 VARIANT "}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "The CTCFL variant affects sedentary-light activity during sleep, reflecting the genetic influence on low-intensity movements.", "entity_type": "UNKNOWN", "id": "CTCFL VARIANT "}, {"entity_type": "GENE", "description": "APOBR is a gene studied for its role in obesity through sequence variant analysis.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 3}]", "id": "APOBR"}, {"entity_type": "GENOMIC VARIANT", "description": "These are sequence variants identified in the coding region of APOBR.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS74949322, RS151233, RS149271, RS3833080, RS368546180, RS180743, RS180744, RS151174, RS40831, RS61738759, RS200751685, RS40833, AND RS142786317"}, {"entity_type": "PROTEIN", "description": "This variant is a deletion that affects the amino acid sequence of APOBR and has no predicted function.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 3}]", "id": "RS3833080: P.GLY369_ASP370DEL9"}, {"entity_type": "PROTEIN", "description": "A non-synonymous SNP affecting the amino acid sequence of APOBR, located in a conserved position among species.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 3}]", "id": "RS180743: P.PRO428ALA"}, {"entity_type": "DISEASE", "description": "This refers to individuals suffering from obesity who were part of the study population.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 13}]", "id": "EXTREMELY OBESE CHILDREN AND ADOLESCENTS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These are bioinformatics tools used for predicting the functional impact of genetic variants on proteins and genes.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "MUTATION TASTER, SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, ENSEMBL, PROVEAN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Risk alleles identified in APOBR associated with obesity risk.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 3}]", "id": "GENETIC VARIANT RISK ALLELES"}, {"entity_type": "PROTEIN", "description": "A deletion variant in APOBR affecting an amino acid sequence, identified in a heterozygous state.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS368546180: P.THR321_GLY329DEL9"}, {"entity_type": "GENOMIC VARIANT", "description": "These are additional sequence variants identified in the coding region of APOBR that do not affect amino acid sequences.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 3}]", "id": "RS151233, RS149271, RS180744, RS151174, RS40831, RS61738759, RS200751685, RS40833, AND RS142786317"}, {"entity_type": "TRANSCRIPT", "description": "A common deletion variant affecting a transcript in the repeat region of APOBR with no predicted function.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "C.1036_1062DEL27"}, {"entity_type": "GENOMIC VARIANT", "description": "These alleles are associated with obesity as identified through case-control studies.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS180743 G-ALLELE, RS3833080 DELETION ALLELE"}, {"entity_type": "PROTEIN", "description": "A variant resulting in an in-frame shortened amino acid sequence of the repeat region of APOBR.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS368546180: P.ALA328_GLY329DEL9"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Bioinformatics tools for predicting the impact of genetic variations on proteins and genes.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, MUTATION TASTER, PROVEAN"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a genomic variant that causes changes in splicing enhancer and silencer binding sites, affecting the transcription of SULT1A1.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS142786317: C.*118_*119DELCA"}, {"entity_type": "GENE", "description": "The gene encoding sulfotransferase family 1A member 1, which plays roles in various physiological processes involving sulfur conjugation with substrates for detoxification purposes.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "SULT1A1"}, {"entity_type": "GENOMIC VARIANT", "description": "A non-synonymous variant in SULT1A1 that cannot be explained by other members of the SULT1 gene family and could not be replicated using independent genotyping methods, suggesting it might be an artifact.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "MET1VAL"}, {"entity_type": "GENOMIC VARIANT", "description": "A synonymous variant in SULT1A1 predicted to change the binding domains of splicing regulators and transcription factor AML-1, potentially affecting gene expression regulation.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "P.PRO200 = (RS3176926)"}, {"entity_type": "GENE", "description": "The gene encoding sulfotransferase family 1A member 2, which is closely related to SULT1A1 in sequence but represents a distinct protein with its own wild-type allele and functional differences.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "SULT1A2"}, {"entity_type": "GENOMIC VARIANT", "description": "Non-conservative amino acid exchange detected in the coding region of SULT1A2, predicted to have no significant effect on function based on in silico analysis.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS4149403: P.ILE7THR"}, {"entity_type": "GENOMIC VARIANT", "description": "Detected non-conservative SNP with potential functional modification as per PolyPhen2 and PANTHER, indicating possible impact on protein function.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS10797300: P.PRO19LEU"}, {"entity_type": "GENOMIC VARIANT", "description": "Conservative amino acid exchange close to the binding pocket of SULT1A2; in silico analysis suggests non-neutral or deleterious impact on function.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS145008170: P.SER44ASN"}, {"entity_type": "GENOMIC VARIANT", "description": "Non-conservative missense variant with potential to affect protein functionality, though the degree of functional change is not uniformly agreed upon by prediction tools.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS4987024: P.TYR62PHE"}, {"entity_type": "GENOMIC VARIANT", "description": "Non-conservative amino acid exchange located away from the binding pocket; predictions suggest lower likelihood of significant functional impact compared to other variants.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS142241142: P.ALA164VAL"}, {"entity_type": "GENOMIC VARIANT", "description": "Conservative SNP predicted to be functionally relevant by multiple tools including PolyPhen2, SNAP and SIFT; indicative of probable protein alteration.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS1059491: P.ASN235THR"}, {"entity_type": "GENOMIC VARIANT", "description": "Known synonymous variant in SULT1A2 with predicted changes to transcription factor binding sites or splicing enhancer/silencer sites.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS1690407: P.SER8 = "}, {"entity_type": "GENE", "description": "TUFM is a gene that harbors multiple variants affecting splicing regulator or transcription factor binding sites.<SEP>The gene encoding mitochondrial thymidine kinase 1, involved in nucleotide metabolism within mitochondria and associated with regulatory elements impacting expression.", "source_id": "chunk-607feda7df4db8151b99560074c91eea<SEP>chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "TUFM"}, {"entity_type": "GENOMIC VARIANT", "description": "Variant detected in the 3\u2019 untranslated region of TUFM; predicted to alter splicing regulator or transcription factor binding sites, potentially affecting gene regulation.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "C.3536C>G "}, {"entity_type": "GENOMIC VARIANT", "description": "A series of non-coding intronic variants in TUFM predicted to lead to changes in transcription factor binding sites or splicing regulatory elements.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "RS7187776: C.-55T>C, RS4788099: C.500\u221219T/C, RS8061877: C.248\u221218G>A, AND RS61737565: C.922+29C>G"}, {"entity_type": "GENOMIC VARIANT", "description": "This genomic variant in TUFM is predicted to alter splicing regulator or transcription factor binding sites, potentially affecting gene expression and regulation.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "RS61737565: C.922+29C>G"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Disruption of transcription factor binding sites can affect gene regulation through altered interactions with DNA.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "TRANSCRIPTION FACTOR BINDING SITE"}, {"entity_type": "PROTEIN", "description": "These are proteins involved in transcription factor activity and their binding to the DNA is crucial for proper gene expression.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "SRY, HFH 2, HMG-IY"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant within TUFM\'s non-coding 3\u2019 UTR affects splice enhancer and silencer sites, potentially impacting mRNA processing.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "G.28854194C/G"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Alterations in splice sites can lead to aberrant splicing events which may result in protein dysfunction or loss of function mutations.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "SPLICE SITES"}, {"entity_type": "GENOMIC VARIANT", "description": "This genomic variant disrupts transcription factor binding sites, affecting gene regulation and expression.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "RS8061877"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Changes in splice enhancer binding sites can influence splicing patterns and mRNA processing.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "SPLICE ENHANCER BINDING SITE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Alterations in splicing silencer sites affect the stability and translation of mRNA.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "SPLICING SILENCER SITE"}, {"source_id": "chunk-b2730f3087aee6d9cff6e4939b229323<SEP>chunk-41c7131af28e2a745ef6b88b8601860f<SEP>chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-7ca64f92964b051cfb1c43f967f243a5<SEP>chunk-e1b4f4dac52e806f19c580640a50c729<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6", "description": "A genomic variant near the LCT gene influences lactase persistence, a condition related to the ability to digest lactose into adulthood.<SEP>A genomic variant within the FADS1/2 gene cluster influences AA concentrations in the colon.<SEP>These bioinformatics tools predict functional effects of genetic variations identified in the study.<SEP>Genomic variants could influence dose prediction and patient outcomes in the context of pharmacogenomics, though specific variants weren\'t detailed.<SEP>Novel and reported mutations within exon 5 of the LPL gene have been identified in a case study.<SEP>Variants in the PPAR\u03b3 gene are associated with conditions like metabolic syndrome, obesity, and type 2 diabetes.", "entity_type": "GENOMIC VARIANT", "id": "GENOMIC VARIANT"}, {"source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "description": "A common deletion variant affecting a transcript, with no predicted function on protein structure.", "entity_type": "UNKNOWN", "id": "APOBR TRANSCRIPT"}, {"source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "description": "These genetic variants were associated with obesity in case-control studies of extremely obese children and adolescents.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 3}]", "id": "RS180743 G-ALLELE AND RS3833080 DELETION ALLELE"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "Detected in SULT1A2, this variant shows potential functional modification based on prediction tools, indicating a possible impact on protein function.", "entity_type": "UNKNOWN", "id": "P.PRO19LEU (RS10797300)"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "This conservative amino acid change in SULT1A2 near the binding pocket of xenobiotics is predicted to have a \'non-neutral\' or \'deleterious\' impact on function.", "entity_type": "UNKNOWN", "id": "P.SER44ASN (RS145008170)"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "This non-conservative missense variant in SULT1A2 is predicted by various tools to have a higher probability of functional changes, though results are mixed.", "entity_type": "UNKNOWN", "id": "P.TYR62PHE (RS4987024)"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The non-conservative exchange in SULT1A2 away from the binding pocket is predicted to have less significant functional impact compared to other variants.", "entity_type": "UNKNOWN", "id": "P.ALA164VAL (RS142241142)"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "This conservative SNP in SULT1A2 is predicted by PolyPhen2, SNAP and SIFT as likely to be functionally relevant, indicating probable alterations to the protein.", "entity_type": "UNKNOWN", "id": "P.ASN235THR (RS1059491)"}, {"entity_type": "GENE", "description": "ALOX15 is an inflammation-related gene whose minor alleles of SNPs are associated with ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "ALOX15 GENE"}, {"entity_type": "GENE", "description": "ALOX5 is a gene in which minor allele of SNP rs1864414 is significantly associated with decreased ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "ALOX5 GENE (ARACHIDONATE 5-LIPOXYGENASE)"}, {"entity_type": "GENE", "description": "A CCL2 gene variant is analyzed but not found to be significantly associated with the risk of ovarian cancer.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "CCL2 GENE"}, {"entity_type": "GENE", "description": "The CRP gene is among those whose minor alleles of SNPs are assessed for association with ovarian cancer risk, though no strong associations are reported.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "CRP GENE (C-REACTIVE PROTEIN)"}, {"entity_type": "GENE", "description": "IL18 is an inflammation-related gene where the minor allele frequency does not significantly associate with ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL18 GENE"}, {"entity_type": "GENE", "description": "IL1A, particularly SNP rs17561 and rs4848300, shows a significant association with decreased risk of ovarian cancer, especially in specific histological subtypes.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1A GENE (INTERLEUKIN 1 ALPHA)"}, {"entity_type": "GENE", "description": "SNP rs7596684 at the IL1B gene suggests an association with ovarian cancer risk but lacks consistency across different phases of study.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1B GENE (INTERLEUKIN 1 BETA)"}, {"entity_type": "GENE", "description": "A variant in the IL1RN gene is not significantly associated with ovarian cancer risk according to findings described here, although it was part of the analysis.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1RN GENE (INTERLEUKIN 1 RECEPTOR N)"}, {"entity_type": "GENE", "description": "The minor alleles of SNPs at the IL6 gene are evaluated but do not show a significant association with increased or decreased ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL6 GENE (INTERLEUKIN 6)"}, {"entity_type": "GENE", "description": "SNP rs743507 within the NOS3 gene is significantly associated with decreased risk of ovarian cancer.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "NOS3 GENE (NITRIC OXIDE SYNTHASE 3)"}, {"entity_type": "GENE", "description": "rs2282169 SNP at PTGS1 gene suggests an association with ovarian cancer risk, but results are inconsistent across different phases of study.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "PTGS1 GENE (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)"}, {"entity_type": "GENE", "description": "The minor alleles of SNPs in the PTGS2 gene did not show significant associations with ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "PTGS2 GENE (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2)"}, {"entity_type": "GENE", "description": "SNP variants in TLR2 do not suggest significant association with increased or decreased risk of ovarian cancer.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "TLR2 GENE (TOLL-LIKE RECEPTOR 2)"}, {"entity_type": "GENE", "description": "No significant associations were found between TNF gene SNP variants and the risk of ovarian cancer.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "TNF GENE (TUMOR NECROSIS FACTOR)"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant is located within intron 1 of the ALOX5 gene, showing a significant association with decreased ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "RS1864414 GENOMIC VARIANT IN ALOX5"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP associated with reduced risk of ovarian cancer found near the NOS3 gene.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "RS743507 GENOMIC VARIANT IN NOS3"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of IL1A gene is highlighted for analysis due to its significant association with reduced ovarian cancer risk, especially in specific histological subtypes.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1A GENE TRANSCRIPT"}, {"entity_type": "PROTEIN", "description": "The protein encoded by the NOS3 gene shows a minor allele SNP rs743507 associated with decreased ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "NOS3 PROTEIN (NITRIC OXIDE SYNTHASE 3)"}, {"entity_type": "DISEASE", "description": "A disease characterized by the uncontrolled growth of ovarian cells.<SEP>A type of malignancy that develops from cells in the ovary, and its risks can be influenced by genetic variations including those in inflammation-related genes like ALOX15, ALOX5, IL1A, IL1B, NOS3.<SEP>Ovarian cancer is a type of cancer that forms in tissues of the ovary, usually the epithelial cells lining the outer layer of the ovary. It can be influenced by genetic variants such as rs11568820 and rs731236.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-089bcdf055eb2f007db49dbe2409429b<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "OVARIAN CANCER"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Inflammatory processes mediated by gene products such as IL18, CRP, PTGS1, and TLR2 are investigated for their potential role in ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "INFLAMMATION-RELATED GENE PRODUCTS"}, {"entity_type": "GENE", "description": "No significant associations were found between IL6R gene SNP variants and the risk of ovarian cancer.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL6R GENE (INTERLEUKIN 6 RECEPTOR)"}, {"entity_type": "GENE", "description": "SNP rs1053023 in STAT3 is assessed but not significantly associated with ovarian cancer risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "STAT3 GENE (SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the IL1B gene (rs7596684) has been suggested to be associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "IL1B RS7596684"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the PTGS1 gene (rs2282169) has been suggested to be associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "PTGS1 RS2282169"}, {"entity_type": "DISEASE", "description": "Ovarian cancer is a disease that has been studied for its association with genetic variants such as FokI, ApaI, and BsmI.<SEP>The risk of developing ovarian cancer, a disease influenced by genetic variants such as IL1B rs7596684 and PTGS1 rs2282169.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c<SEP>chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "OVARIAN CANCER RISK"}, {"entity_type": "GENE", "description": "The IL1B gene encodes interleukin-1 beta, a cytokine involved in immune response.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "IL1B"}, {"entity_type": "GENE", "description": "The PTGS1 gene encodes prostaglandin-endoperoxide synthase 1 (cyclooxygenase-1), which plays a role in inflammation and pain.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "PTGS1"}, {"entity_type": "GENE", "description": "The ALOX15 gene encodes arachidonate 5-lipoxygenase, an enzyme involved in the synthesis of leukotrienes.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "ALOX15"}, {"entity_type": "GENE", "description": "The CCL2 gene encodes chemokine (C-C motif) ligand 2, which is involved in immune cell recruitment and inflammation.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "CCL2"}, {"entity_type": "GENE", "description": "The IL18 gene encodes interleukin-18, which is involved in the regulation of immune responses and inflammation.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "IL18"}, {"entity_type": "GENE", "description": "The IL6 gene encodes interleukin-6, a cytokine that plays important roles in immune response and inflammatory processes.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "IL6"}, {"source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "description": "There was no significant heterogeneity in the association between these genes and histological subtypes of ovarian cancer.", "entity_type": "UNKNOWN", "id": "HISTOLOGICAL SUBTYPE OF OVARIAN CANCER"}, {"source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "description": "There was no significant heterogeneity in the association between these genes and histological subtypes of ovarian cancer.", "entity_type": "UNKNOWN", "id": "IL1B, PTGS1"}, {"entity_type": "GENOMIC VARIANT", "description": "NOS3 rs3918186 is a SNP associated with increased risk of developing childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "NOS3 RS3918186"}, {"entity_type": "GENOMIC VARIANT", "description": "SLC19A1 rs1051266 is a SNP that shows less evidence in the data for association with childhood ALL compared to NOS3 rs3918186.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "SLC19A1 RS1051266"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs of MTHFD2 gene were identified in the initial screening but did not proceed to final analysis due to posterior probability inclusion less than 0.2.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "MTHFD2 SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs of BHMT2 gene were identified in the initial screening but did not proceed to final analysis due to posterior probability inclusion less than 0.2.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "BHMT2 SNPS"}, {"entity_type": "GENE", "description": "The NOS3 gene is associated with childhood ALL risk, specifically through SNP rs3918186.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "NOS3 GENE"}, {"entity_type": "GENE", "description": "The SLC19A1 gene has a SNP (rs1051266) that shows less evidence in the data for association with childhood ALL compared to NOS3 rs3918186.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "SLC19A1 GENE"}, {"entity_type": "DISEASE", "description": "Childhood acute lymphoblastic leukemia is a disease studied for genetic associations, specifically involving folate metabolic genes.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)"}, {"entity_type": "METABOLIC PATHWAY", "description": "The study focuses on 16 folate metabolic genes to identify SNPs associated with childhood ALL risk.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "FOLATE METABOLIC PATHWAY"}, {"entity_type": "GENE", "description": "The MTHFD2 gene is one of the folate metabolic genes studied for SNPs associated with childhood ALL risk.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "MTHFD2 GENE"}, {"entity_type": "GENE", "description": "The BHMT2 gene is another folate metabolic gene identified in the study, showing some SNP associations but not proceeding to final analysis.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "BHMT2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP of NOS3 gene increases the risk of childhood ALL by 2.16 times for each copy of the minor allele.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "NOS3 RS3918186 RISK FACTOR"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP of SLC19A1 gene is associated with a slightly lower risk of childhood ALL compared to NOS3 rs3918186.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "SLC19A1 RS1051266 RISK FACTOR"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Bayes factors are used in statistical analysis to determine the association strength between SNPs and disease, indicating posterior odds against prior odds.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "BAYES FACTORS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "This is a measure indicating whether an SNP has sufficient evidence for further analysis based on its probability after initial screening.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "POSTERIOR PROBABILITY OF INCLUSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The participation rate for the study was 85%, reflecting high compliance among families recruited from Texas Children\u2019s Cancer Center.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "id": "CHILDHOOD ALL PARTICIPATION RATE"}, {"entity_type": "GENE", "description": "The FADS1/2 genes are part of a cluster that influences polyunsaturated fatty acid metabolism.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "FADS1/FADS2 HAPLOTYPE GENES"}, {"entity_type": "DIETARY PATTERN", "description": "Two dietary patterns examined: Healthy Eating group (n=54) and Mediterranean diet group (n=54).", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "HEALTHY EATING DIET GROUP AND MEDITERRANEAN DIET GROUP DIETARY PATTERNS"}, {"entity_type": "NUTRIENT", "description": "Refers to the dietary intake of long-chain omega-3 fatty acids such as EPA and DHA, and their concentrations in serum or colonic mucosa.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "LONG CHAIN N-3 FATTY ACIDS INTAKE AND CONCENTRATION"}, {"entity_type": "NUTRIENT", "description": "A polyunsaturated fatty acid that plays a role in inflammation and other physiological processes.<SEP>Arachidonic acid is a type of polyunsaturated fatty acid that shows significant interaction with genotype and diet interventions, particularly affecting its concentration in the colon.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "ARACHIDONIC ACID (AA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measurement of the baseline serum concentration of arachidonic acid in study participants.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "BASELINE SERUM AA CONCENTRATION MEASUREMENT"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Analysis to determine if dietary intake predicts baseline serum AA concentrations.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "LINEAR REGRESSION ANALYSIS FOR FATTY ACID INTAKE AND BASELINE SERUM AA CONCENTRATION"}, {"entity_type": "METABOLIC PATHWAY", "description": "Measurement of colonic arachidonic acid levels in relation to genetic factors.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 13}]", "id": "BASELINE COLONIC ARACHIDONIC ACID (AA) MEASUREMENT IN PARTICIPANTS WITH OR WITHOUT MINOR ALLELES IN THE FADS GENE CLUSTER"}, {"entity_type": "GENE", "description": "A gene within the FADS gene cluster involved in fatty acid desaturation.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "FADS1 GENE"}, {"entity_type": "GENE", "description": "Another gene within the FADS gene cluster, also involved in fatty acid metabolism.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "FADS2 GENE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The distribution and frequency of genetic variations among participants.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "GENOTYPE DISTRIBUTION OF SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Measurement of arachidonic acid concentration at the beginning of the study.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "BASELINE AA CONCENTRATION MEASUREMENT IN SERUM AND COLON"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Analysis to predict baseline long chain n-3 fatty acid concentrations based on dietary intake.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "DIETARY INTAKE OF LONG CHAIN N-3 FATTY ACIDS AND BASELINE CONCENTRATION PREDICTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Difference in BMI among participants with or without minor alleles of FADS genes.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "BMI DIFFERENCE BETWEEN MINOR ALLELE CARRIERS AND NON-CARRIERS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Age retained as a covariate for statistical analysis despite no significant difference between groups.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "AGE AS A COVARIATE IN GENOTYPE ANALYSIS"}, {"entity_type": "METABOLIC PATHWAY", "description": "Measurement of fatty acid concentrations in serum and colon based on genotype.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "SERUM AND COLON FATTY ACID CONCENTRATIONS BY GENOTYPE GROUP"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Increase in long chain omega-3 polyunsaturated fatty acids after the dietary intervention.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "LONG CHAIN N-3 PUFA DIETARY INTAKE INCREASE IN HEALTHY EATING GROUP"}, {"entity_type": "NUTRIENT", "description": "Reduction of saturated fats and increase in monounsaturated fats observed post-intervention.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "SFA (SATURATED FATS) AND MUFA (MONOUNSATURATED FATS) REDUCTION IN HEALTHY EATING AND MEDITERRANEAN GROUPS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Ratio improved in both diet groups, indicating healthier lipid profile.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "POLYUNSATURATED FAT:SATURATED FAT RATIO INCREASE AFTER DIETARY INTERVENTIONS"}, {"entity_type": "GENE", "description": "The FADS1/2 gene cluster influences fatty acid metabolism and levels of arachidonic acid (AA) in the colon.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "FADS1/2 GENE CLUSTER"}, {"entity_type": "NUTRIENT", "description": "This ratio increased non-significantly from 0.72 to 0.77 in the Mediterranean group over time.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "POLYUNSATURATED FAT: SATURATED FAT RATIO"}, {"entity_type": "NUTRIENT", "description": "MUFA significantly increased in the Mediterranean arm only, indicating a dietary influence on fatty acid levels.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "MUFA (MONOUNSATURATED FATTY ACIDS)"}, {"entity_type": "NUTRIENT", "description": "Both n-3 PUFA and MUFA significantly increased in the Mediterranean arm only.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "N-3 PUFA (OMEGA-3 POLYUNSATURATED FATTY ACIDS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The interaction between genotype and diet showed significant changes in colon concentrations of 20:4, n-6 (AA) for subjects with no minor alleles in the FADS1/2 gene cluster.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "COLON AA CONCENTRATIONS"}, {"entity_type": "DIETARY PATTERN", "description": "This dietary pattern had a significant effect on AA concentration in the colon compared to the Mediterranean diet for individuals without minor alleles in the FADS1/2 gene cluster.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "HEALTHY EATING DIET"}, {"entity_type": "DIETARY PATTERN", "description": "The Mediterranean diet showed different effects on AA concentrations in the colon compared to the Healthy Eating diet, particularly in individuals with no minor alleles in the FADS1/2 gene cluster.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "MEDITERRANEAN DIET"}, {"entity_type": "NUTRIENT", "description": "The level of serum 18:2 n-6 significantly decreased (p=0.02) in response to the Mediterranean dietary intervention.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "SERUM 18:2 N-6"}, {"entity_type": "NUTRIENT", "description": "EPA is a type of omega-3 polyunsaturated fatty acid that was found not to have significant genotype-by-diet interactions.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "EPA (EICOSAPENTAENOIC ACID)"}, {"source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "Used to verify random mating and genetic equilibrium in SNP distribution among participants.", "entity_type": "UNKNOWN", "id": "GENOTYPE DISTRIBUTION OF SNPS"}, {"source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "Baseline arachidonic acid levels serve as an important marker for metabolic pathways.", "entity_type": "UNKNOWN", "id": "FATTY ACID METABOLISM PATHWAY"}, {"source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "Age retained as covariate for more accurate fatty acid concentration analysis based on genotype.", "entity_type": "UNKNOWN", "id": "SERUM AND COLON FATTY ACID CONCENTR\u00c7\u00d5ES BY GENOTYPE GROUP"}, {"source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "description": "The Mediterranean diet significantly increased MUFA levels, indicating its impact on fatty acid metabolism.", "entity_type": "UNKNOWN", "id": "MUFA"}, {"source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "description": "Both long-chain n-3 PUFA and MUFA significantly increased in the Mediterranean arm only, showing a dietary pattern\'s effect on omega-3 polyunsaturated fatty acids.", "entity_type": "UNKNOWN", "id": "N-3 PUFA"}, {"source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "description": "No significant genotype-by-diet interactions were found for EPA, indicating that EPA levels are less influenced by genetic variants in the FADS1/2 gene cluster.", "entity_type": "UNKNOWN", "id": "EPA"}, {"entity_type": "DISEASE", "description": "Snoring is a condition characterized by loud, disruptive breathing during sleep.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "SNORING"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Gender differences influence snoring prevalence, with males having a higher reported rate.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 13}]", "id": "SEX (MALE/FEMALE)"}, {"entity_type": "DISEASE", "description": "A condition characterized by pauses in breathing during sleep, more prevalent among those who snore.<SEP>A sleep disorder characterized by pauses in breathing during sleep.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SLEEP APNOEA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Lower SES was associated with increased risk of snoring in males specifically.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "SOCIOECONOMIC STATUS (SES)"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Smoking more frequently correlates positively with higher prevalence of snoring, particularly among females.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "SMOKING FREQUENCY"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Increased alcohol consumption frequency is associated with elevated risk of snoring, predominantly in males.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "ALCOHOL CONSUMPTION FREQUENCY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of total body fat, including both essential and nonessential fat.<SEP>Fat mass was correlated with snoring prevalence as determined by various studies.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "WHOLE-BODY FAT MASS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A method used to identify genetic variants associated with snoring and other traits.<SEP>A study that scans the entire genome looking for genetic variations associated with a particular trait, such as a disease condition or response to medication.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "GWAS (GENOME-WIDE ASSOCIATION STUDY)"}, {"entity_type": "GENOMIC VARIANT", "description": "Identified through GWAS, these variants are significant in the context of snoring risk factors.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "GENOMIC VARIANTS "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure indicating the proportion of phenotypic variance attributable to genetic effects.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "SNP HERITABILITY (H2SNP)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Analysis revealing associations between snoring and other traits based on shared genetics.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "GENETIC CORRELATIONS "}, {"entity_type": "DISEASE", "description": "Highly genetically correlated with habitual snoring, indicating a strong genetic relationship.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "SELF-REPORTED SLEEP APNOEA "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Indicators like minimum and percent under 90% SpO2 are significant in the context of sleep-disordered breathing related to snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "OXYGEN HEMOGLOBIN SATURATION (SPO2)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Both factors positively correlate with snoring, influencing genetic associations after adjustment.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "BMI, WHOLE-BODY FAT MASS "}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic location impacting obesity that changes significantly in effect size upon BMI adjustment.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "FTO LOCUS "}, {"entity_type": "DISEASE", "description": "A psychiatric disorder negatively genetically correlated with snoring, suggesting differing genetic underpinnings.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "SCHIZOPHRENIA "}, {"entity_type": "GENOMIC VARIANT", "description": "These are genomic regions identified through GWAS that contain variants significantly associated with snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "GENOMIC RISK LOCI "}, {"entity_type": "GENOMIC VARIANT", "description": "Specific loci among the top genetic associations found for snoring, indicating significant risk factors.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "TOP 15 RISK LOCI "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The average level of oxygen hemoglobin saturation during sleep, reflecting changes in ventilation but not necessarily related to sleep apnoea.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "AVERAGE SPO2 "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure indicating the percentage of time during sleep when oxyhemoglobin saturation is below 90%, a proxy for sleep-disordered breathing.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "PERC90 (PERCENT OF SLEEP WITH OXYHEMOGLOBIN SATURATION UNDER 90%) "}, {"entity_type": "DISEASE", "description": "Genetically correlated with habitual snoring, suggesting shared genetic risk factors.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "CORONARY ARTERY DISEASE "}, {"entity_type": "DISEASE", "description": "Traits related to heart attack were no longer genetically associated with snoring after adjusting for BMI.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "HEART ATTACK "}, {"entity_type": "DISEASE", "description": "After adjustment for BMI, hypertension was not found to be genetically correlated with snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "HYPERTENSION "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition showing moderate genetic correlation with habitual snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "MOOD SWINGS "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "As a trait, it correlates phenotypically and genetically with snoring before adjustment for BMI.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "WHOLE-BODY FAT MASS "}, {"entity_type": "PSYCHOLOGICAL TRAIT", "description": "Negative genetic correlation indicates distinct underlying genetic factors between these traits and habitual snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "FLUID INTELLIGENCE SCORE "}, {"entity_type": "SOCIAL DETERMINANT OF HEALTH", "description": "A trait that remains genetically correlated with snoring even after adjusting for BMI, indicating shared genetic influences.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "id": "EDUCATIONAL ATTAINMENT "}, {"entity_type": "DISEASE", "description": "A mental disorder characterized by symptoms such as hallucinations, delusions, and disordered thinking.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SCHIZOPHRENIA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The level of education achieved by an individual or group.<SEP>There was a significant association between educational attainment and milk drinking habits across all countries studied.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "EDUCATIONAL ATTAINMENT"}, {"entity_type": "NUTRIENT", "description": "The concentration of sodium within the urine.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 13}]", "id": "SODIUM IN URINE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Feeling very sleepy during the daytime, often as a result of poor nighttime sleep.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "EXCESSIVE DAYTIME SLEEPINESS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measures indicating low blood oxygen levels at night.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "NOCTURNAL HYPOXIA MEASURES (MINIMUM SPO2, AVERAGE SPO2 AND PERC90)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The genetic correlation between nocturnal hypoxia measures and snoring after adjusting for BMI.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "GENETIC CORRELATION WITH SNORING"}, {"entity_type": "GENE", "description": "A gene located at position 13q21.3 and known to be associated with snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "DLEU7 GENE ON CHROMOSOME 13"}, {"entity_type": "GENE", "description": "A gene located at position 12p13.32 and associated with snoring predisposition.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "MSRB3 GENE ON CHROMOSOME 12"}, {"entity_type": "GENE", "description": "Involved in transcription regulation, previously linked to smoking and alcohol consumption.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "BCL11B GENE"}, {"entity_type": "GENE", "description": "A gene involved in RNA surveillance, associated with musculoskeletal traits such as height and heel bone mineral density.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SMG6 GENE"}, {"entity_type": "GENE", "description": "Involved in axon guidance, previously linked to chronotype and snoring predisposition.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "ROBO2 GENE"}, {"entity_type": "GENE", "description": "Associated with alcohol consumption and coffee consumption, also involved in snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "NSUN3 GENE"}, {"entity_type": "GENE", "description": "A gene associated with sleep disorders such as narcolepsy.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SNAP91 GENE"}, {"entity_type": "GENE", "description": "Linked to insomnia, contributing to the genetic architecture of snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "LMO4 GENE"}, {"entity_type": "GENE", "description": "Associated with alcohol consumption and insomnia, also relevant in relation to narcolepsy and sleep regulation.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "RNA5SP471 GENE"}, {"entity_type": "GENE", "description": "A gene involved in cell cycle control, associated with musculoskeletal traits such as height and heel bone mineral density.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "ANAPC4 GENE"}, {"entity_type": "GENE", "description": "Associated with various neurological disorders, also relevant to snoring predisposition.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "KCNQ5 GENE"}, {"entity_type": "GENE", "description": "A gene involved in centrosome organization and mitotic progression, associated with snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "CEP120 GENE"}, {"entity_type": "GENE", "description": "Associated with musculoskeletal traits such as height and heel bone mineral density, also linked to snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 13}]", "id": "MACF1 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The rate at which the heart beats, measured per minute.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "PULSE RATE"}, {"entity_type": "DISEASE", "description": "Heart disease characterized by atherosclerosis in the coronary arteries.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "MAJOR CORONARY HEART DISEASE"}, {"entity_type": "DISEASE", "description": "Sudden cardiac event caused by an abrupt loss of blood flow to part of the heart muscle due to a blocked artery.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "HEART ATTACK"}, {"entity_type": "METABOLIC PATHWAY", "description": "A study conducted separately in males and females to identify genetic factors contributing to snoring predisposition.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 13}]", "id": "SEX-STRATIFIED GWAS (GENOME-WIDE ASSOCIATION STUDY)"}, {"entity_type": "GENOMIC VARIANT", "description": "A lead SNP identified in GWAS analyses for snoring in males.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "RS199797821"}, {"entity_type": "GENOMIC VARIANT", "description": "A lead SNP identified in GWAS analyses for snoring in females.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "RS200391180"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "GWAS analysis stratified by sex to identify genetic variants associated with snoring in males and females.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 15}]", "id": "SEX-STRATIFIED GWAS ANALYSIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Derived from GWAS summary statistics, PGS is used to predict the likelihood of recent snoring in an independent sample from AGDS.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 15}]", "id": "PGS (POLYGENIC SCORE)"}, {"entity_type": "DISEASE", "description": "A condition characterized by habitual loud breathing during sleep, often associated with increased risk for OSA and cardiovascular diseases.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "RECENT SNORING"}, {"entity_type": "DISEASE", "description": "A disorder where the upper airway repeatedly collapses during sleep, leading to breathing pauses and can be indicated by snoring severity.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "PROBABLE OSA (OBSTRUCTIVE SLEEP APNEA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The degree to which an individual snores, often measured by frequency or loudness.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "SNORING SEVERITY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A measure indicating the genetic correlation between sexes regarding a trait (in this case, snoring), reflecting shared genetic influences across genders.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "id": "CROSS-SEX GENETIC CORRELATION"}, {"entity_type": "GENE/GENOMIC VARIANT", "description": "The most significant genetic variants identified through genome-wide association studies for a particular trait or condition.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 15}]", "id": "TOP HITS IN GWAS"}, {"source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "description": "There is a significant genetic relationship between habitual snoring and self-reported sleep apnea, indicating overlapping risk factors.", "entity_type": "UNKNOWN", "id": "SLEEP APNOEA "}, {"source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "description": "There is a significant genetic relationship between habitual snoring and self-reported sleep apnea, indicating overlapping risk factors.", "entity_type": "UNKNOWN", "id": "SNORING "}, {"source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "description": "Both lifestyle habits are positively correlated with the prevalence of snoring in their respective genders.", "entity_type": "UNKNOWN", "id": "ALCOHOL CONSUMPTION FREQUENCY "}, {"source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "description": "Both lifestyle habits are positively correlated with the prevalence of snoring in their respective genders.", "entity_type": "UNKNOWN", "id": "SMOKING FREQUENCY "}, {"source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "description": "After controlling for BMI in the GWAS analysis, heart attack is no longer genetically associated with snoring.", "entity_type": "UNKNOWN", "id": "BMI ADJUSTMENT ANALYSIS "}, {"source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "description": "Severe cases of recent snoring may indicate probable obstructive sleep apnea, a serious health condition requiring medical attention.", "entity_type": "UNKNOWN", "id": "PROBABLE OSA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Vitamin D status refers to the level of vitamin D in individuals, which is crucial for calcium homeostasis and bone health.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "VITAMIN D STATUS"}, {"entity_type": "GENOMIC VARIANT", "description": "VDBP polymorphisms refer to genetic variations in the Vitamin D Binding Protein gene that can influence vitamin D status and metabolism.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "VDBP POLYMORPHISMS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Neonatal vitamin D status refers to the level of vitamin D in neonates, which is important for early life health outcomes such as bone development and immune function.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "NEONATAL VITAMIN D STATUS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Maternal height is an environmental factor that may influence prenatal care and pregnancy outcomes.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "MATERNAL HEIGHT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "BMI pre-pregnancy refers to the body mass index before conception, which can impact maternal health during pregnancy and neonatal outcomes.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "BMI PRE-PREGNANCY (KG/M2)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "BMI terminal is the body mass index at term of pregnancy, reflecting changes in weight throughout gestation that may affect maternal-fetal conditions.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "BMI TERMINAL (KG/M2)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "UVB exposure is an environmental factor influencing vitamin D synthesis through sunlight absorption by the skin.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "UVB EXPOSURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The gestation period refers to the time from conception to birth, during which maternal and neonatal health are critically influenced.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "GESTATION PERIOD (WEEKS)"}, {"entity_type": "METABOLIC PATHWAY", "description": "25-hydroxyvitamin D (25(OH)D) is a metabolite of vitamin D that serves as a marker for vitamin D status in the body, playing a role in various physiological processes.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "25(OH)D CONCENTRATION"}, {"entity_type": "GENOMIC VARIANT", "description": "The CC genotype at rs2298850 is a specific genetic variation within VDBP that may influence vitamin D metabolism and status.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "CC GENOTYPE (RS2298850)"}, {"entity_type": "GENOMIC VARIANT", "description": "The CC genotype at rs4588 is another genomic variant in the VDBP gene, affecting the binding capacity of Vitamin D Binding Protein and impacting maternal 25(OH)D concentrations during delivery.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "CC GENOTYPE (RS4588)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Neonatal cut-offs for vitamin D levels categorize neonates based on their 25(OH)D concentrations, providing insights into early life vitamin D status.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "NEONATAL CUT-OFFS (\u226550 NMOL/L VS. \u226450 NMOL/L)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Maternal cut-offs for vitamin D levels categorize mothers based on their 25(OH)D concentrations, reflecting maternal vitamin D sufficiency or deficiency.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "MATERNAL CUT-OFFS (\u226425 VS. \u226525 NMOL/L)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "ANCOVA is a statistical method used to adjust for covariates in comparisons of means among groups, evaluating the influence of various factors on neonatal and maternal vitamin D status.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "STATISTICAL ANALYSIS (ANCOVA)"}, {"entity_type": "PROTEIN", "description": "VDBP is a protein that binds vitamin D and influences its metabolism and transport within the body.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "VITAMIN D BINDING PROTEIN (VDBP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The distribution of genotypes in a population or group can influence genetic traits and associated health outcomes.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "GENOTYPE DISTRIBUTION"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific genetic variations in maternal VDBP that may impact vitamin D levels during pregnancy.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "MATERNAL VDBP POLYMORPHISMS"}, {"entity_type": "GENOMIC VARIANT", "description": "Genetic variations in neonates\u2019 VDBP gene that could affect their vitamin D status and metabolism.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "NEONATAL VDBP POLYMORPHISMS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Biochemical measurements taken at birth to assess neonatal health conditions, such as vitamin D levels.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "BIRTH BIOCHEMICAL DATA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A statistical method used for analyzing differences among related groups while controlling for covariates.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "ONE-WAY ANALYSIS OF COVARIANCE (ANCOVA)"}, {"source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "description": "Maternal height may interact with the duration of gestation affecting prenatal care and neonatal outcomes.", "entity_type": "UNKNOWN", "id": "MATERNAL HEIGHT (CM)"}, {"source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "description": "The CC genotype at rs2298850 is associated with higher maternal 25(OH)D concentrations, indicating a positive impact on vitamin D status.", "entity_type": "UNKNOWN", "id": "MATERNAL VITAMIN D STATUS"}, {"entity_type": "GENE", "description": "The VEGFA gene is involved in the regulation of angiogenesis, which is important for various physiological processes including reproductive health.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "VEGFA GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) located at position -583 in the VEGFA gene, with an increased minor allele frequency in women with PCOS compared to controls.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "RS3025020 (-583T>C)"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) located at position -634 in the VEGFA gene, with a trend towards higher minor allele frequency in controls compared to women with PCOS.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "RS2010963 (-634C>G)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The levels of vascular endothelial growth factor (VEGF) circulating in the blood plasma are significantly altered among genotype carriers of specific VEGFA SNPs, reflecting their impact on angiogenesis and possibly other physiological processes such as insulin resistance.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "VEGF SERUM LEVELS"}, {"entity_type": "DISEASE", "description": "A common endocrine disorder characterized by a cluster of symptoms including ovarian dysfunction, hyperandrogenism, and metabolic disturbances, affecting women\'s reproductive health.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "POLYCYSTIC OVARY SYNDROME (PCOS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "HOMA-IR is an index used to assess insulin resistance in the body, which has significantly higher levels among women with PCOS compared to controls.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "INSULIN RESISTANCE INDEX HOMA-IR"}, {"entity_type": "NUTRIENT/METABOLITE", "description": "Free testosterone refers to the biologically active form of testosterone circulating in blood plasma; its levels are elevated in women with PCOS compared to control subjects.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "FREE TESTOSTERONE"}, {"entity_type": "PHYSIOLOGICAL PROCESS/BIOMARKER", "description": "A marker for inflammation, hs-CRP levels correlate positively with the minor allele of VEGFA SNP rs3025020 in women with PCOS, indicating a link between this genetic variant and inflammatory processes.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/BIOMARKER", "description": "A marker for inflammation; ESR levels correlate negatively with the minor allele of VEGFA SNP rs2010963 in women with PCOS, suggesting a protective role against inflammation.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "ERYTHROCYTE SEDIMENTATION RATE (ESR)"}, {"entity_type": "NUTRIENT/METABOLITE", "description": "The total amount of testosterone circulating in the blood plasma, which does not show significant differences between women with PCOS and controls.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "TOTAL TESTOSTERONE LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS/BIOMARKER", "description": "A hormone produced by the pituitary gland that stimulates ovulation; levels are comparable between women with PCOS and control subjects.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "LH (LUTEINIZING HORMONE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/BIOMARKER", "description": "A hormone produced by the pituitary gland that stimulates follicular growth in ovaries; levels are comparable between women with PCOS and control subjects.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "FSH (FOLLICLE-STIMULATING HORMONE)"}, {"entity_type": "NUTRIENT/METABOLITE", "description": "A protein that binds sex hormones like testosterone, significantly lower in women with PCOS compared to controls.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "SHBG (SEX HORMONE BINDING GLOBULIN)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/BIOMARKER", "description": "A hormone produced by the pituitary gland that stimulates thyroid function; levels are higher but within reference range in women with PCOS compared to controls.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "TSH (THYROID-STIMULATING HORMONE)"}, {"entity_type": "NUTRIENT/METABOLITE/BIOMARKER", "description": "An index used to assess the proportion of free testosterone relative to SHBG, which is elevated in women with PCOS compared to control subjects.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "FREE ANDROGEN INDEX (FAI)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/NUTRIENT METABOLITE", "description": "The active form of testosterone circulating in blood plasma, showing a progressive increase among rs3025020 genotype carriers and a reduction in rs2010963 genotype carriers.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "BIOACTIVE TESTOSTERONE LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS/BIOMARKER", "description": "An anti-inflammatory cytokine; its levels are not correlated with VEGFA SNPs rs3025020 or rs2010963.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "IL-10 (INTERLEUKIN-10)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/BIOMARKER", "description": "A pro-inflammatory cytokine; its levels do not correlate with the VEGFA SNPs rs3025020 or rs2010963.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "IL-6 (INTERLEUKIN-6)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/BIOMARKER", "description": "A pro-inflammatory cytokine; its levels do not correlate with the VEGFA SNPs rs3025020 or rs2010963.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "TNF\u0391 (TUMOR NECROSIS FACTOR-ALPHA)"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "The presence of rs2010963 genotype is inversely correlated with free testosterone levels, indicating a protective role against hyperandrogenism characteristic of PCOS.", "entity_type": "UNKNOWN", "id": "FREE TESTOSTERONE LEVELS"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "While total testosterone levels are comparable between women with PCOS and controls, the bioactive forms of these hormones show differences that correlate with disease pathology.", "entity_type": "UNKNOWN", "id": "PCOS"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "The ratio of LH to FSH is elevated in women with PCOS compared to control subjects, indicating a key hormonal imbalance characteristic of this condition.", "entity_type": "UNKNOWN", "id": "LH/FSH RATIO"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "Significantly lower SHBG levels are observed in women with PCOS compared to controls, contributing to increased free androgens.", "entity_type": "UNKNOWN", "id": "SHBG LEVELS"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "While TSH levels are higher but within normal range in women with PCOS compared to controls, this may reflect a subtle thyroid dysfunction or metabolic alteration.", "entity_type": "UNKNOWN", "id": "TSH LEVELS"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "Increased hs-CRP levels are associated with pro-inflammatory processes in women carrying the minor allele of VEGFA SNP rs3025020, reflecting a higher inflammatory response.", "entity_type": "UNKNOWN", "id": "HS-CRP LEVELS"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4<SEP>chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "Increased hs-CRP levels are associated with pro-inflammatory processes in women carrying the minor allele of VEGFA SNP rs3025020, reflecting a higher inflammatory response.<SEP>NF-\u03baB activation leads to enhanced proinflammatory phenotype observed in adipose tissue of SENP1-deficient mice.", "entity_type": "PHYSIOLOGICAL PROCESS", "id": "INFLAMMATION"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "Decreased ESR levels among carriers of the minor allele of VEGFA SNP rs2010963 suggest an anti-inflammatory effect, possibly protective against chronic inflammation in PCOS.", "entity_type": "UNKNOWN", "id": "ANTI-INFLAMMATORY EFFECT"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "Decreased ESR levels among carriers of the minor allele of VEGFA SNP rs2010963 suggest an anti-inflammatory effect, possibly protective against chronic inflammation in PCOS.", "entity_type": "UNKNOWN", "id": "ESR LEVELS"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "No correlation between IL-10 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this anti-inflammatory cytokine is not directly influenced by these genetic variants.", "entity_type": "UNKNOWN", "id": "IL-10 LEVELS"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "No correlation between IL-10 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this anti-inflammatory cytokine is not directly influenced by these genetic variants.", "entity_type": "UNKNOWN", "id": "VEGFA SNPS"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "No correlation between IL-6 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants.", "entity_type": "UNKNOWN", "id": "IL-6 LEVELS"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "No correlation between TNF\u03b1 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants.", "entity_type": "UNKNOWN", "id": "TNF\u0391 LEVELS"}, {"entity_type": "GENOMIC VARIANT", "description": "The val carrier genotype is a variant in relation to the response bias and shock intensity selection.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "VAL CARRIER GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "The iso homozygote genotype represents another genetic variation that contrasts with the val carrier genotype in terms of behavioral outcomes.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "ISO HOMOZYGOTE GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Behavioral measure indicating preference or tendency towards a specific stimulus based on reward history. Changes in this are indicative of cognitive and emotional processes influenced by stress.<SEP>Response bias refers to a cognitive process where participants modify their responses based on reinforcement contingencies.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647<SEP>chunk-5e709975097a773fb3d31e265d76a71b", "id": "RESPONSE BIAS"}, {"entity_type": "BEHAVIORAL PROCESS", "description": "Participants\' selection of shock intensity levels reflects individual differences in aversion tolerance and stress response.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "SHOCK INTENSITY SELECTION"}, {"entity_type": "PHYSIOLOGICAL MEASURE", "description": "State-Trait Anxiety Inventory scores measure anxiety levels at different times during the study.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "STAI SCORES"}, {"entity_type": "PSYCHOMETRIC SCALE", "description": "The PANAS negative affect scale measures emotional distress such as anger, sadness, and fear.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "PANAS NA (NEGATIVE AFFECT)"}, {"entity_type": "PSYCHOMETRIC SCALE", "description": "The PANAS positive affect scale assesses pleasant emotions like joy, interest, and alertness.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "POSITIVE AFFECT (PANAS PA)"}, {"entity_type": "PHYSIOLOGICAL MEASURE", "description": "Measure of emotional arousal through changes in skin conductance due to sweat gland activity.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "SKIN CONDUCTANCE RESPONSES (SC RESPONSES)"}, {"entity_type": "GENETIC VARIANT", "description": "Individuals who carry the val variant of the COMT gene, associated with changes in response bias under stress conditions.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "VAL CARRIERS"}, {"entity_type": "GENETIC VARIANT", "description": "Individuals homozygous for the isoleucine (iso) allele of the COMT gene, typically showing less pronounced effects of stress on response bias compared to val carriers.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "ISO HOMOZYGOTES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Environmental condition manipulating levels of psychological stress to observe effects on cognitive and physiological responses, particularly concerning response bias.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "CONDITION (STRESS VS NO-STRESS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measure of the ability to discriminate between stimuli in a task; it can be influenced by factors such as block number or experimental conditions.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "DISCRIMINABILITY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The level of physical stimulus used, which might influence stress responses and therefore behavioral outcomes like response bias.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "SHOCK INTENSITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measure reflecting autonomic arousal in response to stimuli; elevated SCRs indicate heightened physiological activity often associated with stress or emotion.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "SKIN CONDUCTANCE RESPONSES (SCR)"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific single nucleotide polymorphisms in the CRHR1 gene, recently linked to stress-induced reward learning deficits.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "CRHR1 SNPS (RS12938031, RS10445364, RS4076452)"}, {"entity_type": "GENE", "description": "The genotype at the catechol-O-methyltransferase (COMT) gene locus, consisting of val and iso alleles, influences response bias in stressful conditions.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "MR GENOTYPE (COMT GENE VARIANTS)"}, {"entity_type": "GENE", "description": "The corticotropin-releasing hormone receptor 1 (CRHR1) gene, which regulates the body\'s response to stress through its receptor proteins. Variations in this gene are associated with differences in stress-induced reward learning deficits.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "CRHR1 GENE"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "There was a trend showing that STAI scores increased over time and condition differently across genotypes, suggesting genetic modulation of stress response.", "entity_type": "UNKNOWN", "id": "TIME \u00d7 CONDITION \u00d7 GENOTYPE INTERACTION"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "The PANAS negative affect scale showed an interaction effect with trends indicating differential changes in emotional distress over time for different genotypes.", "entity_type": "UNKNOWN", "id": "CONDITION \u00d7 TIME \u00d7 GENOTYPE TREND"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "The PANAS negative affect scale showed an interaction effect with trends indicating differential changes in emotional distress over time for different genotypes.", "entity_type": "UNKNOWN", "id": "PANAS NA"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "There was a trending effect suggesting that skin conductance responses varied over time differently based on genotype, hinting at genetic modulation of physiological arousal.", "entity_type": "UNKNOWN", "id": "SC RESPONSES"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "There was a trending effect suggesting that skin conductance responses varied over time differently based on genotype, hinting at genetic modulation of physiological arousal.", "entity_type": "UNKNOWN", "id": "TIME \u00d7 GENOTYPE INTERACTION"}, {"source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "description": "Polymorphisms in the CRHR1 gene are linked to variations in reward learning deficits induced by stress, indicating a genetic basis for differential susceptibility to stress effects on cognitive processes.)", "entity_type": "UNKNOWN", "id": "STRESS-INDUCED REWARD LEARNING DEFICITS"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP is a single nucleotide polymorphism that can be associated with specific phenotypes or diseases.<SEP>Single Nucleotide Polymorphism (SNP) is a type of genetic variation that involves a change in a single nucleotide at a specific position within the genome.<SEP>Single Nucleotide Polymorphism (SNP) is a type of genomic variant that refers to a variation at a single position in a DNA sequence.<SEP>Single nucleotide polymorphisms tested in the study did not reach statistical significance after multiple testing adjustments.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8<SEP>chunk-b803830d07bff8ae14550f6458048707<SEP>chunk-50e07db177a6a08799261934e8e71ac4", "id": "SNP"}, {"entity_type": "GENE", "description": "BMP4 gene, also known as Bone Morphogenetic Protein 4, plays roles in the development and maintenance of various tissues including dentition.<SEP>The BMP4 gene plays a role in the development and maintenance of oral structures and is associated with variations affecting age at first tooth and number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-c63d60b991cd7442f690dcc364af47dd", "id": "BMP4 GENE"}, {"entity_type": "GENE", "description": "The CACNB2 gene encodes a voltage-dependent calcium channel beta subunit that is involved in neuronal function, among other processes.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "CACNB2 GENE"}, {"entity_type": "GENE", "description": "CDON (Cell adhesion molecule with Ig and Dome domain) gene plays roles in embryonic development including the specification of facial structures like teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "CDON GENE"}, {"entity_type": "GENE", "description": "AJUBA gene is associated with cellular interactions and developmental signaling, contributing to tissue differentiation.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "AJUBA/C14ORF93 GENE"}, {"entity_type": "GENE", "description": "TEX14/RAD51C gene is involved in DNA repair mechanisms, which can influence developmental outcomes.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "TEX14/RAD51C GENE"}, {"entity_type": "GENE", "description": "A gene associated with tooth development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "KCNJ160"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant associated with the FAM155E-EDA region, linked to craniofacial development and number of teeth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "FAM155E\u2013EDA"}, {"entity_type": "GENE", "description": "Bone Morphogenetic Protein 4 (BMP4), a gene involved in tooth development and craniofacial shape formation.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "BMP4"}, {"entity_type": "GENE", "description": "Insulin-like Growth Factor 2 mRNA Binding Protein 1 (IGF2BP1), linked to tooth development and craniofacial shape.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "IGF2BP1"}, {"entity_type": "GENE", "description": "Potassium inwardly-rectifying channel, subfamily J, member 2, associated with craniofacial phenotypes.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "KCNJ2"}, {"entity_type": "GENE", "description": "Methionine Sulfoxide Reductase B3, a gene linked to tooth development and mid-brow prominence.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "MSRB3"}, {"entity_type": "GENE", "description": "Adenosine Kinase (ADK), associated with nose width and earlier tooth eruption.<SEP>Adenosine Kinase (ADK), associated with nose width measures in craniofacial studies.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "ADK"}, {"entity_type": "GENE", "description": "LIM Domain Containing 7 Protein (LMO7, also known as AJUBA), involved in mid-brow height and prominence.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "AJUBA"}, {"entity_type": "PHYSICAL TRAIT/BODY MEASUREMENT", "description": "Height is positively associated with specific genetic variants such as rs35866622 near the FUT1/FUT2 locus.<SEP>The process of growing taller, influenced by genetic factors like HMGA2 and BMP4.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1<SEP>chunk-938d8bf2e56584de9dd556be5eb70964", "id": "HEIGHT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The biological process where teeth emerge through the gum line, influenced by multiple genes including HMGA2.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "TOOTH ERUPTION"}, {"entity_type": "BIOLOGICAL PATHWAY", "description": "Developmental pathway that includes growth and formation of craniofacial structures, linked to genetic loci like BMP4 and HMGA2.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "CRANIOFACIAL DEVELOPMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The development and maintenance of teeth throughout a lifetime, influenced by genes such as MSRB3 and BMP4.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "DENTAL PHENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the KCNJ160 gene associated with tooth development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS2520397"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant near BMP4, linked to craniofacial measures and number of primary teeth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS1951867"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in HMGA2 associated with both tooth development and craniofacial phenotypes.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS1472259"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant near IGF2BP1, linked to number of teeth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS8069452"}, {"entity_type": "GENOMIC VARIANT", "description": "Associated with tooth development and craniofacial measurements.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS9788982"}, {"entity_type": "GENE", "description": "Voltage-dependent calcium channel subunit beta-2, linked to tooth number at 6-14 years old.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "CACNB2"}, {"entity_type": "GENE", "description": "RecombinaseRAD51-like1 (RAD51L1), associated with earlier tooth eruption and tooth count.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RAD51L1"}, {"entity_type": "GENOMIC VARIANT", "description": "An allele that increases height also influences faster tooth eruption or more teeth development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "HEIGHT INCREASER ALLELE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The rate at which teeth emerge through the gum line, influenced by genetic factors like HMGA2 and RAD51L1.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "TOOTH ERUPTION SPEED"}, {"entity_type": "GENE", "description": "The HMGA2 gene is involved in regulating biological pathways related to dental health and may influence age at first tooth and number of teeth.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "HMGA2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant score constructed from significant SNPs for \'Age at first tooth\' shows a moderate association with height, but this evidence is largely driven by HMGA2 and BMP4 variants.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "GENOME-WIDE SIGNIFICANT SNPS FOR AGE AT FIRST TOOTH SCORE (PMETA = 0.0012)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant score constructed from significant SNPs for \'Number of teeth\' also shows a moderate association with height, driven by HMGA2 and BMP4 variants.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "GENOME-WIDE SIGNIFICANT SNPS FOR NUMBER OF TEETH SCORE (PMETA = 9.8 \u00d7 10\u22124)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The physiological process of growth leading to adult height may be influenced by genetic factors such as those in HMGA2 and BMP4 genes.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "HEIGHT TRAIT"}, {"entity_type": "METABOLIC PATHWAY", "description": "The pathway analysis for \'age at first tooth\' revealed significant overrepresentation of pathways, suggesting biological relevance to the phenotype.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "PATHWAY ANALYSIS RESULTS (AGE AT FIRST TOOTH)"}, {"entity_type": "METABOLIC PATHWAY", "description": "No significant over-representation of pathways was found in the \'number of teeth\' GWAS analysis, indicating limited pathway-level biological impact.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "PATHWAY ANALYSIS RESULTS (NUMBER OF TEETH)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A software tool used for pathway analysis to identify gene sets significantly associated with phenotypes like age at first tooth and number of teeth.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "ALLIGATOR SOFTWARE"}, {"entity_type": "DISEASE", "description": "The pathway analysis results indicating no significant over-representation of pathways in the \'number of teeth\' GWAS, suggesting a lack of clear genetic influence on this trait compared to \'age at first tooth\'.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "SIGNIFICANT SNPS FOR NUMBER OF TEETH PATHWAY ANALYSIS RESULTS (NONE SIGNIFICANT)"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "Variants in CACNB2 are found to be linked to variations in age at first tooth, suggesting a role in the timing of tooth development.", "entity_type": "UNKNOWN", "id": "DENTAL DEVELOPMENT"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs4937076 near CDON gene is associated with phenotypes related to dental morphogenesis.", "entity_type": "UNKNOWN", "id": "TOOTH MORPHOGENESIS"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "Variation in this region affects oral health parameters like age of first tooth and number of teeth.", "entity_type": "UNKNOWN", "id": "CALU/OPN1SW GENE"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "Variation in this region affects oral health parameters like age of first tooth and number of teeth.", "entity_type": "UNKNOWN", "id": "ORAL HEALTH"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "The SNP rs997154 near AJUBA gene is associated with phenotypic variation in dental development traits.", "entity_type": "UNKNOWN", "id": "DENTAL PHENOTYPES"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs7924176 near ADK gene shows association with oral developmental traits such as tooth number.", "entity_type": "UNKNOWN", "id": "ADK GENE"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs7924176 near ADK gene shows association with oral developmental traits such as tooth number.", "entity_type": "UNKNOWN", "id": "ORAL DEVELOPMENT"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "The SNP rs412000 near TEX14/RAD51C is associated with variation in the count of teeth at one year.", "entity_type": "UNKNOWN", "id": "TOOTH COUNT"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "Variation around DLEU7 gene is linked to phenotypes like age at first tooth and number of teeth.", "entity_type": "UNKNOWN", "id": "DENTAL TRAITS"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "Variation around DLEU7 gene is linked to phenotypes like age at first tooth and number of teeth.", "entity_type": "UNKNOWN", "id": "DLEU7 GENE"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "Genetic variations near KCNJ2 are reported to impact dental development including the timing of first tooth appearance.", "entity_type": "UNKNOWN", "id": "KCNJ2 GENE"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "Genetic variations near KCNJ2 are reported to impact dental development including the timing of first tooth appearance.", "entity_type": "UNKNOWN", "id": "TOOTH DEVELOPMENT"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "The SNP rs1956529 in MSRB3 region is associated with phenotypic variation related to dental traits.", "entity_type": "UNKNOWN", "id": "MSRB3 GENE"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "Variations near IGF2BP1 gene influence oral developmental traits such as tooth number and age of eruption.", "entity_type": "UNKNOWN", "id": "IGF2BP1 GENE"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "Variations near IGF2BP1 gene influence oral developmental traits such as tooth number and age of eruption.", "entity_type": "UNKNOWN", "id": "ORAL DEVELOPMENT TRAITS"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNPs in EDA region are associated with phenotypic variations in dental morphology and development.", "entity_type": "UNKNOWN", "id": "DENTAL MORPHOGENESIS"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNPs in EDA region are associated with phenotypic variations in dental morphology and development.", "entity_type": "UNKNOWN", "id": "EDA GENE"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "The SNP rs17101923 in HMGA2 region shows significant association with variability in the number of teeth at one year.", "entity_type": "UNKNOWN", "id": "HMGA2 REGION"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "The SNP rs17101923 in HMGA2 region shows significant association with variability in the number of teeth at one year.", "entity_type": "UNKNOWN", "id": "TOOTH COUNT VARIABILITY"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "Variants around LINC01278 gene are linked to oral developmental traits such as the timing of first tooth eruption.", "entity_type": "UNKNOWN", "id": "LINC01278 GENE"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "Adenosine Kinase (ADK) variants are associated with measures of nose width in craniofacial studies.", "entity_type": "UNKNOWN", "id": "NOSE WIDTH"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "LIM Domain Containing 7 Protein (AJUBA) is involved in mid-brow height increase, possibly linked to height.", "entity_type": "UNKNOWN", "id": "HEIGHT AND CRANIOFACIAL PHENOTYPES"}, {"source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "description": "The GWAS investigates genetic variants associated with when an individual first develops teeth.", "entity_type": "UNKNOWN", "id": "AGE AT FIRST TOOTH TRAIT"}, {"source_id": "chunk-b803830d07bff8ae14550f6458048707<SEP>chunk-c63d60b991cd7442f690dcc364af47dd", "description": "A GWAS is used to identify genetic variations associated with complex traits, like the relationship between SNP and type 2 diabetes.<SEP>The GWAS investigates genetic variants associated with when an individual first develops teeth.", "entity_type": "BIOLOGICAL PATHWAY", "id": "GENOME-WIDE ASSOCIATION STUDY (GWAS)"}, {"source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "description": "The GWAS also explores genetic factors influencing the number of permanent teeth in adults, though less significant pathways were found compared to \'age at first tooth\'.", "entity_type": "UNKNOWN", "id": "NUMBER OF TEETH TRAIT"}, {"entity_type": "GENE", "description": "The IL-10 receptor alpha gene, which plays a role in immune regulation and is selectively deleted in T cells or myeloid cells to study its effects on colitis development.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391"}, {"entity_type": "BIOLOGICAL PATHWAY", "description": "A model used for inducing colitis by transferring naive CD4+CD25\u2212CD45RBhi T cells into Rag1\u2212/\u2212 recipients, used to evaluate the impact of IL-10 signaling.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "T CELL TRANSFER-COLITIS MODEL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Signaling through the interleukin 10 receptor leading to inhibition of pro-inflammatory cytokines such as IL-1\u03b2.<SEP>The process through which interleukin 10 (IL-10) mediates its effects on immune cells such as T cells and macrophages, impacting inflammation and colitis severity.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10 SIGNALING"}, {"entity_type": "BIOLOGICAL PATHWAY", "description": "A model of acute colitis induced by dextran sulfate sodium (DSS), used to study the impact of IL-10 signaling on disease development in a T cell-independent context.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "DSS COLITIS MODEL"}, {"entity_type": "GENOMIC VARIANT", "description": "Mice with selective deletion of IL-10 receptor alpha gene specifically in T cells, used for studying lineage-specific effects of IL-10 signaling.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391TDEL MICE"}, {"entity_type": "GENOMIC VARIANT", "description": "Mice with selective deletion of the IL-10 receptor alpha gene in dendritic cells (IL-10R\u03b1DCdel) or macrophages (IL-10R\u03b1Mdel), used to study immune responses in T cell transfer-mediated colitis.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391DCDEL AND IL-10R\u0391MDEL MICE"}, {"entity_type": "DISEASE", "description": "An inflammatory condition affecting the colon, exacerbated in the presence of a specific genetic modification (IL-10R\u03b1Mdel) which impairs macrophage response to IL-10.<SEP>Inflammation of the colon that can be induced by various genetic mutations or environmental factors such as diet and stress.<SEP>Inflammation of the colon, studied through various models including T cell transfer and DSS-induced inflammation.<SEP>Colitis is an inflammation of the colon that can be exacerbated in mice lacking the CARD9 protein.<SEP>Colitis is an inflammatory bowel disease characterized by inflammation of the colon. In this context, it is influenced by genetic factors such as CARD9 deficiency and environmental factors like gut microbiota composition.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "COLITIS"}, {"entity_type": "PROTEIN", "description": "Helper T cells that produce interferon-gamma (IFN-\u03b3), associated with immune responses to intracellular pathogens and cell-mediated immunity.<SEP>T helper 1 cells that play a role in immune responses against intracellular pathogens and are involved in certain types of autoimmune diseases, though not directly mentioned as affected by IL-10 signaling in this text.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "TH1 CELLS"}, {"entity_type": "PROTEIN", "description": "Regulatory T cells (Tregs) expressing Foxp3 protein which help to maintain immune tolerance and regulate inflammatory responses, though not directly addressed in the effects of IL-10 signaling on colitis development.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "FOXP3+ T CELLS"}, {"entity_type": "CELL TYPE", "description": "Immune cells that play a crucial role in phagocytosis and regulation of inflammation; specific deletion of IL-10R\u03b1 in macrophages intensifies the severity of T cell transfer colitis.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "MACROPHAGES (M\u03a6)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic construct used to selectively delete genes such as IL-10R\u03b1 in a subset of cells, including Ly6C+ monocytes and tissue-resident macrophages, linked with spontaneous colitis development.<SEP>A genetic construct used to selectively delete genes such as IL-10R\u03b1 specifically in cells expressing CX3CR1, leading to spontaneous colitis development.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "CX3CR1-DRIVEN CRE TRANSGENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic construct used for specific deletion of IL-10R\u03b1 gene in granulocytes and macrophages, impacting the severity of T cell transfer-mediated colitis.<SEP>A transgenic construct used to delete the IL-10 receptor alpha specifically in granulocytes and macrophages, impacting T cell transfer-mediated colitis when compared to controls.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "LYS-M-CRE TRANSGENE"}, {"entity_type": "GENE", "description": "The IL-10 gene plays a role in immune modulation and has been studied for its rs1800896 A/G polymorphism, showing significant associations with reduced CRC risk.<SEP>The gene encoding interleukin 10 (IL-10), a cytokine that regulates immune responses and inflammation, crucial for understanding the protective role of IL-10 in colitis.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Mice with a floxed IL-10 receptor alpha gene, used in combination with various Cre recombinase drivers to study the effects of IL-10 signaling.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391FL/FL MICE"}, {"entity_type": "CELL TYPE", "description": "A type of white blood cell that is part of the innate immune system, playing a role in inflammation and phagocytosis. Neutrophil depletion studies indicate their minimal impact on disease exacerbation in IL-10R\u03b1MdelRag1\u2212/\u2212 mice.<SEP>Granulocytes that play a role in immune responses and can influence colitis severity when specific pathways are disrupted.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "NEUTROPHILS"}, {"entity_type": "GENOMIC VARIANT", "description": "Mice lacking the IL-10 receptor alpha gene in a germline deletion, used to assess the overall impact of IL-10 signaling on colitis development.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391\u2212/\u2212 RAG1\u2212/\u2212 MICE"}, {"entity_type": "DISEASE SYMPTOM", "description": "A symptom observed in severe cases of colitis where inflammation and tissue damage lead to protrusion of the rectum, commonly seen in IL-10R\u03b1Mdel mice.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "RECTAL PROLAPSE"}, {"entity_type": "GENE/DISEASE", "description": "A genetic condition or experimental model where the \u03b1 subunit of the IL-10 receptor is deleted specifically in myeloid cells, resulting in heightened immune responses and exacerbated disease states.<SEP>This term describes a genetic modification where the IL-10 receptor alpha chain (IL-10R\u03b1) is deleted in the context of Rag1 deficiency, affecting immune responses and cytokine signaling.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-b971aa450a9b220806bdc000eb5efaad", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212"}, {"entity_type": "PHYSIOLOGICAL PROCESS/PROTEIN", "description": "Macrophages residing in the lamina propria of the intestine that play a critical role in immune regulation. They are characterized by specific surface markers such as CD11bhi, CD11c\u2212/lo/mod, F4/80+, Ly6G\u2212/lo, SiglecF\u2212 and CD64+. These cells exhibit elevated activation markers including CD40, CD80, and CD86.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "LAMINA PROPRIA MACROPHAGES (LPM\u03a6S)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/DISEASE", "description": "Interleukin 10 (IL-10) is a gene encoding a protein that functions to suppress inflammation by inhibiting pro-inflammatory cytokine production and enhancing anti-inflammatory responses.<SEP>Interleukin-10 (IL-10) is a cytokine that suppresses pro-inflammatory responses, including the maturation of IL-1\u03b2 and activation of caspase-1 in macrophages.<SEP>Interleukin-10 is a cytokine that plays an important role in immune regulation and inflammation. Its signaling into macrophages can affect the generation and maintenance of regulatory T cells, but its specific impact on IL-10R\u03b1MdelRag1\u2212/\u2212 mice remains to be elucidated.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-10"}, {"entity_type": "CELL TYPE", "description": "A subset of CD4+ T cells that are critical for suppressing excessive immune responses and maintaining self-tolerance. In the context of IL-10R\u03b1MdelRag1\u2212/\u2212 mice, their suppressive activity remains intact despite impaired signaling through IL-10.<SEP>Specialized immune cells involved in suppressing overactive immune responses and maintaining self-tolerance.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "T REGULATORY CELLS (TREGS)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic background or model where Rag1 is deleted, resulting in mice lacking mature T cells and B cells.<SEP>A genetic variant where Rag1 gene function is disrupted or absent (Rag1\u2212/\u2212), affecting the development of T and B lymphocytes.<SEP>A genomic variant associated with Rag1 deficiency, which affects immune cell development.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "RAG1\u2212/\u2212"}, {"entity_type": "PROTEIN", "description": "T helper cells that play a crucial role in immune responses by secreting cytokines such as IL-2, IL-4, and IFN-gamma. They are involved in the proliferation and differentiation of B cells and CD8+ cytotoxic T lymphocytes.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD4 T CELLS"}, {"entity_type": "PROTEIN", "description": "Professional antigen-presenting cells that link innate and adaptive immunity by uptaking antigens, processing them, and presenting them to T cells via MHC molecules.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "DENDRITIC CELLS (DCS)"}, {"entity_type": "GENE/PROTEIN", "description": "A gene encoding a surface protein (Ly6G) expressed on neutrophils. Antibodies targeting Ly6G are used for selective depletion of neutrophils in experimental settings.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "LY6G"}, {"entity_type": "PHYSIOLOGICAL PROCESS/PROTEIN", "description": "A specific phenotype defining lamina propria macrophages (LPM\u03d5s) based on their surface markers, indicating their role in immune regulation within the intestinal mucosa.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD11BHICD11C\u2212/LO/MODF4/80+LY6G\u2212/LOSIGLECF\u2212"}, {"entity_type": "GENE", "description": "A gene that encodes a transcription factor essential for regulatory T cell development and function. Its upregulation marks the transition of naive CD4+ T cells into Foxp3+ regulatory T cells (Tregs).<SEP>FOXP3 is a gene encoding a transcription factor important for the differentiation, maintenance, and function of regulatory T cells (Tregs).", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "FOXP3"}, {"entity_type": "GENE/DISEASE", "description": "A genetic model where both IL-10 receptor beta subunit and Rag2 are deleted, leading to defects in immune cell development and function.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "IL-10R\u0392\u2212/\u2212RAG2\u2212/\u2212"}, {"entity_type": "PROTEIN", "description": "Induced regulatory T cells that develop from naive CD4+ T cells under specific conditions, such as the presence of appropriate cytokines like TGF-\u03b2 and IL-6. They play a key role in maintaining immune homeostasis.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "ITREG"}, {"entity_type": "PHYSIOLOGICAL PROCESS/PROTEIN", "description": "Lymphoid tissues located along the mesentery that serve as sites for immune cell interactions, particularly relevant to intestinal immunity. They are involved in mounting and regulating adaptive immune responses against intestinal pathogens.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "MESENTERIC LYMPH NODES (MLNS)"}, {"entity_type": "ANATOMY/DISEASE", "description": "A secondary lymphoid organ where immune cells interact with antigens from the blood, leading to the generation of immune responses including antibody production and T cell activation.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "SPLEEN"}, {"entity_type": "DISEASE", "description": "A genetic model of colitis characterized by a mutation in IL-10 receptor alpha with Rag1 knockout.<SEP>A genetic model of colitis characterized by a mutation in IL-10 receptor alpha, with Rag1 knockout.<SEP>These are mice with a specific genetic modification that leads to increased susceptibility to inflammatory bowel disease, specifically colitis.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE"}, {"entity_type": "PROTEIN", "description": "A type of white blood cell that plays a central role in adaptive immunity, including those producing IL-22.<SEP>T cells are immune cells involved in adaptive immunity and play a role in regulating immune responses through the production of cytokines such as IL-10.<SEP>T cells are a type of white blood cell that play an essential role in the adaptive immune system.<SEP>T cells are a type of white blood cell that play a central role in adaptive immunity by recognizing and responding to specific antigens.<SEP>T cells are immune cells whose maintenance is influenced by STAT5B, with reductions often observed in patients lacking functional STAT5B protein.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "T CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which macrophages respond to Interleukin 10 (IL-10) leading to the regulation of inflammatory responses.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "M\u03a6 IL-10 RESPONSE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Production of cytokines such as IL-1\u03b2, IL-6, TNF-\u03b1, MCP-1, IL-17, and IFN-\u03b3 by immune cells which promote inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "PRO-INFLAMMATORY CYTOKINE PRODUCTION"}, {"entity_type": "CELL TYPE", "description": "A specific type of macrophages (LPM\u03d5) from mice with a genetic modification in the IL-10 receptor alpha chain, showing altered cytokine production profiles.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-10R\u0391MDEL LPM\u03a6S"}, {"entity_type": "PROTEIN", "description": "Differentiation of T helper cells into Th17 effector cells involved in promoting inflammation and autoimmune conditions such as colitis.<SEP>Helper T cells characterized by the production of IL-17, involved in promoting inflammation and tissue repair.<SEP>T helper 17 cells are a subset of CD4+ T lymphocytes that play a key role in the pathogenesis of autoimmune diseases like colitis.<SEP>T helper 17 (TH17) cells are a subset of CD4+ T cells that produce interleukin-17 (IL-17). They play roles in immune defense against extracellular pathogens and tissue inflammation. In the context provided, TH17 cell IL-22 production was not affected by CARD9 deficiency.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "TH17 CELLS"}, {"entity_type": "NUTRIENT", "description": "Interleukin 6 (IL-6) is a cytokine that plays a role in immune responses, including the regulation of acute-phase reactions and hematopoiesis.<SEP>Interleukin-6 (IL-6) is a cytokine involved in the maturation of Th17 cells and immune responses; its signaling can be modulated by various factors.<SEP>Interleukin-6 is a cytokine known to induce Th17 cell differentiation and support their activity during inflammation.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-6"}, {"entity_type": "PROTEIN", "description": "Tumor Necrosis Factor alpha (TNF-\u03b1) is a pro-inflammatory cytokine involved in systemic inflammation and the induction of fever.<SEP>Tumor necrosis factor alpha (TNF-\u03b1) is a cytokine that plays a key role in the inflammatory response and immune system activation. Adalimumab targets TNF-\u03b1 to treat inflammatory diseases, but paradoxical psoriasis can occur as a side effect.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "TNF-\u0391"}, {"entity_type": "GENE", "description": "Monocyte Chemoattractant Protein 1 (MCP-1) is a chemokine that attracts monocytes and other immune cells to sites of inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "MCP-1"}, {"entity_type": "GENE", "description": "Interleukin 17 (IL-17) is a cytokine involved in the regulation of inflammatory responses, particularly those associated with tissue destruction and repair.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-17"}, {"entity_type": "PROTEIN", "description": "Interferon gamma (IFN-\u03b3) is a cytokine that plays a critical role in immune defense against intracellular pathogens and tumor surveillance.<SEP>Interferon-gamma (IFN-\u03b3) is a cytokine that plays a critical role in the immune response and inflammation.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IFN-\u0393"}, {"entity_type": "NUTRIENT", "description": "A pro-inflammatory cytokine involved in innate immune responses, including the development of Th17 cells during colitis.<SEP>Interleukin 1 beta (IL-1\u03b2) is a pro-inflammatory cytokine involved in the induction of fever, acute-phase reactions, and the regulation of immune responses.<SEP>Interleukin-1 beta (IL-1\u03b2) is a pro-inflammatory cytokine that plays a critical role in immune responses, often regulated by caspase-1 activation.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-1\u0392"}, {"entity_type": "PROTEIN", "description": "Inducible nitric oxide synthase (iNOS) enzyme that catalyzes the production of nitric oxide from L-arginine, contributing to inflammatory processes and host defense mechanisms.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "INOS"}, {"entity_type": "ENZYME", "description": "An enzyme involved in the metabolism of arginine into ornithine and urea, playing a role in immune regulation and inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "ARGINASE"}, {"entity_type": "GENE", "description": "Interleukin 23 p19 subunit (IL-23p19) is a gene involved in the production of IL-23, a cytokine that promotes Th17 cell differentiation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-23P19"}, {"entity_type": "CELL TYPE", "description": "Helper T cells expressing both CD4 and IL-17A, indicative of Th17 cell phenotype.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "CD4+IL-17A+ T CELLS"}, {"entity_type": "CELL TYPE", "description": "Transgenic T cells that express ROR\u03b3T (a transcription factor important for Th17 differentiation) tagged with GFP for visualization purposes in experiments.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "ROR\u0393T-GFP REPORTER T CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which macrophages increase the production of Arginase, an enzyme involved in metabolic pathways and immune regulation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "ARGINASE EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Macrophage activation results in increased iNOS (inducible nitric oxide synthase) activity leading to enhanced pro-inflammatory functions.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "INOS EXPRESSION"}, {"entity_type": "PROTEIN MARKER", "description": "A protein expressed on the surface of macrophages that serves as a marker for anti-inflammatory M\u03d5s, indicating their regulatory function in inflammation.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "CD163"}, {"entity_type": "GENE", "description": "A transcription factor that promotes the development of Th17 cells by binding to regulatory regions of genes involved in the differentiation of these cells.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "ROR\u0393T"}, {"entity_type": "PROTEIN", "description": "T cells lacking IL-6 receptor alpha subunit, which have diminished clinical and histological measures of colitis.<SEP>T cells lacking the IL-6 receptor alpha subunit, unable to directly respond to IL-6 but may still contribute to inflammation through other pathways.<SEP>T cells lacking the IL-6 receptor alpha subunit, which are unable to respond directly to IL-6 but may still contribute to inflammation through other pathways.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "IL-6R\u0391\u2212/\u2212 T CELLS"}, {"entity_type": "DISEASE", "description": "Mice lacking recombination activating gene 1, resulting in a severe combined immunodeficiency due to an inability to generate adaptive immunity properly.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "RAG1\u2212/\u2212 MICE"}, {"entity_type": "PROTEIN", "description": "T cells lacking the interleukin-1 receptor, which results in decreased responsiveness to IL-1 signaling and reduced ability to induce colitis.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "IL-1R\u2212/\u2212 T CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Regulatory T cells that play a role in maintaining immune tolerance by suppressing activation of other immune cells.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "FOXP3+ CD4+ T CELLS"}, {"entity_type": "NUTRIENT", "description": "Interleukin-1 is a cytokine involved in the regulation of inflammatory responses and cell proliferation.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "IL-1"}, {"entity_type": "GENE", "description": "The gene for the interleukin 6 receptor alpha subunit, which plays a role in immune responses and can influence disease severity.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "IL-6R\u0391"}, {"entity_type": "GENE", "description": "The gene for the interleukin 1 receptor, involved in signaling pathways that regulate inflammation and autoimmune diseases.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "IL-1R"}, {"entity_type": "GENE", "description": "A genetic modification involving the interleukin 10 receptor alpha subunit, leading to altered immune responses and disease susceptibility.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "IL-10R\u0391MDEL"}, {"entity_type": "DISEASE", "description": "Inflammation within the colon, often associated with autoimmune disorders or infections leading to symptoms like diarrhea and abdominal pain.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "COLONIC INFLAMMATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of generating interleukin 1 beta from its precursor pro-IL-1\u03b2 in immune cells during inflammation responses.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "IL-1\u0392 PRODUCTION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A proteolytic interaction that activates the caspase-1 enzyme, cleaving and activating pro-IL-1\u03b2 into active IL-1\u03b2.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "CASPASE-1 CLEAVAGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Activation of the inflammasome complex in immune cells leading to cleavage of pro-IL-1\u03b2 by caspase-1, initiating inflammatory responses.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "INFLAMMASOME STIMULATION"}, {"entity_type": "CELL TYPE", "description": "A type of macrophage cell found in the lamina propria of the intestine, known to produce IL-1\u03b2 during inflammation.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "LPM\u03a6S (LIN\u2212CD11B+ CD11C\u2212/LO F4/80HI LY6G\u2212 SIGLECF\u2212)"}, {"entity_type": "PROTEIN", "description": "Pro-interleukin-1 beta (pro-IL-\u03b2) is the precursor form of the pro-inflammatory cytokine IL-1\u03b2, which becomes mature and active after processing by caspase-1.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "PRO-IL-\u0392"}, {"entity_type": "PROTEIN", "description": "Macrophages (M\u03d5s) are immune cells that play a role in phagocytosis and inflammation, with their activity modulated by various cytokines including IL-10.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "M\u03a6S"}, {"entity_type": "PROTEIN", "description": "Caspase-1 is an enzyme involved in the maturation of pro-inflammatory cytokines such as IL-1\u03b2; its activation can be regulated by signaling pathways like those involving IL-10.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "CASPASE-1"}, {"entity_type": "GENOMIC VARIANT, MOLECULAR INTERACTION", "description": "A genetic modification where a component of the IL-1 receptor is altered or deleted, affecting cytokine signaling and immune responses.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "IL-1R\u0391MDEL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which naive T cells differentiate into Th17 helper T cells in response to specific stimuli like IL-6 and transforming growth factor beta (TGF\u03b2).", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "TH17 CELL MATURATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS, PROTEIN INTERACTION", "description": "Liver sinusoidal endothelial cells (LSEC), which are also known as liver-derived macrophages or LPM\u03d5s, play a role in the regulation of immune responses and can influence T cell maturation.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "LPM\u03a6S"}, {"entity_type": "PROTEIN INTERACTION", "description": "Macrophages (M\u03d5s) derived from mice with an IL-10 receptor alpha chain deletion in the context of Rag1 deficiency, showing altered cytokine signaling compared to normal macrophages.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212 M\u03a6S"}, {"entity_type": "EXPERIMENTAL MODEL, DISEASE", "description": "A model where T cells lacking the IL-6 receptor are transferred into mice for studying the role of IL-6 in immune responses and disease development.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "IL-6R\u2212/\u2212 T CELL TRANSFER"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Lipopolysaccharide (LPS) and adenosine triphosphate (ATP) are environmental factors that stimulate macrophages to produce inflammatory cytokines like IL-1\u03b2.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "LPS AND ATP"}, {"entity_type": "PROTEIN, NUTRIENT, ENVIRONMENTAL FACTOR", "description": "Transforming growth factor beta (TGF\u03b2) is a protein involved in cell differentiation and immune regulation; it can promote Th17 cell maturation when combined with other cytokines like IL-6.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "TGF\u0392"}, {"entity_type": "PHYSIOLOGICAL PROCESS, PROTEIN INTERACTION", "description": "Naive T cells are lymphocytes that have not yet been exposed to specific antigens and can differentiate into various T helper cell subsets, such as Th17 cells.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "NA\u00cfVE T CELLS"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "Selective deletion of IL-10R\u03b1 specifically in T cells does not significantly influence disease development or severity in a T cell transfer-mediated colitis model.)", "entity_type": "UNKNOWN", "id": "DISEASE DEVELOPMENT"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "Deletion of the IL-10 receptor alpha specifically in macrophages intensifies disease severity, suggesting a protective role for IL-10 signaling within this cell type.)", "entity_type": "UNKNOWN", "id": "COLITIS SEVERITY"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "The CX3CR1-driven Cre transgene leads to spontaneous colitis when used to delete IL-10R\u03b1 in a subset of immune cells.)", "entity_type": "UNKNOWN", "id": "SPONTANEOUS COLITIS"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "Deletion of IL-10R\u03b1 using Lys-M-Cre transgene in neutrophils and macrophages shows a complex effect on colitis severity, indicating the need for further studies.)", "entity_type": "UNKNOWN", "id": "NEUTROPHIL ROLE"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "Mice with floxed IL-10 receptor alpha gene are used in various models to understand the cell-specific effects of IL-10 signaling on colitis.)", "entity_type": "UNKNOWN", "id": "DISEASE MODELS"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "Rectal prolapse is a severe symptom observed in mice with high disease severity, indicating advanced stages of colitis.)", "entity_type": "UNKNOWN", "id": "DISEASE OUTCOME"}, {"entity_type": "GENOMIC VARIANT", "description": "The 16S rRNA gene V4 region is a variable segment of the bacterial genome used for microbiome analysis.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "16S RRNA GENE V4 REGION"}, {"entity_type": "GENOMIC VARIANT", "description": "The V3 and V4 hypervariable regions of the 16S rRNA gene are targeted in genomic analyses to study microbial diversity.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "16S RRNA GENE V3-V4 REGIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "V1 and V2 variable regions of the 16S rRNA gene, which are used for sequencing studies.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "16S RRNA GENE V1-V2 REGIONS"}, {"entity_type": "PROTEIN", "description": "The Bacteroides genus is a bacterial group commonly found in human gut microbiota that contributes significantly to microbial composition diversity and health.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "BACTEROIDES GENUS"}, {"entity_type": "PROTEIN", "description": "A genus of bacteria within the Firmicutes phylum known for its role in producing butyrate, an important short-chain fatty acid for intestinal health.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "FAECALIBACTERIUM GENUS"}, {"entity_type": "PROTEIN", "description": "The Blautia genus is a group of bacteria involved in carbohydrate metabolism and fermentation processes in the gut.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "BLAUTIA GENUS"}, {"entity_type": "PROTEIN", "description": "Bacteria within the Bacteroidetes phylum, often associated with dysbiosis in some disease states.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "ALISTIPES GENUS"}, {"entity_type": "PROTEIN", "description": "A bacterial genus that produces short-chain fatty acids and contributes to gut health through its metabolic activities.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "RUMINICLOSTRIDIUM GENUS"}, {"entity_type": "PROTEIN", "description": "A member of the Clostridia class, known for producing butyrate and other beneficial metabolites in the gut microbiota.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "FUSICATENIBACTER GENUS"}, {"entity_type": "PROTEIN", "description": "Bacteria that produce butyrate, an important short-chain fatty acid with anti-inflammatory effects in the colon.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "BUTYRICICOCCUS GENUS"}, {"entity_type": "PROTEIN", "description": "A bacterial genus within the Firmicutes phylum associated with beneficial functions in gut microbiota health.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "EUBACTERIUM GENUS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The method used to extract DNA from samples, which can influence the observed microbial composition and diversity.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "DNA EXTRACTION METHOD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A twin cohort used in genetic studies that helps estimate heritability of gut microbiome traits through MZ and DZ comparisons.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "TWINSUK COHORT TWIN PAIRS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A twin cohort consisting of monozygotic twins used for replicating intraclass correlation coefficients in genetic studies.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "NETHERLANDS TWIN REGISTRY (NTR) COHORT TWIN PAIRS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The study involves estimating the heritable component (H2) of gut microbiota composition based on twin data and genetic association statistics.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "HERITABILITY ESTIMATION OF GUT MICROBIOME COMPOSITION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Heritability estimation from genome-wide summary statistics using LD score regression to assess genetic contribution to microbial taxa variation.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "SNP-BASED HERITABILITY"}, {"entity_type": "COHORT", "description": "A cohort with samples from Middle-Eastern individuals.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "MIDDLE-EASTERN COHORT"}, {"entity_type": "COHORT", "description": "A cohort comprising East Asian ethnic background participants.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "EAST ASIAN COHORT"}, {"entity_type": "COHORT", "description": "A cohort consisting of American Hispanic and Latin individuals.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "AMERICAN HISPANIC/LATIN COHORT"}, {"entity_type": "COHORT", "description": "A specific cohort including African Americans in the study.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "AFRICAN AMERICAN COHORT"}, {"entity_type": "COHORT", "description": "Four cohorts that included samples from multiple ethnic backgrounds.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "MULTI-ANCESTRY COHORTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cohorts consisting of adult or adolescent participants, used for microbiome analysis.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "ADOLESCENT AND ADULT INDIVIDUALS COHORT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Two cohorts that specifically included children for microbial composition study.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "CHILDREN COHORT"}, {"entity_type": "GENOMIC VARIANT", "description": "The variable regions of the 16S rRNA gene used in microbiome sequencing studies.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "16S RRNA GENE VARIABLE REGIONS V4-V5"}, {"entity_type": "PROTEIN", "description": "A bacterial genus known for its role in gut health and production of short-chain fatty acids.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "RUMINOCLOSTRIDIUM GENUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Estimations showing lack of heritability for alpha diversity metrics such as Shannon, Simpson, and inverse Simpson in the gut microbiome.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "HERITABILITY ESTIMATION OF GUT MICROBIOTA ALPHA DIVERSITY METRICS (SHANNON, SIMPSON, INVERSE SIMPSON)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The estimation process that identifies 19 bacterial taxa with evidence for heritability among 159 studied bacterial taxa.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "HERITABILITY ESTIMATION OF 159 BACTERIAL TAXA"}, {"entity_type": "PROTEIN", "description": "Two specific microbial taxa showing SNP-based heritability in the gut microbiome study.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "RUMINICLOSTRIDIUM GENUS AND PEPTOSTREPTOCOCCAEAE FAMILY"}, {"entity_type": "GENE", "description": "The LCT gene encodes lactase-phlorizin hydrolase, an enzyme critical for lactose digestion.<SEP>The LCT gene is associated with the abundance of Bifidobacterium and shows heterogeneity in its effects across different ethnicities and ages.<SEP>The LCT gene is involved in cell-type specific expression and is associated with lactase non-persistence.<SEP>The LCT gene is responsible for the production of lactase, an enzyme that breaks down lactose in milk and other dairy products.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1<SEP>chunk-4964b2db9e3ddddb4967fb7150e4404d<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6<SEP>chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "LCT GENE"}, {"entity_type": "GENE", "description": "Encodes alpha-1,2-fucosyltransferase involved in mucus glycans secretion in gastrointestinal mucosa; non-secretors lack ABO antigens on intestinal mucosa due to mutation.<SEP>Functionally relevant variants, such as those in FUT2, are included among loci that influence gut microbiota composition.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46<SEP>chunk-af413a33fae8d27bdb15cd18447dfad4", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 27}]", "id": "FUT2 GENE"}, {"entity_type": "GENOMIC VARIANT/METABOLIC PATHWAY/ENVIRONMENTAL FACTOR", "description": "Bifidobacterium abundance is influenced by the LCT gene and dietary factors, especially milk product consumption in individuals with specific genotypes.<SEP>Bifidobacterium is a genus of bacteria belonging to Actinobacteria class that shows a potential protective effect on ulcerative colitis, as shown by MR analysis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "BIFIDOBACTERIUM"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs182549) located within the LCT gene is significantly associated with Bifidobacterium abundance.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 26}]", "id": "GENOMIC VARIANT RS182549"}, {"entity_type": "DIETARY PATTERN", "description": "Consumption of milk products correlates positively with Bifidobacterium abundance in individuals homozygous for a specific LCT haplotype.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "MILK PRODUCTS INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The interaction between age, ethnicity, and genetic variants affects the relationship between LCT gene polymorphisms and Bifidobacterium abundance.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 26}]", "id": "AGE AND ETHNICITY HETEROGENEITY"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs4988235) within the LCT gene correlates with Bifidobacterium abundance and is functionally significant.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 26}]", "id": "GENOMIC VARIANT RS4988235"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in linkage with the functional LCT variant, showing significant association with Bifidobacterium abundance.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "GENOMIC VARIANT RS182549 (PROXY FOR RS4988235)"}, {"entity_type": "GENOMIC VARIANT", "description": "This haplotype is associated with higher Bifidobacterium abundance in adults but not in younger individuals.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "LCT HAPLOTYPE CC (RS182549)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "These indices were used to measure alpha diversity but did not show significant genetic hits after meta-GWAS analysis.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "SIMPSON, INVERSE SIMPSON, AND SHANNON DIVERSITY INDICES"}, {"entity_type": "DISEASE", "description": "The TwinsUK cohort showed strong heritability evidence for certain bacterial taxa, which correlates with genome-wide significance in mbTLs.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "TWINSUK COHORT"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "This cohort contributed significantly to the heterogeneity observed in LCT gene associations with Bifidobacterium abundance.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "COPSAC2010 COHORT"}, {"entity_type": "DIETARY PATTERN", "description": "These subcohorts showed a significant SNP-age interaction on the level of Bifidobacterium abundance.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 26}]", "id": "GEM_V12 AND GEM_ICHIP SUBCOHORTS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Mainly composed of Israeli subethnicities, this cohort did not show an mbQTL effect despite genetic influences observed in other cohorts.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "GEM_V24 COHORT"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant that influences the abundance of Bifidobacterium in adult individuals but not in younger ones.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RS182549"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The effect size of LCT (lactase) genetic variants on microbiome traits varies across different ethnic and age groups, particularly lower in Israeli adults.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "LCT MBQTL EFFECT SIZE"}, {"entity_type": "GENOMIC VARIANT", "description": "A locus associated with the abundance of Ruminococcus torques genus group due to a stop-codon mutation introduced by SNP rs601338 in FUT2 gene.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "FUT2-FUT1 LOCUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The Ruminococcus torques group is influenced by genetic variation at the FUT2 locus and correlates with fruit intake.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "R. TORQUES GROUP"}, {"entity_type": "PROTEIN", "description": "Bacteria specialized in degrading complex carbohydrates, impacting the gut microbiome composition and metabolism.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RUMINOCOCCUS SP."}, {"entity_type": "NUTRIENT", "description": "Intake of fruit is correlated with reduced abundance of R. torques group due to genetic variation at FUT2 locus.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "FRUIT INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Abundance of Allisonella associated with SNPs in 9q21 locus (PCSK5, RFK, GCNT1 genes) involved in riboflavin phosphorylation and glycosyltransferase activities.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "ALLISONELLA ABUNDANCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Abundance of Peptostreptococcaceae affected by genetic variants at CUBN gene, related to cobalamin absorption and metabolism.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "PEPTOSTREPTOCOCCACEAE ABUNDANCE"}, {"entity_type": "METABOLIC PATHWAY", "description": "The process of vitamin B12 (cobalamin) absorption regulated by genes like RFK and GCNT1 involved in host-microbiota interactions within the intestine.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 27}]", "id": "COBALAMIN ABSORPTION"}, {"entity_type": "DISEASE", "description": "A disease resulting from cobalamin deficiency affecting intestinal epithelium expression of CUBN gene, leading to albuminuria and anemia.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 27}]", "id": "B12-DEFICIENT ANEMIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Family of bacteria negatively associated with stool levels of gut inflammation markers like chromogranin A and calprotectin due to genetic variants.<SEP>Family of bacteria negatively correlated with gut inflammation markers like chromogranin A and calprotectin, influenced by genetic variants.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "PEPTOCOCCACEAE FAMILY"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at the 9q21 locus associated with abundance of Allisonella family due to influence on riboflavin phosphorylation and glycosyltransferase activities.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "9Q21 LOCUS"}, {"entity_type": "GENE", "description": "Encodes cubilin, a receptor for cobalamin complexes necessary for vitamin B12 absorption; linked to albuminuria and B12 deficiency anemia.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "CUBN GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP associated with stool levels of gut inflammation markers chromogranin A and calprotectin and ulcerative colitis.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "SNP RS7574352"}, {"entity_type": "TAXON", "description": "A family of bacteria negatively associated with stool levels of gut inflammation markers such as chromogranin A and calprotectin, and with ulcerative colitis.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "PEPTOCOCCACEAE"}, {"entity_type": "NUTRIENT/METABOLITE", "description": "Gut inflammation marker negatively correlated with the presence of certain microbial taxa like Peptococcaceae.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "CHROMOGRANIN A"}, {"entity_type": "NUTRIENT/METABOLITE", "description": "A proteinaceous gut inflammation marker negatively associated with the abundance of specific bacterial families such as Peptococcaceae.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "CALPROTECTIN"}, {"entity_type": "DISEASE", "description": "An inflammatory bowel disease negatively correlated with certain microbial taxa and positively linked to genetic variants such as SNPs.<SEP>Ulcerative colitis is an inflammatory bowel disease for which higher abundance of gut microbial taxa such as Bifidobacterium and Actinobacteria may have a protective effect.<SEP>Another form of inflammatory bowel disease (IBD), distinct from Crohn\'s disease, affecting the colon and rectum.", "source_id": "chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-c791a4e35844d642ba0c69774072f7cd", "id": "ULCERATIVE COLITIS"}, {"entity_type": "GENE", "description": "A gene involved in insulin resistance and susceptibility to type 2 diabetes located near a genomic variant associated with gut microbiota composition.<SEP>Interferon regulatory factor 1 gene whose expression level can be influenced by genetic variants such as rs4788084[T] and missense SNP rs181206[G].", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-938d8bf2e56584de9dd556be5eb70964", "id": "IRF1 GENE"}, {"entity_type": "GENE", "description": "The Lactase gene, polymorphisms of which are associated with multiple dietary and metabolic phenotypes including obesity and Type 2 Diabetes Mellitus.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "LCT GENE (RS182549)"}, {"entity_type": "LOCUS", "description": "A locus containing FUT1/FUT2 genes, associated with fish intake, height, cholelithiasis risk and Crohn\u2019s disease risk.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "FUT1/FUT2 LOCUS (RS35866622)"}, {"entity_type": "DIETARY PATTERN", "description": "An aspect of dietary pattern positively associated with the FUT1/FUT2 locus and negatively correlated with certain diseases like cholelithiasis and Crohn\'s disease.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "FISH INTAKE"}, {"entity_type": "ENVIRONMENTAL FACTOR/METABOLIC PATHWAY", "description": "Microbial abundance correlated with dietary intake patterns and metabolic traits such as lactose intolerance, obesity, and Type 2 Diabetes Mellitus.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "BIFIDOBACTERIUM ABUNDANCE"}, {"entity_type": "DISEASE", "description": "A disease associated with certain genetic variants such as rs182549 in the LCT gene, showing positive correlation with T2DM diagnosis.<SEP>A disease characterized by high blood sugar levels due to insulin resistance or insufficient insulin production, linked with specific genomic variants like rs10886471.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-938d8bf2e56584de9dd556be5eb70964", "id": "TYPE 2 DIABETES MELLITUS (T2DM)"}, {"entity_type": "DISEASE/CONDITION", "description": "A condition characterized by the inability to digest lactose due to low levels or absence of lactase enzyme.<SEP>A physiological condition predisposing individuals to a higher risk of Type 2 Diabetes Mellitus and obesity.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-512b044cf65a4e519d519c6239959c6c", "id": "LACTOSE INTOLERANCE"}, {"entity_type": "DIETARY PATTERN", "description": "An aspect of dietary pattern that shows nominal correlation with Bifidobacterium abundance, but not significant after multiple testing correction.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "RAW VEGETABLE INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Traits such as BMI and cholesterol levels associated with genetic loci like LCT and FUT1/FUT2 via gene-based PheWAS analysis.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "METABOLIC TRAITS"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant in the LCT gene associated with multiple dietary and metabolic phenotypes.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "GENOMIC VARIANT (RS182549)"}, {"entity_type": "DISEASE/PHYSIOLOGICAL PROCESS", "description": "The genetic predisposition to Type 2 Diabetes Mellitus, specifically passed from the paternal side.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "TYPE 2 DIABETES MELLITUS FAMILY HISTORY (PATERNAL)"}, {"entity_type": "DISEASE/PHYSIOLOGICAL PROCESS", "description": "Genetic predisposition to Type 2 Diabetes Mellitus, specifically inherited from the maternal lineage.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "TYPE 2 DIABETES MELLITUS FAMILY HISTORY (MATERNAL)"}, {"entity_type": "DISEASE/PHYSIOLOGICAL PROCESS", "description": "Risk of siblings developing Type 2 Diabetes Mellitus based on familial genetic factors.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "SIBLINGS\' TYPE 2 DIABETES MELLITUS RISK"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant near the FUT1/FUT2 locus associated with various nutritional and health outcomes.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "GENOMIC VARIANT (RS35866622)"}, {"entity_type": "LOCUS/VARIANT", "description": "Genetic variants at this locus influence dietary patterns, height, and disease risks such as cholelithiasis.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "FUT1/FUT2 LOCUS GENETIC VARIANTS"}, {"entity_type": "DIETARY PATTERN", "description": "The consumption of oily fish is associated with genetic loci like FUT1/FUT2 in various nutritional phenotypes.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "OILY FISH INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS/BLOOD MARKER", "description": "A blood marker linked to immune and metabolic functions, showing associations with the FUT1/FUT2 locus.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "MEAN PLATELET VOLUME"}, {"entity_type": "DISEASE/CONDITION", "description": "The formation of gallstones, associated with genetic variants at the FUT1/FUT2 locus.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "CHOLELITHIASIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC CONDITION", "description": "A metabolic condition positively correlated with certain genetic loci like FUT1/FUT2.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "HIGH CHOLESTEROL LEVELS"}, {"entity_type": "GENOMIC VARIANT/METABOLIC PATHWAY/ENVIRONMENTAL FACTOR", "description": "Actinobacteria is a class of bacteria found in the gut microbiome that may have a protective effect on ulcerative colitis, as indicated by MR analysis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "ACTINOBACTERIA"}, {"entity_type": "GENOMIC VARIANT/METABOLIC PATHWAY/ENVIRONMENTAL FACTOR", "description": "Higher abundance of the family Oxalobacteraceae has been observed to offer protection against rheumatoid arthritis, as indicated by MR analysis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "OXALOBACTERACEAE"}, {"entity_type": "DISEASE", "description": "Rheumatoid arthritis is an autoimmune disease where higher gut microbial taxa abundance in certain families such as Oxalobacteraceae might provide protective effects.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "RHEUMATOID ARTHRITIS"}, {"entity_type": "ENVIRONMENTAL FACTOR/METABOLIC PATHWAY", "description": "Variability in the composition of gut microbiome due to genetic factors or environmental influences needs careful interpretation in MR analyses.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "MICROBIAL TAXA VARIABILITY"}, {"entity_type": "NUTRIENT/DIETARY PATTERN", "description": "No evidence was found for causal relationships between dietary preferences and gut microbial taxa abundance, as identified through sensitivity analysis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "DIETARY PREFERENCES"}, {"entity_type": "METHODOLOGICAL PROCESS", "description": "A statistical method used to identify potential causal links between gut microbial taxa and phenotypes such as diseases and nutritional traits.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "MR ANALYSIS (MENDELIAN RANDOMIZATION)"}, {"entity_type": "DISEASE CATEGORY", "description": "A category of diseases resulting from an immune response by the body against substances and tissues normally present in it, including Type 1 Diabetes.<SEP>Group of diseases where the immune system attacks healthy cells in the body, considered along with other disease categories for MR analysis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "AUTOIMMUNE DISEASES"}, {"entity_type": "DISEASE", "description": "A cluster of conditions that affect the heart and blood vessels, one category analyzed for causal links to gut microbial taxa.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "CARDIOVASCULAR DISEASES"}, {"entity_type": "DISEASE", "description": "Conditions characterized by disturbances in metabolism, including diabetes or obesity, part of phenotypes examined through MR analysis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "METABOLIC DISEASES"}, {"entity_type": "DISEASE", "description": "Mental health conditions such as depression and schizophrenia, among others, included within the scope of MR analysis for identifying causal links with gut microbiota.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "PSYCHIATRIC DISORDERS"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs4988235 T/T genotype is a genetic variant associated with higher milk intake and altered dietary patterns.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "RS4988235 T/T GENOTYPE"}, {"entity_type": "GENE", "description": "LP (T) alleles refer to the presence of certain alleles related to lactase persistence, impacting various health factors such as blood pressure and diet.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "LP (T) ALLELES"}, {"entity_type": "DIETARY PATTERN", "description": "Milk intake is a dietary pattern that varies between countries and influences plasma C15:0 levels.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "MILK INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Plasma C15:0 levels are physiological markers influenced by milk consumption and genotypes of rs4988235.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "PLASMA C15:0 LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Diabetes risk factors include genetic predisposition from the LP (T) alleles and dietary patterns such as potato intake.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "DIABETES RISK FACTORS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "HDL cholesterol levels are affected by the genotype of rs4988235, showing a modestly lower level in carriers.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "HDL CHOLESTEROL LEVELS"}, {"entity_type": "DIETARY PATTERN", "description": "Intake of dairy products is influenced by LP (T) alleles and includes milk, but not other dairy products.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "DAIRY PRODUCTS INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "Consumption of potatoes is higher in individuals with more LP (T) alleles, contrary to fruits and vegetables.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "POTATOES INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "Intake of cereals is lower in individuals carrying the rs4988235 T allele.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "CEREALS INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "Consumption of fruits decreases with an increase in LP (T) alleles, contrary to potatoes and dairy products.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "FRUITS INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "Intake of non-alcoholic beverages is lower among individuals carrying the rs4988235 T allele.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "NON-ALCOHOLIC BEVERAGES INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "Consumption of wine decreases with an increase in LP (T) alleles, contrary to milk consumption.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "WINE CONSUMPTION"}, {"entity_type": "DISEASE", "description": "Despite associations with dietary patterns and physiological processes, the rs4988235 genotype does not significantly influence the risk of developing diabetes.<SEP>The risk of developing diabetes is not associated with the rs4988235 genotype or milk intake.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "RISK OF DEVELOPING DIABETES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Multivariable adjustment for dietary intakes and genotypes shows varied associations with health outcomes such as HDL cholesterol levels.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "MULTIVARIABLE ADJUSTMENT"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs4988235 genotype is associated with variations in milk intake, dietary patterns, and physiological processes.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "RS4988235 GENOTYPE"}, {"entity_type": "GENE", "description": "Individuals homozygous for the LP (T/T) allele show increased milk consumption and altered baseline characteristics such as higher systolic blood pressure.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "HOMOZYGOUS LP (T/T)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The variability in milk consumption across different countries indicates the influence of environmental factors on dietary habits.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "MILK CONSUMPTION VARIABILITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Deviation from Hardy-Weinberg equilibrium (HWE) for rs4988235 genotypes was observed in several European countries, indicating potential population-specific influences on genotype distribution.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "GENETIC DEVIATION FROM HWE"}, {"entity_type": "DIETARY PATTERN", "description": "Individuals with the LP allele have higher dietary intake of dairy products such as milk and milk beverages, but not other dairy products.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "DIETARY INTAKE OF DAIRY PRODUCTS"}, {"entity_type": "DIETARY PATTERN", "description": "The genotype rs4988235 is also associated with altered intakes of non-dairy foods such as potatoes and cereal products.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "INTAKE OF NON-DAIRY FOODS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Although not statistically significant, plasma C17:0 levels show a trend similar to C15:0 levels in relation to the LP genotype.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "PLASMA C17:0 LEVELS"}, {"entity_type": "DISEASE RISK FACTOR", "description": "The rs4988235 genotype is associated with lower HDL cholesterol levels, contributing to diabetes risk factors.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "HDL CHOLESTEROL VARIABILITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The baseline HbA1c levels are not influenced by the LP genotype or milk intake, indicating no direct genetic link for glycemic control.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "BASELINE HBA1C LEVELS"}, {"entity_type": "NUTRIENT", "description": "A critical nutrient for fetal brain development, often insufficient in maternal diets.<SEP>Choline is an essential nutrient involved in many biological processes, including lipid metabolism and neurotransmitter synthesis.<SEP>Dietary choline intake is a nutrient crucial for fetal development and maternal health.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e<SEP>chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "CHOLINE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Heavy alcohol consumption during pregnancy can negatively impact fetal growth and neurodevelopment.<SEP>The process of consuming alcoholic beverages that is influenced by genetic factors such as CNR1 variation and medication treatments like olanzapine.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e<SEP>chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "ALCOHOL CONSUMPTION"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Maternal smoking, even at low levels, can affect fetal growth and development.<SEP>Smoking is an additional lifestyle factor that showed nominal associations with milk consumption in some populations, particularly the Czech Republic.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e<SEP>chunk-7a423a439657efc1126fb6a075919ea5", "id": "SMOKING"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Use of illicit drugs during pregnancy can have adverse effects on the fetus\'s health.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "ILLICIT DRUGS (METHAMPHETAMINE)"}, {"entity_type": "DISEASE", "description": "FASD is a group of conditions that can occur in a person whose mother drank alcohol during pregnancy.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FETAL ALCOHOL SPECTRUM DISORDERS (FASD)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of neurodevelopment and learning, particularly relevant to assessing effects of prenatal exposure to environmental factors.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "EYEBLINK CONDITIONING (EBC)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Gestation period refers to the time from conception until birth; it\'s crucial for fetal development.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "GESTATIONAL AGE (GA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of physical growth during pregnancy and early infancy, influenced by genetic and environmental factors.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "SOMATIC GROWTH"}, {"entity_type": "DISEASE", "description": "A condition characterized by poor fetal growth due to maternal alcohol consumption.<SEP>A condition where the fetus fails to grow adequately due to maternal alcohol consumption.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FETAL ALCOHOL GROWTH RESTRICTION (FAGR)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Indicates visual recognition memory function in infants, used as a measure of cognitive development.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "NOVELTY PREFERENCE SCORES IN FTII TEST"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The level of education among mothers can influence their understanding of health risks during pregnancy.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "MATERNAL EDUCATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "High perceived stress levels in pregnant women may affect fetal development and maternal well-being.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "PERCEIVED STRESS"}, {"entity_type": "DIETARY PATTERN", "description": "These measures indicate the cognitive abilities of participants, which may be influenced by dietary patterns.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "VERBAL AND NONVERBAL INTELLECTUAL COMPETENCE"}, {"entity_type": "NUTRIENT", "description": "The amount of calories consumed is a key indicator of nutritional status during pregnancy.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "CALORIC INTAKE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Maternal smoking habits can impact the health and growth of the fetus.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "CIGARETTES PER DAY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Use of methamphetamine during pregnancy poses significant risks to fetal development.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "METHAMPHETAMINE USE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The timing of initial clinical assessments is important for tracking gestational age and planning interventions.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "GESTATIONAL AGE AT BOOKING, SCREENING, OR RANDOMIZATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "This measure indicates the stage of pregnancy when treatment allocation occurs.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "WEEKS GESTATION AT RANDOMIZATION"}, {"entity_type": "DIETARY PATTERN", "description": "The length of time choline was supplemented during pregnancy is a key variable in assessing its impact.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "DURATION OF CHOLINE SUPPLEMENTATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The sex ratio can provide insights into the effects of interventions on fetal development.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "SEX OF INFANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Age at which infants are assessed for developmental milestones and neurodevelopmental outcomes.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "INFANT AGE AT ASSESSMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The percentage of conditioned responses observed during eyeblink conditioning sessions.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "PERCENT CRS IN EBC SESSIONS"}, {"entity_type": "DIETARY PATTERN", "description": "Adherence to the choline supplementation protocol correlates with neurodevelopmental outcomes measured by percent CRs.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "PROTOCOL ADHERENCE AND PERCENT CRS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Low birth weight is a measure of growth restriction often associated with poor pregnancy health.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "BIRTH WEIGHT (<2500 G)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measures indicating the physical dimensions of newborns, influenced by prenatal conditions.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "BIRTH SIZE AND PERCENTILES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The phenomenon where infants show improved growth rates after initial restriction, influenced by nutritional interventions.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "CATCH-UP GROWTH IN WEIGHT AND HEAD CIRCUMFERENCE"}, {"entity_type": "DIETARY PATTERN", "description": "A test used to assess visual recognition memory and processing speed in infants.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FAGAN TEST OF INFANT INTELLIGENCE (FTII)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Scores reflecting the ability of infants to recognize new stimuli, indicating cognitive development.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "NOVELTY PREFERENCE SCORES ON FTII TEST"}, {"entity_type": "DISEASE", "description": "Conditions resulting from prenatal alcohol exposure, affecting physical and neurodevelopmental outcomes.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FASD DIAGNOSIS (FETAL ALCOHOL SYNDROME (FAS), PARTIAL FETAL ALCOHOL SYNDROME (PFAS))"}, {"entity_type": "DISEASE", "description": "Fetal Alcohol Spectrum Disorders (FASD) is a range of conditions that can occur in a person whose mother drank alcohol during pregnancy.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "FASD"}, {"entity_type": "DISEASE", "description": "Partial Fetal Alcohol Syndrome (PFAS) involves some but not all diagnostic criteria for Fetal Alcohol Syndrome.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "PFAS"}, {"entity_type": "GENE", "description": "Phosphatidylethanolamine N-methyltransferase (PEMT) gene encodes a protein that catalyzes the conversion of phosphatidylethanolamine to phosphatidylcholine, an essential component in cell membranes.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "PEMT"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genetic variant within the PEMT gene associated with reduced choline synthesis capacity.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "RS12325817"}, {"entity_type": "P-VALUE", "description": "The p-value of 0.393 from the statistical test indicates that there is no statistically significant association between maternal dietary choline intake and FAS/PFAS outcomes.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "P=0.393"}, {"entity_type": "NUTRIENT", "description": "Maternal dietary intake of choline during pregnancy, which can impact infant health outcomes but did not show a significant difference in this study.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "CHOLINE INTAKE"}, {"entity_type": "STATISTICAL TEST RESULT", "description": "A statistical test result indicating no significant difference in FAS/PFAS diagnosis between the choline-treated arm and placebo arm.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "\u03a7\u00b2(1)=0.73"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Proper caloric intake is necessary to support adequate choline status during pregnancy.)", "entity_type": "UNKNOWN", "id": "CHOLINE STATUS"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Timing of initial assessments influences the feasibility and adherence to treatment protocols.)", "entity_type": "UNKNOWN", "id": "PROTOCOL ADHERENCE"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "The effectiveness of choline supplementation may vary based on gestational age at initiation.)", "entity_type": "UNKNOWN", "id": "CHOLINE SUPPLEMENTATION EFFECTIVENESS"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "The sex of the infant can influence growth patterns observed during gestation and after birth.)", "entity_type": "UNKNOWN", "id": "GESTATIONAL AGE AND SOMATIC GROWTH"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Higher adherence to choline supplementation protocols correlates with better neurodevelopmental outcomes, including catch-up growth patterns.)", "entity_type": "UNKNOWN", "id": "CATCH-UP GROWTH"}, {"source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "description": "The rs12325817 variant of the PEMT gene affects choline synthesis capacity and may alter maternal dietary requirements for adequate nutrition during pregnancy.", "entity_type": "UNKNOWN", "id": "PEMT GENE EXPRESSION"}, {"source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "description": "Mothers\' dietary choline intake status is an environmental factor that can significantly impact infant health outcomes, especially in relation to FASD risk.", "entity_type": "UNKNOWN", "id": "MATERNAL DIETARY STATUS"}, {"source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "description": "The study\'s findings suggest that maternal dietary choline status does not significantly impact the diagnosis of FAS or PFAS in infants.", "entity_type": "UNKNOWN", "id": "FAS/PFAS DIAGNOSIS"}, {"source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "description": "The study\'s findings suggest that maternal dietary choline status does not significantly impact the diagnosis of FAS or PFAS in infants.", "entity_type": "UNKNOWN", "id": "MATERNAL DIETARY CHOLINE STATUS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at rs10886471 is associated with intronic (CA)n repeats that play a role in gene splicing and are linked to the risk of prediabetes and T2DM.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "RS10886471 SNP"}, {"entity_type": "GENE", "description": "The GRK5 gene has intronic CA repeat sequences polymorphisms that influence its expression and are associated with prediabetes and T2DM risk.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "GRK5 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "An allele of the (CA)n repeats, (CA)17, is the most common in the NFG group and used as a reference for estimating association strength.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "(CA)17 ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "The (CA)16 allele is used as a reference in studies involving genomic variants related to T2DM and other blood glucose abnormalities.<SEP>The (CA)16 allele shows significantly higher frequencies in IFG, IGT, and T2DM groups compared to the NFG group, indicating increased risk of prediabetes and T2DM.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)16 ALLELE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition characterized by high blood glucose levels measured in the morning before eating, before diabetes is diagnosed.<SEP>A condition where fasting glucose is higher than normal but not high enough to be classified as diabetes; associated with increased risk of T2DM and genomic variants.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-44a871da300abc9be525b468f502f5cb", "id": "IMPAIRED FASTING GLUCOSE (IFG)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The highest pressure exerted on the walls of the arteries during heart contraction; increased in individuals with prediabetes and T2DM compared to those without abnormal glucose levels.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "SBP (SYSTOLIC BLOOD PRESSURE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The lowest pressure in the arteries when the heart is resting between beats; elevated in groups with impaired fasting glucose, glucose tolerance, and Type 2 Diabetes Mellitus compared to normal glucose-tolerant individuals.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "DBP (DIASTOLIC BLOOD PRESSURE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "A measure of blood sugar two hours after consuming a meal; increases in individuals with impaired glucose tolerance and Type 2 Diabetes Mellitus compared to those without abnormal glucose levels.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "2H PG (2-HOUR POSTPRANDIAL GLUCOSE)"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphisms within the GRK5 gene involving CA repeat sequences that influence genetic predisposition towards prediabetes and T2DM.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 22}]", "id": "GRK5 (CA)N REPEATS"}, {"entity_type": "DISEASE", "description": "Type 2 Diabetes Mellitus (T2DM) is a chronic disease characterized by high blood sugar levels over an extended period.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "T2DM"}, {"entity_type": "GENOMIC VARIANT", "description": "(CA)n alleles are genomic variants that have been studied in relation to the risk of developing T2DM, IFG, and IGT conditions.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)N ALLELES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Impaired Fasting Glucose (IFG) is a condition characterized by higher than normal fasting blood glucose levels but not high enough to be classified as diabetes.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "IFG (IMPAIRED FASTING GLUCOSE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Impaired Glucose Tolerance (IGT) refers to a condition where the body\'s ability to handle glucose is diminished, yet it does not meet the criteria for full-blown diabetes.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "IGT (IMPAIRED GLUCOSE TOLERANCE)"}, {"entity_type": "GENOMIC VARIANT", "description": "These multiple alleles are classified together as a single variant in studies examining their association with IFG, IGT, and T2DM.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)15, (CA)17, (CA)18, (CA)19 ALLELES"}, {"entity_type": "DIETARY PATTERN", "description": "The NFG group refers to individuals with Normal Fasting Glucose, used as a control in studies comparing different dietary patterns and their impact on blood glucose levels.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "NFG GROUP"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "Polymorphisms within GRK5\'s CA repeat sequences are linked with higher postprandial glucose levels in individuals moving from normal glucose tolerance to IGT and T2DM, suggesting a genetic component in impaired glucose metabolism.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 22}]", "id": "2H PG"}, {"source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "description": "The multiple alleles (excluding (CA)16) show a significant negative correlation with IFG, indicating a protective effect against this condition.", "entity_type": "UNKNOWN", "id": "IFG"}, {"source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "description": "There is a significant negative association between the studied alleles and IGT, suggesting these variants reduce the risk of impaired glucose tolerance.", "entity_type": "UNKNOWN", "id": "IGT"}, {"source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "description": "The (CA)15, (CA)17, (CA)18, and (CA)19 alleles are classified together as a multiple allele in contrast to the reference (CA)16 allele.", "entity_type": "UNKNOWN", "id": "(CA)N ALLELES"}, {"source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "description": "The NFG group serves as the control for comparing against groups with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and Type 2 Diabetes Mellitus (T2DM).", "entity_type": "UNKNOWN", "id": "IFG, IGT, T2DM GROUPS"}, {"source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "description": "The odds ratio is used to measure the association between specific alleles (such as (CA)n variants) and the risk of developing conditions like Type 2 Diabetes Mellitus.", "entity_type": "UNKNOWN", "id": "(CA)N ALLELES, T2DM"}, {"source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "description": "The odds ratio is used to measure the association between specific alleles (such as (CA)n variants) and the risk of developing conditions like Type 2 Diabetes Mellitus.", "entity_type": "UNKNOWN", "id": "OR"}, {"entity_type": "NUTRIENT", "description": "Selenium is a trace element that plays a role in various physiological processes and can be found in supplements and dietary sources.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "SELENIUM"}, {"entity_type": "DISEASE", "description": "A disease characterized by the growth of cancer cells in the colon or rectum, influenced by genetic and environmental factors.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "COLORECTAL CANCER"}, {"entity_type": "GENE", "description": "The GPX4 gene encodes glutathione peroxidase 4, an enzyme involved in antioxidant defense mechanisms against reactive oxygen species (ROS).", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "GPX4 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) located within the GPX4 gene associated with colorectal cancer risk.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "RS8178974"}, {"entity_type": "DRUG", "description": "Nonsteroidal anti-inflammatory drugs used to manage pain and inflammation, which did not show significant association with colorectal cancer in this study.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "NSAIDS"}, {"entity_type": "THERAPY", "description": "The use of hormone replacement therapy among postmenopausal women; lower usage was observed in cases compared to controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "POSTMENOPAUSAL HORMONE USE"}, {"entity_type": "NUTRIENT", "description": "Intake of calcium was found to be lower in colorectal cancer cases than in controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 30}]", "id": "CALCIUM INTAKE"}, {"entity_type": "NUTRIENT", "description": "Intake of dietary fiber was also found to be lower in cases compared to controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 30}]", "id": "DIETARY FIBER INTAKE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Higher smoking rates were observed in cases compared to controls, indicating an association with increased risk of colorectal cancer.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "SMOKING HABIT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A comprehensive analysis that summarizes the findings from multiple studies, suggesting a protective effect of selenium against colorectal tumor development.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "META-ANALYSIS RESULTS"}, {"entity_type": "STUDY DESIGN", "description": "An observational cohort study within the Women\'s Health Initiative (WHI) that investigates risk factors and outcomes related to colorectal cancer among women.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "WHI OBSERVATIONAL STUDY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The concentration of selenium in participants\' blood serum, found not to be significantly associated with colorectal cancer risk.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "SERUM SELENIUM CONCENTRATION"}, {"entity_type": "DISEASE", "description": "A benign tumor that is a precursor lesion to colorectal cancer; the meta-analysis showed stronger inverse associations between selenium and adenomas compared to cancers.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "COLORECTAL ADENOMA"}, {"source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "description": "Both selenium and calcium intakes were noted to differ between cases of colorectal cancer and controls, indicating possible nutritional influences on disease susceptibility.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 30}]", "id": "SELENIUM INTAKE"}, {"entity_type": "GENE", "description": "The CARD9 gene plays a critical role in shaping the bacterial and fungal gut microbiota, particularly in controlling fungal microbiota expansion in colitis.<SEP>The Card9 gene plays a role in regulating the immune response and susceptibility to DSS-induced colitis.<SEP>The Card9 gene plays a role in the immune response and recovery from colitis induced by dextran sulfate sodium.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "CARD9 GENE"}, {"entity_type": "TRANSCRIPT", "description": "The transcriptome of wild-type (WT) mice shows a different response to colitis compared to Card9\u2212/\u2212 mice, with differences in immune-related pathways and cell proliferation genes.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "WT MICE TRANSCRIPTOME"}, {"entity_type": "GENE", "description": "Reg3g encodes REGIII-\u03b3 protein which is induced by IL-22 and plays a role in the antimicrobial response during colitis recovery.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "REG3G GENE"}, {"entity_type": "GENE", "description": "Reg3b gene expresses the REGIII-\u03b2 protein, involved in the immune defense against pathogens during colitis recovery.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "clusters": "[{level: 0, cluster: 2}]", "id": "REG3B GENE"}, {"entity_type": "GENE", "description": "Interleukin 1 beta (Il1b) is induced and plays a role in inflammatory responses related to colitis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "IL1B GENE"}, {"entity_type": "PROTEIN", "description": "IL-22 protein mediates recovery from DSS-induced colitis through induction of antimicrobial proteins such as REGIII-\u03b3 and REGIII-\u03b2.<SEP>Interleukin-22 (IL-22) is involved in promoting local IL-22 production and contributes to protection against intestinal inflammation.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 2}]", "id": "IL-22 PROTEIN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "DSS is a chemical used to induce colitis in experimental models by damaging the colon\'s epithelial layer.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "DEXTRAN SULFATE SODIUM (DSS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The fungal microbiota composition differs between WT and Card9\u2212/\u2212 mice, with increased instability in Card9\u2212/\u2212 mice during colitis induction.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "FUNGAL MICROBIOTA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Baseline bacterial microbiota differences exist between WT and Card9\u2212/\u2212 mice, and stability is compromised more in Card9\u2212/\u2212 mice during DSS-induced colitis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "BACTERIAL MICROBIOTA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Colitis induced by Dextran Sulfate Sodium (DSS), a condition characterized by inflammation of the colon.<SEP>DSS-induced colitis is a model of inflammatory bowel disease used to study immune responses in mice.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "DSS-INDUCED COLITIS"}, {"entity_type": "PROTEIN", "description": "Ki67 protein is a marker for cell proliferation and its staining decreases in Card9\u2212/\u2212 mice indicating reduced epithelial cell proliferation during DSS-induced colitis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "KI67 PROTEIN"}, {"entity_type": "PROTEIN", "description": "Cleaved caspase 3 is an indicator of apoptosis, which increases in Card9\u2212/\u2212 mice during DSS-induced colitis, suggesting increased cell death.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CASPASE 3"}, {"entity_type": "PROTEIN", "description": "IL-17A protein acts in concert with IL-22 to provide a protective role during DSS-induced colitis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "IL-17A PROTEIN"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of Reg3g gene is induced and differentially expressed between Card9\u2212/\u2212 and WT mice, indicating its role in immune response during colitis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "REG3G TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of Reg3b gene is induced and differentially expressed between Card9\u2212/\u2212 and WT mice, indicating its role in immune response during colitis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "REG3B TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of Il1b gene is upregulated in the colon tissue of mice during DSS-induced colitis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "IL-1BETA TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "Colonic expression of Il22 decreases on day 12 in Card9\u2212/\u2212 mice, suggesting a diminished immune response.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "IL22 TRANSCRIPT"}, {"entity_type": "PROTEIN INTERACTION", "description": "Cells expressing NKp46 protein have altered proportions and activity levels between WT and Card9\u2212/\u2212 mice during DSS-induced colitis, indicating their role in immune responses.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "clusters": "[{level: 0, cluster: 2}]", "id": "NKP46+ CELLS"}, {"entity_type": "CELL TYPE", "description": "This subset of cells decreases on day 12 in Card9\u2212/\u2212 mice compared to WT mice, highlighting the importance of CARD9 and IL-22 in mediating immune responses.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CD3\u2212CD4\u2212NKP46\u2212 SUBSET"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The community of microorganisms living in the gastrointestinal tract, which can influence tryptophan metabolism and AHR activation.<SEP>The gut microbiota refers to the collection of microorganisms residing in the gastrointestinal tract. It plays a crucial role in health and disease, particularly influencing immune responses and intestinal homeostasis.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "GUT MICROBIOTA"}, {"entity_type": "GENE", "description": "IL-22 is an inflammation-associated gene that encodes for IL-22 protein, which mediates innate antimicrobial resistance in the gut and contributes to mucosal healing during colitis recovery.<SEP>The IL-22 gene contains two polymorphisms (rs1179251 C/G and rs2227485 C/T) investigated for their influence on the susceptibility of colorectal cancer development.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-22 GENE"}, {"entity_type": "PROTEIN", "description": "A population of immune cells located within the epithelium, including those that produce IL-22 and IL-17.<SEP>These are immune cells found within the epithelial lining of various tissues including the gut. They contribute to immune responses but were not altered in IL-22 production between WT and Card9\u2212/\u2212 mice.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6<SEP>chunk-29025895ac187b8e88dec5cea9478842", "id": "INTRAEPITHELIAL \u0393\u0394 T CELLS"}, {"entity_type": "PROTEIN", "description": "T helper 22 (TH22) cells are a subset of CD4+ T cells that produce interleukin-22 (IL-22). They contribute to mucosal barrier integrity and repair. IL-22 production by TH22 cells was decreased in Card9\u2212/\u2212\u2192GF mice.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "TH22 CELLS"}, {"entity_type": "PROTEIN", "description": "A group of immune cells that include ILC1, ILC2, and ILC3 subtypes. They play roles in immunity and inflammation without undergoing antigen-specific selection. The study indicates a decrease in IL-22 production by NKp46+ ILCs in Card9\u2212/\u2212\u2192GF mice.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "INNATE LYMPHOID CELLS (ILCS)"}, {"entity_type": "PROTEIN", "description": "Immune cells that are part of the innate immune system and can kill virus-infected or tumor cells. In this context, no difference was observed in IL-22 production by NKp46+ ILCs between Card9\u2212/\u2212\u2192GF mice and WT controls.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "NATURAL KILLER (NK) CELLS"}, {"entity_type": "GENE", "description": "These genes encode for regenerating islet-derived proteins (REG) 3G and REG3B, which are involved in innate immunity. Their expression levels were reduced in Card9\u2212/\u2212\u2192GF mice compared to WT controls.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "REG3G AND REG3B GENES"}, {"entity_type": "PROTEIN", "description": "A cytokine produced by immune cells including TH17 and ILCs, involved in mucosal homeostasis. The study highlights decreased IL-22 expression levels in Card9\u2212/\u2212\u2192GF mice compared to WT controls.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "INTERLEUKIN-22 (IL-22)"}, {"entity_type": "PROTEIN", "description": "A cytokine that plays a role in inflammation and immune responses. No differences were observed in the amounts of IL-6 between Card9\u2212/\u2212\u2192GF mice and WT controls.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "INTERLEUKIN-6 (IL-6)"}, {"entity_type": "PROPTOEN", "description": "An important cytokine involved in host defense against intracellular pathogens. In this context, no difference was observed in IFN-\u03b3 amounts between Card9\u2212/\u2212\u2192GF mice and WT controls.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "INTERFERON-GAMMA (IFN-\u0393)"}, {"entity_type": "PROTEIN", "description": "A cytokine that inhibits inflammation and promotes immune tolerance. No differences were noted in IL-10 levels between Card9\u2212/\u2212\u2192GF mice and WT controls.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "INTERLEUKIN-10 (IL-10)"}, {"entity_type": "GENE", "description": "A gene encoding an antimicrobial peptide involved in innate immunity. The expression of Defb1 was not altered in the context provided when comparing Card9\u2212/\u2212\u2192GF mice with WT controls.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "DEFENSIN BETA 1 (DEFB1) GENE"}, {"entity_type": "METABOLIC PATHWAY", "description": "The process through which tryptophan is metabolized into various products, such as kynurenine and indole derivatives.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "TRYPTOPHAN METABOLISM"}, {"entity_type": "GENE/PROTEIN", "description": "IDO1 gene encodes the enzyme responsible for catalyzing the first and rate-limiting step in tryptophan catabolism to kynurenine.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "IDO1 (INDOLEAMINE 2,3-DIOXYGENASE 1) GENE/PROTEIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "An intracellular receptor that mediates cellular responses to environmental factors, particularly dioxins and other xenobiotics, as well as tryptophan metabolites like indole-3-acetic acid.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 2}]", "id": "AHR (ARYL HYDROCARBON RECEPTOR)"}, {"entity_type": "MOLECULAR INTERACTION/NUTRIENT", "description": "Indoles are aromatic compounds derived from the amino acid tryptophan and can act as ligands for AHR, promoting local IL-22 production in the gut.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "clusters": "[{level: 0, cluster: 2}]", "id": "INDOLE DERIVATIVES (IAA)"}, {"entity_type": "NUTRIENT/METABOLITE", "description": "A metabolite of tryptophan produced via the action of IDO1 enzyme, involved in immune regulation and inflammation control.<SEP>A metabolite of tryptophan that increases in fecal samples from IBD patients, indicating defective AHR activation due to impaired gut microbiota metabolism.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842<SEP>chunk-c791a4e35844d642ba0c69774072f7cd", "id": "KYNURENINE (KYN)"}, {"entity_type": "ENVIRONMENTAL FACTOR/BACTERIA", "description": "Probiotic bacteria that can be used to rescue susceptibility to colitis by enhancing AHR activation and IL-22 production.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "LACTOBACILLUS STRAINS"}, {"entity_type": "PROTEIN", "description": "Interleukin-17 (IL-17) is a cytokine involved in promoting inflammation.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "IL-17 PROTEIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS/CELL TYPE", "description": "Immune cells in the intestine that play a role in producing IL-23 to stimulate IL-22-producing cells.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "INTESTINAL DENDRITIC CELLS/MACROPHAGES"}, {"entity_type": "PROTEIN", "description": "Interleukin-23 (IL-23) is involved in immune responses and stimulates the production of IL-22 by T cells and ILCs.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "IL-23 PROTEIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS/CELL TYPE", "description": "Immune cells similar to T-helper 17 and T-regulatory cells but are innate immune cells that produce cytokines like IL-22.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "ILC (INNATE LYMPHOID CELL)"}, {"entity_type": "MOLECULAR INTERACTION/DRUG", "description": "An agonist for the Aryl Hydrocarbon Receptor (AHR), used in experiments to activate AHR and reduce colitis severity.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "FECZ (6-FORMYLINDOLO(3,2-B)CARBAZOLE)"}, {"entity_type": "GENE", "description": "CARD9 is a gene involved in immune signaling pathways and susceptibility to colitis.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "CARD9"}, {"entity_type": "PROTEIN", "description": "Interleukin 22 (IL-22) is a cytokine involved in immune response, particularly in epithelial barrier integrity and protection against pathogens.<SEP>Interleukin-22 (IL-22) is a cytokine that plays a role in the production of AHR ligands by the gut microbiota.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-c791a4e35844d642ba0c69774072f7cd", "id": "IL-22"}, {"entity_type": "NUTRIENT", "description": "Tryptophan is an essential amino acid involved in tryptophan metabolism, which influences AHR activation and colitis susceptibility.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "TRYPTOPHAN"}, {"entity_type": "ENZYME/PROTEIN", "description": "Indoleamine 2,3-dioxygenase 1 (IDO1) is an enzyme that metabolizes tryptophan to produce Kynurenine (Kyn), affecting AHR activation.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "IDO1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of producing ligands for the Aryl Hydrocarbon Receptor (AHR), which are crucial for immune regulation and colitis resistance.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "AHR LIGAND PRODUCTION"}, {"entity_type": "ANIMAL MODEL", "description": "Knockout mice lacking CARD9 gene, used to study susceptibility to colitis due to impaired IL-22 signaling pathway and tryptophan metabolism.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "CARD9\u2212/\u2212 MICE"}, {"entity_type": "NUTRIENT/AHR LIGAND", "description": "An AHR agonist found in cruciferous vegetables, which can effectively counter defects in AHR activation observed in IBD patients.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "INDOLE-3-CARBINOL (I3C)"}, {"entity_type": "DISEASE", "description": "A chronic inflammatory condition of the gastrointestinal tract including Crohn\'s disease and ulcerative colitis, associated with impaired tryptophan metabolism and reduced AHR activity.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "INFLAMMATORY BOWEL DISEASE (IBD)"}, {"entity_type": "GENOMIC VARIANT", "description": "A single-nucleotide polymorphism in the CARD9 gene linked to increased susceptibility to inflammatory bowel disease by affecting AHR activation.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "GENOMIC VARIANT WITHIN CARD9 (RS10781499)"}, {"entity_type": "DISEASE", "description": "A form of inflammatory bowel disease (IBD) characterized by chronic inflammation of the gastrointestinal tract.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "CROHN\u2019S DISEASE"}, {"entity_type": "GENE", "description": "A gene associated with increased risk of developing Crohn\u2019s disease due to mutations leading to impaired innate immune response.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "NOD2 GENE"}, {"entity_type": "GENE", "description": "Autophagy-related 16-like 1 (ATG16L1) is a gene implicated in the development of inflammatory bowel diseases, particularly Crohn\u2019s disease.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "ATG16L1 GENE"}, {"entity_type": "GENE", "description": "Leucine-rich repeat kinase 2 (LRRK2) is another genetic variant associated with increased susceptibility to Parkinson\'s disease and may also influence IBD risk.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "LRRK2 GENE"}, {"entity_type": "BIOLOGICAL SAMPLE", "description": "Samples collected from the gastrointestinal tract of patients, used in this study to assess AHR activation by gut microbiota-produced metabolites.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "FECAL SAMPLES"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "In mice lacking CARD9 (Card9\u2212/\u2212\u2192GF), there is a significant downregulation of IL-22, which affects the immune response and mucosal repair during colitis recovery.", "entity_type": "UNKNOWN", "id": "CARD9\u2212/\u2212\u2192GF MICE"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "TH17 cells produce IL-17A, but in this context, there were no observed differences in IL-17 production between Card9\u2212/\u2212\u2192GF mice and WT controls.", "entity_type": "UNKNOWN", "id": "INTERLEUKIN-17A (IL-17A)"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "IDO1 mediates tryptophan metabolism into kynurenine, which is involved in immune regulation and can influence AHR activation.", "entity_type": "UNKNOWN", "id": "IDO1 GENE/PROTEIN"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Supplementation with Lactobacillus strains rescues AHR activation in Card9\u2212/\u2212 mice, suggesting their importance for gut health.", "entity_type": "UNKNOWN", "id": "AHR ACTIVATION"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "\u03b3\u03b4 T cells contribute to IL-22 production, which is involved in immune regulation and protection against intestinal inflammation.", "entity_type": "UNKNOWN", "id": "IL-22 PRODUCTION"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "Increased IDO1 activity promotes the production of Kynurenine from tryptophan, indicating defective AHR activation in inflammatory bowel disease (IBD).", "entity_type": "UNKNOWN", "id": "IDO1 ENZYME ACTIVITY"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "Increased IDO1 activity promotes the production of Kynurenine from tryptophan, indicating defective AHR activation in inflammatory bowel disease (IBD).", "entity_type": "UNKNOWN", "id": "KYNURENINE LEVELS"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "The risk allele within CARD9 is associated with reduced ability of fecal microbiota to activate AHR in vitro assays from patients with IBD.", "entity_type": "UNKNOWN", "id": "CARD9 GENOMIC VARIANT"}, {"entity_type": "PROTEIN", "description": "Beta-2-microglobulin (\u03b22M) is a protein that has been associated with hypertension.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "\u03922M"}, {"entity_type": "DISEASE", "description": "A condition characterized by persistently elevated blood pressure, which can contribute to cardiovascular disease and hyperuricemia risk.<SEP>Hypertension is a disease characterized by persistently high blood pressure.<SEP>Hypertension is adjusted for in the multivariate linear regression analysis, showing no significant effect on altering the relationship between daily alcohol intake and blood cortisol level.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "HYPERTENSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "SH2B3 expression is a physiological process that affects \u03b22M levels and hypertension risk.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "SH2B3 EXPRESSION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Angiotensin II is an environmental factor that induces hypertensive responses in mice.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "ANGIOTENSIN II"}, {"entity_type": "GENOMIC VARIANT", "description": "A cis genetic variation within the SH2B3 gene affects its expression and function, influencing \u03b22M levels and hypertension risk.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "CIS GENETIC VARIATION WITHIN SH2B3"}, {"entity_type": "BIOLOGICAL MODEL", "description": "The Sh2b3 knockout mouse model is used to study the effects of reduced SH2B3 function on \u03b22M expression and hypertensive responses.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "SH2B3\u2212/\u2212 MOUSE MODEL"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant associated with plasma \u03b22M levels and SH2B3 expression.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "GENOMIC VARIANT (RS3184504)"}, {"entity_type": "GENE", "description": "The SH2B3 gene encodes for the SH2B3 protein which is involved in regulating blood pressure and kidney function.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "SH2B3 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Albuminuria is a physiological process characterized by the presence of albumin in urine, indicating potential kidney damage.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "ALBUMINURIA"}, {"entity_type": "DIETARY PATTERN", "description": "A clinical model that includes baseline covariates such as age, sex, BMI, diabetes status, smoking habits, cholesterol levels, and blood pressure for predicting new-onset hypertension.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "CLINICAL MODEL"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9", "description": "Low eGFR indicates reduced kidney function, often seen in hypertensive patients.<SEP>The process by which the kidney regulates water and electrolyte balance, blood pressure, acid-base balance, waste products, etc.", "entity_type": "PHYSIOLOGICAL PROCESS", "id": "KIDNEY FUNCTION"}, {"source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "description": "The clinical model improves the prediction of new-onset hypertension when combined with \u03b22M levels.", "entity_type": "UNKNOWN", "id": "NEW-ONSET HYPERTENSION PREDICTION"}, {"entity_type": "GENOMIC VARIANT", "description": "An MTHFD1 single nucleotide polymorphism located at position rs2236224, associated with an increased risk of neural tube defects in infants when compared to the CC genotype in higher folate intake groups.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFD1 SNP RS2236224"}, {"entity_type": "GENOMIC VARIANT", "description": "An MTHFD1 single nucleotide polymorphism located at position rs2236225, associated with an increased risk of neural tube defects in infants when compared to the CC genotype in higher folate intake groups.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFD1 SNP RS2236225"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "An MTHFD1 single nucleotide polymorphism located at position rs11627387 with the AG genotype, associated with a significantly higher risk of neural tube defects when compared to infants with the GG genotype and high maternal folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFD1 SNP RS11627387 AG GENOTYPE"}, {"entity_type": "NUTRIENT (DIETARY PATTERN)", "description": "The daily dietary intake of folate is an important factor in reducing the risk of neural tube defects, showing differential effects based on genetic variations such as those found in MTHFD1 and other genes mentioned.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "FOLATE INTAKE"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the MTHFR gene at position rs1476413, where heterozygous mothers have a decreased risk of an NTD-affected pregnancy compared to common homozygous mothers when they have low folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFR SNP RS1476413"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the MTHFR gene at position rs1801131, where heterozygous mothers have a decreased risk of an NTD-affected pregnancy compared to common homozygous mothers when they have low folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFR SNP RS1801131"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the MTHFR gene at position rs1801133, where heterozygous mothers have a decreased risk of an NTD-affected pregnancy compared to common homozygous mothers when they have low folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFR SNP RS1801133"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the SHMT1 gene at position rs669340, where heterozygous mothers have a reduced risk of an NTD-affected pregnancy compared to those with the CC genotype.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SHMT1 SNP RS669340 CG"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the SHMT1 gene at position rs12939757, where infants have a higher risk of NTDs compared to those with the AA genotype when they are in the low folate intake group.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SHMT1 SNP RS12939757 AG"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the TYMS gene at position rs502396, associated with a reduced risk of NTDs for mothers in the low folate intake group when compared to those in the high folate intake group.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "TYMS SNP RS502396"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the TYMS gene at position rs699517, associated with a reduced risk of NTDs for mothers in the low folate intake group when compared to those in the high folate intake group.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "TYMS SNP RS699517"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the TYMS gene at position rs2847153 with the AG genotype, showing a protective interaction effect against NTDs for infants compared to those with the GG genotype when they are in high folate intake groups.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "TYMS SNP RS2847153 AG GENOTYPE"}, {"entity_type": "DISEASE", "description": "A birth defect resulting from abnormal development of the neural tube during gestation, influenced by genetic and environmental factors such as maternal folate intake and specific gene variants.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "NEURAL TUBE DEFECT (NTD)"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the MTHFR gene at position rs1801131 with the TT genotype, associated with an increased risk of neural tube defects when compared to the CT or CC genotypes in high folate intake groups.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFR SNP RS1801131 TT GENOTYPE"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the SHMT1 gene at position rs4997765 with the AA genotype, associated with a significantly higher risk of neural tube defects when compared to infants with the GG genotype and high maternal folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SHMT1 SNP RS4997765 AA GENOTYPE"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the TYMS gene at position rs2847153 with the CG genotype, showing a protective interaction effect against NTDs for infants compared to those with the GG genotype when they are in high folate intake groups.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "TYMS SNP RS2847153 CG GENOTYPE"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "An MTHFD1 single nucleotide polymorphism located at position rs6966057 with the AG genotype, associated with a significantly higher risk of neural tube defects when compared to infants with the GG genotype and high maternal folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFD1 SNP RS6966057 AG GENOTYPE"}, {"entity_type": "GENOMIC VARIANT (PROTEIN)", "description": "A single nucleotide polymorphism in the SHMT1 gene at position rs3787486 with the AA genotype, associated with a significantly higher risk of neural tube defects when compared to infants with the GG genotype and high maternal folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "SHMT1 SNP RS3787486 AA GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant located in the CHI3LI gene, found to have no significant association with Type 2 Diabetes (T2D) but shows a borderline protective association with Impaired Glucose Tolerance (IGT).", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "RS10399931"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the CHI3LI gene, found to have no significant association with Type 2 Diabetes (T2D) and other quantitative traits.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "RS4950928"}, {"entity_type": "GENE", "description": "The CHI3LI gene harbors several tgSNPs that were investigated for their potential associations with T2D but showed no significant linkage after adjustments for age, sex, BMI, and glucose tolerance.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "CHI3LI GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Quantitative traits associated with Type 2 Diabetes (T2D), including serum C-peptide concentration, which shows a borderline significant association with rs10399931.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "T2D QUANTITATIVE TRAITS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process measured as the level of serum C-peptide after 2 hours, showing a borderline significant association with genomic variant rs10399931.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "SERUM C-PEPTIDE CONCENTRATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A set of tag single nucleotide polymorphisms (tag SNPs) associated with the CHI3LI gene, which were analyzed for their association with Type 2 Diabetes (T2D) but showed no significant linkage after adjustments.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "TGSNPS OF CHI3LI"}, {"entity_type": "GENOMIC VARIANT", "description": "Two identified haplotype blocks within the CHI3LI gene that were studied for their potential associations with Type 2 Diabetes (T2D) but showed no significant linkage.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "HAPLOTYPE BLOCKS OF CHI3LI"}, {"source_id": "chunk-1327975b50e4a0aac1792cb595041ee5<SEP>chunk-44a871da300abc9be525b468f502f5cb", "description": "Body Mass Index (BMI) was multiadjusted and associated with T2D-related quantitative traits, though no significant associations were found.<SEP>The process of DNA replication and transcription is involved in the amplification and genotyping of CYP24A1 gene variants.", "entity_type": "PHYSIOLOGICAL PROCESS", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 22}]", "id": "PHYSIOLOGICAL PROCESS"}, {"entity_type": "GENOMIC VARIANT", "description": "The CFH Y402H risk allele is a genetic variant that increases the odds of developing AMD.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "CFH Y402H RISK ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "The A69S risk allele in ARMS2 gene increases the odds of developing AMD when combined with poor lifestyle scores.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "A69S RISK ALLELE (ARMS2)"}, {"entity_type": "GENOMIC VARIANT", "description": "Homogeneity for the G allele of rs641153 is associated with increased odds of AMD.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "RS641153 (CFB/C2) G ALLELE"}, {"entity_type": "DIETARY PATTERN", "description": "The HLS score reflects a healthy lifestyle and dietary pattern that influences risk factors for AMD, such as diet stability.<SEP>The healthy lifestyle score is a measure that includes dietary patterns and other health behaviors.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6<SEP>chunk-23a090455f50ab98c53e8b90941c6da5", "id": "HEALTHY LIFESTYLE SCORE (HLS)"}, {"entity_type": "DISEASE", "description": "A disease characterized by progressive damage to the macula, increasing the odds of developing with certain genetic variants like Y402H and A69S alleles.<SEP>Age-related macular degeneration is a condition that affects the central part of the retina, leading to loss of vision in older individuals.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6<SEP>chunk-23a090455f50ab98c53e8b90941c6da5", "id": "AGE-RELATED MACULAR DEGENERATION (AMD)"}, {"entity_type": "NUTRIENT", "description": "A dietary nutrient, omega-7 fatty acids, may influence PPAR\u03b3 activity through molecular interactions reducing inflammation.<SEP>A type of polyunsaturated fatty acid that can reduce triglyceride levels when consumed as part of a fat-restricted diet, showing promising results in managing hypertriglyceridemia.<SEP>Omega-3 fatty acids are nutrients that were explored for their role in explaining the association between HLS and AMD but found not to influence interaction terms.", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f<SEP>chunk-23a090455f50ab98c53e8b90941c6da5<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "OMEGA-3 FATTY ACIDS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process involving low intake of lutein and zeaxanthin which was adjusted for in analyses with HLS and AMD risk, potentially explaining some associations.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "LOW/LOW LZ (LUTEIN/ZEAXANTHIN)"}, {"entity_type": "NUTRIENT", "description": "Intake of LZ nutrients is a factor explored to explain the association between HLS and AMD risk in high genetic risk individuals.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "DIETARY INTAKE OF LUTEIN/ZEAXANTHIN (LZ)"}, {"entity_type": "GENE", "description": "The CFH gene harbors the Y402H variant which is associated with increased risk of AMD.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "CFH GENE"}, {"entity_type": "GENE", "description": "The ARMS2 gene contains the A69S allele, a genetic variant linked to an increased risk of developing AMD.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "ARMS2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in C3 did not show main effect within CAREDS study, but was mentioned as a gene of interest.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "C3 (COMPLEMENT COMPONENT 3)"}, {"entity_type": "GENE", "description": "The CFI gene does not have a main effect on AMD risk within the CAREDS dataset.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "CFI GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the CFI gene did not show an impact on AMD risk as observed in CAREDS study.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "RS10033900 (CFI)"}, {"entity_type": "DIETARY PATTERN", "description": "Levels of dietary intake of lutein and zeaxanthin (LZ) were explored for their role in explaining the association between HLS and AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "LUTEIN AND ZEAXANTHIN INTAKE LEVELS"}, {"entity_type": "GENOMIC VARIANT", "description": "The ARMS2 genotype refers to genetic variations within the ARMS2 gene, which are associated with increased risk for age-related macular degeneration.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "ARMS2 GENOTYPE"}, {"entity_type": "GENE", "description": "These genes encode proteins involved in the complement pathway of the immune system, which is implicated in several diseases including AMD.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "COMPLEMENT PATHWAY GENES (CFB/C2, C3, AND CFI)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "The Synergy Index is a measure used to determine whether the combined effect of two factors (such as genetic risk and lifestyle) is more than additive or less than expected multiplicatively.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "SYNERGY INDEX (SI)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/STATISTICAL MEASURE", "description": "Odds ratio is a statistical tool used in epidemiology to quantify the strength of an association between a variable and a disease, reflecting how much higher the odds are for those with versus without exposure to risk factors.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "ODDS RATIO (OR)"}, {"entity_type": "GENE", "description": "These genes encode proteins involved in the complement pathway, which plays a role in immune response and inflammation, potentially influencing disease susceptibility including AMD.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "COMPLEMENT PATHWAY GENES (CFB/C2)"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2230199 is a single nucleotide polymorphism (SNP) located within the complement pathway gene C3, which may influence risk for age-related macular degeneration.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "SNP C3 RS2230199"}, {"entity_type": "GENOMIC VARIANT", "description": "rs10033900 is a single nucleotide polymorphism (SNP) located within the complement pathway gene CFI, which may influence risk for age-related macular degeneration.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "SNP CFI RS10033900"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "The A69S risk allele in ARMS2 gene increases odds for AMD when combined with poor lifestyle scores.", "entity_type": "UNKNOWN", "id": "AMD"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "Adjusting for low dietary intake of lutein and zeaxanthin attenuates the association between HLS and AMD risk in women with high genetic risk.", "entity_type": "UNKNOWN", "id": "AMD RISK IN HIGH GENETIC RISK WOMEN"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "Intake of omega-3 fatty acids does not influence the interaction terms explaining HLS and AMD risk.", "entity_type": "UNKNOWN", "id": "OMEGA-3 FATTY ACIDS INTAKE"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "The ARMS2 gene harbors an A69S allele that increases AMD risk when combined with poor lifestyle scores.", "entity_type": "UNKNOWN", "id": "A69S ALLELE"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "While C3 does not show a main effect, it\'s considered in the context of other genetic factors influencing AMD risk.", "entity_type": "UNKNOWN", "id": "CFH AND ARMS2 GENES"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "Higher dietary intake levels of lutein and zeaxanthin can partially explain some associations between HLS and AMD risk in high genetic risk individuals.", "entity_type": "UNKNOWN", "id": "LUTEIN/ZEAXANTHIN INTAKE LEVELS"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "CFI gene status does not interact significantly with Y402H variant in CFH to influence AMD risk as much as other factors like HLS.", "entity_type": "UNKNOWN", "id": "Y402H VARIANT IN CFH GENE"}, {"source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "description": "Variants in the complement pathway genes are associated with the risk of AMD through their role in immune response and inflammation.", "entity_type": "UNKNOWN", "id": "COMPLEMENT PATHWAY GENES (CFB/C2, C3, CFI)"}, {"entity_type": "GENE", "description": "A gene located at one of the genomic variants identified in the GWAS related to habitual coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "HECTD4 GENE"}, {"entity_type": "GENE", "description": "A gene located at one of the genomic variants identified in the GWAS associated with habitual coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "ACAD10 GENE"}, {"entity_type": "GENE", "description": "A gene located at one of the genomic variants found to be significant in the study on habitual coffee intake.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "MYL2 GENE"}, {"entity_type": "GENE", "description": "A gene situated at a significant SNP identified through GWAS for habitual coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "CUX2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "One of the three genotyped SNPs found to be highly correlated and relevant to habitual black coffee intake.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "SNP RS2074356"}, {"entity_type": "GENOMIC VARIANT", "description": "Another one of the three genotyped SNPs considered as coffee-related genetic variants in the GWAS study.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "SNP RS11066015"}, {"entity_type": "GENOMIC VARIANT", "description": "A third genotyped SNP identified to be associated with habitual black coffee consumption and used for calculating genetic risk scores.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "SNP RS12229654"}, {"entity_type": "GENOMIC VARIANT", "description": "An imputed SNP selected as a key variant in relation to habitual coffee consumption based on high correlation with genotyped SNPs.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "SNP RS11065828"}, {"entity_type": "GENOMIC VARIANT", "description": "Another imputed SNP chosen for genetic risk score calculations due to its strong association with habitual coffee intake.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "SNP RS79105258"}, {"entity_type": "DISEASE", "description": "An intermediate state of glucose metabolism characterized by elevated blood sugar levels but not high enough for a diabetes diagnosis, linked to habitual coffee intake.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "PREDIABETES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The habit of drinking coffee regularly was found to influence the risk of developing type 2 diabetes and prediabetes over time.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "COFFEE CONSUMPTION"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern associated with a reduced risk of prediabetes and type 2 diabetes compared to non-consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "BLACK COFFEE INTAKE"}, {"entity_type": "DIETARY PATTERN", "description": "An additional dietary habit linked to lower risks of developing prediabetes and type 2 diabetes in the study.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "SUGARED COFFEE CONSUMPTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A calculated score based on genetic variants influencing coffee consumption and risk for prediabetes/type 2 diabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "GENETIC RISK SCORES"}, {"entity_type": "GENE", "description": "A gene located at a genomic variant identified in GWAS for habitual coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "PRDM16 GENE"}, {"entity_type": "GENE", "description": "A gene situated near one of the significant SNPs associated with habitual black and sugared coffee intake.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "GCKR GENE"}, {"entity_type": "GENE", "description": "Located at a genomic variant linked to both black and sugared coffee consumption in GWAS studies.<SEP>The HLA-DQB1 gene, along with the HLA-DRB1 gene, forms haplotypes important for immune responses and disease susceptibility.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b<SEP>chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA-DQB1 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The frequency of an allele within a population can influence genetic risk factors for diseases such as type 2 diabetes.", "source_id": "chunk-b803830d07bff8ae14550f6458048707", "id": "ALLELE FREQUENCY"}, {"entity_type": "GENE", "description": "SENP1 gene plays a critical role in regulating inflammation and diabetes through its expression in adipocytes.<SEP>SENP1 is a gene that regulates the activation of NF-\u03baB and cytokine production in adipocytes.<SEP>SENP1 is a gene whose expression levels are associated with the progression of type 1 diabetes and immune cell infiltration.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-8382a49b61215482f9fc75e3a86cb987", "id": "SENP1"}, {"entity_type": "GENOMIC VARIANT", "description": "An adipocyte-specific deletion of the SENP1 gene was introduced into mice to investigate the function of SENP1 in inflammation and diabetes.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "ADIPOCYTE-SPECIFIC DELETION OF SENP1"}, {"entity_type": "TRANSCRIPT", "description": "Specific Cre recombinase-driven promoters (Adipoq, PdgfR\u03b1, and aP2/Fabp4) were used to generate adipocyte-specific SENP1 knockout mice.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "ADIPOQ-CRE, PDGFR\u0391-CRE, AP2/FABP4-CRE"}, {"entity_type": "PROTEIN", "description": "The protein product of the SENP1 gene was reduced in isolated adipocytes from different fat tissues but not in macrophages or pancreatic islets.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "SENP1 PROTEIN"}, {"entity_type": "DISEASE", "description": "SENP1-deficient mice exhibit a type-1-like diabetic phenotype characterized by high blood glucose levels and reduced insulin secretion.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "DIABETES MELLITUS, TYPE 1 (T1DM)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Increased age-dependent glucose levels were observed in SENP1-deficient mice compared to controls, indicating the development of diabetes.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "GLUCOSE LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Plasma insulin levels decline with increasing age in SENP1-AdipoqKO and SENP1-aP2KO mice.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "INSULIN LEVELS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "GTT showed prolonged hyperglycaemia in SENP1-deficient mice compared to control mice, indicating impaired glucose tolerance.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "GLUCOSE TOLERANCE TEST (GTT)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "ITT revealed no significant difference between SENP1-deficient and control mice, suggesting normal insulin responsiveness despite the diabetic phenotype.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "INSULIN TOLERANCE TEST (ITT)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glucose-stimulated insulin secretion from islets was significantly reduced in SENP1-deficient mice compared to controls.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "GLUCOSE-STIMULATED INSULIN SECRETION"}, {"entity_type": "DISEASE", "description": "Damages caused by the body\'s immune system attacking its own tissues, particularly in the context of diabetes mellitus.<SEP>SENP1 deficiency leads to autoimmune-mediated damage, likely contributing to the development of diabetes mellitus type 1.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "id": "AUTOIMMUNE MEDIATED DAMAGES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Diabetes in SENP1-deficient mice is associated with T-cell mediated destruction of pancreatic \u03b2 cells.<SEP>The process by which activated cytotoxic T cells attack and destroy insulin-producing pancreatic islet \u03b2 cells in Type 1 Diabetes Mellitus (T1DM).", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "id": "T-CELL-MEDIATED DESTRUCTION"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific knockout variant of the SENP1 gene in mice with adipocyte-specific deletion driven by Adipoq-Cre.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "SENP1-ADIPOQKO"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific knockout variant of the SENP1 gene in mice with adipocyte-specific deletion driven by PdgfR\u03b1-Cre.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "SENP1-PDGFR\u0391KO"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant associated with alterations in peri-pancreatic adipocyte function and increased cytokine production.<SEP>A specific knockout variant of the SENP1 gene in mice with adipocyte-specific deletion driven by aP2/Fabp4-Cre.<SEP>SENP1-aP2KO is a genetic model where the SENP1 gene interacts with aP2 knockout leading to altered adipose tissue characteristics and metabolic phenotypes.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-174831b97ed170039b374ba254d4f506", "id": "SENP1-AP2KO"}, {"entity_type": "TRANSCRIPT", "description": "Specific transcript associated with the deletion of SENP1 in smooth muscle cells and pericytes using SM22\u03b1-Cre.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "SMOOTH MUSCLE CELLS/PERICYTES (SM22\u0391-CRE)"}, {"entity_type": "TRANSCRIPT", "description": "Specific transcript associated with the deletion of SENP1 in vascular endothelial cells using VE-cadherin-Cre.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "VASCULAR ENDOTHELIAL CELLS (VE-CADHERIN-CRE)"}, {"entity_type": "DIETARY PATTERN", "description": "Gene promoters used to drive Cre recombinase expression for adipocyte-specific deletion of SENP1 gene.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "ADIPONECTIN, PDGFR\u0391, AP2/FABP4 GENE PROMOTER"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Tissue where SENP1 expression was diminished in isolated adipocytes from SENP1-deficient mice.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "INTERSCAPULAR BROWN ADIPOSE TISSUE (IBAT)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Tissue where SENP1 expression was decreased leading to glucose intolerance and insulin resistance.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "WHITE ADIPOSE TISSUE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Reduced body weight in SENP1-deficient mice compared with control mice after the onset of diabetes.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "BODY WEIGHT AND BODY MASS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Normal lipid profiles up to 14 weeks in SENP1-deficient mice but slightly reduced cholesterol and TG levels after age of 18 weeks.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "CHOLESTEROL, LOW-DENSITY LIPOPROTEIN (LDL), HIGH-DENSITY LIPOPROTEIN (HDL), TRIGLYCERIDE (TG), FREE FATTY ACID (FFA)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Increased water consumption with similar food intake observed in SENP1-aP2KO mice compared to control mice.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "WATER CONSUMPTION, FOOD INTAKE"}, {"entity_type": "GENE", "description": "The SENP1 gene is responsible for producing the SENP1 protein which, when deficient, can lead to type-1-like diabetic phenotypes.<SEP>The SENP1 gene plays a critical role in regulating cytokine production and autoimmune responses observed in mice.<SEP>The SENP1 gene plays a critical role in the regulation of cytokine production and autoimmune responses observed in mice.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "id": "SENP1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant leading to adipocyte-specific deficiency of the SENP1 gene contributes to the development of autoimmune-mediated damages and diabetes mellitus in mice.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "ADIPOCYTE-SPECIFIC SENP1 DEFICIENCY"}, {"entity_type": "DISEASE", "description": "A disease characterized by T-cell mediated destruction of insulin-producing pancreatic islet \u03b2 cells leading to a loss of functional \u03b2 cells and autoimmunity.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "INSULIN-DEPENDENT DIABETES MELLITUS (TYPE 1)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process involving the destruction of pancreatic islet \u03b2 cells due to autoimmune attack leading to type 1 diabetes mellitus (T1DM).", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "\u0392-CELLS AND ISLETS DESTRUCTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The production of autoantibodies targeting insulin and \u03b2 cells in the pre-diabetic phase preceding T1DM.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "AUTOANTIBODIES, INSULIN AUTOANTIBODY (IAA)"}, {"entity_type": "CLINICAL PARAMETER", "description": "Levels of beta-hydroxybutyrate, a ketone produced when the body loses its ability to absorb glucose properly, are elevated in individuals who develop diabetes.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "BETA-HYDROXYBUTYRATE LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The characterization of immune cell populations and responses in SENP1-deficient mice, including skin transplantation studies to assess immune function.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "IMMUNE SYSTEM CHARACTERIZATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Insulin-producing cells located within pancreatic islets that are targeted and destroyed by T-cells in Type 1 Diabetes Mellitus (T1DM).", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "PANCREATIC ISLET \u0392 CELLS"}, {"entity_type": "DISEASE CONDITION", "description": "The infiltration of immune cells into the pancreatic islet \u03b2 cells, causing inflammation and destruction.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "INSULITIS"}, {"entity_type": "PROTEIN", "description": "A subset of T cells that recognize antigens presented by HLA class I molecules and play a crucial role in the adaptive immune system\'s cytotoxic function.<SEP>A type of cytotoxic T cell that plays a crucial role in attacking and destroying infected or abnormal cells, including pancreatic \u03b2 cells in T1DM.<SEP>A type of immune cell involved in directly killing infected or cancerous cells. Differential splicing and gene expression are detectable in CD8+ T cells.<SEP>CD8+ T cells are cytotoxic T lymphocytes that destroy virus-infected or cancerous cells by releasing perforin and granzyme, leading to apoptosis of target cells.<SEP>Cytotoxic T lymphocytes responsible for direct destruction of virus-infected or cancerous cells, modulated by gene expression changes.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "id": "CD8+ T CELLS"}, {"entity_type": "CELL TYPE", "description": "A type of immune cell involved in regulating immune responses. These cells can be influenced by genetic variants leading to differential gene expression.<SEP>CD4+ T cells are immune cells that play critical roles in regulating adaptive immunity, including differentiation into distinct subsets such as na\u00efve, memory, and regulatory (Treg) cells.<SEP>Helper T cells that play a regulatory role in the immune system by activating other immune cells and are involved in autoimmune responses.<SEP>CD4+ T cells, also known as helper T cells, assist other immune cells during an immune response. They produce cytokines involved in the activation of B cells and macrophages.<SEP>T helper cells that play a central role in the immune response by regulating other cell types through cytokine secretion and cell surface interactions.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "id": "CD4+ T CELLS"}, {"entity_type": "PROTEIN", "description": "Subsets of helper T cells that promote inflammation and contribute to the autoimmune response seen in type 1 diabetes mellitus.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "TH1 (IFN-\u0393+CD4+) AND TH17 (IL-17+CD4+) EFFECTOR T CELLS"}, {"entity_type": "PROTEIN", "description": "A subset of CD4+ T cells involved in maintaining immune tolerance by suppressing activation of other immune cells, their reduction contributes to autoimmunity.<SEP>Tregs are a subset of T cells whose numbers and function may be reduced over time in STAT5B deficient patients due to impaired FOXP3 expression maintenance.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "id": "REGULATORY T CELLS (TREGS)"}, {"entity_type": "PROTEIN", "description": "Dendritic cells that have been activated and are capable of presenting antigens to T-cells, initiating an immune response.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "ACTIVATED DENDRITIC CELLS"}, {"entity_type": "PROTEIN", "description": "Specific type of cytotoxic T cells targeting a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), involved in autoimmune responses against pancreatic \u03b2-cells.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "NRP-V7-POSITIVE CD8+ T CELLS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These cells target a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein, indicating an involvement in autoimmune response against pancreatic \u03b2-cells.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "NRP-V7 POSITIVE CD8+ T CELLS"}, {"entity_type": "PROTEIN", "description": "This protein is the target of autoantigen NRP-V7 positive CD8+ T cells, indicating its role in autoimmune response.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "ISLET-SPECIFIC GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PROTEIN (IGP1)"}, {"entity_type": "DISEASE", "description": "An autoimmune disease characterized by immunological destruction of pancreatic \u03b2-cells leading to insulin deficiency.<SEP>An autoimmune disease in which the immune system destroys insulin-producing beta cells in the pancreas leading to high blood sugar levels.<SEP>Autoimmune disease characterized by the destruction of insulin-producing beta cells in the pancreas.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "TYPE 1 DIABETES MELLITUS (T1DM)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These cytokines are significantly elevated in the SENP1-deficient mice before diabetes onset, suggesting a role in initiating autoimmune responses.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PROINFLAMMATORY CYTOKINES IL-6, TNF-\u0391 AND IL-1\u0392"}, {"entity_type": "TISSUE", "description": "Produces high levels of proinflammatory cytokines to induce local pancreatic inflammatory response and diabetic phenotype.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PATS (PERI-PANCREATIC ADIPOSE TISSUES)"}, {"entity_type": "PROTEIN", "description": "Upregulated in pancreatic islets and contributes to the recruitment of immune cells, playing a role in type-1 diabetes development.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CHEMOKINE CCL5 (RANTES)"}, {"entity_type": "CELL TYPE", "description": "Infiltrate into pancreases at later phases and express high levels of proinflammatory cytokines contributing to tissue damage.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PANCREATIC MACROPHAGES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These cytokines are secreted by peri-pancreatic adipose tissues leading to local inflammatory responses in the pancreas.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CYTOKINE TNF-\u0391, IL-6, AND IL-1\u0392"}, {"entity_type": "TISSUE", "description": "Pancreatic islets are affected directly by adipocyte-derived cytokines leading to \u03b2-cell death and pancreatic disruption.<SEP>Upregulation of CCL5 and other chemokines occurs here, contributing to immune cell recruitment and \u03b2-cell damage.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PANCREATIC ISLETS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Recruitment into pancreas due to increased levels of chemokine CCL5 expression in islets under the influence of proinflammatory cytokines from PATs.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "IMMUNE CELL RECRUITMENT"}, {"entity_type": "PROTEIN", "description": "These are proinflammatory cytokines that can be neutralized by antibodies to reduce their effects on CCL5 expression and \u03b2-cell death.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "IL-6, TNF OR IL-1\u0392"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of secretion of cytokines such as IL-6, TNF, or IL-1\u03b2 from adipocytes affects pancreatic islet function.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "CYTOKINE SECRETION"}, {"entity_type": "TRANSCRIPT", "description": "A marker for inflammation and immune response, particularly relevant to pancreatic islets during diabetes progression.<SEP>Expression of CCL5 in the pancreas can be induced by high levels of local proinflammatory cytokines and contributes to immune cell recruitment.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4<SEP>chunk-8382a49b61215482f9fc75e3a86cb987", "id": "CCL5 EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The activation of NF-\u03baB leads to the upregulation of inflammatory genes such as IL-6, TNF-\u03b1, and IL-1\u03b2 in adipose tissues.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "NF-\u039aB DEPENDENT INFLAMMATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "SUMOylation of PPAR\u03b3 does not significantly contribute to reduced adipogenesis or increased cytokine production in SENP1-deficient mice.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "PPAR\u0393 SUMOYLATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Phosphorylation events lead to the activation of the NF-\u03baB pathway in adipose tissues of SENP1-aP2KO mice.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "PHOSPHORYLATION OF IKK, I\u039aB\u0391 AND NF-\u039aB P65/RELA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Differentiation markers such as fatty acid synthase, lipoprotein lipase, and others are reduced in peri-pancreatic adipocytes from SENP1-aP2KO mice.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "ADIPOCYTE DIFFERENTIATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Immune cell recruitment into the pancreas is influenced by elevated levels of CCL5 expression due to high local concentrations of cytokines from peri-pancreatic adipocytes.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "MACROPHAGE INFILTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "NF-\u03baB is a critical activator of genes for inflammation and immune regulation.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "NF-\u039aB"}, {"entity_type": "PROTEIN", "description": "These proteins are involved in the phosphorylation events leading to the activation of the NF-\u03baB pathway.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "IKK, I\u039aB\u0391 AND NF-\u039aB P65/RELA"}, {"entity_type": "PROTEIN", "description": "Adipocyte-specific marker used for identifying adipocytes during staining and analysis.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "FABP4"}, {"entity_type": "GENOMIC VARIANT", "description": "Promoter regions of these cytokine genes show increased NF-\u03baB binding in SENP1-deficient cells.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "IL-6, IL-1\u0392 AND TNF-\u0391 PROMOTERS"}, {"entity_type": "CELL LINE", "description": "Mouse cell line used for differentiation into mature adipocytes to study the effects of SENP1 knockdown.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "3T3-L1 PREADIPOCYTES"}, {"entity_type": "GENOMIC VARIANT", "description": "Reduction in SENP1 expression leads to increased NF-\u03baB activation and cytokine production in adipocytes.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "SENP1 KNOCKDOWN"}, {"entity_type": "PROTEIN", "description": "Macrophage marker used for distinguishing macrophages from other cell types during staining analysis.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "F4/80"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Chromatin immunoprecipitation assays are used to determine the binding of NF-\u03baB p65/RelA to cytokine promoters.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "CHIP ASSAYS"}, {"entity_type": "PROTEIN", "description": "IKK (I\u03baB Kinase) is a protein complex critical for activating NF-\u03baB signaling pathway.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "IKK"}, {"entity_type": "PROTEIN", "description": "I\u03baB\u03b1 is a protein that inhibits the nuclear translocation of the NF-\u03baB transcription factor complex by binding to it in the cytoplasm.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "I\u039aB\u0391"}, {"entity_type": "PROTEIN", "description": "p65/RelA, also known as RelA, is a subunit of the NF-\u03baB protein family involved in regulating immune responses and inflammatory processes.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NF-\u039aB P65/RELA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Interleukin 6 (IL-6), Tumor Necrosis Factor alpha (TNF-\u03b1), and Interleukin 1 beta (IL-1\u03b2) are pro-inflammatory cytokines that contribute to immune responses.<SEP>These are proinflammatory cytokines expressed at high levels in PATs of SENP1-aP2KO mice even before the onset of diabetes. They play a role in islet disruption and contribute to insulin resistance.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-174831b97ed170039b374ba254d4f506", "id": "IL-6, TNF-\u0391, IL-1\u0392"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The process by which SUMO proteins covalently attach to IKK subunit NEMO and NF-\u03baB p65/RelA proteins, modifying their activity.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "SUMOYLATION OF IKK SUBUNIT NEMO AND NF-\u039aB P65/RELA"}, {"entity_type": "PROTEIN", "description": "SENP2 is a protein that can deSUMOylate NEMO and inhibit NF-\u03baB activation in 293T cells.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "SENP2"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The process by which SUMO proteins covalently attach to the IKK subunit NEMO, modulating its activity.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NEMO SUMOYLATION"}, {"entity_type": "PROTEIN", "description": "A form of NEMO tagged with Flag for detection and isolation purposes in experiments.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "FLAG-NEMO"}, {"entity_type": "GENE VARIANT", "description": "Mutant forms of the gene coding for NEMO that have lysine to arginine substitutions at specific sites, affecting SUMOylation.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NEMO K277R OR K309R MUTANTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which NF-\u03baB regulates the transcription and expression of pro-inflammatory cytokines such as IL-6, TNF-\u03b1, and IL-1\u03b2.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NF-\u039aB-DEPENDENT CYTOKINE EXPRESSION"}, {"entity_type": "DISEASE MODEL", "description": "Mouse model with adipocyte-specific SENP1 deletion used for studying inflammatory responses.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "SENP1-AP2KO MICE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic alteration in the Senp1 gene leading to its absence or non-functionality.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "SENP1 GENE KNOCKOUT"}, {"entity_type": "TISSUE", "description": "Adipose tissue cells located around the pancreas, studied for their role in inflammation and insulin resistance.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "PANCREATIC ADIPOCYTES (PATS)"}, {"entity_type": "GENOMIC VARIANT", "description": "A family of SUMO proteins including SUMO1, SUMO2, and SUMO3 that participate in various cellular processes.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "SUMO1\u20133"}, {"entity_type": "PROTEIN", "description": "Members of the second family of SENPs with specificity for SUMO2/3 substrates.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "SENP3 AND SENP5"}, {"entity_type": "PROTEIN", "description": "Members of the third family of SENPs, also preferentially deSUMOylating SUMO2/3 substrates.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "SENP6 AND SENP7"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A DNA-damaging agent used to induce stress responses and evaluate cellular pathways involved in inflammation.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "ETOPOSIDE VP16"}, {"entity_type": "DISEASE MODEL", "description": "Non-obese diabetic (NOD) mouse model for studying Type 1 Diabetes Mellitus (T1DM).", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NOD MICE"}, {"entity_type": "GENOMIC VARIANT", "description": "A mouse strain used as a model for studying type 1 diabetes, characterized by late-onset spontaneous diabetes and specific genetic traits.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "NOD MOUSE MODEL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process involving cytokine production that is elevated in type 1 diabetes patients and associated with inflammation.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "PROINFLAMMATORY CYTOKINES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An interferon gamma molecule involved in the induction of insulitis and leukocyte infiltration leading to pancreatic islet disruption.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "IFN-\u0393 (INTERFERON GAMMA)"}, {"entity_type": "DRUG", "description": "A drug used to inhibit NF-\u03baB activation, showing efficacy in reducing blood glucose levels and islet damage in diabetic mice models.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "NF-\u039aB ACTIVATION INHIBITOR JSH-23"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "An environmental factor that influences the development of diabetes and inflammation by affecting adipocyte morphology.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "HIGH-FAT DIET (HFD)"}, {"entity_type": "CELL TYPE", "description": "A type of cell found in adipose tissue that stores energy as fat.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "ADIPOCYTE"}, {"entity_type": "CELL TYPE", "description": "Pancreatic cell type responsible for producing insulin and other hormones to maintain proper blood sugar levels.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "\u0392-CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Clusters of cells in the pancreas that include beta cells, alpha cells, delta cells, etc., involved in hormone secretion.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "ISLET CELLS (ISLETS OF LANGERHANS)"}, {"entity_type": "METABOLIC PATHWAY", "description": "A signaling pathway involved in inflammatory responses and cell survival mechanisms that plays a role in the development of type 1 diabetes.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "id": "NF-\u039aB PATHWAY"}, {"entity_type": "DIETARY PATTERN", "description": "High-fat diet (HFD) is a dietary pattern that leads to increased fat weight in various depots, including epididymal fat and peri-inguinal adipose tissues (PATs), as well as contributing to inflammatory cytokine production and insulin resistance.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 37}]", "id": "HFD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of adipocyte development or fat cell formation, which is stimulated by HFD in PATs of SENP1-aP2KO mice.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "ADIPOGENESIS"}, {"entity_type": "DISEASE", "description": "Type 1 Diabetes Mellitus (T1DM) and Type 2 Diabetes Mellitus (T2DM), both conditions are exacerbated by HFD in the context of SENP1-aP2KO mice.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "T1DM AND T2DM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition marked as a hallmark of obesity-linked T2DM development, observed to be more pronounced under HFD conditions in SENP1 knockout (KO) mice.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "LIVER INSULIN RESISTANCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An anatomical site for fat storage, including epididymal fat and peri-inguinal adipose tissues (PATs), where HFD increases fat weight.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "ADIPOSE DEPOT"}, {"entity_type": "DISEASE CONDITION", "description": "The condition characterized by an increase in fat mass within adipose depots due to dietary changes like HFD.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "FAT WEIGHT INCREASE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A reduction in the size of adipocytes (fat cells) observed in PATs from SENP1-aP2KO mice under both normal chow and HFD conditions.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 37}]", "id": "CELL SIZE REDUCTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An increase in cell numbers within adipose tissues, particularly noted in PATs of SENP1-aP2KO mice compared to control adipocytes.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "CELL NUMBER INCREASE"}, {"entity_type": "DISEASE CONDITION", "description": "A condition observed where HFD causes disruption of islet structures in the pancreas of SENP1-aP2KO mice, contributing to diabetes development.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 37}]", "id": "ISLET STRUCTURE DISRUPTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which blood glucose levels rise above normal, starting earlier (at age 8 weeks) under HFD conditions compared to standard chow in SENP1-aP2KO mice.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "HYPERGLYCEMIA ONSET"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The measurement of insulin levels both at rest (basal) and after glucose stimulation, significantly reduced in SENP1-aP2KO mice.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "BASAL AND GLUCOSE-STIMULATED INSULIN LEVELS"}, {"entity_type": "DISEASE CONDITION", "description": "Reduced sensitivity to insulin observed in both SENP1-deficient mice and control under standard chow conditions, but exacerbated by HFD leading to more severe phenotypes.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 37}]", "id": "INSULIN RESPONSE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A test used to assess the ability of insulin to lower blood glucose levels in response to an intraperitoneal injection of glucose, showing induced insulin resistance under HFD conditions.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "INTRAPERITONEAL TOLERANCE TEST (ITT)"}, {"source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "description": "Mice with smooth muscle cells/pericytes or vascular endothelial cells-specific deletion of the SENP1 gene do not develop high glucose levels despite similar Cre-mediated expression.)", "entity_type": "UNKNOWN", "id": "SENP1-SMKO AND SENP1-ECKO"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "During the pre-diabetic phase preceding T1DM, autoantibodies such as IAA are directed against \u03b2 cells indicating an autoimmune response.)", "entity_type": "UNKNOWN", "id": "PRE-DIABETIC PHASE"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "Elevated CRP levels in the blood serve as a clinical parameter aiding in the diagnosis of diabetes, particularly T1DM.)", "entity_type": "UNKNOWN", "id": "DIABETES DIAGNOSIS"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "Increased beta-hydroxybutyrate levels indicate impaired glucose metabolism and can be used to diagnose diabetes, reflecting a loss in the body\'s ability to absorb glucose properly.)", "entity_type": "UNKNOWN", "id": "GLUCOSE METABOLISM DYSFUNCTION"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "Activated CD8+ T cells infiltrate pancreatic islets destroying insulin-producing \u03b2-cells in individuals with Type 1 Diabetes Mellitus (T1DM).)", "entity_type": "UNKNOWN", "id": "\u0392-CELLS DESTRUCTION"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "Helper T cells such as Th1 and Th17 promote inflammation and contribute to the autoimmune destruction of pancreatic islet \u03b2 cells in type 1 diabetes mellitus.)", "entity_type": "UNKNOWN", "id": "AUTOIMMUNE RESPONSE"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "Reduction in regulatory T cells leads to a loss of immune tolerance, exacerbating autoimmune responses and contributing to the destruction of pancreatic islet \u03b2-cells.)", "entity_type": "UNKNOWN", "id": "IMMUNE TOLERANCE"}, {"source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "description": "Activated dendritic cells present antigens to T-cells initiating an immune response, leading to autoimmunity in Type 1 Diabetes Mellitus (T1DM).)", "entity_type": "UNKNOWN", "id": "AUTOIMMUNE RESPONSE INITIATION"}, {"source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "description": "Autoantigen NRP-V7 positive CD8+ T cells target IGP1 protein in pancreatic lymph nodes and spleen, indicating an autoimmune response targeting this protein.)<SEP>These cells target IGP1 protein, indicating a direct role in the autoimmune response against pancreatic \u03b2-cells.)", "entity_type": "UNKNOWN", "id": "IGP1 PROTEIN"}, {"source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "description": "Elevation of these cytokines is associated with an increased risk of developing T1DM through their inflammatory roles.)<SEP>High levels of these cytokines are associated with the onset of T1DM through mechanisms involving immune cell expansion and inflammation.)", "entity_type": "UNKNOWN", "id": "T1DM"}, {"source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "description": "Upregulation of CCL5 in islets recruits immune cells into pancreas, causing damages to \u03b2-cells and contributing to T1DM progression.)", "entity_type": "UNKNOWN", "id": "CCL5 (RANTES)"}, {"source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "description": "Upregulation of CCL5 in islets recruits immune cells into pancreas, causing damages to \u03b2-cells and contributing to T1DM progression.)", "entity_type": "UNKNOWN", "id": "IMMUNE CELLS"}, {"source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "description": "Infiltration and expression of high levels of proinflammatory cytokines by macrophages cause damage to pancreatic tissues at later stages.)", "entity_type": "UNKNOWN", "id": "TISSUE DAMAGE"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "SENP1 plays a crucial role in regulating inflammatory responses within pancreatic adipocytes.", "entity_type": "UNKNOWN", "id": "SENP1 REGULATION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "SENP3 and SENP5 contribute to the removal of SUMO2/3 from target proteins.", "entity_type": "UNKNOWN", "id": "SUMO2/3 DESUMOYLATION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Stress induction by Etoposide VP16 leads to enhanced NF-\u03baB activity in adipocytes.", "entity_type": "UNKNOWN", "id": "NF-\u039aB ACTIVATION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "The NOD mouse model is utilized to study the pathogenesis and progression of T1DM.", "entity_type": "UNKNOWN", "id": "T1DM DEVELOPMENT"}, {"source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "description": "The NF-\u03baB pathway is involved in mediating the effects of high-fat diet on adipocyte inflammation and diabetes progression.", "entity_type": "UNKNOWN", "id": "HFD (HIGH-FAT DIET)"}, {"source_id": "chunk-174831b97ed170039b374ba254d4f506", "description": "The loss of SENP1 gene function leads to liver insulin resistance under basal conditions, which is exacerbated under high-fat diet (HFD) conditions.)", "entity_type": "UNKNOWN", "id": "SENP1-KO"}, {"entity_type": "GENOMIC VARIANT", "description": "The FokI variant is associated with an increased risk of ovarian cancer.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "FOKI (RS2228570 OR RS10735810)"}, {"entity_type": "GENOMIC VARIANT", "description": "The ApaI variant does not show a significant association with ovarian cancer risk according to the fixed-effect model.<SEP>The ApaI variant does not show significant association with ovarian cancer risk according to the fixed-effect model.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "APAI (RS7975232)"}, {"entity_type": "GENOMIC VARIANT", "description": "The BsmI variant is not significantly associated with an increased risk of ovarian cancer when using a fixed effect model, but genotype distribution in controls from some subgroup studies deviates from Hardy-Weinberg equilibrium.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "BSMI (RS1544410)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A principle stating that the allele and genotype frequencies in a population remain constant from generation to generation in the absence of evolutionary influences.<SEP>The Hardy-Weinberg equilibrium is a principle that predicts the genetic variation in a population and is often used as a baseline for evaluating departures from expected genotype frequencies due to factors such as mutation, selection, or migration.<SEP>The equilibrium where allele and genotype frequencies remain constant from generation to generation under certain conditions, used here to validate SNP data consistency.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4<SEP>chunk-1c470c93632f3704d6f3566de7a1dd0c<SEP>chunk-814fe155e9cb953da61f6a79d1d25784", "id": "HARDY-WEINBERG EQUILIBRIUM (HWE)"}, {"entity_type": "METHODOLOGY", "description": "A meta-analysis is a statistical method of combining data from multiple studies to obtain a more precise estimate of effect size. It was used in this text to evaluate the association between genetic variants and ovarian cancer risk.<SEP>A statistical method combining results from different studies to provide more precise estimates compared to those derived from individual studies.<SEP>A statistical method that combines data from multiple studies to increase sample size and improve the precision of estimates.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e<SEP>chunk-1c470c93632f3704d6f3566de7a1dd0c<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "META-ANALYSIS"}, {"entity_type": "MODEL TYPE", "description": "A model used in meta-analysis where it is assumed that the effect size is consistent across all studies.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "FIXED-EFFECT MODEL"}, {"entity_type": "GENETIC INHERITANCE PATTERN", "description": "A genetic inheritance pattern where a single copy of an allele is enough for an organism to express a particular phenotype.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "DOMINANT GENETIC MODEL"}, {"entity_type": "GENETIC INHERITANCE PATTERN", "description": "A genetic inheritance pattern where two copies of the recessive allele are needed for an individual to exhibit a trait.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "RECESSIVE GENETIC MODEL"}, {"entity_type": "DEMOGRAPHIC GROUP", "description": "A broad term referring to individuals with European ancestry, used here as a demographic subgroup in studies.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "id": "CAUCASIANS"}, {"entity_type": "GENE, GENOMIC VARIANT", "description": "The Cdx-2 gene is a genomic variant associated with the risk of ovarian cancer. The rs11568820 variant has been studied in relation to its effect on ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "CDX-2 GENE (RS11568820)"}, {"entity_type": "GENE, GENOMIC VARIANT", "description": "The TaqI gene is a genomic variant associated with the risk of ovarian cancer. The rs731236 variant has been studied in relation to its effect on ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "TAQI GENE (RS731236)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A genetic model used to assess how specific gene variants influence disease risk. In this case, it is applied to evaluate the rs11568820 variant of Cdx-2 and ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "GENETIC MODEL (DOMINANT)"}, {"entity_type": "GENOMIC VARIANT", "description": "The AA or GA genotypes are variations in the Cdx-2 gene, where A represents an allele associated with increased risk for ovarian cancer compared to GG carriers.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "AA/GA GENOTYPE (CDX-2)"}, {"entity_type": "GENOMIC VARIANT", "description": "The GG genotype is a reference genotype used as a control group when studying the association of other genotypes like AA or GA in the Cdx-2 gene with ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "GG GENOTYPE (CDX-2)"}, {"entity_type": "DIETARY PATTERN, ENVIRONMENTAL FACTOR", "description": "A specific subgroup within a study population focusing on individuals of Japanese descent. This subgroup was found to depart from Hardy-Weinberg equilibrium in the context of Cdx-2 and ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "JAPANESE SUBGROUP (LURIE ET AL.)"}, {"entity_type": "DIETARY PATTERN, ENVIRONMENTAL FACTOR", "description": "A specific subgroup within a study population focusing on individuals within the Nurses\' Health Study II cohort. This subgroup also departed from Hardy-Weinberg equilibrium in the context of Cdx-2 and ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "NECC SUBGROUP (TWOROGER ET AL.)"}, {"entity_type": "DIETARY PATTERN, ENVIRONMENTAL FACTOR", "description": "A specific subgroup within a study population focusing on individuals from Northern Sweden. This subgroup departed from Hardy-Weinberg equilibrium in the context of TaqI and ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "NORTHERN SWEDEN SUBGROUP (CLENDENEN ET AL.)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A test used to detect publication bias in meta-analyses, which assesses whether smaller studies with less precise estimates are more likely to be published. It was applied here for evaluating the association of gene variants and ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "PUBLICATION BIAS TEST (EGGER\'S TEST)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Statistical analysis used to evaluate how robust the results of a meta-analysis or other statistical analyses are when individual studies are removed one at a time, ensuring that no single study disproportionately influences the overall result.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "SENSITIVITY TEST"}, {"source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "description": "The genotype distribution of controls in several subgroup studies for ApaI and BsmI variants deviated from Hardy-Weinberg equilibrium, affecting the validity of these genetic associations.", "entity_type": "UNKNOWN", "id": "OVARIAN CANCER RISK STUDIES"}, {"source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "description": "Sensitivity tests were conducted on the meta-analysis of Cdx-2 gene to assess its robustness against individual studies\' influence, confirming the overall findings are not significantly influenced by any single study.", "entity_type": "UNKNOWN", "id": "META-ANALYSIS (CDX-2 GENE)"}, {"source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "description": "Sensitivity tests were conducted on the meta-analysis of TaqI gene to assess its robustness against individual studies\' influence, confirming the overall findings are not significantly influenced by any single study.", "entity_type": "UNKNOWN", "id": "META-ANALYSIS (TAQI GENE)"}, {"entity_type": "GENE", "description": "The VDR gene is a focus of analysis for its polymorphisms\' influence on susceptibility to infection by T. cruzi and the development of chronic Chagas cardiomyopathy (CCC).", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "VDR GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "These three SNPs in VDR showed a high linkage disequilibrium and were analyzed for their influence on the susceptibility to T. cruzi infection and CCC development.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS731236, RS7975232, RS1544410 GENOMIC VARIANTS"}, {"entity_type": "GENOMIC VARIANT", "description": "The minor allele of rs2228570*A was significantly associated with a reduced risk of developing CCC and a trend towards protective effect against T. cruzi infection, even after correction for multiple testing.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS2228570 GENOMIC VARIANT"}, {"entity_type": "DISEASE", "description": "T. cruzi causes Chagas disease, which can lead to chronic Chagas cardiomyopathy (CCC). The study explores the role of VDR polymorphisms in susceptibility to T. cruzi infection.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "INFECTION BY TRYPANOSOMA CRUZI (T. CRUZI)"}, {"entity_type": "DISEASE", "description": "CCC is a complication of Chagas disease, and the study investigates the association between VDR SNPs and the risk of developing CCC.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "CHRONIC CHAGAS CARDIOMYOPATHY (CCC)"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in the VDR gene was analyzed for its influence on susceptibility to T. cruzi infection but showed no significant association after multiple testing correction.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS731236 GENOMIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in the VDR gene was analyzed for its influence on susceptibility to T. cruzi infection but showed no significant association after multiple testing correction.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS7975232 GENOMIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in the VDR gene was analyzed for its influence on susceptibility to T. cruzi infection but showed no significant association after multiple testing correction.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "RS1544410 GENOMIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "The IL-1A -889C>T variant is a genetic polymorphism that was studied in relation to the risk of having Hypnopompic Hallucinations and/or Narcolepsy (HNP).", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "IL-1A -889C>T"}, {"entity_type": "GENOMIC VARIANT", "description": "The TNF-A 238G>A variant is a genetic polymorphism that was studied in relation to the risk of having Hypnopompic Hallucinations and/or Narcolepsy (HNP).", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "TNF-A 238G>A"}, {"entity_type": "GENOMIC VARIANT", "description": "The VDR TaqI variant is a genetic polymorphism that was studied in relation to the risk of having Hypnopompic Hallucinations and/or Narcolepsy (HNP).", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "VDR TAQI RS731236"}, {"entity_type": "DISEASE", "description": "HNP is a condition characterized by experiencing vivid, often frightening hallucinations while in the transitional state between sleeping and waking.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "HYPNOPOMPIC HALLUCINATIONS AND/OR NARCOLEPSY (HNP)"}, {"entity_type": "GENE", "description": "The IL-1A gene harbors a polymorphism rs1800587 which was studied for its association with Hypnopompic Hallucinations and/or Narcolepsy (HNP).", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "IL-1A (RS1800587)"}, {"entity_type": "GENE", "description": "The TNF-A gene harbors a polymorphism rs361525 which was studied for its association with Hypnopompic Hallucinations and/or Narcolepsy (HNP).", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "TNF-A (RS361525)"}, {"entity_type": "GENE", "description": "The VDR gene harbors a polymorphism rs731236 which was studied for its association with Hypnopompic Hallucinations and/or Narcolepsy (HNP).", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "VDR (RS731236)"}, {"entity_type": "NUTRIENT", "description": "B12 is a vitamin that plays a critical role in maternal and fetal health.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "B12"}, {"entity_type": "NUTRIENT", "description": "A nutrient essential for DNA synthesis and repair, often found in dietary supplements.<SEP>Folate is a key nutrient involved in the analysis of causal effects on B12 levels and offspring birthweight.<SEP>Folate is another essential nutrient, crucial for pregnancy outcomes.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45<SEP>chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-22216738ccbae0a6276bb4499018c434", "id": "FOLATE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum levels of B12 in pregnant women are influenced by genetic variants and dietary intake.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "MATERNAL SERUM B12 LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Folate levels in pregnant women affect fetal development, particularly birthweight.<SEP>Maternal folate levels are examined for their influence on offspring birthweight without mediating through B12 levels.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-22216738ccbae0a6276bb4499018c434", "id": "MATERNAL FOLATE LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Birthweight is a measure of newborn health and developmental outcomes.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "BIRTHWEIGHT"}, {"entity_type": "GENOMIC VARIANT", "description": "These variants are associated with maternal serum B12 levels.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "GWAS VARIANTS FOR B12 LEVELS"}, {"entity_type": "GENOMIC VARIANT", "description": "These genomic variants explain variation in maternal serum folate levels.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "GWAS VARIANTS FOR FOLATE LEVELS"}, {"entity_type": "GENE", "description": "The MMACHC gene variant is implicated in B12 metabolism, with a lesser effect on pregnant women\'s B12 levels.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "MMACHC GENE (RS12272669)"}, {"entity_type": "GENE", "description": "FUT2 genetic variation influences B12 serum concentrations and may have pleiotropic effects.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "FUT2 GENE (RS602662)"}, {"entity_type": "GENE", "description": "The MTHFR gene variant is significant in the analysis of maternal folate levels on birthweight.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "MTHFR GENE (RS1801133)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "B12 levels during fetal development influence growth and health outcomes.<SEP>Fetal B12 levels are analyzed for their effect on gestational duration, but no evidence of causal relationship is found.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-22216738ccbae0a6276bb4499018c434", "id": "FETAL B12 LEVELS"}, {"entity_type": "NUTRIENT", "description": "B12, also known as Cobalamin, is a nutrient analyzed for its causal effect on folate levels and offspring birthweight.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "B12 (COBALAMIN)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Maternal B12 levels are examined for their influence on offspring birthweight and gestational duration.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "MATERNAL B12 LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Offspring birthweight is a physiological process measured to assess the impact of maternal nutrient levels such as B12 and folate.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "OFFSPRING BIRTHWEIGHT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Gestational duration is a physiological process examined in relation to maternal and fetal nutrient levels without finding any significant causal effects.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "GESTATIONAL DURATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A statistical analysis method, MR Egger, was applied to assess potential biases from genetic instruments in studies involving folate and B12 levels.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "MR EGGER ANALYSIS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An IVW analysis detected a small causal effect of folate on B12 levels within the Danish cohorts.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "IVW ANALYSIS (INVERSE VARIANCE WEIGHTED)"}, {"entity_type": "DIETARY PATTERN, ENVIRONMENTAL FACTOR", "description": "The study involves two Danish cohorts used to analyze the impact of maternal nutrient levels on offspring health outcomes.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "DANISH COHORTS"}, {"source_id": "chunk-22216738ccbae0a6276bb4499018c434", "description": "An IVW analysis detected a small but significant effect of folate levels on B12 levels within the Danish cohorts, indicating a molecular interaction between these nutrients.", "entity_type": "UNKNOWN", "id": "FOLATE LEVELS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant located at position 677 in the MTHFR gene, often associated with changes in folate metabolism and cardiovascular disease risk.<SEP>The MTHFR C677T variant is a genetic polymorphism associated with changes in methionine metabolism and elevated homocysteine levels, potentially leading to increased cardiovascular risk.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb<SEP>chunk-d0476488384aadcae4630e94d982d2e0", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 34}]", "id": "MTHFR C677T"}, {"entity_type": "GENOMIC VARIANT", "description": "Another genetic variant within the MTHFR gene, differing from C677T at position 1298, affecting similar metabolic pathways.<SEP>The MTHFR A1298C variant is another common genetic polymorphism that can affect folate metabolism and methionine synthesis, impacting cardiovascular health.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb<SEP>chunk-d0476488384aadcae4630e94d982d2e0", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 33}]", "id": "MTHFR A1298C"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism in the promoter region of PAI-1, influencing thrombosis risk and cardiovascular health.<SEP>The PAI-1 -675 4G/5G variant is a polymorphism associated with increased plasminogen activator inhibitor type 1 activity, which can lead to hypercoagulability and thrombotic disorders.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb<SEP>chunk-d0476488384aadcae4630e94d982d2e0", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 33}]", "id": "PAI-1 -675 4G/5G"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant within the PAI-1 gene affecting platelet aggregation and clotting factors.<SEP>The PAI-1 A844G variant is a genetic polymorphism that affects the activity of plasminogen activator inhibitor type 1, playing a role in thrombosis and fibrinolysis.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb<SEP>chunk-d0476488384aadcae4630e94d982d2e0", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 35}]", "id": "PAI-1 A844G"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic alteration in prothrombin, increasing thrombosis risk due to elevated levels of circulating prothrombin.<SEP>The Prothrombin G20210A variant is a genetic polymorphism that leads to an increase in prothrombin levels, potentially contributing to hypercoagulability and thrombotic events.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb<SEP>chunk-d0476488384aadcae4630e94d982d2e0", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 33}]", "id": "PROTHROMBIN G20210A"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism within the Factor V gene that impacts blood coagulation factors and clotting efficiency.<SEP>The Factor V G1691A variant results in resistance to activated protein C (APC), leading to an increased risk of venous thromboembolism (VTE).", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb<SEP>chunk-d0476488384aadcae4630e94d982d2e0", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 33}]", "id": "FACTOR V G1691A"}, {"entity_type": "DISEASE", "description": "A condition characterized by a mottled skin appearance due to underlying vascular or autoimmune issues.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "LV (LIVEDO RETICULARIS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Maintaining heart health through regulation of blood flow, vessel integrity, and prevention of cardiovascular diseases.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "CARDIOVASCULAR HEALTH"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A laboratory technique used to amplify DNA sequences, commonly utilized for detecting and analyzing SNPs.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "PCR (POLYMERASE CHAIN REACTION)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A method used in molecular biology to detect genetic variations by cutting DNA at specific recognition sites.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "HIND III RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The process of determining the precise order of nucleotides within a DNA molecule, often used for genotyping and analyzing SNPs.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "SEQUENCING"}, {"entity_type": "DISEASE", "description": "Leiomyoma Venosa is a rare vascular disease characterized by the development of benign tumors in veins, often associated with genetic predispositions such as certain genomic variants.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 33}]", "id": "LEIOMYOMA VENOSA (LV)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Methionine metabolism involves the conversion of methionine to homocysteine and further breakdown or remethylation to form other metabolites, affected by MTHFR variants.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 33}]", "id": "METHIONINE METABOLISM"}, {"source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "description": "The PAI\u20101 \u2010675 4G/5G variant is directly linked to increased thrombotic tendencies and cardiovascular disease risk.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 33}]", "id": "THROMBOSIS RISK"}, {"source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "description": "This genetic variant within PAI-1 affects platelet function and can lead to abnormal clot formation patterns.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 35}]", "id": "PLATELET AGGREGATION"}, {"source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "description": "The factor V variant impacts coagulation factors, contributing to altered clotting efficiency and increased thrombosis risk.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 33}]", "id": "BLOOD COAGULATION"}, {"entity_type": "NUTRIENT", "description": "A vitamin important for nerve function, DNA synthesis, and red blood cell production.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "VITAMIN B12 (COBALAMIN)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "The total concentration of homocysteine in the serum, an amino acid that can be harmful when present in excess. It is involved in methylation reactions and its metabolism is dependent on folate and B12.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "THCY (TOTAL HOMOCYSTEINE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "A ratio indicating the balance between reduced cystathionine and folate levels, suggesting a role in homocysteine metabolism.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "RCF (REDUCED CYSTATHIONINE/FOLATE RATIO)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant associated with male infertility when homozygous for the minor V allele.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE (PEMT) M175V GENE VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the B12 transcobalamin receptor gene, associated with male infertility when heterozygous.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "TRANSCOBALAMIN RECEPTOR GENE TCBLR (CD320) RS173665 VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the methylenetetrahydrofolate reductase (MTHFR) gene that impacts folate metabolism and is associated with male infertility.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "MTHFR 1298A>C MINOR C ALLELE"}, {"entity_type": "DIETARY PATTERN/NUTRIENT", "description": "Vitamin supplements containing folic acid, used for their nutritional benefits and to potentially reduce the risk of certain diseases or conditions like male infertility.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "FOLIC ACID-CONTAINING VITAMIN SUPPLEMENTS"}, {"entity_type": "DISEASE", "description": "A condition characterized by difficulty in achieving conception despite unprotected intercourse over a prolonged period.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "MALE INFERTILITY"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the methylenetetrahydrofolate reductase (MTHFR) gene, which is not associated with male infertility in this study population.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "MTHFR 677C>T GENE VARIANT"}, {"entity_type": "DIETARY PATTERN/NUTRIENT", "description": "The dietary pattern involving the use of supplements containing folic acid.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "DIETARY PATTERN OF FOLIC ACID SUPPLEMENT USE"}, {"source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "description": "B12 levels were found to be lower in infertile men compared to fertile controls but did not reach statistical significance.)", "entity_type": "UNKNOWN", "id": "INFERTILE MEN"}, {"source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "description": "Subjects who reported taking vitamin supplements had higher folate and B12 concentrations compared to non-users, suggesting a role in maintaining optimal nutrient levels.)", "entity_type": "UNKNOWN", "id": "FOLATE AND B12 LEVELS"}, {"entity_type": "GENE", "description": "The SHMT1 gene encodes an enzyme that catalyzes the reversible conversion of serine to glycine, transferring methyl groups to tetrahydrofolate (THF) which is converted into 5,10-methylenetetrahydrofolate (5,10-CH2-THF).", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "SHMT1"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism in the SHMT1 gene that results in a change from leucine to phenylalanine at position 435.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS1979277"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism located in the promoter region of SHMT1 (5\'-UTR) linked to an increased risk for TMD patients.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS638416"}, {"entity_type": "GENE", "description": "The MTHFD1 gene encodes a protein with three distinct enzymatic activities: 5,10-methylenetetrahydrofolate dehydrogenase, cyclohydrolase, and synthetase.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "MTHFD1"}, {"entity_type": "GENOMIC VARIANT", "description": "A transition from G to A in the MTHFD1 gene that results in an alteration of ARG-653-GLN, associated with neural tube defects sensitive to folates.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS2236225"}, {"entity_type": "GENE", "description": "The GSTM1 gene encodes mu-class glutathione S-transferase which plays a role in detoxifying electrophilic compounds such as carcinogens and drugs.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GSTM1"}, {"entity_type": "GENOMIC VARIANT", "description": "A deletion of the GSTM1 gene associated with an increase of cancer and male infertility due to greater susceptibility to environmental toxins and carcinogens.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GSTM1-NULL POLYMORPHISM"}, {"entity_type": "GENE", "description": "The MTRR gene is responsible for the regeneration of Methionine Synthase (MTR) through reductive methylation using SAM as a methyl donor.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "MTRR"}, {"entity_type": "GENOMIC VARIANT", "description": "A substitution from A to G in the encoding region of MTRR gene leading to an Ile22Met change, affecting enzyme efficiency and substrate affinity.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS1801394"}, {"entity_type": "GENE", "description": "The 48-bp VNTR in exon 3 of the DRD4 gene encodes for dopamine receptor D4 with varying repeat lengths between 2 to 11, affecting genotype frequencies.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "DRD4-48BPTR"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism characterized by 2 to 5 repeats in the exon 3 of the DRD4 gene.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "S-DRD4"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism with 6 or more repeats in the exon 3 of the DRD4 gene, not found in individuals with TMD.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "L-DRD4"}, {"entity_type": "NUTRIENT", "description": "THF is a form of folate involved in one-carbon metabolism and the synthesis of purines and thymidylates.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "TETRAHYDROFOLATE (THF)"}, {"entity_type": "NUTRIENT", "description": "A derivative of THF important for methylation reactions in the body.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "5,10-METHYLENETETRAHYDROFOLATE (5,10-CH2-THF)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which pyrimidines are synthesized from amino acids, involving methyltransferases like SHMT1.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "PYRIMIDINE SYNTHESIS"}, {"entity_type": "DISEASE", "description": "Congenital malformations characterized by defects in the development of the brain and spinal cord due to problems with neural tube closure during early embryogenesis.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "NEURAL TUBE DEFECTS (NTDS)"}, {"entity_type": "DISEASE", "description": "A set of conditions that affect the temporomandibular joint, muscles, or other tissues involved in jaw movement.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "TMD (TEMPOROMANDIBULAR DISORDERS)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Substances capable of causing cancer through interaction with DNA and cellular mechanisms.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "CARCINOGENS"}, {"source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "description": "Tetrahydrofolate undergoes methylation to produce 5,10-methylenetetrahydrofolate which is essential in many metabolic pathways.", "entity_type": "UNKNOWN", "id": "THF"}, {"entity_type": "TECHNIQUE/METABOLIC PATHWAY ANALYSIS TOOL", "description": "The CDC MBA method measures serum folate levels and compares with HPLC-MS/MS to assess agreement and accuracy.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "CDC MBA METHOD"}, {"entity_type": "TECHNIQUE/METABOLIC PATHWAY ANALYSIS TOOL", "description": "A highly accurate technique used for measuring serum folate, providing precise data compared to the CDC MBA method.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "CDC HPLC-MS/MS METHOD"}, {"entity_type": "ENVIRONMENTAL FACTOR/LABORATORY PROCEDURE", "description": "Refers to the use of different types of internal calibrators among participating laboratories, affecting measurement precision and accuracy.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "IH-CAL (INTERNAL HOMOGENEOUS CALIBRATION)"}, {"entity_type": "NUTRIENT", "description": "Folic acid is a B-vitamin crucial for DNA synthesis and repair, especially important during pregnancy.<SEP>Folic acid, also known as vitamin B9, is an essential nutrient involved in numerous physiological processes including DNA synthesis and repair, red blood cell formation, and amino acid metabolism.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-7c25217961fba65d15f20beda8a58f1c", "id": "FOLIC ACID"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "CDC reagents refer to the standard materials provided by the Centers for Disease Control (CDC) used for laboratory testing and calibration purposes.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "CDC REAGENTS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "IH reagents are specific materials or standards used in laboratories, differing from CDC reagents in their composition or source.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "IH REAGENTS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The microorganism calibrator provided by the CDC is a standard reference material used for calibration purposes in laboratory settings to ensure accurate and consistent testing results.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "MICROORGANISM CALIBRATOR (CDC-MO)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A calibrator provided by the CDC is a standardized substance or sample used to calibrate instruments, ensuring their accuracy and consistency across different laboratories.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "CALIBRATOR (CDC-CAL)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Conditions for testing WB-FOL (whole blood folate) and S-FOL (serum folate), representing the procedures and environmental factors affecting the measurement of these substances in clinical settings.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "WB-FOL & S-FOL TESTING CONDITIONS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Harmonized laboratory test conditions involve standardizing reagents, calibrators, and protocols to ensure consistency and comparability across different laboratories when measuring analytes like folate levels.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "LABORATORY TEST HARMONIZATION CONDITION"}, {"entity_type": "METABOLIC PATHWAY", "description": "The target value established by the CDC for folate measurements, representing a standard against which laboratory results are compared.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "CDC MBA TARGET VALUE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measurement of serum folate levels in blood, indicating folic acid status in circulation.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 34}]", "id": "S-FOL (SERUM FOLATE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measurement of whole blood folate levels, providing a comprehensive measure of circulating and intracellular folate.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 34}]", "id": "WB-FOL (WHOLE BLOOD FOLATE)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A standardized kit provided by the CDC containing microorganism and calibrator to ensure uniform testing conditions across different laboratories.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "CDC ROUND-ROBIN KIT (CDC-MO & CDC-CAL)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "These laboratories exhibited inconsistent results compared with the CDC MBA target value, indicating potential issues in calibration or measurement protocols.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "LABORATORY #6 AND LABORATORY #9 RESULTS ANOMALIES"}, {"source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "description": "Both measurements reflect the metabolic pathways of folate in serum and whole blood respectively, influencing nutritional assessment.", "entity_type": "UNKNOWN", "id": "S-FOL"}, {"source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "description": "Both measurements reflect the metabolic pathways of folate in serum and whole blood respectively, influencing nutritional assessment.", "entity_type": "UNKNOWN", "id": "WB-FOL"}, {"source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "description": "Folic acid undergoes metabolism within the body involving various physiological processes such as DNA synthesis and amino acid metabolism.", "entity_type": "UNKNOWN", "id": "NUTRIENT METABOLISM"}, {"source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "description": "CDC reagents are used to calibrate laboratory instruments, ensuring accurate measurements of analytes like folate levels across different testing conditions.", "entity_type": "UNKNOWN", "id": "LABORATORY CALIBRATION"}, {"source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "description": "The microorganism calibrator provided by the CDC ensures accurate calibration of laboratory instruments, contributing to precise measurements across different conditions.", "entity_type": "UNKNOWN", "id": "CALIBRATION ACCURACY"}, {"source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "description": "The CDC-provided calibrators are critical for maintaining consistent standards in folate testing among various laboratories.", "entity_type": "UNKNOWN", "id": "LABORATORY STANDARDS"}, {"source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "description": "These conditions are essential for the accurate measurement of whole blood and serum folate levels, influencing health assessments related to folic acid intake and metabolism.", "entity_type": "UNKNOWN", "id": "FOLIC ACID MEASUREMENT"}, {"source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "description": "Harmonizing laboratory test conditions improves comparability and consistency in the measurements of folate levels across different laboratories.", "entity_type": "UNKNOWN", "id": "INTER-LABORATORY COMPARABILITY"}, {"source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "description": "The folic acid calibrator ensures accurate measurements of serum folate levels across different laboratory settings.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 34}]", "id": "FOLIC ACID CALIBRATOR"}, {"source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "description": "This kit ensures uniform calibration across different laboratories, enhancing comparability in folic acid measurement protocols.", "entity_type": "UNKNOWN", "id": "LABORATORY STANDARDIZATION"}, {"source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "description": "The inconsistencies observed in these laboratories suggest potential problems with their calibration processes or adherence to standard protocols.", "entity_type": "UNKNOWN", "id": "CALIBRATION ISSUES"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs1695 polymorphism is associated with an increased risk of breast cancer, specifically for homozygote genotype GG.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "RS1695 POLYMORPHISM"}, {"entity_type": "DISEASE", "description": "A disease characterized by uncontrolled cell growth in the tissues of the breast. Increased risk due to genetic factors such as rs1695 polymorphism.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "BREAST CANCER"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs1138272 polymorphism does not show a significant association with increased risk of breast cancer, based on genotype analysis.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "RS1138272 POLYMORPHISM"}, {"entity_type": "PROTEIN", "description": "A protein studied for its function and potential influence due to single nucleotide polymorphisms such as Ile105Val SNP.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "GSTP1 PROTEIN"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific single nucleotide polymorphism in GSTP1 that decreases the amyloid propensity of the enzyme, according to WALTZ analysis.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ILE105VAL POLYMORPHISM"}, {"entity_type": "GENOMIC VARIANT", "description": "The AG genotype of rs1695 polymorphism also does not show a significant association with the increased risk of breast cancer.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "AG GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "The CC genotype is a specific genetic variant associated with an increased occurrence of colorectal cancer.<SEP>The CC genotype of rs1138272 polymorphism is the most common among both control and case groups, showing no association with breast cancer risk.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e<SEP>chunk-5b0cc96debf110f3544685d3b227ff27", "id": "CC GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "Heterozygous CT genotype of rs1138272 does not demonstrate a significant impact on breast cancer susceptibility based on our analysis.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "CT GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "The homozygous TT genotype of rs1138272 has been evaluated but shows no association with an increased risk for breast cancer, despite its low frequency among controls and cases.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "TT GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "The allele G variant of rs1695 polymorphism is associated with an increased risk of breast cancer compared to the A allele based on statistical analysis.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ALLELE G (RS1695)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Analysis of Ile105Val SNP shows that this single nucleotide change does not affect protein aggregation tendency or chaperone binding but decreases amyloid formation propensity.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ILE105VAL SNP ANALYSIS"}, {"entity_type": "GENOMIC VARIANT", "description": "A pathogenic genomic variant in China that is associated with haplogroups A, B, and C.<SEP>p.R778L is a prevalent pathogenic variant among WD patients, with an allelic frequency of 31.7% across the entire patient group.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450<SEP>chunk-fa2d834930246b534181c3d6d2c049e1", "id": "P.R778L"}, {"entity_type": "GENOMIC VARIANT", "description": "A pathogenic genomic variant that is associated with a more complex spectrum of six different haplogroups.<SEP>p.P992L is another prevalent pathogenic variant among WD patients, with an allelic frequency of 15.7% in total and higher in certain regions like Jiangxi.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450<SEP>chunk-fa2d834930246b534181c3d6d2c049e1", "id": "P.P992L"}, {"entity_type": "GENOMIC VARIANT", "description": "A pathogenic genomic variant characterized by only one kind of haplogroup (J) on WD chromosomes with high significance compared to controls.<SEP>p.T935M is a rare but significant pathogenic variant among WD patients, especially prevalent in Fujian province compared to other regions.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450<SEP>chunk-fa2d834930246b534181c3d6d2c049e1", "id": "P.T935M"}, {"entity_type": "DISEASE", "description": "The WD patients group includes individuals with Wilson\'s disease, characterized by the presence of certain pathogenic variants like p.R778L, p.P992L and p.T935M.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "WD PATIENTS GROUP"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The geographical regions in southeastern China are an environmental factor influencing the distribution of pathogenic variants among WD patients.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "GEOGRAPHICAL REGIONS (SOUTHEASTERN CHINA)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "These provinces and cities account for a significant proportion of WD patients carrying p.R778L, p.P992L, or p.T935M variants.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "FUJIAN PROVINCE, ZHEJIANG, JIANGSU, SHANGHAI, JIANGXI"}, {"entity_type": "METHODOLOGY", "description": "Analyzes how often certain gene variants are inherited together more than would be expected by chance.<SEP>Linkage disequilibrium analysis is used to study the association between specific genetic markers and pathogenic variants among WD patients.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e<SEP>chunk-047f259db19cbb4de945706a1bd1b450", "id": "LINKAGE DISEQUILIBRIUM ANALYSIS"}, {"entity_type": "BIOLOGICAL PATHWAY", "description": "A haplotype association study elucidates the relationship between genetic haplotypes and prevalent disease-causing variants in WD patients.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "HAPLOTYPE ASSOCIATION STUDY"}, {"entity_type": "GENOMIC VARIANT", "description": "Microsatellite markers used in the study to analyze linkage disequilibrium with pathogenic variants.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "D13S314, D13S301, D13S316"}, {"entity_type": "BIOLOGICAL PATHWAY", "description": "A haplotype group predominantly associated with the p.R778L variant in WD patients.<SEP>The most common haplogroup associated with the p.R778L variant, mostly found on WD chromosomes compared to controls.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450<SEP>chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP A"}, {"entity_type": "GENOMIC VARIANT", "description": "Chromosomal material carrying pathogenic variants like p.R778L, p.P992L and p.T935M in WD patients.<SEP>Chromosomes found to be associated with specific pathogenic variants in individuals with a particular condition.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450<SEP>chunk-fa2d834930246b534181c3d6d2c049e1", "id": "WD CHROMOSOMES"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant within haplogroup A that is the most prevalent among all haplotypes related to p.R778L.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "VARIANT A1 (10-7-7)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Less common haplogroups associated with the p.R778L variant compared to haplogroup A.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUPS B AND C"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The most common haplogroup in the p.P992L group, significantly represented on WD chromosomes compared to controls.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP E (10-9-5)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant within haplogroup E that occupies a significant part of the spectrum related to p.P992L.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "VARIANT E1 (10-9-5)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The unique haplogroup associated with the p.T935M variant that is found exclusively in WD chromosomes.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP J, VARIANTS J1 AND J2"}, {"entity_type": "GENOMIC VARIANT", "description": "Chromosomes from control subjects used for comparison against those with pathogenic variants.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "CONTROL ONES (CHROMOSOMES)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A rare haplogroup associated with the p.P992L variant, found sporadically on WD chromosomes.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP D (9-7-5)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Another rare haplogroup related to the p.P992L variant, appearing infrequently on WD chromosomes.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP F (10-9-8)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A less common haplogroup in the spectrum of p.P992L, found at a 3.4% frequency on WD chromosomes.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP G (10-11-5)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "This rare haplogroup related to the p.P992L variant is also present in a small percentage of WD chromosomes.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP H (12-4-5; 12-5-5)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A less frequent haplogroup found within individuals with the p.P992L variant, showing low representation on WD chromosomes.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP I (12-5-8)"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant is part of haplogroup E but is much rarer than variant E1 in the context of p.P992L.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "VARIANT E2 (10-9-6)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant within haplogroup J that shows high prevalence among WD chromosomes related to the p.T935M variant.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "VARIANT J1 (12-4-8)"}, {"entity_type": "GENOMIC VARIANT", "description": "Another variant within haplogroup J but found less commonly than variant J1 in relation to p.T935M.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "VARIANT J2 (12-5-8)"}, {"source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "description": "The p.T935M variant shows particularly high prevalence in patients from Fujian province compared to other regions.", "entity_type": "UNKNOWN", "id": "FUJIAN PROVINCE"}, {"source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "description": "This analysis reveals significant linkage disequilibrium between the p.R778L variant and specific microsatellite markers.", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT (P.R778L)"}, {"source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "description": "The genomic variant p.T935M is uniquely associated with haplogroup J, representing a significant difference in genetic information on WD chromosomes.)", "entity_type": "UNKNOWN", "id": "HAPLOGROUP J (VARIANTS J1 AND J2)"}, {"source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "description": "These rare haplogroups are sporadically represented among WD chromosomes associated with p.P992L.)", "entity_type": "UNKNOWN", "id": "HAPLOGROUPS F, G, H AND I"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant reducing CYP2C9 activity, part of a group of variants combined due to low frequency in the population.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*2"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant reducing CYP2C9 activity, part of a group of variants combined due to low frequency in the population.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*3"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant reducing CYP2C9 activity, part of a group of variants combined due to low frequency in the population.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*5"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant reducing CYP2C9 activity, part of a group of variants combined due to low frequency in the population.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*8"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant reducing CYP2C9 activity, part of a group of variants combined due to low frequency in the population.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*11"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism (SNP) reducing CYP2C9 activity and grouped with other rare SNPs for analysis.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS1799853"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism (SNP) reducing CYP2C9 activity and grouped with other rare SNPs for analysis.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS1057910"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism (SNP) reducing CYP2C9 activity and grouped with other rare SNPs for analysis.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS28371686"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism (SNP) reducing CYP2C9 activity and grouped with other rare SNPs for analysis.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS7900194"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism (SNP) reducing CYP2C9 activity and grouped with other rare SNPs for analysis.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS28371685"}, {"entity_type": "DRUG", "description": "An anticoagulant medication used to prevent blood clots in patients at risk of deep vein thrombosis or pulmonary embolism.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "WARFARIN"}, {"entity_type": "DISEASE", "description": "Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), conditions frequently treated with warfarin.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "DVT/PE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP with a minor allele frequency of 0.06, affecting warfarin dose prediction.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS9923231"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The principle used to assess deviations in genetic variation frequencies.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "HWE (HARDY-WEINBERG EQUILIBRIUM)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A combination of CYP2C9 variants due to their low individual frequency but combined impact on drug metabolism.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9 STAR VARIANT GROUP"}, {"entity_type": "ALGORITHM", "description": "An IWPC pharmacogenomics algorithm is used to predict therapeutic doses in patients, showing an inverse correlation with percent WAA among those requiring high doses.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "IWPC PHARMACOGENOMICS ALGORITHM"}, {"entity_type": "ALGORITHM", "description": "The IWPC clinical algorithm correctly assigned 2% of high-dose patients compared to the novel AA algorithm that detected 53%.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "IWPC CLINICAL ALGORITHM"}, {"entity_type": "ALGORITHM", "description": "A novel AA algorithm outperformed IWPC algorithms in detecting high-dose patients and predicting doses closer to observed values.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "NOVEL AA ALGORITHM"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The availability of AIMs has made it possible to accurately measure admixture among African Americans (AAs).", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "AIMS (ANCESTRY INFORMATIVE MARKERS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The whole ancestral admixture is a factor that influences the performance of different algorithms in predicting therapeutic doses.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "WAA (WHOLE ANCESTRAL ADMIXTURE)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Self-reporting race for African Americans is not a strong proxy for genetic background, highlighting the importance of genetic markers like AIMs.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "SELF-REPORTED RACE FOR AAS "}, {"entity_type": "GENE", "description": "Genes are implied to be part of pharmacogenomics algorithms, but specific gene names were not mentioned.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "GENE"}, {"entity_type": "TRANSCRIPT", "description": "The expression levels or mutations in transcripts might be part of algorithms used to predict therapeutic doses, but specifics are not provided.<SEP>The transcript of the LPL gene is expressed primarily by myocytes and adipocytes.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323<SEP>chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "TRANSCRIPT"}, {"entity_type": "PROTEIN", "description": "Proteins involved in drug metabolism and response could affect the efficacy of pharmacogenomics algorithms, though specific proteins were not mentioned.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "PROTEIN"}, {"entity_type": "METABOLIC PATHWAY", "description": "CYP24A1 is part of metabolic pathways involving vitamin D metabolism and calcium homeostasis.<SEP>Drug metabolism pathways are implied by pharmacogenomics but specific pathways were not detailed.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5<SEP>chunk-b2730f3087aee6d9cff6e4939b229323", "id": "METABOLIC PATHWAY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Interactions between molecules, such as drug-protein interactions, may influence dose prediction but weren\'t specified in the text.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "MOLECULAR INTERACTION"}, {"entity_type": "DISEASE", "description": "The disease context implied by the study involves patients requiring HU treatment, suggesting conditions like sickle cell anemia or beta-thalassemia.<SEP>The text discusses therapeutic doses which could be relevant to managing diseases but does not specify particular diseases.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323<SEP>chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "DISEASE"}, {"source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "description": "The CYP2C9*2 variant influences the predicted dose of warfarin based on its effect on drug metabolism.", "entity_type": "UNKNOWN", "id": "WARFARIN DOSE PREDICTION"}, {"source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "description": "Patients with DVT or PE are commonly treated with warfarin to prevent blood clots.", "entity_type": "UNKNOWN", "id": "WARFARIN TREATMENT"}, {"source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "description": "Used to evaluate deviations in SNP frequencies for genomic studies and drug response predictions.", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT ANALYSIS"}, {"source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "description": "The combination of CYP2C9 variants affects the prediction models for warfarin dosages based on genetic factors.", "entity_type": "UNKNOWN", "id": "WARFARIN DOSAGE PREDICTION"}, {"source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "description": "Our novel AA algorithm did not show association with WAA because population-specific variables are incorporated, accounting for admixture effects.)", "entity_type": "UNKNOWN", "id": "WAA"}, {"source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "description": "Ancestry Informative Markers (AIMs) enable accurate measurement of ancestral admixture among African Americans, influencing the efficacy of pharmacogenomics algorithms.)", "entity_type": "UNKNOWN", "id": "AIMS"}, {"entity_type": "GENE", "description": "The CYP27B1 gene encodes an enzyme involved in vitamin D metabolism.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "CYP27B1"}, {"entity_type": "GENE", "description": "The CYP24A1 gene is associated with the metabolism of 25(OH)D and plays a role in colorectal adenoma recurrence.<SEP>The CYP24A1 gene is associated with the metabolism of vitamin D and plays a role in calcium homeostasis.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5<SEP>chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 7}]", "id": "CYP24A1"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant within the CYP24A1 gene is associated with vitamin D concentrations and colorectal adenoma recurrence.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 7}]", "id": "RS927650"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in CYP24A1 that influences advanced adenoma recurrence risk.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "RS35051736"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant within the CYP24A1 gene is associated with increased odds of recurrent adenomas with villous histology.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "RS2296241"}, {"entity_type": "METABOLIC PATHWAY", "description": "The pathway involved in converting vitamin D into its active forms, influenced by genes like CYP27B1 and CYP24A1.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 7}]", "id": "VITAMIN D METABOLISM"}, {"entity_type": "DISEASE", "description": "A condition involving the recurrence of colorectal adenomas, which is influenced by genetic factors such as SNPs in CYP24A1.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "COLORECTAL ADENOMA RECURRENCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of advanced adenoma recurrence, characterized by specific histological features and influenced by genetic variants like rs35051736.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "ADVANCED ADENOMA RECURRENCE"}, {"entity_type": "NUTRIENT", "description": "Levels of vitamin D in the body that play a role in colorectal health, particularly regarding adenoma recurrences.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "VITAMIN D CONCENTRATION"}, {"entity_type": "NUTRIENT", "description": "A circulating form of vitamin D, also known as calcifediol.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "25(OH)D"}, {"entity_type": "NUTRIENT", "description": "The active form of vitamin D in the body, also known as calcitriol.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 7}]", "id": "1,25(OH)2D"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition involving the recurrence of adenomas with villous histology.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 7}]", "id": "VILLOUS ADENOMA RECURRENCE"}, {"entity_type": "GENOMIC VARIANT", "description": "The genotype for a specific single nucleotide polymorphism (SNP).", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "clusters": "[{level: 0, cluster: 7}]", "id": "SNP GENOTYPE"}, {"entity_type": "DISEASE", "description": "A disease involving the recurrence of colorectal adenomas with advanced features.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "ADVANCED LESION RECURRENCE"}, {"source_id": "chunk-2fb95100a1290b27baae869c6560419a", "description": "Genetic variants within the CYP24A1 gene are linked to a higher risk of advanced lesion recurrence.", "entity_type": "UNKNOWN", "id": "CYP24A1 SNP GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant involves the deletion of AAG nucleotides at positions 428-430, leading to altered CYP24A1 gene expression and function.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "C.428_430DELAAG VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant involves the substitution of a T for a C at position 1186 in the CYP24A1 gene, affecting its coding sequence.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "clusters": "[{level: 0, cluster: 7}]", "id": "C.1186C\u2009>\u2009T VARIANT"}, {"entity_type": "TRANSCRIPT", "description": "The amplicon related to rs777676129 is used for genotyping and includes the c.428_430delAAG variant.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "RS777676129 AMPLICON"}, {"entity_type": "TRANSCRIPT", "description": "The amplicon related to rs114368325 is used for genotyping and includes the c.1186C\u2009>\u2009T variant.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "clusters": "[{level: 0, cluster: 7}]", "id": "RS114368325 AMPLICON"}, {"entity_type": "TECHNIQUE", "description": "Sanger sequencing is a method used to confirm HRMA results by directly analyzing DNA sequences.<SEP>Used to validate HLA-DQ haplotypes determined by Real-time PCR genotyping.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5<SEP>chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "SANGER SEQUENCING"}, {"entity_type": "DISEASE", "description": "IIH, or idiopathic intracranial hypertension, is a condition that may be associated with genetic variants, such as those in the CYP24A1 gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "IIH (IDIOPATHIC INTRACRANIAL HYPERTENSION)"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of CYP24A1 is subject to genotyping for variants such as c.428_430delAAG and c.1186C\u2009>\u2009T.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "clusters": "[{level: 0, cluster: 7}]", "id": "CYP24A1 TRANSCRIPT"}, {"source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "description": "Sanger sequencing confirms HRMA results by providing direct DNA sequence data.", "entity_type": "UNKNOWN", "id": "HRMA"}, {"source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "description": "CYP24A1 is involved in metabolic pathways that process vitamin D and maintain calcium homeostasis.", "entity_type": "UNKNOWN", "id": "CYP24A1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "The P1001L mutation is a genomic variant confirmed in the proband\u2019s genomic DNA, contributing to mosaicism.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "P1001L MUTATION"}, {"entity_type": "TRANSCRIPT", "description": "ATP7A exon 7 serves as a control for completeness of BsmAI digestion in quantitative real-time PCR experiments.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "ATP7A EXON 7"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The deficiency of dopamine-b-hydroxylase activity, which is copper-dependent, reflects biochemical findings inconsistent with Menkes disease in the proband.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "COPPER DEPENDENCY"}, {"entity_type": "DISEASE", "description": "Classical Menkes disease is characterized by specific cerebrospinal fluid (CSF) copper and catecholamine ratios within established ranges for this condition.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MENKES DISEASE"}, {"entity_type": "NUTRIENT/METABOLIC PATHWAY PRODUCT", "description": "Plasma catecholamine ratios reflect deficient activity of dopamine-b-hydroxylase, an enzyme dependent on copper, not consistent with Menkes disease in the proband.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "CATECHOLAMINES"}, {"entity_type": "DIETARY PATTERN/PHYSIOLOGICAL PROCESS", "description": "The Denver Developmental Screening Test II is used to assess developmental skills levels including gross motor, fine motor, language, and personal-social skills.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "DENVER DEVELOPMENTAL SCREENING TEST II"}, {"entity_type": "DIAGNOSTIC TOOL/METABOLIC PATHWAY", "description": "A brain MRI at 20 months of age showed atrophy and delayed myelination in the patient, indicating neurodevelopmental issues.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "BRAIN MRI"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "Clinical neurophysiology studies measured median nerve compound motor action potentials to assess peripheral nervous system function.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS"}, {"entity_type": "MOLECULAR INTERACTION/PHYSIOLOGICAL PROCESS", "description": "The velocity of the median nerve conduction was 50 m/s, within normal range for infants aged 1-2 years.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MEDIAN NERVE CONDUCTION VELOCITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "Sensory action potentials were measured to assess peripheral sensory function; in this case, it was 36 \u03bcV, above the lower limit of normal for infants aged 1-2 years.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MEDIAN NERVE SENSORY ACTION POTENTIAL"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "The deficiency of dopamine-b-hydroxylase activity is copper-dependent and reflects biochemical findings inconsistent with Menkes disease in the proband, indicating a physiological process that may influence neurodevelopmental outcomes.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "DOPAMINE-B-HYDROXYLASE ACTIVITY"}, {"entity_type": "PROTEIN/DIETARY PATTERN", "description": "Primary fibroblast cultures from skin biopsies were used to analyze tissue-specific mosaicism of the P1001L mutation.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "FIBROBLASTS"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "The cerebrospinal fluid (CSF) copper and catecholamine ratios fall within ranges established for classical Menkes disease, providing diagnostic criteria.", "entity_type": "UNKNOWN", "id": "CEREBROSPINAL FLUID COPPER AND CATECHOLAMINE RATIOS"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "This test measures developmental skills levels which are significantly delayed compared to age-appropriate milestones in the patient.", "entity_type": "UNKNOWN", "id": "DEVELOPMENTAL SKILLS ASSESSMENT"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "MRI findings of atrophy and delayed myelination indicate neurodevelopmental issues in the patient.", "entity_type": "UNKNOWN", "id": "NEURODEVELOPMENTAL ISSUES"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "Clinical studies measured motor action potentials to assess peripheral nervous system function, which were within normal ranges for infants aged 1-2 years.", "entity_type": "UNKNOWN", "id": "PERIPHERAL NERVOUS SYSTEM FUNCTION"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "Velocity measurement is a part of neurophysiological assessment, indicating the patient\'s conduction velocity was within normal range for age.", "entity_type": "UNKNOWN", "id": "NEUROPHYSIOLOGICAL ASSESSMENT"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "Sensory action potentials were measured to assess peripheral sensory function in the patient, showing results above the lower limit of normal.", "entity_type": "UNKNOWN", "id": "PERIPHERAL SENSORY FUNCTION"}, {"entity_type": "CELL LINE", "description": "A human intestinal epithelial cell line used to investigate how lncRNA LOC100507600 influences LCT mRNA levels.<SEP>Caco-2 cells are a human colon adenocarcinoma cell line used for studying intestinal absorption and transport of nutrients.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-ea45644d73f260cf365527dcc3af86e1", "id": "CACO-2 CELLS"}, {"entity_type": "GENE", "description": "The deiodinase gene is not expressed at detectable levels by enzyme assay in Caco-2 cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "DEIODINASE GENE (DIO)"}, {"entity_type": "GENOMIC VARIANT", "description": "Rat IDI coding sequences are used for transfecting Caco-2 cells with either the T (IDI-T) or C (IDI-C) variant of rs713041.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "RAT IDI CODING SEQUENCES"}, {"entity_type": "TRANSCRIPT FEATURE", "description": "The GPX4 3\u2032 untranslated region is used to link rat IDI coding sequences in transfection experiments with Caco-2 cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "GPX4 3\u2032UTR"}, {"entity_type": "TRANSCRIPT", "description": "IDI-T (T variant) and IDI-C (C variant) transcripts are generated following transfection of Caco-2 cells with rat IDI coding sequences linked to the GPX4 3\u2032UTR.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "IDI-T AND IDI-C TRANSCRIPTS"}, {"entity_type": "TRANSCRIPT REFERENCE GENE", "description": "Relative transcript levels of IDI-T and IDI-C are measured against GAPDH transcripts as a reference gene for normalization.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "GAPDH TRANSCRIPT"}, {"entity_type": "CHEMICAL COMPOUND", "description": "Tert-butylhydroperoxide is used to challenge cells in oxidative stress experiments, with varying concentrations applied depending on cell culture conditions.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "TERT-BUTYLHYDROPEROXIDE (T-BHP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glutathione peroxidase (GPx) activity is a measure of the antioxidant defense capacity against oxidative stress in cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "GPX ACTIVITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Reactive oxygen species levels are measured to assess the impact of IDI-T and IDI-C on cellular oxidative stress response.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "ROS LEVELS"}, {"entity_type": "NUTRIENT ENVIRONMENTAL FACTOR", "description": "Selenium is an essential micronutrient that plays a critical role in selenoprotein synthesis, including antioxidant enzymes like GPx4.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SELENIUM (SE)"}, {"entity_type": "TRANSCRIPT EXPRESSION LEVEL", "description": "Glutathione peroxidase 1 (GPX1) mRNA levels are measured to assess the impact of IDI-T and IDI-C on selenoprotein hierarchy under different Se supply conditions.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "GPX1 MRNA LEVELS"}, {"entity_type": "TRANSCRIPT EXPRESSION LEVEL", "description": "Selenoprotein H mRNA levels serve as an indicator for differential expression under varying selenium supplies in transfected Caco-2 cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SELENOPROTEIN H MRNA LEVELS"}, {"entity_type": "GENOMIC VARIANT", "description": "The T variant of rs713041 is one form of the IDI gene that was transfected into Caco-2 cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "T VARIANT (IDI-T)"}, {"entity_type": "GENOMIC VARIANT", "description": "The C variant of rs713041 is another form of the IDI gene used in transfection experiments with Caco-2 cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "C VARIANT (IDI-C)"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP is located within the 3\u2032UTR region of the IDI gene and affects transcript levels when transfected into Caco-2 cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "RS713041"}, {"entity_type": "TRANSCRIPT EXPRESSION LEVEL", "description": "Glutathione peroxidase 4 (GPX4) mRNA levels are measured to evaluate changes in antioxidant enzyme expression under different conditions.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "GPX4 MRNA LEVELS"}, {"entity_type": "PROTEIN EXPRESSION LEVEL", "description": "Thioredoxin reductase 1 (TR1) protein levels are assessed to understand the impact of IDI-T and IDI-C variants on selenoprotein hierarchy.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "TR1 PROTEIN LEVELS"}, {"entity_type": "NUTRIENT", "description": "Selenium is a trace element essential for the synthesis of selenoproteins, including GPx4.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SE (SELENIUM)"}, {"entity_type": "TRANSCRIPT", "description": "The transcript encoding glutathione peroxidase 4 (GPx4), which plays a role in antioxidant defense against oxidative stress.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "GPX4 TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "A transcript whose expression levels are similar to GPx1 and GPx4 under both Se-depleted and supplemented conditions but significantly lower for selenoprotein H mRNA in IDI-C cells compared to IDI-T cells.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "TR1 TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "The gene encoding glutathione peroxidase 1, which along with TR1 shows similar levels under both Se-depleted and supplemented conditions.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "GPX1 TRANSCRIPT"}, {"entity_type": "TRANSCRIPT", "description": "A transcript whose expression is significantly lower in IDI-C cells compared to IDI-T cells regardless of selenium supply.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SELENOPROTEIN H MRNA"}, {"entity_type": "TRANSCRIPT", "description": "The transcriptional level of the IDI gene that differs between IDI-T and IDI-C clones, affecting GPx activity and ROS levels post oxidative challenge.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "IDI TRANSCRIPT"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "An oxidant used to assess cell viability in serum-free conditions under varying selenium concentrations.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "TERT-BUTYLHYDROPEROXIDE (TBHP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process induced by the presence of reactive oxygen species, which can be influenced by selenium levels and selenoprotein expression.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "OXIDATIVE STRESS"}, {"entity_type": "CELL LINE", "description": "Cells in which IDI gene expression leads to higher GPx activity but lower cell viability under low Se conditions compared to IDI-T cells.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "IDI-C CELLS"}, {"entity_type": "CELL LINE", "description": "Cells in which IDI gene expression has less impact on endogenous GPx activity and ROS levels compared to IDI-C cells, showing greater sensitivity to oxidative stress when selenium is limited.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "IDI-T CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A byproduct of cellular metabolism that can cause oxidative damage but also signals for repair mechanisms involving selenoproteins like GPx4.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "ROS (REACTIVE OXYGEN SPECIES)"}, {"entity_type": "PROTEIN", "description": "Glutathione peroxidase 4 (GPx4) protein, involved in antioxidant defense against oxidative stress.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "GPX4 PROTEIN"}, {"entity_type": "PROTEIN", "description": "A selenoprotein whose expression is affected by selenium supply and varies between IDI-C and IDI-T cells.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SELENOPROTEIN H PROTEIN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Medium lacking sufficient selenium, affecting cell viability and ROS levels in experiments involving oxidative stress challenges.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SE-DEPLETED MEDIUM"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Medium containing adequate amounts of selenium, which influences cell viability and selenoprotein expression under oxidative conditions.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SE-SUPPLEMENTED MEDIUM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Conditions used to deplete cells of selenium before oxidative stress challenges.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SERUM-FREE CONDITIONS"}, {"source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "description": "Levels of GPX4 mRNA do not differ significantly between IDI-T and IDI-C cells under both depleted and supplemented selenium conditions.", "entity_type": "UNKNOWN", "id": "SE-SUPPLY CONDITIONS"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "The expression of selenoprotein H mRNA is significantly lower in IDI-C cells compared to IDI-T cells under both Se-depleted and supplemented conditions, indicating a differential response to selenium levels.", "entity_type": "UNKNOWN", "id": "SE SUPPLY"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "Cells grown under serum-free conditions experience selenium depletion, affecting their response to oxidative challenges and selenoprotein expression.", "entity_type": "UNKNOWN", "id": "SELENIUM DEPLETION"}, {"entity_type": "GENE", "description": "CHAT is a gene that undergoes mutations leading to missense and nonsense variations.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "CHAT"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense mutation (p.Val136Met) identified in the CHAT gene, affecting three patients.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "P.VAL136MET"}, {"entity_type": "GENOMIC VARIANT", "description": "Another missense mutation (p.Ala557Thr) detected in five patients and homozygous in one patient.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "P.ALA557THR"}, {"entity_type": "TRANSCRIPT", "description": "The CHAT transcript expresses two protein isoforms of 70 kDa and 74 kDa from alternative start sites in the spinal cord (S-type).", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "CHAT TRANSCRIPT"}, {"entity_type": "PROTEIN", "description": "The wild type of ChAT protein expressed at a higher level compared to most missense mutants, indicating its significance in expression levels.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "WILD-TYPE CHAT PROTEIN"}, {"entity_type": "PROTEIN", "description": "Several missense mutations lead to lower expression levels and altered kinetic parameters of the CHAT proteins.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "MISSENSE MUTANTS CHAT PROTEINS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The kinetic properties of wild-type and mutant ChATs were evaluated, revealing changes in activation rate constants for some mutants.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "KINETIC PROPERTIES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Mutations affect the thermal stability of CHAT proteins, with two mutations significantly compromising this property.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "THERMAL STABILITY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cells and bacterial cultures used in expressing and purifying wild-type and mutant ChATs for analysis.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "BOSC 23 CELLS AND E. COLI "}, {"entity_type": "GENOMIC VARIANT", "description": "A missense mutation (p.Trp421Ser) identified in CHAT gene with altered expression levels.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "P.TRP421SER"}, {"entity_type": "GENOMIC VARIANT", "description": "Missense mutation (p.Ser498Pro) affecting the expression level of ChAT protein.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "P.SER498PRO"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense mutation (p.Thr553Asn) identified in CHAT gene with reduced expression levels.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "P.THR553ASN"}, {"entity_type": "CONSERVED RESIDUES", "description": "These residues are conserved across multiple species indicating their functional importance.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "MET202, TRP421, THR553, AND ALA557"}, {"entity_type": "MODEL ORGANISMS", "description": "Species used to identify conserved residues in CHAT gene for comparative analysis.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "DROSOPHILA AND C. ELEGANS "}, {"entity_type": "INDIVIDUAL WITH MUTATION", "description": "Homozygous for p.Ala557Thr mutation, showing a specific phenotype.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "PATIENT 8"}, {"entity_type": "INDIVIDUAL WITH MUTATION", "description": "Carries a nonsense mutation on one allele and is homozygous for p.Ala557Thr.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "PATIENT 10"}, {"entity_type": "INDIVIDUAL WITH MUTATION", "description": "Born to consanguineous parents, homozygous for p.Ile689Ser mutation.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "PATIENT 11"}, {"entity_type": "PROTEIN CONSTRUCT", "description": "His-tagged constructs of wild-type and mutant ChATs used in kinetic studies.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "HISTIDINE-TAGGED CHAT CDNAS"}, {"entity_type": "TECHNIQUE FOR PROTEIN PURIFICATION", "description": "Used to purify His-tagged CHAT proteins from bacterial lysates.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "NI-NTA COLUMN"}, {"entity_type": "TECHNIQUE FOR PROTEIN ANALYSIS", "description": "Instrument used in purification and analysis of ChAT mutants.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "FAST PROTEIN LIQUID CHROMATOGRAPHY (FPLC)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Changes in DNA methylation patterns near the LCT and MCM6 genes are critical for regulating lactose digestion ability over a person\'s lifetime, linking genetic variation with nutritional metabolism.<SEP>The DNA methylation patterns at specific genomic sites (CpGs) are associated with markers of oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "DNA METHYLATION PATTERNS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Oxidative stress markers are indicators of the physiological process related to oxidative stress.<SEP>Oxidative stress markers such as TGSH, GSH, GSSG, HCY, oxLDL, OLAB, CD, BCD-LDL and TAOC are used to measure the oxidative state of an individual.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28<SEP>chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "OXIDATIVE STRESS MARKERS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Total glutathione (TGSH) is a marker for measuring total levels of reduced glutathione in biological systems.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "TGSH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glutathione (GSH), the reduced form, acts as an antioxidant and its level indicates the oxidative state of cells.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "GSH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glutathione disulfide (GSSG) is the oxidized form of glutathione used to measure oxidative stress in biological systems.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "GSSG"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Homocysteine (HCY) levels are associated with cardiovascular disease and methylation patterns may influence this association.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "HCY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Oxidized low-density lipoprotein (oxLDL) is a marker for lipid peroxidation and oxidative stress in the vascular system.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "OXLDL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Copper-dependent lysyl oxidase activity (CD) measures products of lipid peroxidation indicating oxidative damage to LDL.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "CD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Bilirubin-copper-dependent low-density lipoprotein (BCD-LDL) is another marker for assessing lipid peroxidation and oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "BCD-LDL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The balance between reduced glutathione (GSH) and oxidized glutathione (GSSG) reflects the redox status of a cell or tissue.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "GLUTATHIONE BALANCE"}, {"entity_type": "GENE", "description": "BCL2-like 11 gene is associated with methylation patterns linked to oxidative stress markers TGSH and GSH.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "BCL2L11"}, {"entity_type": "GENE", "description": "NADH dehydrogenase Fe-S protein 7 (NDUFS7) shows methylation levels associated with oxidative stress marker TGSH or GSH.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "NDUFS7"}, {"entity_type": "GENE", "description": "Eukaryotic translation initiation factor 3, subunit J (EIF3J), is a gene linked to methylation patterns related to oxidative stress markers TGSH and GSH.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "EIF3J"}, {"entity_type": "GENE", "description": "Zinc finger protein 761 (ZNF761) shows significant methylation levels associated with the ratio of oxidized to reduced glutathione (GSSG/GSH).", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "ZNF761"}, {"entity_type": "GENE", "description": "Proteasome assembly chaperone 3 (PSMG3), is a gene whose promoter region methylation level is strongly associated with GSSG/GSH ratio.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "PSMG3"}, {"entity_type": "GENE", "description": "Sema domain, transmembrane and cytoplasmic domain protein 6A (SEMA6A) has methylation patterns significantly correlated with oxidized LDL levels.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "SEMA6A"}, {"entity_type": "GENE", "description": "Tap binding protein (TAPBP), is a gene whose 3\'-UTR region methylation level correlates with copper-dependent lysyl oxidase activity (CD).", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "TAPBP"}, {"entity_type": "GENE", "description": "Ral guanine nucleotide dissociation stimulator-like 2 (RGL2) shows promoter region methylation associated with CD.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "RGL2"}, {"entity_type": "GENE", "description": "Cytoskeleton-associated protein 5 (CKAP5), is a gene linked to BCD-LDL through its CpG site methylation levels.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "CKAP5"}, {"entity_type": "GENE", "description": "FOS-like antigen 2 (FOSL2) exhibits significant methylation patterns associated with BCD-LDL marker of oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FOSL2"}, {"entity_type": "GENE", "description": "Family with sequence similarity 20, member C (FAM20C), has CpG site methylation levels significantly linked to BCD-LDL.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FAM20C"}, {"entity_type": "GENE", "description": "FERM domain containing 6 (FRMD6) is a gene whose CpGs are associated with the oxidative marker BCD-LDL.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FRMD6"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Oxidative stress leads to oxidative damage in biological systems, affecting various cellular components and processes.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "OXIDATIVE DAMAGE"}, {"entity_type": "GENE", "description": "EIF3J is involved in protein synthesis regulation and its methylation patterns correlate with oxidative stress markers TGSH and GSH.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT J (EIF3J)"}, {"entity_type": "GENE", "description": "NDUFS7 is a component of the mitochondrial respiratory chain, and its methylation level is associated with oxidative stress marker TGSH or GSH.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "NADH DEHYDROGENASE FE-S PROTEIN 7 (NDUFS7)"}, {"entity_type": "GENE, PROTEIN", "description": "E2F1 is a gene and protein with potential roles in atherosclerosis and coronary heart disease (CHD).", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "E2F1 GENE/PROTEIN"}, {"entity_type": "GENOMIC LOCATION, REGULATORY ELEMENT", "description": "CpG island shores are genomic locations enriched in phenotype-associated CpGs and have potential regulatory functions.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "CPG ISLAND SHORES"}, {"entity_type": "REGULATORY ELEMENT", "description": "Promoters are regions of DNA where transcription factors bind to initiate gene expression; phenotype-associated CpGs are more likely located near them than other CpGs.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "PROMOTERS"}, {"entity_type": "MOLECULAR INTERACTION, REGULATORY ELEMENT", "description": "TF binding sites identified using JASPAR database are potential regulatory elements that influence gene expression.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "TF BINDING SITES (JASPAR DATABASE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "These processes relate to functional annotations of genes clustered into terms such as phosphorylation and phosphate/phosphorus metabolism, which are associated with oxidative stress markers.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "PHOSPHORYLATION AND PHOSPHATE/PHOSPHOROUS METABOLIC PROCESSES"}, {"entity_type": "GENOMIC VARIANT, MOLECULAR INTERACTION", "description": "MeQTLs refer to genetic sequence variants contributing to DNA methylation variation across different genomic locations.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "MEQTLS (METHYLATION QUANTITATIVE TRAIT LOCI)"}, {"entity_type": "GENETIC VARIANT", "description": "SNPs associated with cis-meQTL, indicating the relationship between genotype and DNA methylation levels at a nearby CpG site.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "CIS-MEQTL SNPS"}, {"entity_type": "DISEASE", "description": "CHD is a condition related to coronary heart disease which can be influenced by genetic factors like SNPs associated with oxidative stress markers.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "CHD (CORONARY HEART DISEASE)"}, {"entity_type": "DISEASE", "description": "T2D, or Type 2 diabetes, may have associations mediated through epigenetics and specific genetic variants linked to methylation at CpG sites.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "T2D (TYPE 2 DIABETES)"}, {"entity_type": "RESEARCH ORGANIZATION", "description": "The CARDIoGRAM consortium is a research organization focused on identifying genetic risk factors for coronary heart disease (CHD).", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "CARDIOGRAM CONSORTIUM"}, {"entity_type": "RESEARCH ORGANIZATION", "description": "DIAGRAM consortium is dedicated to studying genetic determinants of type 2 diabetes (T2D) through genome-wide association studies.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "DIAGRAM CONSORTIUM"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant site within the BCL2L11 gene, specifically cg07547695, associated with methylation level and linked to SNP rs726430.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "BCL2L11 GENE CPG SITE (CG07547695)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant site within the CEP55 gene, specifically cg24371383, associated with methylation level and linked to SNP rs12782691.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CEP55 GENE CPG SITE (CG24371383)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant site within the CPB1 gene, specifically cg04072156, associated with methylation level and linked to SNP rs16861015.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CPB1 GENE CPG SITE (CG04072156)"}, {"entity_type": "GENOMIC VARIANT", "description": "An intergenic site on chromosome 4, specifically cg14532755, associated with methylation level and linked to multiple SNPs including rs1665364.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "INTERGENIC SITE ON CHROMOSOME 4 (CG14532755)"}, {"entity_type": "GENOMIC VARIANT", "description": "A CpG site in the 3\'-UTR of histone cluster 1, H4d gene, associated with methylation level and linked to Type 2 Diabetes.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "HISTONE CLUSTER 1 H4D (HIST1H4D) CPG SITE (CG08170869)"}, {"entity_type": "GENOMIC VARIANT", "description": "A CpG site in the body of DVL1 gene, associated with methylation level and linked to Type 2 Diabetes.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "DISHEVELLED-1 (DVL1) CPG SITE (CG03465880)"}, {"entity_type": "GENOMIC VARIANT", "description": "A CpG site within the ZNF341 gene body, associated with methylation level and linked to cardiovascular disease, particularly heart failure.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "ZNF341 CPG SITE (CG11842944)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Oxidative stress is a physiological process involving an imbalance between the production of reactive oxygen species (ROS) and the ability of cells to detoxify them.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "OXIDATIVE STRESS PHYSIOLOGICAL PROCESS"}, {"entity_type": "DISEASE", "description": "A class of diseases that involve the heart and blood vessels, often resulting from poor blood flow leading to heart attack, stroke, or peripheral artery disease.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CARDIOVASCULAR DISEASE (CVD)"}, {"entity_type": "DISEASE", "description": "A condition where part of the myocardium dies due to an extended lack of oxygen supply.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "MYOCARDIAL INFARCTION"}, {"entity_type": "DISEASE", "description": "A chronic condition wherein the heart muscle is unable to pump enough blood to meet the body\'s needs.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "HEART FAILURE"}, {"entity_type": "DISEASE", "description": "A type of stroke that occurs when a major artery in the brain becomes blocked, leading to an insufficient supply of oxygen and nutrients to brain tissue.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "ISCHAEMIC STROKE"}, {"entity_type": "GENE", "description": "A gene involved in apoptosis regulation.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "BCL2L11 GENE"}, {"entity_type": "GENE", "description": "A gene that encodes a centrosomal protein essential for cell division and cytokinesis.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CEP55 GENE"}, {"entity_type": "GENE", "description": "A gene involved in the regulation of calcium signaling pathways.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CPB1 GENE"}, {"entity_type": "PROTEIN", "description": "A protein product encoded by ZNF341, involved in transcriptional regulation.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "ZNF341 GENE PRODUCT"}, {"entity_type": "PROTEIN", "description": "A signaling molecule that functions as a critical link between cell surface receptors and intracellular signal transduction pathways, particularly Wnt signaling.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "DVL1 PROTEIN"}, {"entity_type": "PROTEIN", "description": "A protein product encoded by histone cluster 1, H4d gene, involved in chromatin structure and transcriptional regulation.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "HIST1H4D PROTEIN"}, {"entity_type": "PATHWAY", "description": "Cellular processes involving the production of reactive oxygen species (ROS) and their detoxification by antioxidant mechanisms.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "OXIDATIVE STRESS PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Regulation of gene expression at the transcription level.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "TRANSCRIPTIONAL REGULATION PROCESS"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "Phenotype-associated CpGs located near promoters suggest their potential regulatory influence over gene expression through transcriptional control mechanisms.)", "entity_type": "UNKNOWN", "id": "GENE EXPRESSION REGULATION"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "Identified TF binding sites provide evidence for the functionality of specific regulatory elements in influencing gene expression patterns.)", "entity_type": "UNKNOWN", "id": "REGULATORY ELEMENT FUNCTIONALITY"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "These processes cluster into functional annotations based on their enrichment scores, implying a biological significance related to oxidative stress markers.)", "entity_type": "UNKNOWN", "id": "FUNCTIONAL ANNOTATION CLUSTERING"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "The presence of meQTLs suggests that genetic variation can significantly impact DNA methylation levels, a key epigenetic modification involved in gene regulation.)", "entity_type": "UNKNOWN", "id": "GENETIC VARIATION AND DNA METHYLATION REGULATION"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "Specific SNPs associated with cis-meQTL show modest associations with CHD risk genes identified through GWAS data.)", "entity_type": "UNKNOWN", "id": "CHD RISK GENES"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "This consortium contributes to the analysis of GWAS data aimed at identifying genetic risk factors specific to coronary heart disease (CHD).)", "entity_type": "UNKNOWN", "id": "GWAS DATA ANALYSIS FOR CHD"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "The DIAGRAM consortium facilitates research into understanding genetic risk factors contributing to type 2 diabetes (T2D), enhancing our knowledge of the condition\'s heritability and biological basis.)", "entity_type": "UNKNOWN", "id": "T2D GENETIC RISK FACTORS IDENTIFICATION"}, {"entity_type": "GENE", "description": "The MT-ATP6 gene is located in mitochondrial DNA and codes for a protein subunit of ATP synthase, which plays a crucial role in the electron transport chain.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "MT-ATP6 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a de novo mutation in the MT-ATP6 gene resulting in an amino acid change from Leucine to Arginine at position 156 of the protein.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "MTDNA 8993T>G (C.467T>G, P.LEU156ARG)"}, {"entity_type": "DISEASE", "description": "A neurodegenerative disorder affecting the central nervous system, caused by mutations in mitochondrial DNA or nuclear genes involved in oxidative phosphorylation pathways.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "LEIGH SYNDROME"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The final complex of the electron transport chain that uses energy from electrons to synthesize ATP from ADP and Pi.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "COMPLEX V (ATP SYNTHASE)"}, {"entity_type": "GENE", "description": "A gene encoding a protein involved in mitochondrial oxidative phosphorylation, specifically subunit 8 of NADH dehydrogenase (ubiquinone), which is part of complex I of the electron transport chain.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "NDUFV1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense variant in NDUFV1 gene that results in an amino acid change from Glutamic Acid to Lysine at position 246 of the protein.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "C.736G>A, P.GLU246LYS VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense variant in NDUFV1 gene that results in an amino acid change from Alanine to Threonine at position 117 of the protein.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "C.349G>A, P.ALA117THR VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The first complex of the electron transport chain involved in transferring electrons from NADH to ubiquinone, with concomitant proton pumping across the mitochondrial membrane.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "COMPLEX I (NADH DEHYDROGENASE)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A technique used to sequence only the exons (protein-coding regions) of the genome, which helps in identifying genetic variants associated with diseases.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "EXOME SEQUENCING"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An alignment tool that maps sequencing reads to a reference genome and is used to identify variant calls.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "GSNAP ALIGNMENT TOOL"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants present in some but not all mitochondrial DNA copies within the same cell, indicating a mix of mutated and normal mtDNA sequences.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "HETEROPLASMIC VARIANTS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A technique used to detect specific DNA sequences by cutting them with restriction enzymes and then separating the resulting fragments using gel electrophoresis.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "RFLP ASSAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The lack of proper function in ATP synthase (complex V) that can result from mutations affecting its components, leading to impaired ATP production.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "COMPLEX V DEFICIENCY"}, {"entity_type": "METABOLIC PATHWAY", "description": "A series of redox reactions involving complexes I through IV and the mobile electron carriers ubiquinone (CoQ) and cytochrome c, culminating in complex V (ATP synthase).", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "ELECTRON TRANSPORT CHAIN"}, {"entity_type": "GENE", "description": "The COQ2 gene encodes a protein involved in coenzyme Q10 biosynthesis.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COQ2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a genomic variant located at position c.437 of the COQ2 gene, causing an amino acid change from Serine to Asparagine.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "C.437G>A (SER146ASN)"}, {"entity_type": "DISEASE", "description": "A disease caused by mutations in the COQ2 gene or other genes involved in coenzyme Q10 biosynthesis.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COENZYME Q10 DEFICIENCY"}, {"entity_type": "PROTEIN", "description": "The protein encoded by the COQ2 gene, which is involved in the synthesis of coenzyme Q10.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COQ2 PROTEIN"}, {"entity_type": "GENE", "description": "A mitochondrial gene encoding a subunit of complex I of the electron transport chain.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "MT-ND1 GENE (MITOCHONDRIAL)"}, {"entity_type": "GENOMIC VARIANT", "description": "This is a novel genomic variant found in the MT-ND1 gene, causing heteroplasmic changes in the mtDNA sequence.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "3754C>A MUTATION"}, {"entity_type": "PROTEIN", "description": "One of seven subunits encoded by mitochondrial DNA and part of complex I of the electron transport chain.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "SUBUNIT 1 (MT-ND1)"}, {"entity_type": "DISEASE", "description": "A disease caused by mutations in the MT-ND1 gene, resulting in optic nerve dysfunction.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "LEBER OPTIC ATROPHY"}, {"entity_type": "DISEASE", "description": "A disorder due to mutations affecting complex I of the electron transport chain.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "MITOCHONDRIAL COMPLEX I DEFICIENCY"}, {"entity_type": "DISEASE", "description": "A mitochondrial disease characterized by a wide range of symptoms including neurological and myopathic features, often caused by mutations in mtDNA.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "MELAS SYNDROME"}, {"entity_type": "PROTEIN/MOLECULAR INTERACTION", "description": "A large protein complex involved in the electron transport chain that uses NADH to reduce ubiquinone.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "NADH DEHYDROGENASE COMPLEX (COMPLEX I)"}, {"entity_type": "MOLECULE/NUTRIENT", "description": "A molecule that accepts electrons from NADH dehydrogenase complex (Complex I) as part of oxidative phosphorylation.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "UBIQUINONE"}, {"entity_type": "PROTEIN FEATURE", "description": "An essential binding site on the NADH dehydrogenase protein for flavin mononucleotide, involved in electron transfer.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "FMN BINDING SITE"}, {"entity_type": "PROTEIN", "description": "A hypothetical acidic protein that may be involved in the regulation of complex I activity or electron transport chain functions.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "ELONGATED ACIDIC PROTEIN (EAP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "The process by which genomic DNA is isolated from peripheral blood cells, enriched for exome content, and sequenced to analyze genetic variants.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "PERIPHERAL BLOOD CELLS DNA EXTRACTION AND SEQUENCING PROCESS"}, {"entity_type": "GENOMIC FEATURE/METABOLIC PATHWAY", "description": "A subset of the nuclear genome that encodes proteins involved in various cellular functions including mitochondrial biogenesis.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "NUCLEAR EXOME"}, {"entity_type": "METABOLIC PATHWAY/PHYSIOLOGICAL PROCESS", "description": "Coverage obtained from sequencing the mitochondrial DNA, which is crucial for studying genetic variants related to mitochondrial disorders.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "MTDNA COVERAGE"}, {"entity_type": "MOLECULAR INTERACTION/DISEASE", "description": "A bioinformatics tool used to classify genomic variants into categories based on their potential impact and frequency in a database.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "VARIANT CLASSIFICATION (RUNES)"}, {"entity_type": "GENOMIC VARIANT/PHYSIOLOGICAL PROCESS", "description": "Highly impactful genetic variations classified by RUNES as potentially deleterious to health or function.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "CATEGORY 1-3 VARIANTS"}, {"entity_type": "GENE", "description": "A gene encoding a protein involved in the biosynthesis of coenzyme Q10, which is essential for mitochondrial electron transport chain function.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COENZYME Q2 HOMOLOG, PRENYLTRANSFERASE (COQ2)"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant introduces a premature stop codon at position 387, potentially disrupting COQ2 protein function and leading to coenzyme Q10 deficiency.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "C.1159C>T VARIANT"}, {"entity_type": "GENE/METABOLIC PATHWAY", "description": "A gene encoding one of seven subunits necessary for the proper functioning of complex I in mitochondria, crucial for ATP synthesis.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "MITOCHONDRIAL GENOME-ENCODED NADH DEHYDROGENASE SUBUNIT 1 (MT-ND1)"}, {"entity_type": "GENOMIC VARIANT/MOLECULAR INTERACTION", "description": "A novel heteroplasmic variant identified within the mitochondrial DNA-encoded NADH dehydrogenase subunit 1 gene.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "3754C>A VARIANT IN MT-ND1 GENE"}, {"source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "description": "Mutations in the COQ2 gene can result in coenzyme Q10 deficiency and are associated with specific genetic variants.", "entity_type": "UNKNOWN", "id": "C.437G>A VARIANT AND C.1159C>T VARIANT"}, {"entity_type": "GENE", "description": "The OPRM1 gene is a focus in the text regarding genotype differences in drinking variables and pharmacogenetic effects on alcohol craving and subjective response.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "OPRM1"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant of ALDH2 used as a covariate to control for in analyses related to OPRM1 genotype group differences.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "ALDH2 (RS671)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant of ADH1B also controlled for in the same manner as ALDH2\'s rs671.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "ADH1B (RS1229984)"}, {"entity_type": "DRUG", "description": "A medication tested for its effect on alcohol craving and subjective response, notably associated with side effects like drowsiness and ringing in ears.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "NALTREXONE"}, {"entity_type": "DRUG", "description": "Used as a control in the study to compare against naltrexone\'s effects.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "PLACEBO"}, {"entity_type": "SIDE EFFECT", "description": "A significant medication association found during analyses, more prevalent with naltrexone than placebo use.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "DROWSINESS"}, {"entity_type": "SIDE EFFECT", "description": "Another significant side effect observed specifically for participants on naltrexone compared to placebo users.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "RINGING IN THE EARS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An outcome measured during alcohol infusion sessions, analyzed based on OPRM1 genotype and medication effects.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "ALCOHOL CRAVING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Includes sedation and stimulation levels experienced by participants in response to alcohol consumption, examined across genotypes and drug conditions.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "SUBJECTIVE RESPONSE TO ALCOHOL"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Blood alcohol concentration level used as an important factor influencing subjective responses during the study.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "BRAC LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "AUDIT score is a measure used in drinking variables comparisons among OPRM1 genotype groups.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "AUDIT SCORE"}, {"entity_type": "DISEASE RISK FACTOR", "description": "The number of days participants engaged in drinking alcohol over the past 30 days was compared across OPRM1 genotype groups as part of baseline and demographic comparisons.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "NUMBER OF DRINKING DAYS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure used to compare alcohol consumption patterns between different genotypes during the study period.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "DRINKS PER DRINKING DAY"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant was controlled for in analyses of OPRM1\'s effects on drinking variables and subjective responses, alongside ADH1B.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "ALDH2 GENOTYPE (RS671)"}, {"entity_type": "GENOMIC VARIANT", "description": "Like ALDH2 rs671, this variant was included as a covariate in analyses to understand its influence on drinking behavior and subjective alcohol responses.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "ADH1B GENOTYPE (RS1229984)"}, {"entity_type": "BASELINE MEASURE", "description": "AUQ values are baseline measures of alcohol use that were significant covariates influencing the study results.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "AUQ VALUES"}, {"entity_type": "LIFESTYLE FACTOR", "description": "This status was considered in analyses to determine its role as a moderator of effects related to OPRM1 genotype and medication.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "id": "CURRENT CIGARETTE SMOKING STATUS"}, {"entity_type": "GENOMIC VARIANT", "description": "The ALDH2 genotype is a genetic variant that influences alcohol metabolism and consumption behavior.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "ALDH2 GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "Asp40 carriers have a specific genetic variation affecting their response to alcohol compared to Asn40 homozygotes.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "ASP40 CARRIER GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "Individuals with the Asn40 homozygous genotype exhibit different behavior in alcohol consumption and metabolism as opposed to Asp40 carriers.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "ASN40 HOMOZYGOTE GENOTYPE"}, {"entity_type": "DRUG", "description": "Naltrexone is a medication that affects opioid receptors, used here to study its effects on alcohol self-administration compared to placebo.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "NALTREXONE MEDICATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "This process refers to the voluntary intake of alcohol under controlled conditions, which is influenced by genetic factors such as ALDH2 genotype and medication effects.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 28}]", "id": "ALCOHOL SELF-ADMINISTRATION BEHAVIOR"}, {"entity_type": "GENOMIC VARIANT", "description": "The OPRM1 genotype is a genetic variant that influences opioid receptor function and may impact alcohol consumption behavior.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "OPRM1 GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Baseline stimulation values refer to the initial level of brain activity or other physiological measures before experimental manipulation.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "BASELINE STIMULATION VALUES"}, {"entity_type": "PHYSIOLOGICAL MEASUREMENT", "description": "BrAC is a measure used to determine alcohol concentration in breath, reflecting recent alcohol consumption.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 28}]", "id": "BRAC (BREATH ALCOHOL CONCENTRATION)"}, {"entity_type": "LIFESTYLE FACTOR", "description": "The status of whether an individual smokes nicotine-containing cigarettes and its impact on physiological processes like alcohol consumption.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "NICOTINE SMOKING STATUS"}, {"entity_type": "GENOMIC VARIANT", "description": "The ALDH2 rs671 genotype is a genetic variant that influences daily alcohol consumption and blood cortisol levels, with GG genotype individuals consuming the highest amount of alcohol.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "ALDH2 RS671 GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Daily alcohol consumption varies significantly by ALDH2 genotypes; men with GG genotypes consume more than those with GA or AA genotypes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "DAILY ALCOHOL CONSUMPTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Blood cortisol levels show variation based on ALDH2 genotypes, particularly in men where the GA group has lower levels compared to others.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "CORTISOL LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The distribution of age varies significantly across different ALDH2 genotypes, with the GA genotype group being older than other groups in both sexes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 13}]", "id": "AGE DISTRIBUTION"}, {"entity_type": "DISEASE", "description": "Adjusting for diabetes status in multivariate analysis does not significantly alter the association between alcohol consumption and cortisol levels.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "DIABETES"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Educational attainment is a lifestyle factor that, when adjusted for, does not change the relationship between daily alcohol intake and blood cortisol levels.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "EDUCATION STATUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The genetically predicted amount of alcohol consumption influences blood cortisol level positively in men but shows no significant association in women according to multivariate linear regression models.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "GENETICALLY PREDICTED ALCOHOL CONSUMPTION"}, {"entity_type": "GENE", "description": "The ALDH2 gene is associated with alcohol metabolism, particularly through its rs671 polymorphism which affects daily alcohol consumption.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "ALDH2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs671 genetic polymorphism in the ALDH2 gene influences daily alcohol intake and cortisol levels, showing significant differences among genotypes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "GENETIC POLYMORPHISM (RS671)"}, {"entity_type": "SEXUAL GROUP", "description": "Men show higher baseline characteristics of alcohol consumption compared to women, with significant variations across different genotypes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "MEN"}, {"entity_type": "SEXUAL GROUP", "description": "Women display a lower daily alcohol intake and less variation in cortisol levels compared to men based on ALDH2 genotypes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "WOMEN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cortisol metabolism is influenced by ALDH2 genotypes, showing differential patterns across sexes and genotypic groups.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "CORTISOL METABOLISM"}, {"entity_type": "STATISTICAL MEASURE", "description": "Used in the sensitivity analysis to determine the association between genetically predicted alcohol consumption and blood cortisol levels.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "CONFIDENCE INTERVAL (CI)"}, {"entity_type": "BIOSTATISTICAL METHOD", "description": "This model assesses the direct relationship between daily alcohol consumption and blood cortisol levels without adjusting for confounders.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "UNIVARIATE LINEAR REGRESSION MODEL"}, {"entity_type": "BIOSTATISTICAL METHOD", "description": "Adjusts for factors such as age, physical activity, smoking status, hypertension, diabetes, and education to understand the true association between variables.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "MULTIVARIATE LINEAR REGRESSION MODEL"}, {"entity_type": "BIOSTATISTICAL TECHNIQUE", "description": "Used in sensitivity analysis to establish a causal relationship between genetically predicted alcohol consumption and blood cortisol levels.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "MENDELIAN RANDOMIZATION (MR)"}, {"entity_type": "GENE", "description": "ABCG2 is a gene associated with uric acid levels and hyperuricemia (HUA) risk.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "ABCG2"}, {"entity_type": "GENE", "description": "SLC2A9 is a gene involved in the regulation of uric acid transport and its variants are linked to increased sUA levels and HUA risk.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "SLC2A9"}, {"entity_type": "GENE", "description": "SLC22A12 is a gene associated with uric acid metabolism, but its role in increasing sUA levels or HUA risk may be gender-dependent.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "SLC22A12"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant of the SLC2A9 gene is associated with higher serum uric acid (sUA) levels and increased risk of hyperuricemia, particularly in females.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "RS3733591 SLC2A9 VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant of the ABCG2 gene significantly increases sUA levels and HUA risk across both genders.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "RS2231142 ABCG2 VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant is associated with increased sUA levels in males but not necessarily with an elevated HUA risk.<SEP>This variant of the SLC22A12 gene is associated with increased serum uric acid levels, particularly in males.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "RS893006 SLC22A12 VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum uric acid level is a physiological process that reflects the balance between urate production and excretion.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "SERUM URIC ACID (SUA)"}, {"entity_type": "DISEASE", "description": "A condition characterized by abnormally high levels of serum uric acid, which can lead to gout and other health issues.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "HYPERURICEMIA (HUA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An indicator of kidney function reflecting the level of creatinine in blood serum.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "SERUM CREATININE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A type of lipid present in the bloodstream, indicating fat metabolism and storage.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "TG (TRIGLYCERIDES)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A cholesterol-carrying lipoprotein that is associated with cardiovascular health risks when elevated.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "LDL (LOW-DENSITY LIPOPROTEIN)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A lipoprotein that plays a role in cholesterol metabolism and is generally associated with lower cardiovascular disease risks when high.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "HDL (HIGH-DENSITY LIPOPROTEIN)"}, {"entity_type": "GENOMIC VARIANT", "description": "The SLC2A9 gene variant rs3733951 is associated with serum uric acid (sUA) levels.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "SLC2A9 RS3733951"}, {"entity_type": "GENOMIC VARIANT", "description": "The ABCG2 gene variant rs2231142 influences hyperuricaemia (HUA) risk and serum uric acid (sUA) levels, especially in the presence of cardiovascular risk factors.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 23}]", "id": "ABCG2 RS2231142"}, {"entity_type": "GENOMIC VARIANT", "description": "The SLC22A12 gene variant rs893006 does not show significant association with sUA levels, except in male carriers of the C/C genotype.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "SLC22A12 RS893006"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "sUA (serum uric acid) levels are influenced by genetic variants and cardiovascular risk factors such as obesity, hypertension, and lipid profile anomalies.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "SUA LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A score reflecting the number of alleles associated with high sUA levels is positively correlated with actual sUA levels in both males and females.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "GENETIC RISK SCORE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Factors such as obesity, hypertension, higher triglycerides (TG), lower HDL cholesterol levels are linked to increased HUA risk when combined with specific genetic variants.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 23}]", "id": "CARDIOVASCULAR RISK FACTORS"}, {"entity_type": "DISEASE", "description": "A condition characterized by high uric acid levels in the blood which can lead to gout and kidney stones, influenced by genetic predisposition and lifestyle factors.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 23}]", "id": "HYPERURICAEMIA (HUA)"}, {"entity_type": "GENOMIC VARIANT", "description": "The SLC2A9 C/C genotype is associated with higher serum uric acid (sUA) levels compared to T/T carriers.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "SLC2A9 C/C GENOTYPE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Higher triglyceride (TG) levels are associated with increased serum uric acid (sUA) levels and higher hyperuricaemia (HUA) risk in individuals carrying the ABCG2 rs2231142 T allele.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "id": "TG LEVELS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Higher low-density lipoprotein cholesterol (LDL) levels are associated with increased serum uric acid (sUA) levels and higher hyperuricaemia (HUA) risk in individuals carrying the ABCG2 rs2231142 T allele.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 23}]", "id": "LDL LEVELS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Lower high-density lipoprotein cholesterol (HDL) levels are associated with increased serum uric acid (sUA) levels and higher hyperuricaemia (HUA) risk in individuals carrying the ABCG2 rs2231142 T allele, but not significantly for females.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 23}]", "id": "HDL LEVELS"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs2231142 T allele is a genetic variant associated with increased uric acid levels and hyperuricemia risk.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "id": "RS2231142 T ALLELE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of metabolizing uric acid in the body, which is influenced by genetic factors like rs2231142 T allele.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "id": "URIC ACID METABOLISM"}, {"entity_type": "DISEASE", "description": "A condition characterized by high levels of uric acid in the blood, often associated with certain genetic variants and risk factors.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "id": "HYPERURICEMIA"}, {"source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "description": "The rs3733591 variant of SLC2A9 is significantly associated with increased risk for hyperuricemia, particularly in female subjects.", "entity_type": "UNKNOWN", "id": "SLC2A9 VARIANT"}, {"source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "description": "Variants of the ABCG2 gene affect serum uric acid levels across both genders and populations.", "entity_type": "UNKNOWN", "id": "GENOMIC VARIANT ABCG2"}, {"source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "description": "Variants of the ABCG2 gene affect serum uric acid levels across both genders and populations.", "entity_type": "UNKNOWN", "id": "SERUM URIC ACID LEVELS"}, {"entity_type": "GENE", "description": "The LRP2 gene is associated with kidney function and identified through genome-wide association studies.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "LRP2 GENE"}, {"entity_type": "GENE", "description": "The NFATC1 gene is linked to kidney function, discovered in GWASs of individuals with European ancestry.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "NFATC1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific allele variant associated with a decrease in estimated glomerular filtration rate (eGFR), indicating potential risk for chronic kidney disease.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "EGFR-DECREASING ALLELE"}, {"entity_type": "DISEASE", "description": "Chronic Kidney Disease is defined by eGFR < 60 mL/min/1.73 m2 and/or incidence of ESRD, influenced by genetic factors such as the lead SNPs identified in the study.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "CKD"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant within the UNCX gene showing significant association with chronic kidney disease risk.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "UNCX GENE VARIANT (RS62435145)"}, {"entity_type": "GENE, GENOMIC VARIANT", "description": "The ALMS1 gene and its associated SNP are linked to chronic kidney disease risk as indicated by genome-wide association studies.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "ALMS1 GENE (RS7587577)"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant in the PDILT-UMOD locus showing significant linkage to chronic kidney disease and eGFR, identified through whole-genome sequencing and long-range haplotype imputation.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "PDILT-UMOD GENE VARIANTS (RS77924615)"}, {"entity_type": "GENE, GENOMIC VARIANT", "description": "The PRKAG2 gene variant is associated with changes in eGFR in individuals with diabetes, indicating a role in kidney function regulation.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "PRKAG2 GENE VARIANTS (RS7463059)"}, {"entity_type": "DISEASE", "description": "Diabetes types 2 (T2D) and 1 (T1D) contribute to the risk of chronic kidney disease and influence eGFR as indicated by genetic studies.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "T2D AND T1D"}, {"entity_type": "GENE, GENOMIC VARIANT", "description": "The LRP2 gene variant rs57989581 is associated with kidney function in individuals across different ancestry groups.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "LRP2 GENE (RS57989581)"}, {"entity_type": "GENE, GENOMIC VARIANT", "description": "The NFATC1 gene variant rs8096658 has been linked to an increased risk of kidney function impairment according to genome-wide studies.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "NFATC1 GENE (RS8096658)"}, {"entity_type": "GENE, GENOMIC VARIANT", "description": "A specific variant in the PDILT-UMOD locus associated with chronic kidney disease and significant impact on eGFR.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "PDILT-UMOD GENE (RS77924615)"}, {"entity_type": "GENE, GENOMIC VARIANT", "description": "Variants within the SLC34A1 gene linked to changes in estimated glomerular filtration rate (eGFR) and kidney function.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "SLC34A1 GENE VARIANTS (RS7805792)"}, {"entity_type": "GENE, GENOMIC VARIANT", "description": "The GCKR gene variant rs1260326 is associated with changes in eGFR and has been localized through fine mapping studies.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "GCKR GENE VARIANTS (RS1260326)"}, {"entity_type": "GENE, GENOMIC VARIANT", "description": "Variants within the DCDC5-MPPED2 locus associated with changes in eGFR and chronic kidney disease risk.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "DCDC5-MPPED2 GENE VARIANTS (RS7944877)"}, {"entity_type": "GENE", "description": "NFATC1 is a gene that plays a central role in inducible gene transcription during immune response.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "NFATC1"}, {"entity_type": "GENE", "description": "SLC34A1 is involved in kidney function and is associated with variants impacting eGFR levels.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "SLC34A1"}, {"entity_type": "GENOMIC VARIANT", "description": "This missense variant has been shown to result in increased de novo triglyceride and cholesterol synthesis, decreased plasma glucose concentrations, and associated with risk of CKD.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "GCKR P.PRO446LEU (RS1260326)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "DNase I Hypersensitive Sites (DHSs) are DNA regions where chromatin is more accessible to DNase I digestion.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "DHSS FOR 145 CELL TYPES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These refer to the genomic locations where specific transcription factors bind, which can regulate gene expression.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "CHIP-SEQ BINDING SITES FOR 165 TRANSCRIPTION FACTORS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Histone Deacetylase 8 (HDAC8) binding sites are critical for kidney function and development.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "HDAC8 BINDING SITES"}, {"entity_type": "GENE", "description": "Regulator of G protein signaling family member, modulates downstream effects of G\u03b1 subunits, with unknown function in kidneys.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "RGS14"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "This process involves the regulation and transcriptional activity driven by NFATC1 gene.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "NFATC1 GENE EXPRESSION REGULATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These are specific DNA sequences where transcription factors bind to regulate gene expression.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "TRANSCRIPTION FACTOR BINDING SITES (TFBS)"}, {"entity_type": "PROTEIN", "description": "HDACs are a family of enzymes involved in modifying histones, affecting chromatin structure and transcriptional regulation.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "HISTONE DEACETYLASES (HDACS)"}, {"entity_type": "DRUG", "description": "An immunosuppressant drug that targets NFATC1 as part of its mechanism of action.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "CYCLOSPORINE A"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Expression Quantitative Trait Loci (eQTL) influencing the expression levels of NFATC1 and RGS14 genes in multiple tissues.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "EQTLS FOR NFATC1 AND RGS14"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process involving maintaining ion concentrations within biological systems, particularly relevant to kidney function.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "IONIC REGULATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "This describes the sensitivity of organisms to dietary salt intake and its impact on health conditions like hypertension or heart disease.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "SALT SENSITIVITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Regulation that involves maintaining balance between water concentration inside cells and outside, critical for cell survival.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "OSMOTIC REGULATION"}, {"entity_type": "DISEASE", "description": "A long-term condition in which the kidneys lose their ability to filter blood effectively.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "CKD (CHRONIC KIDNEY DISEASE)"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants at the NFATC1 locus are associated with changes in gene expression regulation.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "NFATC1 VARIANTS"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants at SLC34A1 locus impact eGFR levels and regulatory chromatin state in kidney cells.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "SLC34A1 VARIANTS"}, {"entity_type": "CELL TYPE", "description": "These cells are involved in developmental processes and play a role in understanding gene regulation during early development.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "FETAL KIDNEY CELLS"}, {"entity_type": "CELL TYPE", "description": "These cells are crucial for kidney function and studies show that DHSs in RPTECs influence the posterior probability of driving association signals with eGFR.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "ADULT RENAL PROXIMAL TUBULAR EPITHELIAL CELLS (RPTECS)"}, {"entity_type": "CELL TYPE", "description": "Cells important for kidney physiology, especially in renal function and disease mechanisms.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "RENAL CORTICAL EPITHELIAL CELLS (HRCES)"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants at the SLC34A1 locus are also eQTLs for RGS14 in multiple tissues, indicating its role in eGFR regulation.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "RGS14 VARIANTS"}, {"entity_type": "GENOMIC VARIANT", "description": "These variants in Drosophila melanogaster reduce expression of the loco gene and are associated with improved survival under salt stress conditions.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "LOCO LOSS-OF-FUNCTION VARIANTS"}, {"entity_type": "DRUG", "description": "A drug used for suppressing immune responses, particularly relevant in organ transplantation, targeting NFATC1 as a downstream target.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "TRANSPLANT IMMUNOSUPPRESSION DRUG (CYCLOSPORINE A)"}, {"entity_type": "GENE", "description": "The loco gene has a role in resistance to salt stress in Drosophila mutants.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "LOCO GENE"}, {"entity_type": "PROTEIN", "description": "NFATC1 is a protein whose renal mRNA expression decreases significantly during high-salt exposure and chronic kidney disease (CKD).", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "NFATC1 PROTEIN"}, {"entity_type": "PROTEIN", "description": "RGS14 is a protein whose renal mRNA expression also shows significant reduction in high-salt diet conditions and trends towards reduction in CKD.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "RGS14 PROTEIN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "An environmental factor that alters the gene expression of NFATC1 and RGS14 in mice, contributing to kidney dysfunction.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "HIGH-SALT DIET"}, {"entity_type": "DISEASE", "description": "A disease condition induced by sub-total nephrectomy, associated with changes in renal mRNA expression of NFATC1 and RGS14.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "CHRONIC KIDNEY DISEASE (CKD)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A physiological process related to kidney function that is exacerbated by salt sensitivity in mice.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "GLOMERULOSCLEROSIS"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific genomic variants of the loco gene in Drosophila that exhibit resistance to salt stress.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "LOCO MUTANTS (Y1W1; LOCOD06164/+ AND Y1W1; LOCOEY-P283/+) "}, {"entity_type": "GENOMIC VARIANT", "description": "These are genetically identical control strains used for comparison with LoCo mutants to study the effects of genetic modifications on salt stress resistance.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "ISOGENIC CONTROLS (Y1W1)"}, {"entity_type": "GENOMIC VARIANT", "description": "Strains resulting from crossbreeding different genetic backgrounds, used for studying the role of loco gene in salt resistance.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "HYBRID HETEROGENIC STRAINS "}, {"entity_type": "GENOMIC VARIANT", "description": "A specific mouse strain known to be salt-sensitive and susceptible to glomerulosclerosis, used as a model for studying kidney disease.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "129S6 MOUSE STRAIN "}, {"entity_type": "GENE", "description": "The gene that encodes the NFATC1 protein, which is involved in regulating renal mRNA expression during high-salt diet exposure and CKD.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "NFATC1 GENE "}, {"entity_type": "GENE", "description": "The gene that codes for RGS14 protein, whose renal mRNA levels are altered under conditions of salt stress and chronic kidney disease.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "RGS14 GENE "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A surgical procedure that involves the removal of a part of one or both kidneys, used to induce chronic kidney disease (CKD) in experimental models.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "SUB-TOTAL NEPHRECTOMY "}, {"entity_type": "NUTRIENT", "description": "Sodium chloride, an environmental factor and dietary salt component that influences gene expression in renal tissue when administered in high concentrations.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "NACL "}, {"source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "description": "Variants within the PDILT-UMOD locus, notably rs77924615, impact both chronic kidney disease risk and estimated glomerular filtration rate.", "entity_type": "UNKNOWN", "id": "CKD, EGFR"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "The GCKR missense variant is associated with metabolic changes that increase the risk of cardiovascular diseases, such as CKD.", "entity_type": "UNKNOWN", "id": "CARDIOVASCULAR DISEASE RISK"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "Binding of HDAC8 to specific genomic regions may regulate kidney function and development through chromatin modification.", "entity_type": "UNKNOWN", "id": "KIDNEY FUNCTION REGULATION"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "These variants are eQTLs for RGS14 and NFATC1 in multiple tissues, indicating their regulatory roles.", "entity_type": "UNKNOWN", "id": "GENE EXPRESSION IN TISSUES"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "Studies on DHSs in fetal kidney cells suggest that these cells play a role in early gene regulation during development.", "entity_type": "UNKNOWN", "id": "GENOMIC REGULATION"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "These cells indicate that DHSs play a crucial role in the posterior probability of driving association signals with eGFR.", "entity_type": "UNKNOWN", "id": "GENE REGULATION MECHANISMS"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "The gene RGS14, influenced by variants at SLC34A1 locus, is involved in immune responses and regulation.", "entity_type": "UNKNOWN", "id": "IMMUNE RESPONSE"}, {"source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "description": "These variants reduce expression of loco gene, improving survival under salt stress conditions in Drosophila.", "entity_type": "UNKNOWN", "id": "SALT SENSITIVITY REGULATION"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "The loco gene plays a role in conferring resistance against salt stress, especially evident in mutant strains of Drosophila when supplemented with NaCl.", "entity_type": "UNKNOWN", "id": "SALT STRESS RESISTANCE"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "When compared with isogenic controls under non-NaCl conditions, loco mutants show no significant differences in viability, indicating the specific role of NaCl supplementation.", "entity_type": "UNKNOWN", "id": "ISOGENIC CONTROLS"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "In hybrid heterogenic strains, loco mutants exhibit salt-resistance similar to their isogenic counterparts, excluding effects due to inbreeding depression.", "entity_type": "UNKNOWN", "id": "HYBRID HETEROGENIC STRAINS"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "In hybrid heterogenic strains, loco mutants exhibit salt-resistance similar to their isogenic counterparts, excluding effects due to inbreeding depression.", "entity_type": "UNKNOWN", "id": "LOCO MUTANTS"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "The 129S6 mouse strain serves as a model for studying the regulation of NFATC1 gene expression under conditions of high salt intake and CKD.", "entity_type": "UNKNOWN", "id": "129S6 MOUSE STRAIN"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "Renal mRNA levels of RGS14 are significantly reduced after exposure to a high-salt diet, indicating its role in kidney dysfunction under stress conditions.", "entity_type": "UNKNOWN", "id": "RGS14 GENE"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "The procedure of sub-total nephrectomy induces chronic kidney disease in mice models, leading to alterations in renal mRNA expression of RGS14 and NFATC1 genes.", "entity_type": "UNKNOWN", "id": "CKD MODEL"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "The procedure of sub-total nephrectomy induces chronic kidney disease in mice models, leading to alterations in renal mRNA expression of RGS14 and NFATC1 genes.", "entity_type": "UNKNOWN", "id": "SUB-TOTAL NEPHRECTOMY"}, {"entity_type": "DISEASE", "description": "A bacterial infection caused by Campylobacter species, commonly affecting gastrointestinal health.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "CAMPYLOBACTER INFECTIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant resulting in resistance to quinolone antibiotics in Campylobacter strains.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "QUINOLONE RESISTANCE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant leading to resistance against erythromycin, an antibiotic used for bacterial infections.<SEP>A specific genetic mutation leading to erythromycin resistance, observed primarily in C. coli isolates.<SEP>Erythromycin resistance is a genomic variant present in some Campylobacter jejuni and C. coli isolates that confers resistance to the antibiotic erythromycin.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9<SEP>chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "ERYTHROMYCIN RESISTANCE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Foreign travel was associated with a higher prevalence of quinolone-resistant Campylobacter infections, indicating the influence of environment on disease susceptibility.<SEP>Foreign travel was associated with a higher prevalence of quinolone-resistant Campylobacter isolates, highlighting the influence of environment on disease susceptibility.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "TRAVEL"}, {"entity_type": "DISEASE", "description": "Infections caused by two species of Campylobacter bacteria differing in their geographical origin and resistance patterns.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "C. COLI AND C. JEJUNI INFECTIONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The duration patients experience symptoms from a disease, which can vary based on the type of infection (quinolone-resistant vs. quinolone-sensitive).<SEP>The period during which a patient experiences symptoms from an infection, varying with the type of bacterial strain (quinolone-resistant vs. quinolone-sensitive).", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "DURATION OF ILLNESS"}, {"entity_type": "DISEASE", "description": "Infections caused by two species of Campylobacter bacteria differing in their geographical origin and resistance patterns.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "C. JEJUNI AND C. COLI INFECTIONS"}, {"entity_type": "DIETARY PATTERN", "description": "A dietary pattern associated with increased risk of quinolone-resistant Campylobacter infections.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "EATING FRESH POULTRY OTHER THAN CHICKEN AND TURKEY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Engaging in swimming as an activity that increases the risk for quinolone-resistant C. jejuni infections.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "SWIMMING"}, {"entity_type": "DEMOGRAPHIC FACTOR", "description": "The age of patients affected by Campylobacter infections, with no significant difference found between younger and older groups (younger or older than 15 years) in terms of resistance patterns.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "AGE GROUP"}, {"entity_type": "DRUG", "description": "A class of antibiotics that includes quinolone drugs used to treat bacterial infections.<SEP>Fluoroquinolones are antibiotics used in the treatment of campylobacteriosis; however, resistance against fluoroquinolones was observed among some isolates.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9<SEP>chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "FLUOROQUINOLONES"}, {"entity_type": "STUDY DESIGN", "description": "A method to identify risk factors for specific types of infections by comparing cases with similar characteristics.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "CASE-COMPARISON STUDY"}, {"entity_type": "GENE (INDIRECT)", "description": "Campylobacter jejuni is a bacterial pathogen that can cause campylobacteriosis and may contain genes related to resistance against antimicrobial agents.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "CAMPYLOBACTER JEJUNI"}, {"entity_type": "GENOMIC VARIANT", "description": "Nalidixic acid resistance is a genomic variant that confers resistance to the antibiotic nalidixic acid in Campylobacter jejuni isolates.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "NALIDIXIC ACID RESISTANCE"}, {"entity_type": "DIETARY PATTERN", "description": "Consumption of fresh poultry other than chicken and turkey was found to be associated with a higher likelihood of domestically acquired quinolone-resistant Campylobacter infections.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "FRESH POULTRY OTHER THAN CHICKEN AND TURKEY"}, {"entity_type": "DRUG", "description": "Macrolides represent another class of antibiotics used for treating campylobacteriosis, with a lower prevalence of resistance compared to fluoroquinolones.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "MACROLIDES"}, {"entity_type": "DISEASE", "description": "Campylobacteriosis is an infection caused by Campylobacter bacteria that can lead to gastroenteritis and may be treated with antimicrobial agents.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "CAMPYLOBACTERIOSIS"}, {"entity_type": "GENE (INDIRECT)", "description": "Campylobacter coli is a bacterial pathogen that can cause campylobacteriosis similar to Campylobacter jejuni.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "C. COLI"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Isolates from retail food products, including chicken, turkey, pork, and broiler chickens, were compared with human isolates for resistance patterns and origin analysis.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "RETAIL FOOD PRODUCTS AND BROILER CHICKENS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The geographic area and time period of both human and animal isolations are critical factors in comparing infection sources and origins.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "GEOGRAPHIC AREA AND TIME PERIOD"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "Consumption of fresh poultry other than chicken and turkey is associated with a higher risk of domestically acquired quinolone-resistant Campylobacter infections.", "entity_type": "UNKNOWN", "id": "DOMESTICALLY ACQUIRED QUINOLONE-RESISTANT INFECTIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located on HTR2A gene that is significantly associated with social disinhibition.<SEP>The minor allele for rs9534511 is associated with an increased risk of social disinhibition, with a parameter estimate of 0.32 (95% CI = 0.14\u20130.50, P < 0.001).", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS9534511"}, {"entity_type": "GENE", "description": "Serotonin receptor 2A gene, which has a SNP (rs9534511) linked to an increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "HTR2A GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located on HTR3B that is significantly associated with social disinhibition.<SEP>The minor allele for rs4938056 is associated with an increased risk of social disinhibition.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS4938056"}, {"entity_type": "GENE", "description": "Serotonin receptor 3B gene, which has a SNP (rs4938056) linked to an increased risk of social disinhibition.<SEP>Serotonin receptor 3B gene, which has an additional SNP (rs7514628) linked to an increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "HTR3B GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located in the intronic region of OPRM1 gene that is significantly associated with social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS1998220"}, {"entity_type": "GENE", "description": "Opioid receptor mu 1 gene, which has an intronic SNP (rs1998220) linked to an increased risk of social disinhibition.<SEP>Opioid receptor mu 1 gene, which has another intronic SNP (rs3025971) linked to an increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "OPRM1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the intronic region of KCNC1 gene that is significantly associated with social disinhibition.<SEP>The minor allele for rs1003921 is associated with a strong protective effect against social disinhibition, with a parameter estimate of \u22120.64 (95% CI = \u22121.13 to \u22120.15, P = 0.011).", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS1003921"}, {"entity_type": "GENE", "description": "Potassium voltage-gated channel subfamily C member 1, which has an intronic SNP (rs1003921) linked to an increased risk of social disinhibition.<SEP>Potassium voltage-gated channel subfamily C member 1, which has another intronic SNP (rs12830955) linked to an increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "KCNC1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the intergenic region downstream of NPY that is significantly associated with social disinhibition.<SEP>The minor allele for rs16116 is associated with a protective effect against social disinhibition, with a parameter estimate of \u22120.29 (95% CI = \u22120.48 to \u22120.09, P = 0.004).", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS16116"}, {"entity_type": "GENE", "description": "Neuropeptide Y gene, which has an intergenic SNP (rs16116) linked to an increased risk of social disinhibition.<SEP>Neuropeptide Y gene, which has another intergenic SNP (rs16867458) linked to an increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "NPY GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP part of LINC00518 that is significantly associated with social disinhibition.<SEP>The minor allele for rs16870286 is associated with a protective effect against social disinhibition.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS16870286"}, {"entity_type": "GENE", "description": "Long intergenic non-protein coding RNA 518, which has a SNP (rs16870286) linked to an increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "LINC00518 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure reflecting the extent to which youth deviate from social norms and engage in risky behaviors, influenced by demographic characteristics, psychosocial factors, and genetic variants.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "SOCIAL DISINHIBITION SCORE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Level of education attained by parents is an environmental factor that influences social disinhibition but was not significantly associated in the final model.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "PARENTAL EDUCATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A score reflecting the degree to which youth are assimilated into a new cultural environment, positively correlated with higher levels of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "LINGUISTIC ACCULTURATION SCORE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Transactional Assessment System (TAS) and Depressive Anhedonia Scale (DAS) scores were significantly associated with increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "TAS AND DAS SCORES"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located in the intronic region of OPRM1 gene that is significantly associated with social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS3025971"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located in the intergenic region downstream of NPY that is significantly associated with social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS16867458"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the intronic region of KCNC1 gene that is significantly associated with social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "RS12830955"}, {"entity_type": "DISEASE", "description": "Social disinhibition is a condition or behavior trait that can be influenced by genetic factors such as specific SNPs.<SEP>Social disinhibition is influenced by genetic factors such as specific SNPs.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "id": "SOCIAL DISINHIBITION"}, {"source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "description": "These SNPs are part of the group associated with an increased risk of social disinhibition, compared to protective effects shown by other SNPs.", "entity_type": "UNKNOWN", "id": "RS9534511 AND RS4938056"}, {"source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "description": "These SNPs are associated with a protective effect against social disinhibition.", "entity_type": "UNKNOWN", "id": "RS16116, RS16870286, AND RS1003921"}, {"source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "description": "These SNPs are associated with a protective effect against social disinhibition.", "entity_type": "UNKNOWN", "id": "SOCIAL DISINHIBITION (PROTECTIVE)"}, {"source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "description": "These SNPs are associated with an increased risk of social disinhibition.", "entity_type": "UNKNOWN", "id": "RS1998220, RS9534511, AND RS4938056"}, {"source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "description": "These SNPs are associated with an increased risk of social disinhibition.", "entity_type": "UNKNOWN", "id": "SOCIAL DISINHIBITION (RISK)"}, {"entity_type": "GENE", "description": "The CNR1 gene codes for cannabinoid receptor 1, which is involved in modulating mesocorticolimbic neurocircuitry and is associated with drug-seeking behavior.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "CNR1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Rs2023239 is a genetic variant located upstream of exon 3 in the CNR1 gene, described as an alternative promoter that influences CB1 receptor levels and binding.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "RS2023239 GENOMIC VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The level of CB1 receptors in postmortem human prefrontal cortex (PFC) is influenced by genetic variation in the CNR1 gene, such as rs2023239.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "CB1 RECEPTOR BINDING LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The mesocorticolimbic neurocircuitry involves brain regions modulated by CB1 receptor levels and activity that is linked to drug-seeking behavior, particularly in the context of alcohol addiction.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "MESOCORTICOLIMBIC NEUROCIRCUITRY"}, {"entity_type": "METABOLIC PATHWAY", "description": "A neuroimaging study investigates the differential activation of brain structures during exposure to alcohol cues in individuals with different genotypes at rs2023239, showing greater activation in NAcc, VMPFC, VTA, and OFC for CT genotype compared to TT genotype.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "NEUROIMAGING STUDY ON BRAIN ACTIVATION "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The AUDIT score measures alcohol use disorder severity and correlates with brain activation in the ventromedial prefrontal cortex (VMPFC) in individuals with the CT genotype at rs2023239.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "ALCOHOL USE DISORDER SCORE (AUDIT)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The total AUQ score measures alcohol craving and correlates significantly with left and right orbitofrontal cortex activation in those with the CT genotype, indicating a link between genetic variation and subjective craving experiences.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "URGE TO CONSUME ALCOHOL (AUQ SCORE)"}, {"entity_type": "METABOLIC PATHWAY", "description": "Individuals carrying the rs2023239 CT or CC genotypes report significantly greater reward sensitivity after consuming alcohol compared to those with TT genotype, based on repeated-measures ANOVA.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "SHORT-TERM EFFECTS OF ALCOHOL ON REWARD SENSITIVITY "}, {"entity_type": "LIFESTYLE FACTOR", "description": "Smoking tobacco is a lifestyle factor that was considered in the study but did not show significant differences between genotypes at rs2023239.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "TOBACCO SMOKING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The past-month quantity of alcohol use was measured using a 30-day timeline follow-back method and showed no significant difference between individuals with TT or CT/CC genotypes at rs2023239.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "PAST-MONTH QUANTITY OF ALCOHOL USE "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Breath alcohol levels after consumption of three drinks did not differ significantly by genotype (TT vs CT/CC) in the study on short-term effects of alcohol on reward sensitivity.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "BREATH ALCOHOL LEVELS "}, {"entity_type": "GENOMIC VARIANT", "description": "The genomic variant rs2023239 is found in the region upstream of exon 3 of CNR1, which has been described as an alternative promoter.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "RS2023239 GENOMIC VARIANT - EXON REGION "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CB1 receptor binding levels influenced by rs2023239 are particularly relevant in Brodmann areas 9 and 10 of the prefrontal cortex, indicating localized effects on neural function.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "BRODMANN AREAS 9 AND 10 "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The NAcc is a brain region activated differentially between CT and TT genotypes during alcohol exposure, suggesting genetic modulation of reward processing.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "NUCLEUS ACCUMBENS (NACC) "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "VMPFC activation correlates with AUDIT scores in individuals carrying the rs2023239 CT genotype, linking genetic variation to brain function during alcohol craving.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "VENTRAL MIDBRAIN PREFRONTAL CORTEX (VMPFC) "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "VTA is one of the regions showing differential activation between TT and CT genotypes in response to alcohol exposure, indicating its role in reward processing mediated by CNR1 gene variation.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "VENTRAL TEGMENTAL AREA (VTA) "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Activation in both left and right OFC correlates with AUQ scores in individuals carrying the rs2023239 CT genotype, linking genetic influence to alcohol craving.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "ORBITOFRONTAL CORTEX (OFC) "}, {"entity_type": "LIFESTYLE FACTOR", "description": "The AUDIT score measures alcohol use disorder severity and is used as an indicator of behavioral impact of CNR1 gene variation.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "AUDIT SCORE "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Total AUQ score measures the subjective urge to consume alcohol, which correlates with brain activation patterns in specific regions like OFC in individuals carrying CT genotype at rs2023239.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "AUQ SCORE "}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the CNR1 gene identified by its rs number, linked to differential responses to alcohol consumption and olanzapine treatment.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "RS2023239"}, {"entity_type": "GENE", "description": "The CNR1 gene is involved in cannabinoid signaling that influences reward pathways and may interact with genotypes and medications such as olanzapine.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "CNR1"}, {"entity_type": "DRUG", "description": "An antipsychotic medication that targets the dopamine system, used to treat mental health conditions and studied for its interaction with CNR1 gene variations.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "OLANZAPINE"}, {"entity_type": "DRUG", "description": "A drug used as an active control in studies examining interactions between genotypes and medications on alcohol consumption responses.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "CYPROHEPTADINE HYDROCHLORIDE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A treatment condition used in clinical trials where participants are given a substance with no active pharmacological effect to assess the efficacy of an intervention, such as olanzapine, on cue-elicited craving and drinking behavior.<SEP>Used as a comparison in assessing colesevelam\'s differential effects on AC t1/2, GC24, and CT.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070<SEP>chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "PLACEBO TREATMENT"}, {"entity_type": "DRUG", "description": "A medication used in studies as a comparison against olanzapine for its effects on alcohol consumption and reward pathways in individuals with specific CNR1 genotypes.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "ACTIVE CONTROL MEDICATION (CYPROHEPTADINE)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A neural system involved in regulating reward, motivation, and motor functions; targeted by medications like olanzapine which can interact with genetic factors such as CNR1 variations.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "DOPAMINE SYSTEM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Behavioral responses to environmental cues that trigger alcohol consumption, influenced by genotypes and medication treatments.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "CUE-ELICITED DRINKING BEHAVIOR"}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "CNR1 gene variants like rs2023239 affect mesocorticolimbic neurocircuitry by altering CB1 receptor levels, influencing drug-seeking behavior.", "entity_type": "UNKNOWN", "id": "CB1 RECEPTOR BINDING LEVELS "}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "CNR1 gene variants like rs2023239 affect mesocorticolimbic neurocircuitry by altering CB1 receptor levels, influencing drug-seeking behavior.", "entity_type": "UNKNOWN", "id": "MESOCORTICOLIMBIC NEUROCIRCUITRY "}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "Both tobacco smoking and past-month quantity of alcohol use were considered as factors in the study but showed no significant differences related to genotypes at rs2023239, suggesting no confounding effects.", "entity_type": "UNKNOWN", "id": "TOBACCO SMOKING "}, {"source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "description": "The genetic variant rs2023239 is located upstream of exon 3 in the CNR1 gene, suggesting its role as an alternative promoter affecting CB1 receptor expression.", "entity_type": "UNKNOWN", "id": "CNR1 GENE "}, {"source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "description": "Individuals with the CT genotype report significantly greater reward from drinking alcoholic beverages compared to other genotypes.", "entity_type": "UNKNOWN", "id": "REWARD"}, {"source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "description": "The drug olanzapine interacts with self-reported high measures, showing different effects based on participant genotypes.", "entity_type": "UNKNOWN", "id": "SELF-REPORTED HIGH"}, {"source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "description": "Individuals receiving placebo treatment showed increased cue-elicited craving compared to those treated with olanzapine in the context of specific CNR1 genotypes.", "entity_type": "UNKNOWN", "id": "CUE-ELICITED CRAVING"}, {"entity_type": "GENE", "description": "The LPL gene encodes for lipoprotein lipase (LPL), an enzyme crucial in lipid metabolism by catalyzing the hydrolysis of triglycerides in chylomicrons and very-low-density lipoproteins (VLDL). Mutations in this gene can lead to severe hypertriglyceridemia.<SEP>The LPL gene is involved in lipid metabolism, specifically the hydrolysis of chylomicrons.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LPL GENE"}, {"entity_type": "PROTEIN", "description": "LPL is a protein responsible for the hydrolysis of chylomicrons and other lipids.<SEP>LPL protein plays a critical role in lipid metabolism through hydrolysis of chylomicrons.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "LIPOPROTEIN LIPASE (LPL)"}, {"entity_type": "NUTRIENT", "description": "Dietary fat is packaged into chylomicrons and undergoes processing by LPL for further metabolism.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "DIETARY FAT"}, {"entity_type": "NUTRIENT", "description": "MCTs are a form of dietary fat that does not require LPL activity for metabolism.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "MEDIUM-CHAIN TRIGLYCERIDES (MCT)"}, {"entity_type": "TRANSCRIPT", "description": "Chylomicrons are lipoprotein particles synthesized in the small intestine to transport dietary triglycerides.<SEP>Large lipoprotein particles secreted into the blood from the intestine after a meal rich in fats, which transport dietary triglycerides to adipose and muscle tissues for storage or energy use.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "CHYLOMICRONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A clinical feature associated with LPL deficiency, characterized by lipid deposition in the eye due to high levels of blood triglycerides.<SEP>A condition where retinal veins appear white due to lipoprotein particles in the blood leading to fat deposition and vessel occlusion, typically observed at triglyceride levels over 2500 mg/dl.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LIPEMIA RETINALIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An acute skin eruption consisting of small yellow papules typically appearing on shoulders, buttocks and limbs due to high levels of triglycerides (TG) exceeding 2000 mg/dl.<SEP>Yellow papules on skin caused by cholesterol-rich deposits under the epidermis, a symptom of hypertriglyceridemia.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "ERUPTIVE XANTHOMAS"}, {"entity_type": "PROTEIN", "description": "A molecule responsible for transporting LPL to capillary lumen for lipid metabolism.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "GPIHBP1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition characterized by abnormally high levels of triglycerides in the blood, often resulting from genetic mutations like those found in the LPL gene.<SEP>An abnormal elevation of triglycerides in the blood, often seen in patients with LPL deficiency.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "HYPERTRIGLYCERIDEMIA"}, {"entity_type": "DISEASE", "description": "A rare autosomal recessive disorder caused by mutations in the LPL gene leading to decreased lipoprotein lipase activity.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "LPL DEFICIENCY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "An environmental or genetic factor influencing disease prevalence, specifically noted for this case study patient.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "PUERTO RICAN DESCENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which lipoprotein lipase (LPL) breaks down chylomicrons into free fatty acids and monoglycerides.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "CHYLOMICRON HYDROLYSIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A test measuring levels of various lipids in the blood after a period without food, used to diagnose lipid metabolism disorders such as LPL deficiency.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "FASTING LIPID PROFILE"}, {"entity_type": "NUTRIENT", "description": "Special dietary formula with high MCT content designed for patients with certain metabolic conditions.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "ENFAPORT LIPIL FORMULA"}, {"entity_type": "NUTRIENT", "description": "A component of the diet tailored to avoid lipoprotein lipase activity and manage hypertriglyceridemia effectively.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "MEDIUM-CHAIN TRIGLYCERIDES (MCT) FAT CONTENT IN ENFAPORT LIPIL"}, {"entity_type": "DISEASE", "description": "Condition where both copies of the LPL gene are mutated, leading to severe lipid metabolism impairment.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "HOMOZYGOUS LPL DEFICIENCY"}, {"entity_type": "DISEASE", "description": "A less severe but still debilitating form of LPL deficiency where two different mutations in one allele cause disease symptoms.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "COMPOUND HETEROZYGOUS LPL DEFICIENCY"}, {"entity_type": "GENOMIC VARIANT", "description": "Reported mutation in the LPL gene leading to a substitution of glycine to glutamic acid at position 215, causing functional impairment.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "MUTATION P.G215E (C.644G>A)"}, {"entity_type": "GENOMIC VARIANT", "description": "Novel mutation identified in exon 5 of the LPL gene, leading to a substitution of glutamine to histidine at position 240.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "MUTATION P.Q240H (C.721G>T)"}, {"entity_type": "GENOMIC VARIANT", "description": "A novel genomic variant, specifically a missense mutation at position 240 changing glutamine (Q) to histidine (H), in the LPL gene identified in a patient presenting with severe hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "GENOMIC VARIANT: P.Q240H MUTATION"}, {"entity_type": "PROTEIN", "description": "The lipoprotein lipase protein, encoded by the LPL gene, is essential for lipid metabolism by breaking down triglycerides into free fatty acids and monoacylglycerols.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LIPOPROTEIN LIPASE PROTEIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition caused by excessive thickening of bodily fluids due to high lipid content, often associated with elevated triglycerides leading to abdominal pain and gastrointestinal hemorrhage.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "HYPERVISCOSITY SYNDROME"}, {"entity_type": "DISEASE", "description": "Inflammation of the pancreas commonly occurring in patients with LPL deficiency and hypertriglyceridemia, risk increases as triglyceride levels rise above 1000 mg/dl.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "PANCREATITIS"}, {"entity_type": "NUTRIENT", "description": "A dietary supplement containing medium-chain fatty acids that are directly absorbed into the portal vein and used for energy, useful in managing hypertriglyceridemia without compromising nutritional needs.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "MCT (MEDIUM CHAIN TRIGLYCERIDES) FAT SUPPLEMENT"}, {"entity_type": "DRUG", "description": "An oral medication prescribed to reduce triglyceride levels by inhibiting lipoprotein synthesis and increasing HDL cholesterol levels, often used in combination with dietary fat restriction for patients with hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "GEMFIBROZIL DRUG THERAPY"}, {"entity_type": "DRUG", "description": "An oral medication used to inhibit pancreatic lipase, reducing the absorption of dietary fats and thus lowering triglyceride levels, often prescribed alongside dietary changes for patients with hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "ORLISTAT DRUG THERAPY"}, {"entity_type": "THERAPY", "description": "A therapeutic approach approved in Europe involving the introduction of a gain-of-function variant of the LPL gene through intramuscular injection, aimed at increasing lipase activity and lowering triglyceride levels.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "INTRAMUSCULAR INTRODUCTION OF GAIN-OF-FUNCTION LPL VARIANT THERAPY"}, {"entity_type": "THERAPY", "description": "An investigational treatment targeting diacylglycerol O-acyltransferase 1 (DGAT1), an enzyme involved in lipid synthesis during fat absorption, aiming to lower triglyceride levels through oral administration.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "DGAT1 INHIBITORS TREATMENT APPROACH"}, {"entity_type": "NUTRIENT", "description": "A type of lipid that is transported via lipoproteins in the bloodstream. Elevated levels can lead to various health issues such as pancreatitis and cardiovascular disease.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "TRIGLYCERIDES (TG)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Particles synthesized by the liver containing triglycerides, cholesterol, and proteins. They are involved in transporting lipids from the liver to peripheral tissues where they can be broken down by LPL.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "VERY-LOW-DENSITY LIPOPROTEINS (VLDL)"}, {"source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "description": "The p.Q240H mutation alters the structure and function of the lipoprotein lipase protein, contributing to hypertriglyceridemia.", "entity_type": "UNKNOWN", "id": "P.Q240H MUTATION"}, {"source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "description": "Medium-chain triglyceride supplements provide an alternative source of energy without increasing triglyceride levels in patients managing hypertriglyceridemia.", "entity_type": "UNKNOWN", "id": "MCT FAT SUPPLEMENT"}, {"source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "description": "Elevated VLDL particles contribute significantly to hypertriglyceridemia due to insufficient breakdown by LPL in patients with LPL gene mutations.", "entity_type": "UNKNOWN", "id": "VLDL"}, {"entity_type": "DRUG", "description": "Topiramate is a drug used to treat alcohol dependence, with efficacy and adverse event profiles varying by genotype.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "TOPIRAMATE"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs2832407 genotype moderates the effect of topiramate in European-American subgroups, influencing both treatment efficacy and adverse events.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "RS2832407 GENOTYPE"}, {"entity_type": "DISEASE", "description": "Heavy drinking days (HDDs) are a measure used to assess alcohol dependence, with reduction indicating therapeutic efficacy.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "HDDS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The severity of adverse events experienced by patients treated with topiramate is influenced by both genotype and treatment group.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "ADVERSE EVENT SEVERITY"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2832407*C-homozygotes is a specific genotype associated with the rs2832407 genomic variant, showing significant differences in treatment response and adverse events when treated with topiramate.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "RS2832407*C-HOMOZYGOTES"}, {"entity_type": "GENOMIC VARIANT", "description": "A-allele carriers are individuals carrying the less responsive allele of rs2832407, showing minimal difference in treatment efficacy and adverse event severity compared to placebo.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "A-ALLELE CARRIERS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the ABCB1 gene at position rs1045642 has been associated with acute nausea severity.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ABCB1 RS1045642 VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The CYP2D6 intermediate or extensive metabolizer phenotype refers to the genetic variation influencing drug metabolism, particularly for anti-emetic medications.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "CYP2D6 INTERMEDIATE OR EXTENSIVE METABOLIZER PHENOTYPE"}, {"entity_type": "THERAPEUTIC TREATMENT", "description": "Chemotherapy regimens that are highly likely to cause severe nausea and vomiting in patients receiving cancer treatment.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Acute nausea reported by patients undergoing chemotherapy, with severity classified as CTCAE grade 2 or above.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "CTCAE GRADE 2 OR ABOVE ACUTE NAUSEA"}, {"entity_type": "DISEASE", "description": "A condition characterized by delayed onset of nausea and vomiting following the administration of anti-emetic medications post-chemotherapy treatment.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "DELAYED CINV (NAUSEA AND VOMITING)"}, {"entity_type": "DRUG", "description": "Prescribed anti-emetic medication used in the study to prevent chemotherapy-induced nausea and vomiting (CINV).", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "PALONOSETRON"}, {"entity_type": "DRUG", "description": "Anti-inflammatory steroid often prescribed alongside palonosetron for prophylaxis against CINV.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "DEXAMETHASONE"}, {"entity_type": "DRUG", "description": "Additional anti-emetic medication commonly used in the treatment of acute and delayed nausea following chemotherapy.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "PROCHLORPERAZINE"}, {"entity_type": "DRUG", "description": "Another common anti-nausea drug administered to patients undergoing chemotherapy.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ONDANSETRON"}, {"entity_type": "DRUG", "description": "A neurokinin-1 receptor antagonist used for the prevention of acute and delayed CINV.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "FOSAPREPITANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant in the HTR3B gene, which was examined for its association with chemotherapy-induced nausea and vomiting.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "HTR3B (RS45460698)"}, {"entity_type": "PATIENT-REPORTED VARIABLE", "description": "Amount of sleep reported by patients the night before undergoing chemotherapy treatment.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "HOURS OF SLEEP BEFORE CHEMOTHERAPY"}, {"source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "description": "The CYP2D6 activity score reflects the functional activity of patients with intermediate or extensive metabolizer phenotypes.", "entity_type": "UNKNOWN", "id": "CYP2D6 ACTIVITY SCORE"}, {"source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "description": "Less sleep before chemotherapy was associated with more severe acute nausea reported by patients.", "entity_type": "UNKNOWN", "id": "PATIENT-REPORTED SEVERITY OF ACUTE NAUSEA"}, {"source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "description": "Patients with a history of morning sickness were more likely to report CTCAE grade 2 or above acute nausea.", "entity_type": "UNKNOWN", "id": "HISTORY OF MORNING SICKNESS"}, {"entity_type": "TRANSCRIPT", "description": "The LCT transcript shows significant age-related reduction in lactase non-persistent individuals, but remains stable or slightly increases in persistent individuals.<SEP>The steady-state level of LCT mRNA varies significantly across individuals and decreases with age, affecting lactase enzyme production.<SEP>The transcript of the lactase gene (LCT) that is regulated by LOC100507600 lncRNA.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c<SEP>chunk-ea45644d73f260cf365527dcc3af86e1<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "LCT MRNA"}, {"entity_type": "EPIGENETIC MODIFICATION", "description": "Epigenetic modifications such as DNA methylation play a critical role in regulating the expression levels of the LCT gene over time and among individuals.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "EPIGENETIC MODIFICATION"}, {"entity_type": "GENE", "description": "The MCM6 gene is involved in DNA replication and repair and has regulatory regions that are modified with age, influencing LCT activity.<SEP>The MCM6 gene is located near the LCT gene and harbors variants that are associated with lactase persistence, influencing the DNA methylation patterns around the LCT gene.<SEP>The MCM6 gene, located near the LCT gene, shows differential DNA modifications linked to lactose persistence or non-persistence.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1<SEP>chunk-4964b2db9e3ddddb4967fb7150e4404d<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "MCM6 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism (SNP) in MCM6 intron 13 at position -13910 that influences lactase persistence and non-persistence, affecting DNA modification density near the LCT gene.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "C/T-13910 SNP"}, {"entity_type": "NUTRIENT", "description": "Lactose is a sugar found primarily in milk and dairy products; its digestion depends on the activity of lactase produced by the LCT gene.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "LACTOSE"}, {"entity_type": "FOOD", "description": "Dairy products are sources of dietary lactose, and their consumption is influenced by lactase persistence determined by genetic and epigenetic factors.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "DAIRY PRODUCTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The physiological process of lactase non-persistence involves a gradual decline in lactase production after infancy due to changes in DNA methylation patterns around the LCT gene.<SEP>The physiological process where individuals may maintain (persistence) or lose (non-persistence) lactose digestion capability after weaning.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "LACTASE PERSISTENCE/NON-PERSISTENCE"}, {"entity_type": "CELL TYPE", "description": "Jejunum enterocytes are specialized intestinal cells that express the LCT gene and produce lactase to digest dietary lactose.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "INTESTINAL EPITHELIAL CELLS (ENTEROCYTES)"}, {"entity_type": "PROTEIN", "description": "The enzyme responsible for breaking down lactose into glucose and galactose, synthesized from the LCT mRNA.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "LACTASE ENZYME"}, {"entity_type": "GENOMIC REGION", "description": "These chromosomes contain genetic regions under investigation for their role in lactase persistence/non-persistence via DNA modification analysis.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "CHROMOSOME 2, 9, 19"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The density of unmodified cytosine bases within specific genomic regions is inversely correlated with LCT mRNA levels, indicating a key molecular interaction in lactose digestion regulation.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "CYTOSINES"}, {"entity_type": "TECHNIQUE", "description": "A technique used to enrich the unmodified DNA fraction for chromosome-wide analysis of DNA modification patterns around genes such as LCT.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "MTAG-CLICK METHOD"}, {"entity_type": "GENE", "description": "The gene encoding lactase, essential for breaking down lactose in milk and dairy products, showing age-related decline in activity.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "LACTASE GENE (LCT)"}, {"entity_type": "DEVELOPMENTAL STAGE", "description": "Comparative stage used to study the decline of intestinal lactase activity from infancy to adulthood in mice models.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "POSTNATAL DAY 6 VS. 60"}, {"entity_type": "DISEASE", "description": "A genetic condition characterized by varying levels of lactase expression in adulthood based on specific haplotypes at the LCT and MCM6 loci.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "LACTASE PERSISTENCE/DISEASE NON-PERSISTENCE"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific DNA modification sites observed at 35 CpG locations within the LCT and MCM6 regions, indicating differential methylation patterns.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "CPG SITES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Changes in DNA methylation levels that influence gene expression and cellular functions.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "DNA MODIFICATIONS"}, {"entity_type": "TRANSCRIPT", "description": "A region within the LCT gene that shows significant modification differences between white blood cells and intestinal tissues, indicating regulatory function.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "LCT EXON 1"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic region in MCM6 where DNA modifications differ significantly based on genetic background, influencing lactase expression.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "MCM6 INTRON 13-EXON 16 REGION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Chromatin marks that indicate active enhancers or promoters in regions around LCT and MCM6 genes.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "HISTONE MARKS (H3K4ME1 AND H3K27AC)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A process where differential DNA methylation patterns develop over time, linked to lactase persistence or non-persistence.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "DNA METHYLATION CHANGES WITH AGE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic region within intron 5 of LCT where significant DNA modification differences were observed.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "LCT INTRON 5"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic region within intron 3 of LCT showing differential methylation patterns.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "LCT INTRON 3"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic region within intron 2 of LCT with significant DNA modification differences.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "LCT INTRON 2"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The promoter region for the long non-coding RNA LOC100507600 located in intron 5 of LCT.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "LOC100507600 LNCRNA PROMOTER REGION"}, {"entity_type": "TRANSCRIPT", "description": "A genomic region within exon 17 and 3\u2032 untranslated region (3\u2032-UTR) of MCM6 with significant DNA modification differences linked to lactase expression regulation.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "MCM6 EXON 17-3\u2032 UTR"}, {"entity_type": "TISSUE/SAMPLE TYPE", "description": "Samples used for assessing the differential methylation patterns in LCT-MCM6 regions compared to intestinal tissues.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "WHITE BLOOD CELLS"}, {"entity_type": "CELL TYPE", "description": "The main cell type of interest for studying DNA modification profiles and their relation to lactase expression.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "ENTEROCYTES"}, {"entity_type": "TISSUE/SAMPLE TYPE", "description": "A tissue sample used in comparison with enterocytes to observe differential methylation patterns.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "ENTEROCYTE-DEFICIENT JEJUNUM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Differential DNA methylation observed across different tissues (white blood cells vs. intestinal tissues) linked to the regulation of LCT expression.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "DNA METHYLATION CHANGES ACROSS TISSUES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Sites within chromatin that are sensitive to DNase I, indicating active regulatory elements in LCT and MCM6 regions.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "DNASE I HYPERSENSITIVITY SITES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Histone marks indicative of enhancer activity observed at specific genomic loci around LCT and MCM6 genes.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "H3K4ME1 AND H3K27AC ENHANCERS"}, {"entity_type": "DISEASE", "description": "A condition characterized by reduced lactase expression in adulthood, associated with certain genetic haplotypes at the LCT-MCM6 locus.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "LACTASE NON-PERSISTENCE (LNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific single nucleotide polymorphism within the MCM6 gene linked to lactase persistence or non-persistence conditions.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "C/T-13910 SNP RS4988235"}, {"entity_type": "GENOMIC VARIANT", "description": "Another single nucleotide polymorphism within the MCM6 gene that shows linkage with lactose persistence or non-persistence.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "G/A-22018 SNP RS182549"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variation involving an insertion-deletion event located in intron 1 of the LCT gene, affecting mRNA levels.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "INSERTION/DELETION IN LCT INTRON 1 "}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant (-13910) within the MCM6 gene associated with different DNA modification patterns across age groups and genotypes.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "C-13910 GENOMIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "These haplotypes influence the level of DNA modifications and LCT activity across different age groups.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "HAPLOTYPES CONTAINING C-13910"}, {"entity_type": "DISEASE", "description": "Individuals with CC genotype at -13910 variant exhibit lactase non-persistence, characterized by a decrease in LCT mRNA levels with aging.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LACTASE NON-PERSISTENCE (CC) INDIVIDUALS"}, {"entity_type": "DISEASE", "description": "Individuals with TT genotype at -13910 variant show persistence of lactase activity across age groups.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LACTASE PERSISTENCE (TT) INDIVIDUALS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which DNA modifications accumulate or decrease over time, influencing gene expression and enzyme activities such as LCT in enterocytes.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "AGE-RELATED DNA MODIFICATIONS"}, {"entity_type": "TRANSCRIPT", "description": "A highly conserved region within the LCT intron that is involved in regulatory functions across mammalian species.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LCT INTRON 2 REGION"}, {"entity_type": "TRANSCRIPT", "description": "An antisense transcript of LOC100507600, which positively correlates with and modulates LCT mRNA levels.<SEP>Long non-coding RNA that regulates LCT mRNA levels in Caco-2 cells.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c<SEP>chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LOC100507600 LNCRNA"}, {"entity_type": "TRANSCRIPT", "description": "A part of the MCM6 transcript that shows significant differences in DNA modification between haplotypes containing C-13910 and T-13910.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "MCM6 EXON 16"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The enzymatic activity of lactase which is regulated by genetic and epigenetic factors, particularly showing differential patterns with aging in different genotypes.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LCT ACTIVITY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Processes involving changes to DNA methylation or other modifications that do not alter the primary sequence but influence gene expression over time.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "EPIGENETIC PROCESSES"}, {"entity_type": "METABOLIC PATHWAY", "description": "Regulatory sequences within LCT and MCM6 genes involved in modulating lactase activity through epigenetic mechanisms, specifically DNA methylation patterns changing with age.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LCT\u2013MCM6 REGULATORY ELEMENTS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The extent to which the regulatory elements contributing to the downregulation of lactase expression are conserved across different mammalian species.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "EVOLUTIONARY CONSERVATION OF EPIGENETIC FACTORS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Specific chromatin marks (H3K27ac, H3K4me1) identified in adult mice that correlate with the regulation of Lct and Mcm6 genes.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "CHROMATIN MARKS IN MICE"}, {"entity_type": "TRANSCRIPT", "description": "A conserved region within LCT intron 8 showing significant age-related DNA modification changes, similar to those observed in human studies.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LCT INTRON 8 REGION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Specific introns that are highly conserved across mammalian species and play a role in regulating lactase expression.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "INTRONIC CONSERVED ELEMENTS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The regulation of LCT mRNA by the natural antisense lncRNA LOC100507600, which positively correlates with and modulates lactase enzyme expression.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LNCRNA LOC100507600 REGULATION"}, {"entity_type": "CELL LINE", "description": "Human intestinal epithelial cell line Caco-2 used for studying lactase persistence and gene expression.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CACO-2 CELL LINE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific single nucleotide polymorphism in the Caco-2 cell line, characterized by the presence of two thymine (T) alleles (-13910 position).", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "SNP -13910 TT GENOTYPE"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of the MCM6 gene, which remains unchanged upon silencing of LOC100507600 lncRNA in Caco-2 cells.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "MCM6 MRNA"}, {"entity_type": "PROTEIN INTERACTION", "description": "A protein binding site for CTCF (CCCTC-binding factor), a DNA-binding protein involved in chromosome architecture and regulation of gene expression.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CTCF BINDING SITE"}, {"entity_type": "EPIGENETIC MODIFICATION", "description": "DNA methylation is an epigenetic modification that can influence the differential splicing and expression of genes such as CTLA4.<SEP>The addition of methyl groups to DNA, which can affect the interaction between proteins like CTCF and their binding sites on DNA.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-512b044cf65a4e519d519c6239959c6c", "id": "DNA METHYLATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A regulatory sequence upstream of a gene that controls its transcription rate. In this case, it\'s part of an intron within the LCT gene in mice.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "LCT PROMOTER ELEMENT"}, {"entity_type": "DISEASE/CONDITION", "description": "The genetic condition where individuals continue to express high levels of lactase into adulthood.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "LACTASE PERSISTENCE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A genome editing technology that uses a Cas9 protein guided by guide RNA to make precise edits in DNA sequences, used here to delete specific intronic regions.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CRISPR-CAS9 SYSTEM"}, {"entity_type": "PROTEIN", "description": "The product of LCT mRNA, which is the enzyme responsible for breaking down lactose into glucose and galactose.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "LCT PROTEIN"}, {"entity_type": "PROTEIN", "description": "A protein encoded by the MCM6 gene, which influences the regulation of neighboring genes like LCT through its intronic regions.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "MCM6 PROTEIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process governing the expression and activity levels of lactase enzymes throughout life, influenced by genetic variations and environmental factors.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "LACTASE GENE REGULATION"}, {"entity_type": "GENETIC ELEMENT", "description": "DNA sequences that increase the transcriptional activity of genes, often located in introns like those in LCT and MCM6.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "ENHANCER ELEMENTS"}, {"source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "description": "Consumption patterns of dairy products can influence the digestive capability based on LCT gene expression levels and epigenetic modifications.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 29}]", "id": "LACTOSE DIGESTION CAPABILITY"}, {"source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "description": "Genomic regions within these chromosomes are critical for understanding the transcriptional regulation of the LCT gene across individuals with varying lactase persistence statuses.", "entity_type": "UNKNOWN", "id": "LCT GENE REGULATION"}, {"source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "description": "This method enables comprehensive epigenetic analysis by enriching unmodified DNA fractions for detailed investigation of DNA modification changes around key genes like the LCT gene.", "entity_type": "UNKNOWN", "id": "EPIGENETIC ANALYSIS"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "Genetic variations at these SNPs are strongly associated with lactase persistence or non-persistence conditions.", "entity_type": "UNKNOWN", "id": "C/T-13910 SNP RS4988235 AND G/A-22018 SNP RS182549"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at rs4988235 is associated with lactase persistence and influences milk consumption patterns.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "RS4988235"}, {"entity_type": "GENE", "description": "The T allele of the rs4988235 variant is associated with lactase persistence in individuals, indicating an ability to digest lactose efficiently.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "LACTASE PERSISTENCE ALLELE (T)"}, {"entity_type": "GENOMIC VARIANT", "description": "Individuals carrying the CC genotype at rs4988235 are less likely to consume milk due to lactase non-persistence, leading to difficulties in digesting milk products.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "CC GENOTYPE AT RS4988235"}, {"entity_type": "DIETARY PATTERN", "description": "The pattern of milk consumption varies between individuals with different genotypes at the rs4988235 locus, particularly showing a lower rate among those with the CC genotype.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "MILK CONSUMPTION"}, {"entity_type": "DISEASE", "description": "Milk consumption is associated with an elevated risk of RCC compared to non-consumers, although the variant at rs4988235 does not influence this risk directly.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "RENAL CELL CARCINOMA (RCC)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The Czech Republic shows a notable association between milk consumption and an increased risk of renal cell carcinoma (RCC).", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "CZECH REPUBLIC"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "In Romania, there was no observed association between the genotype at rs4988235 and milk drinking habits.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "ROMANIA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Minor allele frequency for rs4988235 in Poland is 0.40, showing a moderate influence on lactase persistence among the population.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "POLAND"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "In Russia, the minor allele frequency of rs4988235 is 0.35, reflecting intermediate frequencies within Eastern European populations.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "RUSSIA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The UK shows a different pattern for the lactase persistence allele at rs4988235 compared to other regions, with the \'C\' allele being more common (0.26 frequency).", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "UK"}, {"source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "description": "While individuals with the T allele of rs4988235 show normal milk consumption patterns, there was no observed direct influence on RCC risk compared to other factors.", "entity_type": "UNKNOWN", "id": "RCC"}, {"entity_type": "GENE", "description": "The BCL11A gene is associated with baseline, MTD (Maximum Tolerated Dose), and delta HbF levels in patients treated with hydroxyurea.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "BCL11A"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1427407 is a SNP within the BCL11A gene that correlates with higher baseline, MTD, and delta HbF levels after hydroxyurea treatment.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "RS1427407"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4671393 is another SNP in the BCL11A gene that shows association with increased baseline, MTD, and delta HbF values following hydroxyurea treatment.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "RS4671393"}, {"entity_type": "GENOMIC VARIANT", "description": "rs11886868 is a SNP in the BCL11A gene that approaches statistical significance for an association with baseline HbF levels and is significantly associated with MTD and delta HbF.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "RS11886868"}, {"entity_type": "GENE", "description": "The HMIP-2 gene harbors SNPs rs9399137 and rs9402686, which are associated with increased baseline and MTD HbF levels but not delta HbF.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HMIP-2 (OR HBS1L-MYB) "}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in HMIP-2 is associated with higher baseline and MTD HbF values, but loses significance when corrected for baseline HbF.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "RS9399137"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant within HMIP-2 that also shows an association with increased baseline and MTD HbF levels after hydroxyurea treatment.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "RS9402686 "}, {"entity_type": "DRUG", "description": "An antineoplastic drug used in the study for its hematological benefits, particularly increasing HbF levels.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HYDROXYUREA (HU)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The physiological process of elevated hemoglobin F levels as a response to hydroxyurea treatment, which has therapeutic implications.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HEMOGLOBIN F (HBF)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The absolute neutrophil count is a hematological parameter measured before and after hydroxyurea treatment to assess its impact on blood cell counts.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "ANC (ABSOLUTE NEUTROPHIL COUNT)"}, {"entity_type": "PHYSIOLOGICAL FACTOR", "description": "Gender, used as a covariate in the regression models for baseline HbF levels, MTD HbF, and delta HbF.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "SEX"}, {"entity_type": "PHYSIOLOGICAL FACTOR", "description": "The age of patients when they started hydroxyurea treatment, used as a covariate in regression models to correct for baseline and post-treatment HbF levels.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "AGE AT START OF HU TREATMENT (AGE)"}, {"entity_type": "GENOMIC FEATURE", "description": "Combinations of alleles at different loci that are inherited together on the same chromosome, analyzed for their association with HbF levels.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HAPLOTYPES "}, {"entity_type": "GENOMIC VARIANT", "description": "A specific single nucleotide polymorphism (SNP) in the HMIP-2 region.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "id": "HMIP-2 SNP"}, {"entity_type": "GENOMIC VARIANT", "description": "A haplotype consisting of a C to A substitution, which was associated with MTD HbF levels before correction for baseline HbF.<SEP>A rare haplotype combination in CD subjects, associated with MAPbacteremia presence but not as strongly linked compared to the C-G haplotype.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-3ae06e9a3330573da28ca0a76aa685ce", "id": "C-A HAPLOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "MTD HbF refers to the physiological process or level of fetal hemoglobin (HbF) in mature blood cells, often used as a measure in medical studies related to conditions like sickle cell disease.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "id": "MTD HBF"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The baseline level of fetal hemoglobin (HbF), serving as a reference point for assessing changes or associations with other genomic variants or haplotypes.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "id": "BASELINE HBF"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Delta HbF refers to the change in levels of fetal hemoglobin (HbF) from baseline, used to measure responses or effects over time or due to genetic factors.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "id": "DELTA HBF"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "The BCL11A gene includes rs11886868 SNP that shows association with MTD and delta HbF levels but not baseline.", "entity_type": "UNKNOWN", "id": "RS11886868 "}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "The HMIP-2 gene contains rs9399137 SNP, which is linked to increased baseline and MTD HbF levels post-HU treatment.", "entity_type": "UNKNOWN", "id": "HMIP-2 (OR HBS1L-MYB)"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "The HMIP-2 gene contains rs9399137 SNP, which is linked to increased baseline and MTD HbF levels post-HU treatment.", "entity_type": "UNKNOWN", "id": "RS9399137 "}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "The age when patients begin hydroxyurea treatment is used as a covariate in regression models to correct for baseline and post-treatment hemoglobin F (HbF) levels.", "entity_type": "UNKNOWN", "id": "REGRESSION MODELS "}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "Absolute neutrophil count is one of the hematological parameters measured before or after hydroxyurea treatment to assess its impact on blood cell counts, though no correlations were found with these SNPs.", "entity_type": "UNKNOWN", "id": "MEASURED PARAMETERS "}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "The BCL11A gene contains haplotypes that influence baseline and MTD HbF levels in patients treated with hydroxyurea, particularly the G-G-T reference haplotype vs. T-A-C variant.", "entity_type": "UNKNOWN", "id": "BCL11A "}, {"entity_type": "GENE", "description": "The FANCA gene is involved in the Fanconi anemia pathway, responsible for DNA repair and genomic stability.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FANCA GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific mutation in the FANCA gene that leads to a change from serine to arginine at position 858, previously identified in individuals with Fanconi anemia.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "C.2574C>G/P.SER858ARG MUTATION IN FANCA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of monoubiquitination of FANCD2 protein is deficient in the subject\'s fibroblasts but normal in lymphoblastoid cells, indicating cellular heterogeneity.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FANCD2 PROTEIN MONOUBIQUITINATION DEFECT"}, {"entity_type": "DISEASE", "description": "A rare genetic disorder characterized by bone marrow failure, genomic instability, and hypersensitivity to DNA crosslinking agents.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FANCONI ANEMIA (FA) DISEASE"}, {"entity_type": "GENE", "description": "The UBE2T gene encodes for a protein that is essential in the Fanconi anemia pathway, particularly involved in ubiquitination of FANCD2.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "UBE2T GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "The subject has two mutations in the UBE2T gene: a paternal deletion resulting in loss of the start codon, and a maternal duplication causing a frameshift mutation.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "COMPOUND HETEROZYGOUS MUTATIONS IN UBE2T (G.202332626_202341295DEL AND G.202332626_202341295DUP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A deficiency of the UBE2T protein is observed in fibroblast cells derived from the subject but not in lymphoblastoid cell lines, indicating somatic mosaicism.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "UBE2T PROTEIN DEFICIENCY IN FIBROBLASTS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Chemical agents that cause DNA crosslinks leading to chromosomal breakage; hypersensitivity of Fanconi anemia cells to these agents is a characteristic phenotype.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "DNA CROSSLINKING AGENTS (DEB AND MMC)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Similar to FANCD2, the monoubiquitination defect of FANCI protein in RA2627 fibroblasts indicates a disrupted Fanconi anemia pathway due to UBE2T deficiency.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FANCI PROTEIN MONOUBIQUITINATION DEFECT"}, {"entity_type": "CELL TYPE", "description": "A type of cell line derived from lymphocytes, often used for genetic studies; in this case, it shows normal UBE2T levels and function compared to fibroblasts.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "LYMPHOBLASTOID CELL LINE (LCL)"}, {"entity_type": "TECHNIQUE", "description": "A high-throughput sequencing approach used to quantify gene expression profiles; RNA-seq was performed on RA2627 fibroblasts for transcriptome analysis.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "RNA SEQUENCING (RNA-SEQ)"}, {"entity_type": "TECHNIQUE", "description": "Quantitative PCR method used to confirm the reduction in UBE2T transcript levels observed by RNA sequencing.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "RT-QPCR ANALYSIS OF UBE2T TRANSCRIPT LEVELS"}, {"entity_type": "PROTEIN", "description": "UBE2T is a gene associated with Fanconi Anemia-T subtype.<SEP>Ube2T is a protein that interacts specifically with the RING domain of human proteins, but not directly with URD according to experimental data.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f<SEP>chunk-e097891654194982dfc0ef87401d3aa9", "id": "UBE2T"}, {"entity_type": "TRANSCRIPT", "description": "Expression of wild type UBE2T in RA2627 fibroblasts rescued cellular hypersensitivity to crosslinking agents and restored monoubiquitination of FANCD2 and FANCI.<SEP>Expression of wild type UBE2T in RA2627 fibroblasts rescued cellular hypersensitivity to crosslinking agents and restored physiological processes essential for DNA damage repair.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "WILD TYPE UBE2T EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Monoubiquitination of FANCD2 is a physiological process essential for the repair of DNA crosslinking damage, which is restored by UBE2T expression in RA2627 cells.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "FANCD2 MONOUBIQUITINATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Monoubiquitination of FANCI is a physiological process involved in the DNA repair mechanism, similar to that of FANCD2, and is also restored by UBE2T expression.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "FANCI MONOUBIQUITINATION"}, {"entity_type": "DISEASE", "description": "Fanconi anemia subtype T results from deficiencies in the UBE2T gene, leading to defects in DNA repair processes.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "FANCONI ANEMIA-T SUBTYPE (FA-T)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "MMC is a crosslinking agent that induces cellular hypersensitivity and triggers FANCD2 and FANCI monoubiquitination for DNA repair.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "MMC (METHYL METHANESULFONATE)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "DEB is another crosslinking agent used in the study to induce cellular hypersensitivity, similar to MMC.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "DEB (DIEPOXYBUTANE)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cisplatin is an environmental factor that causes DNA crosslinks and affects cell cycle distribution when introduced to cells with UBE2T deficiency.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "CISPLATIN"}, {"entity_type": "PROTEIN (CELL LINE)", "description": "RA2627 fibroblasts are a cellular model used in experiments to study the effects of wild type UBE2T expression on DNA repair processes.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "RA2627 CELLS"}, {"entity_type": "PROTEIN (CELL LINE)", "description": "BJ cells serve as a control for normal cell lines, contrasting with RA2627 cells in experiments involving DNA repair and hypersensitivity to crosslinking agents.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "id": "BJ CELLS"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "The presence of compound heterozygous mutations leads to protein deficiency observed specifically in fibroblast cells, indicating tissue-specific expression or recombination.", "entity_type": "UNKNOWN", "id": "COMPOUND HETEROZYGOUS MUTATIONS IN UBE2T"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "Individuals with Fanconi anemia are hypersensitive to DNA cross-linking agents like DEB and MMC, leading to chromosomal breakage.", "entity_type": "UNKNOWN", "id": "ENVIRONMENTAL FACTOR - DNA CROSSLINKING AGENTS (DEB AND MMC)"}, {"source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "description": "Deficiency of UBE2T leads to Fanconi anemia subtype T due to impaired DNA repair processes.", "entity_type": "UNKNOWN", "id": "UBE2T DEFICIENCY"}, {"source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "description": "Overexpression of wild type UBE2T restores physiological processes essential for DNA damage repair.", "entity_type": "UNKNOWN", "id": "FANCD2 MONOUBIQUITINATION/FANCI MONOUBIQUITINATION"}, {"source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "description": "Crosslinking agents cause cellular hypersensitivity in RA2627 fibroblasts due to impaired DNA repair mechanisms when UBE2T is deficient.", "entity_type": "UNKNOWN", "id": "MMC/DEB/CISPLATIN"}, {"entity_type": "GENE", "description": "RPS19 is a gene associated with Diamond Blackfan Anemia (DBA) where mutations lead to defects in erythroid development.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPS19 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "This mutation is one of the genetic variants affecting RPS19, leading to DBA symptoms.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "MISSENSE MUTATION P.ARG62TRP"}, {"entity_type": "GENOMIC VARIANT", "description": "Another missense mutation in the RPS19 gene that contributes to DBA pathology.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "MISSENSE MUTATION P.ARG101HIS"}, {"entity_type": "GENOMIC VARIANT", "description": "A frameshift mutation causing a loss of function effect and leading to reduced levels of the RPS19 protein due to NMD activation.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "FRAMESHIFT MUTATION C.58DELG"}, {"entity_type": "GENOMIC VARIANT", "description": "This mutation affects the intron 1 acceptor splice site, resulting in exon 2 skipping and reducing functional transcripts.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "SPLICE SITE MUTATION C.1-1G>A"}, {"entity_type": "TRANSCRIPT", "description": "The transcriptome of dermal fibroblasts isolated from DBA patients with RPS19 mutations is altered compared to healthy individuals.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "DERMAL FIBROBLASTS TRANSCRIPTOME"}, {"entity_type": "GENE", "description": "Genes that are differentially expressed in DBA patients, implicating pathways like aminoacyl-tRNA biosynthesis and glycine metabolism.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "DBA PATIENTS GENES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "IPA is used to analyze the dataset of genes differentially expressed in DBA patients relative to controls for pathway enrichment and biological function clustering.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "INGENUITY PATHWAYS ANALYSIS (IPA)"}, {"entity_type": "METABOLIC PATHWAY", "description": "This metabolic pathway is significantly enriched among differentially expressed genes in DBA, involving enzymes like LARS, WARS, GARS, SARS, QARS, EPRS.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "AMINOACYL-TRNA BIOSYNTHESIS PATHWAY"}, {"entity_type": "METABOLIC PATHWAY", "description": "Genes involved in this pathway are differentially expressed in DBA patients indicating metabolic dysregulation.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "GLYCINE SERINE AND THREONINE METABOLISM PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Enrichment of genes related to death receptor signaling suggests a role in cell death regulation in DBA pathology.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "DEATH RECEPTOR SIGNALING PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "This pathway is enriched among differentially expressed genes, indicating potential immune dysregulation due to RPS19 mutations.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "PKR ROLE IN INTERFERON INDUCTION AND ANTIVIRAL RESPONSE PATHWAY"}, {"entity_type": "METABOLIC PATHWAY", "description": "Enrichment of this pathway suggests roles in cellular signaling and transcriptional regulation affected by DBA-associated gene expression changes.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "RAR ACTIVATION PATHWAY"}, {"entity_type": "GENE CLUSTER", "description": "RP genes are significantly enriched among differentially expressed genes, implicating a role in protein synthesis dysregulation in DBA.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "PROTEIN SYNTHESIS GENES (RP GENES)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Genes involved in cell death regulation are found to be altered in DBA patients according to IPA analysis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "CELL DEATH REGULATION GENES"}, {"entity_type": "METABOLIC PATHWAY", "description": "Enrichment of genes involved in lipid metabolism indicates dysregulation in this pathway among differentially expressed genes in DBA.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "LIPID METABOLISM GENES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Genes related to molecular transport are enriched, suggesting a role in cellular function alteration due to RPS19 mutations.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "MOLECULAR TRANSPORT GENES"}, {"entity_type": "GENE", "description": "This cluster includes multiple ribosomal protein genes that are involved in various cellular processes such as lipid metabolism and molecular transport.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RP GENES CLUSTER (RPL22, RPL27A, RPL29, ETC.)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cell death refers to the process by which a cell ends its life cycle. It is regulated by specific biochemical pathways involving proteins and other molecules.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CELL DEATH"}, {"entity_type": "METABOLIC PATHWAY", "description": "This pathway involves the synthesis, breakdown, and transport of lipids in cells and tissues.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "LIPID METABOLISM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The movement of molecules across cellular membranes is essential for maintaining cell function.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "MOLECULAR TRANSPORT"}, {"entity_type": "GENE", "description": "This gene encodes the adenosine monophosphate-activated phosphatase 3, involved in metabolic regulation and energy homeostasis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "AMPD3"}, {"entity_type": "GENE", "description": "Involved in cell cycle regulation, its overexpression is associated with cancer progression.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CCND2 (CYCLIN D2)"}, {"entity_type": "GENE", "description": "A gene encoding a mitochondrial enzyme that dismutates superoxide radicals into hydrogen peroxide and molecular oxygen.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "SOD2 (SUPEROXIDE DISMUTASE 2)"}, {"entity_type": "GENE", "description": "This gene is involved in regulating the inflammatory response and plays a role in cancer and autoimmune diseases.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "TNFAIP3 (TUMOR NECROSIS FACTOR, ALPHA-INDUCED PROTEIN 3)"}, {"entity_type": "GENE", "description": "A gene encoding a protein that is abundant in cartilage and bone tissues, playing a crucial role in tissue development and homeostasis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "COMP (CARTILAGE OLIGOMERIC MATRIX PROTEIN)"}, {"entity_type": "GENE", "description": "Encodes an enzyme involved in protein synthesis by activating tryptophan for incorporation into proteins.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "WARS (TRYPTOPHANYL-TRNA SYNTHETASE)"}, {"entity_type": "GENE", "description": "A gene coding for a zinc finger transcription factor that is important in embryonic development and neural tube formation.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "ZIC1 (ZIC FAMILY MEMBER 1)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "This refers to the process by which cells develop into specialized cell types through differentiation.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CELLULAR DEVELOPMENT"}, {"entity_type": "DISEASE", "description": "A category of diseases affecting blood, bone marrow, and lymph nodes.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "HAEMATOLOGICAL DISORDERS"}, {"entity_type": "DISEASE", "description": "Disorders related to the immune system\'s malfunction or abnormal response.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "IMMUNOLOGICAL DISORDERS"}, {"entity_type": "DISEASE", "description": "Conditions that affect kidney function.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RENAL DISORDERS"}, {"entity_type": "DISEASE", "description": "A range of diseases affecting bones and joints.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "SKELETAL DISORDERS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which an embryo forms during early development.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "EMBRYONIC DEVELOPMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Processes involved in the formation, maintenance, and function of connective tissues such as bone and cartilage.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CONNECTIVE TISSUE FUNCTION"}, {"source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "description": "CCND2 is involved in cell cycle regulation, particularly in promoting progression from G1 to S phase.", "entity_type": "UNKNOWN", "id": "CELL CYCLE REGULATION"}, {"source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "description": "TNFAIP3 regulates inflammatory responses by controlling the NF-kappaB pathway.", "entity_type": "UNKNOWN", "id": "INFLAMMATORY RESPONSE"}, {"source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "description": "SOD2 plays a critical role in antioxidant defense mechanisms, protecting cells from oxidative damage.", "entity_type": "UNKNOWN", "id": "ANTIOXIDANT DEFENSE"}, {"source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "description": "WARS is involved in the process of protein synthesis by activating tryptophan for incorporation into proteins.", "entity_type": "UNKNOWN", "id": "PROTEIN SYNTHESIS"}, {"source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "description": "ZIC1 plays a critical role in neural tube formation during embryonic development.", "entity_type": "UNKNOWN", "id": "NEURAL TUBE FORMATION"}, {"entity_type": "GENE", "description": "The BDNF gene is associated with the polymorphisms rs6265 and rs2049046, influencing susceptibility to migraine.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "BDNF GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant of the BDNF gene (G/A) that has been studied for its association with migraine.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "RS6265 POLYMORPHISM"}, {"entity_type": "GENOMIC VARIANT", "description": "Another genetic variant of the BDNF gene (A/T) associated with migraine susceptibility.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "RS2049046 POLYMORPHISM"}, {"entity_type": "DISEASE", "description": "Chronic neurological disease characterized by severe headaches, often accompanied by nausea and sensitivity to light/sound.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "MIGRAINE"}, {"entity_type": "POPULATION GROUP", "description": "Five different Caucasian population groups were included in the studies, two of which came from Australian-based independent cohorts.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "CAUCASIAN POPULATION GROUPS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic polymorphism within the BDNF gene that was analyzed for its association with migraine susceptibility.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "BDNF RS6265 (G/A)"}, {"entity_type": "GENOMIC VARIANT", "description": "Another genetic variant in the BDNF gene assessed for its link to migraines.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "BDNF RS2049046 (A/T)"}, {"entity_type": "QUALITY METRIC", "description": "A scoring system used to evaluate the quality of studies included in a meta-analysis, with scores above 6 indicating good quality.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "NOS SCORE"}, {"source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "description": "The NOS score is used to evaluate the quality of studies included in the meta-analysis, ensuring high-quality results.", "entity_type": "UNKNOWN", "id": "STUDY QUALITY ASSESSMENT"}, {"entity_type": "DISEASE", "description": "A disease condition characterized by psoriasiform reactions developing after treatment with adalimumab in patients suffering from severe hidradenitis suppurativa (HS).", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PARADOXICAL PSORIASIS"}, {"entity_type": "DRUG", "description": "An anti-TNF-\u03b1 biological therapy used to treat chronic inflammatory conditions, such as HS. Paradoxical psoriasis can develop following treatment with adalimumab.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "ADALIMUMAB"}, {"entity_type": "DISEASE", "description": "A chronic skin disease characterized by inflammation and scarring within hair follicles and sweat glands.<SEP>A severe disease characterized by painful nodules, abscesses, and tunnels in the armpits, groin, and buttocks. HS patients treated with anti-TNF-\u03b1 drugs such as adalimumab may develop paradoxical psoriasis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "HIDRADENITIS SUPPURATIVA (HS)"}, {"entity_type": "DISEASE", "description": "A dermatological condition that mimics psoriasis and can occur as a side effect of TNF inhibitors in patients with HS. It involves erythematous, pustular, and scaly lesions.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PSORIASIFORM DERMATITIS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Cytokines involved in the immune response and inflammation. They play significant roles in various inflammatory conditions including paradoxical psoriasis, where their expression levels differ from those seen in classical psoriasis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "IL-17A, IFN-\u0393, IL-22, IL-36\u0393"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Immune cell populations that are significantly increased in paradoxical psoriasis compared to classical psoriasis, playing a crucial role in the inflammatory response.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "BDCA2+ PDCS, CD15+ NEUTROPHILS, C-KIT/CD117+ MAST CELLS, CD68+ MACROPHAGES AND MONOCYTES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Histological changes observed in skin lesions of patients experiencing paradoxical psoriasis following anti-TNF-\u03b1 treatment. This condition is characterized by thickened epidermis and retention of nuclei in the stratum corneum.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "EPIDERMAL HYPERPLASIA WITH PARAKERATOSIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process where innate immunity cells, including neutrophils, mast cells, macrophages, and monocytes, infiltrate paradoxical psoriasiform lesions to a greater extent than in classical psoriasis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "INNATE IMMUNITY CELLS INFILTRATION"}, {"entity_type": "DISEASE CASE STUDY", "description": "A 48-year-old Caucasian woman with severe HS who developed psoriasiform eruptions after adalimumab treatment.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PATIENT 1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A psoriasiform reaction is a skin condition resembling psoriasis, characterized by erythematous plaques covered with silvery scales.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "PSORIASIFORM REACTIONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An eczematous reaction refers to atopic dermatitis or other forms of dermatitis causing inflammation and irritation of the skin.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "ECZEMATOUS REACTIONS"}, {"entity_type": "PROTEIN", "description": "CD3+ cells are T lymphocytes expressing CD3 antigen that plays an essential role in the activation of T cells.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CD3+ CELLS"}, {"entity_type": "DISEASE", "description": "Psoriasiform lesions refer to skin lesions resembling psoriasis, often seen in other inflammatory dermatoses or as a reaction pattern to drugs or irritants.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "PSORIASIFORM LESIONS"}, {"entity_type": "DISEASE", "description": "A chronic inflammatory skin condition characterized by red, scaly patches on the body and scalp.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CLASSICAL PSORIASIS"}, {"entity_type": "PROTEIN", "description": "Peripheral blood mononuclear cells (PBMCs) are a mixture of white blood cells including lymphocytes, monocytes, and dendritic cells.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "PBMCS"}, {"entity_type": "POPULATION GROUP", "description": "HS patients refer to individuals suffering from hidradenitis suppurativa, a chronic inflammatory skin disease.<SEP>Patients suffering from HS disease where specific SNPs in genes like CCHCR1 and IL23R were detected.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-72f4505e43f67f3564607392cb178656", "id": "HS PATIENTS"}, {"entity_type": "PROTEIN", "description": "Type I interferon beta is a cytokine that plays an important role in antiviral defense and immune regulation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IFN-\u0392 (INTERFERON BETA)"}, {"entity_type": "CELL TYPE", "description": "Keratinocytes are the predominant cell type in the epidermis, responsible for forming a protective barrier against environmental factors.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "KERATINOCYTES"}, {"entity_type": "PROTEIN", "description": "Type I interferon kappa is another keratinocyte-derived cytokine involved in immune response and inflammation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IFN-\u039a (INTERFERON KAPPA)"}, {"entity_type": "PROTEIN", "description": "LL-37, also known as cathelicidin antimicrobial peptide (CAMP), is an important component of innate immunity in epithelial cells.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "LL-37"}, {"entity_type": "PROTEIN", "description": "A cytokine member of the tumor necrosis factor family involved in immune responses and lymphoid tissue development.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "LT-\u0391 (LYMPHOTOXIN ALPHA)"}, {"entity_type": "PROTEIN", "description": "Another cytokine from the TNF family, LT-\u03b2 plays a role in immune regulation through interactions with lymphotoxins.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "LT-\u0392 (LYMPHOTOXIN BETA)"}, {"entity_type": "THERAPY", "description": "Treatment for inflammatory conditions using agents that block or reduce tumor necrosis factor alpha (TNF-\u03b1).", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "ANTI-TNF-\u0391 THERAPY"}, {"entity_type": "GENE", "description": "Endoplasmic Reticulum Aminopeptidase 1 is involved in the processing of peptides presented by MHC class I molecules, and polymorphisms are associated with diseases like psoriasis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "ERAP1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Human leukocyte antigen C (HLA-C) region contains genes encoding proteins critical for immune recognition and regulation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "HLA-C REGION"}, {"entity_type": "PROTEIN", "description": "Cytokine involved in systemic inflammation, regulating cell survival, proliferation, differentiation, and apoptosis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "TNF-\u0391 (TUMOR NECROSIS FACTOR ALPHA)"}, {"entity_type": "GENE", "description": "A member of the IL-17 cytokine family, implicated in immune response to various stimuli and conditions such as psoriasis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IL-17F (INTERLEUKIN 17F)"}, {"entity_type": "PROTEIN", "description": "Cell surface receptor for interleukins involved in mediating responses against fungi and bacteria.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IL-17RA (INTERLEUKIN 17 RECEPTOR A)"}, {"entity_type": "GENE", "description": "Receptor for the cytokine IL-23, part of signaling pathways involved in immune regulation and inflammatory diseases such as psoriasis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IL-23R (INTERLEUKIN 23 RECEPTOR)"}, {"entity_type": "PROTEIN", "description": "Subunit of interleukin-12, a cytokine important for innate and adaptive immunity responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "IL-12B (INTERLEUKIN 12 SUBUNIT BETA)"}, {"entity_type": "GENE", "description": "Inhibitor of kappa B kinase epsilon (I\u03baB\u03b6) gene involved in NF-\u03baB signaling pathway regulation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "NFKBIZ GENE"}, {"entity_type": "GENE", "description": "Tumor necrosis factor alpha-induced protein, encoding A20, a negative regulator of inflammatory responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "TNFAIP GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Corneodesmosin gene, involved in epidermal cell adhesion and integrity.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CDSN GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Cockayne syndrome C helicase and RNAse D homolog 1, associated with skin barrier function.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CCHCR1 GENE"}, {"entity_type": "GENETIC MARKER", "description": "Human leukocyte antigen Cw6 is an allele of HLA-C associated with increased susceptibility to autoimmune diseases like psoriasis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "HLA-CW6 ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphisms in the ERAP1 gene, contributing to genetic variation and disease susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS30187/RS30186/RS26653 (ERAP1 SNPS)"}, {"entity_type": "GENOMIC VARIANT", "description": "Various single nucleotide polymorphisms in the HLA-C region linked to increased risk for psoriasis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS9264942/RS10484554/RS2524095/RS28383849/RS9264944/RS147538049/RS9264946 (HLA-C SNPS)"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism in IL23R gene previously associated with paradoxical reactions to anti-TNF therapies.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS11209026 (IL23R SNP)"}, {"entity_type": "BIOLOGICAL FUNCTION", "description": "Functions of various proteins that help maintain the integrity and protective capabilities of epithelial layers against pathogens and inflammation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "EPITHELIAL BARRIER INTEGRITY PROTECTIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphisms within the HLA-C genomic region, linked to psoriasis susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "HLA-C GENOMIC REGION VARIANTS"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism in NFKBIZ gene affecting I\u03baB\u03b6 protein involved in NF-\u03baB signaling pathway regulation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "NFKBIZ GENE VARIANTS (RS3217713)"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphisms in TNFAIP gene, associated with A20 protein that regulates inflammatory responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "TNFAIP GENE VARIANTS (RS610604)"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphisms in CDSN gene associated with psoriasis and skin barrier integrity.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CDSN GENE VARIANTS (RS1062470/RS707913)"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants of the CCHCR1 gene, possibly influencing skin barrier function and disease susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CCHCR1 GENE VARIANTS (RS1576/RS130079/RS746647)"}, {"entity_type": "RESEARCH METHODOLOGY", "description": "The investigation into genetic variations, such as SNPs and other genomic alterations, contributing to the development of paradoxical reactions in hidradenitis suppurativa patients treated with biologic agents.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "GENETIC POLYMORPHISM ANALYSIS OF HIDRADENITIS SUPPURATIVA PARADOXICAL REACTIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific position on chromosome associated with HLA-Cw6 allele, linked to increased susceptibility for autoimmune conditions.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS17192540 (HLA-CW6 SNP POSITION)"}, {"entity_type": "GENOMIC VARIANT", "description": "Different genomic regions containing variants of HLA-C genes that could contribute to disease predisposition.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "SECOND HLA-C VARIANTS REGION"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide variation observed within the CCHCR1 gene, potentially linked to skin barrier integrity and disease susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS707913 CCHCR1 SNP IN PATIENT 3"}, {"entity_type": "GENOMIC VARIANT", "description": "Common genetic variant shared between two patients with paradoxical reactions after anti-TNF therapy.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS280519 SHARED BETWEEN PATIENTS 1 AND 3 "}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism within the CDSN gene, associated with skin barrier function and psoriasis susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS6869870 (CDSN SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism in interleukin 23 receptor gene linked to inflammatory diseases such as psoriasis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS20541 (IL23R SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism within the NFKBIZ gene, associated with NF-\u03baB signaling pathway regulation and disease susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS6978583 (NFKBIZ SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism in HLA-C region linked to psoriasis risk.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS10484562 (HLA-C SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism within the CCHCR1 gene, possibly influencing skin barrier function and disease susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS2097370 (CCHCR1 SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism in TNFAIP gene associated with inflammatory responses regulation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS6865241 (TNFAIP SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism within the ERAP1 gene, contributing to genetic variation and disease susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS907717 (ERAP1 SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism in CDSN gene linked to skin barrier integrity and psoriasis risk.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS6432587 (CDSN SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism within the IL-23 receptor gene, associated with inflammatory disease susceptibility.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS10924937 (IL23R SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism in TNFAIP gene affecting A20 protein regulation of inflammation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS6871574 (TNFAIP SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "Polymorphism within the HLA-C region linked to psoriasis risk and disease progression.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS10936144 (HLA-C SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphism in NFKBIZ gene, associated with NF-\u03baB signaling pathway regulation and inflammatory response modulation.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "RS7528684 (NFKBIZ SNP)"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP variant in the CCHCR1 gene identified by rs1576.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "CCHCR1 (RS1576)"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP variant in the CCHCR1 gene identified by rs130079.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "CCHCR1 (RS130079)"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP variant in the CCHCR1 gene identified by rs746647.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "CCHCR1 (RS746647)"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP variant in the IL23R gene previously associated with paradoxical psoriasiform reactions to anti\u2010TNFs, but not found in HS patients.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "IL23R (RS11209026)"}, {"entity_type": "GENOMIC VARIANT", "description": "An SNP variant detected in patient 2.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "IL23R (RS72676067)"}, {"entity_type": "GENOMIC VARIANT", "description": "An SNP variant detected in patient 1.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "IL23R (RS1004819)"}, {"entity_type": "DISEASE", "description": "A condition characterized by paradoxical psoriasiform reactions that may occur with anti-TNF treatments, previously associated with the IL23R (rs11209026) SNP.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "PARADOXICAL PSORIASIFORM REACTIONS TO ANTI\u2010TNFS"}, {"entity_type": "GENOMIC VARIANT", "description": "An SNP variant within the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS1576"}, {"entity_type": "GENOMIC VARIANT", "description": "An SNP variant within the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS130079"}, {"entity_type": "GENOMIC VARIANT", "description": "An SNP variant within the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS746647"}, {"entity_type": "GENE", "description": "A gene where multiple SNPs have been identified and are associated with paradoxical psoriasiform reactions to anti-TNFs.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "IL23R"}, {"entity_type": "GENOMIC VARIANT", "description": "An SNP variant in the IL23R gene previously associated with paradoxical psoriasiform reactions to anti-TNF treatments.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS11209026"}, {"entity_type": "GENOMIC VARIANT", "description": "An SNP variant detected in patient 2.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS72676067"}, {"entity_type": "GENOMIC VARIANT", "description": "An SNP variant detected in patient 1.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS1004819"}, {"entity_type": "DISEASE", "description": "A condition characterized by paradoxical psoriasiform reactions that may occur with anti-TNF treatments, previously associated with the IL23R (rs11209026) SNP.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "PARADOXICAL PSORIASIFORM REACTIONS TO ANTI\u2010TNFS "}, {"entity_type": "PATIENT GROUP", "description": "Patients suffering from HS disease where specific SNPs in genes like CCHCR1 and IL23R were detected.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "HS PATIENTS "}, {"source_id": "chunk-72f4505e43f67f3564607392cb178656", "description": "The SNP IL23R (rs11209026) has been previously associated with paradoxical psoriasiform reactions to anti-TNF treatments.", "entity_type": "UNKNOWN", "id": "DISEASE, PARADOXICAL PSORIASIFORM REACTIONS TO ANTI\u2010TNFS "}, {"entity_type": "GENE", "description": "The FANCL gene encodes a protein that is involved in DNA repair pathways.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "FANCL GENE"}, {"entity_type": "PROTEIN", "description": "The human FANCL central domain, also known as the UBC-RWD domain or URD, has a unique structure compared to its Drosophila counterpart and contains an intermediary position between E2 fold with \u03b2-flap in the catalytic position and \u03b1-helix in non-catalytic RWD-like folds.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "HUMAN FANCL CENTRAL DOMAIN STRUCTURE (URD)"}, {"entity_type": "PROTEIN", "description": "The DRWD domain structure of Drosophila melanogaster is a structural homologue to human FANCL central domain but with differences in secondary structures and conserved residues, particularly in the N-terminal lobe.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "DRWD DOMAIN STRUCTURE (DMFANCL)"}, {"entity_type": "PROTEIN", "description": "The E2 Ubiquitin-Conjugating Enzymes are structurally similar to both lobes of the human FANCL central domain but more so with the C-terminal lobe containing a significant RWD fold hit.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "E2 UBC ENZYME STRUCTURE"}, {"entity_type": "PROTEIN", "description": "A cysteine residue located within the \u03b2-element of the human FANCL central domain\'s N-terminal lobe, although structurally positioned similarly to a catalytic cysteine of E2 enzymes like Ube2T, does not form thioester bonds with ubiquitin as observed in typical E2 enzymes.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "CYSTEINE IN URD N-TERMINAL LOBE (URD)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A biochemical test used to determine the ability of the URD cysteine residue to form a covalent bond via thioester linkage with activated C terminus of ubiquitin, showing that the URD is unable to do so.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "THIOESTER CHARGE ASSAY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The hydrophobic core formed between the N-terminal and C-terminal lobes in human FANCL central domain, though not entirely conserved with residues in the same position for interaction being different between vertebrate and invertebrate FANCLs, maintains a highly conserved region contributing to structural stability.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "HYDROPHOBIC CORE BETWEEN LOBES OF HUMAN FANCL CENTRAL DOMAIN AND DMDRWD DOMAINS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The surface conservation between human URD and Drosophila DRWD is approximately 32%, with the C-terminal lobe being more conserved than the N-terminal lobe at 20% versus 12% respectively.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "SURFACE CONSERVATION COMPARISON (URD VS DMDRWD)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The human URD exhibits additional surface hydrophobic residues compared to DmDRWD, including a patch on the N-terminal lobe and another near \u03b1-helix 1, possibly contributing to differential interactions required in vertebrate systems.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "HYDROPHOBIC PATCHES ON HUMAN FANCL CENTRAL DOMAIN (URD)"}, {"entity_type": "PROTEIN", "description": "A vertebrate-specific feature of FANCL proteins where an element swap occurs, placing the N-terminal lobe in a position intermediary between E2 fold with \u03b2-flap and \u03b1-helix in non-catalytic RWD-like folds.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "VERTEBRATE FANCLS FEATURE (ELEMENT SWAP)"}, {"entity_type": "PROTEIN", "description": "The catalytic cysteine residue of Ube2T, an E2 ubiquitin-conjugating enzyme, which forms a thioester bond with ubiquitin.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "UBE2T CATALYTIC CYSTEINE RESIDUE (UBIQUITIN-CONJUGATING ENZYME)"}, {"entity_type": "PROTEIN", "description": "A cysteine residue within the \u03b2-element of human FANCL central domain\u2019s N-terminal lobe, located structurally similar to Ube2T\'s catalytic cysteine but unable to form a thioester bond with ubiquitin.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "CATALYTIC CYSTEINE IN URD N-TERMINAL LOBE (URD)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Specific residues interacting between the N- and C-terminal lobes of human FANCL central domain (URD) compared to Drosophila DRWD, not entirely conserved but showing high conservation in hydrophobic core regions.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "INTERACTION RESIDUES BETWEEN LOBES (HUMAN URD VS DMDRWD)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Detailed surface conservation analysis comparing human URD and Drosophila DRWD domains reveals differences in surface exposure and hydrophobic patches, indicative of potential differential interaction requirements in vertebrate systems.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "SURFACE CONSERVATION COMPARISON DETAILS (URD VS DMDRWD)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Additional hydrophobic residues on the human URD\u2019s N-terminal lobe compared to DmDRWD, suggesting possible unique surface features contributing to interaction specificity in vertebrates.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "HYDROPHOBIC EXPOSURE PATCHES (URD N-TERMINAL LOBE)"}, {"entity_type": "PROTEIN", "description": "Comparative conservation analysis showing vertebrate-specific elements and differences between vertebrate and invertebrate FANCL proteins, highlighting evolutionary adaptations.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "CONSERVATION OF FANCL PROTEINS (VERTEBRATE VS INVERTEBRATE)"}, {"entity_type": "PROTEIN", "description": "The URD is a protein domain involved in interactions with other proteins such as Ube2T and FANCI/FANCD2.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "URD"}, {"entity_type": "PROTEIN PART", "description": "The RING domain binds Ube2T and plays a role in substrate binding via hydrophobic patches on its surface.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "RING DOMAIN"}, {"entity_type": "PROTEIN", "description": "A protein involved in DNA repair and maintenance, specifically part of the Fanconi anemia pathway.<SEP>FANCI is one of the substrates that interact with URD through specific hydrophobic patches.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "FANCI"}, {"entity_type": "PROTEIN", "description": "A protein involved in DNA repair and maintenance, particularly in the Fanconi anemia pathway, which interacts with FANCI.<SEP>FANCD2 is another substrate that interacts with URD via exposed hydrophobic patches on its surface.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "FANCD2"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "Hydrophobic patches on the URD are crucial for binding to FANCI and FANCD2, as observed in mutagenesis experiments.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "HYDROPHOBIC PATCHES"}, {"entity_type": "PROTEIN PART", "description": "The DmDRWD is a part of the protein FANCL in Drosophila, which has conserved regions similar to human URD.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "DMDRWD"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "This patch lies between \u03b1-helix 1 and the N-terminal region of the large kinked helix, corresponding to residues Leu-121, Ala-140, Ile-184, Tyr-187, and Leu-191.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "\u0391-HELIX 1 AND LARGE KINKED HELIX PATCH"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "A patch resides on the URD between the last \u03b2-strand of the four-stranded \u03b2-meander (\u03b24) and the \u03b2-element corresponding to residues Leu-149, Tyr-165, Phe-166, and Val-167.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "\u0392-MEANDER PATCH"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "A hydrophobic groove exists between the last \u03b2-strand of the four-stranded \u03b2-meander and \u03b1-helix 3 that follows, corresponding to residues Ile-243, Met-246, Leu-248, Leu-264, Leu-268, and Trp-271.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "HYDROPHOBIC GROOVE ON C-TERMINAL DOMAIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS/MOLECULAR INTERACTION", "description": "The electrostatic potential surfaces differ between human URD and Drosophila DRWD, with a large positive patch on the latter that is absent in the former.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "ELECTROSTATIC POTENTIAL OF SURFACE URD VS DMDRWD"}, {"entity_type": "GENOMIC VARIANT", "description": "This mutant variant of the URD protein shows reduced binding affinity with FANCI and FANCD2 compared to wild type.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "L248A/F252A/L254A/I265A MUTANT URD"}, {"entity_type": "GENOMIC VARIANT", "description": "This mutant variant of the URD protein behaves similarly to wild type in substrate binding assays.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "W212A/L214A MUTANT URD"}, {"entity_type": "GENOMIC VARIANT", "description": "The FGFR4 rs351855 variant is a functional genetic variant associated with differential treatment effects of colesevelam on AC t1/2 and GC24.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "FGFR4 RS351855 (GLY388ARG)"}, {"entity_type": "GENOMIC VARIANT", "description": "KLB rs4975017 is a genomic variant that shows differential treatment effects associated with CT, specifically affecting GC24 value.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "KLB RS4975017"}, {"entity_type": "GENOMIC VARIANT", "description": "The KLB rs17618244 variant is a functional genetic variant showing numerical but not statistically significant differential treatment effects of colesevelam on AC t1/2 and GC24.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "KLB RS17618244 (ARG728GLN)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Colesevelam treatment affects the CT, AC t1/2, and GC24 levels in patients with different genotypes.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "COLESEVELAM TREATMENT"}, {"entity_type": "METABOLIC PATHWAY", "description": "AC t1/2 refers to the half-life of the area under the curve measurement for a substance, used here to assess the effect of treatment on drug metabolism and pharmacodynamics.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "AC T1/2 (AREA UNDER CURVE TIME 1/2)"}, {"entity_type": "METABOLIC PATHWAY", "description": "GC24 is a measure reflecting glycemic control over 24 hours post-treatment with colesevelam, indicating the impact of treatment on blood glucose levels.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "GC24 (GLYCEMIC CONTROL 24 HOURS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CT refers to changes in the transit time or clearance rate associated with drug effects and genetic variations.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "CT"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in FGFR4 that did not show significant differential treatment effects but was part of the study\'s candidate SNPs.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "FGFR4 RS376618"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The control group used to assess Hardy-Weinberg equilibrium and differential treatment effects for various genotypes.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "HEALTHY CONTROL PATIENTS"}, {"source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "description": "This genomic variant failed to satisfy Hardy-Weinberg equilibrium in the study.", "entity_type": "UNKNOWN", "id": "HWE ASSESSMENT"}, {"entity_type": "DISEASE", "description": "Irritable Bowel Syndrome with Diarrhea (IBS-D) is a disease characterized by chronic abdominal pain and loose, frequent stools.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 22}]", "id": "IBS-D"}, {"entity_type": "DISEASE", "description": "Irritable Bowel Syndrome with Constipation (IBS-C) is a disease characterized by chronic abdominal pain and infrequent, hard stools.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "IBS-C"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cholecystectomy is the surgical removal of the gallbladder, which can affect bile acid metabolism and digestion.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "CHOLECYSTECTOMY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FGF19, or Fibroblast Growth Factor 19, is a physiological process involved in regulating bile acid synthesis and metabolism.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 22}]", "id": "SERUM FGF19"}, {"entity_type": "METABOLIC PATHWAY", "description": "The metabolic pathway of bile acids involves their production, secretion into the intestines, and reabsorption through enterohepatic circulation.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "STOOL BA (BILE ACIDS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "C4 is a biomarker associated with cholestasis and liver dysfunction, indicating altered bile acid metabolism.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "SERUM C4"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the FGFR4 gene that has been marginally associated with stool BA levels.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "FGFR4 RS1966265"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the KLB gene that was tested for association but did not show significant results with serum C4 or stool BA.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "KLB RS17618244"}, {"entity_type": "METABOLIC PATHWAY", "description": "Bile acids are metabolic products of cholesterol that play a crucial role in fat digestion and absorption.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "BILE ACIDS (BA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FGF19 levels measured after fasting, which are involved in bile acid synthesis regulation.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "FASTING SERUM FGF19 LEVELS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measurement of stool weight over a 48-hour period, used to assess fat malabsorption and overall digestive health.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "48-HOUR STOOL WEIGHT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measurement of fat content in stool over a 48-hour period, an indicator of fat digestion efficiency.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "48-HOUR STOOL FAT"}, {"source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "description": "Genetic variants KLB rs17618244 and other FGFR4 SNPs were tested but showed no significant associations with serum C4 or stool BA.", "entity_type": "UNKNOWN", "id": "FGFR4 RS351855, FGFR4 RS376618"}, {"source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "description": "Higher BMI is correlated with higher serum C4 levels and total stool bile acids, indicating a relationship between metabolic status and FGF19 regulation.", "entity_type": "UNKNOWN", "id": "BMI, STOOL BA (BILE ACIDS)"}, {"source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "description": "Higher BMI is correlated with higher serum C4 levels and total stool bile acids, indicating a relationship between metabolic status and FGF19 regulation.", "entity_type": "UNKNOWN", "id": "FGF19 LEVELS"}, {"entity_type": "PROTEIN", "description": "FAAP20 is a 20 kDa protein that binds to FANCA through its N-terminal region and contains a conserved UBZ domain in its C-terminal extremity.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "FAAP20"}, {"entity_type": "PROTEIN", "description": "FANCA is a protein with which FAAP20 interacts, particularly through the binding of FAAP20\'s N-terminal region.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "FANCA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A molecular interaction involving two ubiquitin molecules linked by K63 residue.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "K63-LINKED UB2 (K63-UB2)"}, {"entity_type": "PROTEIN DOMAIN", "description": "The UBZ domain is a conserved C-terminal region in the FAAP20 protein that specifically interacts with K63-linked Ub chains.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "UBZ DOMAIN (OF FAAP20-UBZ)"}, {"entity_type": "STRUCTURE TYPE", "description": "A classical structure type for UBZ domains, though FAAP20-UBZ lacks the two short \u03b2 strands found in this fold.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "\u0392\u0392\u0391-FOLD "}, {"entity_type": "PROTEIN STRUCTURE FEATURE", "description": "The central part of the FAAP20 protein structure that interacts with one Ub moiety of K63-Ub2.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "CENTRAL \u0391-HELIX (RESIDUES 160\u2013173)"}, {"entity_type": "METAL ION INTERACTION", "description": "A zinc ion coordinated by conserved residues Cys147, Cys150, His166 and Cys170 to bridge the first loop and the \u03b1-helix of FAAP20-UBZ.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "ZINC ION"}, {"entity_type": "PROTEIN STRUCTURE FEATURE", "description": "A specific region in ubiquitin involved in interactions with other proteins, particularly through hydrophobic patches including Ile44 residue.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "ILE44 PATCH (OF UB)"}, {"entity_type": "MOLECULAR INTERACTION POSITION", "description": "The Lys63 residue on the distal ubiquitin molecule that interacts specifically with FAAP20-UBZ via a canonical Ile44-centered hydrophobic patch.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "K63 OF DISTAL UB"}, {"entity_type": "PROTEIN STRUCTURE FEATURE", "description": "The specific region of the FAAP20 protein that binds K63-linked Ub2.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "FAAP20-UBZ (RESIDUES 143\u2013180)"}, {"entity_type": "MOLECULAR INTERACTION ", "description": "A small regulatory protein, commonly attached to other proteins and involved in various cellular processes.<SEP>Ubiquitin is a small protein modifier involved in various cellular processes such as ubiquitination and signal transduction. In this context, it interacts with FAAP20-UBZ through specific residues to facilitate the recruitment of FAAP20 to DNA damage sites.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "UBIQUITIN (UB)"}, {"entity_type": "MOLECULAR INTERACTION ", "description": "Two ubiquitins linked by a lysine 48 residue, involved in interactions with FAAP20.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "K48-LINKED UB2"}, {"entity_type": "MOLECULAR INTERACTION ", "description": "Direct linkage of two ubiquitin molecules at their N-terminal methionines.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "M1-LINKED UB2"}, {"entity_type": "BIOLOGICAL ASSAY ", "description": "Technique used to study protein-protein interactions, involving glutathione S-transferase (GST) fusion proteins.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "GST-PULLDOWN ASSAY"}, {"entity_type": "PHYSICAL METHOD ", "description": "A method for measuring heats associated with binding events and determining affinity constants.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "ISOTHERMAL TITRATION CALORIMETRY (ITC)"}, {"entity_type": "STRUCTURE TYPE ", "description": "Structural elements typically present in the classical UBZ fold but absent in FAAP20-UBZ structure.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "TWO SHORT \u0392 STRANDS "}, {"entity_type": "PROTEIN RESIDUES ", "description": "Specific residues and their aliphatic portions involved in hydrophobic interactions with FAAP20-UBZ.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "LEU8, ILE44, VAL70, THR66, HIS68 (OF UB)"}, {"entity_type": "PROTEIN", "description": "FAAP20-UBZ is a protein that interacts with Ubiquitin (Ub) through specific intermolecular interactions, contributing to the binding and recruitment of FAAP20 to DNA damage sites.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "FAAP20-UBZ"}, {"entity_type": "DISEASE OR PHYSIOLOGICAL PROCESS", "description": "ICL (Interstrand Crosslink) Sites are locations on DNA where interstrand crosslinks occur, which can lead to DNA damage and are recognized by proteins like FAAP20 for repair processes.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ICL SITES"}, {"entity_type": "PROTEIN", "description": "WRNIP1-UBZ is a protein that interacts with Ubiquitin (Ub) through specific residues in its \u03b2\u03b2\u03b1 fold structure, contributing to the binding and recruitment of WRNIP1 to DNA damage sites.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "WRNIP1-UBZ"}, {"entity_type": "PROTEIN", "description": "RAD18-UBZ is a protein that interacts with Ubiquitin (Ub) through specific residues in its \u03b2\u03b2\u03b1 fold structure, contributing to the binding and recruitment of RAD18 to DNA damage sites.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "RAD18-UBZ"}, {"entity_type": "PROTEIN", "description": "Pol\u03b7-UBZ is a protein that seems to interact differently with Ubiquitin (Ub) compared to other UBZ proteins like WRNIP1-CREB3L2 and RAD18, contributing uniquely to cellular processes.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "POL\u0397-UBZ"}, {"entity_type": "PROTEIN", "description": "NEMO-UBZ is a protein that interacts with Ubiquitin (Ub) through specific residues in its structure, distinct from the canonical \u03b2\u03b2\u03b1 fold seen in WRNIP1 and RAD18 UBZs.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "NEMO-UBZ"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Specific molecular interactions between FAAP20\'s C-terminal loop and \u03b1-helix residues with Ubiquitin (Ub) are essential for the binding of FAAP20 to DNA damage sites.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "FAAP20 C-TERMINAL LOOP AND \u0391-HELIX INTERACTIONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Interactions between specific residues on proteins like FAAP20-UBZ, WRNIP1-UBZ, RAD18-UBZ, NEMO-UBZ, and Pol\u03b7-UBZ with Ubiquitin (Ub) are critical for protein binding and localization to DNA damage sites.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "UB-INTERACTING RESIDUES"}, {"entity_type": "PHYSIOLOGICAL PROCESS OR MOLECULAR INTERACTION", "description": "This patch, centered around Ile44 in ubiquitin (Ub), is a hydrophobic region that interacts with FAAP20-UBZ.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ILE44-CENTERED HYDROPHOBIC PATCH OF UB"}, {"entity_type": "PHYSIOLOGICAL PROCESS OR MOLECULAR INTERACTION", "description": "These residues contribute to the Ile44-centered hydrophobic patch in ubiquitin (Ub) that interacts with FAAP20-UBZ.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "LEU8, VAL70, THR66, HIS68 OF UB"}, {"entity_type": "PHYSIOLOGICAL PROCESS OR MOLECULAR INTERACTION", "description": "These residues interact with Arg42 in ubiquitin (Ub) to facilitate binding and localization of proteins like WRNIP1 and FAAP20.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ASP37 IN WRNIP1 \u0391-HELIX AND ASP177 IN C-TERMINAL LOOP OF FAAP20"}, {"entity_type": "PHYSIOLOGICAL PROCESS OR MOLECULAR INTERACTION", "description": "These residues interact with Ile44 in ubiquitin (Ub) to facilitate binding and localization of WRNIP1 protein.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "PRO21-VAL22 IN THE \u0392-LOOP OF WRNIP1"}, {"entity_type": "PHYSIOLOGICAL PROCESS OR MOLECULAR INTERACTION", "description": "These residues are involved in interactions with ubiquitin (Ub) that differ from canonical \u03b2\u03b2\u03b1 fold structures seen in WRNIP1 and RAD18 UBZs.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "PRO398-LYS399 IN NEMO-UBZ AND GLU636-LYS637 IN POL\u0397-UBZ"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The C-terminal loop interacts specifically with residues on ubiquitin (Ub) to facilitate binding and localization of FAAP20 protein.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "C-TERMINAL LOOP OF FAAP20-UBZ"}, {"entity_type": "MOLECULAR INTERACTION", "description": "This loop contributes to the interaction between WRNIP1-UBZ and ubiquitin (Ub).", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "\u0392-LOOP OF WRNIP1"}, {"entity_type": "PROTEIN", "description": "A protein with a unique binding mechanism for Ub compared to other proteins like WRNIP1-UBZ and RAD18-UBZ, characterized by distinct residues in the \u03b2-loop.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "NEMO-UBZ (PDB CODE: 2JVX)"}, {"entity_type": "PROTEIN", "description": "A protein that interacts with Ub similarly to FAAP20-UBZ but differently from NEMO-UBZ due to specific residue conservation and replacements.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "POL\u0397-UBZ (PDB CODE: 2I5O)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Ubiquitin, a small regulatory protein involved in various cellular processes including the modification of other proteins through ubiquitination.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "UB"}, {"entity_type": "PROTEIN", "description": "A protein that interacts with Ub through its \u03b2-loop and has residues that are differently conserved compared to NEMO-UBZ and Pol\u03b7-UBZ.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "WRNIP1-UBZ (PDB CODE: 2JVX)"}, {"entity_type": "PROTEIN", "description": "A protein that interacts with Ub through specific residues in the \u03b1-helix, similar to Rabex5-MIU and different from NEMO-UBZ due to residue conservation.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "FAAP20-UBZ (PDB CODE: 2I5O)"}, {"entity_type": "PROTEIN", "description": "A protein that interacts with Ub through its \u03b2-loop in a manner distinct from FAAP20-UBZ and Pol\u03b7-UBZ.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "RAD18-UBZ (PDB CODE: 2JVX)"}, {"entity_type": "PROTEIN", "description": "A UBD involved in binding to ubiquitin, with similar critical residues for Ub binding compared to Rabex5-MIU and FAAP20-UBZ.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "VPS27-UIM (PDB CODE: 1Q0W)"}, {"entity_type": "PROTEIN", "description": "A UBD that binds ubiquitin similarly to FAAP20-UBZ, with convergent evolution of critical Ub binding residues compared to Vps27-UIM.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "RABEX5-MIU (PDB CODE: 2C7M AND 2FIF)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A motif interacting with ubiquitin that shares similarity in critical binding residues with FAAP20-UBZ and Rabex5-MIU, suggesting convergent evolution.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "MIU (MOTIF INTERACTING WITH UBIQUITIN)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An Ub-binding motif involved in interactions with ubiquitin, with polarity opposite to FAAP20-UBZ but similar critical residues for binding compared to Vps27-UIM and Rabex5-MIU.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "UIM (UB-INTERACTING MOTIF)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A structural element of UBZ domains involved in the interaction with Ub, characterized by distinct residue patterns among different groups of proteins.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "\u0392-LOOP (IN UBZ DOMAINS)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A structural element crucial for Ub binding in FAAP20-UBZ and Rabex5-MIU, showing convergent evolution with Vps27-UIM.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "\u0391-HELIX (IN UBZ/UIM/MIU STRUCTURES)"}, {"source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "description": "The central \u03b1-helix in FAAP20-UBZ interacts specifically with the K63 residue on the distal ubiquitin molecule.", "entity_type": "UNKNOWN", "id": "K63 OF DISTAL UB "}, {"source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "description": "FAAP20 can bind to K48-linked diubiquitin chains, indicating non-specific binding preference.", "entity_type": "UNKNOWN", "id": "K48-LINKED UB2 "}, {"source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "description": "FAAP20 interacts with M1-linked diubiquitin chains, demonstrating non-specific binding capability.", "entity_type": "UNKNOWN", "id": "M1-LINKED UB2 "}, {"source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "description": "GST-pulldown technique used to investigate binding interactions between FAAP20 and FANCA.", "entity_type": "UNKNOWN", "id": "FANCA INTERACTION STUDIES "}, {"source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "description": "GST-pulldown technique used to investigate binding interactions between FAAP20 and FANCA.", "entity_type": "UNKNOWN", "id": "GST-PULLDOWN ASSAY "}, {"source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "description": "ITC measures equilibrium dissociation constants for protein-protein interactions, such as Pol\u03b7 UBZ with ubiquitin.", "entity_type": "UNKNOWN", "id": "BINDING AFFINITY MEASUREMENT "}, {"source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "description": "Typically present in classical UBZ folds but absent in FAAP20-UBZ structure.", "entity_type": "UNKNOWN", "id": "CLASSICAL UBZ FOLD "}, {"source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "description": "Residues and their aliphatic portions involved in hydrophobic interactions with FAAP20-UBZ.", "entity_type": "UNKNOWN", "id": "HYDROPHOBIC INTERACTIONS "}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "The presence of ICL sites indicates a need for DNA repair processes, where proteins like FAAP20-UBZ play crucial roles in recruitment and repair.", "entity_type": "UNKNOWN", "id": "DNA DAMAGE REPAIR PROCESS"}, {"source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "description": "These residues interact with Arg42 on ubiquitin to facilitate binding and localization.", "entity_type": "UNKNOWN", "id": "ARG42 IN UBIQUITIN (UB)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at position rs2395182, where the minor \'G\' allele is more prevalent in healthy controls than in CD patients.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "RS2395182"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at position rs7775228, where the minor \'C\' allele has a higher frequency among healthy controls compared to CD patients.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "RS7775228"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at position rs2187668 with the minor \'T\' allele more frequently present in CD patients than in controls.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "RS2187668"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The homozygous HLA-DQ2.5 haplotype is significantly higher among CD patients compared to healthy controls and is considered a risk factor for the disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HLA-DQ2.5 HAPLOTYPE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Heterozygous DQ8 (in combination with DQ2.2) haplotypes were highly frequent among CD patients, suggesting its role as an additional risk factor.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HLA-DQ8 HAPLOTYPE"}, {"entity_type": "DISEASE", "description": "An inflammatory bowel disease characterized by chronic inflammation of the gastrointestinal tract.<SEP>Crohn\u2019s disease is a chronic inflammatory bowel disorder that affects the digestive tract and shows genetic predisposition based on HLA-DQ haplotypes.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc<SEP>chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "CROHN\'S DISEASE (CD)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Individuals without Crohn\'s Disease used as a control group in genetic studies.<SEP>Individuals without asthma used as a comparison group for studying asthmatic patients.<SEP>The healthy control group includes individuals without Crohn\'s disease, used for comparison with CD patients in genetic studies.<SEP>The group serving as a control in genetic studies to compare against HIV-infected individuals.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-6f7ce1c71bd46f223756da44b0d0bb2c<SEP>chunk-1418daebca32811d9530c70d8e9bf4cc<SEP>chunk-84ec948f22126cef7d93b1d7465b79db", "id": "HEALTHY CONTROLS"}, {"entity_type": "DISEASE", "description": "A common autoimmune manifestation seen in the patient group of CD patients.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "TYPE 1 DIABETES MELLITUS"}, {"entity_type": "DISEASE", "description": "An autoimmune condition observed in a small subset (8%) of CD patients.<SEP>Anti-thyroglobulin and anti-thyroid peroxidase antibodies indicate the presence of autoimmune thyroiditis in STAT5B deficient siblings.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "AUTOIMMUNE THYROIDITIS"}, {"entity_type": "DISEASE", "description": "A rare autoimmune disease manifestation found in 3% of the CD patient group.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "SYSTEMIC LUPUS ERYTHEMATOSUS"}, {"entity_type": "DISEASE", "description": "Non-autoimmune disease manifestations observed in a small percentage (5%) of CD patients.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "OSTEOMALACIA"}, {"entity_type": "DISEASE", "description": "A neurological disorder seen in 4% of the patient group with Crohn\'s disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "SEIZURE DISORDERS"}, {"entity_type": "DISEASE", "description": "Found in 4% of the study participants diagnosed with CD, indicating an associated genetic condition.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "DOWN SYNDROME"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at position rs7454108 with no significant difference in minor allele frequency between CD patients and controls.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "RS7454108"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Predicted to be more frequent among control groups than CD patient group, suggesting its potential protective effect against Crohn\'s disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HOMOZYGOUS HLA-DQ2.2 HAPLOTYPE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Heterozygous DQ8 in combination with DQX haplotype is significantly more frequent among CD patients compared to healthy controls, indicating a risk factor for the disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "DQ8/DQX HAPLOTYPES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A common clinical symptom seen in CD patients, characterized by prolonged diarrhea lasting more than 4 weeks.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "CHRONIC DIARRHEA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Another common symptom observed in Crohn\u2019s disease patients, typically localized to the lower abdomen.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "ABDOMINAL PAIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A condition of loss of appetite or disinterest in food commonly seen in CD patients due to gastrointestinal inflammation.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "ANOREXIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Symptom characterized by the swelling of the abdomen, often associated with bowel obstruction or gas accumulation in Crohn\u2019s disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "ABDOMINAL DISTENSION"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Validation method used to confirm the accuracy of HLA-DQ haplotypes determined by Real-time PCR genotyping, showing 100% concordance in randomly selected individuals from both study groups.", "entity_type": "UNKNOWN", "id": "REAL-TIME PCR GENOTYPING"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs1128503 in the ABCB1 gene is associated with grade 3\u20134 anemia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS1128503 (ABCB1)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs12762549 in the ABCC2 gene is associated with grade 3\u20134 anemia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS12762549 (ABCC2)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs363717 in the ABCA1 gene is associated with grade 3\u20134 anemia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS363717 (ABCA1)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs11615 in the ERCC1 gene is associated with grade 3\u20134 anemia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS11615 (ERCC1)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs4986910 in the CYP3A4 gene is associated with thrombocytopenia grade 3\u20134.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS4986910 (CYP3A4)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs2074087 in the ABCC1 gene is significantly correlated with use of erythropoietin-stimulating agents (ESAs).", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS2074087 (ABCC1)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs2073337 in the ABCC2 gene is significantly correlated with use of colony-stimulating factors (CSFs).", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS2073337 (ABCC2)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs1695 in the GSTP1 gene is significantly correlated with use of CSFs.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS1695 (GSTP1)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs1799793 in the ERCC2 gene is significantly associated with progression-free interval (PFI).", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS1799793 (ERCC2)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs3814879 in the TGFBR2 gene is associated with an increased risk for severe radiation pneumonitis.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS3814879 (TGFBR2)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs7156029 in the HLA-DQB1 gene is correlated with response to immunotherapy.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS7156029 (HLA-DQB1)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant rs113498797 in the MYH6 gene is associated with increased risk of atrial fibrillation.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "RS113498797 (MYH6)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in ERCC2 gene, specifically the G>A substitution at position rs1799793, is significantly correlated with platinum-free interval (PFI) survival.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RS1799793 (ERCC2 G\u2009>\u2009A)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in ABCC2 gene, specifically the A>G substitution at position rs12762549, was significantly associated with platinum-free interval (PFI) survival when fully adjusted for multiple factors but not significant after adjusting only for age.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RS12762549 (ABCC2 A\u2009>\u2009G)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in SERPINB2 gene, specifically the C>G substitution at position rs6104, was significantly associated with platinum-free interval (PFI) survival when fully adjusted for multiple factors but not significant after adjusting only for age.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RS6104 (SERPINB2 C\u2009>\u2009G)"}, {"entity_type": "GENE", "description": "The ERCC2 gene is involved in nucleotide excision repair and its variant rs1799793 correlates with platinum-free interval (PFI) survival.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "ERCC2 GENE"}, {"entity_type": "GENE", "description": "The ABCC2 gene, also known as MRP2, plays a role in drug transport and its variant rs12762549 is associated with platinum-free interval (PFI) survival.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "ABCC2 GENE"}, {"entity_type": "GENE", "description": "The SERPINB2 gene encodes a serine protease inhibitor that is involved in inflammation regulation, and its variant rs6104 shows an association with platinum-free interval (PFI) survival.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "SERPINB2 GENE"}, {"entity_type": "GENOMIC VARIANT CARRIER GROUP", "description": "Individuals carrying the GG genotype of rs1799793 in ERCC2 gene show a significant advantage in platinum-free interval compared to AA or GA carriers.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "ERCC2 G\u2009>\u2009A VARIANT CARRIERS (GG)"}, {"entity_type": "GENOMIC VARIANT CARRIER GROUP", "description": "Individuals carrying the AA or GA genotype of rs1799793 in ERCC2 gene show a significant disadvantage in platinum-free interval compared to GG carriers.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "ERCC2 G\u2009>\u2009A VARIANT CARRIERS (AA/GA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY", "description": "Platinum-free interval is a measure of the time between the end of primary chemotherapy and the start of subsequent therapy or disease progression, indicating survival duration.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "PLATINUM-FREE INTERVAL (PFI)"}, {"entity_type": "ENVIRONMENTAL FACTOR/LIFESTYLE FACTOR", "description": "Age at diagnosis is an environmental factor that influences patient prognosis in medical studies.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "AGE AT DIAGNOSIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS/PATHOLOGICAL CONDITION", "description": "The FIGO stage indicates the extent of ovarian cancer progression and affects survival outcomes.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "FIGO STAGE"}, {"entity_type": "DISEASE SEVERITY INDICATOR", "description": "Tumor grade is a measure used to classify tumor aggressiveness and impact prognosis.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "TUMOR GRADE"}, {"entity_type": "PHYSIOLOGICAL PROCESS/PATHOLOGICAL CONDITION", "description": "The amount of residual disease after debulking surgery influences patient outcomes following treatment.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RESIDUAL DISEASE AFTER DEBULKING SURGERY"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs1128503 variant in ABCB1 is significantly associated with grade 3-4 anemia.", "entity_type": "UNKNOWN", "id": "GRADE 3\u20134 ANEMIA"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs4986910 variant in CYP3A4 is significantly associated with thrombocytopenia grade 3-4.", "entity_type": "UNKNOWN", "id": "THROMBOCYTOPENIA GRADE 3\u20134"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs2074087 variant in ABCC1 is significantly associated with the use of ESAs.", "entity_type": "UNKNOWN", "id": "ERYTHROPOIETIN-STIMULATING AGENTS (ESAS)"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs2073337 variant in ABCC2 is significantly associated with the use of CSFs.", "entity_type": "UNKNOWN", "id": "COLONY-STIMULATING FACTORS (CSFS)"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs1799793 variant in ERCC2 is significantly associated with PFI.", "entity_type": "UNKNOWN", "id": "PROGRESSION-FREE INTERVAL (PFI)"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs3814879 variant in TGFBR2 is associated with an increased risk for severe radiation pneumonitis.", "entity_type": "UNKNOWN", "id": "RADIATION PNEUMONITIS"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs7156029 variant in HLA-DQB1 is correlated with the response to immunotherapy.", "entity_type": "UNKNOWN", "id": "RESPONSE TO IMMUNOTHERAPY"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs113498797 variant in MYH6 increases the risk of atrial fibrillation.", "entity_type": "UNKNOWN", "id": "ATRIAL FIBRILLATION"}, {"source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "description": "The genomic variant rs1799793 in ERCC2 gene is significantly correlated with platinum-free interval (PFI) survival.", "entity_type": "UNKNOWN", "id": "PLATINUM-FREE INTERVAL"}, {"entity_type": "GENE", "description": "UMPS is a gene identified as containing genetic alterations that may contribute to certain phenotypes.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "UMPS GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A de novo 6.4 Mb deletion on chromosome 3, chr3:121233326\u2013127618464, contains the UMPS gene and may contribute to a patient\u2019s phenotype.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "DE NOVO DELETION ON CHROMOSOME 3"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous alteration (c.302delA) found in individual I4 leading to premature stop and loss of protein function.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.302DELA IN I4"}, {"entity_type": "GENOMIC VARIANT", "description": "Maternally inherited variant (c.385G>T) found in individuals I7, their healthy brother S7, and possibly others leading to premature stop codon.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.385G>T IN I7 AND S7"}, {"entity_type": "GENOMIC VARIANT", "description": "Maternally inherited variant (c.889G>T) found in individuals I10 and I11 causing protein truncation leading to loss of normal function.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.889G>T IN I10 AND I11"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous missense alteration (c.224C>A) found in multiple members of pedigree 2, potentially derived from either parent or unknown origin.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.224C>A IN PEDIGREE 2 FAMILY MEMBERS"}, {"entity_type": "GENOMIC VARIANT", "description": "Two heterozygous missense alterations (c.286A>G and c.1285G>C) found in individuals I3 and his healthy mother M3, possibly on the same allele.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.286A>G AND C.1285G>C IN I3 AND M3"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous missense alteration (c.310G>A) detected in individual I5 leading to a change from Gly104 to Arg, potentially pathogenic.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.310G>A IN I5"}, {"entity_type": "GENOMIC VARIANT", "description": "Maternally inherited missense alterations (c.689G>A and c.688C>T) found in individuals I6 and I7 leading to Arg230His and Arg230Cys changes, respectively.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.689G>A AND C.688C>T IN I6 AND I7"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous missense alteration (c.857T>A) detected in individual I9 leading to a change from Ile286 to Asn, potentially pathogenic.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.857T>A IN I9"}, {"entity_type": "GENOMIC VARIANT", "description": "A heterozygous missense alteration (c.451G>A) found in individual I11 leading to a change from Val151 to Met, potentially pathogenic.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.451G>A IN I11"}, {"entity_type": "GENOMIC VARIANT", "description": "Maternally inherited synonymous variant (c.360A>G) found in individual I6 leading to no change in protein sequence but still considered relevant for further study.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.360A>G IN I6"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A process that leads to loss of normal protein function due to premature stop codons in mRNAs.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "PROTEIN TRUNCATION OR NONSENSE-MEDIATED MRNA DECAY (NMD)"}, {"entity_type": "GENOMIC VARIANT", "description": "Different heterozygous missense alterations were found across individuals, potentially leading to changes in UMPS protein functionality.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "HETEROZYGOUS MISSENSE ALTERATIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "Two different variants (c.286A>G and c.1285G>C) found within the UMPS gene of individual I3 and his mother M3.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.286A>G AND C.1285G>C VARIANTS IN I3 AND M3"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Software programs used to predict the pathogenicity of genetic variants detected in individuals.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "POLYPHEN-2, SIFT, MUTATIONTASTER PROGRAMS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A testing method used to identify gene-specific deletions or duplications, particularly for UMPS gene.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "HIGH-DENSITY GENE-CENTRIC ARRAY CGH TESTING"}, {"entity_type": "GENOMIC VARIANT", "description": "The TGF-\u00df1 (rs1800469 C/T) SNP is a genetic variant in the promoter region of the TGF-\u00df1 gene, showing significant association with colorectal cancer risk.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "TGF-SS1 (RS1800469 C/T)"}, {"entity_type": "GENOMIC VARIANT", "description": "The IL-8 (rs4073 T/A) polymorphism is a genetic variant in the promoter region of the interleukin-8 gene, not significantly associated with CRC risk.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-8 (RS4073 T/A)"}, {"entity_type": "GENOMIC VARIANT", "description": "The IL-10 (rs1800896 A/G) polymorphism is a genetic variant in the promoter region of the interleukin-10 gene, showing significant association with reduced CRC risk.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-10 (RS1800896 A/G)"}, {"entity_type": "GENOMIC VARIANT", "description": "The IL-22 (rs1179251 C/G) polymorphism is a genetic variant in the promoter region of the interleukin-22 gene, showing an association with CRC risk.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-22 (RS1179251 C/G)"}, {"entity_type": "GENOMIC VARIANT", "description": "The IL-22 (rs2227485 C/T) polymorphism is a genetic variant in the promoter region of the interleukin-22 gene, not significantly associated with CRC risk.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-22 (RS2227485 C/T)"}, {"entity_type": "GENOMIC VARIANT", "description": "The IL-27 (rs17855750 T/G) polymorphism is a genetic variant in the promoter region of the interleukin-27 gene, showing an association with reduced CRC risk.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-27 (RS17855750 T/G)"}, {"entity_type": "DISEASE", "description": "Colorectal cancer is a disease where several genes\' variants have been studied for their association with increased or decreased risk.<SEP>Colorectal cancer is a type of cancer that starts in the colon or rectum.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "COLORECTAL CANCER (CRC)"}, {"entity_type": "GENE", "description": "The IL-8 gene encodes the protein interleukin-8, which is involved in immune and inflammatory responses.<SEP>The IL-8 gene is involved in immune response regulation and has a polymorphism (rs4073 T/A) studied for its association with colorectal cancer risk.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-8 GENE"}, {"entity_type": "GENE", "description": "The IL-27 gene has a promoter SNP (rs17855750 T/G) showing an association with reduced risk of CRC, although not highly significant.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-27 GENE"}, {"entity_type": "GENE", "description": "The TGF-\u00df1 gene is involved in various cellular processes and contains the rs1800469 C/T polymorphism which significantly correlates with colorectal cancer development.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "TGF-SS1 GENE"}, {"entity_type": "DISEASE", "description": "Colorectal Cancer (CRC) is a disease characterized by the uncontrolled growth of cells in the colon or rectum.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "id": "CRC"}, {"entity_type": "GENOMIC VARIANT", "description": "The T allele is another genetic variant that has been observed in relation to colorectal cancer, though its association did not reach statistical significance.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "id": "T ALLELE"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "The rs1179251 C/G polymorphism in IL-22 gene is associated with a decreased risk of developing CRC but lacks strong statistical significance.", "entity_type": "UNKNOWN", "id": "IL-22 GENE (RS1179251 C/G)"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "The G allele in IL-27 gene shows protective effects against colorectal cancer development, though the association is weak.", "entity_type": "UNKNOWN", "id": "IL-27 GENE (RS17855750 T/G)"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "The genetic variants of IL-8 and IL-10 both contribute to immune system modulation, with IL-10 showing a more pronounced effect on CRC risk reduction.", "entity_type": "UNKNOWN", "id": "IL-10 GENE (RS1800896 A/G)"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "The genetic variants of IL-8 and IL-10 both contribute to immune system modulation, with IL-10 showing a more pronounced effect on CRC risk reduction.", "entity_type": "UNKNOWN", "id": "IL-8 GENE (RS4073 T/A)"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "Both TGF-\u00df1 and IL-10 genes have polymorphisms studied for CRC risk, with contrasting outcomes: increased risk in TGF-\u00df1, reduced risk in IL-10.", "entity_type": "UNKNOWN", "id": "TGF-SS1 GENE (RS1800469 C/T)"}, {"source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "description": "A lower frequency of the T allele was observed in CRC patients compared to the control group but did not reach statistical significance.)", "entity_type": "UNKNOWN", "id": "CONTROL GROUP VS CRC PATIENTS"}, {"source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "description": "A lower frequency of the T allele was observed in CRC patients compared to the control group but did not reach statistical significance.)", "entity_type": "UNKNOWN", "id": "T ALLELE FREQUENCY"}, {"entity_type": "GENE", "description": "The TSLP gene is implicated in asthma susceptibility as evidenced by the association of specific SNPs with asthma risk.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "TSLP GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located in the TSLP gene, rs1898671, has been associated with increased risk for asthma in certain populations.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "RS1898671"}, {"entity_type": "GENOMIC VARIANT", "description": "This specific variant shows different effects on asthma susceptibility depending on smoking history.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "SNP (RS1898671)"}, {"entity_type": "LIFESTYLE FACTOR", "description": "The subgroup of ex-smokers has a higher risk associated with the TSLP SNP rs1898671 compared to never-smokers.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "EX-SMOKERS"}, {"entity_type": "LIFESTYLE FACTOR", "description": "In contrast, individuals who have never smoked did not show significant association between SNP rs1898671 and asthma risk.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "NEVER-SMOKERS"}, {"entity_type": "DISEASE", "description": "The genetic variant in the TSLP gene influences susceptibility to asthma depending on lifestyle factors such as smoking history.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "ASTHMA SUSCEPTIBILITY"}, {"entity_type": "GENOMIC VARIANT", "description": "This specific haplotype shows a significant increased risk of asthma after adjusting for age, BMI and population stratification.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "TSLP HAPLOTYPE (GAGGGCAAAG)"}, {"entity_type": "DISEASE", "description": "This entity refers to individuals diagnosed with asthma included in the study.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "ASTHMATIC PATIENTS"}, {"entity_type": "STUDY POPULATION", "description": "A specific population of 387 unrelated asthmatic patients and 212 unrelated healthy controls included in the analysis.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 13}]", "id": "NYUBAR POPULATION"}, {"entity_type": "DEMOGRAPHIC CHARACTERISTIC", "description": "Information provided by participants regarding their racial and ethnic background used to adjust for population stratification in genetic studies.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "SELF-REPORTED RACE/ETHNICITY INFORMATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Measurements assessing lung function that were significantly different between asthmatic patients and healthy controls.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "LUNG FUNCTION TESTS (FEV1, FVC)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Blood levels of immunoglobulin E which were higher in asthma cases compared to controls.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "TOTAL IGE LEVELS"}, {"entity_type": "PHYSIOLOGICAL CONDITION", "description": "The presence of atopy, characterized by elevated total IgE and sensitization to common allergens, was more prevalent among asthmatic patients.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "ATOPIC STATUS"}, {"source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "description": "Race/ethnicity information is used to adjust for potential biases in genetic association studies.", "entity_type": "UNKNOWN", "id": "POPULATION STRATIFICATION ADJUSTMENT"}, {"entity_type": "GENE", "description": "The PTPN2 gene is associated with CD through a significant SNP, rs478582.<SEP>The PTPN2 gene is associated with autoimmune diseases such as celiac disease, inflammatory bowel disease, rheumatoid arthritis and type 1 diabetes.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1<SEP>chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN2 GENE"}, {"entity_type": "GENE", "description": "The PTPN22 gene is studied for its potential role in CD and inflammatory autoimmune diseases due to the SNP rs2476601.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN22 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP in the PTPN2 gene is significant in Crohn\'s Disease (CD) compared to healthy controls, showing an increased frequency of heterozygous and minor alleles in CD subjects.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS478582"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific SNP in the PTPN22 gene associated with various inflammatory autoimmune diseases but not significant in CD compared to healthy controls, except for haplotype analysis.<SEP>The rs2476601 variant of the PTPN22 gene is a risk allele associated with certain autoimmune diseases. It influences the expression and function of LYP protein variants, impacting Treg-mediated suppression.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-dee0a8a550579bff19f48d41446e842d", "id": "RS2476601"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of the PTPN2 gene shows significantly lower relative expression levels in CD subjects than in healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN2 TRANSCRIPT"}, {"entity_type": "PROTEIN", "description": "No direct effect on protein level described, but changes at genetic and transcript levels suggest potential influence on protein function or stability.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN2 PROTEIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Expression of IFN-gamma is evaluated in relation to the SNPs rs478582 and rs2476601, but specific effects are not detailed in this text.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "IFN-\u0393 EXPRESSION"}, {"entity_type": "DISEASE", "description": "A disease characterized by lower expression of PTPN2/PTPN22 genes compared to healthy controls, influenced by certain SNPs.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "CD (CROHN\'S DISEASE)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "This haplotype combination between PTPN2:rs478582 and PTPN22:rs2476601 was found more frequently in healthy controls than CD subjects.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "HAPLOTYPE COMBINATION T-G"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The haplotype combination of heterozygous/major alleles for rs478582 and rs2476601 is significantly higher in CD compared to healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "HAPLOTYPE COMBINATION C-G"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A haplotype with a minor allele for PTPN2:rs478582 combined with the heterozygous or minor allele for PTPN22:rs2476601.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "HAPLOTYPE COMBINATION T-A"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The haplotype combination of heterozygous/major alleles for rs478582 and the minor/heterozygous or minor allele for rs2476601 is significantly higher in CD compared to healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "HAPLOTYPE COMBINATION C-A"}, {"entity_type": "DISEASE SUSCEPTIBILITY", "description": "Certain genetic variants like rs478582 and rs2476601 influence predisposition to Crohn\'s Disease.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PREDISPOSITION TO CD"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the PTPN2 gene associated with increased susceptibility to MAPbacteremia in Crohn\'s disease (CD) subjects.<SEP>A genomic variant in the PTPN2 gene associated with changes in relative gene expression and susceptibility to Mycobacterium avium subsp. Paratuberculosis (MAP) infection.<SEP>A genomic variant located on the PTPN2 gene, specifically rs478582.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "PTPN2:RS478582"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The average relative gene expression of CD subjects was lower when comparing heterozygous or minor alleles in PTPN2:rs478582 and PTPN22:rs2476601 compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "CD AVERAGE RELATIVE GENE EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The expression of IFN-\u03b3 increases when there is a combined presence of MAPbacteremia and specific genetic variants (SNPs) related to PTPN2 or PTPN22 genes.<SEP>The gene expression of IFN-\u03b3 was higher in CD subjects with heterozygous or minor alleles in PTPN2:rs478582, but not affected by similar alleles in PTPN22:rs2476601.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "id": "IFN-\u0393 GENE EXPRESSION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "An environmental factor that shows increased detection and susceptibility in CD subjects with specific genetic variants compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS (MAP)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant in the PTPN22 gene associated with increased susceptibility to MAPbacteremia in CD subjects.<SEP>A genomic variant in the PTPN22 gene not changing the expression of its protein but affecting susceptibility when combined with MAP infection.<SEP>Another genomic variant located on the PTPN22 gene, specifically rs2476601.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "PTPN22:RS2476601"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Expression of the PTPN2 gene is reduced in CD subjects relative to healthy controls regardless of MAPbacteremia status.<SEP>Gene expression analysis of PTPN2 gene shows significant changes in CD subjects with heterozygous or minor alleles compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "id": "PTPN2 GENE EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Gene expression analysis of the PTPN22 gene does not show significant differences between carriers and non-carriers of minor alleles but shows a lower expression in CD subjects overall.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "id": "PTPN22 GENE EXPRESSION"}, {"entity_type": "GENOMIC VARIANT", "description": "Heterozygous or minor alleles in PTPN2:rs478582, specifically the TC and CC genotypes.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "TC ALLELES"}, {"entity_type": "GENOMIC VARIANT", "description": "Minor allele (CC) of PTPN2:rs478582 associated with increased susceptibility to MAPbacteremia in CD subjects.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "CC ALLELE"}, {"entity_type": "DISEASE", "description": "A disease condition characterized by the presence of Mycobacterium avium subspecies paratuberculosis (MAP) bacteria in blood, often linked to inflammatory bowel diseases like Crohn\'s disease.<SEP>Presence of Mycobacterium avium complex (MAC) bacteria within the bloodstream, often associated with immunocompromised states.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "MAPBACTEREMIA"}, {"entity_type": "GENOMIC VARIANT", "description": "Heterozygous alleles (GA) of PTPN22:rs2476601 associated with increased MAPbacteremia presence compared to healthy controls.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "GA ALLELES"}, {"entity_type": "GENOMIC VARIANT", "description": "Minor allele (AA) in PTPN22:rs2476601, rare and not strongly linked to MAPbacteremia in CD subjects.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "AA ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A haplotype combination of C-G alleles in PTPN2:rs478582 and PTPN22:rs2476601, significantly associated with MAPbacteremia presence in CD subjects.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "C-G HAPLOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "A haplotype combination of T-A alleles in PTPN2:rs478582 and PTPN22:rs2476601, associated with MAPbacteremia presence but less common than C-G haplotype.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "id": "T-A HAPLOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which T-cells multiply and increase in number.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "T-CELL PROLIFERATION RESPONSE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The functional capabilities and responsiveness of T-cells to various stimuli in the immune system.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "T-CELL FUNCTIONALITY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Phytohemagglutinin (PHA), a lectin used as a mitogen to stimulate cell proliferation in vitro.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "PHA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A substance similar to purified protein derivative of Mycobacterium avium complex (MAC) used for antigenic stimulation in immune responses.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "MAP PPD-LIKE"}, {"entity_type": "GENE", "description": "The gene encoding interferon-gamma (IFN-\u03b3), which plays a critical role in immune response.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "IFNG"}, {"entity_type": "GENE", "description": "A gene involved in regulation of T-cell activation and cytokine production.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "PTPN2"}, {"entity_type": "GENE", "description": "A gene associated with autoimmune diseases, including Crohn\'s Disease (CD).<SEP>PTPN22 is a gene associated with autoimmune disorders, particularly through its risk variant rs2476601. It influences Treg-mediated suppression and is expressed more highly in regulatory T cells (Tregs) compared to conventional T cells.<SEP>PTPN22 is a gene that encodes the protein tyrosine phosphatase non-receptor type 22 (LYP), which plays an important role in immune cell function.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-883c371ea1f500a1ba8af8366328e8b0<SEP>chunk-dee0a8a550579bff19f48d41446e842d", "id": "PTPN22"}, {"source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "description": "The susceptibility to MAP infection is increased among CD subjects with heterozygous or minor alleles in PTPN22:rs2476601 compared to healthy controls.", "entity_type": "UNKNOWN", "id": "MAP INFECTION SUSCEPTIBILITY"}, {"source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "description": "CD subjects carrying heterozygous or minor alleles in PTPN2:rs478582 have significantly lower gene expression compared to healthy controls.", "entity_type": "UNKNOWN", "id": "CD SUBJECTS WITH MINOR ALLELES"}, {"source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "description": "CD subjects with MAPbacteremia have significantly lower relative gene expression levels of PTPN2 compared to healthy controls, irrespective of MAP presence status.", "entity_type": "UNKNOWN", "id": "MAPBACTEREMIA PRESENCE"}, {"source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "description": "The presence of specific genetic variants (SNPs in PTPN2 or PTPN22) combined with MAPbacteremia leads to increased IFN-\u03b3 expression.", "entity_type": "UNKNOWN", "id": "PTPN2:RS478582 AND PTPN22:RS2476601 SNPS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The differentiation and activation of lymphocytes into distinct subsets such as na\u00efve, memory, and regulatory T cells is a physiological process regulated by various genes including PTPN22.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "LYMPHOCYTE SUBSET"}, {"entity_type": "GENOMIC VARIANT", "description": "The LYP-620R variant of the PTPN22 gene encodes a non-risk allele associated with lower risk for Type 1 Diabetes (T1D).", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "T1D NON-RISK ALLELE (LYP-620R)"}, {"entity_type": "GENOMIC VARIANT", "description": "The LYP-620W variant of the PTPN22 gene is considered a risk allele and is associated with higher susceptibility to T1D.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "RISK ALLELE (LYP-620W)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The expression of PTPN22 is a molecular interaction involving transcriptional regulation and post-transcriptional modifications in various cell states.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "PTPN22 EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "T-cell receptor (TCR) signaling pathway is the process by which T cells recognize antigens and initiate immune responses, involving multiple downstream pathways such as calcium signaling and MAPK/ERK activation.<SEP>The process by which T cell receptor engagement initiates a series of signaling events leading to cellular activation and differentiation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "TCR SIGNALING PATHWAY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Calcium flux is a molecular interaction that occurs during TCR signaling, affecting cell functions like gene expression and proliferation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "CA2+ FLUX"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Phosphorylation of extracellular signal-regulated kinase (pERK) is part of the MAPK/ERK pathway activated in response to TCR ligation, influencing cell survival and differentiation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "PERK SIGNALING PATHWAY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Surface expression of activation markers such as CD69, ICOS, CD25, and CTLA-4 on T cells is a molecular interaction indicative of immune cell activation and response to stimuli.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "ACTIVATION MARKERS ON T CELLS"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of the PTPN22 gene is quantified in different T cell subsets to assess expression levels under various conditions.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "TRANSCRIPT OF PTPN22"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Na\u00efve CD4+ Tconv cells are an initial stage of differentiation for T helper cells before encountering antigens.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "NA\u00cfVE CD4+ TCONV"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Memory Tconv cells represent a subset of T cells that have previously encountered and responded to an antigen, remaining in circulation to provide rapid response upon re-exposure.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "MEMORY TCONV CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Regulatory T cells (Tregs) are a specialized population of T cells responsible for maintaining self-tolerance and suppressing immune responses to prevent autoimmunity.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "TREGS (REGULATORY T CELLS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which resting T cells are activated by exposure to multiple antigens, leading to increased expression of activation markers.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "POLYCLONAL ACTIVATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Bicistronic constructs express two proteins from a single mRNA transcript, commonly used in gene therapy for simultaneous delivery and regulation of two genes or their products.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "BICISTRONIC CONSTRUCTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which lentiviruses are used to introduce genetic material into cells, often utilized in research and therapeutic applications for modifying cellular function.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "LENTIVIRUS TRANSDUCTION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A protein commonly used as a reporter gene to track the expression of other genes or proteins within living cells due to its fluorescence under UV light.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "id": "EGFP (ENHANCED GREEN FLUORESCENT PROTEIN)"}, {"entity_type": "PROTEIN", "description": "A protein marker expressed following Tconv activation and involved in immune cell signaling.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CD69"}, {"entity_type": "PROTEIN", "description": "Inducible Co-Stimulator, a protein that is dynamically expressed during T-cell activation indicating an active state of the cell.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "ICOS"}, {"entity_type": "PROTEIN", "description": "The high-affinity component of IL-2 receptor, upregulated in activated T-cells, contributing to IL-2 signaling.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CD25"}, {"entity_type": "PROTEIN", "description": "A protein involved in cell adhesion and signaling during T-cell activation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CD226"}, {"entity_type": "PROTEIN", "description": "Programmed Cell Death Protein 1, a marker of T cell exhaustion or activation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "PD-1"}, {"entity_type": "PROTEIN", "description": "Cytotoxic T-Lymphocyte Antigen 4, involved in the regulation of immune responses by binding to CD80 and CD86.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CTLA-4"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant form of PTPN22 that confers altered function on the LYP protein involved in T-cell activation and proliferation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "PTPN22 R620W VARIANT"}, {"entity_type": "PROTEIN", "description": "LYP-620R is a variant of the LYP protein that significantly represses T helper responder cell (Tresp) proliferation.<SEP>Variant of LYP associated with reduced impact on T cell activation compared to LYP-620W, affecting signaling pathways.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-dee0a8a550579bff19f48d41446e842d", "id": "LYP-620R"}, {"entity_type": "PROTEIN", "description": "A variant of the LYP protein that exhibits less ability to downregulate activation markers in Tconv cells compared to LYP-620R.<SEP>LYP-620W is a variant of the LYP protein with reduced suppression compared to LYP-620R in T helper responder cells (Tresps).", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-dee0a8a550579bff19f48d41446e842d", "id": "LYP-620W"}, {"entity_type": "CELL TYPE", "description": "T-helper cells that contribute to the adaptive immune response through cytokine production.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "T CONVOLUTIONAL CELLS (TCONV)"}, {"entity_type": "CYTOKINE", "description": "A cytokine produced by activated T-cells that stimulates proliferation and survival of immune cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-2"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The Th1 signature refers to the immune response mediated predominantly by Th1-type CD4+ helper T cells. It has been implicated in several autoimmune disorders associated with genetic risk factors such as rs2476601 variant of PTPN22.<SEP>The process by which certain autoimmune disorders are associated with a Th1-type response characterized by IFN\u03b3 secretion.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-dee0a8a550579bff19f48d41446e842d", "id": "TH1 SIGNATURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which cells increase in number through repeated cell divisions.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "PROLIFERATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A method used to activate T-cells, involving antibodies against CD3 and CD28 receptors.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "ANTI-CD3 AND ANTI-CD28 STIMULATION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Mitogens used for inducing cell proliferation in vitro.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "PMA AND IONOMYCIN"}, {"entity_type": "CELL TYPE", "description": "A type of artificial antigen-presenting cells (aAPC) used to stimulate T-cell responses in experiments.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "K562 AAPCS"}, {"entity_type": "CYTOKINE PANEL", "description": "A set of cytokines secreted by CD4+ effector T cells that play roles in Th2-type immune responses.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-4, IL-5, IL-9, IL-10, AND IL-13"}, {"entity_type": "CYTOKINE", "description": "Interferon gamma (IFN\u03b3) is a signaling molecule produced by T cells that plays a significant role in cellular immune responses and inflammation.<SEP>Interferon gamma, a cytokine important for Th1-mediated immunity and plays a role in promoting cell-mediated immune response.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-dee0a8a550579bff19f48d41446e842d", "id": "IFN\u0393"}, {"entity_type": "PROTEIN", "description": "LYP is a protein that has variants such as LYP-620R and LYP-620W which influence the effector cytokine secretion in T cells.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "LYP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Treg stands for regulatory T cells, which play a crucial role in maintaining immunological tolerance by suppressing immune responses through various mechanisms including cytokine secretion.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "TREG"}, {"entity_type": "DISEASE", "description": "Autoimmune disorders are diseases where the body\'s immune system attacks healthy tissues. The PTPN22 gene variant rs2476601 is associated with an increased risk of these conditions.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "AUTOIMMUNE DISORDERS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Tconv stands for conventional T cells, which are distinct from regulatory T cells (Tregs) and play roles in immune responses. Overexpressed LYP variants can alter their susceptibility to regulation by Treg.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "TCONV"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Tresps refer to activated T helper cells or effector T cells that respond to antigen stimulation, their proliferation is regulated by molecules like LYP variants and influenced by Treg suppression.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "TRESP"}, {"entity_type": "PROTEIN", "description": "Enhanced green fluorescent protein (eGFP) is used to mark and track cells in experiments, allowing for the assessment of cellular functions like proliferation and suppression by Tregs or LYP variants.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "EGFP"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "These cytokines together form a panel of markers used to assess Th2-mediated immune responses.", "entity_type": "UNKNOWN", "id": "CYTOKINE PANEL"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "The rs2476601 risk variant influences PTPN22 gene expression, altering the function of LYP protein variants and contributing to disease risk.", "entity_type": "UNKNOWN", "id": "RS2476601 RISK VARIANT"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "Overexpressed LYP-620W in Tregs slightly increased their suppressive capacity compared to controls, indicating an intrinsic impact on regulatory function.", "entity_type": "UNKNOWN", "id": "LYP-620W VARIANT"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "The secretion of IFN\u03b3 was not altered by the overexpression of LYP variants, suggesting that its production may be independent of PTPN22 gene regulation in this context.", "entity_type": "UNKNOWN", "id": "LYP VARIANTS"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "Overexpression of LYP-620R significantly represses the proliferation of T helper responder cells (Tresps).", "entity_type": "UNKNOWN", "id": "TRESP PROLIFERATION"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "The overexpression of LYP-620W variant slightly increased the suppressive capacity of regulatory T cells compared to controls.", "entity_type": "UNKNOWN", "id": "TREG SUPPRESSION CAPACITY"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "The PTPN22 risk variant may alter Treg-mediated suppression capacity, influencing disease risk in autoimmune disorders.", "entity_type": "UNKNOWN", "id": "PTPN22 RISK VARIANT"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "The PTPN22 risk variant may alter Treg-mediated suppression capacity, influencing disease risk in autoimmune disorders.", "entity_type": "UNKNOWN", "id": "TREG-MEDIATED SUPPRESSION CAPACITY"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "Enhanced green fluorescent protein (eGFP) is used to track and differentiate cells such as transduced Tregs from untransduced cells for studying their functions like proliferation and suppression capacity.", "entity_type": "UNKNOWN", "id": "CELL TRACKING"}, {"entity_type": "GENE", "description": "TAG72 is a gene expressed on the surface of ovarian cancer cells and used as a target for CAR T cell therapy.<SEP>TAG72 is a gene that codes for a transmembrane glycoprotein commonly expressed in ovarian and breast cancers, serving as an antigen target for CAR T cell therapy.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TAG72"}, {"entity_type": "PROTEIN", "description": "The 4-1BB intracellular co-stimulatory domain enhances the anti-tumor activity of CAR T cells by providing additional signaling pathways.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN"}, {"entity_type": "PROTEIN", "description": "A humanized single-chain variable fragment derived from CC49 antibody, used as a targeting moiety in CAR constructs to bind TAG72 antigen on tumor cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CC49 HUMANIZED SCFV"}, {"entity_type": "PROTEIN", "description": "The CD3\u03b6 cytoplasmic domain is part of the T-cell receptor complex and mediates downstream signaling involved in cell activation, proliferation, and cytotoxicity.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CD3\u0396 CYTOLYTIC DOMAIN"}, {"entity_type": "CELL TYPE", "description": "Chimeric Antigen Receptor (CAR) T cells are engineered immune cells designed to express a synthetic receptor that recognizes specific antigens on cancer cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CAR T CELLS"}, {"entity_type": "DISEASE", "description": "A collection of cell lines derived from ovarian tumors used in laboratory research for understanding tumor biology and testing therapeutic agents.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "OVARIAN CANCER CELL LINES"}, {"entity_type": "PROTEIN", "description": "CAR T cells engineered to express a chimeric receptor targeting TAG72 with co-stimulation provided by 4-1BB signaling domain, used in the treatment of ovarian cancer.<SEP>CAR T cells targeting the TAG72 antigen, which are used to treat ovarian cancer.<SEP>CAR T cells that target the TAG72 antigen for cancer therapy.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf<SEP>chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TAG72-BB\u0396 CAR T CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process where the TAG72 antigen is shed from tumor cells into a soluble form in the extracellular environment.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "SOLUBLE TAG72 ANTIGEN SHEDDING"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Interferon-gamma (IFN-\u03b3) release is a measure of T cell activity and its ability to recognize and respond to specific antigens expressed on cancer cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "IFN\u0393 RELEASE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The capability of CAR T cells to specifically target, bind, and kill tumor cells expressing the antigen TAG72.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TUMOR KILLING ABILITY"}, {"entity_type": "PROTEIN", "description": "A second-generation chimeric antigen receptor (CAR) construct targeting TAG72 with components including CC49 scFv, \u0394CH2 Fc spacer, CD4 transmembrane domain, 4-1BB co-stimulatory domain, and CD3\u03b6 signaling domain.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TAG72-BB\u0396 CAR CONSTRUCT"}, {"entity_type": "CELL TYPE", "description": "Peripheral blood mononuclear cells (PBMC) that have been depleted of CD14+ and CD25+ cells, used as a source for CAR T cell generation.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "DPBMCS"}, {"entity_type": "PROTEIN", "description": "A truncated version of the CD19 protein used for tracking CAR T cells during manufacturing and expansion.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "CD19T"}, {"entity_type": "DISEASE", "description": "Human ovarian cancer cell line, SKOV3, which does not express surface TAG72 antigen.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "SKOV3 CELLS"}, {"entity_type": "DISEASE", "description": "A cell line derived from ovarian cancer cells that expresses low levels of MUC1 but lacks TAG72 and MUC16 expression.<SEP>Human ovarian cancer cell line, OVCAR8, which does not express surface TAG72 antigen.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "OVCAR8 CELLS"}, {"entity_type": "DISEASE", "description": "Human ovarian cancer cell line with low expression of surface TAG72 antigen.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "COV362.4 CELLS"}, {"entity_type": "CELL LINE", "description": "A human epithelial ovarian carcinoma cell line used to establish tumors in immune-compromised mice for evaluating the efficacy of TAG72-BB\u03b6 CAR T cells.<SEP>Human ovarian cancer cell line expressing high levels of surface TAG72 antigen, approximately 42% by flow cytometry.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "OVCAR3 CELLS"}, {"entity_type": "DISEASE", "description": "Human ovarian cancer cell line with very high expression of surface TAG72 antigen, approximately 90% by flow cytometry.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "OV90 CELLS"}, {"entity_type": "DISEASE", "description": "Colon cancer cell line expressing the TAG72 antigen, used as a positive control in experiments targeting ovarian cancer cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "LS174T COLON CANCER LINE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The quantitative measurement of TAG72 protein expression on tumor cell surfaces or in ascites samples from patients with ovarian cancer.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TAG72 EXPRESSION LEVELS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The ability of CAR T cells to recognize, bind, and kill tumor cells based on the presence of specific antigens like TAG72.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "id": "TUMOR KILLING POTENTIAL"}, {"entity_type": "DISEASE", "description": "Ascites from three patients with ovarian cancer expressing different levels of the TAG72 protein.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "OAS3, OAS4, AND OAS7"}, {"entity_type": "ANIMAL MODEL", "description": "NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice are an immune-deficient mouse strain used for xenograft studies of human cancer models.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "NSG MICE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of administering drugs or cells directly into the peritoneal cavity to target abdominal cancers, enhancing local drug concentration and efficacy.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "INTRAPERITONEAL DELIVERY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A method for delivering therapeutic agents throughout the body via intravenous injection, with systemic distribution.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "SYSTEMIC INTRAVENOUS DELIVERY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The uncontrolled growth of abnormal cells to form a mass or lump in the body, often associated with cancer development and progression.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "TUMOR GROWTH"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An interaction that describes the effectiveness of treatments aimed at inhibiting tumor growth or killing cancerous cells.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "ANTI-TUMOR ACTIVITY"}, {"entity_type": "THERAPY", "description": "A therapeutic approach involving multiple administrations of a drug or treatment to enhance efficacy and prolong response duration.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "REPEAT DOSING"}, {"entity_type": "CELL MARKER", "description": "CAR T cells can be identified in the blood of treated mice using this marker, indicating their presence and circulation following intraperitoneal administration.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "HUCD45+CD19T+"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure used to track the progression or regression of tumor growth over time relative to untreated controls or baseline measures.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "RELATIVE TUMOR GROWTH KINETICS"}, {"entity_type": "DISEASE", "description": "Experimental models of ovarian cancer used for testing therapeutic interventions like CAR T cell therapy.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "OVARIAN CANCER XENOGRAFT MODELS"}, {"entity_type": "GENE", "description": "A gene encoding an antigen expressed on the surface of some ovarian cancer cells, targeted by CAR T cells in this study.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "TAG72 ANTIGEN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process where tumors regrow after initial treatment response.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "TUMOR RECURRENCE"}, {"entity_type": "GENE", "description": "A gene encoding another cell surface antigen expressed on some ovarian cancer cells, involved in tumor heterogeneity and escape mechanisms.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "MUC1 ANTIGEN"}, {"entity_type": "GENE", "description": "Another gene coding for an antigen found on the surface of certain ovarian cancer cells, related to therapeutic targeting strategies.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "MUC16 ANTIGEN"}, {"entity_type": "THERAPY", "description": "A form of immunotherapy where T cells are engineered to express a chimeric antigen receptor (CAR) that targets specific antigens expressed by tumor cells.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "CAR T CELL THERAPY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The presence of genetic and phenotypic diversity within tumors, contributing to resistance against targeted therapies.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "TUMOR HETEROGENEITY"}, {"entity_type": "DISEASE", "description": "Experimental tumors derived from OVCAR3 cells, used to study the efficacy of CAR T cell therapy in ovarian cancer models.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "OVCAR3 TUMORS"}, {"entity_type": "CELL LINE", "description": "A model system using OV90 cells to evaluate the impact of CAR T cell therapy on tumor growth and recurrence.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "OV90 TUMOR MODEL"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at the THSD4-UACA-TLE3 locus on chromosome 15q23 was found to be significantly associated with FEV1/FVC in Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "THSD4-UACA-TLE3 LOCUS ON CHROMOSOME 15Q23"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP is the most significant variant at the THSD4-UACA-TLE3 locus, explaining 2.9% of residual variance in FEV1/FVC among Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "RS12441227"}, {"entity_type": "GENE", "description": "This gene is associated with FEV1/FVC and has shown genome-wide significance when analyzed excluding asthmatics.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "C10ORF11 GENE ON CHROMOSOME 10Q22.3"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant at this locus, near the CCL23-CCL18 genes, is associated with FEV1/FVC in Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "CCL23-CCL18 LOCUS ON CHROMOSOME 17Q12"}, {"entity_type": "GENOMIC VARIANT", "description": "The PITPNC1 gene region has been found to be associated with FEV1/FVC among Hutterite subjects.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "PITPNC1 LOCUS ON CHROMOSOME 17Q24.2"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant near the CHAF1B gene is significantly associated with FEV1/FVC, particularly in non-asthmatic samples.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "CHAF1B LOCUS ON CHROMOSOME 21Q22.13"}, {"entity_type": "GENE", "description": "This gene has been identified as being associated with FEV1 among Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "IL37 GENE ON CHROMOSOME 2Q13"}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic SNP in the ASXL3 gene is associated with FVC among Hutterite subjects.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "ASXL3 LOCUS ON CHROMOSOME 18Q12.1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Forced expiratory volume in one second, a physiological process measure of lung function.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "FEV1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Forced vital capacity, another measure used to assess lung health and function.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "FVC"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FEV1/FVC is a physiological process representing forced expiratory volume in one second as a proportion of forced vital capacity, often used to assess lung function.<SEP>The ratio of FEV1 to FVC is a critical physiological process indicator for assessing respiratory health.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a<SEP>chunk-7efd4f037425eeac77e329347b16beb2", "id": "FEV1/FVC"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Broad and narrow sense heritabilities measuring the proportion of phenotypic variance attributable to genetic variation in lung function measures among Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "HERITABILITY (H2/H2)"}, {"entity_type": "GENOMIC VARIANT", "description": "Allelic variants associated with lower FEV1/FVC values, indicating genetic influences on lung function.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "LOW FEV1/FVC ALLELES"}, {"entity_type": "GENE", "description": "Clusters of \u03b2-defensin genes identified in the GRAIL analysis as being significantly related to the predictive SNPs for FEV1/FVC.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "\u0392-DEFENSIN GENES CLUSTER 1-3"}, {"entity_type": "GENE", "description": "A chemokine gene (CC motif ligand 18) identified in the GRAIL analysis and functionally connected to \u03b2-defensin genes and CXCL12/TNFRSF13B.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "CCL18 GENE"}, {"entity_type": "GENE", "description": "A chemokine gene (C-X-C motif ligand 12) found to be significantly related in the GRAIL analysis, connected to CCL18 and TNFRSF13B genes.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "CXCL12 GENE"}, {"entity_type": "GENE", "description": "Tumor necrosis factor receptor superfamily member 13B gene identified as functionally significant in the GRAIL analysis for FEV1/FVC variance explanation.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "TNFRSF13B GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Genetic variants at this locus did not show functional connections to other genes defined by 80 SNPs, but are replicated loci in the GWAS study.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "THSD4-UACA-TLE3 LOCUS SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs at this locus were not functionally connected to any other genes defined by the 80 SNPs identified in the study.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "C10ORF11 LOCUS SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "A significant genomic variant located between CCL23 and CCL18, showing functional connections with \u03b2-defensin gene clusters, CXCL12, and TNFRSF13B.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "CCL23-CCL18 LOCUS SNP"}, {"entity_type": "GENE", "description": "A gene located within the THSD4-UACA-TLE3 locus, identified in the GWAS study.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "THSD4 GENE"}, {"entity_type": "GENE", "description": "A gene located within the THSD4-UACA-TLE3 locus, identified in the GWAS study.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "UACA GENE"}, {"entity_type": "GENE", "description": "A gene located within the THSD4-UACA-TLE3 locus, identified in the GWAS study.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "TLE3 GENE"}, {"entity_type": "GENE", "description": "A gene at the C10orf11 locus, which did not show functional connections to other genes defined by 80 SNPs.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "C10ORF11 GENE"}, {"entity_type": "RESEARCH METHOD", "description": "A type of research study that searches the entire genome to find genetic variations associated with particular diseases, traits, or states.<SEP>Genome-wide association study (GWAS) aimed at identifying genetic variants associated with FEV1/FVC in the Hutterite population.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-7efd4f037425eeac77e329347b16beb2", "id": "GWAS STUDY"}, {"entity_type": "ALGORITHM", "description": "A computational method used to identify functional connections between genes near GWAS predictive SNPs.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "GRAIL ALGORITHM"}, {"entity_type": "GENE", "description": "CTLA4 is a gene that plays a role in immune regulation and its expression levels can be influenced by epigenetic DNA methylation.<SEP>CTLA4 is a gene that plays a role in the immune system regulation.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e<SEP>chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CTLA4"}, {"entity_type": "GENOMIC VARIANT", "description": "rs231775 is a genomic variant of CTLA4 associated with primary biliary cholangitis (PBC) susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS231775"}, {"entity_type": "GENOMIC VARIANT", "description": "rs231725 is another genomic variant of CTLA4 linked to PBC susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS231725"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3087243 is a genomic variant of CTLA4, but it does not show an association with PBC susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS3087243"}, {"entity_type": "GENOMIC VARIANT", "description": "rs5742909 is another genomic variant of CTLA4 that was investigated for its association with PBC susceptibility and found to be non-significant.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS5742909"}, {"entity_type": "DISEASE", "description": "PBC is a chronic liver disease characterized by the progressive destruction of bile ducts, often associated with specific genetic polymorphisms such as those in CTLA4.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "PRIMARY BILIARY CHOLANGITIS (PBC)"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism of rs3087243 within the CTLA4 gene that does not show a significant association with PBC susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS3087243 POLYMORPHISM"}, {"entity_type": "GENOMIC VARIANT", "description": "Another polymorphism in CTLA4, rs5742909, is also found to be non-significantly associated with primary biliary cholangitis (PBC) risk.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS5742909 POLYMORPHISM"}, {"entity_type": "STATISTICAL METHOD", "description": "In meta-analysis, this model assumes that there is a single true effect size across all included studies.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "FIXED-EFFECTS MODEL"}, {"entity_type": "STATISTICAL METHOD", "description": "Used in meta-analysis when it\'s assumed that the true effect sizes differ between studies due to variability (heterogeneity).", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RANDOM-EFFECTS MODEL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Refers to the likelihood or predisposition for individuals to develop primary biliary cholangitis, influenced by genetic factors such as CTLA4 variants.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "PRIMARY BILIARY CHOLANGITIS SUSCEPTIBILITY"}, {"entity_type": "STATISTICAL METHOD", "description": "Evaluates the robustness of meta-analysis results to individual studies or assumptions about study effects.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "SENSITIVITY ANALYSES"}, {"entity_type": "METHODOLOGY", "description": "Assesses whether smaller, less significant studies are underrepresented in published research findings.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "PUBLICATION BIAS EVALUATION"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "The genetic variant rs231775 increases susceptibility to primary biliary cholangitis (PBC).", "entity_type": "UNKNOWN", "id": "PBC"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "The polymorphism rs3087243 within CTLA4 does not influence the risk of primary biliary cholangitis (PBC).", "entity_type": "UNKNOWN", "id": "PBC SUSCEPTIBILITY"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "The meta-analysis focuses on the association between CTLA4 polymorphisms and primary biliary cholangitis (PBC) susceptibility.", "entity_type": "UNKNOWN", "id": "CTLA4 POLYMORPHISMS"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "Preferred for meta-analysis when there is significant variability among study results.", "entity_type": "UNKNOWN", "id": "HETEROGENEOUS STUDIES"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "The susceptibility to PBC varies based on specific genetic variants within the CTLA4 gene, affecting immune system regulation.", "entity_type": "UNKNOWN", "id": "CTLA4 VARIANTS"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "Assesses whether certain polymorphisms are inherited together more frequently than expected by chance, providing insights into their co-occurrence.", "entity_type": "UNKNOWN", "id": "GENETIC POLYMORPHISMS"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "Conducted to ensure the stability of meta-analysis results when individual studies or assumptions about study effects are omitted.", "entity_type": "UNKNOWN", "id": "META-ANALYSIS STABILITY"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "description": "Ensures that the conclusions drawn from the meta-analysis are not skewed by publication bias, maintaining research integrity and validity.", "entity_type": "UNKNOWN", "id": "RESEARCH INTEGRITY"}, {"entity_type": "GENE", "description": "The IKBKE gene, located upstream of the long coding RNA RP11\u2212534L20.5, plays a role in regulating inflammatory responses to viral infections.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "IKBKE GENE"}, {"entity_type": "PROTEIN", "description": "STAT6 is a transcriptional activator involved in T cell differentiation and has genetic regulatory effects within CD4+ and CD8+ T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "STAT6 PROTEIN"}, {"entity_type": "GENE", "description": "The STX2 gene, involved in intracellular vesicle transport, shows evidence of genetic regulation by cis-eQTLs in both CD4+ and CD8+ T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "STX2 GENE (SYNTAXIN 2)"}, {"entity_type": "GENOMIC VARIANT", "description": "A cis-regulatory SNP that influences gene expression near the IKBKE gene, regulating inflammatory responses to viral infections through genetic control of long coding RNA RP11\u2212534L20.5.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CIS-REGULATORY SNP (EQTL) FOR IKBKE GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A cis-regulatory SNP that influences the expression of STAT6, a transcriptional activator involved in T cell differentiation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CIS-REGULATORY SNP (EQTL) FOR STAT6 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A cis-regulatory SNP affecting gene expression levels of syntaxin 2, which is involved in intracellular vesicle transport in CD4+ and CD8+ T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CIS-REGULATORY SNP (EQTL) FOR STX2 GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A statistical method used to assess the specificity and proportion of shared eQTLs between different cell types by combining information across genes within one framework.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "BAYESIAN HIERARCHICAL MODELLING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The measure of how much gene expression levels change due to genetic variants, which influences the statistical power in detecting significant eQTL effects.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "EFFECT SIZE (EQTL)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Genetic control over CTLA4 gene expression and alternative splicing patterns specific to CD4+ T cells, with differential methylation affecting mRNA levels between CD4+ and CD8+ T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CTLA4 GENE EXPRESSION REGULATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Differential DNA methylation at a CpG site near the second exon of CTLA4 inversely correlates with gene expression levels, indicating cell type-specific regulation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "DNA METHYLATION OF CTLA4 GENE LOCUS"}, {"entity_type": "GENOMIC VARIANT", "description": "This genetic variant in strong linkage disequilibrium with the MH30C/G polymorphism is associated with lower CTLA4 mRNA expression and increased risk of autoimmune diseases.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CTLA4 POLYMORPHISM CT60A/G (RS3087243)"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific SNPs associated with Type 1 Diabetes (T1D) and Rheumatoid Arthritis (RA), influencing CTLA4 gene expression levels in CD4+ and CD8+ T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "T1D AND RA-ASSOCIATED VARIANTS (E.G., RS231775, RS3087243)"}, {"entity_type": "GENOMIC VARIANT", "description": "Length variation in this repeat region is associated with differential mRNA expression levels of CTLA4, contributing to disease risk in autoimmune conditions.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "(AT)N REPEAT POLYMORPHISM IN THE 3\u2019UTR OF CTLA4"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The process where a single gene can produce multiple transcripts and proteins due to different ways in which the exons are spliced together.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "ALTERNATIVE SPLICING"}, {"entity_type": "GENOMIC VARIANT", "description": "A CpG site (cg26091609) associated with CTLA4 gene expression.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CG26091609"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Expression Quantitative Trait Loci (eQTLs) are genomic variants that influence the expression levels of genes, particularly in specific cell types like CD4+ and CD8+ T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "EQTL"}, {"entity_type": "DISEASE", "description": "Type 1 Diabetes (T1D) is a disease influenced by genetic variants and associated with specific gene functions in CD4+ and CD8+ T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "T1D"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The mTOR signaling pathway plays a role in the regulation of cellular processes such as growth, metabolism, and autophagy. It is influenced by genetic variants associated with T1D.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "MTOR SIGNALING PATHWAY"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (rs1131017) located in the 5\'UTR of RPS26 gene, linked to eQTL effects and several GWAS SNPs associated with autoimmune diseases.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RS1131017"}, {"entity_type": "GENE", "description": "The ribosomal small subunit protein RPS26 gene is affected by trans-acting regulatory locus in T cells. Its expression level can be regulated by genetic variants such as rs1131017.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RPS26"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Trans-Expression Quantitative Trait Loci (trans-eQTL) refers to the effect of a SNP on gene expression located far (>5 Mb) from the locus. It can have significant effects in specific cell types like CD4+ T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "TRANS-EQTL"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic region close to IL27 associated with trans-eQTLs and genetic variants linked to lower expression of IRF1, STAT1, and reduced risk for Type 1 Diabetes.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "IL27 GENE REGION"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP is located near the IL27 gene and is associated with a decreased expression level of STAT1 in CD4+ T cells, contributing to lower T1D risk.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RS4788084[T]"}, {"entity_type": "GENOMIC VARIANT", "description": "A missense variant within the IL27 gene that changes an amino acid (Leu119Pro) and influences expression levels of IRF1, STAT1, and REC8. It is associated with T1D susceptibility.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "MISSENSE SNP RS181206[G]"}, {"entity_type": "GENE", "description": "Signal transducer and activator of transcription 1 (STAT1) gene, whose expression level can be influenced by genetic variants associated with T1D risk.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "STAT1 GENE"}, {"entity_type": "STATISTICAL METHOD", "description": "A method used to determine whether a variant in the genome is causally related to both a disease and changes of expression in genes, suggesting shared causal variants.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "BAYESIAN TEST FOR COLOCALISATION"}, {"entity_type": "GENE REGION", "description": "The 5\' untranslated region (5\' UTR) is the section at the beginning of an mRNA molecule that precedes the start codon and does not code for any protein but can affect gene expression.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "5\'UTR"}, {"entity_type": "GENOMIC VARIANT", "description": "Single nucleotide polymorphisms (SNPs) identified through Genome-Wide Association Studies (GWAS) as being associated with particular traits or diseases.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "GWAS SNPS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which a cell digests parts of itself or damaged organelles. It is regulated by signaling pathways such as mTOR.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "AUTOPHAGY"}, {"entity_type": "DISEASE CATEGORY", "description": "A category of diseases caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "INFECTIOUS DISEASES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process through which the immune system responds to pathogens or other triggers, often influenced by genetic factors like CTLA4 expression.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "IMMUNE RESPONSE REGULATION"}, {"entity_type": "PROTEIN", "description": "The protein encoded by IL27RA functions as part of a receptor complex for the cytokine interleukin-27 (IL-27), which activates signaling pathways involved in immune regulation.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL27RA"}, {"entity_type": "PROTEIN", "description": "Gp130, also known as IL6ST, is a transmembrane protein that functions as an accessory subunit for various cytokine receptors including those for IL-27 and IL-12.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "GP130"}, {"entity_type": "GENE", "description": "Interferon regulatory factor 1 (IRF1) is a transcription factor involved in the regulation of interferon-responsive genes and plays a role in immune responses against viral infections.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IRF1"}, {"entity_type": "GENE", "description": "Signal transducer and activator of transcription 1 (STAT1) is a protein that functions as an intracellular signal transducer for cytokines like IL-27, involved in the regulation of gene expression in response to immune stimuli.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "STAT1"}, {"entity_type": "PROTEIN", "description": "GP130 acts as an accessory subunit for receptors of several interleukins including IL-27 and IL-12. It is critical for signaling pathways that regulate inflammatory responses.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL6ST (GP130)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "This receptor complex forms when IL27 binds to its corresponding receptors, initiating intracellular signal transduction pathways involved in immune regulation.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL27RA, GP130 (RECEPTOR COMPLEX)"}, {"entity_type": "GENE", "description": "Epstein-Barr virus-induced gene 3 (EBI3) is a subunit of the interleukin-35 and interleukin-27 cytokines that plays a role in modulating the immune response.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "EBI3"}, {"entity_type": "PROTEIN", "description": "Interleukin-27 (IL-27) is a cytokine involved in immune regulation, particularly in inducing interferon-stimulated genes such as IRF1 and STAT1.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL27"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant (Single Nucleotide Polymorphism) located in the IL-27 gene region that is associated with changes in expression levels of IRF1 and STAT1 genes.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "SNP RS181206[G]"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Binding sites for transcription factors like STAT1 and IRF1, involved in the regulation of interferon-responsive gene expression.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "INTERFERON-STIMULATED RESPONSE ELEMENTS (ISRE)"}, {"entity_type": "DISEASE", "description": "A chronic autoimmune condition characterized by destruction of insulin-producing beta cells in the pancreas leading to high blood sugar levels.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "TYPE 1 DIABETES (T1D)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The measurement and regulation of transcript levels for genes IRF1 and STAT1 are critical processes in understanding gene expression changes due to genetic variants.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "TRANSCRIPT LEVELS OF IRF1, STAT1"}, {"entity_type": "PROTEIN", "description": "Interleukin-27 (IL-27) is a cytokine involved in immune responses, produced by innate immune cells and binding to its receptor complex to activate signaling pathways.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL-27 CYTOKINE"}, {"entity_type": "CELL LINE", "description": "Human embryonic kidney 293 cells are commonly used for transient expression studies of proteins and for the production of recombinant proteins.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "HEK293 CELLS"}, {"entity_type": "CELL TYPE", "description": "PBMCs are isolated from blood, consisting mainly of lymphocytes including T-cells and B-cells, and monocytes used in immunological studies.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "PBMCS (PERIPHERAL BLOOD MONONUCLEAR CELLS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Immune cells such as macrophages and dendritic cells that provide an immediate defense against pathogens by recognizing them and initiating immune responses.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "INNATE IMMUNE CELLS"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "Together, IL27RA and gp130 form a receptor complex necessary for the signal transduction pathway activated by IL-27 binding.", "entity_type": "UNKNOWN", "id": "GP130 (IL6ST)"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "Binding of STAT1 or STAT3 dimers to ISREs initiates transcriptional regulation of interferon-responsive genes such as IRF1 and STAT1.", "entity_type": "UNKNOWN", "id": "STAT1/STAT3 PATHWAY"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "The genetic variant IL27 SNP rs181206[G] is associated with decreased expression of IRF1 and STAT1 genes in CD4+ T cells.", "entity_type": "UNKNOWN", "id": "IL27 SNP RS181206[G]"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "The genetic variant IL27 SNP rs181206[G] is associated with decreased expression of IRF1 and STAT1 genes in CD4+ T cells.", "entity_type": "UNKNOWN", "id": "IRF1, STAT1 EXPRESSION LEVELS"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "Innate immune cells produce IL-27 which interacts with its receptor complex on T cells, leading to activation of the STAT1/STAT3 pathway.", "entity_type": "UNKNOWN", "id": "IL-27 SIGNALING"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "Human embryonic kidney 293 cells are used to produce and study IL-27 protein variants (Leu119 and Pro119) in the context of their effects on IRF1 and STAT1 expression.", "entity_type": "UNKNOWN", "id": "IL-27 TRANSFECTION EXPERIMENT"}, {"source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "description": "Human peripheral blood mononuclear cells are used to assess how different IL-27 variants affect IRF1 and STAT1 transcript levels, providing insight into gene regulation mechanisms.", "entity_type": "UNKNOWN", "id": "IL-27 EFFECTS STUDY"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism located at rs4073 within the IL-8 gene that affects asthma risk.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "RS4073 GENOMIC VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism at rs2227306 within the IL-8 gene associated with increased susceptibility to asthma.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "RS2227306 GENOMIC VARIANT"}, {"entity_type": "PROTEIN", "description": "The protein encoded by the IL-8 gene, involved in immune and inflammatory responses.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8 PROTEIN"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of the IL-8 gene that is expressed at higher levels in asthma patients compared to controls.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8 MRNA TRANSCRIPT"}, {"entity_type": "DISEASE", "description": "A chronic disease affecting the airways, associated with genetic and environmental factors.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "ASTHMA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The composition of peripheral blood mononuclear cells, which did not differ significantly between asthma patients and healthy controls in this study.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "PBMC COMPOSITION"}, {"entity_type": "DISEASE", "description": "A more severe form of asthma characterized by higher IL-8 serum concentrations compared to mild asthma.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "MODERATE-SEVERE ASTHMA"}, {"entity_type": "DISEASE", "description": "A less severe form of asthma with lower levels of IL-8 mRNA and protein compared to moderate-severe asthma.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "MILD ASTHMA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The level of IL-8 protein measured in serum, which is significantly higher in asthma patients compared to controls.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8 SERUM LEVELS"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "Carrying the homozygous TT genotype at rs4073 increases asthma susceptibility, indicating a strong genetic link to disease risk.", "entity_type": "UNKNOWN", "id": "ASTHMA RISK"}, {"entity_type": "GENE", "description": "The ASAH1 gene is located on chromosome 8p22-p21.3 and contains 86 HapMap SNPs and 14 typed SNPs.<SEP>The ASAH1 gene is under study in genetic analyses involving different kernels and tests for detecting gene effects.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a<SEP>chunk-2e31819d63b80079cb6422efd6e684e0", "id": "ASAH1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A kernel machine SNP-set test was used for the ASAH1 gene with a linear kernel, showing higher power than the min test when causal SNPs have moderate LD with typed SNPs.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "SNP-SET TEST (KERNEL MACHINE)"}, {"entity_type": "GENOMIC VARIANT", "description": "The min test, when applied to imputed data and gene effects, typically has lower empirical power compared to other tests like IBS kernel or linear kernel.<SEP>The single SNP-based min test is used as a benchmark and gives correct size but lower power compared to the kernel machine method for ASAH1 and NAT2 genes under certain conditions.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a<SEP>chunk-2e31819d63b80079cb6422efd6e684e0", "id": "MIN TEST"}, {"entity_type": "GENE", "description": "Located on 8p22, NAT2 has 22 HapMap SNPs and 4 typed SNPs. The power of the min test is higher in specific scenarios where a single causal SNP is highly correlated with one typed SNP.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "NAT2 GENE"}, {"entity_type": "GENE", "description": "A gene used for illustrating the performance of kernel machine method compared to the min test, showing superiority in regions with high LD and comparable power in regions with weak LD.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "FGFR2 GENE"}, {"entity_type": "GENE", "description": "Part of the human leukocyte antigen (HLA) complex on chromosome 6p21.3, HLA-B has only 6 HapMap SNPs and 2 typed SNPs, demonstrating how rare alleles can be upweighted by using MAF as weights.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "HLA-B GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "The genomic variants or single nucleotide polymorphisms (SNPs) are used in the SNP-set test to determine genetic associations and predict disease susceptibility.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "GENETIC VARIANTS (SNPS)"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP, rs2523608, has a higher MAF and acts as a causal variant in some studies.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "GENOMIC VARIANT (RS2523608)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The IBS kernel is used to test for gene effects and shows high power when the model is correctly specified.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "IBS KERNEL"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A linear kernel used in genetic studies often suffers from substantial power loss due to mis-specification of the model.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "LINEAR KERNEL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "In genetic studies, the empirical type 1 error rate is an important measure of test reliability, with rates for linear kernel and min test being reported as 0.0566 and 0.0404 respectively at \u03b1=0.05.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "EMPIRICAL TYPE 1 ERROR RATE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Empirical power measures the ability of a statistical test to detect an effect when there is one, with IBS kernel showing higher empirical power compared to linear kernel and min test in some cases.<SEP>Measures the actual ability of tests to detect gene effects under study conditions.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "EMPIRICAL POWER"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Good linkage disequilibrium structure between causal SNPs and typed SNPs can impact the performance of gene set tests, like in the case of ASAH1 where good LD leads to better test performance.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "LD (LINKAGE DISEQUILIBRIUM)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The weighted IBS kernel incorporates information on rare variants\' importance into its function.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "WEIGHTED IBS KERNEL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "MAF is used to describe the frequency of less common alleles in a population, impacting gene effect studies.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "MAF (MINOR ALLELE FREQUENCY)"}, {"entity_type": "GENOMIC VARIANT", "description": "This SNP acts as a causal variant influencing the power of different kernel functions.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "CAUSAL SNP (RS2523608)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Epistatic interactions influence gene effect studies and model specification.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "EPISTASIS (INTERACTIONS BETWEEN GENES)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The LD structure between SNPs is crucial for the performance of SNP-set tests, especially in the context of ASAH1 gene effects.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "LD STRUCTURE (LINKAGE DISEQUILIBRIUM)"}, {"source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "description": "The minor allele frequency of rs2523608 influences its role as a causal variant in genetic studies.)", "entity_type": "UNKNOWN", "id": "MAF"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (SNP) mapped to the PTPN2 gene that influences response rates for anti-CTLA-4 treatment in metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "RS1893217"}, {"entity_type": "GENOMIC REGION", "description": "The genomic region containing IL2, ADAD1 and IL21 is associated with allergy, colitis and type 1 diabetes.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "IL2, ADAD1 AND IL21 LOCUS"}, {"entity_type": "GENOMIC VARIANT", "description": "A significant SNP mapped to the IL2-IL21 locus that influences response rates for anti-PD-1 treatment in metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "RS17388568"}, {"entity_type": "THERAPY", "description": "A type of immunotherapy used to treat metastatic melanoma by targeting CTLA-4.<SEP>Anti-CTLA-4 treatment is one of the treatments considered in the pooled association analysis.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1<SEP>chunk-0d49552280a277a8a26456d06f8f26a8", "id": "ANTI-CTLA-4 TREATMENT"}, {"entity_type": "THERAPY", "description": "A type of immunotherapy used to treat metastatic melanoma by targeting PD-1.<SEP>Anti-PD-1 treatment is another therapy included in the pooled association analysis across different treatments.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1<SEP>chunk-0d49552280a277a8a26456d06f8f26a8", "id": "ANTI-PD-1 TREATMENT"}, {"entity_type": "THERAPY", "description": "A combination therapy involving both anti-CTLA-4 and anti-PD-1 treatments for treating metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "COMBINATION THERAPY (ANTI-CTLA-4 AND ANTI-PD-1)"}, {"entity_type": "DISEASE", "description": "An advanced stage of melanoma cancer that has spread from its original site to other parts of the body.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "METASTATIC MELANOMA"}, {"entity_type": "DRUG", "description": "A type of PD-1 inhibitor used in immunotherapy for treating metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "NIVOLUMAB"}, {"entity_type": "DRUG", "description": "Another type of PD-1 inhibitor used in immunotherapy for treating metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "PEMBROLIZUMAB"}, {"entity_type": "DRUG", "description": "A CTLA-4 inhibitor used in immunotherapy for treating metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "IPILIMUMAB"}, {"entity_type": "DRUG", "description": "Another CTLA-4 inhibitor used in immunotherapy for treating metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "TREMELIMUMAB"}, {"entity_type": "THERAPY CLASS", "description": "Class of drugs including anti-PD-1 and anti-CTLA-4 treatments that boost the immune system\'s ability to fight cancer.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "ICIS (IMMUNE CHECKPOINT INHIBITORS)"}, {"entity_type": "GENOMIC REGION", "description": "The genomic region containing PTPN2, linked to autoimmune diseases and response to immunotherapy in metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "PTPN2 GENE REGION"}, {"entity_type": "GENOMIC REGION", "description": "A genetic locus containing IL2, ADAD1, and IL21, associated with allergy, colitis, type 1 diabetes, and response to immunotherapy in metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "IL2-IL21 GENOMIC LOCUS"}, {"entity_type": "THERAPY", "description": "Combination therapy, involving a combination of anti-CTLA-4 and anti-PD-1 treatments, was studied for its effect on patient response.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "COMBINATION THERAPY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The treatment response is the physiological process being analyzed in patients treated with different therapies.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "TREATMENT RESPONSE"}, {"entity_type": "METHODOLOGICAL PROCEDURE", "description": "A method used to adjust for multiple testing, which was applied in the study but did not yield significant associations.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "BONFERRONI METHOD"}, {"entity_type": "METHODOLOGICAL PROCEDURE", "description": "Another method used to adjust for multiple testing alongside the Bonferroni method.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "HOLM-BONFERRONI METHOD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The sample size of 43 patients is too small, leading to limited power in detecting significant associations between SNPs and treatment response.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "SAMPLE SIZE"}, {"entity_type": "STATISTICAL MEASURE", "description": "Wide confidence intervals indicate the limitations due to a smaller sample size, affecting the study\'s ability to detect meaningful differences.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "id": "CONFIDENCE INTERVAL"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "The IL2-IL21 locus contains rs17388568, a significant SNP linked to increased efficacy of anti-PD-1 therapy in metastatic melanoma.", "entity_type": "UNKNOWN", "id": "IL2-IL21 LOCUS"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "The presence of the minor allele G in rs1893217 is associated with a reduced likelihood of response to anti-CTLA-4 treatment.", "entity_type": "UNKNOWN", "id": "ANTI-CTLA-4 TREATMENT RESPONSE RATE"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "The presence of the minor allele GA or AA in rs17388568 is associated with a higher likelihood of response to anti-PD-1 treatment.", "entity_type": "UNKNOWN", "id": "ANTI-PD-1 TREATMENT RESPONSE RATE"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "The SNP rs17388568 is associated with increased risk for conditions like allergy, colitis and type 1 diabetes.", "entity_type": "UNKNOWN", "id": "ALLERGY, COLITIS, TYPE 1 DIABETES"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "Ipilimumab and tremelimumab are drugs used in anti-CTLA-4 treatment for metastatic melanoma.", "entity_type": "UNKNOWN", "id": "IPILIMUMAB, TREMELIMUMAB"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "Nivolumab and pembrolizumab are drugs used in anti-PD-1 treatment for metastatic melanoma.", "entity_type": "UNKNOWN", "id": "NIVOLUMAB, PEMBROLIZUMAB"}, {"source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "description": "The presence of rs1893217 influences the efficacy of anti-CTLA-4 treatment in metastatic melanoma patients.", "entity_type": "UNKNOWN", "id": "METASTATIC MELANOMA PATIENTS"}, {"entity_type": "PROTEIN", "description": "EBNA2 is a protein that binds chromatin at multiple sclerosis (MS) risk loci dependent on the MS risk allele.<SEP>EBNA2 is a protein that interacts with MS risk loci and alters gene expression, potentially affecting immune evasion.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "EBNA2"}, {"entity_type": "GENOMIC VARIANT", "description": "Multiple genomic variants have been identified as eQTLs in lymphoblastoid cell lines (LCLs), with evidence suggesting their binding sites are occupied by EBNA2.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "MS RISK SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant located at the TRAF3/RCOR1 locus has been shown to affect chromatin binding of EBNA2 and is associated with MS risk.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TRAF3/RCOR1 SNP (RS1258869)"}, {"entity_type": "GENOMIC VARIANT", "description": "Another genomic variant, rs1883832, at the CD40 locus shows preferential EBNA2 binding to its risk allele, impacting gene expression and MS risk.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "CD40 SNP (RS1883832)"}, {"entity_type": "GENOMIC VARIANT", "description": "The genomic variant rs32658 at the TNFAIP8 locus demonstrates a protective effect with EBNA2 binding to its non-risk allele, altering gene expression in LCLs.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TNFAIP8 SNP (RS32658)"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP rs180069 at the TNFRSF1A locus is preferentially bound by EBNA2 to its protective allele, affecting gene expression and MS risk.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TNFRSF1A SNP (RS180069)"}, {"entity_type": "GENOMIC VARIANT", "description": "The genomic variant rs3809627 at the TBX6 locus is associated with a protective effect when EBNA2 binds to its non-risk allele, influencing MS risk.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TBX6 SNP (RS3809627)"}, {"entity_type": "PROTEIN", "description": "A modified form of EBNA2 that inhibits its transcriptional function by disrupting the interaction with RBP-J\u03ba. It affects LCL proliferation and alters expression of several MS risk genes.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "EBNA2-TAT"}, {"entity_type": "GENE", "description": "Expression of LMP1, an Epstein-Barr virus (EBV) gene regulated by EBNA2, is significantly reduced in response to EBNA2-TAT treatment.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "LMP1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Alteration in TRAF3 gene expression due to inhibition of EBNA2 function suggests its role in MS risk regulation.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TRAF3 GENE EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Changes in CD40 gene expression as a result of inhibiting EBNA2 function imply an involvement in MS pathogenesis through altered transcriptional activity.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "CD40 GENE EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Significant reduction in CLECL1 gene expression following inhibition of EBNA2 indicates its role influenced by this protein\'s regulation.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "CLECL1 GENE EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Modulation of TNFAIP8 gene expression through interaction with EBNA2 suggests a link between this process and MS risk factors.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TNFAIP8 GENE EXPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Alterations in TNFRSF1A gene expression due to inhibition of EBNA2 function may contribute to changes in MS susceptibility.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TNFRSF1A GENE EXPRESSION"}, {"entity_type": "METABOLIC PATHWAY/MOLECULAR INTERACTION", "description": "The copy number variation of EBV DNA within LCLs is a stable phenotype, influenced by both genetic factors and transcriptional regulators like EBNA2.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "EBV DNA COPY NUMBER"}, {"entity_type": "DISEASE", "description": "A disease involving the immune system attacking the central nervous system, with several genomic risk variants identified in association studies.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "MULTIPLE SCLEROSIS (MS)"}, {"entity_type": "GENOMIC VARIANT", "description": "MS risk loci are genomic variants associated with multiple sclerosis (MS) that interact with EBNA2 to alter gene expression and influence immune evasion.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "MS RISK LOCI"}, {"entity_type": "GENE", "description": "TRAF3 is a gene at an MS risk locus where EBNA2 binds preferentially to the risk allele, leading to lower expression of TRAF3.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TRAF3"}, {"entity_type": "GENE", "description": "CD40 is a gene at an MS risk locus where EBNA2 binds preferentially to the protective allele, resulting in relatively lower expression compared to B cells.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "CD40"}, {"entity_type": "GENE", "description": "TNFAIP8 is a gene at an MS risk locus that exhibits altered allelic association with expression upon EBNA2 binding and treatment with EBNA2-TAT.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TNFAIP8"}, {"entity_type": "GENE", "description": "TNFRSF1A is a gene at an MS risk locus where EBNA2 preferentially binds to the protective allele, leading to lower expression compared to B cells.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TNFRSF1A"}, {"entity_type": "GENE", "description": "TBX6 is a gene at an MS risk locus that exhibits altered allelic association with expression upon EBNA2 binding and treatment with EBNA2-TAT.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TBX6"}, {"entity_type": "GENE", "description": "RCOR1 is a gene at an MS risk locus where the effect of EBNA2 on expression alters relative allelic expression compared to B cells.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "RCOR1"}, {"entity_type": "GENE", "description": "CLECL1 is a gene at an MS risk locus that exhibits altered allelic association with expression upon EBNA2 binding and treatment with EBNA2-TAT, but no significant effect of genotype on expression.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "CLECL1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The EBV latency III program is a physiological process involving the Epstein-Barr virus (EBV) where EBNA2 interacts with MS risk genes to influence gene expression and immune evasion.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "EBV LATENCY III PROGRAM"}, {"entity_type": "MOLECULAR INTERACTION", "description": "LMP1 and LMP2 signalling refers to molecular interactions involved in the latency III program of Epstein-Barr virus (EBV) infection, which are influenced by EBNA2 interaction with MS risk genes.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "LMP1 AND LMP2 SIGNALLING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Host immune evasion is a physiological process where pathogens or viruses alter host gene expression to evade the immune system\'s detection and response.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "HOST IMMUNE EVASION"}, {"entity_type": "THERAPY", "description": "EBNA2-TAT treatment is used in experiments to inhibit EBNA2 function, thereby altering gene expression at MS risk loci and influencing immune evasion.<SEP>Treatment with EBNA2-TAT inhibits the function of EBNA2, leading to alterations in gene expression at MS risk loci.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "EBNA2-TAT TREATMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The genotype effect refers to differences in gene expression or phenotype due to genetic variation at MS risk loci.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "GENOTYPE EFFECT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Allelic association refers to the relationship between specific alleles and their influence on gene expression or phenotype, particularly relevant for MS risk genes.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "ALLELIC ASSOCIATION"}, {"source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "description": "The effect of EBNA2 on expression at risk loci is postulated to increase host immune evasion through regulation of these risk genes in the latency III program.)", "entity_type": "UNKNOWN", "id": "EBNA2/RISK GENE INTERACTION"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism in the COX-2 gene, rs20417, has been associated with aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "COX-2 GENE POLYMORPHISM (RS20417)"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism in the ITGA2 gene, rs1126643, is significantly linked to increased risk of aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "ITGA2 GENE POLYMORPHISM (RS1126643)"}, {"entity_type": "GENOMIC VARIANT", "description": "No significant association found between the COX-1 gene polymorphism rs3842787 and aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "COX-1 GENE POLYMORPHISM (RS3842787)"}, {"entity_type": "GENOMIC VARIANT", "description": "The ITGA2B gene polymorphism rs20118426 shows no significant association with aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "ITGA2B GENE POLYMORPHISM (RS20118426)"}, {"entity_type": "DISEASE", "description": "A condition where aspirin does not effectively prevent blood clots, associated with specific genetic variants.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "ASPIRIN INSENSITIVITY"}, {"entity_type": "POPULATION GROUP", "description": "Study participants of Caucasian ethnicity involved in the research on aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "CAUCASIAN PATIENTS AND CONTROLS"}, {"entity_type": "POPULATION GROUP", "description": "Study participants of Chinese ethnicity involved in the research on aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "CHINESE PATIENTS AND CONTROLS"}, {"entity_type": "DISEASE CONDITION", "description": "A condition where coronary arteries are narrowed or blocked, significantly contributing to heterogeneity in studies involving genetic polymorphisms and aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "CAD (CORONARY ARTERY DISEASE)"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant associated with differences in percentage of CAD between patients and controls.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "RS20417"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant for which averaged platelet number was a significant source of heterogeneity.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "RS1126643"}, {"source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "description": "Averaged platelet number was found to be a significant source of heterogeneity for rs1126643, indicating an interaction between averaged platelet count and the genomic variant.", "entity_type": "UNKNOWN", "id": "AVERAGED PLATELET NUMBER"}, {"source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "description": "CAD is associated with various physiological processes including platelet function and number.", "entity_type": "UNKNOWN", "id": "PLATELETS"}, {"entity_type": "GENE", "description": "A homozygous nonsense mutation (c.1892G>A) was identified in the STAT5B gene leading to a truncated protein.<SEP>The STAT5B gene is associated with a loss-of-function variant that affects CD8+ T cell activation and homeostasis.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5<SEP>chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "STAT5B GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A homozygous nonsense mutation (c.1892G>A) in STAT5B that converts a tryptophan at position 631 to a stop codon.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "HOMOZYGOUS NONSENSE MUTATION C.1892G>A, P.W631*"}, {"entity_type": "PROTEIN", "description": "A wild-type protein of the STAT5B gene used for comparison in functional analyses.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "WILD-TYPE FLAG-STAT5B (F-STAT5B WT)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "GH is a physiological process that stimulates phosphorylation and nuclear localization of STAT5B, critical for its function.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "GROWTH HORMONE (GH)"}, {"entity_type": "DRUG", "description": "A recombinant protein used to treat growth hormone insensitivity syndrome in the three siblings.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR 1 (RHIGF-1)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The physiological condition characterized by significantly below-normal height for age among the siblings.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "SEVERE SHORT STATURE, HEIGHT SDS \u22126.5, \u22125.06, AND \u22124.7 "}, {"entity_type": "DISEASE", "description": "A disease characterized by inflammation of the thyroid gland with an autoimmune response in two of the siblings.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "AUTOIMMUNE THYROIDITIS "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The severe failure to grow and develop normally after birth, evident in all three siblings.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "SEVERE POST-NATAL GROWTH FAILURE "}, {"entity_type": "PROCEDURE", "description": "A medical procedure used for conception of patient 1.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "IN-VITRO FERTILIZATION (IVF) "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "An immune response observed in STAT5B deficient patients characterized by sustained B cell hyperactivity leading to atopy and autoimmunity.<SEP>Sustained B cell hyperactivity is observed in STAT5B deficient siblings leading to atopy and autoimmunity.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "B CELL HYPERACTIVITY "}, {"entity_type": "TRANSCRIPT", "description": "The transcript of the STAT5B gene is affected by the homozygous nonsense mutation c.1892G>A.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "TRANSCRIPT OF STAT5B GENE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "These domains are critical for STAT5B activation, homodimer formation, and transcriptional activity.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "SRC HOMOLOGY 2 (SH2) DOMAIN AND TRANSACTIVATION DOMAIN (TAD)"}, {"entity_type": "PROTEIN", "description": "The GH receptor is used in HEK cells to evaluate the functional capacity of STAT5B p.W631* protein.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "GH RECEPTOR (GHRS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Following GH treatment, nuclear localization of wild-type STAT5B protein occurs but not in mutant form.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "NUCLEAR LOCALIZATION "}, {"entity_type": "PROTEIN", "description": "Cells that are reduced in number and impaired function due to deficiency in STAT5B.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "NK CELLS "}, {"entity_type": "DISEASE", "description": "A condition characterized by airway inflammation and constriction, developed similarly across the siblings.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "REACTIVE AIRWAY DISEASE "}, {"entity_type": "DISEASE", "description": "An allergic skin condition observed in two of the siblings.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "ATOPIC ECZEMA "}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A set of features that resemble fetal alcohol syndrome observed due to the mutation\'s effects.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "FETAL ALCOHOL SYNDROME LIKE FEATURES "}, {"entity_type": "GENE", "description": "STAT5B is a gene that plays a critical role in immune function, including the maintenance of T cell levels and regulation of B cells.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "STAT5B"}, {"entity_type": "GENOMIC VARIANT", "description": "A loss-of-function variant of STAT5B leads to reduced expression and impaired function of STAT5B protein.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "LOF STAT5B VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "GH stimulation is a physiological process that typically induces phosphorylation and nuclear translocation of the STAT5B protein, but is affected in patients with the LOF variant.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "GH STIMULATION"}, {"entity_type": "PROTEIN", "description": "NK cells are immune cells whose number and function are impaired in STAT5B deficient individuals due to reduced STAT5B activity.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "NK CELLS"}, {"entity_type": "PROTEIN", "description": "B cells are immune cells that exhibit increased immunoglobulin production in STAT5B deficient patients, often leading to elevated serum levels of IgE and associated atopic symptoms.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "B CELLS"}, {"entity_type": "NUTRIENT", "description": "IgG, IgA, IgM, and IgE are immunoglobulins that show normal or increased levels in STAT5B deficient patients, with elevated IgE being associated with atopic conditions.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "IGG, IGA, IGM, IGE"}, {"entity_type": "DISEASE", "description": "Chronic eczema is a disease condition often found in children with STAT5B deficiency due to high levels of IgE.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "CHRONIC ECZEMA"}, {"entity_type": "DISEASE", "description": "Reactive airway disease, commonly seen in atopic individuals, can be linked to increased IgE levels in STAT5B deficient patients.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "REACTIVE AIRWAY DISEASE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of thymic T cell production may be impaired in STAT5B deficient individuals, leading to reduced numbers of mature T cells.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "THYMIC T CELL PRODUCTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Peripheral destruction is a possible mechanism for the reduction of T cells in STAT5B deficient patients.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "PERIPHERAL DESTRUCTION"}, {"entity_type": "TRANSCRIPT", "description": "RTEs are young T cells that have recently emigrated from the thymus, with their levels being assessed to evaluate thymic output in STAT5B deficient individuals.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "RECENT THYMIC EMIGRANTS (RTE)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "IL-2 signaling pathway involves STAT5B in inducing FOXP3 expression and maintaining self-tolerance.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "IL-2 SIGNALING"}, {"entity_type": "PROTEIN", "description": "Memory CD8+ T cells exhibit pronounced dysregulation in young STAT5B deficient siblings, with reduced na\u00efve subsets and elevated memory/activation phenotypes.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "MEMORY CD8+ T CELLS"}, {"entity_type": "CONDITION", "description": "The impaired regulation of immune responses in individuals with STAT5B deficiency, leading to various clinical manifestations such as increased IgE levels and autoimmune conditions.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "IMMUNE DYSREGULATION"}, {"entity_type": "MOLECULE", "description": "Antibodies against thyroglobulin are elevated in patients with autoimmune thyroiditis associated with STAT5B deficiency.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "ANTI-THYROGLOBULIN ANTIBODIES"}, {"entity_type": "MOLECULE", "description": "Antibodies targeting TPO are found to be increased in individuals suffering from autoimmune thyroiditis linked to STAT5B deficiency.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "ANTI-THYROID PEROXIDASE (TPO) ANTIBODIES"}, {"entity_type": "CONDITION", "description": "The ability of the immune system to distinguish self-cells from foreign cells, which is compromised by defects in IL-2 signaling due to reduced STAT5B activity.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "SELF-TOLERANCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The development and maturation process occurring within the thymus for T lymphocytes, potentially impaired in individuals with defective STAT5B function.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "THYMIC FUNCTION"}, {"entity_type": "PROTEIN", "description": "T cells that have not yet matured fully are affected by reduced STAT5B activity, leading to an accumulation of immature T cells or their accelerated destruction.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "IMMATURE T CELLS"}, {"entity_type": "DISEASE", "description": "Inflammation of the thyroid gland, commonly associated with autoimmune conditions in STAT5B deficient individuals.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "THYROIDITIS"}, {"entity_type": "SYMPTOM", "description": "Symptoms arising from allergic reactions due to elevated IgE levels observed in STAT5B deficiency patients.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "ALLERGIC SYMPTOMS"}, {"entity_type": "CONDITION", "description": "An altered immune response causing overproduction of certain immunoglobulins and increased susceptibility to autoimmune conditions, characteristic of individuals with STAT5B deficiency.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "IMMUNE RESPONSE DYSREGULATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A loss-of-function (LOF) STAT5B genomic variant is associated with dysregulation of CD8+ T cells.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "STAT5B VARIANT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The proportion of CD4+ TEM cells remained within normal ranges, indicating no significant alterations in this cell subset.<SEP>The proportion of CD4+ TEM cells remained within normal ranges, suggesting no significant impact from the genomic variant on this cell subset.<SEP>The proportion of CD4+ TEM cells remained within normal ranges, unaffected by the STAT5B variant.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD4+ TEM CELLS"}, {"entity_type": "PROTEIN", "description": "Increases in CD8+ TEM cell proportions became significant with age, indicating a critical role for STAT5B variant in their regulation.<SEP>Increases in the percentage of CD8+ TEM cells became clinically significant with age, suggesting a critical role for STAT5B variant in their activation and homeostasis.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD8+ TEM CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Elevations in CD8+ TEMRA cell proportions during infancy suggest a critical period influenced by STAT5B deficiency.<SEP>Elevations in the percentage of CD8+ TEMRA cells detected during infancy normalized around age 4, indicating a developmental trajectory influenced by STAT5B deficiency.<SEP>Elevations of CD8+ TEMRA cells during infancy suggest an early impact of STAT5B deficiency on T cell development.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD8+ TEMRA CELLS"}, {"entity_type": "DISEASE", "description": "Patients with STAT5B deficiency exhibit elevated CD8+ memory T cells from birth, indicating a fundamental role in T cell regulation.<SEP>Patients with STAT5B deficiency exhibit elevated proportions of CD8+ memory T cells beginning in infancy, suggesting a critical role for this genomic variant in immune cell regulation.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "STAT5B DEFICIENCY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "No alterations were identified in the proportion of CD4+ memory T cells, indicating normal regulation despite STAT5B deficiency.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD4+ MEMORY T CELLS"}, {"entity_type": "GENOMIC VARIANT", "description": "A loss-of-function mutation in the STAT5B gene leads to abnormal regulation of CD8+ T cells.<SEP>A specific genomic mutation in the STAT5B gene causes dysregulation of CD8+ T cells and memory T cell proportions.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "LOF MUTATION IN STAT5B"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "GH stimulation typically results in phosphorylation and nuclear translocation of STAT5B, but this process is impaired by the LOF variant.)", "entity_type": "UNKNOWN", "id": "PHOSPHORYLATION/NUCLEAR TRANSLOCATION"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "Impaired expression or function of STAT5B leads to reduced numbers and function of NK cells in deficient individuals.)", "entity_type": "UNKNOWN", "id": "STAT5B GENE EXPRESSION"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "Increased immunoglobulin production by B cells, particularly IgE, is associated with elevated serum levels leading to allergic conditions such as chronic eczema and reactive airway disease.)", "entity_type": "UNKNOWN", "id": "IGE LEVELS"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "Maintenance of T cell levels is influenced by the expression level of FOXP3, which is affected in patients with defective STAT5B function.)", "entity_type": "UNKNOWN", "id": "FOXP3 EXPRESSION"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "Evaluation of RTEs helps assess the function and maintenance of regulatory T cells in STAT5B deficient patients over time.)", "entity_type": "UNKNOWN", "id": "TREG FUNCTION"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "The IL-2 signaling pathway is crucial for Treg differentiation and function, mediated by STAT5B\'s role in FOXP3 induction.)", "entity_type": "UNKNOWN", "id": "IL-2 SIGNALING PATHWAY"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "Young STAT5B deficient siblings exhibit dysregulated memory CD8+ T cells with reduced na\u00efve subsets and elevated memory/activation phenotypes.)", "entity_type": "UNKNOWN", "id": "NAIVE T CELLS"}, {"source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "description": "Patients with STAT5B deficiency have elevated proportions of CD8+ memory T cells from infancy onwards, indicating a critical role for the STAT5B variant in CD8+ T cell homeostasis.", "entity_type": "UNKNOWN", "id": "CD8+ MEMORY T CELLS"}, {"entity_type": "GENE", "description": "The HLA-DRB1 gene is involved in immune responses and has specific alleles such as HLA-DRB1*07:01.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA-DRB1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs28383172 is a Single Nucleotide Polymorphism (SNP) associated with HLA-DRB1*07:01 carrier status.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "SNP RS28383172"}, {"entity_type": "GENOMIC VARIANT", "description": "The HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype is a genetic variant associated with E. coli ASP hypersensitivity.<SEP>This specific haplotype is associated with certain immune responses and genetic predispositions to diseases.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62<SEP>chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2395182 is a SNP involved in predicting the HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype carrier status.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "SNP RS2395182"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4713586 is a SNP used in predicting the HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype carrier status.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "SNP RS4713586"}, {"entity_type": "GENOMIC VARIANT", "description": "rs7775228 is a SNP involved in predicting the HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype carrier status.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "SNP RS7775228"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Linkage disequilibrium refers to the non-random association of alleles at different loci in a genome, which is important for genetic studies and predicting disease susceptibility.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "LINKAGE DISEQUILIBRIUM (LD)"}, {"entity_type": "GENE", "description": "The HLA-DQA1 gene is part of the human leukocyte antigen complex and forms haplotypes with other genes like HLA-DRB1 and HLA-DQB1.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA-DQA1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "Refers to the presence or absence of specific alleles in an individual\'s genome, important for predicting disease susceptibility and immune responses.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "ALLELE CARRIER STATUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of using a set of genetic markers (SNPs) to predict haplotype carrier status, crucial for genotyping large populations efficiently.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HAPLOTYPE TAGGING"}, {"entity_type": "MEASUREMENT METRIC", "description": "A measure indicating the proportion of actual positives that are correctly identified as such.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "SENSITIVITY"}, {"entity_type": "MEASUREMENT METRIC", "description": "A measure indicating the proportion of actual negatives that are correctly identified as such.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "SPECIFICITY"}, {"entity_type": "MEASUREMENT METRIC", "description": "The probability that subjects with a positive test truly have the condition.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "POSITIVE PREDICTIVE VALUE (PPV)"}, {"entity_type": "MEASUREMENT METRIC", "description": "The probability that subjects with a negative test truly do not have the condition.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "NEGATIVE PREDICTIVE VALUE (NPV)"}, {"entity_type": "DISEASE", "description": "E. coli ASP hypersensitivity is an allergic condition caused by the dietary protein alpha-lactalbumin from E. coli.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "E. COLI ASP HYPERSENSITIVITY"}, {"entity_type": "GENE", "description": "The TLR7 gene is involved in the immune response to HIV infection, with specific polymorphisms (rs179008 and rs179009) being studied for their association with disease progression.<SEP>The TLR7 gene is studied for its polymorphisms (rs179008 and rs179009) in relation to HIV disease progression.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "id": "TLR7 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "These genomic variants in the TLR7 gene are associated with altered risk of HIV infection, as indicated by reduced occurrence in infected individuals compared to healthy controls.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "POLYMORPHISM RS179008 AND RS179009"}, {"entity_type": "DISEASE STAGE", "description": "The progression of HIV disease is linked to genetic factors such as the presence or absence of certain TLR7 polymorphisms.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "HIV DISEASE STAGES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Consumption of tobacco and alcohol in individuals with HIV infection shows a non-significant impact on the distribution of TLR7 gene variants.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 24}]", "id": "TOBACCO AND ALCOHOL CONSUMPTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The demographic profile includes age and sex distributions that influence genetic associations in HIV-infected individuals versus healthy controls.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "DEMOGRAPHIC PROFILE"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific haplotypes of the TLR7 gene polymorphisms are analyzed for association with HIV infection, particularly focusing on AG and other combinations.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "id": "TLR7 HAPLOTYPES (RS179008 AND RS179009)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Baseline CD4 counts represent the initial level of CD4 cells in patients before considering any changes due to treatment or disease progression.<SEP>CD4 counts at the baseline are used to assess immune system health and its correlation with TLR7 gene polymorphisms.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 24}]", "id": "BASELINE CD4 COUNTS"}, {"entity_type": "GENOMIC VARIANT", "description": "TLR7 (rs179008) is a specific polymorphism of the TLR7 gene that has been studied for its correlation with HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "TLR7 (RS179008)"}, {"entity_type": "GENOMIC VARIANT", "description": "TLR7 (rs179009) is another polymorphism of the TLR7 gene examined in relation to HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "TLR7 (RS179009)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Age and sex are physiological processes or attributes that were correlated with HIV disease progression through multivariate logistic regression analysis.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "AGE AND SEX"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The use of tobacco is an environmental factor considered in the correlation study for HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "TOBACCO USAGE"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Alcohol usage is a lifestyle factor that was analyzed along with other factors in relation to its effect on HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "ALCOHOL USAGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Baseline CD4 counts, an indicator of immune system status, were correlated with HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "CD4 COUNTS"}, {"entity_type": "DISEASE", "description": "HIV disease progression is the condition that was examined for factors influencing its course and severity through statistical analysis.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "HIV DISEASE PROGRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Multivariate logistic regression analysis was used to correlate age, sex, tobacco use, alcohol usage, baseline CD4 counts, and TLR7 polymorphisms with HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "MULTIVARIATE LOGISTIC REGRESSION ANALYSIS"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Both tobacco and alcohol usage are lifestyle factors that were analyzed for their impact on HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "TOBACCO AND ALCOHOL USAGE"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "Consumption of tobacco or alcohol does not significantly alter the distribution patterns of TLR7 gene polymorphisms in HIV-infected individuals.", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 24}]", "id": "TLR7 GENE POLYMORPHISM RS179008 AND RS179009"}, {"entity_type": "GENOMIC VARIANT", "description": "ALK R1275Q is a genomic variant known as a hotspot mutation in neuroblastoma (NBL) tumors.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "ALK R1275Q"}, {"entity_type": "GENOMIC VARIANT", "description": "NRAS Q61K is an activating mutation commonly found in melanoma, thyroid, and colorectal cancers.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "NRAS Q61K"}, {"entity_type": "PROTEIN", "description": "Another allele of the HLA class I protein involved in presenting peptides to T cells for immune recognition.<SEP>HLA-B*15:01 is a protein that functions as an MHC molecule involved in presenting peptides to TCRs.<SEP>HLA-B*15:01 is a protein that interacts with neoepitopes derived from ALK R1275Q to form p/MHC complexes in vitro.<SEP>HLA-B*15:01 is another allele of the HLA class I protein that also presents peptides to T cells for immune recognition.<SEP>The HLA-B*15:01 protein binds peptide antigens for presentation to T cells.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-830d8819004960d1d149ac70149c72a0<SEP>chunk-52a8c1d4352526a90e26deb6f06682d2<SEP>chunk-de413ae6100407d8dadd5bdee87c1074", "id": "HLA-B*15:01"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These are two predicted HLA-B*15:01-restricted decamer neoepitopes arising from ALK R1275Q mutation.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "MAQDIYRASY AND AQDIYRASYY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "This is a nonamer neoepitope derived from ALK R1275Q that binds to HLA-B*15:01 with better binding affinity compared to its parental self-antigen.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "AQDIYRASY"}, {"entity_type": "PROTEIN", "description": "HLA-A*02:01 is a protein that interacts with ALK R1275Q-derived nonamer (GMAQDIYRA) to form p/MHC complexes.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "HLA-A*02:01"}, {"entity_type": "PROTEIN", "description": "An allele of the HLA class I protein that presents peptides to T cells for immune recognition.<SEP>HLA-A*01:01 binds the NRAS-derived neoepitope ILDTAGKEEY arising from Q61K mutation.<SEP>HLA-A*01:01 is an allele of the HLA class I protein, involved in presenting peptides to T cells for immune recognition.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "HLA-A*01:01"}, {"entity_type": "DISEASE", "description": "Neuroblastoma is a disease where ALK R1275Q and other recurrent mutations play significant roles.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "NEUROBLASTOMA (NBL)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Formation of stable p/MHC complexes from neoepitopes with HLA proteins in vitro provides insights for therapeutic interventions.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "PEPTIDE/MHC COMPLEXES"}, {"entity_type": "SOFTWARE TOOL", "description": "ProTECT software is used to identify neoepitope-generating mutations and their corresponding HLA binding affinities.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "PROTECT SOFTWARE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "ILDTAGKEEY is a neoepitope arising from the NRAS Q61K mutation, which binds to HLA-A*01:01.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "NRAS Q61K NEOEPITOPE ILDTAGKEEY"}, {"entity_type": "GENOMIC VARIANT", "description": "A ZNF717 mutation (Q716) present in three samples of the NBL cohort.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "ZNF717 Q716 MUTATION"}, {"entity_type": "GENOMIC VARIANT", "description": "Three different mutations (F1174L, F1174I, and F1174C) found in ALK among samples of the NBL cohort.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "F1174L/I/C MUTATIONS IN ALK "}, {"entity_type": "PROTEIN", "description": "Close relative of HLA-B*15:01 that binds to ARDIYRASYY with a score of 2.2% and ARDIYRASY with a score of 4.7%.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "HLA-B*15:03"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A nonamer derived from ALK R1275Q that binds to HLA-A*02:01.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "GMAQDIYRA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Formation of stable peptide/MHC complexes is crucial for the interaction between neoepitopes and HLAs.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "P/MHC COMPLEX STABILITY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "ALK neoepitopes are specific sequences from ALK proteins recognized by the immune system, shown to bind with HLA-B*15:01.<SEP>ALK-derived neoepitopes are peptide sequences presented by MHC molecules in cancer patients, potentially leading to an immune response.<SEP>Peptide sequences derived from ALK mutations that can be presented by MHC molecules and recognized by CD8+ T cells, potentially leading to an immune response.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-830d8819004960d1d149ac70149c72a0", "id": "ALK NEOEPITOPES"}, {"entity_type": "PROTEIN", "description": "A nonamer peptide (AQDIYRASY) binds specifically to HLA-B*15:01 and forms an extended conformation within the binding groove.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "NONAMER PEPTIDE AQDIYRASY"}, {"entity_type": "PROTEIN", "description": "A specific decamer peptide sequence that binds HLA-A*01:01 and is structurally characterized by X-ray crystallography.<SEP>The decamer peptide (AQDIYRASYY) also binds specifically to HLA-B*15:01, adopting a more compact 310 helical conformation within the groove.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-830d8819004960d1d149ac70149c72a0", "id": "DECAMER PEPTIDE AQDIYRASYY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A technique used to assess the kinetic stability of p/MHC complexes based on melting temperature measurements.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "DIFFERENTIAL SCANNING FLUORIMETRY (DSF)"}, {"entity_type": "PATHOGEN", "description": "Epstein-Barr virus is a pathogen from which HLA-B*15:01-restricted antigens are derived and studied for their structural properties.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "EPSTEIN\u2013BARR VIRUS"}, {"entity_type": "PROTEIN", "description": "The protein UBE2M is another source of peptides that bind to HLA-B*15:01, used in comparative studies with ALK-derived neoepitopes.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 (UBE2M)"}, {"entity_type": "PATHOGEN", "description": "A pathogen from which the peptide VQQESSFVM is derived and studied for its structural binding characteristics with HLA-B*15:01.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "SARS CORONAVIRUS"}, {"entity_type": "PROTEIN", "description": "T-cell receptors are molecules that recognize specific peptides presented by MHC complexes, such as those bound to ALK neoepitopes and HLA-B*15:01.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "TCRS (T-CELL RECEPTORS)"}, {"entity_type": "TRANSCRIPT", "description": "Neoepitopes are specific peptide sequences derived from tumor antigens or mutated proteins, recognized by T-cells via MHC complexes.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "NEOEPITOPES"}, {"entity_type": "GENOMIC VARIANT, PROTEIN", "description": "The ALK R1275Q mutation produces neoepitopes that can be recognized by the immune system as altered peptides.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "ALK R1275Q NEOEPITOPE"}, {"entity_type": "GENE, GENOMIC VARIANT", "description": "ALK is a gene involved in cancer development and can harbor mutations such as R1275Q that produce neoepitopes recognized by the immune system.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "ALK (ANAPLASTIC LYMPHOMA KINASE)"}, {"entity_type": "PROTEIN", "description": "A peptide derived from ALK sequence without the C-terminal Tyr, which forms less stable complexes with HLA-B*15:01 compared to its decamer counterpart.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "NONAMER PEPTIDE"}, {"entity_type": "PROTEIN", "description": "A peptide derived from ALK sequence with an additional C-terminal Tyr that forms more stable complexes with HLA-B*15:01, enhancing immune recognition.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "DECAMER PEPTIDE"}, {"entity_type": "DISEASE", "description": "The self-peptide ARDIYRASY is derived from normal ALK sequence and its binding to HLA-B*15:01 implies tolerance rather than immunity, suggesting it is excluded due to steric hindrance.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "SELF-PEPTIDE (ARDIYRASY)"}, {"entity_type": "PROTEIN", "description": "TCRs are proteins that recognize peptide antigens presented by MHC molecules and initiate an immune response against foreign or altered cells.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "TCRS (T CELL RECEPTORS)"}, {"entity_type": "PROTEIN", "description": "Neoepitopes derived from ALK gene mutation at position R1275Q, which are targeted in cancer immunotherapies.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "ALK R1275Q NEOEPITOPES"}, {"entity_type": "GENE", "description": "HLA alleles, such as HLA-A, B, and C types, play a role in presenting neoepitopes to T cells for immune response.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA ALLELES"}, {"entity_type": "PROTEIN", "description": "Peptides derived from ALK R1275Q mutation are evaluated for their interaction with various HLAs.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "PEPTIDES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "X-ray structure of HLA-B*15:01 used as a template to model peptide/HLA interactions.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-B*15:01 STRUCTURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Comparative modeling approach to predict peptide/HLA binding, using fixed-peptide backbone threading and energy minimization.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "ROSETTA COMPARATIVE MODELING CALCULATIONS"}, {"entity_type": "METHODOLOGY", "description": "Developed method that combines structural templates with computational predictions to assess peptide/HLA interactions across a wide range of HLA alleles.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HIGH-THROUGHPUT APPROACH FOR PEPTIDE/HLA INTERACTIONS"}, {"entity_type": "PROTEIN", "description": "Peptides derived from ALK mutation, evaluated for their binding affinity with various HLAs in the study.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "NONAMER AND DECAMER ALK PEPTIDES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Predicted energy values indicating the strength of interaction between peptides and HLA alleles.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "BINDING ENERGY PREDICTIONS"}, {"entity_type": "GENE", "description": "HLA allele that shows lowest binding energy for decamer peptide, suggesting strong binding affinity.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-B*15:84 ALLELE"}, {"entity_type": "GENE", "description": "HLA allele demonstrating the lowest binding energy for nonamer peptide, indicating high affinity binding.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-B*15:107 ALLELE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Sequence logo revealing preferred residues in HLA peptide-binding groove that facilitate strong peptide/MHC interactions.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "KULLBACK\u2013LEIBLER SEQUENCE LOGO"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Refolding experiment confirming the thermal stability and structural integrity of decamer peptide complexed with HLA-A*01:01.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "THERMAL STABILITY OF DECAMER COMPLEX WITH HLA-A*01:01"}, {"entity_type": "MOLECULAR INTERACTION", "description": "X-ray structure of HLA-A*01:01 used for refolding experiments to validate peptide/HLA interactions.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "HLA-A*01:01 STRUCTURE"}, {"entity_type": "GENE", "description": "An artificial HLA allele in which all residues are mutated to Ala, serving as a negative control for binding energy predictions.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "MOCK POLYALA HLA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Refolding experiments performed in vitro to validate the structural stability of peptide/HLA complexes.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "IN VITRO REFOLDING EXPERIMENTS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Specific polar interactions observed between residues in HLA and peptides, such as Thr, Lys, Trp, and Tyr residues.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "POLAR CONTACTS IN MHC BINDING GROOVE"}, {"entity_type": "PROTEIN", "description": "Recombinant complexes formed by refolding experiments, showing thermal stability and structural integrity.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "STABLE RECOMBINANT P/MHC COMPLEXES"}, {"entity_type": "PROTEIN", "description": "A decamer peptide that binds HLA-A*01:01 and is structurally characterized by X-ray crystallography.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "DECAMER PEPTIDE AQDIYRASYY (PDB ID 6AT9)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "T-cell receptors (TCRs) are responsible for recognizing MHC-bound peptides, initiating an immune response.<SEP>T-cell receptors responsible for recognizing MHC-bound peptides, initiating an immune response.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "TCRS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An immunodominant epitope derived from SARS-CoV that is recognized by CD8+ T cells.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "SARS CORONAVIRUS-DERIVED EPITOPE (VQQESSFVM)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A purified complex formed between the peptide and HLA-A*01:01, characterized by X-ray crystallography.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "PURIFIED COMPLEX WITH HLA-A*01:01"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Specific hydrogen bonding interactions between the peptide and residues in the MHC groove, contributing to stability of the p/MHC complex.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "POLAR CONTACTS WITHIN MHC GROOVE"}, {"entity_type": "GENE", "description": "The PPAR\u03b3 gene plays a crucial role in adipocyte differentiation and insulin sensitivity, influencing metabolic processes such as lipid metabolism and inflammation.", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f", "id": "PPAR\u0393 GENE"}, {"entity_type": "PROTEIN", "description": "The protein product of PPAR\u03b3 interacts with RXR\u03b1 to regulate gene expression involved in lipid metabolism and inflammation.", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f", "id": "PPAR\u0393 PROTEIN"}, {"entity_type": "PROTEIN", "description": "RXR\u03b1 is a partner protein for PPAR\u03b3, involved in the regulation of genes important for lipid metabolism and inflammation.", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f", "id": "RXR\u0391 PROTEIN"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "HLA-B*15:03 binds to both ARDIYRASYY and ARDIYRASY with scores of 2.2% and 4.7%, respectively, indicating its role in immune recognition.", "entity_type": "UNKNOWN", "id": "ARDIYRASYY AND ARDIYRASY"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "In vitro analysis of p/MHC complexes stability provides insights into therapeutic target validation for neuroblastoma mutations.", "entity_type": "UNKNOWN", "id": "PROTECT SOFTWARE ANALYSIS"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "DSF is used to measure the kinetic stability of p/MHC complexes formed by HLA-B*15:01 and neoepitopes, indicating thermal stabilities.", "entity_type": "UNKNOWN", "id": "HLA-B*15:01 BINDING COMPLEXES"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "Peptides derived from Epstein\u2013Barr virus follow established binding motifs for HLA-B*15:01, similar to those of ALK neoepitopes.", "entity_type": "UNKNOWN", "id": "HLA-B*15:01 BINDING MOTIF"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "The interaction between TCRs and the p/MHC complexes formed by ALK-derived peptides bound to HLA-B*15:01 mediates immune recognition.", "entity_type": "UNKNOWN", "id": "ALK NEOEPITOPES BOUND TO HLA-B*15:01"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "The binding of neoepitopes to \u03b22m is crucial for the formation of stable MHC class I complexes.", "entity_type": "UNKNOWN", "id": "\u03922M (BETA-2-MICROGLOBULIN)"}, {"source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "description": "The HLA-B*15:01 protein binds the ALK R1275Q decamer peptide, facilitating immune recognition and response.", "entity_type": "UNKNOWN", "id": "ALK R1275Q NEOEPITOPE (DECAMER)"}, {"source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "description": "TCRs recognize the HLA-B*15:01 complexed with ALK R1275Q decamer peptide, initiating an immune response against cancer cells.", "entity_type": "UNKNOWN", "id": "HLA-B*15:01/DECAMER PEPTIDE COMPLEX"}, {"entity_type": "GENOMIC VARIANT", "description": "A single nucleotide polymorphism located in 3p14.1, achieving genome-wide significance in TwinGene study.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS74420772"}, {"entity_type": "GENOMIC VARIANT", "description": "The leading SNP identified in the discovery GWAS meta-analysis for IgM anti-PC measurement with an effect size of 0.19 (rank order normalized SD).", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS35923643-G"}, {"entity_type": "GENE", "description": "A gene located within a linkage disequilibrium block that includes six SNPs achieving genome-wide significance in the discovery GWAS meta-analysis.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "GRAMD1B GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "A proxy SNP for rs35923643-G, associated with IgM levels and CLL risk.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS735665-A"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "IgM antibodies directed against polyreactive antigens, often associated with immune responses or autoimmunity.<SEP>Measurement of IgM antibodies against phosphatidylcholine, an important marker in autoimmune and inflammatory conditions.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a<SEP>chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "IGM ANTI-PC"}, {"entity_type": "DISEASE", "description": "A type of cancer affecting B lymphocytes that have accumulated in the bone marrow and blood.<SEP>A type of cancer characterized by the presence of too many lymphocytes in the blood, bone marrow, and lymph nodes.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a<SEP>chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific single nucleotide polymorphisms identified as significant in GWAS studies for IgM anti-PC levels.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "SNPS IN 1P31.3 AND 11Q24.1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Levels of immunoglobulins (IgG, IgA, IgM) measured in the blood, which are indicators of immune system activity and health.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "GENERAL IMMUNOGLOBULIN LEVELS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant located in the LD block at locus 11q24.1, associated with IgM anti-PC and CLL.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "RS35923643"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Monomethylated histone H3 lysine 4 (H3K4Me1) is a chromatin mark indicative of regulatory elements such as enhancers or promoters.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "H3K4ME1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "DNase I hypersensitive sites are regions in the genome that are more accessible to DNase I, indicating active transcriptional regulatory regions.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "DNASEI HYPERSENSITIVITY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These binding sites are where specific proteins (transcription factors) attach to DNA to control gene expression.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "TRANSCRIPTION FACTOR BINDING SITES"}, {"entity_type": "PROTEIN", "description": "Runt-related transcription factor 3 (RUNX3) is a protein that binds to DNA at specific sequences, influencing the regulation of genes involved in various biological processes including cell proliferation and differentiation.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "RUNX3 BINDING MOTIF"}, {"entity_type": "DISEASE", "description": "This refers to the association between IgM anti-polyclonal antibodies (anti-PC) and Chronic Lymphocytic Leukemia (CLL), a disease characterized by an accumulation of B lymphocytes in the bone marrow, blood, and lymph nodes.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "IGM ANTI-PC AND CLL PHENOTYPIC ASSOCIATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A statistical method used to analyze survival data and estimate hazard ratios for different groups or strata while adjusting for potential confounders.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "STRATIFIED COX PROPORTIONAL HAZARDS MODEL"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific region of chromosome 11, q-arm at position 24.1, shared between IgM anti-PC and CLL.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "LOCUS 11Q24.1"}, {"source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "description": "The SNP rs35923643 alters the predicted affinity of RUNX3 to bind DNA, potentially affecting gene regulation.", "entity_type": "UNKNOWN", "id": "SNP RS35923643 BINDING IMPACT ON RUNX3"}, {"source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "description": "There is an association between Chronic Lymphocytic Leukemia (CLL) and IgM anti-PC levels, indicating potential biological relevance to disease progression or diagnosis.", "entity_type": "UNKNOWN", "id": "CLL"}], "links": [{"weight": 4.0, "description": "Skeletal muscle mass is often inversely related to body fat content in obese individuals.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY", "target": "SKELETAL MUSCLE MASS"}, {"weight": 8.0, "description": "Increased hs-CRP concentrations are often associated with obesity and systemic inflammation.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY", "target": "HS-CRP CONCENTRATION"}, {"weight": 10.0, "description": "Renal function can be impaired in obese individuals due to increased metabolic and vascular pressures.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY", "target": "EGFR"}, {"weight": 13.0, "description": "Intake of a Korean balanced diet can influence obesity risk through its nutritional profile.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY", "target": "KOREAN BALANCED DIET INTAKE"}, {"weight": 1.0, "description": "The prevalence of obesity tends to increase with age due to changes in metabolism and lifestyle.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY", "target": "AGE"}, {"weight": 3.0, "description": "Higher physical activity levels are associated with lower obesity risk through increased energy expenditure.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY", "target": "PHYSICAL ACTIVITY LEVEL"}, {"weight": 4.0, "description": "Variants in the PPAR\u03b3 gene are associated with an increased risk of developing metabolic syndrome, which includes conditions like obesity and type 2 diabetes.)", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f", "order": 1, "source": "METABOLIC SYNDROME", "target": "PPAR\u0393 GENE"}, {"weight": 3.0, "description": "A higher waist circumference generally correlates with greater abdominal fat mass, a component of obesity risk.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "WAIST CIRCUMFERENCE", "target": "FAT MASS"}, {"weight": 9.0, "description": "Higher waist circumference is commonly linked to higher blood pressure, indicating cardiovascular risks.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "WAIST CIRCUMFERENCE", "target": "BLOOD PRESSURE (SBP/DBP)"}, {"weight": 3.0, "description": "The presence of (CA)16 allele is associated with increased waist circumference in individuals moving from normal glucose levels to impaired fasting glucose, impaired glucose tolerance, and Type 2 Diabetes Mellitus.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "WAIST CIRCUMFERENCE", "target": "(CA)16 ALLELE"}, {"weight": 5.0, "description": "Total cholesterol levels are influenced by LDL concentration, with higher levels contributing to cardiovascular risks.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "SERUM TOTAL CHOLESTEROL", "target": "LDL CONCENTRATION"}, {"weight": 6.0, "description": "Consumption of alcohol can lead to elevated serum triglycerides due to its metabolic effects.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "SERUM TRIGLYCERIDE", "target": "ALCOHOL INTAKE"}, {"weight": 7.0, "description": "Engaging in regular exercise tends to increase HDL levels, promoting cardiovascular health.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "SERUM HDL CONCENTRATION", "target": "REGULAR EXERCISE"}, {"weight": 2.0, "description": "Low eGFR indicates reduced kidney function, often seen in hypertensive patients.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "EGFR", "target": "KIDNEY FUNCTION"}, {"weight": 10.0, "description": "The PRKAG2 gene variant is associated with changes in eGFR, particularly in individuals with diabetes, highlighting its role in kidney function regulation.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "EGFR", "target": "PRKAG2 GENE VARIANTS (RS7463059)"}, {"weight": 11.0, "description": "High ALT concentrations often indicate liver damage or disease, which can also affect AST levels.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "ALT CONCENTRATION", "target": "AST CONCENTRATION"}, {"weight": 12.0, "description": "Higher dietary inflammatory index scores are associated with higher intake of sugar-containing foods.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "DII (DIETARY INFLAMMATORY INDEX)", "target": "SUGAR-CONTAINING FOODS INTAKE"}, {"weight": 14.0, "description": "A Western-style dietary pattern often includes high intake of fried foods, contributing to health risks.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "FRIED FOOD INTAKE", "target": "WESTERN-STYLE DIET INTAKE"}, {"weight": 15.0, "description": "Following a plant-based diet combined with regular exercise can reduce obesity risk through multiple pathways.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "PLANT-BASED DIET INTAKE", "target": "REGULAR EXERCISE"}, {"weight": 3.0, "description": "A high intake of plant-based foods can mitigate genetic impact on BMI, suggesting a protective role against obesity risk when combined with low PRS.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "PLANT-BASED DIET INTAKE", "target": "BMI"}, {"weight": 3.0, "description": "A high intake of plant-based diet can reduce the genetic impact (high PRS) on obesity risk, highlighting the protective role of dietary patterns against genetic predisposition.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "PLANT-BASED DIET INTAKE", "target": "OBESITY RISK"}, {"weight": 2.0, "description": "Participant\'s age was positively correlated with higher scores of social disinhibition, indicating a significant environmental influence.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "AGE", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 3.0, "description": "Younger age was associated with a higher risk of reporting CTCAE grade 2 or above acute nausea.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "AGE", "target": "CTCAE GRADE 2 OR ABOVE ACUTE NAUSEA"}, {"weight": 2.0, "description": "Average BMI differs between genders, often reflecting differences in body composition and fat distribution.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "GENDER", "target": "BMI (BODY MASS INDEX)"}, {"weight": 4.0, "description": "A family history of obesity can lead to higher BMI and related health risks due to shared genetics and environment.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "FAMILY HISTORY OF OBESITY"}, {"weight": 6.0, "description": "The presence of the FTO SNP is associated with increased BMI in individuals without university studies but not in those with higher education.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "FTO SNP"}, {"weight": 8.0, "description": "A measure used to categorize the severity of obesity, studied in association with genetic risk alleles.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "EXTREMELY OBESE CHILDREN AND ADOLESCENTS"}, {"weight": 5.0, "description": "Participants with minor alleles in the FADS gene cluster had a lower BMI at baseline.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "BASELINE COLONIC ARACHIDONIC ACID (AA) MEASUREMENT IN PARTICIPANTS WITH OR WITHOUT MINOR ALLELES IN THE FADS GENE CLUSTER"}, {"weight": 4.0, "description": "Both males and females experience a positive correlation between BMI and increased snoring, though mechanisms may vary by sex.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "SEX (MALE/FEMALE)"}, {"weight": 3.0, "description": "Higher sodium levels in urine are often associated with higher BMI values due to dietary habits and salt intake.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "SODIUM IN URINE"}, {"weight": 8.0, "description": "The FTO gene is associated with obesity risk, indicating a potential causal relationship between the genetic variation in this region and BMI values.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "FTO GENE"}, {"weight": 11.0, "description": "The MACF1 gene\'s association with musculoskeletal traits also includes an influence on BMI values, linking physical structure to obesity risk.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "MACF1 GENE"}, {"weight": 14.0, "description": "Separate analyses conducted on males and females revealed distinct genetic factors contributing to variations in BMI, influencing snoring predisposition differently between sexes.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "SEX-STRATIFIED GWAS (GENOME-WIDE ASSOCIATION STUDY)"}, {"weight": 16.0, "description": "Adjusting for BMI in the GWAS reduces SNP heritability but does not eliminate genetic predisposition to snoring as indicated by PGS.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "PGS (POLYGENIC SCORE)"}, {"weight": 3.0, "description": "Older age associated with the GA genotype group may influence BMI, particularly in men where variations are more pronounced.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "AGE DISTRIBUTION"}, {"weight": 3.0, "description": "The BMI of asthmatic cases was significantly higher than that of the control group within the NYUBAR population.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "BMI (BODY MASS INDEX)", "target": "NYUBAR POPULATION"}, {"weight": 4.0, "description": "The DNAJC27 variant influences the process of regulating energy intake or expenditure via interaction with transcription factors involved in obesity development.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "DNAJC27_RS713586", "target": "ENERGY INTAKE AND EXPENDITURE"}, {"weight": 5.0, "description": "The CDKAL1 variant affects energy intake/expenditure through its influence on the regulation of transcription factors, impacting obesity risk.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "CDKAL1_RS9356744", "target": "ENERGY INTAKE AND EXPENDITURE"}, {"weight": 3.0, "description": "A genetic variation in TFAP2B influences the development of obesity by modulating energy intake/expenditure pathways through interaction with transcription factors.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "TFAP2B_RS2206277", "target": "OBESITY RISK"}, {"weight": 4.0, "description": "The BDNF variant impacts energy intake or expenditure, contributing to the risk of developing obesity via its role in modulating transcription factors.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "BDNF_RS6265", "target": "ENERGY INTAKE AND EXPENDITURE"}, {"weight": 1.5, "description": "Although MYL2 SNP does not meet statistical significance, it is implicated in obesity risk through regulation of energy intake/expenditure pathways.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "MYL2_RS3782889", "target": "OBESITY RISK"}, {"weight": 3.5, "description": "The OLFM4 variant influences the process of regulating energy intake or expenditure, playing a role in obesity development through its interaction with transcription factors.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OLFM4_RS9568856", "target": "ENERGY INTAKE AND EXPENDITURE"}, {"weight": 4.0, "description": "A genetic variant in FTO affects the regulation of energy intake/expenditure, thereby influencing the obesity risk by acting as a hub gene.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "FTO_RS1421085", "target": "ENERGY INTAKE AND EXPENDITURE"}, {"weight": 4.5, "description": "The MC4R variant acts as a hub gene in regulating energy intake/expenditure pathways, contributing significantly to obesity risk through its modulation of transcription factors.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "MC4R_RS6567160", "target": "ENERGY INTAKE AND EXPENDITURE"}, {"weight": 4.0, "description": "A genetic variant in GIPR impacts energy intake/expenditure via regulation of transcription factors, thereby influencing the risk of obesity.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "GIPR_RS1444988703", "target": "ENERGY INTAKE AND EXPENDITURE"}, {"weight": 4.0, "description": "Adherence to the Mediterranean diet contributes to a reduction in body mass index among individuals.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "BODY MASS INDEX (BMI)", "target": "MEDITERRANEAN DIET ADHERENCE (MD)"}, {"weight": 2.0, "description": "High fried-food consumption mitigates the genetic impact from high PRS on BMI, showing that diet plays a crucial role in modifying obesity risk.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "OBESITY RISK", "target": "FRIED-FOOD INTAKE"}, {"weight": 4.0, "description": "Educational level interacts with the FTO SNP to determine obesity risk, showing an inverse relationship between higher education and obesity prevalence.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "OBESITY RISK", "target": "EDUCATION LEVEL"}, {"weight": 4.0, "description": "Adjusting for physical activity does not change the significant association between the FTO SNP and obesity risk in most populations but modifies this effect when education is considered as an environmental factor.)", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "OBESITY RISK", "target": "PHYSICAL ACTIVITY (PA)"}, {"weight": 2.0, "description": "High fried-food consumption offsets the genetic impact from PRS in terms of increasing BMI; thus, diet can modify obesity risk independent of genetic predisposition.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "PRS", "target": "FRIED-FOOD INTAKE"}, {"weight": 7.0, "description": "Higher BMI levels are positively associated with IFG/IGT status at baseline in comparison to normal glucose tolerance subjects (NGT).)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "BMI", "target": "IFG/IGT"}, {"weight": 5.0, "description": "Body Mass Index is a key mediator in the pleiotropy observed between certain SNPs and metabolic phenotypes.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "BMI", "target": "MEDIATOR OF PLEIOTROPIC EFFECTS"}, {"weight": 4.0, "description": "Polymorphisms within GRK5\'s CA repeat sequences are linked with higher BMI in individuals progressing from normal glucose levels to prediabetes and T2DM, indicating a genetic influence on obesity.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "BMI", "target": "GRK5 (CA)N REPEATS"}, {"weight": 3.0, "description": "Higher BMI was observed alongside less physical activity among the colorectal cancer cases compared to controls.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "BMI", "target": "PHYSICAL ACTIVITY"}, {"weight": 10.0, "description": "Body Mass Index (BMI) was multiadjusted and associated with T2D-related quantitative traits, though no significant associations were found.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "BMI", "target": "PHYSIOLOGICAL PROCESS"}, {"weight": 5.0, "description": "Higher body mass index (BMI) significantly increases HUA risk in both male and female carriers of the ABCG2 rs2231142 T allele.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "BMI", "target": "HYPERURICAEMIA (HUA)"}, {"weight": 3.0, "description": "Patients with IBS-D have a higher BMI compared to IBS-C and HV, indicating potential metabolic differences.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BMI", "target": "IBS-D"}, {"weight": 4.0, "description": "Higher BMI is correlated with higher serum C4 and total stool BA, which are also related to lower fasting serum FGF19 levels.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BMI", "target": "SERUM FGF19"}, {"weight": 4.0, "description": "The FTO rs1558902 genotype interacts with high-protein diets to influence weight loss and body composition changes, particularly in terms of fat-free mass and total fat.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902 GENOTYPE", "target": "HIGH-PROTEIN DIET"}, {"weight": 3.0, "description": "Individuals carrying the FTO risk allele (A) experience greater weight loss on a high-protein diet compared to those without this genotype.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902 GENOTYPE", "target": "WEIGHT LOSS"}, {"weight": 4.0, "description": "A high-protein diet leads to changes in fat distribution, including reductions in visceral and subcutaneous adipose tissue, which is modulated by the FTO rs1558902 genotype.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "FAT DISTRIBUTION CHANGES"}, {"weight": 4.0, "description": "Individuals carrying the A allele show greater weight loss and changes in body composition when consuming a high-protein diet compared to non-carriers.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "A ALLELE (RISK ALLELE)"}, {"weight": 4.0, "description": "The high-protein diet significantly influenced fat distribution changes in individuals with the AA genotype, leading to more substantial decreases in body fat.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "FAT DISTRIBUTION"}, {"weight": 4.0, "description": "Particularly in individuals with specific genotypes, high-protein diets can lead to significant reductions in total body fat.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "TOTAL FAT CHANGE"}, {"weight": 2.0, "description": "Genotype-time interactions on changes in fat distribution are observed under low-fat dietary conditions.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "FAT DISTRIBUTION CHANGES", "target": "LOW-FAT DIET"}, {"weight": 3.0, "description": "The interaction between genotype and dietary intake over time significantly impacts changes in fat distribution.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "FAT DISTRIBUTION CHANGES", "target": "GENOTYPE-TIME INTERACTION"}, {"weight": 3.0, "description": "The analysis using linear mixed models reveals that individuals with the AA genotype on a high-protein diet show greater total fat loss over time compared to those without this genotype.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "LINEAR MIXED MODELS ANALYSIS", "target": "TOTAL FAT LOSS"}, {"weight": 2.0, "description": "Changes in total fat are often accompanied by corresponding losses or gains in fat-free mass, indicating an overall shift in body composition.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "TOTAL FAT LOSS", "target": "FAT-FREE MASS LOSS"}, {"weight": 3.0, "description": "Loss in trunk fat is a component of total fat loss, reflecting changes in central adiposity due to dietary and genetic influences.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "TOTAL FAT LOSS", "target": "TRUNK FAT LOSS"}, {"weight": 2.0, "description": "The baseline BMI provides a reference for measuring the impact of genetic variants such as those in the FTO gene on body mass over time.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO GENE", "target": "BASELINE BMI"}, {"weight": 8.0, "description": "The FTO gene variant (rs9939609) has a significant association with various anthropometric measurements, indicating its role in obesity risk.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO GENE", "target": "ANTHROPOMETRIC MEASUREMENTS"}, {"weight": 1.0, "description": "The FTO gene contains a specific single nucleotide polymorphism (SNP) that influences obesity risk.)", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "FTO GENE", "target": "FTO SNP"}, {"weight": 3.0, "description": "This specific SNP within FTO influences CRP levels, highlighting gene-specific impacts on systemic inflammation markers.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "FTO GENE", "target": "RS1558902 SNP"}, {"weight": 2.0, "description": "The initial FM% provides context for how genetic factors and dietary interventions can influence the percentage of body fat over time.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "BASELINE BMI", "target": "FM%"}, {"weight": 4.0, "description": "Alterations in trunk fat, as measured by FM%, can be influenced by genotype-time interactions and specific diets like the high-protein diet.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "FM% (FAT MASS PERCENTAGE)", "target": "TRUNK FAT CHANGE"}, {"weight": 4.0, "description": "Analysis reveals that gene-diet interactions significantly impact changes in visceral adipose tissue, particularly in response to high-protein diets.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "VISCERAL ADIPOSE TISSUE (VAT) CHANGES", "target": "GENE-DIET INTERACTION ANALYSIS"}, {"weight": 6.0, "description": "Those carrying the AA genotype had less loss of TAT and SAT during the low-protein dietary intervention relative to non-carriers.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "AA GENOTYPE", "target": "LOW-PROTEIN DIET"}, {"weight": 3.0, "description": "Individuals carrying the GG genotype have lower TAG concentrations compared to those with AA genotypes for GCKR rs780094 SNP, indicating a genetic influence on lipid levels.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "AA GENOTYPE", "target": "GG GENOTYPE"}, {"weight": 2.0, "description": "The AA genotype of rs1695 polymorphism does not show a significant association with breast cancer, according to our findings.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "AA GENOTYPE", "target": "BREAST CANCER"}, {"weight": 2.0, "description": "In response to a low-protein diet, participants carrying the AA genotype exhibited less reduction of total abdominal adipose tissue compared to others.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "LOW-PROTEIN DIET", "target": "TAT (TOTAL ABDOMINAL ADIPOSE TISSUE)"}, {"weight": 2.0, "description": "The AA genotype carriers showed smaller decreases in subcutaneous abdominal adipose tissue during low-protein diet interventions.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "LOW-PROTEIN DIET", "target": "SAT (SUBCUTANEOUS ABDOMINAL ADIPOSE TISSUE)"}, {"weight": 1.0, "description": "The FTO rs9939609 polymorphism is associated with anthropometric measurements, including weight, BMI and waist circumference.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "ANTHROPOMETRIC VARIABLES"}, {"weight": 5.0, "description": "Educational level interacts significantly with the FTO rs9939609 polymorphism to determine BMI and obesity risk, highlighting environmental-genetic interactions.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "EDUCATION LEVEL", "target": "FTO SNP"}, {"weight": 7.0, "description": "Individuals with higher education do not exhibit a significant association between the FTO rs9939609 polymorphism and anthropometric measures, suggesting mitigating factors in these groups.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO SNP", "target": "UNIVERSITY STUDIES EDUCATION LEVEL"}, {"weight": 8.0, "description": "The level of physical activity interacts with the presence of the FTO SNP to influence BMI, especially among certain educational groups.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO SNP", "target": "PHYSICAL ACTIVITY (PA)"}, {"weight": 3.0, "description": "The effect of the FTO SNP on obesity risk varies depending on educational attainment, indicating a gene-environment interaction.)", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "FTO SNP", "target": "EDUCATION"}, {"weight": 6.0, "description": "Both primary and secondary education levels show similar patterns of increased obesity risk associated with the FTO SNP compared to university studies.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "PRIMARY STUDIES EDUCATION LEVEL", "target": "SECONDARY STUDIES EDUCATION LEVEL"}, {"weight": 14.0, "description": "Increased physical activity as part of an intervention group helps in reducing weight and lowering type 2 diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "PHYSICAL ACTIVITY (PA)", "target": "INTENSIVE LIFESTYLE INTERVENTION GROUP"}, {"weight": 2.0, "description": "Individuals who undertake university studies are part of the broader category of education level, which can influence health outcomes related to genetic factors such as the FTO SNP.)", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "EDUCATION", "target": "UNIVERSITY STUDIES"}, {"weight": 5.0, "description": "The TCF7L2 gene interacts with various dietary patterns in the context of type 2 diabetes risk assessment.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "TCF7L2 GENE", "target": "DIETARY PATTERN"}, {"weight": 16.0, "description": "The rs7903146 variant within the TCF7L2 gene modifies the association between other genetic factors and Type 2 diabetes risk.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "TCF7L2 GENE", "target": "RS7903146"}, {"weight": 4.0, "description": "The TCF7L2 gene contains SNPs that are significantly associated with BMI at baseline, indicating its role in obesity predisposition.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "TCF7L2 GENE", "target": "SNPS"}, {"weight": 7.0, "description": "The TCF7L2 gene contains the SNP rs7903146, a significant obesity predisposing SNP associated with BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "TCF7L2 GENE", "target": "SNPS IN FTO, TAL1, AND TCF7L2 GENES"}, {"weight": 12.0, "description": "Genetic variants interact with environmental factors to modify the susceptibility or resistance to developing type 2 diabetes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "GENETIC VARIANT", "target": "TYPE 2 DIABETES (T2D)"}, {"weight": 2.0, "description": "The presence of specific genetic variants, including CC genotype and T allele, influences the risk or occurrence of colorectal cancer.)", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "order": 1, "source": "GENETIC VARIANT", "target": "COLORECTAL CANCER (CRC)"}, {"weight": 9.0, "description": "Longitudinal studies like the NHS help to understand how dietary patterns influence long-term health outcomes such as type 2 diabetes risk.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "DIETARY PATTERN", "target": "NURSES\' HEALTH STUDY (NHS)"}, {"weight": 4.0, "description": "Dietary patterns interact with genotypes to modify physiological processes such as lipid metabolism.)", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "order": 1, "source": "DIETARY PATTERN", "target": "GENE-DIET INTERACTION"}, {"weight": 6.0, "description": "Both dietary patterns and physical activity are lifestyle factors that influence glucose tolerance and diabetes risk.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "DIETARY PATTERN", "target": "PHYSICAL ACTIVITY"}, {"weight": 0.5, "description": "IL-22 protein levels may be influenced by dietary patterns, though this specific link was not detailed in the text.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "DIETARY PATTERN", "target": "IL-22 PROTEIN"}, {"weight": -1.0, "description": "The text does not directly link nutrients to dietary patterns affecting pharmacogenomics algorithms.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "DIETARY PATTERN", "target": "NUTRIENT"}, {"weight": 3.0, "description": "Unspecified dietary patterns may influence the expression and activity of CYP24A1.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "DIETARY PATTERN", "target": "CYP24A1 TRANSCRIPT"}, {"weight": 3.0, "description": "Consumption patterns of dairy products can influence the digestive capability based on LCT gene expression levels and epigenetic modifications.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "DIETARY PATTERN", "target": "LACTOSE DIGESTION CAPABILITY"}, {"weight": 10.0, "description": "The DPS uses an intensive lifestyle intervention group to assess the impact of lifestyle changes on reducing type 2 diabetes risk compared to usual care.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "INTENSIVE LIFESTYLE INTERVENTION GROUP", "target": "FINISH DIABETES PREVENTION STUDY (DPS)"}, {"weight": 16.0, "description": "The Mediterranean diet groups focus on extra-virgin olive oil or mixed nuts, which are associated with whole grain intake and fiber consumption.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "MEDITERRANEAN DIET GROUPS", "target": "WHOLE GRAIN INTAKE AND FIBER CONSUMPTION"}, {"weight": 12.0, "description": "The PREDIMED study assesses how a Mediterranean diet affects cardiovascular disease and type 2 diabetes risk factors in at-risk populations.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "PREVENCI\u00d3N CON DIETA MEDITERR\u00c1NEA (PREDIMED)"}, {"weight": 2.0, "description": "Interventions aimed at promoting weight loss can reduce the incidence of T2D among individuals carrying certain genetic variants.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "WEIGHT LOSS INTERVENTIONS"}, {"weight": 12.0, "description": "Multiple genetic variants are associated with an increased risk of Type 2 Diabetes, highlighting the polygenic nature of the disease.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "GENETIC VARIANTS"}, {"weight": 10.0, "description": "The cumulative risk score, derived from multiple genetic variants, significantly differentiates between individuals with T2D and those without, indicating its utility as a predictive tool.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "CUMULATIVE RISK SCORE"}, {"weight": 3.0, "description": "Methylation at this site is associated with a higher risk of Type 2 Diabetes, suggesting its role in the disease\'s pathogenesis.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "BCL2L11 GENE CPG SITE (CG07547695)"}, {"weight": 3.0, "description": "Methylation at this site is associated with a higher risk of Type 2 Diabetes, suggesting its role in the disease\'s pathogenesis.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "CEP55 GENE CPG SITE (CG24371383)"}, {"weight": 3.0, "description": "Methylation at this site is associated with a higher risk of Type 2 Diabetes, suggesting its role in the disease\'s pathogenesis.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "CPB1 GENE CPG SITE (CG04072156)"}, {"weight": 4.0, "description": "Decreased methylation at this site is associated with an increased risk of Type 2 Diabetes, indicating a role in disease progression.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "HISTONE CLUSTER 1 H4D (HIST1H4D) CPG SITE (CG08170869)"}, {"weight": 4.0, "description": "Decreased methylation at this site is associated with an increased risk of Type 2 Diabetes, indicating a role in disease progression.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "TYPE 2 DIABETES (T2D)", "target": "DISHEVELLED-1 (DVL1) CPG SITE (CG03465880)"}, {"weight": 11.0, "description": "Studies like DPP evaluate how glycemic index and load affect type 2 diabetes risk when combined with lifestyle interventions.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "AMERICAN DIABETES PREVENTION PROJECT (DPP)", "target": "GLYCEMIC INDEX AND GLYCEMIC LOAD"}, {"weight": 5.0, "description": "The rs7903146 variant in the TCF7L2 gene shows interaction with fiber and whole-grain intake among individuals carrying a specific allele, increasing T2D incidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "TCF7L2", "target": "RS7903146 RISK T-ALLELE"}, {"weight": 5.0, "description": "The rs4506565 variant within the TCF7L2 gene interacts with dietary fiber and whole-grain intake to modify type 2 diabetes risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "TCF7L2", "target": "RS4506565"}, {"weight": 4.0, "description": "The rs12255372 variant within the TCF7L2 gene shows interaction with dietary fiber but not carbohydrates, affecting type 2 diabetes risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "TCF7L2", "target": "RS12255372"}, {"weight": 3.0, "description": "The ADH1C genotype modifies the association between alcohol intake and T2D risk among women carrying a specific allele of TCF7L2 gene.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "TCF7L2", "target": "ADH1C *1/*2 VARIANT"}, {"weight": 4.0, "description": "Carriers of the TCF7L2 variant rs12255372 show interaction with dietary fiber to modify type 2 diabetes risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FIBER INTAKE", "target": "TCF7L2 RS12255372 CARRIERS"}, {"weight": 5.0, "description": "A-allele carriers of TCF7L2 variant rs11196208 show interaction with whole-grain intake to modify type 2 diabetes risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "WHOLE-GRAIN INTAKE", "target": "TCF7L2 RS11196208 A-ALLELE CARRIERS"}, {"weight": 5.0, "description": "AA-genotype carriers of TCF7L2 variant rs7903146 show interaction with whole-grain intake to modify type 2 diabetes risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "WHOLE-GRAIN INTAKE", "target": "TCF7L2 RS7903146 AA-GENOTYPE CARRIERS"}, {"weight": 5.0, "description": "AC-genotype carriers of TCF7L2 variant rs7903146 show interaction with whole-grain intake to modify type 2 diabetes risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "WHOLE-GRAIN INTAKE", "target": "TCF7L2 RS7903146 AC-GENOTYPE CARRIERS"}, {"weight": 5.0, "description": "Carriers of the TCF7L2 variant rs4506565 show interaction with whole-grain intake to modify type 2 diabetes risk.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "WHOLE-GRAIN INTAKE", "target": "TCF7L2 RS4506565 CARRIERS"}, {"weight": 4.0, "description": "A genetic variant in the NOTCH2 gene interacts with fiber intake, influencing type 2 diabetes risk among individuals carrying a specific allele of this gene.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "RS10923931 NOTCH2 GENE", "target": "NOTCH2 GENE"}, {"weight": 5.0, "description": "The ZBED3 gene shows interaction with dietary fiber intake and modifies T2D risk similar to NOTCH2 gene interactions, both involved in WNT signaling pathway.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "ZBED3 GENE", "target": "NOTCH2 GENE"}, {"weight": 5.0, "description": "Both genetic variants (IRS1 and GIPR) interact with carbohydrate intake to modify type 2 diabetes risk, but findings are not consistent across studies.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "IRS1 RS2943641", "target": "GIPR RS10423928"}, {"weight": 5.0, "description": "Both CAV2 variant and HECTD4 variants show interaction with dietary fat to modify T2D risk, though findings vary between studies.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "CAV2 VARIANT RS2270188", "target": "HECTD4 VARIANTS"}, {"weight": 6.0, "description": "Polymorphisms in TCF7L2 interact with various dietary factors, including fiber and whole grains, to influence type 2 diabetes incidence.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "TCF7L2 POLYMORPHISMS ", "target": "DIETARY FACTORS"}, {"weight": 1.0, "description": "The effect of a Western dietary pattern on T2D risk is amplified in individuals with high genetic susceptibility (high T2D-GRS).", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "WESTERN DIETARY PATTERN ", "target": "T2D-GRS "}, {"weight": 2.0, "description": "This genetic variant of TCF7L2 is significantly associated with a reduced incidence of type 2 diabetes in intervention studies compared to control groups.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "TCF7L2 RS12255372", "target": "T2D"}, {"weight": 3.0, "description": "The presence of the rs7903146 T allele is linked to an increased risk of developing type 2 diabetes but showed lower incidence in intervention groups.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "RS7903146 RISK T\u2010ALLELE", "target": "T2D"}, {"weight": 4.0, "description": "This variant of ENPP1 is associated with a higher risk for type 2 diabetes but weight loss interventions seem to mitigate this risk.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "ENPP1 RS1044498 DIABETOGENIC VARIANT", "target": "T2D"}, {"weight": 5.0, "description": "While there\'s a trend towards interaction, the MC4R variant does not show significant interactions with weight loss interventions for reducing T2D incidence.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "MC4R RS17066829", "target": "WEIGHT LOSS INTERVENTION"}, {"weight": 6.0, "description": "The PPAR\u03b3 gene variant is associated with a reduced risk of type 2 diabetes under intervention conditions compared to controls.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "PPAR\u0393 RS1152003 CC\u2010GENOTYPE", "target": "T2D"}, {"weight": 7.0, "description": "This genetic variant shows lower T2D incidence among individuals who undergo weight loss interventions.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "TNF\u0391 RS1800629 GG\u2010GENOTYPE", "target": "T2D"}, {"weight": 8.0, "description": "The ADRA2B gene\'s Glu9 allele is associated with a reduced risk of type 2 diabetes upon undergoing weight loss interventions.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "ADRA2B GLU9-ALLELE", "target": "WEIGHT LOSS INTERVENTION"}, {"weight": 9.0, "description": "This genetic variant in LIPC shows a lower incidence of T2D under intervention conditions compared to non-intervention groups.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "LIPC RS2070895 A\u2010ALLELE", "target": "T2D"}, {"weight": 3.0, "description": "Certain genetic variations increase susceptibility to developing type 2 diabetes, and their interaction with lifestyle factors can modify disease risk.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "GENETIC VARIANTS", "target": "TYPE 1 DIABETES (T2D)"}, {"weight": 2.0, "description": "Genetic variants have a limited impact on variability in microbial taxa composition in the gut, highlighting the need for caution when interpreting results from MR analyses.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "GENETIC VARIANTS", "target": "MICROBIAL TAXA VARIABILITY"}, {"weight": 4.0, "description": "Randomized controlled trials investigating the effects of weight loss interventions on populations carrying different genetic variants for T2D.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "WEIGHT LOSS INTERVENTIONS", "target": "RCT STUDY POPULATIONS"}, {"weight": 5.0, "description": "Variants in PPAR\u03b3 show a trend for interaction with fat intake and FFAR4 variant interacts with low-fat diet to influence T2D risk, indicating similar dietary impact on genetic interactions.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FFAR4 VARIANT", "target": "PPAR\u0393 VARIANTS"}, {"weight": 8.0, "description": "Individuals with IFG/IGT have an increased risk of developing T2D compared to those with NGT, as indicated by baseline clinical characteristics and longitudinal data from the EpiDREAM cohort study.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "T2D", "target": "IFG/IGT"}, {"weight": 8.0, "description": "A specific variant in the WFS1 gene (rs10010131) is associated with Type 2 Diabetes risk.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "WFS1 GENE", "target": "RS10010131 GENOMIC VARIANT"}, {"weight": 10.0, "description": "An association between a CDKAL1 variant and T2D was observed for a specific variant (rs10946398), indicating its role in disease susceptibility.<SEP>An association between a CDKAL1 variant and T2D was observed in the study sample, indicating its role in disease susceptibility.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "CDKAL1 GENE", "target": "RS10946398 GENOMIC VARIANT"}, {"weight": 10.0, "description": "A genomic variant (rs864745) within JAZF1 is associated with an increased risk of Type 2 Diabetes, showing the gene\'s importance in disease pathogenesis.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "JAZF1 GENE", "target": "RS864745 GENOMIC VARIANT"}, {"weight": 10.0, "description": "An association between ADAMTS9 and T2D was noted for a specific variant (rs4607103), with differing effects observed in different populations.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "ADAMTS9 GENE", "target": "RS4607103 GENOMIC VARIANT"}, {"weight": 12.0, "description": "A logistic regression model was applied to assess the relationship between cumulative risk scores and disease status in T2D patients compared to controls, showing significant associations.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "CUMULATIVE RISK SCORE", "target": "LOGISTIC REGRESSION MODEL"}, {"weight": 7.0, "description": "Genetic analysis shows that adjusting for the genomic variant rs7903146 in TCF7L2 gene removes significant associations with Type 2 diabetes, suggesting its importance.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "RS7903146", "target": "TYPE 7 DIABETES RISK ANALYSIS"}, {"weight": 9.0, "description": "Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "TYPE 2 DIABETES", "target": "TCF7L2 RISK VARIANT"}, {"weight": 9.0, "description": "Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "TYPE 2 DIABETES", "target": "TCF7LL2 RISK VARIANT"}, {"weight": 6.0, "description": "The count of risk alleles is a factor influencing the association with Type 2 diabetes, particularly when considering variants like rs7903146 in TCF7L2.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "TYPE 2 DIABETES", "target": "RISK ALLELES COUNT"}, {"weight": 10.0, "description": "Decreased insulin sensitivity is a significant risk factor for developing type 2 diabetes, as shown by associations with KB levels in the METSIM study.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "TYPE 2 DIABETES", "target": "INSULIN SENSITIVITY (ISI)"}, {"weight": 8.0, "description": "Environmental factors such as diet, smoking, and BMI play significant roles in the development of type 2 diabetes.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "TYPE 2 DIABETES", "target": "ENVIRONMENTAL FACTOR"}, {"weight": 6.0, "description": "Genetic variations such as SNPs associated with type 2 diabetes influence the levels of ketone bodies in individuals.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "TYPE 2 DIABETES", "target": "KBS (KETONE BODIES)"}, {"weight": 0.8, "description": "The minor allele of SNP rs79105258 is inversely associated with the risk of developing Type 2 diabetes among black coffee consumers.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "TYPE 2 DIABETES", "target": "SNP RS79105258"}, {"weight": 1.0, "description": "Regular black coffee intake was associated with a reduced risk of developing type 2 diabetes compared to non-consumers.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "TYPE 2 DIABETES", "target": "BLACK COFFEE INTAKE"}, {"weight": 7.0, "description": "The minor allele of each SNP has an inverse association with the risk of developing type 2 diabetes, suggesting protective effects.<SEP>The minor allele of each SNP has an inverse relationship with type 2 diabetes, indicating that the presence of this variant may reduce the risk of developing the disease.", "source_id": "chunk-b803830d07bff8ae14550f6458048707", "order": 1, "source": "TYPE 2 DIABETES", "target": "SNP"}, {"weight": 5.0, "description": "GWAS studies identify genetic variants, such as SNPs, that are associated with increased risk or protective effects against type 2 diabetes.", "source_id": "chunk-b803830d07bff8ae14550f6458048707", "order": 1, "source": "TYPE 2 DIABETES", "target": "GENOME-WIDE ASSOCIATION STUDY (GWAS)"}, {"weight": 5.0, "description": "There was no evidence for interaction between age and Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "TYPE 2 DIABETES RISK ANALYSIS", "target": "AGE FACTOR"}, {"weight": 4.0, "description": "No significant interaction with sex was found in the analysis of Type 2 diabetes risk associated with the TCF7L2 gene variant.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "TYPE 2 DIABETES RISK ANALYSIS", "target": "SEX FACTOR"}, {"weight": 3.0, "description": "Body Mass Index (BMI) did not significantly interact with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "TYPE 2 DIABETES RISK ANALYSIS", "target": "BMI FACTOR"}, {"weight": 2.0, "description": "The degree of African ancestry had no significant interaction with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "TYPE 2 DIABETES RISK ANALYSIS", "target": "DEGREE OF AFRICAN ANCESTRY"}, {"weight": 7.0, "description": "The transition from NGT to IFG/IGT is significantly correlated with higher baseline BMI levels and a positive increase in BMI change over time compared to stable NGT status.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "IFG/IGT", "target": "NGT"}, {"weight": 8.0, "description": "Specific genomic variants or SNPs influence susceptibility to IFG/IGT, affecting baseline BMI levels and the progression from NGT to IFG/IGT over time.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "IFG/IGT", "target": "GENOMIC VARIANT (SNPS)"}, {"weight": 8.0, "description": "Native North Americans showed lower prevalence of IFG/IGT, suggesting potential protective genetic or environmental factors unique to this ethnic group.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "IFG/IGT", "target": "NATIVE NORTH AMERICAN"}, {"weight": 6.0, "description": "FPG levels above normal but below diabetic thresholds indicate IFG, a condition associated with an increased risk of developing type 2 diabetes.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "FASTING PLASMA GLUCOSE (FPG)", "target": "IMPAIRED FASTING GLYCAEMIA (IFG)"}, {"weight": 6.0, "description": "In East Asian populations, Fasting Plasma Glucose levels might be influenced by genetic factors contributing to lower prevalence of T2D compared to other ethnic groups.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "EAST ASIAN", "target": "FPG"}, {"weight": 7.0, "description": "Higher rates of Two-hour Plasma Glucose indicate that African ancestry may be associated with increased risk due to higher 2hPG levels leading to greater BMI changes over time.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "AFRICAN", "target": "2HPG"}, {"weight": 3.0, "description": "The TAL1 gene has SNPs that are significantly associated with BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "TAL1 GENE", "target": "SNPS"}, {"weight": 6.0, "description": "The TAL1 gene contains the SNP rs2984618, another obesity predisposing SNP associated with BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "TAL1 GENE", "target": "SNPS IN FTO, TAL1, AND TCF7L2 GENES"}, {"weight": 5.0, "description": "While the LEPR gene alone does not show a significant main effect on BMI, it interacts with GRS in relation to glycemic status traits like FPG.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "LEPR GENE", "target": "GRS"}, {"weight": 8.0, "description": "FPG interacts with the rs1011527 SNP in LEPR on baseline BMI, suggesting a role of glycemic status traits in modulating genetic effects on obesity.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "LEPR GENE", "target": "FPG (FASTING PLASMA GLUCOSE)"}, {"weight": 6.0, "description": "SNPs are significantly associated with baseline BMI but not with changes in BMI over time.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "SNPS", "target": "BMI BASELINE AND CHANGE"}, {"weight": 7.0, "description": "The GRS is a significant predictor of increased BMI at baseline, indicating the cumulative genetic risk for obesity.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "GRS", "target": "BMI BASELINE AND CHANGE"}, {"weight": 1.5, "description": "The Genetic Risk Score (GRS) is associated with performance on Trail Making Test Part A (TMTA), a measure of visual search speed and processing speed.)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "TMTA"}, {"weight": 2.5, "description": "Survivors with higher GRS scores performed significantly worse on Trail Making Test Part B (TMTB) than those with lower GRS scores, indicating an association between genetic risk and cognitive flexibility.)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "TMTB"}, {"weight": 1.0, "description": "No significant association was found between the Genetic Risk Score (GRS) and performance on Paired Associate Learning Digit Span High Load (PEGDH).)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "PEGDH"}, {"weight": 1.0, "description": "Similarly, no significant association was observed between GRS and the performance of patients in Paired Associate Learning Number Digit High Load (PEGNDH).)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "PEGNDH"}, {"weight": 1.0, "description": "The Genetic Risk Score (GRS) did not show any association with impairment on the Digit Span Test (DIG), assessing working memory and attention.)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "DIG"}, {"weight": 1.0, "description": "No significant correlation was found between GRS and impaired performance in Coding Figure Learning (CFL).)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "CFL"}, {"weight": 3.0, "description": "The Genetic Risk Score (GRS) is computed based on the presence and frequency of polymorphisms across six genomic loci.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "POLYMORPHISM"}, {"weight": 3.0, "description": "The cumulative intravenous exposure to methotrexate influences the Genetic Risk Score, affecting cognitive outcomes.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "CUMULATIVE IV MTX EXPOSURE"}, {"weight": 2.0, "description": "No significant association was found between GRS and impairment on DIVERGT battery performance scores, suggesting variability in how genetic risk impacts different aspects of cognition.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "GRS", "target": "DIVERGT BATTERY"}, {"weight": 9.0, "description": "This SNP interacts with FPG on baseline BMI but does not show a significant main effect on BMI without considering the interaction term.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "FPG (FASTING PLASMA GLUCOSE)", "target": "RS1011527 SNP IN LEPR"}, {"weight": 8.0, "description": "The GRS is significantly associated with increased BMI at baseline, indicating cumulative genetic risk in the context of obesity.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "GRS (GENOTYPE RISK SCORE)", "target": "BMI BASELINE AND CHANGE ASSOCIATIONS AND INTERACTIONS"}, {"weight": 6.0, "description": "Both Fasting Plasma Glucose and Two-hour Plasma Glucose are physiological processes that, when elevated, contribute to increased risk for T2D and are positively associated with baseline BMI.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "2HPG", "target": "FPG"}, {"weight": 3.0, "description": "Polymorphisms within GRK5\'s CA repeat sequences are associated with increased fasting plasma glucose in individuals transitioning from normal glucose levels to IFG and T2DM, indicating a genetic predisposition towards hyperglycemia.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "FPG", "target": "GRK5 (CA)N REPEATS"}, {"weight": 3.0, "description": "Carriers of the MTHFR 1298AC/CC genotypes are at a higher risk for neurocognitive deficits compared to those with AA genotype.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTHFR 1298A>C", "target": "NEUROCOGNITIVE IMPAIRMENT"}, {"weight": 3.0, "description": "Survivors with MTHFR 1298AC/CC genotypes scored significantly lower on TMTB compared to those with AA genotype.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTHFR 1298A>C", "target": "TMTB PERFORMANCE"}, {"weight": 4.0, "description": "Survivors with MS 2756AA genotype scored lower on the PEGNDH test compared to those with AG/GG genotypes.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MS 2756A>G", "target": "PEGNDH SCORE DIFFERENCE"}, {"weight": 4.0, "description": "Survivors carrying MS 2756AA genotype performed worse on TMTA than survivors with AG/GG genotypes.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MS 2756A>G", "target": "TMTA PERFORMANCE"}, {"weight": 5.0, "description": "Individuals carrying MTRR 66AA genotype showed significantly worse performance in executive function tests (CFL).", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTRR 66A>G", "target": "CFL PERFORMANCE"}, {"weight": 5.0, "description": "Individuals with TSER 2R/3R and 3R/3R genotypes scored lower on TMTB compared to those with 2R/2R genotype.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "TSER POLYMORPHISMS", "target": "TMTB PERFORMANCE"}, {"weight": 6.0, "description": "Early MTX-induced neurotoxic symptoms were predictive of long-term cognitive deficits, despite no significant effect on all test measures.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTX-RELATED NEUROTOXICITY", "target": "LONG-TERM NEUROCOGNITIVE IMPAIRMENT"}, {"weight": 2.0, "description": "Intrathecal methotrexate administration affects cognitive performance as measured by Trail Making Test Part B (TMTB).", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "TMTB", "target": "INTRATHECAL MTX EXPOSURE"}, {"weight": 6.0, "description": "The PEGDH test is used to assess fine motor skills, showing some association with genetic polymorphisms but not all covariates.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "FINE MOTOR SKILLS", "target": "PEGDH TEST"}, {"weight": 7.0, "description": "Survivors with MTRR 66AA genotype scored lower on PEGNDH compared to those with AG/GG genotypes, indicating an impact on fine motor skills.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTRR 66A>G GENOTYPES", "target": "PEGNDH TEST"}, {"weight": 8.0, "description": "The DIG test assesses working memory and did not show significant associations with genetic polymorphisms or other covariates.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "DIG TEST", "target": "WORKING MEMORY"}, {"weight": 5.0, "description": "The genomic variant at SLC30A8 is associated with higher baseline fasting proinsulin levels and this association remains significant even after adjusting for various factors.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "SLC30A8 RS13266634", "target": "FASTING PROINSULIN LEVELS"}, {"weight": 5.0, "description": "The genomic variant SLC30A8 rs13266634 shows significant association with higher fasting proinsulin levels in the DPP cohort at baseline.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "SLC30A8 RS13266634", "target": "DPP COHORT"}, {"weight": 6.0, "description": "Adjustment for fasting insulin is necessary to accurately determine the relationship between SLC30A8 risk alleles and proinsulin levels.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "SLC30A8 RS13266634", "target": "FASTING INSULIN"}, {"weight": 7.0, "description": "The use of troglitazone as an intervention led to a decrease in fasting proinsulin levels, similar to metformin but less effective than lifestyle changes.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "FASTING PROINSULIN LEVELS", "target": "TROGLITAZONE"}, {"weight": 8.0, "description": "Higher proinsulin levels are associated with the presence of the C risk allele at SLC30A8, but this association becomes non-significant after one year of DPP intervention.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "FASTING PROINSULIN LEVELS", "target": "C RISK ALLELE AT SLC30A8 RS13266634"}, {"weight": 7.0, "description": "These demographic factors were accounted for when assessing the impact of interventions on fasting proinsulin levels.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "FASTING PROINSULIN LEVELS", "target": "AGE, SEX, ETHNICITY"}, {"weight": 6.0, "description": "Both lifestyle changes and metformin interventions reduce proinsulin levels, but the decrease in the lifestyle group is significantly larger than that of the metformin group (p<0.001).)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "LIFESTYLE INTERVENTION GROUP", "target": "METFORMIN"}, {"weight": 9.0, "description": "Both metformin and troglitazone showed similar effects on reducing fasting proinsulin levels compared to each other, but both were less effective than the lifestyle intervention group.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "METFORMIN", "target": "TROGLITAZONE"}, {"weight": 8.0, "description": "Expression levels of PNPLA3 are positively correlated with SREBP1c, indicating they are part of the same regulatory pathway for lipid metabolism.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "SREBP1C"}, {"weight": 9.0, "description": "Accumulation of hepatic triacylglycerol is associated with elevated PNPLA3 and ACC-1 expression levels, suggesting a coordinated regulation in lipogenesis.<SEP>The expression of ACC-1 parallels that of PNPLA3 in response to different stimuli such as citrate or glucose conditions.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "ACC-1"}, {"weight": 5.0, "description": "The expression level of PNPLA3 gene is regulated by glucose concentration, as shown by depletion-refeeding conditions experiments.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "GLUCOSE"}, {"weight": 9.0, "description": "Citrate increases PNPLA3 protein levels but its isomer, isocitrate, does not have this effect.<SEP>Incubation with citrate increases PNPLA3 expression, suggesting a role for this Krebs cycle intermediate in lipid synthesis regulation.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "CITRATE"}, {"weight": 1.0, "description": "Pyruvate has no impact on the expression of PNPLA3 in cells compared to citrate or acetate.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "PYRUVATE"}, {"weight": 2.0, "description": "Expression patterns of FAS and PNPLA3 are similar under various metabolic conditions, including high glucose levels.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "FAS"}, {"weight": 2.5, "description": "Oleic acid decreases PNPLA3 gene expression without affecting lipid accumulation when PNPLA3 is knocked down.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "OLEIC ACID (OA)"}, {"weight": 1.0, "description": "Unlike other unsaturated fatty acids like OA or LA, ALA does not suppress PNPLA3 expression.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "\u0391-LINOLENIC ACID (ALA)"}, {"weight": 4.0, "description": "Inclusion of lipid emulsion with a high carbohydrate diet attenuates PNPLA3 expression dose-dependently.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "HIGH CARBOHYDRATE DIET (HC)", "target": "LIPID EMULSION (LE)"}, {"weight": 6.0, "description": "Voluntary exercise suppresses the elevation of PNPLA3 mRNA induced by high-fat diet in mice.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "HIGH-FAT DIET (HF)", "target": "EXERCISE"}, {"weight": 4.0, "description": "Expression patterns of ChREBP are similarly modulated to those of PNPLA3 in response to changes in glucose availability.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "GLUCOSE", "target": "CHREBP"}, {"weight": 2.0, "description": "PNPLA3 knockdown results in increased mRNA levels of FAS, a key lipogenic enzyme.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "FATTY ACID SYNTHASE (FAS)", "target": "PNPLA3 KNOCKDOWN"}, {"weight": 6.0, "description": "Treatment with 2-deoxy-D-glucose inhibits the induction of SREBP1c and PNPLA3 by high glucose levels, indicating it disrupts metabolic pathways dependent on glucose metabolism.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "2-DEOXY-D-GLUCOSE", "target": "HIGH GLUCOSE LEVELS"}, {"weight": 1.5, "description": "While insulin increases FAS expression, it does not affect the hepatic PNPLA3 levels in HepG2 cells.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "INSULIN", "target": "FAS"}, {"weight": 3.0, "description": "Prophylactic insulin administration can delay but does not prevent diabetes in NOD mice by potentially inducing a state of \'\u03b2-cell rest\' that reduces metabolic stress and immune-mediated destruction.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "INSULIN", "target": "TYPE 1 DIABETES MELLITUS (T1DM)"}, {"weight": 4.0, "description": "Insulin is produced and secreted by \u03b2-cells. Its deficiency or dysfunction leads to diabetes.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "INSULIN", "target": "\u0392-CELLS"}, {"weight": 1.0, "description": "Treatment with glucagon stimulates PC expression while having no effect on PNPLA3 mRNA levels, indicating specificity of hormonal effects.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "GLUCAGON", "target": "PYRUVATE CARBOXYLASE (PC)"}, {"weight": 2.0, "description": "La and oleic acid reduce the mRNA levels of SREBP1c, FAS, and PNPLA3 under both low and high glucose conditions.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "LINOLEIC ACID (LA)", "target": "SREBP1C, FAS, PNPLA3"}, {"weight": 2.0, "description": "Both EPA and DHA decrease the gene expressions of SREBP1c, FAS, and PNPLA3 under various glucose conditions.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "EICOSAPENTAENOIC ACID (EPA)", "target": "SREBP1C, FAS, PNPLA3"}, {"weight": 2.0, "description": "The combination of OA:LA:ALA suppresses the gene expressions of SREBP1c, FAS, and PNPLA3 to a greater extent than individual fatty acids.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "DOCOSAHEXAENOIC ACID (DHA)", "target": "FATTY ACIDS RATIO MIX"}, {"weight": 1.5, "description": "Used for assessing lipid accumulation in HepG2 cells following metabolic perturbations like varying glucose conditions or exogenous fatty acid treatments.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "OIL RED O STAINING", "target": "LIPID ACCUMULATION"}, {"weight": 1.0, "description": "Under low glucose conditions, glucagon stimulation increases the expression of PC but does not affect PNPLA3 mRNA levels.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "LOW GLUCOSE CONDITION", "target": "GLUCAGON, PYRUVATE CARBOXYLASE (PC)"}, {"weight": 5.0, "description": "Changes in miRNA levels correlate with alterations observed in the hippocampal transcriptome due to PNS exposure.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "HIPPOCAMPAL TRANSCRIPTOME CHANGES", "target": "MIRNOME CHANGES"}, {"weight": 3.0, "description": "Both neurodevelopment and inflammation pathways are affected by PNS exposure, highlighting a broad impact on biological processes.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "NEURODEVELOPMENT PATHWAYS", "target": "INFLAMMATION PATHWAYS"}, {"weight": 4.0, "description": "Exposure to early life trauma leads to significant changes in blood mRNA transcriptomics, similar to those seen following PNS exposure.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "BLOOD MRNA TRANSCRIPTOMICS CHANGES", "target": "EARLY LIFE TRAUMA EXPOSURE"}, {"weight": 5.0, "description": "The interaction between genes and pathways modulated by environmental factors (PNS or early life trauma) results in a subset of overlapping genes with altered expression patterns.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "GENE-PATHWAY INTERACTION", "target": "COMMON GENE OVERLAP"}, {"weight": 5.0, "description": "The IPA Software analysis identified FoxO1 and TGF-\u03b21 as interacting within the same cluster, forming part of signaling pathways related to cytokines, glucocorticoid receptors, and TGF-\u03b21.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "TGF-\u03921", "target": "FOXO1"}, {"weight": 7.0, "description": "Genetic variations within A2M show significant GxE interactions when exposed to sexual abuse during early life, predicting adult depressive symptoms.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "A2M", "target": "CHILDHOOD SEXUAL ABUSE"}, {"weight": 8.0, "description": "The interaction between FoxO1 gene variants and early emotional stress predicts depressive symptoms in adulthood, as observed in two independent clinical cohorts.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "ENVIRONMENTAL FACTOR (EMOTIONAL STRESS IN CHILDHOOD)"}, {"weight": 4.0, "description": "AS1842856 inhibits FoxO1, countering the cortisol-induced upregulation of FoxO1 and reduction in neuronal proliferation.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1", "target": "AS1842856"}, {"weight": 5.0, "description": "SGK-1 is a downstream target gene regulated by FoxO1, involved in mediating some glucocorticoid effects on brain function.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1", "target": "SERUM GLUCOCORTICOID KINASE 1 (SGK-1)"}, {"weight": 4.0, "description": "FoxO1 is up-regulated in the hippocampus following exposure to stress or trauma.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1", "target": "HIPPOCAMPUS"}, {"weight": 6.0, "description": "Exposure to childhood trauma leads to upregulation of FoxO1 in blood samples, indicating a link between environmental factors and gene expression.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1", "target": "CHILDHOOD TRAUMA"}, {"weight": 9.0, "description": "BDI scores are a measure of the severity of depression and its symptomatology.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "DEPRESSION", "target": "BDI SCORES"}, {"weight": 5.0, "description": "Gene BCL2 is involved in cellular processes that may contribute to the development or progression of depressive symptoms through its interaction with environmental factors.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "DEPRESSION", "target": "BCL2"}, {"weight": 6.0, "description": "Gene BCL9, associated with Wnt signaling pathways, interacts with environmental stressors during childhood, contributing to depression in adulthood.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "DEPRESSION", "target": "BCL9"}, {"weight": 4.0, "description": "The impact of maternal depression on neurodevelopmental outcomes in infants needs further investigation.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "DEPRESSION", "target": "EYEBLINK CONDITIONING (EBC)"}, {"weight": 8.0, "description": "The FADS1/2 genes are studied through specific SNPs for their influence on fatty acid metabolism.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)", "target": "FADS1/FADS2 HAPLOTYPE GENES"}, {"weight": 3.0, "description": "Genomic variants or SNPs were analyzed using MR Egger to detect potential biases in causal inference studies.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)", "target": "MR EGGER ANALYSIS"}, {"weight": 10.0, "description": "Minor alleles for certain SNPs are associated with an increased risk of social disinhibition, while others have a protective effect against it.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)", "target": "SOCIAL DISINHIBITION"}, {"weight": 6.0, "description": "Cortisol negatively affects neurogenesis through the activation of FoxO1 signaling pathway.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "CORTISOL", "target": "NEUROGENESIS"}, {"weight": 8.0, "description": "Elevated SGK-1 levels are observed in stressed rats, indicating a link with glucocorticoid effects on brain function.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "SERUM GLUCOCORTICOID KINASE 1 (SGK-1)", "target": "STRESSED RATS"}, {"weight": 9.0, "description": "Blood samples from depressed patients show elevated SGK-1 levels, linking stress and brain function alterations to disease states.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "SERUM GLUCOCORTICOID KINASE 1 (SGK-1)", "target": "DEPRESSED PATIENTS"}, {"weight": 5.0, "description": "This cell line is used to study the effects of cortisol on neuronal proliferation mediated by FoxO1.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "HUMAN FETAL HIPPOCAMPAL PROGENITOR CELL LINE (HPC0A07/03C)", "target": "NEURONAL PROLIFERATION"}, {"weight": 7.0, "description": "These cells play a role in neuronal proliferation which is negatively affected by cortisol through the FoxO1 pathway.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "PROGENITOR STEM CELLS", "target": "NEURONAL PROLIFERATION"}, {"weight": 6.0, "description": "The genomic variant rs4771122 is nominally significantly associated with long-term weight loss after bariatric surgery, indicating its influence on this outcome.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "LONG-TERM WEIGHT LOSS"}, {"weight": 6.0, "description": "The association of the minor allele (G) in rs4771122 with pre-surgical weight and BMI suggests a genetic predisposition to higher pre-operative obesity levels.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "PRE-SURGICAL BMI"}, {"weight": 3.0, "description": "The rs4771122 variant is associated with trajectory group membership, indicating its role in determining different post-surgical weight management outcomes.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "TRAJECTORY GROUP MEMBERSHIP"}, {"weight": 4.0, "description": "Measurements of body weight over time post-surgery are crucial for assessing the long-term effectiveness of bariatric surgery in achieving sustained weight loss.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "LONG-TERM WEIGHT LOSS", "target": "WEIGHT OBSERVATIONS"}, {"weight": 4.0, "description": "Achieving significant nadir weight loss early on can predict a more favorable long-term weight maintenance outcome after bariatric surgery.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "LONG-TERM WEIGHT LOSS", "target": "NADIR WEIGHT LOSS"}, {"weight": 3.0, "description": "The level of two-year percent weight loss is an initial indicator of the likelihood and extent of sustained long-term weight loss post-surgery.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "LONG-TERM WEIGHT LOSS", "target": "TWO YEAR PERCENT WEIGHT LOSS"}, {"weight": 5.0, "description": "Mutations within the GCK gene are the cause of genetic disorders such as GCK-MODY, with these specific variants being critical for diagnosis and understanding disease mechanism.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK GENE", "target": "GCK VARIANTS (PATHOGENIC OR LIKELY PATHOGENIC)"}, {"weight": 9.0, "description": "The ACMG guidelines are used to classify the pathogenicity of GCK gene mutations, impacting clinical management and genetic counseling for patients with GCK-MODY.<SEP>The ACMG guidelines provide a framework for interpreting the pathogenicity of identified genomic variants in the context of GCK-MODY.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK VARIANTS (PATHOGENIC OR LIKELY PATHOGENIC)", "target": "ACMG GUIDELINES FOR GENOMIC VARIANT INTERPRETATION"}, {"weight": 4.0, "description": "After identifying potential disease-causing variants through sequencing analysis, co-segregation testing is used to confirm their clinical significance in familial contexts.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "SEQUENCING ANALYSIS OF GENETIC VARIANTS ", "target": "CO-SEGREGATION WITH DIABETES PHENOTYPE TESTING "}, {"weight": 5.0, "description": "Testing family members for VUS helps confirm co-segregation with disease phenotype, aiding in variant classification.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "PARENTAL/EXTENDED FAMILY DNA TESTING ", "target": "GCK VARIANTS (VUS)"}, {"weight": 4.0, "description": "Both tests assess blood sugar control but HbA1c provides a broader time frame assessment.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "FASTING HYPERGLYCEMIA LEVELS ", "target": "HBA1C TESTING "}, {"weight": 5.0, "description": "Adherence to the Mediterranean diet is inversely associated with triglyceride concentrations.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE (MD)", "target": "TAG CONCENTRATION"}, {"weight": 4.0, "description": "Higher adherence to the Mediterranean diet is directly associated with higher HDL cholesterol levels.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE (MD)", "target": "HDL-C CONCENTRATION"}, {"weight": 3.0, "description": "Adherence to the Mediterranean diet lowers the apolipoprotein B to apolipoprotein A-I ratio, indicating reduced cardiovascular risk.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE (MD)", "target": "APOB:APOA-1 RATIO"}, {"weight": 4.0, "description": "Higher adherence to the Mediterranean diet is inversely associated with hypertriacylglycerolaemia risk.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE (MD)", "target": "HYPERTRIACYLGLYCEROLAEMIA"}, {"weight": 2.0, "description": "Individuals who are physically active tend to have higher adherence to the Mediterranean diet.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE (MD)", "target": "PHYSICAL ACTIVITY"}, {"weight": 2.0, "description": "Adherence to the Mediterranean diet correlates with reduced systolic blood pressure levels.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE (MD)", "target": "SYSTOLIC BLOOD PRESSURE (SBP)"}, {"weight": 3.0, "description": "Higher adherence to the Mediterranean diet is associated with lower diastolic blood pressure levels.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE (MD)", "target": "DIASTOLIC BLOOD PRESSURE (DBP)"}, {"weight": 2.0, "description": "Higher adherence to the Mediterranean diet is associated with improved insulin sensitivity and reduced insulin resistance.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE (MD)", "target": "INSULIN RESISTANCE"}, {"weight": 4.0, "description": "The GCKR rs780094 single nucleotide polymorphism is positively associated with TAG levels in individuals carrying the AA genotype compared to GG genotypes.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "TAG CONCENTRATION", "target": "GCKR RS780094 SNP"}, {"weight": 2.0, "description": "The rs1260326 single nucleotide polymorphism similarly affects TAG concentrations as the GCKR rs780094 SNP, indicating a genetic impact on lipid metabolism.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "TAG CONCENTRATION", "target": "RS1260326 SNP"}, {"weight": 2.0, "description": "Higher adherence to the Mediterranean diet is associated with lower HbA1c concentrations.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "HBA1C CONCENTRATION", "target": "MEDITERRADIAN DIET ADHERENCE (MD)"}, {"weight": 5.0, "description": "The GCKR rs780094 single nucleotide polymorphism is associated with an increased risk of hypertriacylglycerolaemia.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "HYPERTRIACYLGLYCEROLAEMIA", "target": "GCKR RS780094 SNP"}, {"weight": 3.0, "description": "The GG genotype is associated with a higher risk of developing breast cancer compared to other genotypes, according to our study.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "GG GENOTYPE", "target": "BREAST CANCER"}, {"weight": 3.0, "description": "The GCKR rs780094 single nucleotide polymorphism affects LDL cholesterol concentrations, similar to its impact on triglycerides and other lipid markers.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "LDL-C CONCENTRATION", "target": "GCKR RS780094 SNP"}, {"weight": 4.0, "description": "High-fat diets exacerbate insulin resistance in both control and SENP1-aP2KO mice, with more severe effects observed in the latter.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "INSULIN RESISTANCE", "target": "HFD"}, {"weight": 2.0, "description": "The smoking status of individuals influences their behavior in alcohol self-administration, with trends suggesting a marginally shorter latency to drink for smokers.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "SMOKING STATUS", "target": "ALCOHOL SELF-ADMINISTRATION BEHAVIOR"}, {"weight": 2.0, "description": "Both physical activity and smoking status are lifestyle factors that do not significantly alter the relationship between alcohol consumption and cortisol levels when adjusted for.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "SMOKING STATUS", "target": "PHYSICAL ACTIVITY"}, {"weight": 5.0, "description": "The genotype of an individual influences TAG levels in blood, indicating a genetic effect on lipid metabolism.)", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "order": 1, "source": "TAG LEVELS", "target": "GENOTYPE"}, {"weight": 2.0, "description": "Lower dietary fiber intake and less physical activity were observed in cases compared to controls for colorectal cancer risk.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "PHYSICAL ACTIVITY", "target": "DIETARY FIBER INTAKE"}, {"weight": 4.0, "description": "Interactions between dietary factors and specific genomic variants (such as rs4988235) modulate gut microbial abundance.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "GENE-DIET INTERACTION", "target": "GENOMIC VARIANT RS4988235"}, {"weight": 1.0, "description": "Mutations in ABCC8 gene are associated with CHI symptoms and patient classification into diazoxide-responsive or unresponsive groups.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "ABCC8 MUTATIONS", "target": "CONGENITAL HYPERINSULINISM (CHI)"}, {"weight": 2.0, "description": "Mutations in GLUD1 contribute to the pathogenesis of CHI among patients with hypoglycemia and hyperinsulinemia.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "GLUD1 MUTATIONS", "target": "CONGENITAL HYPERINSULINISM (CHI)"}, {"weight": 4.0, "description": "This scan is used for diagnosing and understanding the focal lesions causing CHI, particularly when surgery confirms diffuse pancreatic disease.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "CONGENITAL HYPERINSULINISM (CHI)", "target": "18F-DOPA PET/CT SCAN"}, {"weight": 3.0, "description": "Abnormally high levels of insulin hormone can lead to hypoglycemia in CHI patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "HYPOGLYCEMIA", "target": "INSULIN HORMONE"}, {"weight": 8.0, "description": "This dietary pattern aims to manage hypoglycaemia by restricting protein intake and was successful in three patients without recurrence of symptoms.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "HYPOGLYCEMIA", "target": "LOW-PROTEIN DIET (1.5 G/KG/DAY)"}, {"weight": 6.0, "description": "Effective treatment strategy for many CHI patients, reducing the frequency of hypoglycemic episodes and improving overall health outcomes.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "DIAZOXIDE THERAPY", "target": "HYPOGLYCEMIA MANAGEMENT"}, {"weight": 2.0, "description": "Mutations in both KATP channel genes (ABCC8 and KCNJ11) and GLUD1 gene are identified among CHI patients, indicating diverse genetic factors contributing to the disease.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "KATP CHANNEL GENE MUTATIONS", "target": "GLUD1 GENE MUTATIONS"}, {"weight": 3.0, "description": "Patients who do not respond to diazoxide treatment often show diffuse rather than focal pancreatic lesions upon surgical examination.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "DIAZOXIDE-UNRESPONSIVE GROUP", "target": "DIFFUSE PANCREATIC DISEASE"}, {"weight": 4.0, "description": "Persistent hypoglycemia due to CHI can lead to epilepsy and brain injury, particularly in patients who do not receive timely therapeutic intervention.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "EPILEPSY", "target": "HYPOGLYCEMIC BRAIN INJURY"}, {"weight": 5.0, "description": "Frequent feeding is often initiated early after birth or during infancy to manage blood glucose levels in CHI patients, especially for those with hypoglycemia detected shortly after birth.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "FREQUENT FEEDINGS AND DIETARY MANAGEMENT", "target": "NEONATAL PERIOD AND INFANCY PERIOD (1-12 MONTHS)"}, {"weight": 7.0, "description": "Diazoxide treatment for hypoglycemia can lead to hypertrichosis, a side effect observed in 55% of treated patients.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "DIAZOXIDE TREATMENT", "target": "HYPERTRICHOSIS"}, {"weight": 5.0, "description": "A few cases experienced malabsorption symptoms after stopping diazoxide therapy, affecting their ability to maintain stable blood glucose levels post-treatment.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "DIAZOXIDE TREATMENT", "target": "MALABSORPTION SYMPTOMS"}, {"weight": 8.0, "description": "Patients treated with diazoxide often experience nausea and vomiting as side effects, impacting their quality of life.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "DIAZOXIDE TREATMENT", "target": "NAUSEA AND VOMITING"}, {"weight": 7.0, "description": "A more severe form of gastrointestinal disturbance that can be caused by diazoxide treatment and necessitates nasogastric feeding.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "DIAZOXIDE TREATMENT", "target": "SEVERE GASTROINTESTINAL UPSET"}, {"weight": 6.0, "description": "One patient had to stop diazoxide due to thrombocytopenic purpura, a side effect which is serious and required discontinuation of the treatment.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "DIAZOXIDE TREATMENT", "target": "THROMBOCYTOPENIC PURPURA"}, {"weight": 6.0, "description": "Following pancreatectomy surgery for managing hypoglycaemia, some patients developed diabetes mellitus requiring insulin treatment.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "PANCREATECTOMY", "target": "DIABETES MELLITUS"}, {"weight": 5.0, "description": "Pancreatic surgery can lead to diabetes mellitus in patients, requiring them to use insulin therapy post-surgery.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "DIABETES MELLITUS", "target": "SUBTOTAL PANCREATECTOMY"}, {"weight": 1.0, "description": "Patients with diabetes mellitus may exhibit higher serum uric acid levels due to altered metabolism and medication effects.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "DIABETES MELLITUS", "target": "SERUM URIC ACID LEVELS"}, {"weight": 6.0, "description": "Higher insulin secretion is associated with lower AcAc and BHB levels, suggesting a role of insulin in regulating ketone body metabolism.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "ACAC AND BHB LEVELS", "target": "INSULIN SECRETION"}, {"weight": 8.0, "description": "Certain genetic variants are linked to elevated KB levels, indicating a potential molecular basis for their role in diabetes risk.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "ACAC AND BHB LEVELS", "target": "RISK SNPS FOR TYPE 2 DIABETES OR HYPERGLYCEMIA"}, {"weight": 6.0, "description": "Elevated 2hPG levels indicate IGT, a condition linked to an increased risk of developing type 2 diabetes.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "TWO-HOUR POST-PRANDIAL GLUCOSE (2HPG)", "target": "IMPAIRED GLUCOSE TOLERANCE (IGT)"}, {"weight": 8.0, "description": "Impaired glucose tolerance is a physiological process that shows borderline protective association with IGT for rs12123883.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "IMPAIRED GLUCOSE TOLERANCE (IGT)", "target": "T2D QUANTITATIVE TRAITS"}, {"weight": 8.0, "description": "The METSIM study tracks participants over time to identify factors that increase the risk of hyperglycemia and incident diabetes.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "METSIM STUDY", "target": "HYPERGLYCEMIA AND INCIDENT DIABETES"}, {"weight": 3.0, "description": "In SENP1-aP2KO mice, hyperglycemia is observed earlier under HFD conditions than in normal diet scenarios, accelerating the onset of diabetic phenotypes.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HYPERGLYCEMIA", "target": "SENP1-AP2KO"}, {"weight": 2.0, "description": "Folate metabolism is part of broader nutrient-related physiological processes.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "FOLATE METABOLISM", "target": "NUTRIENT"}, {"weight": 4.0, "description": "The MTHFR C677T variant affects folate metabolism efficiency and thus impacts cardiovascular health outcomes.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "FOLATE METABOLISM", "target": "MTHFR C677T"}, {"weight": 3.0, "description": "Like MTHFR C677T, the A1298C variant also influences the metabolic pathways involving folate and its derivatives.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "FOLATE METABOLISM", "target": "MTHFR A1298C"}, {"weight": 4.0, "description": "Disruptions in folate metabolism, influenced by MTHFR A1298C variant, can exacerbate cardiovascular risk factors in patients with Leiomyoma Venosa.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "FOLATE METABOLISM", "target": "LEIOMYOMA VENOSA (LV)"}, {"weight": 10.0, "description": "The serum folate measurement reflects the current status of folic acid metabolism within an individual\'s body.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "FOLATE METABOLISM", "target": "S-FOL (SERUM FOLATE)"}, {"weight": 11.0, "description": "Whole blood folate measurement provides a more comprehensive view of intracellular and circulating folate levels, impacting metabolic pathway assessment.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "FOLATE METABOLISM", "target": "WB-FOL (WHOLE BLOOD FOLATE)"}, {"weight": 2.0, "description": "Genetic background and environmental factors like ancestral admixture affect disease management through pharmacogenomics algorithms.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "ENVIRONMENTAL FACTOR", "target": "DISEASE"}, {"weight": 3.0, "description": "The FADS1 gene shows associations with AcAc or BHB levels, indicating an influence on ketone body metabolism.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "FADS1", "target": "KBS (KETONE BODIES)"}, {"weight": 5.0, "description": "High Mobility Group AT-Hook 2 is a key gene for height variation in individuals.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "HMGA2", "target": "HEIGHT"}, {"weight": 4.0, "description": "The expression of CPT1A gene correlates positively with fasting FFAs and negatively with insulin sensitivity, linking fatty acid oxidation to metabolic health.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "FFAS (FREE FATTY ACIDS)", "target": "CPT1A (CARNITINE PALMITOYLTRANSFERASE 1A)"}, {"weight": 5.0, "description": "The CPT1A gene regulates the entry of long-chain acyl-CoAs into mitochondria for fatty acid oxidation.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "CPT1A (CARNITINE PALMITOYLTRANSFERASE 1A)", "target": "FATTY ACIDS OXIDATION (FFA OXIDATION)"}, {"weight": 4.0, "description": "The HMGCS2 gene plays a role in ketogenesis by catalyzing the production of 3-hydroxy-3-methylglutaryl-CoA from acetyl-CoA.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "HMGCS2 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2, MITOCHONDRIAL)", "target": "KBS (KETONE BODIES)"}, {"weight": 5.0, "description": "The HMGCS2 gene plays a critical role in ketogenesis by catalyzing the formation of 3-hydroxy-3-methylglutaryl-CoA from acetyl-CoA.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "HMGCS2 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2, MITOCHONDRIAL)", "target": "KETOGENESIS"}, {"weight": 5.0, "description": "ACAT1 is involved in the breakdown of ketone bodies, specifically converting acetoacetyl-CoA into two molecules of acetyl-CoA.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ACAT1 (ACETYL-COA ACETYLTRANSFERASE 1)", "target": "KBS (KETONE BODIES)"}, {"weight": 5.0, "description": "The ACAT1 gene encodes an enzyme that catalyzes the final step in ketone body breakdown, converting acetoacetyl-CoA into two molecules of acetyl-CoA.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ACAT1 (ACETYL-COA ACETYLTRANSFERASE 1)", "target": "KETOLYSIS"}, {"weight": 5.0, "description": "The BDH1 gene is involved in BHB metabolism and regulates its levels through enzymatic activity.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "BDH1 (BHB DEHYDROGENASE, TYPE 1)", "target": "KBS (KETONE BODIES)"}, {"weight": 5.0, "description": "OXCT1 catalyzes the conversion of acetoacetyl-CoA to acetyl-CoA, an essential step in ketolysis and regulation of BHB levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "OXCT1 (3-OXOACID COA TRANSFERASE 1)", "target": "KBS (KETONE BODIES)"}, {"weight": 4.0, "description": "The ACSS2 gene product activates fatty acids, influencing beta-oxidation and metabolic processes like insulin sensitivity.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ACSS2 (ACYL-COA SYNTHETASE SHORT-CHAIN FAMILY MEMBER 2)", "target": "KBS (KETONE BODIES)"}, {"weight": 6.0, "description": "The synthesis of ketone bodies from acetyl-CoA during periods of fasting or low carbohydrate intake is a central component of ketogenesis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "KBS (KETONE BODIES)", "target": "KETOGENESIS"}, {"weight": 5.0, "description": "Ketolysis involves the breakdown of ketone bodies back into acetyl-CoA and other metabolites, regulating their levels in the body.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "KBS (KETONE BODIES)", "target": "KETOLYSIS"}, {"weight": 4.0, "description": "The APOC1 locus variant influences cholesterol metabolism by affecting serum CRP and lipid profiles.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "APOC1 GENE VARIANT", "target": "CHOLESTEROL METABOLISM"}, {"weight": 3.0, "description": "SNPs in the HNF1A gene affect fasting glucose levels, illustrating genetic influence on metabolic conditions such as diabetes.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "HNF1A GENE VARIANT", "target": "GLYCEMIC PHENOTYPES"}, {"weight": 4.0, "description": "Variants near IL6R are linked to inflammatory responses measured by CRP and may modulate cardiovascular risks.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "IL6R GENE VARIANT", "target": "INFLAMMATION REGULATION"}, {"weight": 4.0, "description": "Variants near MC4R contribute to CRP variability, underscoring the genetic underpinnings of inflammation in cardiometabolic disorders.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "CRP LEVELS", "target": "MC4R GENE"}, {"weight": 18.0, "description": "Effects on CRP levels remain significant after adjustments for BMI, cholesterol, or HbA1C.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "CRP LEVELS", "target": "IL6R"}, {"weight": 1.0, "description": "SNPs near MC4R do not significantly affect CRP levels in the WGHS study.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "CRP LEVELS", "target": "MC4R"}, {"weight": 2.0, "description": "SNPs near PLTP are not associated with CRP levels after correction for multiple testing.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "CRP LEVELS", "target": "PLTP"}, {"weight": 12.0, "description": "Significantly enriched pathway involved in the influence of genetic loci on CRP and cardiometabolic traits.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "CRP LEVELS", "target": "LXR/RXR ACTIVATION PATHWAY"}, {"weight": 2.0, "description": "Elevated CRP levels in the blood serve as a clinical parameter aiding in the diagnosis of diabetes, particularly T1DM.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "CRP LEVELS", "target": "DIABETES DIAGNOSIS"}, {"weight": 4.0, "description": "Significant association of this SNP near TMEM18 suggests a role for this genomic region in CRP regulation and cardiometabolic conditions.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "RS2867125 SNP", "target": "TMEM18 GENE"}, {"weight": 3.0, "description": "Genetic variations around PLTP affect LDL-cholesterol levels, highlighting complex interactions between genes and lipid metabolism.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "PLTP GENE", "target": "LDL-CHOLESTEROL METABOLISM"}, {"weight": 4.0, "description": "IL1F10 was not previously reported in GWAS for the specific phenotype, indicating novel associations.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "IL1F10", "target": "GWAS NOT REPORTED"}, {"weight": 6.0, "description": "PPP1R3B gene shows pleiotropic effects on CRP levels and multiple cardiometabolic traits.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "PPP1R3B", "target": "CRP AND METABOLIC PHENOTYPES"}, {"weight": 8.0, "description": "HNF4A influences risk of T2D and CRP levels, showing biological pleiotropy.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "HNF4A", "target": "T2D RISK"}, {"weight": 10.0, "description": "Genetic locus near PABPC4 is associated with changes in CRP levels, influenced by lipid mediators.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "PABPC4", "target": "CRP"}, {"weight": 12.0, "description": "Association between BCL7B and HDL cholesterol decreases considerably after adjustment for CRP.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "BCL7B", "target": "HDL CHOLESTEROL"}, {"weight": 14.0, "description": "SNPs in HNF1A are associated with an increased risk of coronary artery disease (CAD).)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "HNF1A", "target": "CAD RISK"}, {"weight": 16.0, "description": "Genetic variants near APOC1 influence the risk of type 2 diabetes and serum CRP levels.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "APOC1", "target": "T2D RISK"}, {"weight": 0.0, "description": "No consistent associations were found between variants of CRP gene and ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "CRP", "target": "OVARIAN CANCER RISK"}, {"weight": 4.0, "description": "The genomic variant rs20417 is associated with differences in the percentage of CAD between patients and controls.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "order": 1, "source": "CAD", "target": "RS20417"}, {"weight": 1.0, "description": "CAD is associated with various physiological processes including platelet function and number.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "order": 1, "source": "CAD", "target": "PLATELETS"}, {"weight": 6.0, "description": "Levels of cholesterol influence genetic associations with CRP and cardiometabolic phenotypes.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "CHOLESTEROL LEVELS", "target": "CRP ASSOCIATIONS"}, {"weight": 8.0, "description": "Adjustment for HbA1C decreases the association between certain SNPs and metabolic traits.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "HBA1C", "target": "CRP ASSOCIATIONS"}, {"weight": 10.0, "description": "Pathway enriched by genes showing pleiotropic effects on CRP levels and metabolic phenotypes.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "FXR/RXR ACTIVATION PATHWAY", "target": "GENETIC PLEIOTROPY"}, {"weight": 16.0, "description": "Pathway significantly enriched by genetic loci influencing CRP and cardiometabolic traits.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "CRP ASSOCIATIONS", "target": "HEPATIC CHOLESTASIS PATHWAY"}, {"weight": 14.0, "description": "Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "GENETIC EFFECTS", "target": "MODY SIGNALING"}, {"weight": 18.0, "description": "Pathway involved in the effects of pleiotropic genes on CRP levels and metabolic phenotypes.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "ACUTE PHASE RESPONSE SIGNALING PATHWAY", "target": "GENETIC INFLUENCES"}, {"weight": 2.0, "description": "The CC genotype of miR-34b/c rs4938723 was associated with a decreased risk of intracranial aneurysm compared to the TT genotype.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "MIR-34B/C RS4938723", "target": "IA (INTRACRANIAL ANEURYSM)"}, {"weight": 1.0, "description": "The genotype frequencies of miR-34b/c rs4938723 in the control group meet Hardy-Weinberg equilibrium requirements.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "MIR-34B/C RS4938723", "target": "HARDY-WEINBERG EQUILIBRIUM"}, {"weight": -2.0, "description": "No association between TP53 Arg72Pro and IA risk was observed in genotypic or allelic analysis.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "TP53 ARG72PRO", "target": "IA (INTRACRANIAL ANEURYSM)"}, {"weight": 0.5, "description": "The TP53 Arg72Pro genotypes show a distribution pattern that aligns with genetic expectations for this polymorphism.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "TP53 ARG72PRO", "target": "GENOTYPE FREQUENCY DISTRIBUTION"}, {"weight": 4.0, "description": "PCR is commonly utilized to detect SNP variations in genetic studies.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "SNP (SINGLE NUCLEOTIDE POLYMORPHISM)", "target": "PCR (POLYMERASE CHAIN REACTION)"}, {"weight": 3.0, "description": "RFLP analysis can be used to identify specific SNPs within a gene or genomic region.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "SNP (SINGLE NUCLEOTIDE POLYMORPHISM)", "target": "HIND III RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)"}, {"weight": 4.0, "description": "High-resolution sequencing technologies enable the precise identification of SNP variants in individual genomes.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "SNP (SINGLE NUCLEOTIDE POLYMORPHISM)", "target": "SEQUENCING"}, {"weight": 7.0, "description": "Used to verify random mating and genetic equilibrium in SNP distribution among participants.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM", "target": "GENOTYPE DISTRIBUTION OF SNPS"}, {"weight": 8.0, "description": "The genotype distribution of controls matches Hardy-Weinberg equilibrium in most studies, indicating no significant deviation from expected genetic frequencies.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM", "target": "GENOTYPE DISTRIBUTION"}, {"weight": 1.0, "description": "The Odds Ratio is reported alongside the 95% confidence interval to provide an estimate of the precision of the association between genotypes and IA risk.", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "OR (ODDS RATIO)", "target": "95% CI (CONFIDENCE INTERVAL)"}, {"weight": 9.0, "description": "An intronic variant in COL4A1 on chromosome 13 is associated with changes in weight z-score.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "COL4A1", "target": "WEIGHT Z-SCORE CHANGE"}, {"weight": 7.2, "description": "A gene on chromosome 19 where a variant in the 5\u2032UTR region significantly influences linear growth, measured as height change.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "TSEN34", "target": "LINEAR GROWTH (HEIGHT CHANGE)"}, {"weight": 8.0, "description": "An intronic SNP in MTNR1B on chromosome 11 is strongly linked to fasting glucose levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "MTNR1B", "target": "FASTING GLUCOSE"}, {"weight": 6.7, "description": "Variants within this genomic area significantly affect triglyceride levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "APOA5-ZNF259 REGION", "target": "TRIGLYCERIDES"}, {"weight": 8.3, "description": "An intronic SNP in PCSK2 on chromosome 20 is associated with total antioxidants in the body.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "PCSK2", "target": "TOTAL ANTIOXIDANTS"}, {"weight": 6.3, "description": "An intronic SNP in GCH1 on chromosome 14 influences the ratio of 24-hour urinary dopamine to creatinine.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "GCH1", "target": "24-H URINARY DOPAMINE:CREATININE RATIO"}, {"weight": 8.6, "description": "A group of SNPs in the flanking region of XPA/FOXE1 on chromosome 9 are highly associated with serum thyroid-stimulating hormone levels.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "XPA/FOXE1 (TTF-2)", "target": "SERUM TSH"}, {"weight": 2.0, "description": "This variant is associated with sleep duration, indicating a genetic influence on this physiological process.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "ARHGAP11A INTRONIC VARIANT", "target": "SLEEP DURATION"}, {"weight": 2.0, "description": "The SNP in C21orf34 was detected for respiratory quotient during sleep, suggesting an impact on metabolic efficiency during rest.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "C21ORF34 SNP", "target": "RESPIRATORY QUOTIENT (RQ)"}, {"weight": 2.0, "description": "This variant is associated with accelerometer-measured light activity, implying a genetic effect on physical behavior patterns.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "RPL7P3 VARIANT", "target": "LIGHT ACTIVITY"}, {"weight": 2.0, "description": "The variant in the 3\u2032UTR of CTCFL is linked to sedentary-light activity during sleep, indicating an influence on daily movement patterns through genetic variation.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "CTCFL VARIANT", "target": "SEDENTARY-LIGHT ACTIVITY"}, {"weight": 3.0, "description": "Highly significant variants for total energy expenditure were identified in the MATK gene, suggesting a strong genetic association with overall metabolic rate.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "MATK GENE ", "target": "TOTAL ENERGY EXPENDITURE"}, {"weight": 4.0, "description": "Genetic variants in MATK are significantly associated with total energy expenditure, highlighting its role in overall metabolic pathways.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "MATK GENE ", "target": "TOTAL ENERGY EXPENDITURE "}, {"weight": 3.0, "description": "Genetic associations detected for CHRNA3 linked to sleeping energy expenditure, indicating this gene\'s role in basal metabolism during sleep.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "CHRNA3 GENE ", "target": "SLEEPING ENERGY EXPENDITURE"}, {"weight": 4.0, "description": "The CHRNA3 gene is linked to sleeping energy expenditure, indicating a genetic impact on basal metabolism during sleep.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "CHRNA3 GENE ", "target": "SLEEPING ENERGY EXPENDITURE "}, {"weight": 3.0, "description": "The intronic variant in ARHGAP11A is associated with sleep duration, indicating a direct genetic influence on this physiological process.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "SLEEP DURATION ", "target": "ARHGAP11A INTRONIC VARIANT "}, {"weight": 3.0, "description": "The SNP in C21orf34 influences the respiratory quotient during sleep, suggesting a significant impact of genetic variation on metabolic efficiency.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "RESPIRATORY QUOTIENT (RQ)", "target": "C21ORF34 SNP "}, {"weight": 3.0, "description": "Genetic variation in RPL7P3 is associated with accelerometer-measured light activity, indicating its role in physical behavior patterns.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "LIGHT ACTIVITY ", "target": "RPL7P3 VARIANT "}, {"weight": 3.0, "description": "The CTCFL variant affects sedentary-light activity during sleep, reflecting the genetic influence on low-intensity movements.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "SEDENTARY-LIGHT ACTIVITY ", "target": "CTCFL VARIANT "}, {"weight": 7.5, "description": "Variants near RNASE1 and ASS1P11 genes are linked to urinary nitrogen excretion and creatinine excretion, respectively.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "RNASE1, ASS1P11", "target": "URINARY NITROGEN EXCRETION, CREATININE EXCRETION"}, {"weight": 7.9, "description": "Variants within KLKB1 and MPRIP genes are associated with serum free IGF-1 and IGFBP-3 levels, respectively.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "KLKB1, MPRIP", "target": "SERUM FREE IGF-1, SERUM IGFBP-3"}, {"weight": 9.8, "description": "Coding variants in DARC, GREB1, and DFNB31; as well as an intronic SNP in CCR3 and RASGEF1A are associated with MCP-1 levels. Additionally, a variant within the ABO gene is strongly linked to IL-6.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "DARC, GREB1, DFNB31, CCR3, RASGEF1A, ABO", "target": "MCP-1, IL-6"}, {"weight": 7.8, "description": "An intronic SNP in TMEM229B is associated with energy intake at dinner. An intronic SNP in ARHGAP11A affects sleep duration and an SNP near C21orf34 influences respiratory quotient during sleep.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION, RESPIRATORY QUOTIENT (RQ) DURING SLEEP", "target": "TMEM229B, ARHGAP11A, C21ORF34"}, {"weight": 4.0, "description": "The genomic variant rs3833080 affects the amino acid sequence of the APOBR protein.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "APOBR", "target": "RS3833080: P.GLY369_ASP370DEL9"}, {"weight": 5.0, "description": "A non-synonymous SNP in APOBR that alters an amino acid, potentially affecting protein function.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "APOBR", "target": "RS180743: P.PRO428ALA"}, {"weight": 6.0, "description": "The study population of extremely obese children and adolescents were screened for variants in the APOBR gene.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "APOBR", "target": "EXTREMELY OBESE CHILDREN AND ADOLESCENTS"}, {"weight": 8.0, "description": "Risk alleles within APOBR are associated with increased odds for obesity in individuals.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "APOBR", "target": "GENETIC VARIANT RISK ALLELES"}, {"weight": 5.0, "description": "These are additional variants in APOBR that do not affect amino acid sequences but may influence gene expression or regulation.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "APOBR", "target": "RS151233, RS149271, RS180744, RS151174, RS40831, RS61738759, RS200751685, RS40833, AND RS142786317"}, {"weight": 7.0, "description": "These genetic variants were associated with obesity in case-control studies of extremely obese children and adolescents.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "APOBR", "target": "RS180743 G-ALLELE AND RS3833080 DELETION ALLELE"}, {"weight": 7.0, "description": "These bioinformatics tools predict functional effects of genetic variations identified in the study.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "MUTATION TASTER, SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, ENSEMBL, PROVEAN", "target": "GENOMIC VARIANT"}, {"weight": 6.0, "description": "A common deletion variant affecting a transcript, with no predicted function on protein structure.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "C.1036_1062DEL27", "target": "APOBR TRANSCRIPT"}, {"weight": 5.0, "description": "The SULT1A1 gene contains the genomic variant rs142786317, which affects transcription factor binding sites and splicing enhancer/silencer elements.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "RS142786317: C.*118_*119DELCA", "target": "SULT1A1"}, {"weight": 4.0, "description": "This non-synonymous variant in SULT1A1 was not reproducibly identified across multiple samples, suggesting it may be a false positive or an artifact of sequencing.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A1", "target": "MET1VAL"}, {"weight": 5.0, "description": "This synonymous variant in SULT1A1 is predicted to alter the binding domains for splicing regulators and transcription factor AML-1, potentially impacting gene expression.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A1", "target": "P.PRO200 = (RS3176926)"}, {"weight": 4.0, "description": "Detected in SULT1A2, this variant shows potential functional modification based on prediction tools, indicating a possible impact on protein function.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "P.PRO19LEU (RS10797300)"}, {"weight": 5.0, "description": "This conservative amino acid change in SULT1A2 near the binding pocket of xenobiotics is predicted to have a \'non-neutral\' or \'deleterious\' impact on function.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "P.SER44ASN (RS145008170)"}, {"weight": 5.0, "description": "This non-conservative missense variant in SULT1A2 is predicted by various tools to have a higher probability of functional changes, though results are mixed.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "P.TYR62PHE (RS4987024)"}, {"weight": 5.0, "description": "The non-conservative exchange in SULT1A2 away from the binding pocket is predicted to have less significant functional impact compared to other variants.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "P.ALA164VAL (RS142241142)"}, {"weight": 5.0, "description": "This conservative SNP in SULT1A2 is predicted by PolyPhen2, SNAP and SIFT as likely to be functionally relevant, indicating probable alterations to the protein.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "P.ASN235THR (RS1059491)"}, {"weight": 4.0, "description": "Detected in TUFM\'s 3\' untranslated region, this variant is predicted to alter splicing regulator or transcription factor binding sites, impacting gene regulation.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "TUFM", "target": "C.3536C>G "}, {"weight": 4.0, "description": "A series of intronic variants in TUFM are predicted to lead to changes in transcription factor binding sites or splicing regulatory elements, potentially affecting gene expression.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "TUFM", "target": "RS7187776: C.-55T>C, RS4788099: C.500\u221219T/C, RS8061877: C.248\u221218G>A, AND RS61737565: C.922+29C>G"}, {"weight": 6.0, "description": "Disruption of transcription factor binding sites in TUFM may alter gene expression regulation.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "TUFM", "target": "TRANSCRIPTION FACTOR BINDING SITE"}, {"weight": 8.0, "description": "The rs61737565 variant affects the binding sites for transcription factors such as SRY, HFH 2, and HMG-IY.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "RS61737565: C.922+29C>G", "target": "SRY, HFH 2, HMG-IY"}, {"weight": 3.0, "description": "Disruption of transcription factor binding sites by rs8061877 affects the interaction with proteins like SRY, HFH 2, and HMG-IY.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "SRY, HFH 2, HMG-IY", "target": "RS8061877"}, {"weight": 6.0, "description": "The g.28854194C/G variant affects splice enhancer and silencer sites impacting mRNA processing.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "G.28854194C/G", "target": "SPLICE SITES"}, {"weight": 3.0, "description": "The g.28854194C/G variant alters splice enhancer binding sites affecting splicing patterns.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "G.28854194C/G", "target": "SPLICE ENHANCER BINDING SITE"}, {"weight": 3.0, "description": "The g.28854194C/G variant changes splicing silencer sites impacting mRNA stability and translation.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "G.28854194C/G", "target": "SPLICING SILENCER SITE"}, {"weight": 6.0, "description": "No significant genotype-by-diet interactions were found for EPA, indicating that EPA levels are less influenced by genetic variants in the FADS1/2 gene cluster.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "GENOMIC VARIANT", "target": "EPA"}, {"weight": 1.0, "description": "Mutations in the LPL gene are causative of LPL deficiency and contribute to hypertriglyceridemia symptoms.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "GENOMIC VARIANT", "target": "LPL GENE"}, {"weight": 5.0, "description": "The genomic variant C/T-13910 SNP in MCM6 influences DNA modification density around the LCT gene, affecting lactase persistence.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "GENOMIC VARIANT", "target": "MCM6 GENE"}, {"weight": 2.0, "description": "The genomic variant in the IL1B gene is suggested to be associated with increased risk of ovarian cancer.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "OVARIAN CANCER", "target": "IL1B"}, {"weight": 2.0, "description": "Genomic variants in the PTGS1 gene are also suggested to influence ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "OVARIAN CANCER", "target": "PTGS1"}, {"weight": 2.0, "description": "The TaqI gene variant rs731236 has been evaluated for its association with an increased risk of ovarian cancer, and while it shows no significant association in all populations, a slight increase is observed specifically in Caucasians.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OVARIAN CANCER", "target": "TAQI GENE (RS731236)"}, {"weight": 3.0, "description": "The GG genotype serves as a reference group in studies evaluating the association between other genotypes like AA or GA and ovarian cancer risk, showing no significant increase over this baseline.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OVARIAN CANCER", "target": "GG GENOTYPE (CDX-2)"}, {"weight": 2.0, "description": "This genomic variant is suggested to have an association with the risk of developing ovarian cancer.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "IL1B RS7596684", "target": "OVARIAN CANCER RISK"}, {"weight": 2.0, "description": "This genomic variant is suggested to be associated with the risk of developing ovarian cancer.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "PTGS1 RS2282169", "target": "OVARIAN CANCER RISK"}, {"weight": 0.0, "description": "No consistent associations were observed between variants of ALOX15 gene and the risk of developing ovarian cancer.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "OVARIAN CANCER RISK", "target": "ALOX15"}, {"weight": 1.0, "description": "Variants in the CCL2 gene showed no significant association with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "OVARIAN CANCER RISK", "target": "CCL2"}, {"weight": 0.0, "description": "Results for the IL18 gene did not show significant associations with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "OVARIAN CANCER RISK", "target": "IL18"}, {"weight": 1.0, "description": "No strong association was observed between variants in IL6 gene and ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "OVARIAN CANCER RISK", "target": "IL6"}, {"weight": 2.0, "description": "No significant association was found between the ApaI variant and ovarian cancer risk as determined by fixed-effect model analysis.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER RISK", "target": "APAI (RS7975232)"}, {"weight": 4.0, "description": "The BsmI variant does not show a significant association with increased ovarian cancer risk according to the fixed-effect model, although heterogeneity exists across studies due to deviation from Hardy-Weinberg equilibrium in some cases.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER RISK", "target": "BSMI (RS1544410)"}, {"weight": 4.0, "description": "The FokI variant has a significant association with an increased risk of ovarian cancer, particularly in TT and CT carriers compared to CC carriers.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER RISK", "target": "FOKI (RS2228570 OR RS10735810)"}, {"weight": 2.0, "description": "There was no significant heterogeneity in the association between these genes and histological subtypes of ovarian cancer.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "HISTOLOGICAL SUBTYPE OF OVARIAN CANCER", "target": "IL1B, PTGS1"}, {"weight": 4.0, "description": "There is less evidence for an association between SLC19A1 SNP and childhood ALL risk compared to NOS3 rs3918186.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "SLC19A1 RS1051266", "target": "CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)"}, {"weight": 10.0, "description": "The NOS3 gene is part of the folate metabolic pathway, and genetic variations within this gene are associated with childhood ALL risk.<SEP>The NOS3 gene, as part of the folate metabolic pathway, is associated with increased risk for childhood ALL through SNP rs3918186.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "NOS3 GENE", "target": "FOLATE METABOLIC PATHWAY"}, {"weight": 5.0, "description": "Genetic variations in the NOS3 gene significantly increase the risk of developing childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "NOS3 GENE", "target": "CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)"}, {"weight": 4.0, "description": "The SLC19A1 gene, part of the folate metabolic pathway, shows less evidence in data for association with childhood ALL risk compared to NOS3 rs3918186.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "SLC19A1 GENE", "target": "FOLATE METABOLIC PATHWAY"}, {"weight": 4.0, "description": "While associated with increased risk, evidence for SLC19A1 in contributing to childhood ALL is less compelling compared to NOS3.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "SLC19A1 GENE", "target": "CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)"}, {"weight": 4.0, "description": "The MTHFD2 gene is part of the folate metabolic pathway and has SNPs associated with childhood ALL risk in initial screening.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "FOLATE METABOLIC PATHWAY", "target": "MTHFD2 GENE"}, {"weight": 3.0, "description": "Like MTHFD2, BHMT2 is a gene within the folate metabolic pathway showing SNP associations but not proceeding to final analysis due to lower posterior probability.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "FOLATE METABOLIC PATHWAY", "target": "BHMT2 GENE"}, {"weight": 4.0, "description": "The posterior probability measure helps determine which SNPs from the folate metabolic pathway genes should proceed for further analysis based on initial screening data.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "FOLATE METABOLIC PATHWAY", "target": "POSTERIOR PROBABILITY OF INCLUSION"}, {"weight": 5.0, "description": "The Bayes factor of 7.38 for NOS3 rs3918186 indicates strong evidence that this SNP is associated with childhood ALL risk.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "NOS3 RS3918186 RISK FACTOR", "target": "BAYES FACTORS"}, {"weight": 4.0, "description": "The Bayes factor of SLC19A1 rs1051266 indicates less evidence compared to NOS3 rs3918186, showing a weaker association with childhood ALL risk.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "SLC19A1 RS1051266 RISK FACTOR", "target": "BAYES FACTORS"}, {"weight": 7.0, "description": "Dietary patterns significantly influenced long chain n-3 fatty acid concentrations in serum after dietary interventions.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "HEALTHY EATING DIET GROUP AND MEDITERRANEAN DIET GROUP DIETARY PATTERNS", "target": "LONG CHAIN N-3 FATTY ACIDS INTAKE AND CONCENTRATION"}, {"weight": 7.0, "description": "Fatty acid intake was a significant predictor of baseline serum long chain n-3 fatty acid concentration.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "LONG CHAIN N-3 FATTY ACIDS INTAKE AND CONCENTRATION", "target": "LINEAR REGRESSION ANALYSIS FOR FATTY ACID INTAKE AND BASELINE SERUM AA CONCENTRATION"}, {"weight": 6.0, "description": "The baseline measurement of arachidonic acid concentration is critical for understanding its influence on health outcomes.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "ARACHIDONIC ACID (AA)", "target": "BASELINE SERUM AA CONCENTRATION MEASUREMENT"}, {"weight": 5.0, "description": "Significant BMI difference correlates with the presence of minor alleles in genotypes.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "GENOTYPE DISTRIBUTION OF SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)", "target": "BMI DIFFERENCE BETWEEN MINOR ALLELE CARRIERS AND NON-CARRIERS"}, {"weight": 6.0, "description": "Baseline arachidonic acid levels serve as an important marker for metabolic pathways.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "BASELINE AA CONCENTRATION MEASUREMENT IN SERUM AND COLON", "target": "FATTY ACID METABOLISM PATHWAY"}, {"weight": 7.0, "description": "Predictive analysis aligns with observed dietary intervention outcomes for long chain omega-3 intake.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "DIETARY INTAKE OF LONG CHAIN N-3 FATTY ACIDS AND BASELINE CONCENTRATION PREDICTION", "target": "LONG CHAIN N-3 PUFA DIETARY INTAKE INCREASE IN HEALTHY EATING GROUP"}, {"weight": 4.0, "description": "Age retained as covariate for more accurate fatty acid concentration analysis based on genotype.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "AGE AS A COVARIATE IN GENOTYPE ANALYSIS", "target": "SERUM AND COLON FATTY ACID CONCENTR\u00c7\u00d5ES BY GENOTYPE GROUP"}, {"weight": 4.0, "description": "The Mediterranean group had a slight increase in the polyunsaturated fat:saturated fat ratio, but this change was not statistically significant.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "POLYUNSATURATED FAT: SATURATED FAT RATIO", "target": "MEDITERRANEAN DIET"}, {"weight": 5.0, "description": "For individuals without minor alleles in FADS1/2 gene cluster, colon AA concentrations increased significantly under the Healthy Eating diet compared to the Mediterranean diet.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "COLON AA CONCENTRATIONS", "target": "HEALTHY EATING DIET"}, {"weight": 7.0, "description": "The Mediterranean diet significantly increased MUFA levels, indicating its impact on fatty acid metabolism.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "MEDITERRANEAN DIET", "target": "MUFA"}, {"weight": 6.0, "description": "Both long-chain n-3 PUFA and MUFA significantly increased in the Mediterranean arm only, showing a dietary pattern\'s effect on omega-3 polyunsaturated fatty acids.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "MEDITERRANEAN DIET", "target": "N-3 PUFA"}, {"weight": 7.0, "description": "The Mediterranean dietary pattern significantly decreased serum levels of 18:2 n-6.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "MEDITERRANEAN DIET", "target": "SERUM 18:2 N-6"}, {"weight": 12.0, "description": "An increase in pulse rate is observed to be causally influenced by snoring according to the generalized summary-data-based MR (GSMR) analysis.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "SNORING", "target": "PULSE RATE"}, {"weight": 4.0, "description": "Individuals suffering from sleep apnea commonly experience excessive daytime sleepiness as a result of poor quality nighttime sleep.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "SLEEP APNOEA", "target": "EXCESSIVE DAYTIME SLEEPINESS"}, {"weight": 7.0, "description": "These variants were identified through GWAS as having a significant impact on the genetic predisposition to snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "GWAS (GENOME-WIDE ASSOCIATION STUDY)", "target": "GENOMIC VARIANTS "}, {"weight": 8.0, "description": "The heritability measure captures variance explained by genomic risk loci associated with snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "GENOMIC VARIANTS ", "target": "SNP HERITABILITY (H2SNP)"}, {"weight": 4.0, "description": "Specific genomic variants within these top risk loci are significant in influencing the genetic predisposition to snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "GENOMIC VARIANTS ", "target": "TOP 15 RISK LOCI "}, {"weight": 10.0, "description": "The negative genetic correlation indicates distinct underlying genetic factors between schizophrenia and the tendency to snore.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "GENETIC CORRELATIONS ", "target": "SCHIZOPHRENIA "}, {"weight": 5.0, "description": "Despite being a measure of oxygen saturation, average SpO2 does not show a significant genetic correlation with habitual snoring compared to minimum SpO2 and Perc90.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "GENETIC CORRELATIONS ", "target": "AVERAGE SPO2 "}, {"weight": 6.0, "description": "This measure is significantly genetically correlated with habitual snoring, especially after adjusting for BMI.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "GENETIC CORRELATIONS ", "target": "PERC90 (PERCENT OF SLEEP WITH OXYHEMOGLOBIN SATURATION UNDER 90%) "}, {"weight": 7.0, "description": "A disease that shows a moderate genetic correlation with habitual snoring, indicating overlapping risk factors.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "GENETIC CORRELATIONS ", "target": "CORONARY ARTERY DISEASE "}, {"weight": 10.0, "description": "A negative genetic correlation suggests that the genetic factors influencing fluid intelligence and habitual snoring are distinct.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "GENETIC CORRELATIONS ", "target": "FLUID INTELLIGENCE SCORE "}, {"weight": 9.0, "description": "These measures, particularly minimum and percent under 90% SpO2, correlate genetically with sleep apnea and thereby with habitual snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SELF-REPORTED SLEEP APNOEA ", "target": "OXYGEN HEMOGLOBIN SATURATION (SPO2)"}, {"weight": 8.0, "description": "After controlling for BMI in the GWAS analysis, heart attack is no longer genetically associated with snoring.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "HEART ATTACK ", "target": "BMI ADJUSTMENT ANALYSIS "}, {"weight": 9.0, "description": "Similar to heart attack, hypertension shows a loss of genetic correlation with habitual snoring upon adjustment for BMI.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "HYPERTENSION ", "target": "BMI ADJUSTMENT ANALYSIS "}, {"weight": 0.7, "description": "Both educational attainment and smoking show nominal associations with milk consumption, suggesting they could be confounding factors in the relationship between dietary patterns and health outcomes.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "EDUCATIONAL ATTAINMENT", "target": "SMOKING"}, {"weight": 5.0, "description": "These measures correlate genetically with snoring after adjustment for BMI, indicating a strong genetic influence on the relationship between nocturnal hypoxia and snoring.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "NOCTURNAL HYPOXIA MEASURES (MINIMUM SPO2, AVERAGE SPO2 AND PERC90)", "target": "GENETIC CORRELATION WITH SNORING"}, {"weight": 6.0, "description": "Both genes are identified in association studies for snoring, highlighting their potential role in the genetic architecture of this condition.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "DLEU7 GENE ON CHROMOSOME 13", "target": "MSRB3 GENE ON CHROMOSOME 12"}, {"weight": 7.0, "description": "These two genes share some associations with snoring and musculoskeletal traits, suggesting common underlying biological pathways or mechanisms.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "BCL11B GENE", "target": "ROBO2 GENE"}, {"weight": 9.0, "description": "These genes are both linked to musculoskeletal traits such as height and heel bone mineral density, suggesting interconnected pathways related to body morphology and snoring.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "SMG6 GENE", "target": "ANAPC4 GENE"}, {"weight": 10.0, "description": "Both genes have been associated with sleep disorders like insomnia and narcolepsy, indicating a shared role in the regulation of sleep patterns.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "LMO4 GENE", "target": "RNA5SP471 GENE"}, {"weight": 13.0, "description": "The risk of heart attack is strongly linked with coronary heart disease, which can result from atherosclerosis in the coronary arteries.)", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "order": 1, "source": "MAJOR CORONARY HEART DISEASE", "target": "HEART ATTACK"}, {"weight": 10.0, "description": "This genomic variant identified in females significantly influences the likelihood of recent snoring.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "RS200391180", "target": "RECENT SNORING"}, {"weight": 12.0, "description": "The polygenic score derived from GWAS results can predict recent snoring based on genetic risk factors.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "SEX-STRATIFIED GWAS ANALYSIS", "target": "PGS (POLYGENIC SCORE)"}, {"weight": 8.0, "description": "The top hits from GWAS analyses contribute significantly to the polygenic score which predicts recent snoring risk.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "PGS (POLYGENIC SCORE)", "target": "TOP HITS IN GWAS"}, {"weight": 14.0, "description": "Severe cases of recent snoring may indicate probable obstructive sleep apnea, a serious health condition requiring medical attention.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "RECENT SNORING", "target": "PROBABLE OSA"}, {"weight": 4.0, "description": "The severity of snoring increases with the frequency and intensity of recent snoring episodes.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "RECENT SNORING", "target": "SNORING SEVERITY"}, {"weight": 6.0, "description": "High genetic correlation between sexes indicates similar genetic predispositions towards snoring in both males and females.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "RECENT SNORING", "target": "CROSS-SEX GENETIC CORRELATION"}, {"weight": 5.0, "description": "There is a significant genetic relationship between habitual snoring and self-reported sleep apnea, indicating overlapping risk factors.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SLEEP APNOEA ", "target": "SNORING "}, {"weight": 6.0, "description": "Both lifestyle habits are positively correlated with the prevalence of snoring in their respective genders.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "ALCOHOL CONSUMPTION FREQUENCY ", "target": "SMOKING FREQUENCY "}, {"weight": 3.0, "description": "Pre-pregnancy BMI can influence maternal vitamin D status due to lifestyle factors including diet and exercise.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "VITAMIN D STATUS", "target": "BMI PRE-PREGNANCY (KG/M2)"}, {"weight": 3.0, "description": "Genomic variants in VDBP can influence neonatal vitamin D status at birth.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "VDBP POLYMORPHISMS", "target": "NEONATAL VITAMIN D STATUS"}, {"weight": 4.0, "description": "Pre-pregnancy BMI and UVB exposure both influence maternal vitamin D status during pregnancy.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "BMI PRE-PREGNANCY (KG/M2)", "target": "UVB EXPOSURE"}, {"weight": 5.0, "description": "Exposure to UVB light is a critical environmental factor affecting the production of vitamin D in pregnant women.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "UVB EXPOSURE", "target": "MATERNAL VITAMIN D STATUS"}, {"weight": 1.0, "description": "Maternal height may interact with the duration of gestation affecting prenatal care and neonatal outcomes.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "GESTATION PERIOD (WEEKS)", "target": "MATERNAL HEIGHT (CM)"}, {"weight": 3.0, "description": "The CC genotype at rs2298850 is associated with higher maternal 25(OH)D concentrations, indicating a positive impact on vitamin D status.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "CC GENOTYPE (RS2298850)", "target": "MATERNAL VITAMIN D STATUS"}, {"weight": 4.0, "description": "The CC genotype at rs4588 also shows association with elevated maternal 25(OH)D during delivery, impacting neonatal health.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "CC GENOTYPE (RS4588)", "target": "MATERNAL VITAMIN D STATUS"}, {"weight": 2.0, "description": "Maternal height may correlate with biochemical data taken at birth, impacting prenatal care and neonatal health outcomes.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "order": 1, "source": "BIRTH BIOCHEMICAL DATA", "target": "MATERNAL HEIGHT (CM)"}, {"weight": 1.0, "description": "The presence of rs3025020 genotype is positively correlated with higher serum VEGF levels, indicating its role in angiogenesis and possibly exacerbating PCOS-related metabolic disturbances.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS3025020 (-583T>C)", "target": "VEGF SERUM LEVELS"}, {"weight": 1.0, "description": "The presence of rs3025020 genotype is positively correlated with increased insulin resistance, suggesting its role in the pathogenesis of metabolic disturbances associated with PCOS.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS3025020 (-583T>C)", "target": "INSULIN RESISTANCE INDEX HOMA-IR"}, {"weight": 1.0, "description": "The minor allele carrier of rs3025020 SNP is associated with higher levels of hs-CRP, indicating a pro-inflammatory effect.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS3025020 (-583T>C)", "target": "HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP)"}, {"weight": 1.0, "description": "The presence of rs3025020 genotype is positively correlated with increased bioactive testosterone levels, contributing to hyperandrogenism in PCOS.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS3025020 (-583T>C)", "target": "BIOACTIVE TESTOSTERONE LEVELS"}, {"weight": 1.0, "description": "The presence of rs2010963 genotype is inversely correlated with serum VEGF levels, indicating a protective role against PCOS metabolic disturbances.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS2010963 (-634C>G)", "target": "VEGF SERUM LEVELS"}, {"weight": 1.0, "description": "The presence of rs2010963 genotype is inversely correlated with free testosterone levels, indicating a protective role against hyperandrogenism characteristic of PCOS.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS2010963 (-634C>G)", "target": "FREE TESTOSTERONE LEVELS"}, {"weight": 1.0, "description": "The minor allele carrier of rs2010963 SNP is associated with lower levels of ESR, indicating an anti-inflammatory effect.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS2010963 (-634C>G)", "target": "ERYTHROCYTE SEDIMENTATION RATE (ESR)"}, {"weight": 1.0, "description": "The presence of rs2010963 genotype is inversely correlated with bioactive testosterone levels, suggesting a protective effect against hyperandrogenism.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS2010963 (-634C>G)", "target": "BIOACTIVE TESTOSTERONE LEVELS"}, {"weight": 0.5, "description": "While total testosterone levels are comparable between women with PCOS and controls, the bioactive forms of these hormones show differences that correlate with disease pathology.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "TOTAL TESTOSTERONE LEVELS", "target": "PCOS"}, {"weight": 1.0, "description": "The ratio of LH to FSH is elevated in women with PCOS compared to control subjects, indicating a key hormonal imbalance characteristic of this condition.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "PCOS", "target": "LH/FSH RATIO"}, {"weight": 1.0, "description": "Significantly lower SHBG levels are observed in women with PCOS compared to controls, contributing to increased free androgens.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "PCOS", "target": "SHBG LEVELS"}, {"weight": 0.5, "description": "While TSH levels are higher but within normal range in women with PCOS compared to controls, this may reflect a subtle thyroid dysfunction or metabolic alteration.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "PCOS", "target": "TSH LEVELS"}, {"weight": 1.0, "description": "Increased hs-CRP levels are associated with pro-inflammatory processes in women carrying the minor allele of VEGFA SNP rs3025020, reflecting a higher inflammatory response.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "HS-CRP LEVELS", "target": "INFLAMMATION"}, {"weight": 3.0, "description": "Increased phosphorylation events are associated with enhanced inflammation in adipose tissues of SENP1-aP2KO mice.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "INFLAMMATION", "target": "PHOSPHORYLATION OF IKK, I\u039aB\u0391 AND NF-\u039aB P65/RELA"}, {"weight": 3.0, "description": "Phosphorylation of these proteins leads to NF-\u03baB activation contributing to the inflammatory response in adipose tissues.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "INFLAMMATION", "target": "IKK, I\u039aB\u0391 AND NF-\u039aB P65/RELA"}, {"weight": 1.0, "description": "Decreased ESR levels among carriers of the minor allele of VEGFA SNP rs2010963 suggest an anti-inflammatory effect, possibly protective against chronic inflammation in PCOS.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "ANTI-INFLAMMATORY EFFECT", "target": "ESR LEVELS"}, {"weight": 0.0, "description": "No correlation between IL-10 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this anti-inflammatory cytokine is not directly influenced by these genetic variants.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "IL-10 LEVELS", "target": "VEGFA SNPS"}, {"weight": 0.0, "description": "No correlation between IL-6 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "VEGFA SNPS", "target": "IL-6 LEVELS"}, {"weight": 0.0, "description": "No correlation between TNF\u03b1 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "VEGFA SNPS", "target": "TNF\u0391 LEVELS"}, {"weight": 8.0, "description": "Individuals carrying the val variant showed higher response bias compared to iso homozygotes, indicating a genetic influence on behavioral responses.<SEP>Individuals carrying the val variant showed higher response bias compared to iso homozygotes, indicating a relationship between this genotype and behavior.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "VAL CARRIER GENOTYPE", "target": "RESPONSE BIAS"}, {"weight": 3.0, "description": "Individuals with the iso homozygote genotype exhibited lower response bias as compared to val carriers, suggesting a genetic influence on behavioral responses.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "ISO HOMOZYGOTE GENOTYPE", "target": "RESPONSE BIAS"}, {"weight": 3.0, "description": "Individuals with the iso homozygote genotype selected lower levels of shock intensity than val carriers, indicating differential stress sensitivity.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "ISO HOMOZYGOTE GENOTYPE", "target": "SHOCK INTENSITY SELECTION"}, {"weight": 4.0, "description": "Individuals homozygous for the iso allele show less pronounced changes in response bias under stress conditions compared to val carriers, suggesting differential susceptibility to environmental stressors.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "ISO HOMOZYGOTES"}, {"weight": 6.0, "description": "The manipulation of stress condition significantly affects response bias, with reduced bias towards rewarded stimuli observed under stress compared to no-stress conditions.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "CONDITION (STRESS VS NO-STRESS)"}, {"weight": 4.0, "description": "Changes in skin conductance responses are associated with variations in response bias during stress conditions; elevated SCRs correlate with altered cognitive biases under stress, yet do not fully explain genotype effects on response bias.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "SKIN CONDUCTANCE RESPONSES (SCR)"}, {"weight": 2.0, "description": "The presence of CRHR1 SNPs does not significantly alter the effect of MR genotype on stress-induced response bias reductions but slightly modifies variance explanation.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "CRHR1 SNPS (RS12938031, RS10445364, RS4076452)"}, {"weight": 6.0, "description": "Differences in MR genotype, particularly the val allele compared to iso homozygotes, uniquely explain changes in response bias during stress conditions after controlling for other influencing factors like discriminability and SCR.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "MR GENOTYPE (COMT GENE VARIANTS)"}, {"weight": 0.5, "description": "There was a trend showing that STAI scores increased over time and condition differently across genotypes, suggesting genetic modulation of stress response.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "STAI SCORES", "target": "TIME \u00d7 CONDITION \u00d7 GENOTYPE INTERACTION"}, {"weight": 2.0, "description": "Although there were significant main effects for discriminability and block number, no differences emerged between genotype groups in any block regarding the impact of shock intensity on discriminability.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "DISCRIMINABILITY", "target": "SHOCK INTENSITY"}, {"weight": 2.0, "description": "Polymorphisms in the CRHR1 gene are linked to variations in reward learning deficits induced by stress, indicating a genetic basis for differential susceptibility to stress effects on cognitive processes.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "CRHR1 GENE", "target": "STRESS-INDUCED REWARD LEARNING DEFICITS"}, {"weight": 0.6, "description": "The PANAS negative affect scale showed an interaction effect with trends indicating differential changes in emotional distress over time for different genotypes.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "CONDITION \u00d7 TIME \u00d7 GENOTYPE TREND", "target": "PANAS NA"}, {"weight": 0.7, "description": "There was a trending effect suggesting that skin conductance responses varied over time differently based on genotype, hinting at genetic modulation of physiological arousal.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "SC RESPONSES", "target": "TIME \u00d7 GENOTYPE INTERACTION"}, {"weight": 3.0, "description": "The frequency of specific alleles in a population affects the prevalence and severity of genetic diseases like type 2 diabetes.", "source_id": "chunk-b803830d07bff8ae14550f6458048707", "order": 1, "source": "SNP", "target": "ALLELE FREQUENCY"}, {"weight": 4.0, "description": "None of the SNPs tested showed significant association with treatment response after multiple testing adjustments.)", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "SNP", "target": "TREATMENT RESPONSE"}, {"weight": 3.0, "description": "Variants in BMP4 play a role in the number of permanent teeth, though less pronounced than with \'age at first tooth\' trait.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "BMP4 GENE", "target": "NUMBER OF TEETH TRAIT"}, {"weight": 3.0, "description": "Variants in CACNB2 are found to be linked to variations in age at first tooth, suggesting a role in the timing of tooth development.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "CACNB2 GENE", "target": "DENTAL DEVELOPMENT"}, {"weight": 4.0, "description": "SNP rs4937076 near CDON gene is associated with phenotypes related to dental morphogenesis.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "CDON GENE", "target": "TOOTH MORPHOGENESIS"}, {"weight": 6.0, "description": "The SNP rs997154 near AJUBA gene is associated with phenotypic variation in dental development traits.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "AJUBA/C14ORF93 GENE", "target": "DENTAL PHENOTYPES"}, {"weight": 8.0, "description": "The SNP rs412000 near TEX14/RAD51C is associated with variation in the count of teeth at one year.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "TEX14/RAD51C GENE", "target": "TOOTH COUNT"}, {"weight": 3.0, "description": "The genomic variant FAM155E-EDA is involved in craniofacial development measures.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "FAM155E\u2013EDA", "target": "CRANIOFACIAL DEVELOPMENT"}, {"weight": 4.0, "description": "Bone Morphogenetic Protein 4 (BMP4) influences the timing of tooth eruption and number of primary teeth.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "BMP4", "target": "TOOTH ERUPTION"}, {"weight": 6.0, "description": "Insulin-like Growth Factor 2 mRNA Binding Protein 1 (IGF2BP1) influences tooth eruption timing.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "IGF2BP1", "target": "TOOTH ERUPTION"}, {"weight": 9.0, "description": "Methionine Sulfoxide Reductase B3 (MSRB3) contributes significantly to dental phenotype development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "MSRB3", "target": "DENTAL PHENOTYPE"}, {"weight": 7.0, "description": "Adenosine Kinase (ADK) variants are associated with measures of nose width in craniofacial studies.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "ADK", "target": "NOSE WIDTH"}, {"weight": 8.0, "description": "LIM Domain Containing 7 Protein (AJUBA) is involved in mid-brow height increase, possibly linked to height.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "AJUBA", "target": "HEIGHT AND CRANIOFACIAL PHENOTYPES"}, {"weight": 13.0, "description": "This genetic variant is associated with increased height in individuals, reflecting its impact on physical traits.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "HEIGHT", "target": "GENOMIC VARIANT (RS35866622)"}, {"weight": 4.0, "description": "The pathway analysis for \'age at first tooth\' highlights pathways that include genes like HMGA2 and BMP4 as being significant, indicating their importance in dental health.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "HMGA2 GENE", "target": "PATHWAY ANALYSIS RESULTS (AGE AT FIRST TOOTH)"}, {"weight": 4.0, "description": "Genetic variants in HMGA2 significantly influence when an individual develops their first tooth.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "HMGA2 GENE", "target": "AGE AT FIRST TOOTH TRAIT"}, {"weight": 3.0, "description": "The genetic variants associated with age at first tooth show a moderate association with height, suggesting an underlying biological link between these traits.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "GENOME-WIDE SIGNIFICANT SNPS FOR AGE AT FIRST TOOTH SCORE (PMETA = 0.0012)", "target": "HEIGHT TRAIT"}, {"weight": 3.0, "description": "The genetic variants associated with the number of teeth also show a moderate association with height, similarly suggesting an underlying biological link between these traits.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "GENOME-WIDE SIGNIFICANT SNPS FOR NUMBER OF TEETH SCORE (PMETA = 9.8 \u00d7 10\u22124)", "target": "HEIGHT TRAIT"}, {"weight": 5.0, "description": "The ALLIGATOR software is used to conduct pathway analysis for \'age at first tooth\', revealing significant biological pathways involved.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "PATHWAY ANALYSIS RESULTS (AGE AT FIRST TOOTH)", "target": "ALLIGATOR SOFTWARE"}, {"weight": 5.0, "description": "Variation in this region affects oral health parameters like age of first tooth and number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "CALU/OPN1SW GENE", "target": "ORAL HEALTH"}, {"weight": 11.0, "description": "The SNP rs1956529 in MSRB3 region is associated with phenotypic variation related to dental traits.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "DENTAL PHENOTYPES", "target": "MSRB3 GENE"}, {"weight": 7.0, "description": "SNP rs7924176 near ADK gene shows association with oral developmental traits such as tooth number.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "ADK GENE", "target": "ORAL DEVELOPMENT"}, {"weight": 9.0, "description": "Variation around DLEU7 gene is linked to phenotypes like age at first tooth and number of teeth.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "DENTAL TRAITS", "target": "DLEU7 GENE"}, {"weight": 10.0, "description": "Genetic variations near KCNJ2 are reported to impact dental development including the timing of first tooth appearance.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "KCNJ2 GENE", "target": "TOOTH DEVELOPMENT"}, {"weight": 12.0, "description": "Variations near IGF2BP1 gene influence oral developmental traits such as tooth number and age of eruption.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "IGF2BP1 GENE", "target": "ORAL DEVELOPMENT TRAITS"}, {"weight": 2.0, "description": "Variants around LINC01278 gene are linked to oral developmental traits such as the timing of first tooth eruption.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "ORAL DEVELOPMENT TRAITS", "target": "LINC01278 GENE"}, {"weight": 13.0, "description": "SNPs in EDA region are associated with phenotypic variations in dental morphology and development.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "DENTAL MORPHOGENESIS", "target": "EDA GENE"}, {"weight": 14.0, "description": "The SNP rs17101923 in HMGA2 region shows significant association with variability in the number of teeth at one year.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "HMGA2 REGION", "target": "TOOTH COUNT VARIABILITY"}, {"weight": 3.0, "description": "The GWAS investigates genetic variants associated with when an individual first develops teeth.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "AGE AT FIRST TOOTH TRAIT", "target": "GENOME-WIDE ASSOCIATION STUDY (GWAS)"}, {"weight": 2.0, "description": "The GWAS also explores genetic factors influencing the number of permanent teeth in adults, though less significant pathways were found compared to \'age at first tooth\'.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "GENOME-WIDE ASSOCIATION STUDY (GWAS)", "target": "NUMBER OF TEETH TRAIT"}, {"weight": 3.0, "description": "The T cell transfer model is used to evaluate how IL-10 signaling affects disease progression and severity in a T cell-dependent manner.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "T CELL TRANSFER-COLITIS MODEL", "target": "IL-10 SIGNALING"}, {"weight": 7.0, "description": "IL-10 signaling into macrophages is shown to be critical in mitigating the severity of colitis, indicating a protective role for these cells in disease progression.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10 SIGNALING", "target": "MACROPHAGES (M\u03a6)"}, {"weight": 8.0, "description": "Signaling through IL-10 receptor negatively regulates pro-IL-1\u03b2 production and maturation by macrophages, inhibiting inflammation.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-10 SIGNALING", "target": "IL-1\u0392 PRODUCTION"}, {"weight": 4.0, "description": "IL-10 signaling into macrophages plays an important role in reducing inflammation in the DSS colitis model, independent of T cells.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "DSS COLITIS MODEL", "target": "MACROPHAGES (M\u03a6)"}, {"weight": 5.0, "description": "Selective deletion of IL-10R\u03b1 specifically in T cells does not significantly influence disease development or severity in a T cell transfer-mediated colitis model.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10R\u0391TDEL MICE", "target": "DISEASE DEVELOPMENT"}, {"weight": 6.0, "description": "Deletion of the IL-10 receptor alpha specifically in macrophages intensifies disease severity, suggesting a protective role for IL-10 signaling within this cell type.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10R\u0391DCDEL AND IL-10R\u0391MDEL MICE", "target": "COLITIS SEVERITY"}, {"weight": 5.0, "description": "Increased activation and numbers of lamina propria macrophages correlate with exacerbated colitis in IL-10R\u03b1MdelRag1\u2212/\u2212 mice, highlighting their role in disease pathogenesis.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "COLITIS", "target": "LAMINA PROPRIA MACROPHAGES (LPM\u03a6S)"}, {"weight": 6.0, "description": "Absence of IL-6 receptor alpha in T cells results in a decreased ability to induce colitis, indicating its role in disease pathogenesis.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-6R\u0391\u2212/\u2212 T CELLS"}, {"weight": 6.0, "description": "Interleukin-6 signaling supports T cell expansion and contributes to severe clinical disease during colitis, especially in Rag1\u2212/\u2212 mice.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-6"}, {"weight": 10.0, "description": "Elevated expression of IL-1\u03b2 contributes to the pathogenesis of colitis in mice lacking functional IL-10R\u03b1MdelRag1, suggesting its role as a pro-inflammatory mediator.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-1\u0392"}, {"weight": 5.0, "description": "The absolute numbers of Foxp3+ CD4+ T cells are diminished in the absence of disease development in Rag1\u2212/\u2212 mice, indicating their role in maintaining immune tolerance during colitis.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "FOXP3+ CD4+ T CELLS"}, {"weight": 5.0, "description": "Absence of IL-1 receptor signaling reduces the severity of colitis in both IL-10R\u03b1MdelRag1\u2212/\u2212 and Rag1\u2212/\u2212 recipients, indicating a role for IL-1 in disease pathogenesis.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-1R\u2212/\u2212 T CELLS"}, {"weight": 4.0, "description": "Interleukin-1 signaling is essential for the development of colitis, particularly when other inflammatory mediators like IL-6 are not required due to genetic mutations such as those found in IL-10R\u03b1MdelRag1\u2212/\u2212 mice.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-1"}, {"weight": 1.0, "description": "The Il1b gene is involved in inflammatory responses that occur during DSS-induced colitis.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "COLITIS", "target": "IL1B GENE"}, {"weight": 1.0, "description": "Increased cleaved caspase 3 levels indicate higher apoptosis in mice lacking CARD9 during colitis.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "COLITIS", "target": "CASPASE 3"}, {"weight": 3.0, "description": "Abnormalities in the gut microbiota, particularly under conditions of CARD9 deficiency, contribute to the development or exacerbation of colitis symptoms.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "COLITIS", "target": "GUT MICROBIOTA"}, {"weight": 2.0, "description": "IL-10 plays a role in regulating inflammation but no differences were noted between CARD9 deficient and normal mouse models in this context.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "COLITIS", "target": "INTERLEUKIN-10 (IL-10)"}, {"weight": 4.0, "description": "The CX3CR1-driven Cre transgene leads to spontaneous colitis when used to delete IL-10R\u03b1 in a subset of immune cells.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "CX3CR1-DRIVEN CRE TRANSGENE", "target": "SPONTANEOUS COLITIS"}, {"weight": 5.0, "description": "Deletion of IL-10R\u03b1 using Lys-M-Cre transgene in neutrophils and macrophages shows a complex effect on colitis severity, indicating the need for further studies.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "LYS-M-CRE TRANSGENE", "target": "NEUTROPHIL ROLE"}, {"weight": 3.0, "description": "The IL-10 gene\'s product (IL-10) plays a protective role in reducing colitis severity through immune regulation.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10 GENE", "target": "COLITIS SEVERITY"}, {"weight": 6.0, "description": "Mice with floxed IL-10 receptor alpha gene are used in various models to understand the cell-specific effects of IL-10 signaling on colitis.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10R\u0391FL/FL MICE", "target": "DISEASE MODELS"}, {"weight": 3.0, "description": "Depletion studies indicate that neutrophil depletion does not significantly impact the disease state in IL-10R\u03b1MdelRag1\u2212/\u2212 mice, suggesting a minimal role for neutrophils in exacerbating the condition.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "NEUTROPHILS", "target": "IL-10R\u0391MDELRAG1\u2212/\u2212"}, {"weight": 4.0, "description": "Antibodies against Ly6G are used to selectively deplete neutrophils for experimental purposes in models like IL-10R\u03b1MdelRag1\u2212/\u2212, highlighting the importance of specific cell types in disease pathogenesis.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "NEUTROPHILS", "target": "LY6G"}, {"weight": 7.0, "description": "Rectal prolapse is a severe symptom observed in mice with high disease severity, indicating advanced stages of colitis.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "RECTAL PROLAPSE", "target": "DISEASE OUTCOME"}, {"weight": 4.0, "description": "The genetic modification affects the function and activation state of lamina propria macrophages, increasing their numbers and enhancing their activity levels.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212", "target": "LAMINA PROPRIA MACROPHAGES (LPM\u03a6S)"}, {"weight": 4.0, "description": "The IL-10R\u03b1Mdel mutation is studied in a Rag1-deficient background, which lacks mature T cells and B cells, to assess the impact of specific immune cell types on disease severity.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212", "target": "RAG1\u2212/\u2212"}, {"weight": 2.0, "description": "The role and function of dendritic cells in the disease exacerbation are explored but not significantly altered in IL-10R\u03b1MdelRag1\u2212/\u2212 mice, indicating their minimal impact on disease progression.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212", "target": "DENDRITIC CELLS (DCS)"}, {"weight": 4.0, "description": "The lack of IL-10 signaling into lamina propria macrophages leads to heightened activation and proliferation rates, contributing to increased disease severity in IL-10R\u03b1MdelRag1\u2212/\u2212 mice.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "LAMINA PROPRIA MACROPHAGES (LPM\u03a6S)", "target": "IL-10"}, {"weight": 3.0, "description": "The function of regulatory T cells is not overtly impacted by the absence of IL-10 signaling in macrophages, indicating alternative mechanisms for Treg suppressive activity are employed.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "IL-10", "target": "T REGULATORY CELLS (TREGS)"}, {"weight": 3.0, "description": "The production of IL-10 does not significantly affect Th17 cell numbers or functions in colitis models.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-10", "target": "TH17 CELLS"}, {"weight": 3.0, "description": "A subset of CD4+ T cells can differentiate into regulatory T cells upon activation, playing a critical role in maintaining tolerance and preventing autoimmunity. In the context of IL-10R\u03b1MdelRag1\u2212/\u2212 mice, this process remains intact.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "T REGULATORY CELLS (TREGS)", "target": "CD4 T CELLS"}, {"weight": 4.0, "description": "The upregulation of Foxp3 is critical for the differentiation and function of regulatory T cells, playing a key role in immune regulation. Its expression remains intact in IL-10R\u03b1MdelRag1\u2212/\u2212 mice.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "T REGULATORY CELLS (TREGS)", "target": "FOXP3"}, {"weight": 4.0, "description": "Regulatory T cells can be found in high numbers within mesenteric lymph nodes, which are crucial sites for regulating intestinal immunity and preventing excessive inflammation.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "T REGULATORY CELLS (TREGS)", "target": "MESENTERIC LYMPH NODES (MLNS)"}, {"weight": 5.0, "description": "The LYP-620W variant can block Treg proliferation similar to the LYP-620R variant, indicating differential impact on Tconv and Treg.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "T REGULATORY CELLS (TREGS)", "target": "LYP-620W"}, {"weight": 4.0, "description": "In Rag1 deficient cells (Rag1\u2212/\u2212), caspase-1 activity is suppressed by autocrine IL-10, which can be blocked with anti-IL-10R antibody.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "RAG1\u2212/\u2212", "target": "CASPASE-1"}, {"weight": 3.0, "description": "The genetic deletion of IL-10 receptor beta subunit and Rag2 results in impaired induction and function of induced regulatory T cells (iTregs), highlighting the importance of these components for proper immune regulation.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "order": 1, "source": "IL-10R\u0392\u2212/\u2212RAG2\u2212/\u2212", "target": "ITREG"}, {"weight": 2.0, "description": "T cell transfer experiments show that T cells do not significantly influence disease magnitude in IL-10R\u03b1MdelRag1\u2212/\u2212 mice, indicating the immune response is primarily driven by other mechanisms such as M\u03d5.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE", "target": "T CELLS"}, {"weight": 10.0, "description": "The Th17 cell response is increased and critical for the development of colitis in IL-10R\u03b1MdelRag1\u2212/\u2212 mice.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE", "target": "TH17 CELLS"}, {"weight": 9.0, "description": "Innate immune cells produce IL-27 which interacts with its receptor complex on T cells, leading to activation of the STAT1/STAT3 pathway.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "T CELLS", "target": "IL-27 SIGNALING"}, {"weight": 7.0, "description": "IL-27 produced by innate immune cells interacts with T cells via its receptor complex, initiating pathways that regulate immune responses.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "T CELLS", "target": "IL-27 CYTOKINE"}, {"weight": 6.0, "description": "Maintenance of T cell levels is influenced by the expression level of FOXP3, which is affected in patients with defective STAT5B function.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "T CELLS", "target": "FOXP3 EXPRESSION"}, {"weight": 4.0, "description": "An attenuated M\u03d5 IL-10 response leads to increased pro-inflammatory cytokine production and heightened disease severity.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "M\u03a6 IL-10 RESPONSE", "target": "PRO-INFLAMMATORY CYTOKINE PRODUCTION"}, {"weight": 5.0, "description": "LPM\u03d5s from IL-10R\u03b1Mdel mice produce elevated levels of Th17-promoting cytokines, contributing to increased colitis severity.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-10R\u0391MDEL LPM\u03a6S", "target": "TH17 CELLS"}, {"weight": 4.0, "description": "Interleukin-6 is essential for the development and maintenance of Th17 cell populations during inflammation.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "TH17 CELLS", "target": "IL-6"}, {"weight": 8.0, "description": "The transcription factor ROR\u03b3T is required for the differentiation of naive T cells into Th17 cells.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "TH17 CELLS", "target": "ROR\u0393T"}, {"weight": 8.0, "description": "The number of Th17 cells is significantly decreased in Rag1\u2212/\u2212 recipients compared to IL-10R\u03b1MdelRag1\u2212/\u2212, indicating a role for adaptive immunity in Th17 cell regulation.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "TH17 CELLS", "target": "RAG1\u2212/\u2212 MICE"}, {"weight": 3.0, "description": "The IL-1 response modulates Th17 cell populations at the site of inflammation, supporting their role in promoting colonic inflammation.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "TH17 CELLS", "target": "IL-1R"}, {"weight": 2.0, "description": "TH17 cells produce IL-17A, but in this context, there were no observed differences in IL-17 production between Card9\u2212/\u2212\u2192GF mice and WT controls.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "TH17 CELLS", "target": "INTERLEUKIN-17A (IL-17A)"}, {"weight": 6.0, "description": "Both IL-6 and TNF-\u03b1 are involved in the inflammatory response in colitis and their production is upregulated in IL-10R\u03b1Mdel mice.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-6", "target": "TNF-\u0391"}, {"weight": 2.0, "description": "Anti-TNF-\u03b1 drugs, like adalimumab, are used to treat HS by inhibiting TNF-\u03b1, a cytokine involved in inflammation.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "TNF-\u0391", "target": "HIDRADENITIS SUPPURATIVA (HS)"}, {"weight": 3.0, "description": "The condition of psoriasiform dermatitis can develop paradoxically after anti-TNF-\u03b1 therapy such as adalimumab treatment.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "TNF-\u0391", "target": "PSORIASIFORM DERMATITIS"}, {"weight": 4.0, "description": "The presence of MAPbacteremia is associated with higher expression levels of IFN-\u03b3 in CD patients.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "IFN-\u0393", "target": "MAPBACTEREMIA"}, {"weight": 5.0, "description": "The IFN-\u03b3 protein is encoded by the IFNG gene.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "IFN-\u0393", "target": "IFNG"}, {"weight": 7.0, "description": "Increased iNOS expression correlates with elevated IL-1\u03b2 production, indicating enhanced pro-inflammatory activity of M\u03d5s in IL-10R\u03b1Mdel mice.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-1\u0392", "target": "INOS"}, {"weight": 7.0, "description": "These CD4+ IL-17A+ T cells can be identified using ROR\u03b3T-GFP reporter T cells, highlighting the role of Th17 cells in colitis.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "CD4+IL-17A+ T CELLS", "target": "ROR\u0393T-GFP REPORTER T CELLS"}, {"weight": 8.0, "description": "Increased iNOS activity correlates with a decrease in Arginase expression indicating an enhanced pro-inflammatory phenotype for M\u03d5s.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "ARGINASE EXPRESSION", "target": "INOS EXPRESSION"}, {"weight": 2.0, "description": "T cells lacking IL-6 receptor alpha subunit exhibit reduced inflammation compared to WT controls in colitis models.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-6R\u0391\u2212/\u2212 T CELLS", "target": "COLONIC INFLAMMATION"}, {"weight": 4.0, "description": "Genetic modification affecting IL-10 signaling leads to increased pro-IL-1\u03b2 expression and maturation in macrophages, contributing to disease progression.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-10R\u0391MDEL", "target": "IL-1\u0392 PRODUCTION"}, {"weight": 7.0, "description": "Macrophages in the lamina propria are a primary source of IL-1\u03b2, contributing to inflammatory responses in colitis.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "COLONIC INFLAMMATION", "target": "LPM\u03a6S (LIN\u2212CD11B+ CD11C\u2212/LO F4/80HI LY6G\u2212 SIGLECF\u2212)"}, {"weight": 5.0, "description": "Cleavage of pro-IL-1\u03b2 by caspase-1 is essential for the production and release of active IL-1\u03b2 during inflammation.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-1\u0392 PRODUCTION", "target": "CASPASE-1 CLEAVAGE"}, {"weight": 6.0, "description": "Activation of inflammasomes triggers the caspase-1 pathway, leading to cleavage and activation of pro-IL-1\u03b2.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-1\u0392 PRODUCTION", "target": "INFLAMMASOME STIMULATION"}, {"weight": 5.0, "description": "Pro-IL-1\u03b2 requires cleavage and activation by caspase-1 to become mature IL-1\u03b2, a process inhibited by IL-10 signaling.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "PRO-IL-\u0392", "target": "CASPASE-1"}, {"weight": 4.0, "description": "Macrophages (M\u03d5s) can influence Th17 cell differentiation through the secretion of cytokines like IL-1 and IL-6, which are regulated by factors such as IL-10.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "M\u03a6S", "target": "TH17 CELL MATURATION"}, {"weight": 3.0, "description": "In cells with altered IL-1 receptor alpha chain (IL-1R\u03b1Mdel), caspase-1 activation is not properly regulated, leading to increased pro-inflammatory cytokine production.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "CASPASE-1", "target": "IL-1R\u0391MDEL"}, {"weight": 4.0, "description": "Stimulation with LPS and ATP activates caspase-1, leading to the cleavage and maturation of pro-inflammatory cytokines like IL-1\u03b2.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "CASPASE-1", "target": "LPS AND ATP"}, {"weight": 4.0, "description": "Liver-derived macrophages (LPM\u03d5s) can directly influence Th17 cell maturation through the secretion of IL-1 and IL-6, processes regulated by factors like IL-10.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "TH17 CELL MATURATION", "target": "LPM\u03a6S"}, {"weight": 5.0, "description": "Transforming growth factor beta (TGF\u03b2), when combined with other signals such as IL-6, promotes the differentiation of naive T cells into Th17 helper T cells.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "TH17 CELL MATURATION", "target": "TGF\u0392"}, {"weight": 3.0, "description": "The DNA extraction method significantly affects the observed variability in the 16S rRNA gene V4 region.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "16S RRNA GENE V4 REGION", "target": "DNA EXTRACTION METHOD"}, {"weight": 4.0, "description": "Estimations for heritability show significant evidence that the Bacteroides genus is influenced by genetic factors.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "BACTEROIDES GENUS", "target": "HERITABILITY ESTIMATION OF GUT MICROBIOME COMPOSITION"}, {"weight": 4.0, "description": "The DNA extraction method influences the variability observed in sequencing regions of 16S rRNA gene V4-V5.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "DNA EXTRACTION METHOD", "target": "16S RRNA GENE VARIABLE REGIONS V4-V5"}, {"weight": 5.0, "description": "These twin cohorts are used to replicate and validate intraclass correlation coefficients for heritability studies of gut microbiome composition.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "TWINSUK COHORT TWIN PAIRS", "target": "NETHERLANDS TWIN REGISTRY (NTR) COHORT TWIN PAIRS"}, {"weight": 3.0, "description": "Both cohorts represent different ethnic backgrounds contributing to genetic and environmental diversity.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "MIDDLE-EASTERN COHORT", "target": "EAST ASIAN COHORT"}, {"weight": 5.0, "description": "While no heritability was found for alpha diversity metrics, certain bacterial taxa were identified as heritable.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "HERITABILITY ESTIMATION OF GUT MICROBIOTA ALPHA DIVERSITY METRICS (SHANNON, SIMPSON, INVERSE SIMPSON)", "target": "HERITABILITY ESTIMATION OF 159 BACTERIAL TAXA"}, {"weight": 6.0, "description": "These two microbial groups were among the 159 bacterial taxa that showed evidence for heritability in genetic studies.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "HERITABILITY ESTIMATION OF 159 BACTERIAL TAXA", "target": "RUMINICLOSTRIDIUM GENUS AND PEPTOSTREPTOCOCCAEAE FAMILY"}, {"weight": 4.0, "description": "The COPSAC2010 cohort contributed significantly to heterogeneity seen in LCT gene associations with Bifidobacterium abundance.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "LCT GENE", "target": "COPSAC2010 COHORT"}, {"weight": 3.0, "description": "The LCT gene exhibits significant modification differences at CpG sites in enterocytes compared to other tissues, indicating regulatory roles of these genomic variants.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "LCT GENE", "target": "CPG SITES"}, {"weight": 2.0, "description": "Both genes are involved in the regulation of lactase expression, with MCM6 acting as a modulator for LCT activity through regulatory elements.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LCT GENE", "target": "MCM6 GENE"}, {"weight": 3.0, "description": "Functionally relevant variants, such as those in FUT2, are also found among loci influencing gut microbial composition.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "FUT2 GENE", "target": "GENOMIC VARIANT RS182549"}, {"weight": 7.0, "description": "Genetic variations in the FUT2 gene impact cobalamin metabolism and absorption, influencing gut microbiota composition.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "FUT2 GENE", "target": "COBALAMIN ABSORPTION"}, {"weight": 4.0, "description": "Consumption of milk products positively correlates with Bifidobacterium abundance in individuals with specific LCT genotypes.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "BIFIDOBACTERIUM", "target": "MILK PRODUCTS INTAKE"}, {"weight": 6.0, "description": "Increased presence of Bifidobacterium in gut microbiota correlates with reduced risk or impact of ulcerative colitis according to MR analyses.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "BIFIDOBACTERIUM", "target": "ULCERATIVE COLITIS"}, {"weight": 3.0, "description": "The effect of the genomic variant (rs182549) on Bifidobacterium abundance varies significantly across different ethnicities and age groups.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "GENOMIC VARIANT RS182549", "target": "AGE AND ETHNICITY HETEROGENEITY"}, {"weight": 3.0, "description": "These subcohorts demonstrated significant SNP-age interactions affecting Bifidobacterium abundance, highlighting the importance of age and ethnicity.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "AGE AND ETHNICITY HETEROGENEITY", "target": "GEM_V12 AND GEM_ICHIP SUBCOHORTS"}, {"weight": 3.0, "description": "This variant showed differential effects on Bifidobacterium abundance in different age groups within these subcohorts.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "GENOMIC VARIANT RS4988235", "target": "GEM_V12 AND GEM_ICHIP SUBCOHORTS"}, {"weight": 3.0, "description": "These diversity indices were used to evaluate heritability in the TwinsUK cohort but did not show significant genetic hits.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "SIMPSON, INVERSE SIMPSON, AND SHANNON DIVERSITY INDICES", "target": "TWINSUK COHORT"}, {"weight": 8.0, "description": "The FUT2-FUT1 locus influences Ruminococcus torques genus group abundance through genetic variation affecting mucus glycans levels.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "FUT2-FUT1 LOCUS", "target": "R. TORQUES GROUP"}, {"weight": 9.0, "description": "Intake of fruit correlates with reduced abundance of Ruminococcus torques group due to genetic variation at the FUT2 locus.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "R. TORQUES GROUP", "target": "FRUIT INTAKE"}, {"weight": 3.0, "description": "Both Allisonella and Peptostreptococcaceae abundances are affected by genetic variants related to vitamin B2 (riboflavin) and B12 metabolism.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "ALLISONELLA ABUNDANCE", "target": "PEPTOSTREPTOCOCCACEAE ABUNDANCE"}, {"weight": 4.0, "description": "Impaired cobalamin absorption, due to CUBN gene mutations, leads to increased risk of vitamin B12 deficiency anemia.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "order": 1, "source": "COBALAMIN ABSORPTION", "target": "B12-DEFICIENT ANEMIA"}, {"weight": 1.0, "description": "The presence of this SNP is negatively correlated with the abundance of Peptococcaceae, a family of bacteria linked to gut health conditions like ulcerative colitis.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "SNP RS7574352", "target": "PEPTOCOCCACEAE"}, {"weight": 2.0, "description": "High levels of chromogranin A are associated with increased risk of ulcerative colitis and negatively correlated with the presence of Peptococcaceae bacteria.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "CHROMOGRANIN A", "target": "ULCERATIVE COLITIS"}, {"weight": 2.0, "description": "Higher abundance of Actinobacteria suggests a potential protective effect on the occurrence or severity of ulcerative colitis, based on MR analysis results.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "ULCERATIVE COLITIS", "target": "ACTINOBACTERIA"}, {"weight": 4.0, "description": "The missense variant rs181206[G] influences the expression levels of IRF1 gene, which is associated with T1D susceptibility and colocalized variants.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "IRF1 GENE", "target": "MISSENSE SNP RS181206[G]"}, {"weight": 3.0, "description": "Polymorphisms in the LCT gene are associated with increased risk for Type 2 Diabetes Mellitus, particularly in individuals predisposed to lactose intolerance.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "LCT GENE (RS182549)", "target": "TYPE 2 DIABETES MELLITUS (T2DM)"}, {"weight": 4.0, "description": "The FUT1/FUT2 locus is positively associated with the dietary pattern of fish intake and negatively linked to certain diseases like cholelithiasis.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "FUT1/FUT2 LOCUS (RS35866622)", "target": "FISH INTAKE"}, {"weight": 9.0, "description": "This genetic variant is positively associated with dietary patterns such as fish intake, influencing various health outcomes.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "FISH INTAKE", "target": "GENOMIC VARIANT (RS35866622)"}, {"weight": 5.0, "description": "Intake of raw vegetables shows a nominal correlation with abundance of Bifidobacteria, but this relationship needs further validation due to multiple testing issues.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "BIFIDOBACTERIUM ABUNDANCE", "target": "RAW VEGETABLE INTAKE"}, {"weight": 4.0, "description": "The presence of the (CA)16 allele is significantly associated with increased risk for T2DM compared to other alleles, indicating a genetic predisposition.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "TYPE 2 DIABETES MELLITUS (T2DM)", "target": "(CA)16 ALLELE"}, {"weight": 6.0, "description": "The presence of this variant increases the risk for Type 2 Diabetes Mellitus in individuals with a paternal history of T2DM.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "GENOMIC VARIANT (RS182549)", "target": "TYPE 2 DIABETES MELLITUS FAMILY HISTORY (PATERNAL)"}, {"weight": 7.0, "description": "This genetic variant also increases the risk for Type 2 Diabetes Mellitus in individuals with a maternal history of T2DM.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "GENOMIC VARIANT (RS182549)", "target": "TYPE 2 DIABETES MELLITUS FAMILY HISTORY (MATERNAL)"}, {"weight": 8.0, "description": "The rs182549 variant increases the risk for siblings developing Type 2 Diabetes Mellitus based on familial genetic factors.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "GENOMIC VARIANT (RS182549)", "target": "SIBLINGS\' TYPE 2 DIABETES MELLITUS RISK"}, {"weight": 12.0, "description": "The rs35866622 variant near the FUT1/FUT2 locus positively influences high cholesterol levels and metabolic conditions.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "GENOMIC VARIANT (RS35866622)", "target": "HIGH CHOLESTEROL LEVELS"}, {"weight": 10.0, "description": "Genetic variations at this locus are linked to the consumption of oily fish and influence metabolic traits.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "FUT1/FUT2 LOCUS GENETIC VARIANTS", "target": "OILY FISH INTAKE"}, {"weight": 11.0, "description": "These genetic variants impact blood markers such as mean platelet volume, which is associated with immune functions.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "FUT1/FUT2 LOCUS GENETIC VARIANTS", "target": "MEAN PLATELET VOLUME"}, {"weight": 6.0, "description": "Higher abundance of Oxalobacteraceae family members has a negative correlation with rheumatoid arthritis, suggesting protective effects against the disease.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "OXALOBACTERACEAE", "target": "RHEUMATOID ARTHRITIS"}, {"weight": 8.0, "description": "The relationship between genetic factors, microbial taxa variability, and autoimmune diseases is being investigated to understand causality better.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "MICROBIAL TAXA VARIABILITY", "target": "AUTOIMMUNE DISEASES"}, {"weight": 10.0, "description": "Causal links between cardiovascular health and the composition of gut microbiota are being explored using MR analysis for a comprehensive understanding.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "MICROBIAL TAXA VARIABILITY", "target": "CARDIOVASCULAR DISEASES"}, {"weight": 12.0, "description": "MR analysis aims to uncover potential causal relationships between metabolic conditions and microbial taxa variability in the gut.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "MICROBIAL TAXA VARIABILITY", "target": "METABOLIC DISEASES"}, {"weight": 14.0, "description": "Investigations into how microbial taxa variability might influence psychiatric disorders are part of ongoing MR analysis studies.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "MICROBIAL TAXA VARIABILITY", "target": "PSYCHIATRIC DISORDERS"}, {"weight": 6.0, "description": "No evidence of causal relationships between dietary preferences and gut microbial taxa abundance was identified using strict criteria in MR analysis.)", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "DIETARY PREFERENCES", "target": "MR ANALYSIS (MENDELIAN RANDOMIZATION)"}, {"weight": 6.0, "description": "The genomic variant rs1893217, mapped to the PTPN2 gene, is associated with increased risk for autoimmune diseases such as celiac disease and type 1 diabetes.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "AUTOIMMUNE DISEASES", "target": "RS1893217"}, {"weight": 6.0, "description": "The rs4988235 T/T genotype is associated with a higher intake of milk, indicating genetic influence on dietary patterns.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235 T/T GENOTYPE", "target": "MILK INTAKE"}, {"weight": 4.0, "description": "Individuals carrying the LP (T) alleles exhibit increased plasma C15:0 levels due to higher dairy consumption.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "LP (T) ALLELES", "target": "PLASMA C15:0 LEVELS"}, {"weight": 3.0, "description": "Increased number of LP (T) alleles is associated with modestly lower HDL cholesterol, influencing diabetes risk factors.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "DIABETES RISK FACTORS", "target": "HDL CHOLESTEROL LEVELS"}, {"weight": 2.0, "description": "The intake of dairy products is positively correlated with potatoes but negatively correlated with fruits and vegetables.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "DAIRY PRODUCTS INTAKE", "target": "POTATOES INTAKE"}, {"weight": 5.0, "description": "After multivariable adjustment, wine consumption decreases as LP (T) allele count increases.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "WINE CONSUMPTION", "target": "MULTIVARIABLE ADJUSTMENT"}, {"weight": 4.0, "description": "Despite variations in baseline HbA1c levels and dietary patterns, there is no significant association with the risk of developing diabetes for individuals carrying the rs4988235 genotype.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RISK OF DEVELOPING DIABETES", "target": "BASELINE HBA1C LEVELS"}, {"weight": 6.0, "description": "The rs4988235 genotype shows deviation from Hardy-Weinberg equilibrium in several European populations, indicating population-specific genetic influences.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235 GENOTYPE", "target": "GENETIC DEVIATION FROM HWE"}, {"weight": 3.0, "description": "Individuals homozygous for the T/T allele exhibit variability in milk consumption across different countries, suggesting environmental influences on dietary patterns.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "HOMOZYGOUS LP (T/T)", "target": "MILK CONSUMPTION VARIABILITY"}, {"weight": 2.0, "description": "While there is an association with dairy product intake, the rs4988235 genotype also alters intakes of non-dairy foods such as potatoes and cereal products.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "DIETARY INTAKE OF DAIRY PRODUCTS", "target": "INTAKE OF NON-DAIRY FOODS"}, {"weight": 3.0, "description": "Similar to plasma C15:0 levels, variations in C17:0 are observed but do not reach statistical significance, linking them to the LP genotype and HDL cholesterol variability.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "PLASMA C17:0 LEVELS", "target": "HDL CHOLESTEROL VARIABILITY"}, {"weight": 6.0, "description": "Maternal dietary intake of choline during pregnancy may influence FASD outcomes in infants, although more research is needed to fully understand this relationship.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "CHOLINE", "target": "FASD"}, {"weight": 3.0, "description": "Heavy alcohol consumption during pregnancy can lead to poor somatic growth in infants.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "ALCOHOL CONSUMPTION", "target": "SOMATIC GROWTH"}, {"weight": 6.0, "description": "Individuals with the CT genotype exhibit a greater reward response when consuming alcoholic beverages compared to those without this genotype.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "ALCOHOL CONSUMPTION", "target": "CT GENOTYPE"}, {"weight": 4.0, "description": "Maternal smoking, along with heavy drinking, can exacerbate the risks and symptoms of FASD.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "SMOKING", "target": "FETAL ALCOHOL SPECTRUM DISORDERS (FASD)"}, {"weight": 5.0, "description": "The use of illicit drugs during pregnancy may influence neurodevelopmental processes such as eyeblink conditioning in infants.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "ILLICIT DRUGS (METHAMPHETAMINE)", "target": "EYEBLINK CONDITIONING (EBC)"}, {"weight": 7.0, "description": "Infants with FASD may show poorer performance in eyeblink conditioning compared to healthy infants.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "FETAL ALCOHOL SPECTRUM DISORDERS (FASD)", "target": "EYEBLINK CONDITIONING (EBC)"}, {"weight": 11.0, "description": "Age of assessment is crucial for detecting early signs of FASD in infants.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "FETAL ALCOHOL SPECTRUM DISORDERS (FASD)", "target": "INFANT AGE AT ASSESSMENT"}, {"weight": 9.0, "description": "Longer duration of choline supplementation correlates with improved neurodevelopmental outcomes in EBC tests.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "EYEBLINK CONDITIONING (EBC)", "target": "DURATION OF CHOLINE SUPPLEMENTATION"}, {"weight": 6.0, "description": "Proper somatic growth is contingent upon adequate gestational age and the absence of harmful environmental factors.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "GESTATIONAL AGE (GA)", "target": "SOMATIC GROWTH"}, {"weight": 6.0, "description": "Maternal smoking can negatively affect fetal somatic growth and development.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "SOMATIC GROWTH", "target": "CIGARETTES PER DAY"}, {"weight": 5.0, "description": "Proper caloric intake is necessary to support adequate choline status during pregnancy.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "CALORIC INTAKE", "target": "CHOLINE STATUS"}, {"weight": 7.0, "description": "Timing of initial assessments influences the feasibility and adherence to treatment protocols.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "GESTATIONAL AGE AT BOOKING, SCREENING, OR RANDOMIZATION", "target": "PROTOCOL ADHERENCE"}, {"weight": 8.0, "description": "The effectiveness of choline supplementation may vary based on gestational age at initiation.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "WEEKS GESTATION AT RANDOMIZATION", "target": "CHOLINE SUPPLEMENTATION EFFECTIVENESS"}, {"weight": 10.0, "description": "The sex of the infant can influence growth patterns observed during gestation and after birth.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "SEX OF INFANT", "target": "GESTATIONAL AGE AND SOMATIC GROWTH"}, {"weight": 12.0, "description": "Higher adherence to choline supplementation protocols correlates with better neurodevelopmental outcomes, including catch-up growth patterns.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "PROTOCOL ADHERENCE AND PERCENT CRS", "target": "CATCH-UP GROWTH"}, {"weight": 8.0, "description": "The rs12325817 variant of the PEMT gene affects choline synthesis capacity and may alter maternal dietary requirements for adequate nutrition during pregnancy.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "RS12325817", "target": "PEMT GENE EXPRESSION"}, {"weight": 8.0, "description": "Mothers carrying the rs12325817 variant of PEMT gene have reduced endogenous choline synthesis capacity, potentially impacting dietary choline requirements during pregnancy.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "RS12325817", "target": "CHOLINE INTAKE"}, {"weight": 4.0, "description": "The \u03c7\u00b2 test result and the p-value indicate no statistically significant differences between the choline-treated group and placebo group regarding FAS/PFAS diagnosis.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "P=0.393", "target": "\u03a7\u00b2(1)=0.73"}, {"weight": 10.0, "description": "Mothers\' dietary choline intake status is an environmental factor that can significantly impact infant health outcomes, especially in relation to FASD risk.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "CHOLINE INTAKE", "target": "MATERNAL DIETARY STATUS"}, {"weight": 6.0, "description": "The study\'s findings suggest that maternal dietary choline status does not significantly impact the diagnosis of FAS or PFAS in infants.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "FAS/PFAS DIAGNOSIS", "target": "MATERNAL DIETARY CHOLINE STATUS"}, {"weight": 5.0, "description": "The genomic variant at rs10886471 is located within the GRK5 gene, influencing its expression through intronic CA repeat sequences.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "RS10886471 SNP", "target": "GRK5 GENE"}, {"weight": 3.0, "description": "Genetic variations within GRK5, specifically the CA repeat polymorphisms, influence the risk of developing IFG and subsequently T2DM.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "GRK5 GENE", "target": "IMPAIRED FASTING GLUCOSE (IFG)"}, {"weight": 4.0, "description": "The (CA)17 allele is more prevalent in individuals without abnormal blood glucose levels compared to those with prediabetes or T2DM, suggesting a protective genetic factor.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "GRK5 GENE", "target": "(CA)17 ALLELE"}, {"weight": 8.0, "description": "The (CA)15, (CA)17, (CA)18, and (CA)19 alleles are classified together as a multiple allele in contrast to the reference (CA)16 allele.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "(CA)16 ALLELE", "target": "(CA)N ALLELES"}, {"weight": 6.0, "description": "Impaired fasting glucose is one of the physiological processes measured as part of T2D quantitative traits.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "IMPAIRED FASTING GLUCOSE (IFG)", "target": "T2D QUANTITATIVE TRAITS"}, {"weight": 4.0, "description": "Polymorphisms within GRK5\'s CA repeat sequences are linked with higher postprandial glucose levels in individuals moving from normal glucose tolerance to IGT and T2DM, suggesting a genetic component in impaired glucose metabolism.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "GRK5 (CA)N REPEATS", "target": "2H PG"}, {"weight": 6.0, "description": "The multiple alleles (excluding (CA)16) show a significant negative correlation with IFG, indicating a protective effect against this condition.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "(CA)N ALLELES", "target": "IFG"}, {"weight": 4.0, "description": "There is a significant negative association between the studied alleles and IGT, suggesting these variants reduce the risk of impaired glucose tolerance.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "(CA)N ALLELES", "target": "IGT"}, {"weight": 5.0, "description": "The NFG group serves as the control for comparing against groups with impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and Type 2 Diabetes Mellitus (T2DM).", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "NFG GROUP", "target": "IFG, IGT, T2DM GROUPS"}, {"weight": 4.0, "description": "The odds ratio is used to measure the association between specific alleles (such as (CA)n variants) and the risk of developing conditions like Type 2 Diabetes Mellitus.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "(CA)N ALLELES, T2DM", "target": "OR"}, {"weight": 2.0, "description": "A single SNP (rs8178974) in the GPX4 gene was found to be significantly associated with increased risk for colorectal cancer.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "GPX4 GENE", "target": "RS8178974"}, {"weight": 1.0, "description": "Both selenium and calcium intakes were noted to differ between cases of colorectal cancer and controls, indicating possible nutritional influences on disease susceptibility.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "CALCIUM INTAKE", "target": "SELENIUM INTAKE"}, {"weight": 4.0, "description": "Both dietary fiber and calcium intakes were found to be lower in cases with colorectal cancer than in healthy controls.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "CALCIUM INTAKE", "target": "DIETARY FIBER INTAKE"}, {"weight": 8.0, "description": "Used when studies show low heterogeneity, indicating a common effect size across different populations.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "META-ANALYSIS RESULTS", "target": "FIXED-EFFECTS MODEL"}, {"weight": 5.0, "description": "The meta-analysis indicated a stronger inverse association between selenium levels and the risk of developing adenomas compared to cancers.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "SERUM SELENIUM CONCENTRATION", "target": "COLORECTAL ADENOMA"}, {"weight": 3.0, "description": "The CARD9 gene, along with NOD2 mutations, contributes to increased susceptibility to Crohn\u2019s disease by influencing immune responses and gut microbiota interactions.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "CARD9 GENE", "target": "NOD2 GENE"}, {"weight": 1.0, "description": "The transcriptome of WT mice during colitis shows increased expression of Reg3g gene, indicative of an immune response.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "WT MICE TRANSCRIPTOME", "target": "REG3G GENE"}, {"weight": 1.0, "description": "Expression of the Reg3b gene is regulated by IL-22 protein to induce REGIII-\u03b2 during colitis recovery.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "REG3B GENE", "target": "IL-22 PROTEIN"}, {"weight": 1.0, "description": "IL-22 protein influences the proportion and activity of NKp46+ cells during DSS-induced colitis.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "IL-22 PROTEIN", "target": "NKP46+ CELLS"}, {"weight": 4.0, "description": "Interleukin-22 interacts with AHR activation, promoting local IL-22 production in the gut to regulate inflammation.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "IL-22 PROTEIN", "target": "AHR (ARYL HYDROCARBON RECEPTOR)"}, {"weight": 1.0, "description": "The fungal and bacterial microbiotas are both altered but differently between WT and Card9\u2212/\u2212 mice during DSS-induced colitis, with increased instability in Card9\u2212/\u2212 mice.)", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "order": 1, "source": "FUNGAL MICROBIOTA", "target": "BACTERIAL MICROBIOTA"}, {"weight": 3.0, "description": "The gut microbiota influences tryptophan metabolism, producing AHR ligands like indole derivatives that activate AHR.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "GUT MICROBIOTA", "target": "TRYPTOPHAN METABOLISM"}, {"weight": 5.0, "description": "In mice lacking CARD9 (Card9\u2212/\u2212\u2192GF), there is a significant downregulation of IL-22, which affects the immune response and mucosal repair during colitis recovery.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "IL-22 GENE", "target": "CARD9\u2212/\u2212\u2192GF MICE"}, {"weight": 3.0, "description": "\u03b3\u03b4 T cells contribute to IL-22 production, which is involved in immune regulation and protection against intestinal inflammation.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "INTRAEPITHELIAL \u0393\u0394 T CELLS", "target": "IL-22 PRODUCTION"}, {"weight": 5.0, "description": "TH22 cells are a primary source of IL-22, which is crucial for mucosal healing. The study indicates that CARD9 deficiency leads to decreased IL-22 production by TH22 cells.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "TH22 CELLS", "target": "INTERLEUKIN-22 (IL-22)"}, {"weight": 3.0, "description": "While NK cells contribute to innate immune responses, no difference was observed in IL-22 production by NKp46+ ILCs between Card9\u2212/\u2212\u2192GF mice and WT controls.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "NATURAL KILLER (NK) CELLS", "target": "INTERLEUKIN-22 (IL-22)"}, {"weight": 4.0, "description": "Expression of REG proteins, encoded by Reg3g and Reg3b genes, is influenced by IL-22 signaling. Their reduced expression in Card9\u2212/\u2212\u2192GF mice suggests impaired IL-22 signaling.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "REG3G AND REG3B GENES", "target": "INTERLEUKIN-22 (IL-22)"}, {"weight": 3.0, "description": "IDO1 mediates tryptophan metabolism into kynurenine, which is involved in immune regulation and can influence AHR activation.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "TRYPTOPHAN METABOLISM", "target": "IDO1 GENE/PROTEIN"}, {"weight": 3.0, "description": "Impaired tryptophan metabolism leads to defective activation of the Aryl Hydrocarbon Receptor (AHR), contributing to increased susceptibility to colitis in both mouse models and human IBD.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "TRYPTOPHAN METABOLISM", "target": "AHR ACTIVATION"}, {"weight": 4.0, "description": "AHR interacts with indole derivatives like IAA to promote local IL-22 production, essential for gut health.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "AHR (ARYL HYDROCARBON RECEPTOR)", "target": "INDOLE DERIVATIVES (IAA)"}, {"weight": 3.0, "description": "Production of Kynurenine is regulated by the activity of IDO1, impacting immune responses and inflammation.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "KYNURENINE (KYN)", "target": "IDO1 GENE/PROTEIN"}, {"weight": 4.0, "description": "Supplementation with Lactobacillus strains rescues AHR activation in Card9\u2212/\u2212 mice, suggesting their importance for gut health.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "LACTOBACILLUS STRAINS", "target": "AHR ACTIVATION"}, {"weight": 4.0, "description": "Dendritic cells/macrophages produce IL-23 to stimulate the production of IL-22 by T cells and ILCs.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "INTESTINAL DENDRITIC CELLS/MACROPHAGES", "target": "IL-23 PROTEIN"}, {"weight": 4.0, "description": "Fecz activates the Aryl Hydrocarbon Receptor (AHR), which can reduce colitis severity by promoting IL-22 production.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "FECZ (6-FORMYLINDOLO(3,2-B)CARBAZOLE)", "target": "AHR ACTIVATION"}, {"weight": 2.0, "description": "Mutations in the ATG16L1 gene are linked with an increased risk of developing inflammatory bowel diseases, including Crohn\u2019s disease.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "INFLAMMATORY BOWEL DISEASE (IBD)", "target": "ATG16L1 GENE"}, {"weight": 3.0, "description": "Analysis of fecal samples from IBD patients revealed decreased AHR activation compared to healthy subjects, indicating impaired gut microbiota activity in producing AHR ligands.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "FECAL SAMPLES", "target": "AHR ACTIVATION"}, {"weight": 4.0, "description": "The risk allele within CARD9 is associated with reduced ability of fecal microbiota to activate AHR in vitro assays from patients with IBD.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "AHR ACTIVATION", "target": "CARD9 GENOMIC VARIANT"}, {"weight": 2.0, "description": "Increased IDO1 activity promotes the production of Kynurenine from tryptophan, indicating defective AHR activation in inflammatory bowel disease (IBD).", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "IDO1 ENZYME ACTIVITY", "target": "KYNURENINE LEVELS"}, {"weight": 2.0, "description": "Decreased SH2B3 expression leads to higher \u03b22M levels, which is causally related to hypertension.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "\u03922M", "target": "SH2B3 EXPRESSION"}, {"weight": 4.0, "description": "Reduced function of the SH2B3 protein leads to higher \u03b22M levels, contributing to hypertension risk.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "\u03922M", "target": "SH2B3 GENE"}, {"weight": 1.5, "description": "Angiotensin II administration in mice induces hypertensive responses and increases \u03b22M expression.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "ANGIOTENSIN II"}, {"weight": 1.0, "description": "The Sh2b3 knockout mouse model shows enhanced hypertensive responses and end-organ damage due to elevated \u03b22M expression.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "SH2B3\u2212/\u2212 MOUSE MODEL"}, {"weight": 1.5, "description": "The presence of albumin in urine is an indicator of kidney damage associated with hypertension.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "HYPERTENSION", "target": "ALBUMINURIA"}, {"weight": 1.8, "description": "A cis genetic variation affects the expression of SH2B3, influencing its function and \u03b22M levels.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "SH2B3 EXPRESSION", "target": "CIS GENETIC VARIATION WITHIN SH2B3"}, {"weight": 3.0, "description": "The clinical model improves the prediction of new-onset hypertension when combined with \u03b22M levels.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "CLINICAL MODEL", "target": "NEW-ONSET HYPERTENSION PREDICTION"}, {"weight": 7.0, "description": "RPTECs are critical for understanding how genomic variants influence kidney function through their regulatory chromatin state.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "KIDNEY FUNCTION", "target": "ADULT RENAL PROXIMAL TUBULAR EPITHELIAL CELLS (RPTECS)"}, {"weight": 1.0, "description": "Increased risk observed for infants with CT genotype in MTHFD1 SNP rs2236224 when compared to CC genotype with higher folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFD1 SNP RS2236224", "target": "FOLATE INTAKE"}, {"weight": 1.0, "description": "Increased risk observed for infants with CT genotype in MTHFD1 SNP rs2236225 when compared to CC genotype with higher folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFD1 SNP RS2236225", "target": "FOLATE INTAKE"}, {"weight": 4.0, "description": "Infants carrying the AG genotype in MTHFD1 SNP rs11627387 show a four-fold increase in risk of NTD when compared to those with GG genotype and high maternal folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFD1 SNP RS11627387 AG GENOTYPE", "target": "FOLATE INTAKE"}, {"weight": 0.5, "description": "Heterozygous mothers carrying MTHFR SNP rs1476413 show a decreased risk of NTD-affected pregnancies with low folate intake compared to common homozygous mothers.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "MTHFR SNP RS1476413"}, {"weight": 0.5, "description": "Heterozygous mothers carrying MTHFR SNP rs1801131 show a decreased risk of NTD-affected pregnancies with low folate intake compared to common homozygous mothers.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "MTHFR SNP RS1801131"}, {"weight": 0.69, "description": "Heterozygous mothers carrying MTHFR SNP rs1801133 show a decreased risk of NTD-affected pregnancies with low folate intake compared to common homozygous mothers.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "MTHFR SNP RS1801133"}, {"weight": 0.7, "description": "Maternal heterozygous genotype at SHMT1 SNP rs669340 leads to a reduced risk of NTD-affected pregnancies with low folate intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "SHMT1 SNP RS669340 CG"}, {"weight": 2.0, "description": "Infants carrying the SHMT1 SNP rs12939757 AG genotype show an increased risk of NTDs with low maternal folate intake compared to AA genotype with high intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "SHMT1 SNP RS12939757 AG"}, {"weight": 0.91, "description": "Mothers carrying the TYMS SNP rs502396 heterozygous genotype show a reduced risk of NTDs in low folate intake group compared to homozygous in high intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "TYMS SNP RS502396"}, {"weight": 0.7, "description": "Mothers carrying the TYMS SNP rs699517 heterozygous genotype show a reduced risk of NTDs in low folate intake group compared to homozygous in high intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "TYMS SNP RS699517"}, {"weight": 0.73, "description": "Infants carrying the AG genotype at TYMS SNP rs2847153 show a reduced risk of NTDs in low maternal folate intake compared to GG with high intake.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "TYMS SNP RS2847153 AG GENOTYPE"}, {"weight": 4.0, "description": "Infants carrying the MTHFR SNP rs1801131 TT genotype show a higher risk of NTDs with high maternal folate intake compared to CT or CC genotypes.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "MTHFR SNP RS1801131 TT GENOTYPE"}, {"weight": 3.0, "description": "Infants carrying the SHMT1 SNP rs4997765 AA genotype show a higher risk of NTDs with high maternal folate intake compared to GG genotype.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "SHMT1 SNP RS4997765 AA GENOTYPE"}, {"weight": 0.8, "description": "Infants carrying the TYMS SNP rs2847153 CG genotype show a reduced risk of NTDs with high maternal folate intake compared to GG genotype.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "TYMS SNP RS2847153 CG GENOTYPE"}, {"weight": 3.2, "description": "Infants carrying the MTHFD1 SNP rs6966057 AG genotype show a higher risk of NTDs with high maternal folate intake compared to GG genotype.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "MTHFD1 SNP RS6966057 AG GENOTYPE"}, {"weight": 2.9, "description": "Infants carrying the SHMT1 SNP rs3787486 AA genotype show a higher risk of NTDs with high maternal folate intake compared to GG genotype.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "FOLATE INTAKE", "target": "SHMT1 SNP RS3787486 AA GENOTYPE"}, {"weight": 4.0, "description": "Genomic variant rs10399931 is located within the CHI3LI gene and was studied for its association with T2D.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "RS10399931", "target": "CHI3LI GENE"}, {"weight": 8.0, "description": "The genomic variant rs10399931 shows a significant association with the serum C-peptide concentration after 2 hours, indicating its role in T2D quantitative traits.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "RS10399931", "target": "SERUM C-PEPTIDE CONCENTRATION"}, {"weight": 10.0, "description": "The CHI3LI gene is associated with several quantitative traits of Type 2 Diabetes (T2D), though the associations are not significant after adjustments for various factors.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "CHI3LI GENE", "target": "T2D QUANTITATIVE TRAITS"}, {"weight": 8.0, "description": "Tag single nucleotide polymorphisms (tag SNPs) associated with the CHI3LI gene were studied for their potential associations with Type 2 Diabetes (T2D).", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "CHI3LI GENE", "target": "TGSNPS OF CHI3LI"}, {"weight": 12.0, "description": "Two identified haplotype blocks within the CHI3LI gene did not show any association with Type 2 Diabetes (T2D).", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "CHI3LI GENE", "target": "HAPLOTYPE BLOCKS OF CHI3LI"}, {"weight": 8.0, "description": "Quantitative traits in T2D include physiological processes such as serum C-peptide concentration, which showed a borderline significant association with rs10399931.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "T2D QUANTITATIVE TRAITS", "target": "SERUM C-PEPTIDE CONCENTRATION"}, {"weight": 3.0, "description": "Baseline CD4 counts are a physiological process measure used in the study of HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "PHYSIOLOGICAL PROCESS", "target": "BASELINE CD4 COUNTS"}, {"weight": 4.6, "description": "The interaction between CFH genotype and HLS significantly increases the odds for AMD.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "CFH Y402H RISK ALLELE", "target": "HEALTHY LIFESTYLE SCORE (HLS)"}, {"weight": 2.5, "description": "The A69S risk allele in ARMS2 gene increases odds for AMD when combined with poor lifestyle scores.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "A69S RISK ALLELE (ARMS2)", "target": "AMD"}, {"weight": 1.75, "description": "Poor lifestyle score combined with ARMS2 genetic risk shows a sub-additive effect on AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "A69S RISK ALLELE (ARMS2)", "target": "HEALTHY LIFESTYLE SCORE (HLS)"}, {"weight": 3.0, "description": "A higher HLS score is associated with a lower likelihood of developing AMD, especially in women with stable diets.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "HEALTHY LIFESTYLE SCORE (HLS)", "target": "AMD"}, {"weight": 0.0, "description": "Intake of omega-3 fatty acids does not influence the interaction terms explaining HLS and AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "HEALTHY LIFESTYLE SCORE (HLS)", "target": "OMEGA-3 FATTY ACIDS INTAKE"}, {"weight": 1.2, "description": "Higher dietary intake levels of lutein and zeaxanthin can partially explain some associations between HLS and AMD risk in high genetic risk individuals.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "HEALTHY LIFESTYLE SCORE (HLS)", "target": "LUTEIN/ZEAXANTHIN INTAKE LEVELS"}, {"weight": 1.0, "description": "The interaction between healthy lifestyle score and ARMS2 genotype does not show strong deviations from additive or multiplicative effects on AMD risk.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "HEALTHY LIFESTYLE SCORE (HLS)", "target": "ARMS2 GENOTYPE"}, {"weight": 3.0, "description": "Variants in the ARMS2 gene are associated with an increased risk for age-related macular degeneration.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "AGE-RELATED MACULAR DEGENERATION (AMD)", "target": "ARMS2 GENOTYPE"}, {"weight": 4.0, "description": "Genetic variations in complement pathway genes are associated with the risk of age-related macular degeneration.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "AGE-RELATED MACULAR DEGENERATION (AMD)", "target": "COMPLEMENT PATHWAY GENES (CFB/C2, C3, AND CFI)"}, {"weight": 2.0, "description": "The Synergy Index assesses whether the interaction between genetic risk factors and healthy lifestyles has a more than additive effect on AMD risk.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "AGE-RELATED MACULAR DEGENERATION (AMD)", "target": "SYNERGY INDEX (SI)"}, {"weight": 3.0, "description": "The odds ratio measures the increased likelihood of developing age-related macular degeneration among individuals with specific genetic and lifestyle factors compared to those without these factors.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "AGE-RELATED MACULAR DEGENERATION (AMD)", "target": "ODDS RATIO (OR)"}, {"weight": 4.0, "description": "Variants in the complement pathway genes are associated with the risk of AMD through their role in immune response and inflammation.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "AGE-RELATED MACULAR DEGENERATION (AMD)", "target": "COMPLEMENT PATHWAY GENES (CFB/C2, C3, CFI)"}, {"weight": 4.0, "description": "Incorporating omega-3 fatty acids into a fat-restricted diet helps to lower triglyceride levels and manage hypertriglyceridemia in patients with LPL deficiency.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "OMEGA-3 FATTY ACIDS", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 6.0, "description": "Dietary intake of omega-3 fatty acids influences the activity of PPAR\u03b3, reducing inflammatory responses through molecular interactions.)", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f", "order": 1, "source": "OMEGA-3 FATTY ACIDS", "target": "PPAR\u0393 PROTEIN"}, {"weight": 1.34, "description": "Adjusting for low dietary intake of lutein and zeaxanthin attenuates the association between HLS and AMD risk in women with high genetic risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "LOW/LOW LZ (LUTEIN/ZEAXANTHIN)", "target": "AMD RISK IN HIGH GENETIC RISK WOMEN"}, {"weight": 1.8, "description": "The ARMS2 gene harbors an A69S allele that increases AMD risk when combined with poor lifestyle scores.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "ARMS2 GENE", "target": "A69S ALLELE"}, {"weight": 0.5, "description": "While C3 does not show a main effect, it\'s considered in the context of other genetic factors influencing AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "C3 (COMPLEMENT COMPONENT 3)", "target": "CFH AND ARMS2 GENES"}, {"weight": 0.8, "description": "CFI gene status does not interact significantly with Y402H variant in CFH to influence AMD risk as much as other factors like HLS.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "CFI GENE", "target": "Y402H VARIANT IN CFH GENE"}, {"weight": 5.0, "description": "rs2230199 is a specific genetic variant within the complement pathway gene C3 that may influence AMD risk.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "SNP C3 RS2230199", "target": "COMPLEMENT PATHWAY GENES (CFB/C2, C3, CFI)"}, {"weight": 6.0, "description": "rs10033900 is a specific genetic variant within the complement pathway gene CFI that may influence AMD risk.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "SNP CFI RS10033900", "target": "COMPLEMENT PATHWAY GENES (CFB/C2, C3, CFI)"}, {"weight": 1.0, "description": "The ACAD10 gene is located at SNP rs11066015, which was selected as a significant variant for coffee-related genetic risk scores.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "ACAD10 GENE", "target": "SNP RS11066015"}, {"weight": 1.0, "description": "The MYL2 gene is situated at SNP rs12229654, one of the genotyped SNPs selected for genetic risk score calculations.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "MYL2 GENE", "target": "SNP RS12229654"}, {"weight": 1.0, "description": "The CUX2 gene is located near SNP rs79105258, an imputed variant chosen due to its strong association with habitual coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "CUX2 GENE", "target": "SNP RS79105258"}, {"weight": 0.9, "description": "Imputed SNP rs11065828 was used for calculating genetic risk scores influencing the risk of prediabetes and type 2 diabetes.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "SNP RS11065828", "target": "GENETIC RISK SCORES"}, {"weight": 1.0, "description": "Consumption of \u22652 cups/day of black coffee was linked to a significantly lower risk of prediabetes, compared to non-consumers.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "PREDIABETES", "target": "BLACK COFFEE INTAKE"}, {"weight": 0.95, "description": "Consumption of sugared coffee was also linked to lower risks of prediabetes in the study participants.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "PREDIABETES", "target": "SUGARED COFFEE CONSUMPTION"}, {"weight": 0.95, "description": "The association between habitual coffee consumption and the risk of prediabetes/type 2 diabetes varies by genetic risk scores calculated from significant SNPs.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "COFFEE CONSUMPTION", "target": "GENETIC RISK SCORES"}, {"weight": 5.0, "description": "The HLA-DQB1 gene contributes to the formation of this specific haplotype.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DQB1 GENE", "target": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE"}, {"weight": 3.0, "description": "Evaluating sensitivity helps in understanding the effectiveness of HLA-DQB1 gene markers in predicting specific haplotype carrier statuses.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DQB1 GENE", "target": "SENSITIVITY"}, {"weight": 4.0, "description": "SENP1 regulates SUMOylation events on both NEMO and p65/RelA, influencing their activity.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1", "target": "SUMOYLATION OF IKK SUBUNIT NEMO AND NF-\u039aB P65/RELA"}, {"weight": 3.0, "description": "Reduced SENP1 protein expression correlates with declining insulin secretion in SENP1-deficient mice.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "SENP1 PROTEIN", "target": "INSULIN LEVELS"}, {"weight": 3.0, "description": "ITT shows that despite reduced insulin secretion, insulin responsiveness is preserved in SENP1-deficient mice.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "SENP1 PROTEIN", "target": "INSULIN TOLERANCE TEST (ITT)"}, {"weight": 3.0, "description": "Specific promoters are used to drive adipocyte-specific deletion of the SENP1 gene leading to reduced protein expression.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "SENP1 PROTEIN", "target": "ADIPONECTIN, PDGFR\u0391, AP2/FABP4 GENE PROMOTER"}, {"weight": 4.0, "description": "High glucose levels are an indicator of diabetes mellitus type 1 in SENP1-deficient mice.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "DIABETES MELLITUS, TYPE 1 (T1DM)", "target": "GLUCOSE LEVELS"}, {"weight": 2.0, "description": "GTT demonstrates impaired glucose tolerance in SENP1-deficient mice consistent with a type-1-like diabetic phenotype.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "DIABETES MELLITUS, TYPE 1 (T1DM)", "target": "GLUCOSE TOLERANCE TEST (GTT)"}, {"weight": 4.0, "description": "Mice with adipocyte-specific deletion of the SENP1 gene driven by PdgfR\u03b1-Cre exhibit a type-1-like diabetic phenotype.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "DIABETES MELLITUS, TYPE 1 (T1DM)", "target": "SENP1-PDGFR\u0391KO"}, {"weight": 4.0, "description": "Mice with adipocyte-specific deletion of the SENP1 gene driven by aP2/Fabp4-Cre exhibit a type-1-like diabetic phenotype.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "DIABETES MELLITUS, TYPE 1 (T1DM)", "target": "SENP1-AP2KO"}, {"weight": 4.0, "description": "Diminished SENP1 in iBAT correlates with increased glucose levels and development of diabetes.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "GLUCOSE LEVELS", "target": "INTERSCAPULAR BROWN ADIPOSE TISSUE (IBAT)"}, {"weight": 5.0, "description": "Mice with smooth muscle cells/pericytes or vascular endothelial cells-specific deletion of the SENP1 gene do not develop high glucose levels despite similar Cre-mediated expression.)", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "order": 1, "source": "INSULIN LEVELS", "target": "SENP1-SMKO AND SENP1-ECKO"}, {"weight": 4.0, "description": "Activated T-cells mediate destruction of \u03b2 cells and islets leading to a loss of insulin-producing capacity, characteristic of type 1 diabetes mellitus (T1DM).)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "T-CELL-MEDIATED DESTRUCTION", "target": "\u0392-CELLS AND ISLETS DESTRUCTION"}, {"weight": 3.0, "description": "High levels of these proinflammatory cytokines are expressed in PATs from SENP1-aP2KO mice even before the onset of diabetes, indicating their role in islet disruption and insulin resistance.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "IL-6, TNF-\u0391, IL-1\u0392"}, {"weight": 4.0, "description": "HFD stimulates adipogenesis in peri-inguinal adipose tissues (PATs) of SENP1-aP2KO mice, increasing cell numbers at the expense of cell size compared to control mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "ADIPOGENESIS"}, {"weight": 5.0, "description": "In the genetic context of SENP1-aP2KO mice, both Type 1 and Type 2 Diabetes Mellitus are augmented by high-fat dietary patterns leading to metabolic phenotypes.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "T1DM AND T2DM"}, {"weight": 4.0, "description": "An increase in cell numbers within adipose tissues (especially in PATs) is observed more prominently in the genetic model of SENP1-aP2KO compared to control conditions under HFD.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "CELL NUMBER INCREASE"}, {"weight": 4.0, "description": "In SENP1-aP2KO mice, hyperglycemia onset is accelerated (8 weeks under HFD vs. 12 weeks under chow), contributing to earlier development of diabetic phenotypes.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "HYPERGLYCEMIA ONSET"}, {"weight": 4.0, "description": "Significantly reduced insulin levels observed in both basal and glucose-stimulated conditions in SENP1-aP2KO mice, further exacerbated by HFD.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "BASAL AND GLUCOSE-STIMULATED INSULIN LEVELS"}, {"weight": 3.0, "description": "During the pre-diabetic phase preceding T1DM, autoantibodies such as IAA are directed against \u03b2 cells indicating an autoimmune response.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "AUTOANTIBODIES, INSULIN AUTOANTIBODY (IAA)", "target": "PRE-DIABETIC PHASE"}, {"weight": 1.0, "description": "Increased beta-hydroxybutyrate levels indicate impaired glucose metabolism and can be used to diagnose diabetes, reflecting a loss in the body\'s ability to absorb glucose properly.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "BETA-HYDROXYBUTYRATE LEVELS", "target": "GLUCOSE METABOLISM DYSFUNCTION"}, {"weight": 4.0, "description": "Activated CD8+ T cells infiltrate pancreatic islets destroying insulin-producing \u03b2-cells in individuals with Type 1 Diabetes Mellitus (T1DM).)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "CD8+ T CELLS", "target": "\u0392-CELLS DESTRUCTION"}, {"weight": 4.0, "description": "CD8+ T cells can recognize the SARS-CoV epitope presented by HLA-B*15:01, similar to how they recognize ALK neoepitopes.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "CD8+ T CELLS", "target": "SARS CORONAVIRUS-DERIVED EPITOPE (VQQESSFVM)"}, {"weight": 3.0, "description": "Helper T cells such as Th1 and Th17 promote inflammation and contribute to the autoimmune destruction of pancreatic islet \u03b2 cells in type 1 diabetes mellitus.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "CD4+ T CELLS", "target": "AUTOIMMUNE RESPONSE"}, {"weight": 3.0, "description": "The expression of PTPN22 in CD4+ T cells varies across different subsets and activation states, influencing immune function.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "CD4+ T CELLS", "target": "PTPN22 EXPRESSION"}, {"weight": 2.0, "description": "Differential DNA methylation patterns in CD4+ T cells influence the differential splicing and expression of genes like CTLA4.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "CD4+ T CELLS", "target": "DNA METHYLATION"}, {"weight": 2.0, "description": "Reduction in regulatory T cells leads to a loss of immune tolerance, exacerbating autoimmune responses and contributing to the destruction of pancreatic islet \u03b2-cells.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "REGULATORY T CELLS (TREGS)", "target": "IMMUNE TOLERANCE"}, {"weight": 9.0, "description": "The IL-2 signaling pathway is crucial for Treg differentiation and function, mediated by STAT5B\'s role in FOXP3 induction.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "REGULATORY T CELLS (TREGS)", "target": "IL-2 SIGNALING PATHWAY"}, {"weight": 1.0, "description": "Activated dendritic cells present antigens to T-cells initiating an immune response, leading to autoimmunity in Type 1 Diabetes Mellitus (T1DM).)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "ACTIVATED DENDRITIC CELLS", "target": "AUTOIMMUNE RESPONSE INITIATION"}, {"weight": 7.0, "description": "Autoantigen NRP-V7 positive CD8+ T cells target IGP1 protein in pancreatic lymph nodes and spleen, indicating an autoimmune response targeting this protein.)<SEP>These cells target IGP1 protein, indicating a direct role in the autoimmune response against pancreatic \u03b2-cells.)", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "NRP-V7 POSITIVE CD8+ T CELLS", "target": "IGP1 PROTEIN"}, {"weight": 3.0, "description": "The NOD mouse model exhibits late-onset spontaneous diabetes, which is used to study the development of T1DM.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "TYPE 1 DIABETES MELLITUS (T1DM)", "target": "NOD MOUSE MODEL"}, {"weight": 5.0, "description": "JSH-23 treatment in SENP1-aP2KO mice ameliorates diabetes phenotypes, suggesting a critical role of NF-\u03baB-dependent inflammation in T1DM.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "TYPE 1 DIABETES MELLITUS (T1DM)", "target": "NF-\u039aB ACTIVATION INHIBITOR JSH-23"}, {"weight": 5.0, "description": "Disruption of islet cells, including beta cell apoptosis and immune infiltration, characterizes the progression of type 1 diabetes.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "TYPE 1 DIABETES MELLITUS (T1DM)", "target": "ISLET CELLS (ISLETS OF LANGERHANS)"}, {"weight": 10.0, "description": "Elevation of these cytokines is associated with an increased risk of developing T1DM through their inflammatory roles.)<SEP>High levels of these cytokines are associated with the onset of T1DM through mechanisms involving immune cell expansion and inflammation.)", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "PROINFLAMMATORY CYTOKINES IL-6, TNF-\u0391 AND IL-1\u0392", "target": "T1DM"}, {"weight": 10.0, "description": "High levels of these cytokines produced by PATs contribute to local pancreatic inflammation and the development of diabetic phenotypes.)<SEP>PATs express high levels of proinflammatory cytokines that induce local pancreatic inflammatory responses contributing to the development of diabetic phenotypes.)", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "PROINFLAMMATORY CYTOKINES IL-6, TNF-\u0391 AND IL-1\u0392", "target": "PATS (PERI-PANCREATIC ADIPOSE TISSUES)"}, {"weight": 3.0, "description": "Infiltration and expression of high levels of proinflammatory cytokines by macrophages cause damage to pancreatic tissues at later stages.)", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "PANCREATIC MACROPHAGES", "target": "TISSUE DAMAGE"}, {"weight": 4.0, "description": "Upregulation of CCL5 in islets recruits immune cells into pancreas, damaging \u03b2-cells and progressing T1DM.)", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "IMMUNE CELL RECRUITMENT", "target": "CCL5 (RANTES)"}, {"weight": 4.0, "description": "Proinflammatory cytokines from adipocytes induce CCL5 expression in islets, leading to immune cell recruitment and \u03b2-cell damage.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "IL-6, TNF OR IL-1\u0392", "target": "CCL5 EXPRESSION"}, {"weight": 4.0, "description": "High levels of cytokines secreted from peri-pancreatic adipocytes lead to macrophage infiltration and subsequent damage to pancreatic islets.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "CYTOKINE SECRETION", "target": "MACROPHAGE INFILTRATION"}, {"weight": 4.0, "description": "Reduction of SENP1 leads to increased cytokine production by adipocytes, affecting local inflammation and immune regulation.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "CYTOKINE SECRETION", "target": "SENP1 KNOCKDOWN"}, {"weight": 4.0, "description": "Elevated CCL5 expression in pancreatic islets correlates with NF-\u03baB pathway activation, suggesting a link between inflammation and diabetes development.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "CCL5 EXPRESSION", "target": "NF-\u039aB PATHWAY"}, {"weight": 3.0, "description": "Activation of NF-\u03baB contributes to a reduced state of adipocyte differentiation with enhanced proinflammatory phenotype.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "NF-\u039aB DEPENDENT INFLAMMATION", "target": "ADIPOCYTE DIFFERENTIATION"}, {"weight": 2.0, "description": "FABP4-positive staining indicates enhanced NF-\u03baB activity specifically within adipocytes of SENP1-deficient mice.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "NF-\u039aB DEPENDENT INFLAMMATION", "target": "FABP4"}, {"weight": 3.0, "description": "Increased binding to these promoter regions by NF-\u03baB p65/RelA suggests enhanced inflammatory gene expression in SENP1-aP2KO adipocytes.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "NF-\u039aB DEPENDENT INFLAMMATION", "target": "IL-6, IL-1\u0392 AND TNF-\u0391 PROMOTERS"}, {"weight": 2.0, "description": "SUMOylation of PPAR\u03b3 does not contribute significantly to the reduced adipocyte differentiation observed in SENP1-deficient mice.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "PPAR\u0393 SUMOYLATION", "target": "ADIPOCYTE DIFFERENTIATION"}, {"weight": 4.0, "description": "I\u03baB\u03b1 inhibits NF-\u03baB p65/RelA activity by binding it and preventing nuclear translocation.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "I\u039aB\u0391", "target": "NF-\u039aB P65/RELA"}, {"weight": 2.0, "description": "The activation of NF-\u03baB p65/RelA leads to the expression of these pro-inflammatory cytokines.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NF-\u039aB P65/RELA", "target": "IL-6, TNF-\u0391, IL-1\u0392"}, {"weight": 4.0, "description": "These SUMO proteins are involved in the SUMOylation process on NEMO and RelA proteins, affecting their activity.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SUMOYLATION OF IKK SUBUNIT NEMO AND NF-\u039aB P65/RELA", "target": "SUMO1\u20133"}, {"weight": 3.0, "description": "SUMOylation of NEMO enhances NF-\u03baB signaling, leading to increased pro-inflammatory cytokine production.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NEMO SUMOYLATION", "target": "NF-\u039aB-DEPENDENT CYTOKINE EXPRESSION"}, {"weight": 3.0, "description": "In these mice, deletion of SENP1 results in increased NEMO SUMOylation in adipocytes.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NEMO SUMOYLATION", "target": "SENP1-AP2KO MICE"}, {"weight": 4.0, "description": "Knockout of the Senp1 gene enhances NF-\u03baB signaling and pro-inflammatory cytokine production.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NF-\u039aB-DEPENDENT CYTOKINE EXPRESSION", "target": "SENP1 GENE KNOCKOUT"}, {"weight": 3.0, "description": "Elevated pro-inflammatory cytokine levels are observed in SENP1-aP2KO mice, indicating an inflammation-related mechanism involving SENP1.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1-AP2KO MICE", "target": "PROINFLAMMATORY CYTOKINES"}, {"weight": 4.0, "description": "IFN-\u03b3 plays a role in inducing insulitis and leukocyte infiltration in the pancreatic islets of NOD mice, associated with T1DM progression.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1-AP2KO MICE", "target": "IFN-\u0393 (INTERFERON GAMMA)"}, {"weight": 4.0, "description": "HFD exacerbates the diabetic phenotype and adipocyte inflammation in SENP1-deficient mice, indicating a link between diet and disease progression.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1-AP2KO MICE", "target": "HIGH-FAT DIET (HFD)"}, {"weight": 3.0, "description": "SENP1 plays a crucial role in regulating inflammatory responses within pancreatic adipocytes.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "PANCREATIC ADIPOCYTES (PATS)", "target": "SENP1 REGULATION"}, {"weight": 3.0, "description": "SENP3 and SENP5 contribute to the removal of SUMO2/3 from target proteins.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP3 AND SENP5", "target": "SUMO2/3 DESUMOYLATION"}, {"weight": 4.0, "description": "Stress induction by Etoposide VP16 leads to enhanced NF-\u03baB activity in adipocytes.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "ETOPOSIDE VP16", "target": "NF-\u039aB ACTIVATION"}, {"weight": 3.0, "description": "The NOD mouse model is utilized to study the pathogenesis and progression of T1DM.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NOD MICE", "target": "T1DM DEVELOPMENT"}, {"weight": 3.0, "description": "The NF-\u03baB pathway is involved in mediating the effects of high-fat diet on adipocyte inflammation and diabetes progression.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "NF-\u039aB PATHWAY", "target": "HFD (HIGH-FAT DIET)"}, {"weight": 3.0, "description": "Under both normal chow and HFD conditions, HFD causes a reduction in the size of adipocytes within PATs from SENP1-aP2KO mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "CELL SIZE REDUCTION"}, {"weight": 5.0, "description": "High-fat diet significantly disrupts islet structures in the pancreas of SENP1-aP2KO mice, contributing to diabetes development and metabolic phenotypes.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "ISLET STRUCTURE DISRUPTION"}, {"weight": 5.0, "description": "Under high-fat diet conditions, insulin response is significantly induced to become more resistant in both control and SENP1-deficient mice, with a more severe phenotype observed in the latter.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "INSULIN RESPONSE"}, {"weight": 6.0, "description": "The loss of SENP1 gene function leads to liver insulin resistance under basal conditions, which is exacerbated under high-fat diet (HFD) conditions.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "LIVER INSULIN RESISTANCE", "target": "SENP1-KO"}, {"weight": 4.0, "description": "The increase in fat weight within adipose depots, including PATs of SENP1-aP2KO mice, is significantly influenced by HFD conditions.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "ADIPOSE DEPOT", "target": "FAT WEIGHT INCREASE"}, {"weight": 4.0, "description": "Upregulation of CCL5 in islets recruits immune cells into pancreas, causing damages to \u03b2-cells and contributing to T1DM progression.)", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "order": 1, "source": "CCL5 (RANTES)", "target": "IMMUNE CELLS"}, {"weight": 4.0, "description": "Meta-analysis combining results from various studies confirms a significant association between FokI variant and ovarian cancer risk.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "FOKI (RS2228570 OR RS10735810)", "target": "META-ANALYSIS"}, {"weight": 1.0, "description": "Using the fixed-effect model, no significant association was found between ApaI variant and ovarian cancer risk across multiple studies.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "APAI (RS7975232)", "target": "FIXED-EFFECT MODEL"}, {"weight": 3.0, "description": "The genotype distribution of controls in several subgroup studies for ApaI and BsmI variants deviated from Hardy-Weinberg equilibrium, affecting the validity of these genetic associations.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM (HWE)", "target": "OVARIAN CANCER RISK STUDIES"}, {"weight": 4.0, "description": "Departures from Hardy-Weinberg equilibrium for the Cdx-2 gene variant suggest potential biases or confounding factors in the study populations.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM (HWE)", "target": "CDX-2 GENE (RS11568820)"}, {"weight": 4.0, "description": "Departures from Hardy-Weinberg equilibrium for the TaqI gene variant also suggest potential biases or confounding factors in the study populations.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM (HWE)", "target": "TAQI GENE (RS731236)"}, {"weight": 3.0, "description": "The rs6265 polymorphism is found to be in Hardy-Weinberg equilibrium, indicating no significant deviation from expected allele frequencies.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM (HWE)", "target": "RS6265 POLYMORPHISM"}, {"weight": 3.0, "description": "The rs2049046 polymorphism also maintains Hardy-Weinberg equilibrium, confirming the genetic data\'s reliability.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM (HWE)", "target": "RS2049046 POLYMORPHISM"}, {"weight": 4.0, "description": "The meta-analysis of studies involving Cdx-2 gene variant rs11568820 provides a comprehensive estimate of its association with ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "META-ANALYSIS", "target": "CDX-2 GENE (RS11568820)"}, {"weight": 4.0, "description": "The meta-analysis of studies involving TaqI gene variant rs731236 provides a comprehensive estimate of its association with ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "META-ANALYSIS", "target": "TAQI GENE (RS731236)"}, {"weight": 9.0, "description": "The meta-analysis focuses on the association between CTLA4 polymorphisms and primary biliary cholangitis (PBC) susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "META-ANALYSIS", "target": "CTLA4 POLYMORPHISMS"}, {"weight": 5.0, "description": "Both models were used to analyze genetic associations with ovarian cancer risk but provided different insights depending on the genotype distribution.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "DOMINANT GENETIC MODEL", "target": "RECESSIVE GENETIC MODEL"}, {"weight": 4.0, "description": "This subgroup within the population studies showed a departure from Hardy-Weinberg equilibrium, indicating potential genetic or environmental factors affecting the Cdx-2 gene variant\'s impact on ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "CDX-2 GENE (RS11568820)", "target": "JAPANESE SUBGROUP (LURIE ET AL.)"}, {"weight": 4.0, "description": "This subgroup within the population studies showed a departure from Hardy-Weinberg equilibrium, indicating potential genetic or environmental factors affecting the Cdx-2 gene variant\'s impact on ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "CDX-2 GENE (RS11568820)", "target": "NECC SUBGROUP (TWOROGER ET AL.)"}, {"weight": 4.0, "description": "The Egger\u2019s test was used to detect potential publication bias in the meta-analysis evaluating the association between Cdx-2 gene variant rs11568820 and ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "CDX-2 GENE (RS11568820)", "target": "PUBLICATION BIAS TEST (EGGER\'S TEST)"}, {"weight": 4.0, "description": "This subgroup within the population studies showed a departure from Hardy-Weinberg equilibrium, indicating potential genetic or environmental factors affecting the TaqI gene variant\'s impact on ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "TAQI GENE (RS731236)", "target": "NORTHERN SWEDEN SUBGROUP (CLENDENEN ET AL.)"}, {"weight": 4.0, "description": "The Egger\u2019s test was used to detect potential publication bias in the meta-analysis evaluating the association between TaqI gene variant rs731236 and ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "TAQI GENE (RS731236)", "target": "PUBLICATION BIAS TEST (EGGER\'S TEST)"}, {"weight": 4.0, "description": "Sensitivity tests were conducted on the meta-analysis of Cdx-2 gene to assess its robustness against individual studies\' influence, confirming the overall findings are not significantly influenced by any single study.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "SENSITIVITY TEST", "target": "META-ANALYSIS (CDX-2 GENE)"}, {"weight": 4.0, "description": "Sensitivity tests were conducted on the meta-analysis of TaqI gene to assess its robustness against individual studies\' influence, confirming the overall findings are not significantly influenced by any single study.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "SENSITIVITY TEST", "target": "META-ANALYSIS (TAQI GENE)"}, {"weight": 1.0, "description": "The VDR gene contains these three genomic variants that were analyzed for their influence on susceptibility to T. cruzi infection and CCC development.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "VDR GENE", "target": "RS731236, RS7975232, RS1544410 GENOMIC VARIANTS"}, {"weight": 1.0, "description": "A specific SNP in the VDR gene (rs2228570) was associated with a reduced risk of developing CCC and a trend towards protective effect against T. cruzi infection.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "VDR GENE", "target": "RS2228570 GENOMIC VARIANT"}, {"weight": 1.0, "description": "The study investigates whether polymorphisms in the VDR gene are associated with susceptibility to T. cruzi infection.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "VDR GENE", "target": "INFECTION BY TRYPANOSOMA CRUZI (T. CRUZI)"}, {"weight": 1.0, "description": "This SNP is one of the genomic variants analyzed within the VDR gene for its influence on disease susceptibility.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "VDR GENE", "target": "RS731236 GENOMIC VARIANT"}, {"weight": 1.0, "description": "This SNP is one of the genomic variants analyzed within the VDR gene for its influence on disease susceptibility.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "VDR GENE", "target": "RS7975232 GENOMIC VARIANT"}, {"weight": 1.0, "description": "This SNP is one of the genomic variants analyzed within the VDR gene for its influence on disease susceptibility.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "VDR GENE", "target": "RS1544410 GENOMIC VARIANT"}, {"weight": 2.0, "description": "These three SNPs in the VDR gene were analyzed for their influence on susceptibility to T. cruzi infection but showed no significant association after multiple testing correction.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS731236, RS7975232, RS1544410 GENOMIC VARIANTS", "target": "INFECTION BY TRYPANOSOMA CRUZI (T. CRUZI)"}, {"weight": 3.0, "description": "The minor allele of rs2228570*A showed a trend towards protective effect against T. cruzi infection but did not reach significance after correction for multiple testing.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570 GENOMIC VARIANT", "target": "INFECTION BY TRYPANOSOMA CRUZI (T. CRUZI)"}, {"weight": 4.0, "description": "The minor allele of rs2228570*A was significantly associated with a reduced risk of developing CCC after correction for multiple testing.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570 GENOMIC VARIANT", "target": "CHRONIC CHAGAS CARDIOMYOPATHY (CCC)"}, {"weight": 1.0, "description": "The IL-1A -889C>T variant was studied for its association with the risk of developing HNP, but no significant associations were found.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "IL-1A -889C>T", "target": "HYPNOPOMPIC HALLUCINATIONS AND/OR NARCOLEPSY (HNP)"}, {"weight": 2.0, "description": "The IL-1A gene variant rs1800587 corresponds to the genomic variant IL-1A -889C>T.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "IL-1A -889C>T", "target": "IL-1A (RS1800587)"}, {"weight": 1.0, "description": "The TNF-A 238G>A variant was studied for its association with the risk of developing HNP, but no significant associations were found.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "TNF-A 238G>A", "target": "HYPNOPOMPIC HALLUCINATIONS AND/OR NARCOLEPSY (HNP)"}, {"weight": 2.0, "description": "The TNF-A gene variant rs361525 corresponds to the genomic variant TNF-A 238G>A.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "TNF-A 238G>A", "target": "TNF-A (RS361525)"}, {"weight": 1.0, "description": "The VDR TaqI variant was studied for its association with the risk of developing HNP, but no significant associations were found.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "VDR TAQI RS731236", "target": "HYPNOPOMPIC HALLUCINATIONS AND/OR NARCOLEPSY (HNP)"}, {"weight": 2.0, "description": "The VDR gene variant rs731236 corresponds to the genomic variant VDR TaqI rs731236.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "VDR TAQI RS731236", "target": "VDR (RS731236)"}, {"weight": 3.0, "description": "Serum B12 levels are influenced by genetic variants and dietary intake, impacting maternal health.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "B12", "target": "MATERNAL SERUM B12 LEVELS"}, {"weight": 4.0, "description": "Folate levels in pregnant women play a crucial role in fetal development.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "FOLATE", "target": "MATERNAL FOLATE LEVELS"}, {"weight": 10.0, "description": "Higher tHcy concentrations are associated with lower folate levels, indicating a role for folate in the metabolism of homocysteine.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "FOLATE", "target": "THCY (TOTAL HOMOCYSTEINE)"}, {"weight": 4.0, "description": "Men with lower serum folate concentrations are more likely to be infertile, as indicated by the logistic regression analysis.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "FOLATE", "target": "INFERTILE MEN"}, {"weight": 2.0, "description": "The CDC HPLC-MS/MS method provides highly accurate measurements for the assessment of serum folate concentrations.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "FOLATE", "target": "CDC HPLC-MS/MS METHOD"}, {"weight": 5.0, "description": "Genetic variants explain variance in maternal serum B12 concentrations.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "MATERNAL SERUM B12 LEVELS", "target": "GWAS VARIANTS FOR B12 LEVELS"}, {"weight": 3.0, "description": "Variation in FUT2 is associated with changes in maternal serum B12 concentrations.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "MATERNAL SERUM B12 LEVELS", "target": "FUT2 GENE (RS602662)"}, {"weight": 6.0, "description": "These genetic variants contribute to the variation of folate levels in pregnant women.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "MATERNAL FOLATE LEVELS", "target": "GWAS VARIANTS FOR FOLATE LEVELS"}, {"weight": 4.0, "description": "The MTHFR gene variant significantly influences the relationship between maternal folate levels and birthweight.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "MATERNAL FOLATE LEVELS", "target": "MTHFR GENE (RS1801133)"}, {"weight": 2.0, "description": "The MMACHC variant has a lesser impact on birthweight compared to other genetic factors.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTHWEIGHT", "target": "MMACHC GENE (RS12272669)"}, {"weight": -1.0, "description": "No significant causal relationship was identified between fetal B12 levels and gestational duration.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "FETAL B12 LEVELS", "target": "GESTATIONAL DURATION"}, {"weight": -1.0, "description": "No evidence was found for a causal effect of maternal B12 levels on offspring birthweight.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "MATERNAL B12 LEVELS", "target": "OFFSPRING BIRTHWEIGHT"}, {"weight": -1.0, "description": "The Danish cohorts were used to study the impact of maternal and fetal nutrient levels (B12 and folate) on gestational duration without significant findings.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "GESTATIONAL DURATION", "target": "DANISH COHORTS"}, {"weight": 4.0, "description": "An IVW analysis detected a small but significant effect of folate levels on B12 levels within the Danish cohorts, indicating a molecular interaction between these nutrients.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "IVW ANALYSIS (INVERSE VARIANCE WEIGHTED)", "target": "FOLATE LEVELS"}, {"weight": 4.0, "description": "The MTHFR C677T variant is significantly associated with an increased risk of Leiomyoma Venosa, especially in Asian populations.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "MTHFR C677T", "target": "LEIOMYOMA VENOSA (LV)"}, {"weight": 12.0, "description": "The MTHFR A1298C variant is less commonly tested but still relevant in the context of Leiomyoma Venosa, affecting folate metabolism and potentially contributing to cardiovascular risk.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "MTHFR A1298C", "target": "LEIOMYOMA VENOSA (LV)"}, {"weight": 2.0, "description": "The PAI\u20101 \u2010675 4G/5G variant is directly linked to increased thrombotic tendencies and cardiovascular disease risk.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PAI-1 -675 4G/5G", "target": "THROMBOSIS RISK"}, {"weight": 6.0, "description": "The PAI-1 -675 4G/5G variant is highly prevalent among patients with Leiomyoma Venosa, particularly in European and Asian populations.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "PAI-1 -675 4G/5G", "target": "LEIOMYOMA VENOSA (LV)"}, {"weight": 3.0, "description": "This genetic variant within PAI-1 affects platelet function and can lead to abnormal clot formation patterns.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PAI-1 A844G", "target": "PLATELET AGGREGATION"}, {"weight": 2.0, "description": "The PAI-1 A844G variant may contribute to the risk of Leiomyoma Venosa, though less studied compared to other variants.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "PAI-1 A844G", "target": "LEIOMYOMA VENOSA (LV)"}, {"weight": 4.0, "description": "This prothrombin variant increases the risk of thrombotic events due to elevated levels of prothrombin in circulation.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PROTHROMBIN G20210A", "target": "THROMBOSIS RISK"}, {"weight": 8.0, "description": "The Prothrombin G20210A variant is associated with Leiomyoma Venosa, contributing to hypercoagulability which can lead to thrombotic events in these patients.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "PROTHROMBIN G20210A", "target": "LEIOMYOMA VENOSA (LV)"}, {"weight": 5.0, "description": "The factor V variant impacts coagulation factors, contributing to altered clotting efficiency and increased thrombosis risk.", "source_id": "chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "FACTOR V G1691A", "target": "BLOOD COAGULATION"}, {"weight": 10.0, "description": "The Factor V G1691A variant is linked with an increased risk of Leiomyoma Venosa, due to resistance to activated protein C leading to thrombotic complications.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "FACTOR V G1691A", "target": "LEIOMYOMA VENOSA (LV)"}, {"weight": 3.0, "description": "Changes in methionine metabolism due to MTHFR C677T and A1298C variants may increase the risk of Leiomyoma Venosa by elevating homocysteine levels.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0", "order": 1, "source": "LEIOMYOMA VENOSA (LV)", "target": "METHIONINE METABOLISM"}, {"weight": 6.0, "description": "B12 levels were found to be lower in infertile men compared to fertile controls but did not reach statistical significance.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "VITAMIN B12 (COBALAMIN)", "target": "INFERTILE MEN"}, {"weight": 8.0, "description": "In infertile men, RCF was lower compared to fertile controls before adjusting for education but lost significance after adding it to the model.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "RCF (REDUCED CYSTATHIONINE/FOLATE RATIO)", "target": "INFERTILE MEN"}, {"weight": 16.0, "description": "The PEMT gene variant is positively associated with male infertility when homozygous for the minor V allele.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE (PEMT) M175V GENE VARIANT", "target": "MALE INFERTILITY"}, {"weight": 18.0, "description": "The TCblR gene variant is negatively associated with male infertility in heterozygous subjects.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "TRANSCOBALAMIN RECEPTOR GENE TCBLR (CD320) RS173665 VARIANT", "target": "MALE INFERTILITY"}, {"weight": 8.0, "description": "Homozygosity for the MTHFR 1298A>C minor C allele was associated with infertility status but did not meet statistical significance after Bonferroni correction.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "MTHFR 1298A>C MINOR C ALLELE", "target": "INFERTILE MEN"}, {"weight": 14.0, "description": "Subjects who reported taking vitamin supplements had higher folate and B12 concentrations compared to non-users, suggesting a role in maintaining optimal nutrient levels.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "FOLIC ACID-CONTAINING VITAMIN SUPPLEMENTS", "target": "FOLATE AND B12 LEVELS"}, {"weight": 5.0, "description": "This gene variant was not found to be significantly associated with male infertility in this study population, even when analyzing those with lower folate levels.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "MTHFR 677C>T GENE VARIANT", "target": "INFERTILE MEN"}, {"weight": 5.0, "description": "Another polymorphism (rs638416) in the SHMT1 gene is also associated with a higher risk for TMD patients compared to healthy controls.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "RS638416"}, {"weight": 3.0, "description": "The SHMT1 gene product plays a role in pyrimidine synthesis by transferring methyl groups to tetrahydrofolate derivatives.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "PYRIMIDINE SYNTHESIS"}, {"weight": 6.0, "description": "The MTHFD1 gene contains a polymorphism (rs2236225) linked to an increased susceptibility to neural tube defects, sensitive to folates.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTHFD1", "target": "RS2236225"}, {"weight": 5.0, "description": "Polymorphisms within the MTHFD1 gene are associated with an increased risk of neural tube defects, especially in contexts where folates can protect against them.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTHFD1", "target": "NEURAL TUBE DEFECTS (NTDS)"}, {"weight": 7.0, "description": "The GSTM1-null polymorphism increases the risk of cancer and male infertility possibly due to greater sensitivity to environmental carcinogens and toxins.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "GSTM1-NULL POLYMORPHISM", "target": "CARCINOGENS"}, {"weight": 8.0, "description": "A substitution in MTRR (rs1801394) alters enzyme efficiency, reducing the affinity for substrate.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTRR", "target": "RS1801394"}, {"weight": 9.0, "description": "The DRD4 gene\'s 48-bp VNTR polymorphism can be characterized as S-DRD4 based on repeat length and is statistically significant in genotype frequencies.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "DRD4-48BPTR", "target": "S-DRD4"}, {"weight": 4.0, "description": "Tetrahydrofolate undergoes methylation to produce 5,10-methylenetetrahydrofolate which is essential in many metabolic pathways.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "5,10-METHYLENETETRAHYDROFOLATE (5,10-CH2-THF)", "target": "THF"}, {"weight": 1.0, "description": "Folic acid undergoes metabolism within the body involving various physiological processes such as DNA synthesis and amino acid metabolism.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "FOLIC ACID", "target": "NUTRIENT METABOLISM"}, {"weight": 2.0, "description": "CDC reagents are used to calibrate laboratory instruments, ensuring accurate measurements of analytes like folate levels across different testing conditions.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "CDC REAGENTS", "target": "LABORATORY CALIBRATION"}, {"weight": 3.0, "description": "IH reagents serve as alternative standards for calibration in laboratories when not using CDC reagents.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "IH REAGENTS", "target": "LABORATORY CALIBRATION"}, {"weight": 4.0, "description": "The microorganism calibrator provided by the CDC ensures accurate calibration of laboratory instruments, contributing to precise measurements across different conditions.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "MICROORGANISM CALIBRATOR (CDC-MO)", "target": "CALIBRATION ACCURACY"}, {"weight": 5.0, "description": "The CDC-provided calibrators are critical for maintaining consistent standards in folate testing among various laboratories.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "CALIBRATOR (CDC-CAL)", "target": "LABORATORY STANDARDS"}, {"weight": 6.0, "description": "These conditions are essential for the accurate measurement of whole blood and serum folate levels, influencing health assessments related to folic acid intake and metabolism.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "WB-FOL & S-FOL TESTING CONDITIONS", "target": "FOLIC ACID MEASUREMENT"}, {"weight": 7.0, "description": "Harmonizing laboratory test conditions improves comparability and consistency in the measurements of folate levels across different laboratories.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "LABORATORY TEST HARMONIZATION CONDITION", "target": "INTER-LABORATORY COMPARABILITY"}, {"weight": 9.0, "description": "This target value serves as a standard reference for laboratories to adjust their measurement protocols and ensure accuracy in folate analysis.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "CDC MBA TARGET VALUE", "target": "LABORATORY CALIBRATION"}, {"weight": 8.0, "description": "The folic acid calibrator ensures accurate measurements of serum folate levels across different laboratory settings.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "S-FOL (SERUM FOLATE)", "target": "FOLIC ACID CALIBRATOR"}, {"weight": 12.0, "description": "This kit ensures uniform calibration across different laboratories, enhancing comparability in folic acid measurement protocols.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "CDC ROUND-ROBIN KIT (CDC-MO & CDC-CAL)", "target": "LABORATORY STANDARDIZATION"}, {"weight": 13.0, "description": "The inconsistencies observed in these laboratories suggest potential problems with their calibration processes or adherence to standard protocols.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "LABORATORY #6 AND LABORATORY #9 RESULTS ANOMALIES", "target": "CALIBRATION ISSUES"}, {"weight": 3.0, "description": "Both measurements reflect the metabolic pathways of folate in serum and whole blood respectively, influencing nutritional assessment.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "order": 1, "source": "S-FOL", "target": "WB-FOL"}, {"weight": 3.0, "description": "The rs1695 polymorphism is associated with an increased risk of breast cancer.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "RS1695 POLYMORPHISM", "target": "BREAST CANCER"}, {"weight": 2.0, "description": "The AG genotype also lacks strong evidence for an association with increased risk of breast cancer based on our statistical analysis.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "BREAST CANCER", "target": "AG GENOTYPE"}, {"weight": 2.0, "description": "The heterozygous CT genotype did not show a significant link to the development of breast cancer according to our statistical tests.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "BREAST CANCER", "target": "CT GENOTYPE"}, {"weight": 4.0, "description": "The Ile105Val SNP in GSTP1 protein decreases its amyloid-forming propensity, influencing the function and stability of the enzyme.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "GSTP1 PROTEIN", "target": "ILE105VAL POLYMORPHISM"}, {"weight": 4.0, "description": "Analysis indicates that the Ile105Val polymorphism modifies amyloid-forming properties of GSTP1 without altering its overall stability or function.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "GSTP1 PROTEIN", "target": "ILE105VAL SNP ANALYSIS"}, {"weight": 6.0, "description": "Individuals with the CT genotype report significantly greater reward from drinking alcoholic beverages compared to other genotypes.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "CT GENOTYPE", "target": "REWARD"}, {"weight": 7.0, "description": "Participants with the TT genotype reported fewer drinks per drinking day in placebo vs olanzapine conditions compared to those with the CT genotype.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "TT GENOTYPE", "target": "DRINKS PER DRINKING DAY"}, {"weight": 7.0, "description": "Participants with the TT genotype showed less susceptibility to increased craving and drinking behavior in placebo conditions compared to those under active medication such as olanzapine or cyproheptadine.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "TT GENOTYPE", "target": "PLACEBO TREATMENT"}, {"weight": 5.0, "description": "This specific variant within the p.R778L group accounts for the largest proportion in haplogroup A.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.R778L", "target": "VARIANT A1 (10-7-7)"}, {"weight": 6.0, "description": "These less common haplogroups are associated with a lower frequency compared to haplogroup A within p.R778L\'s genetic spectrum.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.R778L", "target": "HAPLOGROUPS B AND C"}, {"weight": 11.0, "description": "Chromosomes from control subjects show a much lower association with p.R778L compared to WD chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.R778L", "target": "CONTROL ONES (CHROMOSOMES)"}, {"weight": 4.0, "description": "The p.P992L variant also contributes significantly to the incidence of Wilson\'s disease in affected individuals.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.P992L", "target": "WD PATIENTS GROUP"}, {"weight": 7.0, "description": "The genomic variant p.P992L is characterized by a more complex haplotype with haplogroup E being the most common.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.P992L", "target": "HAPLOGROUP E (10-9-5)"}, {"weight": 24.0, "description": "This specific variant within haplogroup E makes up 69% of the genetic information related to p.P992L on WD chromosomes.)<SEP>This specific variant within haplogroup E represents a significant portion of the genetic information related to p.P992L.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.P992L", "target": "VARIANT E1 (10-9-5)"}, {"weight": 15.0, "description": "A rare but distinct haplogroup associated with the genomic variant p.P992L on WD chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.P992L", "target": "HAPLOGROUP D (9-7-5)"}, {"weight": 17.0, "description": "These rare haplogroups are sporadically represented among WD chromosomes associated with p.P992L.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.P992L", "target": "HAPLOGROUPS F, G, H AND I"}, {"weight": 4.0, "description": "The p.T935M variant shows particularly high prevalence in patients from Fujian province compared to other regions.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.T935M", "target": "FUJIAN PROVINCE"}, {"weight": 9.0, "description": "The genomic variant p.T935M is uniquely associated with haplogroup J, representing a significant difference in genetic information on WD chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.T935M", "target": "HAPLOGROUP J (VARIANTS J1 AND J2)"}, {"weight": 3.0, "description": "Patients with WD have a distinct geographical distribution, with most cases found in southeastern Chinese regions like Fujian and Zhejiang.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "WD PATIENTS GROUP", "target": "GEOGRAPHICAL REGIONS (SOUTHEASTERN CHINA)"}, {"weight": 5.0, "description": "This analysis reveals significant linkage disequilibrium between the p.R778L variant and specific microsatellite markers.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "LINKAGE DISEQUILIBRIUM ANALYSIS", "target": "GENOMIC VARIANT (P.R778L)"}, {"weight": 4.0, "description": "The haplotype association study builds upon linkage disequilibrium data to further understand genetic associations in WD patients.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "LINKAGE DISEQUILIBRIUM ANALYSIS", "target": "HAPLOTYPE ASSOCIATION STUDY"}, {"weight": 9.0, "description": "Assesses whether certain polymorphisms are inherited together more frequently than expected by chance, providing insights into their co-occurrence.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "LINKAGE DISEQUILIBRIUM ANALYSIS", "target": "GENETIC POLYMORPHISMS"}, {"weight": 12.0, "description": "Haplogroup A is overwhelmingly common on WD chromosomes associated with the p.R778L variant.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "HAPLOGROUP A", "target": "WD CHROMOSOMES"}, {"weight": 13.0, "description": "This variant makes up a large proportion of haplogroup A among WD chromosomes related to p.R778L.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "HAPLOGROUP A", "target": "VARIANT A1 (10-7-7)"}, {"weight": 14.0, "description": "These haplogroups are less common on WD chromosomes compared to haplogroup A in the context of p.R778L.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "WD CHROMOSOMES", "target": "HAPLOGROUPS B AND C"}, {"weight": 18.0, "description": "This variant within haplogroup E is much less common than variant E1 in relation to p.P992L.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "HAPLOGROUP E (10-9-5)", "target": "VARIANT E2 (10-9-6)"}, {"weight": 19.0, "description": "This specific variant within haplogroup J is more frequently observed on WD chromosomes related to p.T935M.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "VARIANT J1 (12-4-8)", "target": "HAPLOGROUP J (VARIANTS J1 AND J2)"}, {"weight": 3.0, "description": "The CYP2C9*2 variant influences the predicted dose of warfarin based on its effect on drug metabolism.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "CYP2C9*2", "target": "WARFARIN DOSE PREDICTION"}, {"weight": 4.0, "description": "The rs1799853 SNP, as part of a group affecting CYP2C9 activity, influences warfarin dose prediction.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "RS1799853", "target": "WARFARIN DOSE PREDICTION"}, {"weight": 5.0, "description": "This SNP affecting CYP2C9 activity contributes to predicting appropriate warfarin dosages.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "RS28371686", "target": "WARFARIN DOSE PREDICTION"}, {"weight": 6.0, "description": "The rs7900194 variant impacting CYP2C9 activity influences the prediction of warfarin doses.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "RS7900194", "target": "WARFARIN DOSE PREDICTION"}, {"weight": 5.0, "description": "Patients with DVT or PE are commonly treated with warfarin to prevent blood clots.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "DVT/PE", "target": "WARFARIN TREATMENT"}, {"weight": 7.0, "description": "Used to evaluate deviations in SNP frequencies for genomic studies and drug response predictions.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "HWE (HARDY-WEINBERG EQUILIBRIUM)", "target": "GENOMIC VARIANT ANALYSIS"}, {"weight": 8.0, "description": "The combination of CYP2C9 variants affects the prediction models for warfarin dosages based on genetic factors.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "CYP2C9 STAR VARIANT GROUP", "target": "WARFARIN DOSAGE PREDICTION"}, {"weight": 3.0, "description": "The novel AA algorithm outperforms the IWPC clinical algorithm in detecting high-dose patients and predicting doses closer to observed values.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "IWPC CLINICAL ALGORITHM", "target": "NOVEL AA ALGORITHM"}, {"weight": 1.0, "description": "Our novel AA algorithm did not show association with WAA because population-specific variables are incorporated, accounting for admixture effects.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "NOVEL AA ALGORITHM", "target": "WAA"}, {"weight": 4.0, "description": "Expression levels or mutations in transcripts might affect protein function, influencing pharmacogenomics outcomes.)<SEP>The transcript of the LPL gene is translated into lipoprotein lipase, which plays a critical role in lipid metabolism.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323<SEP>chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "TRANSCRIPT", "target": "PROTEIN"}, {"weight": 4.0, "description": "Drug metabolism pathways involve molecular interactions that influence the efficacy of pharmacogenomics predictions.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "METABOLIC PATHWAY", "target": "MOLECULAR INTERACTION"}, {"weight": 6.0, "description": "CYP24A1 is involved in metabolic pathways that process vitamin D and maintain calcium homeostasis.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "METABOLIC PATHWAY", "target": "CYP24A1 GENE"}, {"weight": 4.0, "description": "Ancestry Informative Markers (AIMs) enable accurate measurement of ancestral admixture among African Americans, influencing the efficacy of pharmacogenomics algorithms.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "WAA", "target": "AIMS"}, {"weight": 10.0, "description": "The metabolic pathway of vitamin D metabolism involves the action of enzymes encoded by CYP24A1, impacting health outcomes like adenoma recurrence.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "CYP24A1", "target": "VITAMIN D METABOLISM"}, {"weight": 10.0, "description": "The CYP24A1 gene influences the recurrence of adenomas with villous histology.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "CYP24A1", "target": "VILLOUS ADENOMA RECURRENCE"}, {"weight": 3.0, "description": "The rs927650 variant within CYP24A1 is associated with changes in vitamin D levels and increased risk for colorectal adenomas.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "CYP24A1", "target": "RS927650"}, {"weight": 5.0, "description": "The c.1186C\u2009>\u2009T variant is a genomic alteration within the CYP24A1 gene that affects its function.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "C.1186C\u2009>\u2009T VARIANT"}, {"weight": 6.0, "description": "The SNP genotype of rs927650 is associated with changes in vitamin D levels and colorectal adenoma risk.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "RS927650", "target": "SNP GENOTYPE"}, {"weight": 8.0, "description": "Genetic variants such as rs35051736 in the CYP24A1 gene are linked to a higher risk of advanced colorectal adenomas.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "RS35051736", "target": "COLORECTAL ADENOMA RECURRENCE"}, {"weight": 6.0, "description": "The genetic variant rs2296241 modulates the effect of vitamin D concentrations on the recurrence of colorectal adenomas.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "RS2296241", "target": "VITAMIN D CONCENTRATION"}, {"weight": 6.0, "description": "This nutrient is produced through the metabolic pathway of vitamin D metabolism and impacts various physiological processes.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "VITAMIN D METABOLISM", "target": "1,25(OH)2D"}, {"weight": 8.0, "description": "The concentration of 25(OH)D is a measure of vitamin D levels in the body, impacting health outcomes.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "VITAMIN D CONCENTRATION", "target": "25(OH)D"}, {"weight": 8.0, "description": "Genetic variants within the CYP24A1 gene are linked to a higher risk of advanced lesion recurrence.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "ADVANCED LESION RECURRENCE", "target": "CYP24A1 SNP GENOTYPE"}, {"weight": 5.0, "description": "The rs777676129 amplicon includes the c.428_430delAAG variant and is used for genotyping.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "C.428_430DELAAG VARIANT", "target": "RS777676129 AMPLICON"}, {"weight": 5.0, "description": "The rs114368325 amplicon includes the c.1186C\u2009>\u2009T variant and is used for genotyping.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "C.1186C\u2009>\u2009T VARIANT", "target": "RS114368325 AMPLICON"}, {"weight": 5.0, "description": "The c.1186C\u2009>\u2009T variant alters the transcript of CYP24A1, affecting its function.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "C.1186C\u2009>\u2009T VARIANT", "target": "CYP24A1 TRANSCRIPT"}, {"weight": 4.0, "description": "Sanger sequencing confirms HRMA results by providing direct DNA sequence data.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "SANGER SEQUENCING", "target": "HRMA"}, {"weight": 4.0, "description": "Validation method used to confirm the accuracy of HLA-DQ haplotypes determined by Real-time PCR genotyping, showing 100% concordance in randomly selected individuals from both study groups.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "SANGER SEQUENCING", "target": "REAL-TIME PCR GENOTYPING"}, {"weight": 12.0, "description": "Activity levels reflect copper-dependent physiological processes affecting neurodevelopmental outcomes.<SEP>Deficient dopamine-b-hydroxylase activity, which is copper-dependent, indicates a physiological process inconsistent with Menkes disease in the proband.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "COPPER DEPENDENCY", "target": "DOPAMINE-B-HYDROXYLASE ACTIVITY"}, {"weight": 10.0, "description": "The cerebrospinal fluid (CSF) copper and catecholamine ratios fall within ranges established for classical Menkes disease, providing diagnostic criteria.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "MENKES DISEASE", "target": "CEREBROSPINAL FLUID COPPER AND CATECHOLAMINE RATIOS"}, {"weight": 3.0, "description": "This test measures developmental skills levels which are significantly delayed compared to age-appropriate milestones in the patient.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "DENVER DEVELOPMENTAL SCREENING TEST II", "target": "DEVELOPMENTAL SKILLS ASSESSMENT"}, {"weight": 4.0, "description": "MRI findings of atrophy and delayed myelination indicate neurodevelopmental issues in the patient.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "BRAIN MRI", "target": "NEURODEVELOPMENTAL ISSUES"}, {"weight": 3.0, "description": "Clinical studies measured motor action potentials to assess peripheral nervous system function, which were within normal ranges for infants aged 1-2 years.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS", "target": "PERIPHERAL NERVOUS SYSTEM FUNCTION"}, {"weight": 4.0, "description": "Velocity measurement is a part of neurophysiological assessment, indicating the patient\'s conduction velocity was within normal range for age.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "MEDIAN NERVE CONDUCTION VELOCITY", "target": "NEUROPHYSIOLOGICAL ASSESSMENT"}, {"weight": 5.0, "description": "Sensory action potentials were measured to assess peripheral sensory function in the patient, showing results above the lower limit of normal.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "MEDIAN NERVE SENSORY ACTION POTENTIAL", "target": "PERIPHERAL SENSORY FUNCTION"}, {"weight": 3.0, "description": "Transfection of Caco-2 cells with rat IDI coding sequences produces IDI-T (T variant) and IDI-C (C variant) transcripts.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "CACO-2 CELLS", "target": "IDI-T AND IDI-C TRANSCRIPTS"}, {"weight": 5.0, "description": "Cells grown in normal medium show resistance to tert-butylhydroperoxide; lower concentrations are used when cells are Se-depleted.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "CACO-2 CELLS", "target": "TERT-BUTYLHYDROPEROXIDE (T-BHP)"}, {"weight": 2.0, "description": "Cells transfected with the C variant show lower cell viability and increased ROS levels in response to oxidative challenges.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "CACO-2 CELLS", "target": "C VARIANT (IDI-C)"}, {"weight": 2.0, "description": "Rat IDI coding sequences are linked to the GPX4 3\u2032UTR for transfecting Caco-2 cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "RAT IDI CODING SEQUENCES", "target": "GPX4 3\u2032UTR"}, {"weight": 4.0, "description": "Relative transcript levels of IDI-T and IDI-C are measured against GAPDH for normalization purposes.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "IDI-T AND IDI-C TRANSCRIPTS", "target": "GAPDH TRANSCRIPT"}, {"weight": 7.0, "description": "Levels of reactive oxygen species are higher in cells expressing the IDI-C transcript compared to those expressing IDI-T.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "IDI-T AND IDI-C TRANSCRIPTS", "target": "ROS LEVELS"}, {"weight": 6.0, "description": "The activity of glutathione peroxidase, an antioxidant enzyme, varies significantly with selenium supply levels in Caco-2 cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "GPX ACTIVITY", "target": "SELENIUM (SE)"}, {"weight": 3.0, "description": "In Se-supplemented conditions, IDI-C cells show higher GPx activity compared to IDI-T cells, suggesting an impact on antioxidant defense mechanisms.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "GPX ACTIVITY", "target": "SE-SUPPLEMENTED MEDIUM"}, {"weight": 8.0, "description": "In both Se-depleted and supplemented conditions, selenoprotein H mRNA levels are lower in IDI-C cells than in IDI-T cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "SELENOPROTEIN H MRNA LEVELS", "target": "SE-DEPLETED MEDIUM"}, {"weight": 3.0, "description": "The T variant is associated with different transcript expression patterns compared to the C variant when assessed via real-time PCR.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "T VARIANT (IDI-T)", "target": "RS713041"}, {"weight": 4.0, "description": "Levels of GPX4 mRNA do not differ significantly between IDI-T and IDI-C cells under both depleted and supplemented selenium conditions.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "GPX4 MRNA LEVELS", "target": "SE-SUPPLY CONDITIONS"}, {"weight": 5.0, "description": "In Se-depleted medium, TR1 protein levels are similar in IDI-T and IDI-C cells, indicating no significant impact of the variants on this protein under these conditions.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "order": 1, "source": "TR1 PROTEIN LEVELS", "target": "SE-DEPLETED MEDIUM"}, {"weight": 2.0, "description": "The expression of selenoprotein H mRNA is significantly lower in IDI-C cells compared to IDI-T cells under both Se-depleted and supplemented conditions, indicating a differential response to selenium levels.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "SELENOPROTEIN H MRNA", "target": "SE SUPPLY"}, {"weight": 4.0, "description": "Tert-butylhydroperoxide induces oxidative stress in cells, affecting their viability and selenoprotein expression.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "TERT-BUTYLHYDROPEROXIDE (TBHP)", "target": "OXIDATIVE STRESS"}, {"weight": 3.0, "description": "IDI-C cells exhibit greater sensitivity to oxidative stress than IDI-T cells under low selenium conditions but show higher viability with increased selenium concentrations.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-C CELLS", "target": "IDI-T CELLS"}, {"weight": 2.0, "description": "Cells grown under serum-free conditions experience selenium depletion, affecting their response to oxidative challenges and selenoprotein expression.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "SERUM-FREE CONDITIONS", "target": "SELENIUM DEPLETION"}, {"weight": 2.0, "description": "The CHAT gene mutation p.Val136Met affects expression levels and is observed in three patients, indicating its impact on protein function.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT", "target": "P.VAL136MET"}, {"weight": 3.0, "description": "The CHAT gene mutation p.Ala557Thr impacts expression levels significantly and was detected in five patients, with one patient homozygous for this variant.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT", "target": "P.ALA557THR"}, {"weight": 2.0, "description": "Carries both p.Ala557Thr and a nonsense mutation affecting expression levels and phenotype.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "P.ALA557THR", "target": "PATIENT 10"}, {"weight": 4.0, "description": "This mutation compromises the thermal stability of ChAT protein, affecting its functionality.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "P.ALA557THR", "target": "THERMAL STABILITY"}, {"weight": 1.0, "description": "The ChAT transcript translates into two protein isoforms of 70 kDa and 74 kDa from alternative start sites in the spinal cord (S-type).)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT TRANSCRIPT", "target": "WILD-TYPE CHAT PROTEIN"}, {"weight": 4.0, "description": "Missense mutants alter kinetic parameters of wild-type CHAT proteins, affecting their activation rate constants.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "MISSENSE MUTANTS CHAT PROTEINS", "target": "KINETIC PROPERTIES"}, {"weight": 5.0, "description": "Some missense mutations in the CHAT gene compromise the thermal stability of mutant proteins.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "MISSENSE MUTANTS CHAT PROTEINS", "target": "THERMAL STABILITY"}, {"weight": 1.0, "description": "His-tagged constructs are purified from E. coli using Ni-NTA columns for further kinetic analysis.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "HISTIDINE-TAGGED CHAT CDNAS", "target": "NI-NTA COLUMN"}, {"weight": 4.0, "description": "Steady-state levels of LCT mRNA correlate inversely with DNA methylation densities at specific CpG sites near the LCT and MCM6 genes.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "DNA METHYLATION PATTERNS", "target": "LCT MRNA"}, {"weight": 4.0, "description": "The MCM6 gene harbors SNPs that influence DNA methylation near the LCT gene, modulating lactase enzyme production.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "DNA METHYLATION PATTERNS", "target": "MCM6 GENE"}, {"weight": 5.0, "description": "Unmodified cytosine densities serve as a marker for DNA methylation patterns, influencing LCT mRNA levels and enzyme activity over time.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "DNA METHYLATION PATTERNS", "target": "CYTOSINES"}, {"weight": 5.0, "description": "Epigenetic modifications, particularly DNA methylation patterns near this gene, are crucial in determining lactose digestion capability and enzyme production levels over time.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "DNA METHYLATION PATTERNS", "target": "LACTASE GENE (LCT)"}, {"weight": 3.0, "description": "Phenotype-associated CpGs are enriched in CpG island shores compared to all CpGs on the array, indicating a functional role for these regions in oxidative stress regulation.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "OXIDATIVE STRESS MARKERS", "target": "CPG ISLAND SHORES"}, {"weight": 4.0, "description": "Phenotype-associated CpGs located near promoters suggest their potential regulatory influence over gene expression through transcriptional control mechanisms.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "PROMOTERS", "target": "GENE EXPRESSION REGULATION"}, {"weight": 5.0, "description": "Identified TF binding sites provide evidence for the functionality of specific regulatory elements in influencing gene expression patterns.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "TF BINDING SITES (JASPAR DATABASE)", "target": "REGULATORY ELEMENT FUNCTIONALITY"}, {"weight": 6.0, "description": "These processes cluster into functional annotations based on their enrichment scores, implying a biological significance related to oxidative stress markers.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "PHOSPHORYLATION AND PHOSPHATE/PHOSPHOROUS METABOLIC PROCESSES", "target": "FUNCTIONAL ANNOTATION CLUSTERING"}, {"weight": 7.0, "description": "The presence of meQTLs suggests that genetic variation can significantly impact DNA methylation levels, a key epigenetic modification involved in gene regulation.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "MEQTLS (METHYLATION QUANTITATIVE TRAIT LOCI)", "target": "GENETIC VARIATION AND DNA METHYLATION REGULATION"}, {"weight": 8.0, "description": "Specific SNPs associated with cis-meQTL show modest associations with CHD risk genes identified through GWAS data.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "CIS-MEQTL SNPS", "target": "CHD RISK GENES"}, {"weight": 9.0, "description": "Both diseases share some genetic and epigenetic influences, indicating possible common pathways or mechanisms of disease development.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "CHD (CORONARY HEART DISEASE)", "target": "T2D (TYPE 2 DIABETES)"}, {"weight": 10.0, "description": "This consortium contributes to the analysis of GWAS data aimed at identifying genetic risk factors specific to coronary heart disease (CHD).)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "CARDIOGRAM CONSORTIUM", "target": "GWAS DATA ANALYSIS FOR CHD"}, {"weight": 10.0, "description": "The DIAGRAM consortium facilitates research into understanding genetic risk factors contributing to type 2 diabetes (T2D), enhancing our knowledge of the condition\'s heritability and biological basis.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "DIAGRAM CONSORTIUM", "target": "T2D GENETIC RISK FACTORS IDENTIFICATION"}, {"weight": 5.0, "description": "Methylation levels at this site are associated with heart failure, suggesting its importance in the development of cardiovascular diseases.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "ZNF341 CPG SITE (CG11842944)", "target": "HEART FAILURE"}, {"weight": 2.0, "description": "The MT-ATP6 gene harbors a de novo mutation that results in an amino acid change from Leucine to Arginine at position 156.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MT-ATP6 GENE", "target": "MTDNA 8993T>G (C.467T>G, P.LEU156ARG)"}, {"weight": 4.0, "description": "The MT-ATP6 gene encodes a subunit necessary for the function of complex V, which synthesizes ATP from ADP and Pi.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MT-ATP6 GENE", "target": "COMPLEX V (ATP SYNTHASE)"}, {"weight": 3.0, "description": "The mutation in MT-ATP6 gene is responsible for about 10\u201320% of Leigh syndrome cases due to its effect on ATP synthase activity.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MTDNA 8993T>G (C.467T>G, P.LEU156ARG)", "target": "LEIGH SYNDROME"}, {"weight": 2.0, "description": "The technique used to detect the presence of this genomic variant within mitochondrial DNA.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MTDNA 8993T>G (C.467T>G, P.LEU156ARG)", "target": "EXOME SEQUENCING"}, {"weight": 2.0, "description": "Used for aligning reads from next-generation sequencing data to identify the genomic variant in mitochondrial DNA.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MTDNA 8993T>G (C.467T>G, P.LEU156ARG)", "target": "GSNAP ALIGNMENT TOOL"}, {"weight": 2.0, "description": "This mutation might be present as heteroplasmy where it is not detected in all mitochondrial copies due to low levels.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MTDNA 8993T>G (C.467T>G, P.LEU156ARG)", "target": "HETEROPLASMIC VARIANTS"}, {"weight": 2.0, "description": "A method used alongside capillary sequencing for validation of the presence of this mutation in patient DNA.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MTDNA 8993T>G (C.467T>G, P.LEU156ARG)", "target": "RFLP ASSAY"}, {"weight": 2.0, "description": "The mutation leads to deficient activity of ATP synthase (complex V), contributing to the pathogenesis of Leigh syndrome.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MTDNA 8993T>G (C.467T>G, P.LEU156ARG)", "target": "COMPLEX V DEFICIENCY"}, {"weight": 2.0, "description": "The mutation affects complex V within this pathway, reducing ATP production through the electron transport chain.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MTDNA 8993T>G (C.467T>G, P.LEU156ARG)", "target": "ELECTRON TRANSPORT CHAIN"}, {"weight": 5.0, "description": "A missense variant in NDUFV1 that affects the FMN binding site of the protein subunit involved in complex I.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "NDUFV1 GENE", "target": "C.736G>A, P.GLU246LYS VARIANT"}, {"weight": 6.0, "description": "The NDUFV1 gene encodes a subunit required for complex I activity, which is part of the electron transport chain.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "NDUFV1 GENE", "target": "COMPLEX I (NADH DEHYDROGENASE)"}, {"weight": 3.0, "description": "This genomic variant changes an amino acid residue critical for the function of the COQ2 protein.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "C.437G>A (SER146ASN)", "target": "COQ2 PROTEIN"}, {"weight": 3.0, "description": "Mutations at the FMN binding site may affect the COQ2 protein\'s ability to function properly in coenzyme Q10 biosynthesis.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "COQ2 PROTEIN", "target": "FMN BINDING SITE"}, {"weight": 5.0, "description": "The MT-ND1 gene encodes subunit 1, which is a part of complex I in the electron transport chain.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "MT-ND1 GENE (MITOCHONDRIAL)", "target": "SUBUNIT 1 (MT-ND1)"}, {"weight": 3.0, "description": "The variant within the MT-ND1 gene disrupts normal mitochondrial function, contributing to various disorders such as Leber optic atrophy.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "MT-ND1 GENE (MITOCHONDRIAL)", "target": "3754C>A VARIANT IN MT-ND1 GENE"}, {"weight": 2.0, "description": "This mutation can cause Leber optic atrophy by disrupting mitochondrial function.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "3754C>A MUTATION", "target": "LEBER OPTIC ATROPHY"}, {"weight": 4.0, "description": "Mutations in subunit 1 can lead to deficiencies in complex I, causing mitochondrial dysfunction.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "SUBUNIT 1 (MT-ND1)", "target": "MITOCHONDRIAL COMPLEX I DEFICIENCY"}, {"weight": 2.0, "description": "Both diseases are caused by mutations in mtDNA and affect the function of mitochondria.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "LEBER OPTIC ATROPHY", "target": "MELAS SYNDROME"}, {"weight": 4.0, "description": "The process of extracting and sequencing peripheral blood cells\' DNA includes coverage analysis for both nuclear exome and mtDNA.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "PERIPHERAL BLOOD CELLS DNA EXTRACTION AND SEQUENCING PROCESS", "target": "MTDNA COVERAGE"}, {"weight": 5.0, "description": "Runes classifies variants into categories based on their potential impact, with category 1-3 indicating high significance.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "VARIANT CLASSIFICATION (RUNES)", "target": "CATEGORY 1-3 VARIANTS"}, {"weight": 4.0, "description": "Mutations in the COQ2 gene can result in coenzyme Q10 deficiency and are associated with specific genetic variants.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "COENZYME Q2 HOMOLOG, PRENYLTRANSFERASE (COQ2)", "target": "C.437G>A VARIANT AND C.1159C>T VARIANT"}, {"weight": 3.0, "description": "Like ALDH2, ADH1B genotype is also controlled for in the analyses of OPRM1\'s effects.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "OPRM1", "target": "ADH1B (RS1229984)"}, {"weight": 4.0, "description": "The comparison between naltrexone and placebo is central to assessing the pharmacogenetic effects on alcohol craving and side effects.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "NALTREXONE", "target": "PLACEBO"}, {"weight": 4.0, "description": "The analysis focuses on whether naltrexone affects alcohol craving based on OPRM1 genotype groupings.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "NALTREXONE", "target": "ALCOHOL CRAVING"}, {"weight": 5.0, "description": "Both drowsiness and ringing in ears are significant side effects observed more frequently with naltrexone than placebo, indicating an interaction between medication and participant experience.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "DROWSINESS", "target": "RINGING IN THE EARS"}, {"weight": 3.0, "description": "The status was examined as a potential moderator of alcohol craving effects related to OPRM1 genotype and medication, but found not significant.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "ALCOHOL CRAVING", "target": "CURRENT CIGARETTE SMOKING STATUS"}, {"weight": 5.0, "description": "Changes in BrAC levels significantly influence subjective responses, including sedation and stimulation, which are analyzed across genotypes and drug conditions.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "SUBJECTIVE RESPONSE TO ALCOHOL", "target": "BRAC LEVELS"}, {"weight": 3.0, "description": "Together, these factors provide a comprehensive picture of participants\' alcohol consumption patterns over time.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "NUMBER OF DRINKING DAYS", "target": "DRINKS PER DRINKING DAY"}, {"weight": 8.0, "description": "Participants receiving this control medication reported higher drinks per drinking day, especially when combined with specific genotypes like CT/CC in placebo conditions compared to olanzapine.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "DRINKS PER DRINKING DAY", "target": "ACTIVE CONTROL MEDICATION (CYPROHEPTADINE)"}, {"weight": 5.0, "description": "Both variants were considered together in analyses to understand their combined effects on drinking behavior and subjective alcohol responses.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "ALDH2 GENOTYPE (RS671)", "target": "ADH1B GENOTYPE (RS1229984)"}, {"weight": 4.0, "description": "AUQ values influenced the results, indicating they are significant covariates with ALDH2\'s role in drinking variables.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "ALDH2 GENOTYPE (RS671)", "target": "AUQ VALUES"}, {"weight": 3.0, "description": "The ALDH2 genotype in Asn40 homozygotes influences their alcohol consumption behavior, showing a different pattern compared to Asp40 carriers.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ALDH2 GENOTYPE", "target": "ASN40 HOMOZYGOTE GENOTYPE"}, {"weight": 4.0, "description": "The effect of naltrexone on alcohol self-administration varies depending on the ALDH2 genotype, indicating differential responses based on genetic background.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ALDH2 GENOTYPE", "target": "NALTREXONE MEDICATION"}, {"weight": 2.0, "description": "Smoking status may interact with ALDH2 genotype to influence alcohol consumption patterns, though no significant interaction was found in this study.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ALDH2 GENOTYPE", "target": "NICOTINE SMOKING STATUS"}, {"weight": 4.0, "description": "Changes in BrAC reflect the impact of alcohol self-administration behavior and are influenced by genetic factors such as ALDH2 genotype.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ALCOHOL SELF-ADMINISTRATION BEHAVIOR", "target": "BRAC (BREATH ALCOHOL CONCENTRATION)"}, {"weight": 4.0, "description": "There is a positive association between daily alcohol consumption and blood cortisol levels in both sexes before and after adjusting for various factors.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "DAILY ALCOHOL CONSUMPTION", "target": "CORTISOL LEVELS"}, {"weight": 5.0, "description": "The rs671 polymorphism significantly influences daily alcohol consumption, with GG genotype individuals drinking more than those with GA or AA genotypes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "DAILY ALCOHOL CONSUMPTION", "target": "GENETIC POLYMORPHISM (RS671)"}, {"weight": 5.0, "description": "In men, genetically predicted daily alcohol intake positively influences blood cortisol level, while in women, there is no significant association.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "CORTISOL LEVELS", "target": "GENETICALLY PREDICTED ALCOHOL CONSUMPTION"}, {"weight": 4.0, "description": "ALDH2 gene\'s rs671 polymorphism affects cortisol metabolism differently in men and women, indicating sex-specific physiological responses.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "GENETIC POLYMORPHISM (RS671)", "target": "CORTISOL METABOLISM"}, {"weight": 4.0, "description": "Sex differences are observed in baseline characteristics of alcohol consumption and cortisol levels based on ALDH2 genotypes.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "MEN", "target": "WOMEN"}, {"weight": 3.0, "description": "The CI provides a measure of the reliability of estimates from MR analyses, helping to establish the strength of association between genetically predicted alcohol consumption and cortisol levels.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "CONFIDENCE INTERVAL (CI)", "target": "MENDELIAN RANDOMIZATION (MR)"}, {"weight": 4.0, "description": "The rs3733591 variant of SLC2A9 is significantly associated with increased risk for hyperuricemia, particularly in female subjects.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "HYPERURICEMIA (HUA)", "target": "SLC2A9 VARIANT"}, {"weight": 2.0, "description": "Individuals with hyperuricemia tend to have higher serum creatinine levels, indicating potential renal function impairment.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "HYPERURICEMIA (HUA)", "target": "SERUM CREATININE"}, {"weight": 1.0, "description": "Individuals diagnosed with hyperuricemia exhibit elevated triglyceride levels compared to the general population.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "HYPERURICEMIA (HUA)", "target": "TG LEVELS"}, {"weight": 5.0, "description": "The ABCG2 gene variant rs2231142 significantly increases the risk of hyperuricaemia, particularly in individuals with cardiovascular risk factors.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "ABCG2 RS2231142", "target": "HYPERURICAEMIA (HUA)"}, {"weight": 3.0, "description": "The SLC22A12 gene variant rs893006 shows no significant association with sUA levels, except in male carriers of the C/C genotype.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "SLC22A12 RS893006", "target": "SUA LEVELS"}, {"weight": 4.0, "description": "An individual\'s genetic risk score increases linearly with higher serum uric acid (sUA) levels.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "SUA LEVELS", "target": "GENETIC RISK SCORE"}, {"weight": 4.0, "description": "High triglyceride (TG) levels are associated with higher serum uric acid (sUA) levels in individuals carrying the ABCG2 rs2231142 T allele.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "SUA LEVELS", "target": "TG LEVELS"}, {"weight": 5.0, "description": "The presence of cardiovascular risk factors such as obesity, hypertension, high TG and low HDL cholesterol levels significantly increases HUA risk in individuals with specific genetic variants.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "CARDIOVASCULAR RISK FACTORS", "target": "HYPERURICAEMIA (HUA)"}, {"weight": 5.0, "description": "Higher low-density lipoprotein cholesterol (LDL) levels significantly increase HUA risk in both male and female carriers of the ABCG2 rs2231142 T allele.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "HYPERURICAEMIA (HUA)", "target": "LDL LEVELS"}, {"weight": 3.0, "description": "Lower high-density lipoprotein cholesterol (HDL) levels increase HUA risk in males but not significantly in females carrying the ABCG2 rs2231142 T allele.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "HYPERURICAEMIA (HUA)", "target": "HDL LEVELS"}, {"weight": 2.0, "description": "The presence of the rs2231142 T allele is associated with an increased risk of hyperuricemia.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "RS2231142 T ALLELE", "target": "HYPERURICEMIA"}, {"weight": 2.0, "description": "Genetic factors, such as the presence of the rs2231142 T allele, can influence uric acid metabolism.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "RS2231142 T ALLELE", "target": "URIC ACID METABOLISM"}, {"weight": 3.0, "description": "Variants of the ABCG2 gene affect serum uric acid levels across both genders and populations.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "GENOMIC VARIANT ABCG2", "target": "SERUM URIC ACID LEVELS"}, {"weight": 4.0, "description": "The LRP2 gene is associated with a specific allele variant that decreases estimated glomerular filtration rate, impacting kidney function.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "LRP2 GENE", "target": "EGFR-DECREASING ALLELE"}, {"weight": 5.0, "description": "Variants in the NFATC1 gene are linked to an increased risk of chronic kidney disease based on their impact on eGFR.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "NFATC1 GENE", "target": "CKD"}, {"weight": 4.0, "description": "The 129S6 mouse strain serves as a model for studying the regulation of NFATC1 gene expression under conditions of high salt intake and CKD.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "NFATC1 GENE", "target": "129S6 MOUSE STRAIN"}, {"weight": 6.0, "description": "A specific allele variant associated with a decrease in estimated glomerular filtration rate is strongly correlated with the risk for chronic kidney disease.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "EGFR-DECREASING ALLELE", "target": "CKD"}, {"weight": 7.0, "description": "The UNCX gene variant rs62435145 shows a strong association with increased risk of chronic kidney disease as indicated by its impact on eGFR.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "CKD", "target": "UNCX GENE VARIANT (RS62435145)"}, {"weight": 8.0, "description": "The ALMS1 gene variant rs7587577 is linked to a significant risk of chronic kidney disease according to genome-wide studies.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "CKD", "target": "ALMS1 GENE (RS7587577)"}, {"weight": 11.0, "description": "Diabetes types 2 and 1 are risk factors for chronic kidney disease and influence estimated glomerular filtration rate according to genetic studies.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "CKD", "target": "T2D AND T1D"}, {"weight": 9.0, "description": "Variants within the PDILT-UMOD locus, notably rs77924615, impact both chronic kidney disease risk and estimated glomerular filtration rate.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "PDILT-UMOD GENE VARIANTS (RS77924615)", "target": "CKD, EGFR"}, {"weight": 5.0, "description": "Both NFATC1 and RGS14 genes are influenced by variants at the SLC34A1 locus, showing correlation in gene expression regulation across tissues.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "NFATC1", "target": "RGS14"}, {"weight": 5.0, "description": "The GCKR missense variant is associated with metabolic changes that increase the risk of cardiovascular diseases, such as CKD.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "GCKR P.PRO446LEU (RS1260326)", "target": "CARDIOVASCULAR DISEASE RISK"}, {"weight": 6.0, "description": "Binding of HDAC8 to specific genomic regions may regulate kidney function and development through chromatin modification.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "HDAC8 BINDING SITES", "target": "KIDNEY FUNCTION REGULATION"}, {"weight": 7.0, "description": "Cyclosporine A targets NFATC1, which is downstream of HDAC8 activity in the immune response regulation.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "HISTONE DEACETYLASES (HDACS)", "target": "CYCLOSPORINE A"}, {"weight": 4.0, "description": "The ability to regulate ion concentrations can influence an organism\'s sensitivity to dietary salt intake.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "IONIC REGULATION", "target": "SALT SENSITIVITY"}, {"weight": 5.0, "description": "These variants are eQTLs for RGS14 and NFATC1 in multiple tissues, indicating their regulatory roles.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "SLC34A1 VARIANTS", "target": "GENE EXPRESSION IN TISSUES"}, {"weight": 6.0, "description": "Studies on DHSs in fetal kidney cells suggest that these cells play a role in early gene regulation during development.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "FETAL KIDNEY CELLS", "target": "GENOMIC REGULATION"}, {"weight": 8.0, "description": "These cells indicate that DHSs play a crucial role in the posterior probability of driving association signals with eGFR.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "RENAL CORTICAL EPITHELIAL CELLS (HRCES)", "target": "GENE REGULATION MECHANISMS"}, {"weight": 5.0, "description": "The gene RGS14, influenced by variants at SLC34A1 locus, is involved in immune responses and regulation.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "RGS14 VARIANTS", "target": "IMMUNE RESPONSE"}, {"weight": 6.0, "description": "These variants reduce expression of loco gene, improving survival under salt stress conditions in Drosophila.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "LOCO LOSS-OF-FUNCTION VARIANTS", "target": "SALT SENSITIVITY REGULATION"}, {"weight": 5.0, "description": "The loco gene plays a role in conferring resistance against salt stress, especially evident in mutant strains of Drosophila when supplemented with NaCl.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "LOCO GENE", "target": "SALT STRESS RESISTANCE"}, {"weight": 5.0, "description": "When compared with isogenic controls under non-NaCl conditions, loco mutants show no significant differences in viability, indicating the specific role of NaCl supplementation.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "LOCO GENE", "target": "ISOGENIC CONTROLS"}, {"weight": 4.0, "description": "NFATC1\'s renal mRNA expression significantly decreases after exposure to high-salt conditions, indicating a physiological response to environmental stress.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "NFATC1 PROTEIN", "target": "HIGH-SALT DIET"}, {"weight": 3.0, "description": "Renal mRNA levels of NFATC1 are reduced during CKD, reflecting changes in kidney function and disease progression.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "NFATC1 PROTEIN", "target": "CHRONIC KIDNEY DISEASE (CKD)"}, {"weight": 4.0, "description": "Similar to NFATC1, RGS14 shows significant downregulation in its renal mRNA expression upon exposure to a high-salt diet.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "RGS14 PROTEIN", "target": "HIGH-SALT DIET"}, {"weight": 3.0, "description": "The expression of RGS14 decreases with CKD, suggesting its involvement in the pathogenesis or response to chronic kidney disease.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "RGS14 PROTEIN", "target": "CHRONIC KIDNEY DISEASE (CKD)"}, {"weight": 4.0, "description": "Renal mRNA levels of RGS14 are significantly reduced after exposure to a high-salt diet, indicating its role in kidney dysfunction under stress conditions.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "HIGH-SALT DIET", "target": "RGS14 GENE"}, {"weight": 4.0, "description": "In hybrid heterogenic strains, loco mutants exhibit salt-resistance similar to their isogenic counterparts, excluding effects due to inbreeding depression.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "HYBRID HETEROGENIC STRAINS", "target": "LOCO MUTANTS"}, {"weight": 3.0, "description": "The procedure of sub-total nephrectomy induces chronic kidney disease in mice models, leading to alterations in renal mRNA expression of RGS14 and NFATC1 genes.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "CKD MODEL", "target": "SUB-TOTAL NEPHRECTOMY"}, {"weight": 8.0, "description": "Infections caused by Campylobacter bacteria can exhibit genomic variants leading to quinolone resistance, affecting the course and treatment options of the disease.<SEP>Infections caused by Campylobacter bacteria can have a genomic variant leading to quinolone resistance, significantly impacting the course and treatment of the disease.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "CAMPYLOBACTER INFECTIONS", "target": "QUINOLONE RESISTANCE"}, {"weight": 10.0, "description": "Foreign travel is associated with an increased prevalence of quinolone-resistant Campylobacter infections, indicating a link between environment and bacterial resistance patterns.<SEP>Foreign travel is associated with an increased prevalence of quinolone-resistant Campylobacter infections, indicating a link between environmental factors and bacterial antibiotic resistance patterns.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE RESISTANCE", "target": "TRAVEL"}, {"weight": 4.0, "description": "Consuming poultry other than chicken or turkey increases the risk for quinolone-resistant Campylobacter infections, indicating dietary habits as a potential environmental factor influencing disease susceptibility.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE RESISTANCE", "target": "EATING FRESH POULTRY OTHER THAN CHICKEN AND TURKEY"}, {"weight": 5.0, "description": "Engaging in swimming is associated with an increased risk of acquiring quinolone-resistant C. jejuni infections, highlighting recreational activities as environmental factors contributing to disease prevalence.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE RESISTANCE", "target": "SWIMMING"}, {"weight": 5.0, "description": "The age distribution among patients does not significantly affect the likelihood or severity of quinolone-resistant Campylobacter infections, suggesting that other factors such as travel and dietary habits play a more significant role in susceptibility.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE RESISTANCE", "target": "AGE GROUP"}, {"weight": 4.0, "description": "The use of fluoroquinolone antibiotics is associated with the development of quinolone-resistant Campylobacter strains, indicating an important consideration for treatment and prevention strategies.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE RESISTANCE", "target": "FLUOROQUINOLONES"}, {"weight": 2.0, "description": "Some Campylobacter jejuni and C. coli strains harbor genes that confer erythromycin resistance.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "ERYTHROMYCIN RESISTANCE", "target": "CAMPYLOBACTER JEJUNI"}, {"weight": 6.0, "description": "The duration of illness for patients infected with C. jejuni is significantly longer when the infection is quinolone-resistant compared to sensitive strains.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "C. COLI AND C. JEJUNI INFECTIONS", "target": "DURATION OF ILLNESS"}, {"weight": 6.0, "description": "The duration of illness for patients infected with C. jejuni is significantly longer when the infection is quinolone-resistant compared to sensitive strains, highlighting the impact of antibiotic resistance on disease severity.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "DURATION OF ILLNESS", "target": "C. JEJUNI AND C. COLI INFECTIONS"}, {"weight": 4.0, "description": "Fluoroquinolones are used to treat campylobacteriosis, but resistance against fluoroquinolones is a concern in clinical settings.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "FLUOROQUINOLONES", "target": "CAMPYLOBACTERIOSIS"}, {"weight": 1.0, "description": "The nalidixic acid resistance variant is found within the genetic makeup of certain Campylobacter jejuni isolates.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "CAMPYLOBACTER JEJUNI", "target": "NALIDIXIC ACID RESISTANCE"}, {"weight": 3.0, "description": "Consumption of fresh poultry other than chicken and turkey is associated with a higher risk of domestically acquired quinolone-resistant Campylobacter infections.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "FRESH POULTRY OTHER THAN CHICKEN AND TURKEY", "target": "DOMESTICALLY ACQUIRED QUINOLONE-RESISTANT INFECTIONS"}, {"weight": 1.0, "description": "Isolates from retail food products, including chicken, turkey, pork, and broiler chickens, were compared with C. coli isolates for resistance patterns and origin analysis.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "C. COLI", "target": "RETAIL FOOD PRODUCTS AND BROILER CHICKENS"}, {"weight": 2.0, "description": "The geographic area and time period of the samples from retail food products and broiler chickens are critical in determining potential sources of infection.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "RETAIL FOOD PRODUCTS AND BROILER CHICKENS", "target": "GEOGRAPHIC AREA AND TIME PERIOD"}, {"weight": 9.0, "description": "The minor allele for rs9534511 significantly increases the risk of social disinhibition.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS9534511", "target": "SOCIAL DISINHIBITION (RISK)"}, {"weight": 2.0, "description": "The SNP rs4938056 is associated with the HTR3B gene, contributing to higher social disinhibition risks.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS4938056", "target": "HTR3B GENE"}, {"weight": 7.0, "description": "The minor allele for rs4938056 is associated with an increased risk of social disinhibition.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS4938056", "target": "SOCIAL DISINHIBITION (RISK)"}, {"weight": 2.0, "description": "An intronic SNP (rs1998220) in the OPRM1 gene is significantly linked to an increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS1998220", "target": "OPRM1 GENE"}, {"weight": 7.0, "description": "These SNPs are part of the group associated with an increased risk of social disinhibition, compared to protective effects shown by other SNPs.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS1998220", "target": "RS9534511 AND RS4938056"}, {"weight": 2.0, "description": "An intronic SNP (rs3025971) in OPRM1 is significantly linked to an increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "OPRM1 GENE", "target": "RS3025971"}, {"weight": 2.0, "description": "The SNP rs1003921 located within KCNC1 is associated with higher levels of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS1003921", "target": "KCNC1 GENE"}, {"weight": 10.0, "description": "The minor allele for rs1003921 strongly protects against social disinhibition.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS1003921", "target": "SOCIAL DISINHIBITION (PROTECTIVE)"}, {"weight": 2.0, "description": "The SNP rs12830955 located within KCNC1 is associated with higher levels of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "KCNC1 GENE", "target": "RS12830955"}, {"weight": 2.0, "description": "A significant SNP (rs16116) downstream of the NPY gene impacts social disinhibition risk.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS16116", "target": "NPY GENE"}, {"weight": 8.0, "description": "The minor allele for rs16116 provides a protective effect against social disinhibition.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS16116", "target": "SOCIAL DISINHIBITION (PROTECTIVE)"}, {"weight": 2.0, "description": "A significant SNP (rs16867458) downstream of the NPY gene impacts social disinhibition risks.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "NPY GENE", "target": "RS16867458"}, {"weight": 2.0, "description": "The SNP rs16870286 in LINC00518 is linked to increased social disinhibition risks.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS16870286", "target": "LINC00518 GENE"}, {"weight": 2.0, "description": "Higher linguistic acculturation scores are significantly associated with increased levels of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "SOCIAL DISINHIBITION SCORE", "target": "LINGUISTIC ACCULTURATION SCORE"}, {"weight": 2.0, "description": "The TAS and DAS scores were positively correlated with higher social disinhibition risk, indicating a significant physiological influence.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "SOCIAL DISINHIBITION SCORE", "target": "TAS AND DAS SCORES"}, {"weight": 5.0, "description": "These SNPs are associated with a protective effect against social disinhibition.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS16116, RS16870286, AND RS1003921", "target": "SOCIAL DISINHIBITION (PROTECTIVE)"}, {"weight": 7.0, "description": "These SNPs are associated with an increased risk of social disinhibition.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS1998220, RS9534511, AND RS4938056", "target": "SOCIAL DISINHIBITION (RISK)"}, {"weight": 5.0, "description": "The AUDIT score correlates with brain activation in VMPFC during alcohol exposure in individuals with the CT genotype at rs2023239, indicating a link between genetic variation and addiction risk.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "NEUROIMAGING STUDY ON BRAIN ACTIVATION ", "target": "ALCOHOL USE DISORDER SCORE (AUDIT)"}, {"weight": 5.0, "description": "Despite similar breath alcohol levels after consuming three drinks across different genotypes (TT vs CT/CC), individuals with the rs2023239 variant showed increased reward sensitivity, indicating a genetic influence independent of blood alcohol concentration.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "SHORT-TERM EFFECTS OF ALCOHOL ON REWARD SENSITIVITY ", "target": "BREATH ALCOHOL LEVELS "}, {"weight": 4.0, "description": "Both tobacco smoking and past-month quantity of alcohol use were considered as factors in the study but showed no significant differences related to genotypes at rs2023239, suggesting no confounding effects.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "PAST-MONTH QUANTITY OF ALCOHOL USE ", "target": "TOBACCO SMOKING "}, {"weight": 5.0, "description": "The genetic variant rs2023239 is located upstream of exon 3 in the CNR1 gene, suggesting its role as an alternative promoter affecting CB1 receptor expression.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "RS2023239 GENOMIC VARIANT - EXON REGION ", "target": "CNR1 GENE "}, {"weight": 5.0, "description": "Both NAcc and VTA show differential activation between TT and CT genotypes, indicating a common pathway influenced by CNR1 gene variation in reward processing.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "NUCLEUS ACCUMBENS (NACC) ", "target": "VENTRAL TEGMENTAL AREA (VTA) "}, {"weight": 4.0, "description": "Activation patterns in VMPFC and VTA indicate a shared pathway in reward processing affected by CNR1 gene variation, suggesting common neural mechanisms.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "VENTRAL MIDBRAIN PREFRONTAL CORTEX (VMPFC) ", "target": "VENTRAL TEGMENTAL AREA (VTA) "}, {"weight": 4.0, "description": "Both AUDIT and AUQ scores measure aspects of alcohol use disorder severity and craving, with AUQ showing specific correlations with brain activation patterns in the OFC, indicating distinct genetic influences on subjective experiences.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "AUDIT SCORE ", "target": "AUQ SCORE "}, {"weight": 5.0, "description": "Olanzapine interacts with the CNR1 pathway, affecting responses in individuals with specific genotypes to alcohol consumption.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "CNR1", "target": "OLANZAPINE"}, {"weight": 8.0, "description": "The drug olanzapine interacts with self-reported high measures, showing different effects based on participant genotypes.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "OLANZAPINE", "target": "SELF-REPORTED HIGH"}, {"weight": 5.0, "description": "Olanzapine interacts with the dopamine system, affecting neurotransmission and potentially altering responses related to alcohol reward in individuals with specific CNR1 genotypes.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "OLANZAPINE", "target": "DOPAMINE SYSTEM"}, {"weight": 9.0, "description": "Individuals receiving placebo treatment showed increased cue-elicited craving compared to those treated with olanzapine in the context of specific CNR1 genotypes.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "PLACEBO TREATMENT", "target": "CUE-ELICITED CRAVING"}, {"weight": 9.0, "description": "Individuals under placebo treatment exhibited heightened cue-elicited craving and drinking behavior, contrasting with outcomes observed when treated with olanzapine.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "PLACEBO TREATMENT", "target": "CUE-ELICITED DRINKING BEHAVIOR"}, {"weight": 4.0, "description": "CNR1 gene variants like rs2023239 affect mesocorticolimbic neurocircuitry by altering CB1 receptor levels, influencing drug-seeking behavior.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "order": 1, "source": "CB1 RECEPTOR BINDING LEVELS ", "target": "MESOCORTICOLIMBIC NEUROCIRCUITRY "}, {"weight": 3.0, "description": "LPL hydrolyzes chylomicrons as part of its function in lipid metabolism.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LIPOPROTEIN LIPASE (LPL)", "target": "CHYLOMICRONS"}, {"weight": 5.0, "description": "Decreased activity of lipoprotein lipase leads to accumulation of triglycerides in the bloodstream, causing hypertriglyceridemia.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LIPOPROTEIN LIPASE (LPL)", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 6.0, "description": "GPIHBP1 is necessary for transporting LPL to capillary lumen where it can act on chylomicrons.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LIPOPROTEIN LIPASE (LPL)", "target": "GPIHBP1"}, {"weight": 1.0, "description": "The process of breaking down chylomicrons into free fatty acids and monoglycerides is catalyzed by LPL.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LIPOPROTEIN LIPASE (LPL)", "target": "CHYLOMICRON HYDROLYSIS"}, {"weight": 4.0, "description": "Dietary fat is packaged into chylomicrons for transport and processing by LPL.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "DIETARY FAT", "target": "CHYLOMICRONS"}, {"weight": 3.0, "description": "High levels of chylomicrons, particularly after meals rich in fats, can exacerbate hypertriglyceridiaemia due to inadequate hydrolysis by lipoprotein lipase.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "CHYLOMICRONS", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 3.0, "description": "High triglyceride levels (>2500 mg/dl) lead to lipemia retinalis, a condition characterized by white-colored retinal veins due to lipid deposition.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "LIPEMIA RETINALIS", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 11.0, "description": "High levels of triglycerides in the blood lead to eruptive xanthomas as a clinical manifestation.<SEP>Severe hypertriglyceridemia can trigger eruptive xanthomas in patients with LPL deficiency.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "ERUPTIVE XANTHOMAS", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 2.0, "description": "Used to assess the severity of hypertriglyceridemia caused by lipid metabolism disorders like LPL deficiency.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "FASTING LIPID PROFILE"}, {"weight": 4.0, "description": "Elevated triglycerides contribute to hyperviscosity syndrome leading to abdominal pain and gastrointestinal hemorrhage in LPL deficient patients.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "HYPERVISCOSITY SYNDROME"}, {"weight": 5.0, "description": "High levels of triglycerides increase the risk of developing pancreatitis, a condition often found in LPL-deficient individuals.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "PANCREATITIS"}, {"weight": 3.0, "description": "Medium-chain triglyceride supplements provide an alternative source of energy without increasing triglyceride levels in patients managing hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "MCT FAT SUPPLEMENT"}, {"weight": 4.0, "description": "Gemfibrozil is used to reduce high triglyceride levels by inhibiting lipoprotein synthesis and upregulating HDL cholesterol production in patients with hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "GEMFIBROZIL DRUG THERAPY"}, {"weight": 3.0, "description": "Orlistat reduces the absorption of dietary fats, thereby lowering triglyceride levels when combined with dietary restrictions for managing hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "ORLISTAT DRUG THERAPY"}, {"weight": 4.0, "description": "This therapy aims to increase lipase activity through the introduction of a gain-of-function variant, helping to lower triglyceride levels in patients with hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "INTRAMUSCULAR INTRODUCTION OF GAIN-OF-FUNCTION LPL VARIANT THERAPY"}, {"weight": 5.0, "description": "Inhibiting DGAT1 reduces lipid synthesis during fat absorption, potentially lowering triglyceride levels and managing hypertriglyceridemia in LPL-deficient patients.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "DGAT1 INHIBITORS TREATMENT APPROACH"}, {"weight": 4.0, "description": "Elevated VLDL particles contribute significantly to hypertriglyceridemia due to insufficient breakdown by LPL in patients with LPL gene mutations.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "VLDL"}, {"weight": 3.0, "description": "The formula provides a high proportion of MCTs, reducing dependence on LPL for dietary fat metabolism.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "ENFAPORT LIPIL FORMULA", "target": "MEDIUM-CHAIN TRIGLYCERIDES (MCT) FAT CONTENT IN ENFAPORT LIPIL"}, {"weight": 4.0, "description": "Both conditions represent forms of LPL deficiency but differ in severity and genetic basis.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "HOMOZYGOUS LPL DEFICIENCY", "target": "COMPOUND HETEROZYGOUS LPL DEFICIENCY"}, {"weight": 3.0, "description": "The p.Q240H mutation alters the structure and function of the lipoprotein lipase protein, contributing to hypertriglyceridemia.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "LIPOPROTEIN LIPASE PROTEIN", "target": "P.Q240H MUTATION"}, {"weight": 14.0, "description": "Treatment with topiramate leads to a higher mean severity rating of adverse events compared to placebo, particularly among A-allele carriers.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "ADVERSE EVENT SEVERITY"}, {"weight": 5.0, "description": "Among patients with the *C-homozygous genotype, topiramate treatment significantly reduced heavy drinking days (HDDs), demonstrating high efficacy.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "RS2832407*C-HOMOZYGOTES"}, {"weight": 1.0, "description": "Among patients carrying the *A allele, topiramate had no discernible effect on reducing heavy drinking days (HDDs), indicating minimal efficacy.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "A-ALLELE CARRIERS"}, {"weight": 12.0, "description": "Patients with different genotypes for rs2832407 respond differently to topiramate treatment in terms of reducing heavy drinking days (HDDs).", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "RS2832407 GENOTYPE", "target": "HDDS"}, {"weight": 3.0, "description": "Patients with the *C-homozygous genotype showed a non-significant difference in adverse event severity compared to placebo.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "ADVERSE EVENT SEVERITY", "target": "RS2832407*C-HOMOZYGOTES"}, {"weight": 5.0, "description": "Patients with the *A allele had significantly higher adverse event severity when treated with topiramate compared to placebo.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "ADVERSE EVENT SEVERITY", "target": "A-ALLELE CARRIERS"}, {"weight": 6.0, "description": "Patients with the ABCB1 variant at position rs1045642 reported more severe acute nausea than those without this variant.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "ABCB1 RS1045642 VARIANT", "target": "CTCAE GRADE 2 OR ABOVE ACUTE NAUSEA"}, {"weight": 2.0, "description": "Both ABCB1 variant at position rs1045642 and HTR3B variant at position rs45460698 were examined for their association with acute nausea severity.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "ABCB1 RS1045642 VARIANT", "target": "HTR3B (RS45460698)"}, {"weight": 2.0, "description": "Patients characterized as CYP2D6 intermediate or extensive metabolizers were likely to be treated with highly emetogenic chemotherapy regimens.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CYP2D6 INTERMEDIATE OR EXTENSIVE METABOLIZER PHENOTYPE", "target": "HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS"}, {"weight": 1.0, "description": "The CYP2D6 activity score reflects the functional activity of patients with intermediate or extensive metabolizer phenotypes.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CYP2D6 INTERMEDIATE OR EXTENSIVE METABOLIZER PHENOTYPE", "target": "CYP2D6 ACTIVITY SCORE"}, {"weight": 4.0, "description": "Most patients received palonosetron, but the medication did not prevent all cases of CTCAE grade 2 or above acute nausea.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CTCAE GRADE 2 OR ABOVE ACUTE NAUSEA", "target": "PALONOSETRON"}, {"weight": 4.0, "description": "Patients with a history of morning sickness were more likely to report CTCAE grade 2 or above acute nausea.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CTCAE GRADE 2 OR ABOVE ACUTE NAUSEA", "target": "HISTORY OF MORNING SICKNESS"}, {"weight": 6.0, "description": "Despite being prescribed alongside dexamethasone, some patients still experienced delayed CINV following chemotherapy treatment.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "DELAYED CINV (NAUSEA AND VOMITING)", "target": "DEXAMETHASONE"}, {"weight": 4.0, "description": "Less sleep before chemotherapy was associated with more severe acute nausea reported by patients.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "HOURS OF SLEEP BEFORE CHEMOTHERAPY", "target": "PATIENT-REPORTED SEVERITY OF ACUTE NAUSEA"}, {"weight": 8.0, "description": "Silencing of LOC100507600 results in a reduction of LCT mRNA levels, indicating its role in regulating the expression of LCT.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT MRNA", "target": "LOC100507600 LNCRNA"}, {"weight": 4.0, "description": "Different DNA modifications are observed within the MCM6 locus associated with lactase persistence or non-persistence alleles.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "MCM6 GENE", "target": "DNA MODIFICATIONS"}, {"weight": 2.0, "description": "The MCM6 gene influences lactase non-persistence in individuals with CC genotype via age-related DNA modifications.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "MCM6 GENE", "target": "LACTASE NON-PERSISTENCE (CC) INDIVIDUALS"}, {"weight": 5.0, "description": "This SNP affects lactose digestion ability through its impact on DNA modification patterns around the LCT gene, influencing lactase persistence status.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "C/T-13910 SNP", "target": "LACTASE PERSISTENCE/NON-PERSISTENCE"}, {"weight": 4.0, "description": "Genomic regions within these chromosomes are critical for understanding the transcriptional regulation of the LCT gene across individuals with varying lactase persistence statuses.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "CHROMOSOME 2, 9, 19", "target": "LCT GENE REGULATION"}, {"weight": 4.0, "description": "This method enables comprehensive epigenetic analysis by enriching unmodified DNA fractions for detailed investigation of DNA modification changes around key genes like the LCT gene.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "MTAG-CLICK METHOD", "target": "EPIGENETIC ANALYSIS"}, {"weight": 7.0, "description": "Age-dependent changes in DNA methylation patterns within the LCT-MCM6 region influence lactose persistence or non-persistence.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "LACTASE PERSISTENCE/DISEASE NON-PERSISTENCE", "target": "DNA METHYLATION CHANGES WITH AGE"}, {"weight": 7.0, "description": "Genetic variations at these SNPs are strongly associated with lactase persistence or non-persistence conditions.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "LACTASE PERSISTENCE/DISEASE NON-PERSISTENCE", "target": "C/T-13910 SNP RS4988235 AND G/A-22018 SNP RS182549"}, {"weight": 5.0, "description": "The LCT exon 1 region has high levels of H3K4me3 and H3K27ac, indicative of an active promoter state.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "LCT EXON 1", "target": "HISTONE MARKS (H3K4ME1 AND H3K27AC)"}, {"weight": 5.0, "description": "Enhancer activity marked by these histones is observed at this region, indicating regulatory roles for lactase expression.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "HISTONE MARKS (H3K4ME1 AND H3K27AC)", "target": "MCM6 EXON 17-3\u2032 UTR"}, {"weight": 8.0, "description": "This intron region harbors the promoter for a long non-coding RNA, potentially influencing lactase gene expression regulation.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "LCT INTRON 5", "target": "LOC100507600 LNCRNA PROMOTER REGION"}, {"weight": 3.0, "description": "This genomic variant is associated with specific patterns of DNA modification changes over the lifespan, influencing LCT expression differently based on genotype.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "C-13910 GENOMIC VARIANT", "target": "AGE-RELATED DNA MODIFICATIONS"}, {"weight": 3.0, "description": "Individuals with this variant showing persistence of lactose digestion capacity due to protective epigenetic mechanisms against DNA modification changes over time.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "C-13910 GENOMIC VARIANT", "target": "LACTASE PERSISTENCE (TT) INDIVIDUALS"}, {"weight": 4.0, "description": "Individuals showing lactase persistence have a regulatory region that interacts with an antisense transcript modulating LCT mRNA levels positively.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LACTASE PERSISTENCE (TT) INDIVIDUALS", "target": "LOC100507600 LNCRNA"}, {"weight": 4.0, "description": "The region within MCM6 shows significant differences in DNA methylation between different haplotypes with aging, impacting lactase activity regulation.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "AGE-RELATED DNA MODIFICATIONS", "target": "MCM6 EXON 16"}, {"weight": 5.0, "description": "Regulation of LCT activity via epigenetics is conserved across mammals, indicating the importance of these mechanisms in developmental biology.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LCT ACTIVITY", "target": "EVOLUTIONARY CONSERVATION OF EPIGENETIC FACTORS"}, {"weight": 6.0, "description": "The SNP -13910 TT genotype is linked to lactase persistence, a genetic condition affecting lactose digestion into adulthood.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "SNP -13910 TT GENOTYPE", "target": "LACTASE PERSISTENCE"}, {"weight": 8.0, "description": "Increased DNA methylation inhibits CTCF binding at insulator sites, impacting tissue-specific gene expression.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "CTCF BINDING SITE", "target": "DNA METHYLATION"}, {"weight": 6.0, "description": "CRISPR-Cas9 was used to delete intronic regions that include or interact with Lct promoter elements in mouse experiments.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT PROMOTER ELEMENT", "target": "CRISPR-CAS9 SYSTEM"}, {"weight": 4.0, "description": "The MCM6 protein influences the function of enhancer elements within its introns, which regulate neighboring genes like LCT.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "MCM6 PROTEIN", "target": "ENHANCER ELEMENTS"}, {"weight": 0.5, "description": "While individuals with the T allele of rs4988235 show normal milk consumption patterns, there was no observed direct influence on RCC risk compared to other factors.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "LACTASE PERSISTENCE ALLELE (T)", "target": "RCC"}, {"weight": 1.0, "description": "Consumption of milk is associated with an increased risk of renal cell carcinoma (RCC), despite no direct genetic link through rs4988235.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "MILK CONSUMPTION", "target": "RCC"}, {"weight": 1.2, "description": "Contrary to Romania, the Czech Republic exhibits a strong association between milk consumption and RCC risk.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "CZECH REPUBLIC", "target": "ROMANIA"}, {"weight": 0.7, "description": "Both Poland and Russia show intermediate frequencies of lactase persistence alleles (rs4988235), reflecting regional genetic diversity.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "POLAND", "target": "RUSSIA"}, {"weight": 5.0, "description": "The BCL11A gene includes rs4671393 SNP that correlates with elevated baseline, MTD, and delta HbF levels post-treatment.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "BCL11A", "target": "RS4671393"}, {"weight": 4.0, "description": "The BCL11A gene includes rs11886868 SNP that shows association with MTD and delta HbF levels but not baseline.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "BCL11A", "target": "RS11886868 "}, {"weight": 5.0, "description": "The HMIP-2 gene includes rs9402686 SNP that also shows increased baseline and MTD HbF levels after treatment with hydroxyurea.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "RS9402686 ", "target": "HMIP-2 (OR HBS1L-MYB)"}, {"weight": 7.0, "description": "Hydroxyurea treatment increases HbF levels in patients, demonstrating a significant physiological impact on the disease state.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HYDROXYUREA (HU)", "target": "HEMOGLOBIN F (HBF)"}, {"weight": 5.0, "description": "Absolute neutrophil count is one of the hematological parameters measured before or after hydroxyurea treatment to assess its impact on blood cell counts, though no correlations were found with these SNPs.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "ANC (ABSOLUTE NEUTROPHIL COUNT)", "target": "MEASURED PARAMETERS "}, {"weight": 4.0, "description": "The age when patients begin hydroxyurea treatment is used as a covariate in regression models to correct for baseline and post-treatment hemoglobin F (HbF) levels.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "AGE AT START OF HU TREATMENT (AGE)", "target": "REGRESSION MODELS "}, {"weight": 5.0, "description": "The BCL11A gene contains haplotypes that influence baseline and MTD HbF levels in patients treated with hydroxyurea, particularly the G-G-T reference haplotype vs. T-A-C variant.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HAPLOTYPES ", "target": "BCL11A "}, {"weight": 5.0, "description": "The HMIP-2 gene has haplotypes including T-G, C-A, and T-A that influence baseline hemoglobin F levels post-hydroxyurea treatment.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HAPLOTYPES ", "target": "HMIP-2 (OR HBS1L-MYB)"}, {"weight": 3.0, "description": "The HMIP-2 SNP is associated with MTD HbF levels, but this association loses significance when corrected for baseline HbF.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "order": 1, "source": "HMIP-2 SNP", "target": "MTD HBF"}, {"weight": 8.0, "description": "The C-A haplotype was originally associated with MTD HbF before correction for baseline HbF, indicating a potential influence on HbF levels.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "order": 1, "source": "C-A HAPLOTYPE", "target": "MTD HBF"}, {"weight": 4.0, "description": "CD subjects carrying the C-A haplotype show a modest increase in MAPbacteremia presence but with lower association strength compared to other haplotypes.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "C-A HAPLOTYPE", "target": "MAPBACTEREMIA"}, {"weight": 5.0, "description": "Baseline HbF serves as the starting point from which delta HbF is measured, reflecting changes in HbF levels over time or due to interventions.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "order": 1, "source": "BASELINE HBF", "target": "DELTA HBF"}, {"weight": 5.0, "description": "The HMIP-2 gene contains rs9399137 SNP, which is linked to increased baseline and MTD HbF levels post-HU treatment.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HMIP-2 (OR HBS1L-MYB)", "target": "RS9399137 "}, {"weight": 4.0, "description": "Mutations in FANCA can cause Fanconi anemia by disrupting DNA repair and genomic stability mechanisms.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCA GENE", "target": "FANCONI ANEMIA (FA) DISEASE"}, {"weight": 6.0, "description": "This mutation is known to lead to Fanconi anemia by affecting the function of the FANCA protein.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "C.2574C>G/P.SER858ARG MUTATION IN FANCA", "target": "FANCONI ANEMIA (FA) DISEASE"}, {"weight": 8.0, "description": "Deficiency in monoubiquitination of FANCD2 is a hallmark of Fanconi anemia, indicating impaired DNA repair function.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCD2 PROTEIN MONOUBIQUITINATION DEFECT", "target": "FANCONI ANEMIA (FA) DISEASE"}, {"weight": 10.0, "description": "Mutations in UBE2T can cause Fanconi anemia by disrupting the ubiquitination process essential for FANCD2 activation.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCONI ANEMIA (FA) DISEASE", "target": "UBE2T GENE"}, {"weight": 14.0, "description": "Individuals with Fanconi anemia are hypersensitive to DNA cross-linking agents like DEB and MMC, leading to chromosomal breakage.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCONI ANEMIA (FA) DISEASE", "target": "ENVIRONMENTAL FACTOR - DNA CROSSLINKING AGENTS (DEB AND MMC)"}, {"weight": 8.0, "description": "The deficiency in FANCI monoubiquitination is an additional indication of disrupted Fanconi pathway caused by UBE2T mutations.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCONI ANEMIA (FA) DISEASE", "target": "FANCI PROTEIN MONOUBIQUITINATION DEFECT"}, {"weight": 12.0, "description": "The presence of compound heterozygous mutations leads to protein deficiency observed specifically in fibroblast cells, indicating tissue-specific expression or recombination.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "UBE2T PROTEIN DEFICIENCY IN FIBROBLASTS", "target": "COMPOUND HETEROZYGOUS MUTATIONS IN UBE2T"}, {"weight": 9.0, "description": "The contrast between normal UBE2T levels in LCLs and deficiency in fibroblasts suggests tissue-specific reversion or expression.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "UBE2T PROTEIN DEFICIENCY IN FIBROBLASTS", "target": "LYMPHOBLASTOID CELL LINE (LCL)"}, {"weight": 10.0, "description": "RNA-seq identified reduced UBE2T transcript levels in RA2627 fibroblasts, indicating the functional significance of UBE2T mutations.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "UBE2T PROTEIN DEFICIENCY IN FIBROBLASTS", "target": "RNA SEQUENCING (RNA-SEQ)"}, {"weight": 11.0, "description": "RT-qPCR confirmed reduced transcript levels, aligning with protein deficiency observed in fibroblasts.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "UBE2T PROTEIN DEFICIENCY IN FIBROBLASTS", "target": "RT-QPCR ANALYSIS OF UBE2T TRANSCRIPT LEVELS"}, {"weight": 10.0, "description": "Expression of wild type UBE2T rescues cellular hypersensitivity and restores physiological processes essential for DNA damage repair.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "UBE2T", "target": "WILD TYPE UBE2T EXPRESSION"}, {"weight": 1.0, "description": "The RING domain of human proteins binds Ube2T while URD does not interact directly with it according to ITC data.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "UBE2T", "target": "URD"}, {"weight": 9.0, "description": "UBE2T expression restores monoubiquitination of FANCD2, a process crucial for the cellular response to DNA crosslinking damage.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "WILD TYPE UBE2T EXPRESSION", "target": "FANCD2 MONOUBIQUITINATION"}, {"weight": 8.0, "description": "UBE2T expression also restores FANCI monoubiquitination, indicating its role in DNA repair mechanisms.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "WILD TYPE UBE2T EXPRESSION", "target": "FANCI MONOUBIQUITINATION"}, {"weight": 9.0, "description": "Overexpression of wild type UBE2T restores physiological processes essential for DNA damage repair.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "WILD TYPE UBE2T EXPRESSION", "target": "FANCD2 MONOUBIQUITINATION/FANCI MONOUBIQUITINATION"}, {"weight": 10.0, "description": "Introduction of wild type UBE2T expression rescues cellular hypersensitivity and restores DNA repair mechanisms, similar to normal cell lines (BJ).", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "WILD TYPE UBE2T EXPRESSION", "target": "RA2627 CELLS"}, {"weight": 10.0, "description": "Deficiency of UBE2T leads to Fanconi anemia subtype T due to impaired DNA repair processes.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "FANCONI ANEMIA-T SUBTYPE (FA-T)", "target": "UBE2T DEFICIENCY"}, {"weight": 8.0, "description": "Crosslinking agents cause cellular hypersensitivity in RA2627 fibroblasts due to impaired DNA repair mechanisms when UBE2T is deficient.", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "RA2627 CELLS", "target": "MMC/DEB/CISPLATIN"}, {"weight": 2.0, "description": "This frameshift mutation in the RPS19 gene leads to reduced protein levels due to NMD activation.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RPS19 GENE", "target": "FRAMESHIFT MUTATION C.58DELG"}, {"weight": 3.0, "description": "The splice site mutation affects RNA splicing, leading to exon 2 skipping and altered RPS19 expression.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RPS19 GENE", "target": "SPLICE SITE MUTATION C.1-1G>A"}, {"weight": 4.0, "description": "This mutation contributes to the differential gene expression profile seen in DBA patients.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "MISSENSE MUTATION P.ARG62TRP", "target": "DBA PATIENTS GENES"}, {"weight": 6.0, "description": "The transcriptome alterations observed in dermal fibroblasts from DBA patients correspond to the list of differentially expressed genes identified by microarray analysis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "DERMAL FIBROBLASTS TRANSCRIPTOME", "target": "DBA PATIENTS GENES"}, {"weight": 5.0, "description": "IPA analysis shows enrichment of this pathway among differentially expressed genes in DBA patients.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "INGENUITY PATHWAYS ANALYSIS (IPA)", "target": "AMINOACYL-TRNA BIOSYNTHESIS PATHWAY"}, {"weight": 7.0, "description": "Both pathways are enriched among differentially expressed genes in DBA patients, suggesting a connection between metabolic regulation and cell death signaling.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "GLYCINE SERINE AND THREONINE METABOLISM PATHWAY", "target": "DEATH RECEPTOR SIGNALING PATHWAY"}, {"weight": 8.0, "description": "Enrichment of these pathways indicates potential immune system dysregulation due to RPS19 mutations.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "PKR ROLE IN INTERFERON INDUCTION AND ANTIVIRAL RESPONSE PATHWAY", "target": "RAR ACTIVATION PATHWAY"}, {"weight": 9.0, "description": "The differential expression of RP genes and cell death regulation genes suggests a role in protein synthesis and apoptosis control affected by RPS19 mutations.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "PROTEIN SYNTHESIS GENES (RP GENES)", "target": "CELL DEATH REGULATION GENES"}, {"weight": 1.0, "description": "Ribosomal protein genes are part of a cluster involved in lipid metabolism pathways.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RP GENES CLUSTER (RPL22, RPL27A, RPL29, ETC.)", "target": "LIPID METABOLISM"}, {"weight": 1.0, "description": "Ribosomal protein genes are crucial for cellular development processes.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "RP GENES CLUSTER (RPL22, RPL27A, RPL29, ETC.)", "target": "CELLULAR DEVELOPMENT"}, {"weight": 2.0, "description": "These pathways are interconnected as lipid metabolism involves the transport of lipids across membranes.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "LIPID METABOLISM", "target": "MOLECULAR TRANSPORT"}, {"weight": 1.5, "description": "Both genes were found to be up-regulated in DBA patients relative to controls, indicating their potential role in disease pathogenesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "AMPD3", "target": "CCND2 (CYCLIN D2)"}, {"weight": 3.0, "description": "CCND2 is involved in cell cycle regulation, particularly in promoting progression from G1 to S phase.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "CCND2 (CYCLIN D2)", "target": "CELL CYCLE REGULATION"}, {"weight": 2.0, "description": "Both genes play roles in inflammatory responses and cancer progression, with SOD2 involved in antioxidant defense and TNFAIP3 regulating the NF-kappaB pathway.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "SOD2 (SUPEROXIDE DISMUTASE 2)", "target": "TNFAIP3 (TUMOR NECROSIS FACTOR, ALPHA-INDUCED PROTEIN 3)"}, {"weight": 5.0, "description": "SOD2 plays a critical role in antioxidant defense mechanisms, protecting cells from oxidative damage.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "SOD2 (SUPEROXIDE DISMUTASE 2)", "target": "ANTIOXIDANT DEFENSE"}, {"weight": 4.0, "description": "TNFAIP3 regulates inflammatory responses by controlling the NF-kappaB pathway.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "TNFAIP3 (TUMOR NECROSIS FACTOR, ALPHA-INDUCED PROTEIN 3)", "target": "INFLAMMATORY RESPONSE"}, {"weight": 0.5, "description": "These genes are differentially expressed in DBA patients, with COMP involved in cartilage/bone development and ZIC1 in neural tube formation.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "COMP (CARTILAGE OLIGOMERIC MATRIX PROTEIN)", "target": "ZIC1 (ZIC FAMILY MEMBER 1)"}, {"weight": 6.0, "description": "WARS is involved in the process of protein synthesis by activating tryptophan for incorporation into proteins.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "WARS (TRYPTOPHANYL-TRNA SYNTHETASE)", "target": "PROTEIN SYNTHESIS"}, {"weight": 7.0, "description": "ZIC1 plays a critical role in neural tube formation during embryonic development.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "order": 1, "source": "ZIC1 (ZIC FAMILY MEMBER 1)", "target": "NEURAL TUBE FORMATION"}, {"weight": 4.0, "description": "The BDNF gene contains the rs6265 polymorphism which is associated with migraine susceptibility.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "BDNF GENE", "target": "RS6265 POLYMORPHISM"}, {"weight": 3.0, "description": "Another variant of the BDNF gene, rs2049046 (A/T), also influences the risk for developing migraines.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "BDNF GENE", "target": "RS2049046 POLYMORPHISM"}, {"weight": 4.0, "description": "The BDNF gene polymorphisms were studied in five different Caucasian population groups.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "BDNF GENE", "target": "CAUCASIAN POPULATION GROUPS"}, {"weight": 4.0, "description": "The polymorphism in the BDNF gene at position rs6265 is significantly associated with migraine susceptibility.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "RS6265 POLYMORPHISM", "target": "MIGRAINE"}, {"weight": 3.0, "description": "The genetic variant rs2049046 (A/T) in the BDNF gene also shows a significant association with migraine occurrence.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "RS2049046 POLYMORPHISM", "target": "MIGRAINE"}, {"weight": 4.0, "description": "The NOS score is used to evaluate the quality of studies included in the meta-analysis, ensuring high-quality results.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "order": 1, "source": "NOS SCORE", "target": "STUDY QUALITY ASSESSMENT"}, {"weight": 4.0, "description": "These cytokines exhibit altered expression patterns in paradoxical psoriasis compared to classical psoriasis, indicating their involvement in the disease\'s immune response.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PSORIASIFORM DERMATITIS", "target": "IL-17A, IFN-\u0393, IL-22, IL-36\u0393"}, {"weight": 6.0, "description": "Histological changes characterized by hyperplasia and parakeratosis are typical in the skin lesions of patients experiencing paradoxical psoriasiform dermatitis.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PSORIASIFORM DERMATITIS", "target": "EPIDERMAL HYPERPLASIA WITH PARAKERATOSIS"}, {"weight": 5.0, "description": "These cell populations are part of the innate immunity that significantly infiltrates paradoxical psoriasiform lesions compared to classical psoriasis.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "BDCA2+ PDCS, CD15+ NEUTROPHILS, C-KIT/CD117+ MAST CELLS, CD68+ MACROPHAGES AND MONOCYTES", "target": "INNATE IMMUNITY CELLS INFILTRATION"}, {"weight": 9.0, "description": "Human peripheral blood mononuclear cells are used to assess how different IL-27 variants affect IRF1 and STAT1 transcript levels, providing insight into gene regulation mechanisms.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "PBMCS", "target": "IL-27 EFFECTS STUDY"}, {"weight": 8.0, "description": "The SNP IL23R (rs11209026) has been previously associated with paradoxical psoriasiform reactions to anti-TNF treatments.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R (RS11209026)", "target": "DISEASE, PARADOXICAL PSORIASIFORM REACTIONS TO ANTI\u2010TNFS "}, {"weight": 10.0, "description": "The SNP IL23R (rs72676067) was detected in patient 2 of the HS patients.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R (RS72676067)", "target": "HS PATIENTS "}, {"weight": 12.0, "description": "The SNP IL23R (rs1004819) was detected in patient 1 of the HS patients.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R (RS1004819)", "target": "HS PATIENTS "}, {"weight": 4.0, "description": "The human URD and the DRWD domain of Drosophila share structural similarities but differ in secondary structure elements, particularly with an intermediary position for the N-terminal lobe of the human domain.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "HUMAN FANCL CENTRAL DOMAIN STRUCTURE (URD)", "target": "DRWD DOMAIN STRUCTURE (DMFANCL)"}, {"weight": 3.0, "description": "Structural similarity between the C-terminal lobe of the URD and E2 enzymes, especially in RWD folds for the C-terminal lobe, suggests potential evolutionary or functional relationships.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "HUMAN FANCL CENTRAL DOMAIN STRUCTURE (URD)", "target": "E2 UBC ENZYME STRUCTURE"}, {"weight": 5.0, "description": "The unique structure of human URD represents a key difference from Drosophila DRWD due to vertebrate-specific element swap, placing the N-terminal lobe in an intermediary position.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "HUMAN FANCL CENTRAL DOMAIN STRUCTURE (URD)", "target": "VERTEBRATE FANCLS FEATURE (ELEMENT SWAP)"}, {"weight": 5.0, "description": "The thioester charge assay revealed that despite structural similarity to catalytic cysteines of E2 enzymes, the cysteine in the human FANCL central domain\'s N-terminal lobe does not form a thioester bond with ubiquitin.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "CYSTEINE IN URD N-TERMINAL LOBE (URD)", "target": "THIOESTER CHARGE ASSAY"}, {"weight": 4.0, "description": "The hydrophobic core conservation between human URD and Drosophila DRWD indicates a conserved structural interaction, despite differences in surface exposure suggesting evolutionary adaptation for vertebrate systems.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "HYDROPHOBIC CORE BETWEEN LOBES OF HUMAN FANCL CENTRAL DOMAIN AND DMDRWD DOMAINS", "target": "SURFACE CONSERVATION COMPARISON (URD VS DMDRWD)"}, {"weight": 5.0, "description": "While specific interaction residues vary, the hydrophobic core between lobes is highly conserved in human URD compared to Drosophila DRWD.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "HYDROPHOBIC CORE BETWEEN LOBES OF HUMAN FANCL CENTRAL DOMAIN AND DMDRWD DOMAINS", "target": "INTERACTION RESIDUES BETWEEN LOBES (HUMAN URD VS DMDRWD)"}, {"weight": 3.0, "description": "Additional hydrophobic patches on the human URD compared to Drosophila suggest potential for differential interactions required in vertebrate systems, reflecting differences observed in surface conservation analysis.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "SURFACE CONSERVATION COMPARISON (URD VS DMDRWD)", "target": "HYDROPHOBIC PATCHES ON HUMAN FANCL CENTRAL DOMAIN (URD)"}, {"weight": 4.0, "description": "Comparative analysis highlights differences in surface conservation and hydrophobic patches between vertebrate URD and invertebrate DRWD, indicative of unique interaction patterns.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "SURFACE CONSERVATION COMPARISON (URD VS DMDRWD)", "target": "CONSERVATION OF FANCL PROTEINS (VERTEBRATE VS INVERTEBRATE)"}, {"weight": 4.0, "description": "Structural similarity but functional difference, with the cysteine residue in human FANCL central domain unable to form thioester bonds similar to Ube2T\u2019s catalytic cysteine.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "UBE2T CATALYTIC CYSTEINE RESIDUE (UBIQUITIN-CONJUGATING ENZYME)", "target": "CATALYTIC CYSTEINE IN URD N-TERMINAL LOBE (URD)"}, {"weight": 4.0, "description": "Additional surface hydrophobic patches on human URD suggest differential interaction requirements compared to Drosophila DRWD, reflecting evolutionary adaptations.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "SURFACE CONSERVATION COMPARISON DETAILS (URD VS DMDRWD)", "target": "HYDROPHOBIC EXPOSURE PATCHES (URD N-TERMINAL LOBE)"}, {"weight": 1.0, "description": "The \u03b2-meander patch is part of the structural features on the URD contributing to its function.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "URD", "target": "\u0392-MEANDER PATCH"}, {"weight": 2.0, "description": "Distinct electrostatic potential differences between human URD and Drosophila DRWD indicate functional variations in protein-protein interactions.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "URD", "target": "ELECTROSTATIC POTENTIAL OF SURFACE URD VS DMDRWD"}, {"weight": 5.0, "description": "The URD protein interacts with FANCI, a key component in DNA repair mechanisms.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "URD", "target": "FANCI"}, {"weight": 5.0, "description": "The URD protein also interacts with FANCD2, another critical element of the Fanconi anemia pathway.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "URD", "target": "FANCD2"}, {"weight": 2.0, "description": "Experiments show that the hydrophobic patches on the C-terminal lobe of the RING domain are necessary for binding FANCI.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "RING DOMAIN", "target": "FANCI"}, {"weight": 3.0, "description": "Similar to FANCI, mutations in the hydrophobic patches on the RING domain reduce its interaction with FANCD2.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "RING DOMAIN", "target": "FANCD2"}, {"weight": 3.0, "description": "Mutations in hydrophobic patches on the C-terminal lobe affect binding affinity with FANCI and FANCD2, suggesting their importance for substrate interaction.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "RING DOMAIN", "target": "HYDROPHOBIC GROOVE ON C-TERMINAL DOMAIN"}, {"weight": 5.0, "description": "FANCI and FANCD2 proteins interact in substrate binding, indicating a molecular interaction required for proper function in DNA repair pathways.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "FANCI", "target": "FANCD2"}, {"weight": 3.0, "description": "The mutant L248A/F252A/L254A/I265A of URD shows reduced binding affinity with FANCI, indicating a critical role for specific residues in protein-protein interactions.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "FANCI", "target": "L248A/F252A/L254A/I265A MUTANT URD"}, {"weight": 3.0, "description": "The W212A/L214A mutant of URD behaves similarly to wild type in substrate binding assays with FANCI, suggesting that certain mutations do not affect binding.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "FANCI", "target": "W212A/L214A MUTANT URD"}, {"weight": 3.0, "description": "The mutant L248A/F252A/L254A/I265A of URD shows reduced binding affinity with FANCD2, similar to its interaction with FANCI.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "FANCD2", "target": "L248A/F252A/L254A/I265A MUTANT URD"}, {"weight": 3.0, "description": "The W212A/L214A mutant of URD behaves similarly to wild type in substrate binding assays with FANCD2, similar to its interaction with FANCI.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "FANCD2", "target": "W212A/L214A MUTANT URD"}, {"weight": 4.0, "description": "This genomic variant is associated with differential treatment responses to colesevelam, affecting AC t1/2 and GC24.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "FGFR4 RS351855 (GLY388ARG)", "target": "COLESEVELAM TREATMENT"}, {"weight": 6.0, "description": "Differential effects of colesevelam on CT are observed in the presence of this genomic variant, impacting GC24 values significantly.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "KLB RS4975017", "target": "COLESEVELAM TREATMENT"}, {"weight": 6.0, "description": "This genetic variation shows numerical but not statistically significant differential responses to colesevelam, affecting AC t1/2 and GC24.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "KLB RS17618244 (ARG728GLN)", "target": "COLESEVELAM TREATMENT"}, {"weight": 6.0, "description": "The AC t1/2 is influenced by genetic variations in FGFR4 and KLB, showing differential effects of colesevelam treatment.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "COLESEVELAM TREATMENT", "target": "AC T1/2 (AREA UNDER CURVE TIME 1/2)"}, {"weight": 6.0, "description": "The GC24 level changes depending on the presence of certain genetic variations under colesevelam treatment, indicating differential metabolic effects.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "COLESEVELAM TREATMENT", "target": "GC24 (GLYCEMIC CONTROL 24 HOURS)"}, {"weight": 2.0, "description": "This genomic variant failed to satisfy Hardy-Weinberg equilibrium in the study.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "FGFR4 RS376618", "target": "HWE ASSESSMENT"}, {"weight": 2.0, "description": "The genotypes of healthy control patients were used to assess Hardy-Weinberg equilibrium for candidate SNPs.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "HEALTHY CONTROL PATIENTS", "target": "HWE ASSESSMENT"}, {"weight": 8.0, "description": "Increased levels of serum C4 are associated with elevated stool bile acid excretion in IBS-D patients.<SEP>There is a significant correlation between serum C4 levels and stool bile acid excretion in IBS-D patients.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "STOOL BA (BILE ACIDS)", "target": "SERUM C4"}, {"weight": 3.0, "description": "The genomic variant FGFR4 rs1966265 is marginally associated with stool BA levels, suggesting a role in bile acid synthesis or excretion.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "STOOL BA (BILE ACIDS)", "target": "FGFR4 RS1966265"}, {"weight": 3.0, "description": "The genomic variant FGFR4 rs1966265 is marginally associated with stool BA but not serum C4, indicating a potential influence on bile acid metabolism.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "SERUM C4", "target": "FGFR4 RS1966265"}, {"weight": 2.0, "description": "Genetic variants KLB rs17618244 and other FGFR4 SNPs were tested but showed no significant associations with serum C4 or stool BA.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "KLB RS17618244", "target": "FGFR4 RS351855, FGFR4 RS376618"}, {"weight": 4.0, "description": "Higher BMI is correlated with higher serum C4 levels and total stool bile acids, indicating a relationship between metabolic status and FGF19 regulation.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BMI, STOOL BA (BILE ACIDS)", "target": "FGF19 LEVELS"}, {"weight": 4.0, "description": "FAAP20 can bind to K48-linked diubiquitin chains, indicating non-specific binding preference.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FAAP20", "target": "K48-LINKED UB2 "}, {"weight": 4.0, "description": "FAAP20 interacts with M1-linked diubiquitin chains, demonstrating non-specific binding capability.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FAAP20", "target": "M1-LINKED UB2 "}, {"weight": 5.0, "description": "The FAAP20-UBZ protein specifically interacts with K63-linked Ub2, as shown by its crystal structure and biochemical experiments.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "K63-LINKED UB2 (K63-UB2)", "target": "FAAP20-UBZ"}, {"weight": 5.0, "description": "The central \u03b1-helix in FAAP20-UBZ interacts specifically with the K63 residue on the distal ubiquitin molecule.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "CENTRAL \u0391-HELIX (RESIDUES 160\u2013173)", "target": "K63 OF DISTAL UB "}, {"weight": 5.0, "description": "The Ile44-centered hydrophobic patch in ubiquitin is crucial for interaction with FAAP20\'s UBZ domain.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "ILE44 PATCH (OF UB)", "target": "FAAP20-UBZ"}, {"weight": 4.0, "description": "FAAP20-UBZ can bind K48-linked diubiquitin chains.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FAAP20-UBZ (RESIDUES 143\u2013180)", "target": "K48-LINKED UB2 "}, {"weight": 4.0, "description": "FAAP20-UBZ can interact with M1-linked diubiquitin chains.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FAAP20-UBZ (RESIDUES 143\u2013180)", "target": "M1-LINKED UB2 "}, {"weight": 4.0, "description": "Ubiquitin interacts with FAAP20-UBZ through specific residues, contributing to the binding and recruitment of FAAP20 to DNA damage sites.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "UBIQUITIN (UB)", "target": "FAAP20-UBZ"}, {"weight": 2.0, "description": "Specific residues on WRNIP1-UBZ interact with Ubiquitin to facilitate the binding and localization of WRNIP1 to DNA damage sites.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "UBIQUITIN (UB)", "target": "WRNIP1-UBZ"}, {"weight": 3.0, "description": "Similar to WRNIP1, specific residues on RAD18-UBZ interact with Ubiquitin for binding and recruitment to DNA damage sites.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "UBIQUITIN (UB)", "target": "RAD18-UBZ"}, {"weight": 2.0, "description": "Unlike other UBZ proteins, Pol\u03b7-UBZ interacts uniquely with Ubiquitin, suggesting a different role in cellular processes compared to WRNIP1 and RAD18.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "UBIQUITIN (UB)", "target": "POL\u0397-UBZ"}, {"weight": 4.0, "description": "Specific residues on NEMO-UBZ interact differently from other UBZ proteins with Ubiquitin, indicating unique roles in cellular processes.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "UBIQUITIN (UB)", "target": "NEMO-UBZ"}, {"weight": 4.0, "description": "These residues on NEMO-UBZ and Pol\u03b7-UBZ interact uniquely with ubiquitin contributing to different binding mechanisms.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "UBIQUITIN (UB)", "target": "PRO398-LYS399 IN NEMO-UBZ AND GLU636-LYS637 IN POL\u0397-UBZ"}, {"weight": 4.0, "description": "ITC measures equilibrium dissociation constants for protein-protein interactions, such as Pol\u03b7 UBZ with ubiquitin.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "ISOTHERMAL TITRATION CALORIMETRY (ITC)", "target": "BINDING AFFINITY MEASUREMENT "}, {"weight": 5.0, "description": "Typically present in classical UBZ folds but absent in FAAP20-UBZ structure.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "TWO SHORT \u0392 STRANDS ", "target": "CLASSICAL UBZ FOLD "}, {"weight": 5.0, "description": "Residues and their aliphatic portions involved in hydrophobic interactions with FAAP20-UBZ.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "LEU8, ILE44, VAL70, THR66, HIS68 (OF UB)", "target": "HYDROPHOBIC INTERACTIONS "}, {"weight": 3.0, "description": "The hydrophobic patch on ubiquitin interacts with FAAP20-UBZ to facilitate binding and localization.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "FAAP20-UBZ", "target": "ILE44-CENTERED HYDROPHOBIC PATCH OF UB"}, {"weight": 3.0, "description": "The presence of ICL sites indicates a need for DNA repair processes, where proteins like FAAP20-UBZ play crucial roles in recruitment and repair.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "ICL SITES", "target": "DNA DAMAGE REPAIR PROCESS"}, {"weight": 3.0, "description": "These residues contribute to the hydrophobic patch on ubiquitin that interacts with FAAP20-UBZ.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "ILE44-CENTERED HYDROPHOBIC PATCH OF UB", "target": "LEU8, VAL70, THR66, HIS68 OF UB"}, {"weight": 3.0, "description": "The residues in the \u03b2-loop contribute to interactions with Ile44 on ubiquitin facilitating binding and localization.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "ILE44-CENTERED HYDROPHOBIC PATCH OF UB", "target": "PRO21-VAL22 IN THE \u0392-LOOP OF WRNIP1"}, {"weight": 5.0, "description": "The C-terminal loop in FAAP20 interacts specifically with residues on ubiquitin facilitating binding and localization.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "ILE44-CENTERED HYDROPHOBIC PATCH OF UB", "target": "C-TERMINAL LOOP OF FAAP20-UBZ"}, {"weight": 5.0, "description": "These residues interact with Arg42 on ubiquitin to facilitate binding and localization.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "ASP37 IN WRNIP1 \u0391-HELIX AND ASP177 IN C-TERMINAL LOOP OF FAAP20", "target": "ARG42 IN UBIQUITIN (UB)"}, {"weight": 6.0, "description": "Pol\u03b7-UBZ binds Ub in a manner similar to FAAP20-UBZ, suggesting conserved critical residues for interaction.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "POL\u0397-UBZ (PDB CODE: 2I5O)", "target": "UB"}, {"weight": 6.0, "description": "The interaction between WRNIP1-UBZ and Ub involves the \u03b2-loop, distinct from FAAP20-UBZ and Pol\u03b7-UBZ.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "UB", "target": "WRNIP1-UBZ (PDB CODE: 2JVX)"}, {"weight": 8.0, "description": "FAAP20-UBZ interacts with Ub through residues in the \u03b1-helix, showing similarity to Rabex5-MIU and distinctiveness from NEMO-UBZ.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "UB", "target": "FAAP20-UBZ (PDB CODE: 2I5O)"}, {"weight": 8.0, "description": "The interaction between Vps27-UIM and Ub is similar in critical residues to Rabex5-MIU, suggesting convergent evolution of the motif.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "UB", "target": "VPS27-UIM (PDB CODE: 1Q0W)"}, {"weight": 8.0, "description": "The interaction between Rabex5-MIU and Ub shares critical binding residues with FAAP20-UBZ, indicative of convergent evolution.<SEP>The interaction between Rabex5-MIU and Ub shares critical residues with FAAP20-UBZ, indicative of convergent evolution.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "UB", "target": "RABEX5-MIU (PDB CODE: 2C7M AND 2FIF)"}, {"weight": 3.0, "description": "The \u03b2-loop in WRNIP1-UBZ interacts with Ub via specific residues that are different from those of NEMO-UBZ.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "WRNIP1-UBZ (PDB CODE: 2JVX)", "target": "\u0392-LOOP (IN UBZ DOMAINS)"}, {"weight": 8.0, "description": "The MIU motif shares critical binding residues with FAAP20-UBZ and Rabex5-MIU, indicating convergent evolution.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "FAAP20-UBZ (PDB CODE: 2I5O)", "target": "MIU (MOTIF INTERACTING WITH UBIQUITIN)"}, {"weight": 4.0, "description": "The \u03b1-helix in FAAP20-UBZ interacts with Ub through residues that are conserved and critical for binding, showing similarity to Rabex5-MIU.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "FAAP20-UBZ (PDB CODE: 2I5O)", "target": "\u0391-HELIX (IN UBZ/UIM/MIU STRUCTURES)"}, {"weight": 8.0, "description": "The UIM motif interacts with Ub similarly to Vps27-UIM in critical residues, despite opposite polarity.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "VPS27-UIM (PDB CODE: 1Q0W)", "target": "UIM (UB-INTERACTING MOTIF)"}, {"weight": 3.0, "description": "GST-pulldown technique used to investigate binding interactions between FAAP20 and FANCA.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FANCA INTERACTION STUDIES ", "target": "GST-PULLDOWN ASSAY "}, {"weight": 3.0, "description": "The frequency of the minor \'C\' allele at rs7775228 is higher among CD patients than controls, indicating a potential risk association with the disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "RS7775228", "target": "CROHN\'S DISEASE (CD)"}, {"weight": 4.0, "description": "The presence of the minor \'T\' allele at rs2187668 is significantly higher in CD patients, suggesting a strong risk factor for developing Crohn\u2019s disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "RS2187668", "target": "CROHN\'S DISEASE (CD)"}, {"weight": 5.0, "description": "The homozygous HLA-DQ2.5 haplotype is more prevalent in CD patients, contributing to the genetic risk of developing Crohn\u2019s disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "HLA-DQ2.5 HAPLOTYPE", "target": "CROHN\'S DISEASE (CD)"}, {"weight": 6.0, "description": "The heterozygous DQ8 haplotypes are highly frequent among CD patients and contribute significantly to the genetic predisposition for Crohn\u2019s disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "HLA-DQ8 HAPLOTYPE", "target": "CROHN\'S DISEASE (CD)"}, {"weight": 1.0, "description": "The genomic variant rs7454108 does not show a significant difference between CD patients and controls, indicating it is not a strong risk factor for the disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "RS7454108"}, {"weight": 2.0, "description": "The homozygous HLA-DQ2.2 haplotype is more frequent in controls than CD patients, suggesting its potential protective role against developing Crohn\u2019s disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "HOMOZYGOUS HLA-DQ2.2 HAPLOTYPE"}, {"weight": 3.0, "description": "The higher frequency of DQ8/DQX haplotype in CD patients compared to controls indicates its significant contribution as a risk factor for the disease.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "DQ8/DQX HAPLOTYPES"}, {"weight": 5.0, "description": "A common symptom of Crohn\u2019s disease characterized by prolonged diarrhea, often lasting several weeks or longer due to inflammation and altered bowel function.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "CHRONIC DIARRHEA"}, {"weight": 6.0, "description": "Localized abdominal pain is a frequent clinical manifestation in CD patients, reflecting the site of gastrointestinal inflammation and involvement.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "ABDOMINAL PAIN"}, {"weight": 7.0, "description": "Loss of appetite or disinterest in food is commonly observed in CD patients due to systemic responses to chronic inflammation affecting the digestive system.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "ANOREXIA"}, {"weight": 8.0, "description": "Swelling of the abdomen, often linked with bowel obstruction or excessive gas accumulation, is a notable symptom seen in Crohn\u2019s disease patients due to intestinal blockages and inflammation.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CROHN\'S DISEASE (CD)", "target": "ABDOMINAL DISTENSION"}, {"weight": 9.0, "description": "This haplotype combination between PTPN2:rs478582 and PTPN22:rs2476601 was more frequent in healthy controls, suggesting a protective role or reduced disease risk.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "HEALTHY CONTROLS", "target": "HAPLOTYPE COMBINATION T-G"}, {"weight": 9.0, "description": "The transcript level of PTPN2 is higher in healthy controls compared to CD patients, indicating a protective role of normal expression levels.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "HEALTHY CONTROLS", "target": "PTPN2 TRANSCRIPT"}, {"weight": 4.0, "description": "The demographic profile, including age and sex distributions, is compared between healthy controls and HIV-infected individuals to understand genetic associations.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "HEALTHY CONTROLS", "target": "DEMOGRAPHIC PROFILE"}, {"weight": 4.0, "description": "The control group\'s haplotype distribution is compared with HIV-infected individuals to assess genetic associations in TLR7 gene.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "HEALTHY CONTROLS", "target": "TLR7 HAPLOTYPES (RS179008 AND RS179009)"}, {"weight": 5.0, "description": "Both chronic eczema and autoimmune thyroiditis can be outcomes of immune dysregulation in STAT5B deficient individuals.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "AUTOIMMUNE THYROIDITIS", "target": "CHRONIC ECZEMA"}, {"weight": 2.0, "description": "The rs1128503 variant in ABCB1 is significantly associated with grade 3-4 anemia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS1128503 (ABCB1)", "target": "GRADE 3\u20134 ANEMIA"}, {"weight": 2.0, "description": "The rs12762549 variant in ABCC2 is significantly associated with grade 3-4 anemia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS12762549 (ABCC2)", "target": "GRADE 3\u20134 ANEMIA"}, {"weight": 2.0, "description": "The rs363717 variant in ABCA1 is significantly associated with grade 3-4 anemia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS363717 (ABCA1)", "target": "GRADE 3\u20134 ANEMIA"}, {"weight": 2.0, "description": "The rs11615 variant in ERCC1 is significantly associated with grade 3-4 anemia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS11615 (ERCC1)", "target": "GRADE 3\u20134 ANEMIA"}, {"weight": 2.0, "description": "The rs4986910 variant in CYP3A4 is significantly associated with thrombocytopenia grade 3-4.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS4986910 (CYP3A4)", "target": "THROMBOCYTOPENIA GRADE 3\u20134"}, {"weight": 3.0, "description": "The rs2074087 variant in ABCC1 is significantly associated with the use of ESAs.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS2074087 (ABCC1)", "target": "ERYTHROPOIETIN-STIMULATING AGENTS (ESAS)"}, {"weight": 3.0, "description": "The rs2073337 variant in ABCC2 is significantly associated with the use of CSFs.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS2073337 (ABCC2)", "target": "COLONY-STIMULATING FACTORS (CSFS)"}, {"weight": 3.0, "description": "The rs1695 variant in GSTP1 is significantly associated with the use of CSFs.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS1695 (GSTP1)", "target": "COLONY-STIMULATING FACTORS (CSFS)"}, {"weight": 3.0, "description": "The rs1799793 variant in ERCC2 is significantly associated with PFI.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS1799793 (ERCC2)", "target": "PROGRESSION-FREE INTERVAL (PFI)"}, {"weight": 2.0, "description": "The rs3814879 variant in TGFBR2 is associated with an increased risk for severe radiation pneumonitis.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS3814879 (TGFBR2)", "target": "RADIATION PNEUMONITIS"}, {"weight": 3.0, "description": "The rs7156029 variant in HLA-DQB1 is correlated with the response to immunotherapy.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS7156029 (HLA-DQB1)", "target": "RESPONSE TO IMMUNOTHERAPY"}, {"weight": 2.0, "description": "The rs113498797 variant in MYH6 increases the risk of atrial fibrillation.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS113498797 (MYH6)", "target": "ATRIAL FIBRILLATION"}, {"weight": 4.0, "description": "The genomic variant rs1799793 in ERCC2 gene is significantly correlated with platinum-free interval (PFI) survival.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "RS1799793 (ERCC2 G\u2009>\u2009A)", "target": "PLATINUM-FREE INTERVAL"}, {"weight": 3.0, "description": "The ABCC2 gene harbors a significant genomic variant, rs12762549, which affects platinum-free interval (PFI) survival.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "RS12762549 (ABCC2 A\u2009>\u2009G)", "target": "ABCC2 GENE"}, {"weight": 3.0, "description": "The genomic variant rs12762549 in ABCC2 gene is significantly associated with platinum-free interval (PFI) survival when fully adjusted for multiple factors.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "RS12762549 (ABCC2 A\u2009>\u2009G)", "target": "PLATINUM-FREE INTERVAL"}, {"weight": 3.0, "description": "The SERPINB2 gene harbors a significant genomic variant, rs6104, which affects platinum-free interval (PFI) survival.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "RS6104 (SERPINB2 C\u2009>\u2009G)", "target": "SERPINB2 GENE"}, {"weight": 3.0, "description": "The genomic variant rs6104 in SERPINB2 gene is significantly associated with platinum-free interval (PFI) survival when fully adjusted for multiple factors.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "RS6104 (SERPINB2 C\u2009>\u2009G)", "target": "PLATINUM-FREE INTERVAL"}, {"weight": 3.0, "description": "The effect of the ERCC2 G>A variant on survival duration is less pronounced when only age at diagnosis is considered compared to a fully adjusted model.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "ERCC2 G\u2009>\u2009A VARIANT CARRIERS (GG)", "target": "AGE AT DIAGNOSIS"}, {"weight": 4.0, "description": "The FIGO stage, along with other factors, influences the survival advantage observed in GG carriers of rs1799793 in ERCC2 gene.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "ERCC2 G\u2009>\u2009A VARIANT CARRIERS (GG)", "target": "FIGO STAGE"}, {"weight": 4.0, "description": "The tumor grade is a factor that, when adjusted for, reveals the significant advantage of GG carriers in terms of platinum-free interval compared to other genotypes.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "ERCC2 G\u2009>\u2009A VARIANT CARRIERS (GG)", "target": "TUMOR GRADE"}, {"weight": 4.0, "description": "The amount of residual disease after surgery, when adjusted for alongside other factors like ERCC2 genotype, influences patient prognosis and survival outcomes.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "ERCC2 G\u2009>\u2009A VARIANT CARRIERS (GG)", "target": "RESIDUAL DISEASE AFTER DEBULKING SURGERY"}, {"weight": 4.0, "description": "Individuals with AA or GA genotype in rs1799793 have a significant disadvantage in platinum-free interval compared to GG carriers, indicating worse survival outcomes.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "ERCC2 G\u2009>\u2009A VARIANT CARRIERS (AA/GA)", "target": "PLATINUM-FREE INTERVAL (PFI)"}, {"weight": 2.0, "description": "The UMPS gene is part of a de novo deletion on chromosome 3, which may contribute to the patient\'s phenotype due to loss of function of multiple genes.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS GENE", "target": "DE NOVO DELETION ON CHROMOSOME 3"}, {"weight": 3.0, "description": "Individual I4 harbors a variant (c.302delA) within the UMPS gene, leading to premature stop codon and loss of normal protein function.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS GENE", "target": "C.302DELA IN I4"}, {"weight": 4.0, "description": "Individuals I7 and their healthy brother S7 share a maternally inherited variant (c.385G>T) within the UMPS gene leading to loss of protein function.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS GENE", "target": "C.385G>T IN I7 AND S7"}, {"weight": 5.0, "description": "A heterozygous missense alteration (c.224C>A) found across multiple members of pedigree 2 within the UMPS gene, potentially pathogenic.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS GENE", "target": "C.224C>A IN PEDIGREE 2 FAMILY MEMBERS"}, {"weight": 6.0, "description": "Maternally inherited missense alterations (c.689G>A and c.688C>T) found within the UMPS gene leading to changes that are predicted to be pathogenic.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS GENE", "target": "C.689G>A AND C.688C>T IN I6 AND I7"}, {"weight": 12.0, "description": "Testing method used to exclude copy number variations in the UMPS gene, particularly for individuals I4, 6 and 7.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS GENE", "target": "HIGH-DENSITY GENE-CENTRIC ARRAY CGH TESTING"}, {"weight": 8.0, "description": "The variant c.302delA leads to premature stop codon and triggers protein truncation/NMD leading to loss of function.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.302DELA IN I4", "target": "PROTEIN TRUNCATION OR NONSENSE-MEDIATED MRNA DECAY (NMD)"}, {"weight": 9.0, "description": "The variant c.385G>T leads to premature stop codon and triggers protein truncation/NMD leading to loss of function.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.385G>T IN I7 AND S7", "target": "PROTEIN TRUNCATION OR NONSENSE-MEDIATED MRNA DECAY (NMD)"}, {"weight": 10.0, "description": "Predictive software indicates the variant c.224C>A is potentially pathogenic within UMPS gene.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.224C>A IN PEDIGREE 2 FAMILY MEMBERS", "target": "POLYPHEN-2, SIFT, MUTATIONTASTER PROGRAMS"}, {"weight": 11.0, "description": "Predictive software indicates missense alterations (c.689G>A and c.688C>T) within UMPS gene are potentially pathogenic.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "C.689G>A AND C.688C>T IN I6 AND I7", "target": "POLYPHEN-2, SIFT, MUTATIONTASTER PROGRAMS"}, {"weight": 2.0, "description": "The T allele in the TGF-\u00df1 gene is associated with a significantly higher risk of CRC.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "TGF-SS1 (RS1800469 C/T)", "target": "COLORECTAL CANCER (CRC)"}, {"weight": 1.0, "description": "No significant association between the polymorphism in the promoter region of IL-8 and CRC was found.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-8 (RS4073 T/A)", "target": "COLORECTAL CANCER (CRC)"}, {"weight": 3.0, "description": "The G allele in IL-10 is associated with reduced risk of developing colorectal cancer.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-10 (RS1800896 A/G)", "target": "COLORECTAL CANCER (CRC)"}, {"weight": 2.0, "description": "The G allele in rs1179251 in IL-22 is associated with increased risk of CRC, but not significantly.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-22 (RS1179251 C/G)", "target": "COLORECTAL CANCER (CRC)"}, {"weight": 1.0, "description": "No significant association was found between the polymorphism in IL-22 and the occurrence of CRC.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-22 (RS2227485 C/T)", "target": "COLORECTAL CANCER (CRC)"}, {"weight": 3.0, "description": "The presence of the GG genotype for rs17855750 in IL-27 is associated with reduced risk of CRC.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-27 (RS17855750 T/G)", "target": "COLORECTAL CANCER (CRC)"}, {"weight": 2.0, "description": "The rs1179251 C/G polymorphism in IL-22 gene is associated with a decreased risk of developing CRC but lacks strong statistical significance.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "COLORECTAL CANCER (CRC)", "target": "IL-22 GENE (RS1179251 C/G)"}, {"weight": 3.0, "description": "The G allele in IL-27 gene shows protective effects against colorectal cancer development, though the association is weak.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "COLORECTAL CANCER (CRC)", "target": "IL-27 GENE (RS17855750 T/G)"}, {"weight": 1.0, "description": "The T allele showed a slightly lower frequency in CRC patients compared to controls, but this did not reach statistical significance (p=0.161, OR=0.68).)", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "order": 1, "source": "CRC", "target": "T ALLELE"}, {"weight": 2.0, "description": "The genetic variants of IL-8 and IL-10 both contribute to immune system modulation, with IL-10 showing a more pronounced effect on CRC risk reduction.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-10 GENE (RS1800896 A/G)", "target": "IL-8 GENE (RS4073 T/A)"}, {"weight": 2.0, "description": "Both TGF-\u00df1 and IL-10 genes have polymorphisms studied for CRC risk, with contrasting outcomes: increased risk in TGF-\u00df1, reduced risk in IL-10.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-10 GENE (RS1800896 A/G)", "target": "TGF-SS1 GENE (RS1800469 C/T)"}, {"weight": 2.0, "description": "A lower frequency of the T allele was observed in CRC patients compared to the control group but did not reach statistical significance.)", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "order": 1, "source": "CONTROL GROUP VS CRC PATIENTS", "target": "T ALLELE FREQUENCY"}, {"weight": 5.0, "description": "The TSLP gene contributes to asthma susceptibility through genetic variations such as SNPs.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "TSLP GENE", "target": "ASTHMA SUSCEPTIBILITY"}, {"weight": 4.0, "description": "Smoking history affects the association of SNP rs1898671 in TSLP with increased risk for asthma.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "SNP (RS1898671)", "target": "EX-SMOKERS"}, {"weight": 3.0, "description": "There is no significant association between SNP rs1898671 and asthma risk among never-smokers.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "SNP (RS1898671)", "target": "NEVER-SMOKERS"}, {"weight": 4.0, "description": "This specific haplotype within the TSLP gene is linked with increased risk of developing asthma after adjusting for covariates.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "ASTHMA SUSCEPTIBILITY", "target": "TSLP HAPLOTYPE (GAGGGCAAAG)"}, {"weight": 5.0, "description": "Lower lung function tests results such as FEV1 and FVC were observed in asthmatic patients compared to healthy controls.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "ASTHMATIC PATIENTS", "target": "LUNG FUNCTION TESTS (FEV1, FVC)"}, {"weight": 4.0, "description": "Higher total IgE levels are associated with asthma cases, indicating increased immune system activity.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "ASTHMATIC PATIENTS", "target": "TOTAL IGE LEVELS"}, {"weight": 3.0, "description": "The presence of atopy is more common among asthmatic patients compared to the control group.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "ASTHMATIC PATIENTS", "target": "ATOPIC STATUS"}, {"weight": 4.0, "description": "Race/ethnicity information is used to adjust for potential biases in genetic association studies.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "SELF-REPORTED RACE/ETHNICITY INFORMATION", "target": "POPULATION STRATIFICATION ADJUSTMENT"}, {"weight": 9.0, "description": "The transcript level of the PTPN2 gene is regulated by genetic variants like SNP rs478582, leading to lower expression in CD patients compared to healthy controls.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "PTPN2 GENE", "target": "PTPN2 TRANSCRIPT"}, {"weight": 5.0, "description": "The PTPN2 gene is associated with rs1893217, a SNP linked to reduced efficacy of anti-CTLA-4 therapy in metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "PTPN2 GENE", "target": "RS1893217"}, {"weight": 6.0, "description": "The response rate for anti-CTLA-4 treatment is influenced by genetic variations within the PTPN2 gene, particularly rs1893217.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "PTPN2 GENE", "target": "ANTI-CTLA-4 TREATMENT"}, {"weight": 8.0, "description": "The PTPN22 gene is associated with the SNP rs2476601, which though not significant in CD, shows a different haplotype distribution when combined with rs478582 from PTPN2.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "PTPN22 GENE", "target": "RS2476601"}, {"weight": 9.0, "description": "The SNP rs478582 in the PTPN2 gene is significantly associated with Crohn\'s disease, indicating its potential role in the etiology of CD.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "RS478582", "target": "CD (CROHN\'S DISEASE)"}, {"weight": 9.0, "description": "The SNP rs478582 in the PTPN2 gene increases predisposition to Crohn\'s Disease due to altered expression levels and allele frequencies.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "RS478582", "target": "PREDISPOSITION TO CD"}, {"weight": 7.0, "description": "Although not directly significant, haplotype analysis suggests a combined effect with PTPN2:rs478582 influencing Crohn\'s disease risk.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "RS2476601", "target": "CD (CROHN\'S DISEASE)"}, {"weight": 9.0, "description": "Although not directly significant, rs2476601 in the PTPN22 gene can contribute to Crohn\'s Disease predisposition when combined with rs478582.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "RS2476601", "target": "PREDISPOSITION TO CD"}, {"weight": 9.0, "description": "The haplotype combination of heterozygous/major alleles for rs478582 and rs2476601 is significantly higher in CD subjects, indicating a potential genetic risk factor.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "CD (CROHN\'S DISEASE)", "target": "HAPLOTYPE COMBINATION C-G"}, {"weight": 9.0, "description": "The haplotype combination of heterozygous/major alleles for rs478582 and the minor/heterozygous or minor allele for rs2476601 is significantly higher in CD compared to healthy controls, indicating a strong genetic risk factor.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "CD (CROHN\'S DISEASE)", "target": "HAPLOTYPE COMBINATION C-A"}, {"weight": 9.0, "description": "The expression level of the PTPN2 gene is significantly lower in CD patients compared to healthy controls, indicating its role in disease susceptibility.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "CD (CROHN\'S DISEASE)", "target": "PTPN2 GENE EXPRESSION"}, {"weight": 1.0, "description": "The relative gene expression is lower among CD subjects with heterozygous or minor alleles in PTPN2:rs478582 compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN2:RS478582", "target": "CD AVERAGE RELATIVE GENE EXPRESSION"}, {"weight": 1.0, "description": "The relative gene expression of IFN-\u03b3 is higher among CD subjects with heterozygous or minor alleles in PTPN2:rs478582 compared to those with normal alleles.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN2:RS478582", "target": "IFN-\u0393 GENE EXPRESSION"}, {"weight": 3.0, "description": "The susceptibility to MAP infection is higher among CD subjects with heterozygous or minor alleles in PTPN2:rs478582 compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN2:RS478582", "target": "MAP INFECTION SUSCEPTIBILITY"}, {"weight": 3.0, "description": "Genomic variants like PTPN2:rs478582 impact the T-cell proliferation response in CD subjects.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "PTPN2:RS478582", "target": "T-CELL PROLIFERATION RESPONSE"}, {"weight": 5.0, "description": "The genomic variant rs478582 is located within the PTPN2 gene.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "PTPN2:RS478582", "target": "PTPN2"}, {"weight": 2.0, "description": "The relative gene expression of the PTPN22 protein is not affected by heterozygous or minor alleles in PTPN22:rs2476601.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "CD AVERAGE RELATIVE GENE EXPRESSION", "target": "PTPN22:RS2476601"}, {"weight": 5.0, "description": "Combined effect of MAPbacteremia and specific SNPs (PTPN2 or PTPN22) can increase the expression level of IFN-\u03b3 compared to subjects without these factors.<SEP>The higher IFN-\u03b3 gene expression is correlated with lower relative gene expression of PTPN2 in CD subjects carrying specific alleles.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "IFN-\u0393 GENE EXPRESSION", "target": "PTPN2 GENE EXPRESSION"}, {"weight": 1.0, "description": "The presence of specific genetic variants (SNPs in PTPN2 or PTPN22) combined with MAPbacteremia leads to increased IFN-\u03b3 expression.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "IFN-\u0393 GENE EXPRESSION", "target": "PTPN2:RS478582 AND PTPN22:RS2476601 SNPS"}, {"weight": 3.0, "description": "The susceptibility to MAP infection is increased among CD subjects with heterozygous or minor alleles in PTPN22:rs2476601 compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN22:RS2476601", "target": "MAP INFECTION SUSCEPTIBILITY"}, {"weight": 7.0, "description": "The GA alleles in PTPN22:rs2476601 are associated with MAPbacteremia presence, particularly compared to healthy controls.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "PTPN22:RS2476601", "target": "GA ALLELES"}, {"weight": 5.0, "description": "The genomic variant rs2476601 is located within the PTPN22 gene.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "PTPN22:RS2476601", "target": "PTPN22"}, {"weight": 1.0, "description": "CD subjects carrying heterozygous or minor alleles in PTPN2:rs478582 have significantly lower gene expression compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN2 GENE EXPRESSION", "target": "CD SUBJECTS WITH MINOR ALLELES"}, {"weight": 3.0, "description": "Subjects with altered PTPN2 gene expression due to genomic variants have increased susceptibility to MAP infection.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN2 GENE EXPRESSION", "target": "MAP INFECTION SUSCEPTIBILITY"}, {"weight": 2.0, "description": "CD subjects with MAPbacteremia have significantly lower relative gene expression levels of PTPN2 compared to healthy controls, irrespective of MAP presence status.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "PTPN2 GENE EXPRESSION", "target": "MAPBACTEREMIA PRESENCE"}, {"weight": 4.0, "description": "Expression of PTPN22 is not affected by heterozygous or minor alleles in CD subjects but shows lower overall expression compared to healthy controls.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN22 GENE EXPRESSION", "target": "CD SUBJECTS WITH MINOR ALLELES"}, {"weight": 3.0, "description": "The rs2476601 risk variant influences PTPN22 gene expression, altering the function of LYP protein variants and contributing to disease risk.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "PTPN22 GENE EXPRESSION", "target": "RS2476601 RISK VARIANT"}, {"weight": 9.0, "description": "CD subjects carrying the TC or CC alleles of PTPN2:rs478582 exhibit a higher prevalence of MAPbacteremia than those with normal TT alleles.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "TC ALLELES", "target": "MAPBACTEREMIA"}, {"weight": 8.0, "description": "The minor CC allele in PTPN2:rs478582 is linked to an increased risk of MAPbacteremia compared to heterozygous or normal genotypes.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "CC ALLELE", "target": "MAPBACTEREMIA"}, {"weight": 6.0, "description": "CD subjects with the C-G haplotype (combination of alleles in PTPN2:rs478582 and PTPN22:rs2476601) are more likely to have MAPbacteremia than healthy controls.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "MAPBACTEREMIA", "target": "C-G HAPLOTYPE"}, {"weight": 5.0, "description": "The T-A haplotype in CD subjects is linked with a moderate increase in the presence of MAPbacteremia compared to healthy controls, though less pronounced than the C-G haplotype.", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "MAPBACTEREMIA", "target": "T-A HAPLOTYPE"}, {"weight": 5.0, "description": "The presence of MAPbacteremia affects T-cell functionality, indicating an immune system response in CD patients.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "MAPBACTEREMIA", "target": "T-CELL FUNCTIONALITY"}, {"weight": 4.0, "description": "Treatment with PHA significantly increases the T-cell proliferation response in both CD and healthy control subjects.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "T-CELL PROLIFERATION RESPONSE", "target": "PHA"}, {"weight": 5.0, "description": "Stimulation by MAP PPD-like enhances T-cell functionality, particularly in CD patients with MAPbacteremia.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "T-CELL FUNCTIONALITY", "target": "MAP PPD-LIKE"}, {"weight": 5.0, "description": "The T1D non-risk allele LYP-620R and the risk allele LYP-620W differ in their impact on T cell signaling pathways, with LYP-620R being more effective at modulating TCR-induced calcium flux and MAPK/ERK activity.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "T1D NON-RISK ALLELE (LYP-620R)", "target": "RISK ALLELE (LYP-620W)"}, {"weight": 4.0, "description": "Calcium flux is a downstream event in the TCR signaling pathway that affects cell functions such as gene expression and proliferation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "TCR SIGNALING PATHWAY", "target": "CA2+ FLUX"}, {"weight": 4.0, "description": "Overexpression of LYP-620R affects TCR signaling and expression of activation markers on T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "TCR SIGNALING PATHWAY", "target": "LYP-620R"}, {"weight": 4.0, "description": "Stimulates TCR signaling, leading to activation and cytokine production in T-cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "TCR SIGNALING PATHWAY", "target": "ANTI-CD3 AND ANTI-CD28 STIMULATION"}, {"weight": 4.0, "description": "Artificial APCs are used in experiments to study TCR signaling and its regulation by different factors.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "TCR SIGNALING PATHWAY", "target": "K562 AAPCS"}, {"weight": 5.0, "description": "The MAPK/ERK pathway, initiated by pERK signaling following TCR ligation, regulates the surface expression of activation markers on T cells.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "PERK SIGNALING PATHWAY", "target": "ACTIVATION MARKERS ON T CELLS"}, {"weight": 3.0, "description": "Expression analysis of the PTPN22 transcript reveals its role in maintaining memory T cell function and differentiation state.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "TRANSCRIPT OF PTPN22", "target": "MEMORY TCONV CELLS"}, {"weight": 4.0, "description": "The regulation of PTPN22 expression is crucial for the suppressive activity of regulatory T cells, impacting their role in immune tolerance.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "TRANSCRIPT OF PTPN22", "target": "TREGS (REGULATORY T CELLS)"}, {"weight": 3.0, "description": "Upon polyclonal activation, bicistronic constructs are used to introduce specific genetic modifications into activated T cells for studying gene function.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "POLYCLONAL ACTIVATION", "target": "BICISTRONIC CONSTRUCTS"}, {"weight": 4.0, "description": "Lentiviral transduction often includes the use of eGFP as a reporter to monitor transduction efficiency and expression of therapeutic genes.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "LENTIVIRUS TRANSDUCTION", "target": "EGFP (ENHANCED GREEN FLUORESCENT PROTEIN)"}, {"weight": 6.0, "description": "Net accumulation of IL-2 is a function of activation-induced secretion and consumption via the upregulated CD25 receptor.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "CD25", "target": "IL-2"}, {"weight": 3.0, "description": "Overexpression of the PTPN22 variant influences T-cell proliferation negatively.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "PTPN22 R620W VARIANT", "target": "PROLIFERATION"}, {"weight": 3.0, "description": "Overexpression of LYP-620R significantly repressed the proliferation and activation of T helper responder cells (Tresps).", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620R", "target": "TRESP"}, {"weight": 4.0, "description": "Overexpression of LYP-620R significantly represses the proliferation of T helper responder cells (Tresps).", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620R", "target": "TRESP PROLIFERATION"}, {"weight": 5.0, "description": "This variant is deficient in its ability to downregulate activation in Tconv compared to LYP-620R.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "LYP-620W", "target": "T CONVOLUTIONAL CELLS (TCONV)"}, {"weight": 3.0, "description": "The overexpression of LYP-620W variant slightly increased the suppressive capacity of regulatory T cells compared to controls.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620W", "target": "TREG SUPPRESSION CAPACITY"}, {"weight": 7.0, "description": "Despite being part of the Th1 signature, IFN\u03b3 secretion is not altered by PTPN22 variants according to experimental results.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "TH1 SIGNATURE", "target": "IFN\u0393"}, {"weight": 5.0, "description": "Used as a means to induce proliferation regardless of the presence or absence of PTPN22 variants.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "PROLIFERATION", "target": "PMA AND IONOMYCIN"}, {"weight": 6.0, "description": "These cytokines together form a panel of markers used to assess Th2-mediated immune responses.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "IL-4, IL-5, IL-9, IL-10, AND IL-13", "target": "CYTOKINE PANEL"}, {"weight": 3.0, "description": "The secretion of IFN\u03b3 was not altered by the overexpression of LYP variants, suggesting that its production may be independent of PTPN22 gene regulation in this context.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "IFN\u0393", "target": "LYP VARIANTS"}, {"weight": 4.0, "description": "Overexpressed LYP-620W in Tregs slightly increased their suppressive capacity compared to controls, indicating an intrinsic impact on regulatory function.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "TREG", "target": "LYP-620W VARIANT"}, {"weight": 5.0, "description": "The rs2476601 risk variant is associated with an increased risk for autoimmune disorders due to its influence on PTPN22 gene expression and function of LYP variants.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "AUTOIMMUNE DISORDERS", "target": "RS2476601 RISK VARIANT"}, {"weight": 3.0, "description": "Enhanced green fluorescent protein (eGFP) is used to track and differentiate cells such as transduced Tregs from untransduced cells for studying their functions like proliferation and suppression capacity.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "EGFP", "target": "CELL TRACKING"}, {"weight": 4.0, "description": "The PTPN22 risk variant may alter Treg-mediated suppression capacity, influencing disease risk in autoimmune disorders.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "PTPN22 RISK VARIANT", "target": "TREG-MEDIATED SUPPRESSION CAPACITY"}, {"weight": 7.0, "description": "The 4-1BB co-stimulatory domain enhances the activity, expansion, and persistence of CAR T cells in vitro.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN", "target": "CAR T CELLS"}, {"weight": 8.0, "description": "The CC49 humanized scFv specifically recognizes TAG72 on ovarian cancer cell lines, enabling the TAG72-BB\u03b6 CAR to mediate tumor cell killing.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "CC49 HUMANIZED SCFV", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 9.0, "description": "The CD3\u03b6 domain is critical for signaling and activating CAR T cells against targeted antigens such as TAG72 on cancer cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "CD3\u0396 CYTOLYTIC DOMAIN", "target": "CAR T CELLS"}, {"weight": 6.0, "description": "Tracking of CAR T cell expansion and persistence during manufacturing and clinical use is facilitated by the expression of CD19t on these cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "CAR T CELLS", "target": "CD19T"}, {"weight": 8.0, "description": "TAG72-BB\u03b6 CAR T cells specifically target ovarian cancer cell lines expressing the TAG72 antigen for killing activity.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "OVARIAN CANCER CELL LINES", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 7.0, "description": "Measurement of TAG72 expression levels on ovarian cancer cell lines is critical for evaluating the efficacy of TAG72-targeted CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "OVARIAN CANCER CELL LINES", "target": "TAG72 EXPRESSION LEVELS"}, {"weight": 5.0, "description": "CAR T cells do not show significant tumor killing activity against SKOV3 cells due to their lack of surface TAG72 antigen.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "SKOV3 CELLS"}, {"weight": 6.0, "description": "Similarly, OVCAR8 cells are not targeted by TAG72-BB\u03b6 CAR T cells as they do not express sufficient levels of the TAG72 antigen.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OVCAR8 CELLS"}, {"weight": 5.0, "description": "CAR T cells exhibit minimal tumor killing activity against COV362.4 cells due to low expression of surface TAG72 antigen.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "COV362.4 CELLS"}, {"weight": 16.0, "description": "CAR T cells target and eliminate OVCAR3 cells that express the TAG72 antigen in tumor models.<SEP>High levels of TAG72 on OVCAR3 cells make them highly susceptible targets for TAG72-BB\u03b6 CAR T cell-mediated killing activity.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OVCAR3 CELLS"}, {"weight": 6.0, "description": "OV90 cells with very high surface TAG72 expression are effectively targeted and killed by TAG72-BB\u03b6 CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OV90 CELLS"}, {"weight": 6.0, "description": "LS174T colon cancer line serves as a positive control in experiments demonstrating the specificity of TAG72-BB\u03b6 CAR T cell-mediated tumor killing.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "LS174T COLON CANCER LINE"}, {"weight": 4.0, "description": "CAR T cells are used in xenograft models to study their efficacy against ovarian cancer.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OVARIAN CANCER XENOGRAFT MODELS"}, {"weight": 4.0, "description": "CAR T cells targeting the TAG72 antigen can lead to tumor recurrence through antigen escape mechanisms.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "TUMOR RECURRENCE"}, {"weight": 4.0, "description": "The OV90 tumor model demonstrates the impact of TAG72-BB\u03b6 CAR T cells on tumor growth and recurrence over time, indicating potential escape mechanisms.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OV90 TUMOR MODEL"}, {"weight": 5.0, "description": "Shedding of soluble TAG72 minimally impacts the ability of TAG72-BB\u03b6 CAR T cells to kill tumor cells expressing this antigen.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "SOLUBLE TAG72 ANTIGEN SHEDDING", "target": "TUMOR KILLING ABILITY"}, {"weight": 8.0, "description": "The TAG72-BB\u03b6 CAR construct is introduced into dPBMCs to generate CAR T cells targeting ovarian cancer cells expressing TAG72.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR CONSTRUCT", "target": "DPBMCS"}, {"weight": 3.0, "description": "The OVCAR8 cell line is used to study MUC1 expression patterns in ovarian cancer cells, which contributes to understanding resistance mechanisms.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "OVCAR8 CELLS", "target": "MUC1 ANTIGEN"}, {"weight": 6.0, "description": "Regional intraperitoneal delivery of CAR T cells exhibits potent anti-tumor activity, extending survival in ovarian cancer ascites-bearing mice compared to systemic delivery.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "INTRAPERITONEAL DELIVERY", "target": "ANTI-TUMOR ACTIVITY"}, {"weight": 4.0, "description": "Compared with regional i.p. delivery, systemic i.v. delivery shows limited anti-tumor efficacy and less prolonged control over tumor growth.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "SYSTEMIC INTRAVENOUS DELIVERY", "target": "TUMOR GROWTH"}, {"weight": 2.0, "description": "Repeat dosing of TAG72-BB\u03b6 CAR T cells over the course of a month provides more durable control of tumors compared with single dose treatments in aggressive cancer models.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "ANTI-TUMOR ACTIVITY", "target": "REPEAT DOSING"}, {"weight": 6.0, "description": "Expression and study of MUC1 in xenograft models contribute to understanding resistance mechanisms in ovarian cancer treatment.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "OVARIAN CANCER XENOGRAFT MODELS", "target": "MUC1 ANTIGEN"}, {"weight": 6.0, "description": "Both TAG72 and MUC1 antigens play roles in ovarian cancer, showing heterogeneity and potential escape mechanisms following CAR T cell therapy.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72 ANTIGEN", "target": "MUC1 ANTIGEN"}, {"weight": 2.0, "description": "Resistance to CAR T cell therapy can be driven by the genetic diversity within tumors, leading to antigen escape and recurrence.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "CAR T CELL THERAPY", "target": "TUMOR HETEROGENEITY"}, {"weight": 9.0, "description": "This SNP is the most significant variant at the THSD4-UACA-TLE3 locus, contributing notably to FEV1/FVC variance in Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "THSD4-UACA-TLE3 LOCUS ON CHROMOSOME 15Q23", "target": "RS12441227"}, {"weight": 8.0, "description": "A genomic variant near the C10orf11 gene has been linked to FEV1/FVC, providing evidence for its influence on lung function.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "C10ORF11 GENE ON CHROMOSOME 10Q22.3", "target": "FEV1/FVC"}, {"weight": 8.0, "description": "This genomic variant is significantly associated with FEV1/FVC in Hutterites, indicating a role in respiratory health regulation.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "CCL23-CCL18 LOCUS ON CHROMOSOME 17Q12", "target": "FEV1/FVC"}, {"weight": 8.0, "description": "The PITPNC1 gene region shows association with FEV1/FVC, highlighting its importance in lung function.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "PITPNC1 LOCUS ON CHROMOSOME 17Q24.2", "target": "FEV1/FVC"}, {"weight": 8.0, "description": "A genomic variant near CHAF1B is significantly associated with FEV1/FVC, particularly significant when excluding asthmatic individuals.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "CHAF1B LOCUS ON CHROMOSOME 21Q22.13", "target": "FEV1/FVC"}, {"weight": 9.0, "description": "An SNP downstream of IL37 is associated with FEV1 in Hutterites, suggesting genetic influence on expiratory lung function.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "IL37 GENE ON CHROMOSOME 2Q13", "target": "FEV1"}, {"weight": 7.0, "description": "This intronic variant has a significant association with FVC among Hutterite subjects, impacting measures of forced vital capacity.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "ASXL3 LOCUS ON CHROMOSOME 18Q12.1", "target": "FVC"}, {"weight": 9.0, "description": "The heritabilities indicate that substantial genetic variation influences FEV1/FVC ratios in Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "order": 1, "source": "FEV1/FVC", "target": "HERITABILITY (H2/H2)"}, {"weight": 6.0, "description": "The GWAS study aims to identify genetic factors influencing FEV1/FVC in Hutterites.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "FEV1/FVC", "target": "GWAS STUDY"}, {"weight": 4.0, "description": "The \u03b2-defensin genes are significantly connected to the CCL18 gene in the GRAIL analysis.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "\u0392-DEFENSIN GENES CLUSTER 1-3", "target": "CCL18 GENE"}, {"weight": 8.0, "description": "A SNP at CCL23-CCL18 locus is functionally connected to \u03b2-defensin gene clusters in the GRAIL analysis.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "\u0392-DEFENSIN GENES CLUSTER 1-3", "target": "CCL23-CCL18 LOCUS SNP"}, {"weight": 6.0, "description": "The CXCL12 and TNFRSF13B genes show significant functional connections according to the GRAIL analysis.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "CXCL12 GENE", "target": "TNFRSF13B GENE"}, {"weight": 9.0, "description": "The same SNP at the CCL23-CCL18 locus also connects with CXCL12 according to functional analyses.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "CXCL12 GENE", "target": "CCL23-CCL18 LOCUS SNP"}, {"weight": 3.0, "description": "The UACA gene is located within the same locus as significant SNPs identified in the GWAS study.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "THSD4-UACA-TLE3 LOCUS SNPS", "target": "UACA GENE"}, {"weight": 4.0, "description": "The TLE3 gene is located within the THSD4-UACA-TLE3 locus where replicated GWAS findings were reported.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "THSD4-UACA-TLE3 LOCUS SNPS", "target": "TLE3 GENE"}, {"weight": 5.0, "description": "Genetic variants at the C10orf11 locus did not show functional connections to other genes in the study, but were replicated.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "C10ORF11 LOCUS SNPS", "target": "C10ORF11 GENE"}, {"weight": 7.0, "description": "The GRAIL algorithm was used to analyze data from the GWAS study for functional gene connections.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "GWAS STUDY", "target": "GRAIL ALGORITHM"}, {"weight": 9.0, "description": "The rs231775 variant within the CTLA4 gene is significantly associated with PBC susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "CTLA4", "target": "RS231775"}, {"weight": 8.0, "description": "Similarly, the rs231725 variant of CTLA4 also shows a significant association with PBC risk.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "CTLA4", "target": "RS231725"}, {"weight": 9.0, "description": "The genetic variant rs231775 increases susceptibility to primary biliary cholangitis (PBC).", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS231775", "target": "PBC"}, {"weight": 8.0, "description": "Similarly, the genetic variant rs231725 also increases risk for PBC.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS231725", "target": "PBC"}, {"weight": 1.0, "description": "The genomic variant rs3087243 does not show an association with primary biliary cholangitis susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS3087243", "target": "PBC"}, {"weight": 1.0, "description": "Likewise, the genetic variant rs5742909 is found to be non-significantly associated with PBC risk.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS5742909", "target": "PBC"}, {"weight": 1.0, "description": "The polymorphism rs3087243 within CTLA4 does not influence the risk of primary biliary cholangitis (PBC).", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS3087243 POLYMORPHISM", "target": "PBC SUSCEPTIBILITY"}, {"weight": 1.0, "description": "Similarly, the polymorphism rs5742909 within CTLA4 is not associated with PBC risk.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS5742909 POLYMORPHISM", "target": "PBC SUSCEPTIBILITY"}, {"weight": 9.0, "description": "Preferred for meta-analysis when there is significant variability among study results.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RANDOM-EFFECTS MODEL", "target": "HETEROGENEOUS STUDIES"}, {"weight": 8.0, "description": "The susceptibility to PBC varies based on specific genetic variants within the CTLA4 gene, affecting immune system regulation.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "PRIMARY BILIARY CHOLANGITIS SUSCEPTIBILITY", "target": "CTLA4 VARIANTS"}, {"weight": 8.0, "description": "Conducted to ensure the stability of meta-analysis results when individual studies or assumptions about study effects are omitted.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "SENSITIVITY ANALYSES", "target": "META-ANALYSIS STABILITY"}, {"weight": 9.0, "description": "Ensures that the conclusions drawn from the meta-analysis are not skewed by publication bias, maintaining research integrity and validity.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "PUBLICATION BIAS EVALUATION", "target": "RESEARCH INTEGRITY"}, {"weight": 4.0, "description": "Genetic variants have an impact on the transcriptional activity and expression levels of STAT6, crucial for T cell differentiation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "STAT6 PROTEIN", "target": "CIS-REGULATORY SNP (EQTL) FOR STAT6 GENE"}, {"weight": 6.0, "description": "Expression regulation of syntaxin 2 is modulated by genetic variants, impacting intracellular vesicle transport in T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "STX2 GENE (SYNTAXIN 2)", "target": "CIS-REGULATORY SNP (EQTL) FOR STX2 GENE"}, {"weight": 8.0, "description": "The polymorphism CT60 is associated with reduced CTLA4 mRNA expression and increased risk of autoimmune diseases in CD4+ T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CTLA4 GENE EXPRESSION REGULATION", "target": "CTLA4 POLYMORPHISM CT60A/G (RS3087243)"}, {"weight": 14.0, "description": "Length variation in this repeat region influences mRNA levels of CTLA4, impacting autoimmune responses.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CTLA4 GENE EXPRESSION REGULATION", "target": "(AT)N REPEAT POLYMORPHISM IN THE 3\u2019UTR OF CTLA4"}, {"weight": 9.0, "description": "Genetic control over CTLA4 includes alternative splicing patterns specific to CD4+ T cells that influence its function in immune regulation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CTLA4 GENE EXPRESSION REGULATION", "target": "ALTERNATIVE SPLICING"}, {"weight": 10.0, "description": "Differential methylation near the second exon of CTLA4, inversely correlated with gene expression levels due to the presence of CT60 polymorphism.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "DNA METHYLATION OF CTLA4 GENE LOCUS", "target": "CTLA4 POLYMORPHISM CT60A/G (RS3087243)"}, {"weight": 12.0, "description": "These variants are in strong LD with CTLA4 polymorphisms that affect gene expression and disease risk.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CTLA4 POLYMORPHISM CT60A/G (RS3087243)", "target": "T1D AND RA-ASSOCIATED VARIANTS (E.G., RS231775, RS3087243)"}, {"weight": 3.0, "description": "Genetic variants that affect the mTOR signaling pathway contribute to Type 1 Diabetes risk by influencing gene functions in CD4+ T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "T1D", "target": "MTOR SIGNALING PATHWAY"}, {"weight": 4.0, "description": "The SNP rs1131017, located near RPS26, is associated with significant eQTL effects on this gene\'s expression in T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "RS1131017", "target": "RPS26"}, {"weight": 5.0, "description": "A trans-eQTL analysis of the IL27 region revealed that genetic variants influence IRF1 and STAT1 expression, linked to a reduced risk for Type 1 Diabetes.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "TRANS-EQTL", "target": "IL27 GENE REGION"}, {"weight": 3.0, "description": "The SNP rs4788084[T] is associated with decreased expression levels of the STAT1 gene in CD4+ T cells, contributing to lower risk for Type 1 Diabetes.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "RS4788084[T]", "target": "STAT1 GENE"}, {"weight": 5.0, "description": "Together, IL27RA and gp130 form a receptor complex necessary for the signal transduction pathway activated by IL-27 binding.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IL27RA", "target": "GP130 (IL6ST)"}, {"weight": 4.0, "description": "The expression levels of IRF1 and STAT1 are strongly correlated, suggesting a functional relationship where one gene may influence the expression or activity of the other.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IRF1", "target": "STAT1"}, {"weight": 5.0, "description": "The IL-27 cytokine binds to the receptor complex composed of IL27RA and gp130, leading to activation of downstream signaling pathways in cells.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IL27RA, GP130 (RECEPTOR COMPLEX)", "target": "IL-27 CYTOKINE"}, {"weight": 6.0, "description": "EBI3 acts as a subunit of the heterodimeric cytokine IL-27, which binds to its receptor complex consisting of IL27RA and gp130.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "EBI3", "target": "IL27"}, {"weight": 6.0, "description": "EBI3 forms a heterodimer with p28 (IL37) or IL-27beta subunit to form the cytokines IL-27 and IL-35, which bind to specific receptors for signaling.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "EBI3", "target": "IL-27 CYTOKINE"}, {"weight": 7.0, "description": "Binding of STAT1 or STAT3 dimers to ISREs initiates transcriptional regulation of interferon-responsive genes such as IRF1 and STAT1.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "INTERFERON-STIMULATED RESPONSE ELEMENTS (ISRE)", "target": "STAT1/STAT3 PATHWAY"}, {"weight": 8.0, "description": "Human embryonic kidney 293 cells are used to produce and study IL-27 protein variants (Leu119 and Pro119) in the context of their effects on IRF1 and STAT1 expression.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "HEK293 CELLS", "target": "IL-27 TRANSFECTION EXPERIMENT"}, {"weight": 8.0, "description": "The genetic variant IL27 SNP rs181206[G] is associated with decreased expression of IRF1 and STAT1 genes in CD4+ T cells.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IL27 SNP RS181206[G]", "target": "IRF1, STAT1 EXPRESSION LEVELS"}, {"weight": 3.0, "description": "Carrying the homozygous TT genotype at rs4073 increases asthma susceptibility, indicating a strong genetic link to disease risk.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "RS4073 GENOMIC VARIANT", "target": "ASTHMA RISK"}, {"weight": 4.0, "description": "The expression level of IL-8 protein correlates with mRNA levels in serum and PBMCs, impacting immune responses.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "IL-8 PROTEIN", "target": "IL-8 MRNA TRANSCRIPT"}, {"weight": 8.0, "description": "Elevated IL-8 levels are observed in patients with asthma compared to controls, suggesting a role in disease pathogenesis.<SEP>Elevated levels of IL-8 in serum correlate with the presence and severity of asthma.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA", "target": "IL-8 SERUM LEVELS"}, {"weight": 6.0, "description": "The severity of asthma correlates with higher levels of IL-8 protein and mRNA expression, indicating an inflammatory component in severe cases.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "MODERATE-SEVERE ASTHMA", "target": "MILD ASTHMA"}, {"weight": 4.0, "description": "For ASAH1, the kernel machine method using a linear kernel outperforms the min test when the causal SNPs have moderate linkage disequilibrium with typed SNPs.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "ASAH1 GENE", "target": "SNP-SET TEST (KERNEL MACHINE)"}, {"weight": 5.0, "description": "When testing for the effect of the ASAH1 gene, the IBS kernel demonstrates higher empirical power compared to other methods like linear kernel or min test.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "ASAH1 GENE", "target": "IBS KERNEL"}, {"weight": 10.0, "description": "The presence of epistatic interactions can impact the power and accuracy of genetic tests like IBS kernel when studying ASAH1 gene effects.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "ASAH1 GENE", "target": "EPISTASIS (INTERACTIONS BETWEEN GENES)"}, {"weight": 4.0, "description": "The performance of the kernel machine method exceeds that of the min test in regions within FGFR2 with high linkage disequilibrium but is comparable in weak LD regions.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "SNP-SET TEST (KERNEL MACHINE)", "target": "FGFR2 GENE"}, {"weight": 3.0, "description": "The single SNP-based min test shows higher power than the kernel machine method for NAT2 gene in scenarios where a single true casual SNP is highly correlated with one of the typed SNPs.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "MIN TEST", "target": "NAT2 GENE"}, {"weight": 3.0, "description": "Both the linear kernel and min test suffer from substantial power loss when studying genetic effects, indicating they are less effective in certain scenarios than IBS kernels.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "MIN TEST", "target": "LINEAR KERNEL"}, {"weight": 5.0, "description": "In the HLA-B gene, incorporating information about minor allele frequency into the weighted IBS kernel can upweight rare alleles and increase power for SNPs with lower MAF.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "HLA-B GENE", "target": "GENETIC VARIANTS (SNPS)"}, {"weight": 7.0, "description": "When rs2523608, a SNP with higher MAF, is causal, the weighted IBS kernel downweights its common allele effect.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "GENOMIC VARIANT (RS2523608)", "target": "WEIGHTED IBS KERNEL"}, {"weight": 9.0, "description": "In various scenarios, the IBS kernel demonstrates higher empirical power compared to linear or min tests for detecting gene effects.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "IBS KERNEL", "target": "EMPIRICAL POWER"}, {"weight": 8.0, "description": "The minor allele frequency of rs2523608 influences its role as a causal variant in genetic studies.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "CAUSAL SNP (RS2523608)", "target": "MAF"}, {"weight": 11.0, "description": "The LD structure between rs2523608 and other SNPs influences the performance of genetic tests in detecting its effect.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "CAUSAL SNP (RS2523608)", "target": "LD STRUCTURE (LINKAGE DISEQUILIBRIUM)"}, {"weight": 7.0, "description": "The presence of the minor allele G in rs1893217 is associated with a reduced likelihood of response to anti-CTLA-4 treatment.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS1893217", "target": "ANTI-CTLA-4 TREATMENT RESPONSE RATE"}, {"weight": 6.0, "description": "The SNP rs1893217 is located within the genomic region containing PTPN2 and affects response to anti-CTLA-4 therapy.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS1893217", "target": "PTPN2 GENE REGION"}, {"weight": 5.0, "description": "The presence of rs1893217 influences the efficacy of anti-CTLA-4 treatment in metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS1893217", "target": "METASTATIC MELANOMA PATIENTS"}, {"weight": 5.0, "description": "The IL2-IL21 locus contains rs17388568, a significant SNP linked to increased efficacy of anti-PD-1 therapy in metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS17388568", "target": "IL2-IL21 LOCUS"}, {"weight": 7.0, "description": "The presence of the minor allele GA or AA in rs17388568 is associated with a higher likelihood of response to anti-PD-1 treatment.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS17388568", "target": "ANTI-PD-1 TREATMENT RESPONSE RATE"}, {"weight": 6.0, "description": "The SNP rs17388568 is associated with increased risk for conditions like allergy, colitis and type 1 diabetes.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS17388568", "target": "ALLERGY, COLITIS, TYPE 1 DIABETES"}, {"weight": 6.0, "description": "The SNP rs17388568 is located within the genomic region containing IL2, ADAD1, and IL21 and affects response to anti-PD-1 therapy.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS17388568", "target": "IL2-IL21 GENOMIC LOCUS"}, {"weight": 5.0, "description": "The presence of rs17388568 influences the efficacy of anti-PD-1 treatment in metastatic melanoma patients.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "RS17388568", "target": "METASTATIC MELANOMA PATIENTS"}, {"weight": 6.0, "description": "Anti-CTLA-4 treatment is used for the management of metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "ANTI-CTLA-4 TREATMENT", "target": "METASTATIC MELANOMA"}, {"weight": 6.0, "description": "Ipilimumab and tremelimumab are drugs used in anti-CTLA-4 treatment for metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "ANTI-CTLA-4 TREATMENT", "target": "IPILIMUMAB, TREMELIMUMAB"}, {"weight": 6.0, "description": "Anti-CTLA-4 is a component of combination therapy that was studied for its effect on patient response.)", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "ANTI-CTLA-4 TREATMENT", "target": "COMBINATION THERAPY"}, {"weight": 6.0, "description": "Response to anti-PD-1 therapy in metastatic melanoma patients is significantly influenced by genetic variations within the IL2-IL21 locus, particularly rs17388568.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "ANTI-PD-1 TREATMENT", "target": "IL2-IL21 LOCUS"}, {"weight": 6.0, "description": "Anti-PD-1 treatment is also used for the management of metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "ANTI-PD-1 TREATMENT", "target": "METASTATIC MELANOMA"}, {"weight": 6.0, "description": "Nivolumab and pembrolizumab are drugs used in anti-PD-1 treatment for metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "ANTI-PD-1 TREATMENT", "target": "NIVOLUMAB, PEMBROLIZUMAB"}, {"weight": 6.0, "description": "Anti-PD-1 treatment is another part of the combination therapy used in the study.)", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "ANTI-PD-1 TREATMENT", "target": "COMBINATION THERAPY"}, {"weight": 5.0, "description": "This combination therapy targets both CTLA-4 and PD-1 pathways to treat metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "COMBINATION THERAPY (ANTI-CTLA-4 AND ANTI-PD-1)", "target": "METASTATIC MELANOMA"}, {"weight": 5.0, "description": "ICIs, including both anti-PD-1 and anti-CTLA-4 treatments, are used in the immunotherapy of metastatic melanoma.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "METASTATIC MELANOMA", "target": "ICIS (IMMUNE CHECKPOINT INHIBITORS)"}, {"weight": 4.0, "description": "A smaller sample size leads to wider confidence intervals, reducing the power to detect significant associations between SNPs and treatment response.)", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "SAMPLE SIZE", "target": "CONFIDENCE INTERVAL"}, {"weight": 4.0, "description": "EBNA2 binds chromatin at multiple sclerosis (MS) risk loci dependent on the MS risk allele.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2", "target": "MS RISK SNPS"}, {"weight": 5.0, "description": "EBNA2 binds preferentially to the risk allele of TRAF3, leading to decreased expression of this gene at an MS risk locus.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "TRAF3"}, {"weight": 6.0, "description": "EBNA2 binds preferentially to the protective allele of CD40, resulting in relatively lower expression compared to B cells, despite being a risk gene.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "CD40"}, {"weight": 7.0, "description": "EBNA2 alters allelic association with expression upon binding TNFAIP8 at an MS risk locus, affecting the gene\'s role in immune evasion.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "TNFAIP8"}, {"weight": 8.0, "description": "EBNA2 binds preferentially to the protective allele of TNFRSF1A, leading to lower expression compared to B cells at an MS risk locus.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "TNFRSF1A"}, {"weight": 9.0, "description": "The effect of EBNA2 on TBX6 alters relative allelic expression in LCLs compared to uninfected B cells, influencing gene function in immune evasion.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "TBX6"}, {"weight": 10.0, "description": "EBNA2 binding and treatment with EBNA2-TAT alter the effect on RCOR1 expression, impacting relative allelic association at an MS risk locus.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "RCOR1"}, {"weight": 11.0, "description": "EBNA2 increases the expression of CLECL1 at an MS risk locus, altering gene function in immune evasion despite no genotype effect observed.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "CLECL1"}, {"weight": 5.0, "description": "Genetic variations at MS risk loci influence the stability of EBV DNA copy number within LCLs, affecting disease susceptibility.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "MS RISK SNPS", "target": "EBV DNA COPY NUMBER"}, {"weight": 3.0, "description": "EBNA2 binds preferentially to both loci, indicating a role in MS risk regulation through allele-specific binding.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "TRAF3/RCOR1 SNP (RS1258869)", "target": "CD40 SNP (RS1883832)"}, {"weight": 4.0, "description": "Both genomic variants demonstrate protective effects when EBNA2 binds to the non-risk alleles, influencing gene expression and MS risk.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "TNFAIP8 SNP (RS32658)", "target": "TBX6 SNP (RS3809627)"}, {"weight": 5.0, "description": "Treatment with EBNA2-TAT reduces LMP1 expression in lymphoblastoid cell lines (LCLs), indicating inhibition of EBV latency III growth program.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2-TAT", "target": "LMP1"}, {"weight": 4.0, "description": "Both genes show altered expression levels as a result of EBNA2 function inhibition, implicating their role in MS risk regulation.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "TRAF3 GENE EXPRESSION", "target": "TNFRSF1A GENE EXPRESSION"}, {"weight": 2.0, "description": "Allelic association at MS risk loci can be altered due to the influence of EBNA2 and treatment effects on gene expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "MS RISK LOCI", "target": "ALLELIC ASSOCIATION"}, {"weight": 2.0, "description": "The EBV latency III program involves molecular interactions with LMP1 and LMP2 signalling, which are influenced by EBNA2 interaction with MS risk genes.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBV LATENCY III PROGRAM", "target": "LMP1 AND LMP2 SIGNALLING"}, {"weight": 3.0, "description": "The effect of EBNA2 on expression at risk loci is postulated to increase host immune evasion through regulation of these risk genes in the latency III program.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "HOST IMMUNE EVASION", "target": "EBNA2/RISK GENE INTERACTION"}, {"weight": 16.0, "description": "Both rs20417 and rs1126643 are genetic factors associated with increased risk of aspirin insensitivity, but they differ in their effects across ethnic groups.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "COX-2 GENE POLYMORPHISM (RS20417)", "target": "ITGA2 GENE POLYMORPHISM (RS1126643)"}, {"weight": 18.0, "description": "The COX-2 gene polymorphism rs20417 is significantly associated with aspirin insensitivity, contributing to the condition\'s genetic risk.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "COX-2 GENE POLYMORPHISM (RS20417)", "target": "ASPIRIN INSENSITIVITY"}, {"weight": 7.0, "description": "Differences in CAD prevalence contribute to heterogeneity for the association between rs20417 and aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "COX-2 GENE POLYMORPHISM (RS20417)", "target": "CAD (CORONARY ARTERY DISEASE)"}, {"weight": 18.0, "description": "The ITGA2 gene polymorphism rs1126643 confers a high risk for aspirin insensitivity, especially under the dominant model.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "ITGA2 GENE POLYMORPHISM (RS1126643)", "target": "ASPIRIN INSENSITIVITY"}, {"weight": 7.0, "description": "The presence of CAD explains a significant part of heterogeneity for the association between rs1126643 and aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "ITGA2 GENE POLYMORPHISM (RS1126643)", "target": "CAD (CORONARY ARTERY DISEASE)"}, {"weight": 12.0, "description": "The COX-1 gene polymorphism rs3842787 does not show a significant association with aspirin insensitivity, indicating no substantial genetic risk.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "COX-1 GENE POLYMORPHISM (RS3842787)", "target": "ASPIRIN INSENSITIVITY"}, {"weight": 10.0, "description": "The ITGA2B gene polymorphism rs20118426 does not significantly contribute to the risk of aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "ITGA2B GENE POLYMORPHISM (RS20118426)", "target": "ASPIRIN INSENSITIVITY"}, {"weight": 6.0, "description": "Averaged platelet number was found to be a significant source of heterogeneity for rs1126643, indicating an interaction between averaged platelet count and the genomic variant.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "order": 1, "source": "RS1126643", "target": "AVERAGED PLATELET NUMBER"}, {"weight": 4.0, "description": "The STAT5B gene harbors a homozygous nonsense mutation leading to a truncated protein with reduced function and expression.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "STAT5B GENE", "target": "HOMOZYGOUS NONSENSE MUTATION C.1892G>A, P.W631*"}, {"weight": 3.0, "description": "The STAT5B gene harbors a loss-of-function variant that influences CD8+ T cell homeostasis.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "STAT5B GENE", "target": "STAT5B VARIANT"}, {"weight": 2.0, "description": "Despite the presence of the STAT5B variant, CD4+ memory T cells remain within normal ranges.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "STAT5B GENE", "target": "CD4+ MEMORY T CELLS"}, {"weight": 8.0, "description": "Elevations in CD8+ TEMRA cells during infancy are linked to STAT5B deficiency, which normalizes around age 7.<SEP>Elevations of CD8+ TEMRA cells during infancy normalize around age 7, indicating a developmental impact of STAT5B deficiency.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "STAT5B GENE", "target": "CD8+ TEMRA CELLS"}, {"weight": 4.0, "description": "The wild-type protein contrasts with the mutant protein in expression and function following GH treatment.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "HOMOZYGOUS NONSENSE MUTATION C.1892G>A, P.W631*", "target": "WILD-TYPE FLAG-STAT5B (F-STAT5B WT)"}, {"weight": 4.0, "description": "The transcript is affected by the mutation leading to a truncated protein.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "HOMOZYGOUS NONSENSE MUTATION C.1892G>A, P.W631*", "target": "TRANSCRIPT OF STAT5B GENE"}, {"weight": 4.0, "description": "The mutation eliminates the SH2 domain and TAD of STAT5B protein.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "HOMOZYGOUS NONSENSE MUTATION C.1892G>A, P.W631*", "target": "SRC HOMOLOGY 2 (SH2) DOMAIN AND TRANSACTIVATION DOMAIN (TAD)"}, {"weight": 3.0, "description": "GH stimulates phosphorylation and nuclear localization of the wild-type STAT5B protein, which is impaired in the mutant protein.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "WILD-TYPE FLAG-STAT5B (F-STAT5B WT)", "target": "GROWTH HORMONE (GH)"}, {"weight": 3.0, "description": "GH receptors are used to assess functional capacity of wild-type STAT5B in comparison with mutant form.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "WILD-TYPE FLAG-STAT5B (F-STAT5B WT)", "target": "GH RECEPTOR (GHRS)"}, {"weight": 4.0, "description": "Nuclear localization is observed for wild-type protein but impaired for the mutant protein following GH treatment.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "WILD-TYPE FLAG-STAT5B (F-STAT5B WT)", "target": "NUCLEAR LOCALIZATION "}, {"weight": 3.0, "description": "Treatment with rhIGF-1 was initiated to address the severe short stature condition in the siblings.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR 1 (RHIGF-1)", "target": "SEVERE SHORT STATURE, HEIGHT SDS \u22126.5, \u22125.06, AND \u22124.7 "}, {"weight": 2.0, "description": "Reduced NK cells in STAT5B deficient siblings contribute to immune impairments.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "SEVERE SHORT STATURE, HEIGHT SDS \u22126.5, \u22125.06, AND \u22124.7 ", "target": "NK CELLS "}, {"weight": 2.0, "description": "The autoimmune thyroiditis diagnosis is part of the broader clinical presentation of post-natal growth failure among the siblings.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "AUTOIMMUNE THYROIDITIS ", "target": "SEVERE POST-NATAL GROWTH FAILURE "}, {"weight": 3.0, "description": "Both diseases are part of the broader clinical presentation including atopic conditions.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "AUTOIMMUNE THYROIDITIS ", "target": "REACTIVE AIRWAY DISEASE "}, {"weight": 1.0, "description": "The LOF variant of the STAT5B gene leads to a reduction in the expression and function of the STAT5B protein.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "STAT5B", "target": "LOF STAT5B VARIANT"}, {"weight": 2.0, "description": "GH stimulation typically results in phosphorylation and nuclear translocation of STAT5B, but this process is impaired by the LOF variant.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "GH STIMULATION", "target": "PHOSPHORYLATION/NUCLEAR TRANSLOCATION"}, {"weight": 3.0, "description": "Impaired expression or function of STAT5B leads to reduced numbers and function of NK cells in deficient individuals.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "NK CELLS", "target": "STAT5B GENE EXPRESSION"}, {"weight": 4.0, "description": "Increased immunoglobulin production by B cells, particularly IgE, is associated with elevated serum levels leading to allergic conditions such as chronic eczema and reactive airway disease.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "B CELLS", "target": "IGE LEVELS"}, {"weight": 7.0, "description": "In STAT5B deficient individuals, either thymic production or peripheral destruction may account for reduced numbers of mature T cells.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "THYMIC T CELL PRODUCTION", "target": "PERIPHERAL DESTRUCTION"}, {"weight": 8.0, "description": "Evaluation of RTEs helps assess the function and maintenance of regulatory T cells in STAT5B deficient patients over time.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "RECENT THYMIC EMIGRANTS (RTE)", "target": "TREG FUNCTION"}, {"weight": 10.0, "description": "Young STAT5B deficient siblings exhibit dysregulated memory CD8+ T cells with reduced na\u00efve subsets and elevated memory/activation phenotypes.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "MEMORY CD8+ T CELLS", "target": "NAIVE T CELLS"}, {"weight": 4.0, "description": "The STAT5B variant influences the proportion and activation status of CD8+ TEM cells over time.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "STAT5B VARIANT", "target": "CD8+ TEM CELLS"}, {"weight": 3.0, "description": "Elevations in CD8+ TEMRA cell percentages during infancy are linked to the STAT5B variant, which normalizes by age 4.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "STAT5B VARIANT", "target": "CD8+ TEMRA CELLS"}, {"weight": 3.0, "description": "No significant alterations were observed in the proportion of CD4+ TEM cells despite STAT5B mutation.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "CD4+ TEM CELLS", "target": "LOF MUTATION IN STAT5B"}, {"weight": 5.0, "description": "Increases in CD8+ TEM cell proportions with age suggest an important role for the STAT5B variant in T cell homeostasis.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "CD8+ TEM CELLS", "target": "LOF MUTATION IN STAT5B"}, {"weight": 5.0, "description": "Patients with STAT5B deficiency have elevated proportions of CD8+ memory T cells from infancy onwards, indicating a critical role for the STAT5B variant in CD8+ T cell homeostasis.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "STAT5B DEFICIENCY", "target": "CD8+ MEMORY T CELLS"}, {"weight": 3.0, "description": "No alterations were observed in the proportion of CD4+ memory T cells, indicating that STAT5B mutation does not affect this cell subset.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "CD4+ MEMORY T CELLS", "target": "LOF MUTATION IN STAT5B"}, {"weight": 3.0, "description": "The HLA-DRB1 gene\'s alleles show linkage disequilibrium with other genetic markers contributing to immune responses and disease susceptibility.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DRB1 GENE", "target": "LINKAGE DISEQUILIBRIUM (LD)"}, {"weight": 3.0, "description": "Determining the allele carrier status for the HLA-DRB1 gene is crucial in predicting immune responses and disease susceptibility.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DRB1 GENE", "target": "ALLELE CARRIER STATUS"}, {"weight": 5.0, "description": "The SNP rs28383172 is used to predict the carrier status of this specific haplotype.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "SNP RS28383172", "target": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE"}, {"weight": 4.0, "description": "The SNP rs28383172 is used as a marker for haplotype tagging, aiding in the prediction of HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 carrier status.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "SNP RS28383172", "target": "HAPLOTYPE TAGGING"}, {"weight": 4.0, "description": "Determining the NPV of SNP rs28383172 helps assess its reliability for excluding false negatives in predicting HLA-DRB1*07:01 carrier status.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "SNP RS28383172", "target": "NEGATIVE PREDICTIVE VALUE (NPV)"}, {"weight": 4.0, "description": "rs2395182 is a SNP involved in predicting the carrier status of this specific haplotype.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE", "target": "SNP RS2395182"}, {"weight": 4.0, "description": "rs4713586 is a SNP used in predicting the carrier status of this specific haplotype.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE", "target": "SNP RS4713586"}, {"weight": 4.0, "description": "rs7775228 is a SNP involved in predicting the carrier status of this specific haplotype.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE", "target": "SNP RS7775228"}, {"weight": 5.0, "description": "The HLA-DQA1 gene contributes to the formation of this specific haplotype.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE", "target": "HLA-DQA1 GENE"}, {"weight": 8.0, "description": "The HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype is a genetic variant that affects the risk of E. coli ASP hypersensitivity.)<SEP>The presence of this haplotype increases the risk for E. coli ASP hypersensitivity.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE", "target": "E. COLI ASP HYPERSENSITIVITY"}, {"weight": 4.0, "description": "Measuring specificity for SNP rs7775228 aids in determining its reliability in predicting the HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype carrier status.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "SNP RS7775228", "target": "SPECIFICITY"}, {"weight": 3.0, "description": "The PPV of HLA-DQA1 gene markers is crucial for determining the accuracy of predicting haplotypes in populations.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA-DQA1 GENE", "target": "POSITIVE PREDICTIVE VALUE (PPV)"}, {"weight": 10.0, "description": "The TLR7 gene contains specific polymorphisms (rs179008, rs179009) that are associated with different disease susceptibilities in HIV-infected individuals compared to healthy controls.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "TLR7 GENE", "target": "POLYMORPHISM RS179008 AND RS179009"}, {"weight": 3.0, "description": "The TLR7 gene includes the rs179008 polymorphism which was studied in the context of HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TLR7 GENE", "target": "TLR7 (RS179008)"}, {"weight": 3.0, "description": "The TLR7 gene also includes the rs179009 polymorphism, examined for its influence on HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TLR7 GENE", "target": "TLR7 (RS179009)"}, {"weight": 10.0, "description": "The presence of specific TLR7 gene polymorphisms is linked with different stages of HIV disease, showing a significant reduction in early to advanced stages compared to healthy controls.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "POLYMORPHISM RS179008 AND RS179009", "target": "HIV DISEASE STAGES"}, {"weight": 6.0, "description": "Consumption of tobacco or alcohol does not significantly alter the distribution patterns of TLR7 gene polymorphisms in HIV-infected individuals.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "TOBACCO AND ALCOHOL CONSUMPTION", "target": "TLR7 GENE POLYMORPHISM RS179008 AND RS179009"}, {"weight": 5.0, "description": "CD4 counts at the baseline correlate with TLR7 gene polymorphisms, indicating a role in immune response during HIV infection.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "BASELINE CD4 COUNTS", "target": "TLR7 GENE POLYMORPHISM RS179008 AND RS179009"}, {"weight": 2.0, "description": "The TLR7 rs179009 polymorphism is also studied in the context of HIV disease progression, similarly not identified as a standalone risk factor.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TLR7 (RS179009)", "target": "HIV DISEASE PROGRESSION"}, {"weight": 1.0, "description": "Age and sex were examined for their correlation with HIV disease progression through multivariate logistic regression analysis but did not emerge as significant independent factors.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "AGE AND SEX", "target": "HIV DISEASE PROGRESSION"}, {"weight": 2.0, "description": "The use of tobacco was analyzed in relation to its potential impact on HIV disease progression.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TOBACCO USAGE", "target": "HIV DISEASE PROGRESSION"}, {"weight": 3.0, "description": "Both tobacco and alcohol usage were analyzed as potential lifestyle factors affecting HIV disease progression together.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TOBACCO USAGE", "target": "ALCOHOL USAGE"}, {"weight": 2.0, "description": "Alcohol usage was considered as one of the factors influencing HIV disease progression through logistic regression analysis.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "ALCOHOL USAGE", "target": "HIV DISEASE PROGRESSION"}, {"weight": 1.0, "description": "Baseline CD4 counts were correlated with HIV disease progression in the study but did not stand out as independent risk factors.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "CD4 COUNTS", "target": "HIV DISEASE PROGRESSION"}, {"weight": 4.0, "description": "This analysis was conducted to determine factors influencing HIV disease progression, including genetic and lifestyle factors.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "HIV DISEASE PROGRESSION", "target": "MULTIVARIATE LOGISTIC REGRESSION ANALYSIS"}, {"weight": 3.0, "description": "The ALK R1275Q mutation forms a nonamer (GMAQDIYRA) that binds to HLA-A*02:01 with significant binding affinity.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "ALK R1275Q", "target": "HLA-A*02:01"}, {"weight": 3.0, "description": "The NRAS mutation Q61K generates a neoepitope (ILDTAGKEEY) that binds to HLA-A*01:01 with significant binding affinity.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NRAS Q61K", "target": "HLA-A*01:01"}, {"weight": 4.0, "description": "The HLA-B*15:01 protein binds the ALK R1275Q decamer peptide, facilitating immune recognition and response.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "HLA-B*15:01", "target": "ALK R1275Q NEOEPITOPE (DECAMER)"}, {"weight": 3.0, "description": "The nonamer peptide forms less stable complexes with HLA-B*15:01 compared to the decamer peptide due to fewer interactions and more surface exposure.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "HLA-B*15:01", "target": "NONAMER PEPTIDE"}, {"weight": 4.0, "description": "The decamer peptide binds strongly to HLA-B*15:01, forming stable complexes that are recognized by TCRs, enhancing immune response against cancer cells expressing the ALK mutation.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "HLA-B*15:01", "target": "DECAMER PEPTIDE"}, {"weight": 2.0, "description": "The self-peptide ARDIYRASY is poorly bound by HLA-B*15:01, suggesting it may not trigger an immune response due to structural incompatibilities.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "HLA-B*15:01", "target": "SELF-PEPTIDE (ARDIYRASY)"}, {"weight": 4.0, "description": "Similar to HLA-A*01:01, HLA-B*15:01 can also form stable p/MHC complexes with ALK-derived peptides and present them to T cells.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-B*15:01", "target": "ALK NEOEPITOPES"}, {"weight": 3.0, "description": "Both MAQDIYRASY and AQDIYRASYY are neoepitopes derived from ALK R1275Q, but AQDIYRASY has better binding affinity to HLA-B*15:01 compared to its parental self-antigen.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "MAQDIYRASY AND AQDIYRASYY", "target": "AQDIYRASY"}, {"weight": 3.0, "description": "The nonamer GMAQDIYRA derived from ALK R1275Q binds to HLA-A*02:01, demonstrating the interaction between neoepitopes and HLAs in diverse settings.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "HLA-A*02:01", "target": "GMAQDIYRA"}, {"weight": 3.0, "description": "The NRAS mutation generates a neoepitope (ILDTAGKEEY) that binds to HLA-A*01:01, suggesting its potential role in immunotherapy.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "HLA-A*01:01", "target": "NRAS Q61K NEOEPITOPE ILDTAGKEEY"}, {"weight": 4.0, "description": "The decamer peptide forms a stable complex with HLA-A*01:01, which is crucial for its presentation to T cells.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-A*01:01", "target": "DECAMER PEPTIDE AQDIYRASYY (PDB ID 6AT9)"}, {"weight": 6.0, "description": "The HLA-A*01:01 molecule presents peptides in a way that can activate TCRs, leading to an immune response.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-A*01:01", "target": "TCRS"}, {"weight": 4.0, "description": "The ProTECT software is used for the identification of neoepitope-generating mutations in neuroblastoma tumors, aiding in therapeutic development.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NEUROBLASTOMA (NBL)", "target": "PROTECT SOFTWARE"}, {"weight": 3.0, "description": "The ZNF717 mutation is recurrent in neuroblastomas, highlighting its significance in the disease pathology.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NEUROBLASTOMA (NBL)", "target": "ZNF717 Q716 MUTATION"}, {"weight": 3.0, "description": "These mutations indicate genetic diversity within the neuroblastoma cohort and may serve as potential therapeutic targets.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NEUROBLASTOMA (NBL)", "target": "F1174L/I/C MUTATIONS IN ALK "}, {"weight": 3.0, "description": "HLA-B*15:03 binds to both ARDIYRASYY and ARDIYRASY with scores of 2.2% and 4.7%, respectively, indicating its role in immune recognition.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "HLA-B*15:03", "target": "ARDIYRASYY AND ARDIYRASY"}, {"weight": 4.0, "description": "In vitro analysis of p/MHC complexes stability provides insights into therapeutic target validation for neuroblastoma mutations.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "P/MHC COMPLEX STABILITY", "target": "PROTECT SOFTWARE ANALYSIS"}, {"weight": 6.0, "description": "TCRs recognize the ALK-derived peptides presented by MHC molecules, initiating an immune response against cancer cells expressing these epitopes.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "ALK NEOEPITOPES", "target": "TCRS"}, {"weight": 3.0, "description": "The nonamer and decamer peptides display distinct conformations within the HLA-B*15:01 binding groove due to their differing lengths and anchor residues.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NONAMER PEPTIDE AQDIYRASY", "target": "DECAMER PEPTIDE AQDIYRASYY"}, {"weight": 2.0, "description": "DSF is used to measure the kinetic stability of p/MHC complexes formed by HLA-B*15:01 and neoepitopes, indicating thermal stabilities.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "DIFFERENTIAL SCANNING FLUORIMETRY (DSF)", "target": "HLA-B*15:01 BINDING COMPLEXES"}, {"weight": 3.0, "description": "Peptides derived from Epstein\u2013Barr virus follow established binding motifs for HLA-B*15:01, similar to those of ALK neoepitopes.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "EPSTEIN\u2013BARR VIRUS", "target": "HLA-B*15:01 BINDING MOTIF"}, {"weight": 3.0, "description": "Peptides from UBE2M also fit the established binding motifs for HLA-B*15:01, akin to those of ALK-derived peptides.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "HUMAN UBIQUITIN-CONJUGATING ENZYME-E2 (UBE2M)", "target": "HLA-B*15:01 BINDING MOTIF"}, {"weight": 3.0, "description": "Peptides from SARS coronavirus follow established binding motifs for HLA-B*15:01, consistent with patterns observed in ALK neoepitopes.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "SARS CORONAVIRUS", "target": "HLA-B*15:01 BINDING MOTIF"}, {"weight": 4.0, "description": "The interaction between TCRs and the p/MHC complexes formed by ALK-derived peptides bound to HLA-B*15:01 mediates immune recognition.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "TCRS (T-CELL RECEPTORS)", "target": "ALK NEOEPITOPES BOUND TO HLA-B*15:01"}, {"weight": 3.0, "description": "The binding of neoepitopes to \u03b22m is crucial for the formation of stable MHC class I complexes.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "NEOEPITOPES", "target": "\u03922M (BETA-2-MICROGLOBULIN)"}, {"weight": 4.0, "description": "TCRs recognize the HLA-B*15:01 complexed with ALK R1275Q decamer peptide, initiating an immune response against cancer cells.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "TCRS (T CELL RECEPTORS)", "target": "HLA-B*15:01/DECAMER PEPTIDE COMPLEX"}, {"weight": 7.0, "description": "Refolding experiments confirm the stability and structural integrity of decamer peptide complexes formed with high-frequency HLA alleles like HLA-A*01:01.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HLA ALLELES", "target": "THERMAL STABILITY OF DECAMER COMPLEX WITH HLA-A*01:01"}, {"weight": 4.0, "description": "Rosetta modeling is used to predict binding of peptides with HLAs, providing insights into peptide/HLA interactions and stability.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "PEPTIDES", "target": "ROSETTA COMPARATIVE MODELING CALCULATIONS"}, {"weight": 6.0, "description": "Refolding experiments confirm the structural stability of peptide/HLA complexes formed with nonamer and decamer peptides from ALK mutation.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "PEPTIDES", "target": "IN VITRO REFOLDING EXPERIMENTS"}, {"weight": 4.0, "description": "Similarities in X-ray structures between HLA-B*15:01 and HLA-A*01:01, aiding in the structural modeling of peptide/HLA interactions.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HLA-B*15:01 STRUCTURE", "target": "HLA-A*01:01 STRUCTURE"}, {"weight": 4.0, "description": "The high-throughput approach was applied to evaluate binding of nonamer and decamer peptides with a wide array of HLA alleles.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HIGH-THROUGHPUT APPROACH FOR PEPTIDE/HLA INTERACTIONS", "target": "NONAMER AND DECAMER ALK PEPTIDES"}, {"weight": 6.0, "description": "The HLA-B*15:84 allele shows strong binding with decamer peptides, as indicated by low binding energy predictions.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "NONAMER AND DECAMER ALK PEPTIDES", "target": "HLA-B*15:84 ALLELE"}, {"weight": 5.0, "description": "Predicted binding energies correlate with sequence features revealed by the Kullback-Leibler logo, aiding in understanding peptide/MHC interactions.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "BINDING ENERGY PREDICTIONS", "target": "KULLBACK\u2013LEIBLER SEQUENCE LOGO"}, {"weight": 5.0, "description": "The mock polyAla HLA serves as a negative control for binding energy predictions, revealing higher binding energies compared to natural alleles.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "BINDING ENERGY PREDICTIONS", "target": "MOCK POLYALA HLA"}, {"weight": 7.0, "description": "The sequence logo highlights preferred residues involved in polar contacts within the HLA binding groove, contributing to strong peptide/MHC interactions.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "KULLBACK\u2013LEIBLER SEQUENCE LOGO", "target": "POLAR CONTACTS IN MHC BINDING GROOVE"}, {"weight": 2.0, "description": "Specific polar contacts between the peptide and residues in the MHC groove contribute to the stability of the complex formed with HLA-A*01:01.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "DECAMER PEPTIDE AQDIYRASYY (PDB ID 6AT9)", "target": "POLAR CONTACTS WITHIN MHC GROOVE"}, {"weight": 5.0, "description": "The protein product of PPAR\u03b3 interacts molecularly with RXR\u03b1 to regulate gene expression involved in lipid metabolism and inflammation.)", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f", "order": 1, "source": "PPAR\u0393 PROTEIN", "target": "RXR\u0391 PROTEIN"}, {"weight": 12.0, "description": "The SNP rs74420772 is associated with IgM anti-PC measurement in one of the GWAS studies.<SEP>This SNP is associated with IgM anti-PC measurement in one of the GWAS studies.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "RS74420772", "target": "IGM ANTI-PC"}, {"weight": 8.0, "description": "The GRAMD1B gene overlaps a linkage disequilibrium block containing the leading SNP rs35923643-G.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "RS35923643-G", "target": "GRAMD1B GENE"}, {"weight": 7.0, "description": "The rs35923643-G variant has a significant effect size on IgM anti-PC levels, indicating its role in the measurement.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "RS35923643-G", "target": "IGM ANTI-PC"}, {"weight": 7.0, "description": "The rs35923643-G variant shows significant association with IgM levels, indicating its role in the physiological process of general immunoglobulin regulation.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "RS35923643-G", "target": "GENERAL IMMUNOGLOBULIN LEVELS"}, {"weight": 16.0, "description": "The GRAMD1B gene is in close proximity to SNP rs735665-A which shows association with CLL risk.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "GRAMD1B GENE", "target": "RS735665-A"}, {"weight": 9.0, "description": "The SNP rs735665-A is recognized as the top risk allele for CLL based on GWAS meta-analysis results.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "RS735665-A", "target": "CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)"}, {"weight": 8.0, "description": "The genomic variants (specific SNPs) identified in the GWAS meta-analysis are significantly associated with IgM anti-PC levels.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "IGM ANTI-PC", "target": "SNPS IN 1P31.3 AND 11Q24.1"}, {"weight": 3.0, "description": "There is an association between Chronic Lymphocytic Leukemia (CLL) and IgM anti-PC levels, indicating potential biological relevance to disease progression or diagnosis.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "IGM ANTI-PC", "target": "CLL"}, {"weight": 1.0, "description": "The genomic variant rs35923643 is suggested to be a candidate influencing the IgM anti-PC levels in relation to CLL, though direct causality needs further investigation.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "IGM ANTI-PC", "target": "RS35923643"}, {"weight": 1.0, "description": "The genomic variant rs35923643 is also found in regions marked by DNaseI hypersensitivity, suggesting its location within open chromatin regions active for transcription.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RS35923643", "target": "DNASEI HYPERSENSITIVITY"}, {"weight": 1.0, "description": "The genomic variant rs35923643 is suggested to be a candidate for influencing the phenotypic association between IgM anti-PC levels and Chronic Lymphocytic Leukemia (CLL).", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RS35923643", "target": "IGM ANTI-PC AND CLL PHENOTYPIC ASSOCIATION"}, {"weight": 2.0, "description": "The region around rs35923643 contains binding sites for multiple transcription factors, with RUNX3 showing a strong signal particularly at this locus.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "TRANSCRIPTION FACTOR BINDING SITES", "target": "RUNX3 BINDING MOTIF"}, {"weight": 3.0, "description": "The SNP rs35923643 alters the predicted affinity of RUNX3 to bind DNA, potentially affecting gene regulation.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RUNX3 BINDING MOTIF", "target": "SNP RS35923643 BINDING IMPACT ON RUNX3"}, {"weight": 1.0, "description": "The statistical model indicates no significant association between IgM anti-PC levels and incident CLL risk, suggesting that the relationship is complex or influenced by other factors.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "IGM ANTI-PC AND CLL PHENOTYPIC ASSOCIATION", "target": "STRATIFIED COX PROPORTIONAL HAZARDS MODEL"}]}